Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4266065939383522,-1.9955881544059493,0.0,0.33867742910631804,0.236,59/110,21.66%,DCP1A;EIF3E;RPS24;RPL11;SMG5;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;NCBP1;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;UPF3B;RPL36;RPL10;RPL32;RPS28;UPF1;RPS5;RPL15;RPS2;PYM1;RNPS1;RPL39;RPL12;RPL27;RPS17;UPF3A;SMG9;RPS26;RPS27;RPL10A;RPS10;SMG6;ETF1;RPL7A;EIF4A3;RPL31;NCBP2;PPP2CA;RBM8A;HELZ2;RPL36A
prerank,cellular response to copper ion (GO:0071280),-0.6907074303085385,-1.9662221148020271,0.0,0.26438689627009343,0.346,9/16,10.34%,HSF1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,response to copper ion (GO:0046688),-0.6144268466888427,-1.9160945523258088,0.0,0.338677429106318,0.562,9/20,10.34%,HSF1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,skeletal muscle contraction (GO:0003009),0.7749477491192751,1.8258953087525744,0.0,1.0,0.657,4/19,4.00%,TNNI3;TNNC1;TNNI1;MYH14
prerank,body fluid secretion (GO:0007589),0.7873428246409013,1.823437681262759,0.0,0.7384570562716429,0.678,6/15,10.20%,APLN;GUCA1B;SLC22A4;GPAT4;ZBTB7B;PRLR
prerank,clathrin-dependent endocytosis (GO:0072583),-0.5369405931915832,-1.8155970123923155,0.0,0.7693986433810467,0.89,13/26,15.94%,ITSN2;GAK;PICALM;INPP5F;AP2A2;CLTA;GPR107;SGIP1;CLTB;ITSN1;FNBP1L;AP2M1;PIP5K1C
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7992837205319134,1.804971023055211,0.002793296089385475,0.6909196972700291,0.801,4/15,2.19%,PLA2G5;MAPK9;LPL;NFKB1
prerank,sodium-independent organic anion transport (GO:0043252),-0.7192014686408328,-1.8002158962937533,0.0029069767441860465,0.7162481371680711,0.929,4/10,5.80%,SLCO3A1;SLC16A2;SLCO1C1;SLCO2A1
prerank,cytoplasmic translation (GO:0002181),-0.40004206220055016,-1.7996203556877652,0.0,0.5997868018689309,0.929,44/91,17.70%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;EIF4A2;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;FTSJ1;RPL39;RPL12;RPL27;RPS17;TMA7;RPS26;RPS27;RPL10A;RPS10;ETF1;RPL7A
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6201532318465616,-1.7958144073432214,0.007194244604316547,0.5332998964314694,0.936,6/15,17.60%,GRM7;GRM1;GRM3;DAGLB;HOMER3;GRIK3
prerank,gonad development (GO:0008406),0.6561564126329548,1.7856748903455542,0.001142857142857143,0.7394338513196212,0.892,8/41,8.35%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;NR2F2;WNT4;SOX9
prerank,negative regulation of vascular permeability (GO:0043116),-0.6825254493884146,-1.7826860743259467,0.0030959752321981426,0.5316416256092322,0.947,9/12,25.92%,FERMT2;ANGPT1;SLIT2;CLDN5;RAMP2;PTPRJ;VEGFA;PDE2A;CEACAM1
prerank,retina homeostasis (GO:0001895),-0.5408590565093225,-1.7642759888079427,0.01276595744680851,0.5640982125652544,0.97,8/23,17.73%,POTEF;ACTB;CCDC66;POC1B;WHRN;BBS4;ACTG1;HSPB1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5481328136157957,-1.7602428316163883,0.0045871559633027525,0.5271350307864465,0.974,12/22,18.68%,CYRIB;SLIT2;PRKCD;TMSB4X;KANK3;MYADM;KANK4;TWF2;PFN1;KANK1;TWF1;TMSB10
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.8343667999725775,1.7595508679842087,0.0,0.920336294205214,0.969,4/11,4.87%,MST1R;SIRT2;RAC1;NRP1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5381921248703125,-1.7482270960512831,0.0043859649122807015,0.5409900165226141,0.985,17/24,32.79%,SEC31A;TAPBP;ERAP1;SAR1B;CALR;SEC24C;TAP2;SEC24A;ACE;ABCB9;SEC13;IDE;MFSD6;TAP1;HFE;TAPBPL;FCER1G
prerank,regulation of phospholipase activity (GO:0010517),0.8395697156805001,1.7413787038599946,0.0,1.0,0.989,4/10,3.62%,PLA2G5;PDPK1;FGFR2;FGFR1
prerank,visual system development (GO:0150063),-0.47883162368333243,-1.7388329200650425,0.007194244604316547,0.5399719978574119,0.988,19/37,31.41%,HIPK2;SMOC1;RAB18;RBP4;TGFB2;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMG9;PBX2;PBX1;SOX2;ZDHHC16;FREM2;MEIS3;CHRDL1;C1QA
prerank,male gonad development (GO:0008584),0.6553763721742664,1.720546341203825,0.002386634844868735,1.0,0.999,7/34,8.35%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;WNT4;SOX9
prerank,myotube cell development (GO:0014904),0.8108259062500376,1.7182333928742695,0.004373177842565598,1.0,0.999,2/10,1.18%,MYORG;IGF1
prerank,development of primary male sexual characteristics (GO:0046546),0.6483588825967949,1.7027235546800639,0.0011918951132300357,1.0,1.0,7/34,8.35%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;WNT4;SOX9
prerank,neuron projection fasciculation (GO:0106030),0.8054098081125418,1.7019259585970956,0.0074850299401197605,1.0,1.0,2/10,1.72%,AMIGO1;EPHB2
prerank,positive regulation of cyclase activity (GO:0031281),-0.6240565577495222,-1.7012040526487422,0.010638297872340425,0.6988688586719951,0.998,4/14,6.90%,MAPK8;CACNA1D;NOS3;CACNA1C
prerank,regulation of spindle organization (GO:0090224),0.716993039706597,1.698801106016847,0.003973509933774834,1.0,1.0,5/18,11.26%,PSRC1;FSD1;RAE1;MAP9;GPSM2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.6016530846863202,-1.6972361410531107,0.0136986301369863,0.6700974847317863,0.998,7/15,20.22%,STAT3;APPL1;HIF1A;TLR4;IL17RA;GBP5;IL17D
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.6163459822983001,-1.691634798281724,0.025806451612903226,0.6547763629388814,0.999,3/13,3.43%,AXL;LAMP1;ZBTB1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.689138321777495,1.6909778378753746,0.010568031704095112,1.0,1.0,3/22,3.17%,IL10RA;OCIAD2;IL10RB
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.8181994463774163,1.6885563785420228,0.005943536404160475,0.9862624461356924,1.0,6/10,10.15%,SIRT7;SELENOS;USP7;OGT;ZNF692;SDHAF3
prerank,regulation of hormone secretion (GO:0046883),0.7406453913179634,1.6874543818178465,0.008391608391608392,0.9287925484777125,1.0,5/15,9.55%,EDN3;ANXA1;VAMP3;SNX6;SOX11
prerank,lipid catabolic process (GO:0016042),0.7077899432645919,1.6835368880441577,0.007936507936507936,0.9128475321707132,1.0,2/18,1.59%,LPL;SIRT2
prerank,positive regulation of heart contraction (GO:0045823),0.7087191214770314,1.681454928861942,0.007792207792207792,0.8801533879190042,1.0,5/19,7.53%,APLN;ADM;EDN3;ATP2A2;ATP1A2
prerank,respiratory tube development (GO:0030323),0.6575395514941689,1.681149118392283,0.006142506142506142,0.8313675028940554,1.0,6/28,6.59%,FGF9;STRA6;FGFR2;HECA;PCSK5;ZIC3
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3742177257724215,-1.6808329487093958,0.0,0.6742138981846338,0.999,43/91,17.70%,RPS24;SSR1;ARL6IP1;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;RPS26;RPS27;RPL10A;TRAM1;RPS10;RPL7A
prerank,histone methylation (GO:0016571),0.6580886324963543,1.6795081729206416,0.0049504950495049506,0.8005378082098232,1.0,15/26,19.80%,SIRT7;PRMT6;FBL;EZH2;EHMT2;PRMT5;NTMT1;NSD3;SUV39H1;PRMT1;EHMT1;PRMT8;NSD1;PRMT2;CARM1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.5551572877541833,-1.6793048119029268,0.016129032258064516,0.642715933300244,0.999,8/18,19.70%,MFHAS1;ENSA;URI1;INPP5K;PPP1R8;PTPA;SH3RF2;ZCCHC9
prerank,bicarbonate transport (GO:0015701),0.6720415094136716,1.6788440241293725,0.006211180124223602,0.7649333430984248,1.0,3/25,0.31%,CYB5R2;SLC4A4;SLC4A5
prerank,cellular response to zinc ion (GO:0071294),-0.5886788740563041,-1.6776154946967654,0.02888086642599278,0.614474962772825,1.0,9/15,15.35%,MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;GLRA2
prerank,regulation of glucose metabolic process (GO:0010906),0.6455363020302894,1.6657773819394415,0.0024183796856106408,0.8601657192497469,1.0,11/34,10.40%,GPLD1;SIRT7;SELENOS;PDK1;MLYCD;USP7;RORA;OGT;ZNF692;SDHAF3;IRS2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5989524111579109,-1.6641873110319154,0.010948905109489052,0.6496971598424935,1.0,8/13,15.99%,NR3C1;MED1;AR;ABHD2;BMP7;ESR1;PGR;BMP4
prerank,establishment of endothelial barrier (GO:0061028),-0.4730985289836784,-1.660669406357491,0.0,0.6350748049661376,1.0,14/29,23.91%,RDX;RAPGEF6;RAPGEF3;PECAM1;TJP1;EZR;F11R;RAB1A;MYADM;RAP2C;MSN;PDE2A;RAB1B;ROBO4
prerank,response to insulin (GO:0032868),0.5765125643671988,1.6603250265183398,0.0010695187165775401,0.8785108605317786,1.0,33/80,16.50%,CPEB1;GPLD1;SELENOS;PDPK1;PARP1;USF1;XBP1;ZFP36L1;SLC25A33;LPIN1;OGT;CAPN10;PIK3R1;ZBTB7B;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;RAB10;IRS2;DENND4C;PIK3R2;MYO5A;ENPP1;LPIN2;RAB13;ZBED3;PRKCI;RAB31;RAB8A;RAB8B;SLC27A1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6930747821841269,1.6589604266618887,0.01639344262295082,0.8539852705825384,1.0,8/17,15.32%,PPIF;PARP1;FIS1;FLCN;PID1;HDAC4;GIT1;NUPR1
prerank,lung development (GO:0030324),0.6292544023526978,1.658760688323271,0.008403361344537815,0.8185542502058686,1.0,8/33,9.55%,FGF9;STRA6;FGFR2;FGF10;ERRFI1;ZIC3;RCN3;SOX11
prerank,leukotriene biosynthetic process (GO:0019370),0.7452632616834876,1.6572000593028522,0.00851063829787234,0.800971939342258,1.0,2/14,0.56%,PLA2G5;ALOX5AP
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.7501363475228815,1.6552320842129313,0.005925925925925926,0.7872577368686418,1.0,4/13,7.49%,IGF1;IL33;ABCA2;SOAT1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.42126005509850617,-1.6512321443393179,0.0,0.653475758372421,1.0,11/49,9.78%,LRCH1;DAB2IP;RDX;SH3BP4;SLC39A14;CPEB2;URI1;CST3;LRRK2;F11R;ECM1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.7056771031685726,1.649968129362016,0.006868131868131868,0.8080724879602547,1.0,8/18,12.36%,HDAC3;TMEM119;XBP1;HDAC5;FRS2;HDAC4;SOX6;HDAC1
prerank,granulocyte differentiation (GO:0030851),-0.5652896950117736,-1.6489556271668628,0.019762845849802372,0.6358395604512164,1.0,11/18,29.51%,LEF1;LBR;PML;EP300;RARA;CBFA2T3;JAGN1;CDK2;CDK4;TAL1;CDKN1A
prerank,negative regulation of myotube differentiation (GO:0010832),0.763039647228235,1.6479609715693855,0.010309278350515464,0.7984033301420187,1.0,6/12,12.36%,HDAC3;TMEM119;XBP1;HDAC5;HDAC4;HDAC1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.7143749603299586,1.6450507285363445,0.010723860589812333,0.7973089579123392,1.0,5/16,5.73%,SFRP2;CDKN2D;CXCL12;SNAI1;FBH1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.7601117810434594,1.6421600430423693,0.019548872180451128,0.7967952984474541,1.0,3/11,0.80%,SFRP2;WNT2B;WNT5A
prerank,regulation of protein localization to centrosome (GO:1904779),-0.6683219425000764,-1.6398588841588535,0.020289855072463767,0.6518471752631139,1.0,5/10,16.60%,BICD1;UBXN2B;MARK4;NSFL1C;CEP250
prerank,positive regulation of transport (GO:0051050),0.5594626359111089,1.6359698080870417,0.0021208907741251328,0.8292013162288328,1.0,27/85,19.12%,PLA2G5;CALY;FCGR2B;BAX;GPLD1;TUB;CHCHD10;KCTD7;ANXA1;MLC1;ZNF205;CAPN10;CD151;SIRPA;ABCA7;CLIP3;CD47;LRP1;IL15RA;NUMA1;CAMK1D;ANXA2;FMR1;APOE;KMT2A;FLOT1;SMPD1
prerank,response to purine-containing compound (GO:0014074),-0.5553867962801975,-1.6357031044718473,0.024291497975708502,0.6448527500967877,1.0,12/17,37.98%,NDUFS4;STAT1;TRPC3;ABCC9;P2RX7;DGKQ;P2RY1;RYR2;TRPM2;P2RY6;VGF;P2RX4
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4633344949833136,-1.6347329604664553,0.005747126436781609,0.623079068928759,1.0,15/29,19.82%,SMAD4;CYRIB;TJP1;SLIT2;PRKCD;KANK3;MYADM;KANK4;SHANK3;PIK3CA;TWF2;PFN1;KANK1;TWF1;FKBP4
prerank,response to prostaglandin E (GO:0034695),0.7842824951838229,1.6341444062088877,0.011922503725782414,0.8211695401730366,1.0,3/10,6.64%,SFRP1;PTGER4;GNG2
prerank,negative regulation by host of viral process (GO:0044793),-0.655305245962228,-1.6337387550331524,0.02127659574468085,0.6032744230371473,1.0,6/10,26.41%,EIF2AK4;VAPA;CCNK;PSMC3;ZC3H12A;PRKN
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6971609552065996,1.6292590370691158,0.008141112618724558,0.8430657009410757,1.0,2/17,4.97%,PLA2G5;CRLS1
prerank,axonal fasciculation (GO:0007413),0.7393709705881276,1.6287239957113626,0.01911764705882353,0.822254231448211,1.0,2/12,1.72%,AMIGO1;EPHB2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.6879790446109285,1.625345451838372,0.009308510638297872,0.8287818689435243,1.0,1/17,0.14%,PLA2G5
prerank,triglyceride biosynthetic process (GO:0019432),0.678874010199073,1.625001043000811,0.019973368841544607,0.8080606805475867,1.0,7/18,12.41%,MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4999028866487336,-1.6239937266601772,0.021929824561403508,0.6275041302963894,1.0,9/21,22.71%,FOXP1;PRKCH;PTPRC;IKBKG;SLC39A10;NECTIN2;RAB29;CD81;BCL10
prerank,innate immune response in mucosa (GO:0002227),-0.647587559847161,-1.623798276458533,0.0313588850174216,0.6059126493769599,1.0,3/10,14.64%,RNASE3;DEFA6;RPL39
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6866020334484831,1.6223334873953765,0.017639077340569877,0.8100344267318351,1.0,4/17,4.87%,FGF9;VTN;IGF1;NRP1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5891885559745487,1.6214069224888945,0.0022624434389140274,0.7954279674483269,1.0,6/44,2.88%,CARMIL2;SPIRE2;CDC42EP5;CDC42EP4;BIN1;WHAMM
prerank,renal absorption (GO:0070293),0.7787755711045861,1.6200601508944061,0.0075528700906344415,0.7858830263642765,1.0,1/10,0.03%,MAGED2
prerank,response to organophosphorus (GO:0046683),-0.561373541121537,-1.6194335878750534,0.030303030303030304,0.605211668364071,1.0,11/16,37.98%,NDUFS4;STAT1;TRPC3;ABCC9;P2RX7;DGKQ;TRIM16;TYMS;RFC3;VGF;P2RX4
prerank,natural killer cell activation (GO:0030101),-0.5027142561553576,-1.619222832082162,0.0410958904109589,0.5857298677146258,1.0,8/23,22.72%,AXL;TOX;KAT7;ELF4;PTPRC;BAG6;PBX1;PIK3CD
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6589798408308423,1.6189014457824136,0.011568123393316195,0.7755502220679494,1.0,9/23,23.40%,TNNI3;TNNC1;FGFR2;TPM1;TGFB1;TGFBR3;SMAD7;ID2;FKBP1A
prerank,embryonic hemopoiesis (GO:0035162),-0.616205881127256,-1.6187236582749724,0.023972602739726026,0.5692318246540321,1.0,8/12,18.53%,KITLG;KIT;TGFBR2;KDR;THOC5;FLT3LG;SH2B3;ATF4
prerank,phagosome-lysosome fusion (GO:0090385),0.7666656273306536,1.6167810893606853,0.016793893129770993,0.7724251040650905,1.0,3/10,4.78%,PLA2G5;CLN3;RAB34
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6443903603286826,1.6158822282261185,0.021437578814627996,0.7612092336086999,1.0,5/23,10.20%,IL10RA;OCIAD2;IL10RB;PIBF1;PRLR
prerank,"wound healing, spreading of cells (GO:0044319)",0.6541925580896916,1.6151038031961193,0.011734028683181226,0.7492715728742604,1.0,6/24,5.68%,CARMIL2;MMP12;LCP1;DDR1;MRTFA;CD151
prerank,icosanoid biosynthetic process (GO:0046456),0.7609993461969035,1.6128101350034028,0.019374068554396422,0.7517914444847428,1.0,2/10,0.56%,PLA2G5;ALOX5AP
prerank,regulation of membrane repolarization (GO:0060306),-0.5952431449425062,-1.6122374951759482,0.019801980198019802,0.5771514051453938,1.0,5/13,13.21%,CAV1;CACNA2D1;KCNJ2;AKAP9;NEDD4L
prerank,cardiac conduction system development (GO:0003161),-0.4960327437303139,-1.6092425401505324,0.03153153153153153,0.5710174288588242,1.0,9/24,17.79%,SMAD4;GJA1;MAML1;SMAD1;BMPR1A;CACNA1G;TBX18;BMP4;NOTCH2
prerank,epiboly involved in wound healing (GO:0090505),0.6940432036768505,1.603882975479822,0.021917808219178082,0.8101404928607823,1.0,5/16,5.68%,CARMIL2;LCP1;DDR1;MRTFA;CD151
prerank,positive regulation of cellular respiration (GO:1901857),0.7334551336081778,1.6027885980327627,0.029455081001472753,0.8010804721253667,1.0,6/11,15.32%,IFNAR1;IL10RB;PRELID1;VCP;PARK7;NUPR1
prerank,B cell activation involved in immune response (GO:0002312),0.7186148208827845,1.600879155312066,0.022026431718061675,0.7999314402694115,1.0,4/13,8.82%,FCGR2B;EXOSC3;RNF8;RNF168
prerank,phospholipid metabolic process (GO:0006644),0.5546879422547218,1.5973884827995992,0.007502679528403001,0.8122986053241348,1.0,20/71,19.12%,PLA2G5;LPL;PIP4K2B;SMPD2;PCYT2;ABCA2;AGPAT1;AGPAT5;PLPPR2;AGPAT3;GPAM;FADS1;ENPP2;PLPP3;PIP4K2A;PLPPR5;GPX4;GDE1;PIP5K1A;SMPD1
prerank,protein kinase B signaling (GO:0043491),0.6506456802382414,1.5967111711509145,0.02617801047120419,0.8018266350092391,1.0,5/23,4.02%,IGF1;SIRT2;TSC2;THEM4;ZFP36L1
prerank,vacuolar acidification (GO:0007035),0.6534638753997847,1.595309066426863,0.018276762402088774,0.7974634510066623,1.0,7/21,12.68%,CLN3;ATP6AP2;CLN6;ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4
prerank,rRNA 3'-end processing (GO:0031125),0.7664972147565041,1.588028166872279,0.02472952086553323,0.8444197830763356,1.0,4/10,6.42%,EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,lipid phosphorylation (GO:0046834),-0.6343218015677956,-1.587095399894706,0.038922155688622756,0.6483070028130048,1.0,7/10,19.02%,DGKH;DGKB;DGKE;DGKZ;DGKD;DGKG;DGKQ
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5291784140889703,-1.5859386408212923,0.038461538461538464,0.6349031251633648,1.0,5/18,3.85%,SMAD4;IL6R;FER;STAT3;STAT1
prerank,negative regulation of bone remodeling (GO:0046851),0.7548884024570951,1.5856193406867778,0.024691358024691357,0.849045577978056,1.0,3/11,4.85%,TMEM119;SFRP1;TNFAIP3
prerank,regulation of cell division (GO:0051302),0.5529176492499301,1.5855254248967756,0.0021598272138228943,0.8337884960503005,1.0,28/72,21.79%,SFRP2;CCP110;FSD1;SIRT2;RAB11FIP4;MYO19;FGFR2;CALM3;FLCN;PLK5;ENTR1;ORC6;RACK1;GIT1;CSPP1;PRPF40A;KLHL13;TXNIP;PIK3C3;CALM1;PIK3R4;NCOA3;MLLT3;PRDM15;UVRAG;KLHL9;RAB11FIP3;CALM2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6388507795781097,1.5793409666950127,0.018300653594771243,0.8733837835593712,1.0,8/23,10.71%,SLC4A4;IGF1;NFKB1;ARNT;PRXL2C;EGF;ZBTB20;APP
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6359730746698946,1.5774576409694316,0.024081115335868188,0.8743762783181137,1.0,5/24,5.09%,SFRP2;CDKN2D;TAF9B;CXCL12;SNAI1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6897224119871936,1.5762240180456923,0.028493894165535955,0.8697205508099715,1.0,5/15,14.28%,CARMIL2;DDR1;DDR2;LRP1;TGFB1
prerank,actin-myosin filament sliding (GO:0033275),0.5942800663656372,1.5748632215511067,0.0166073546856465,0.8500344695591361,1.0,7/38,10.81%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;TPM1
prerank,muscle filament sliding (GO:0030049),0.5942800663656372,1.5748632215511067,0.0166073546856465,0.8500344695591361,1.0,7/38,10.81%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;TPM1
prerank,actin filament network formation (GO:0051639),0.7413732087831171,1.5724804177575626,0.025297619047619048,0.8566829396648862,1.0,3/11,0.97%,CARMIL2;SPIRE2;LCP1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5230881013864757,-1.572036906276939,0.024896265560165973,0.6817552369958273,1.0,14/19,27.22%,HIPK2;PML;USP28;SIRT1;HIPK1;TP53;EP300;MSH2;TMEM109;BAG6;DYRK2;DDIT4;BCL3;RPS27L
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.463372794829963,-1.5707114772776563,0.028985507246376812,0.670799811197675,1.0,9/27,10.78%,MAPK8;KAT7;IKBKB;CUL1;TAOK2;SKP1;MAP3K8;UBB;IKBKG
prerank,pancreas development (GO:0031016),0.7073452745950373,1.5687428770460723,0.032624113475177303,0.8746454641474058,1.0,4/12,8.62%,NKX6-1;TCF7L2;ZIC3;SELENOT
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6288533501621627,1.5685738497897916,0.020075282308657464,0.8616309118217145,1.0,4/27,2.19%,PLA2G5;MAPK9;LPL;NFKB1
prerank,regulation of gluconeogenesis (GO:0006111),0.6332726895018121,1.5674468137814737,0.009987515605493134,0.8572257262856678,1.0,9/27,10.15%,SIRT7;SELENOS;USP7;OGT;ZNF692;DDB1;SIK1;NNMT;SDHAF3
prerank,regulation of lysosomal lumen pH (GO:0035751),0.7197166554707023,1.5673614316609485,0.019886363636363636,0.8439981857298212,1.0,3/12,2.20%,CLN3;ATP6AP2;CLN6
prerank,female gonad development (GO:0008585),0.6505043194030216,1.566858114564909,0.023809523809523808,0.8346326067892584,1.0,2/19,2.96%,FSHR;NR2F2
prerank,lung epithelium development (GO:0060428),0.761582993277932,1.5666439135706958,0.01059001512859304,0.8235450624041332,1.0,4/10,7.81%,STRA6;FGF10;ERRFI1;RCN3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6892098658245346,1.5656692172318047,0.028112449799196786,0.8196963490311971,1.0,4/16,11.52%,MYORG;IGF1;IGFBP3;BMP5
prerank,vesicle transport along actin filament (GO:0030050),0.6538174668564051,1.5652990704980299,0.018300653594771243,0.8100146934985426,1.0,3/19,5.26%,MYO1A;MYO19;MYO1B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.6908667971888491,1.5630120204742641,0.03840682788051209,0.8163819746514094,1.0,7/14,16.50%,PCYT2;LPIN1;CEPT1;LPIN3;LPIN2;CHKB;SLC27A1
prerank,phagolysosome assembly (GO:0001845),0.7059224099323298,1.5630113606853993,0.03056768558951965,0.8043763573771239,1.0,3/12,4.78%,PLA2G5;CLN3;RAB34
prerank,regulation of stem cell population maintenance (GO:2000036),-0.5108577870108447,-1.5625633640333048,0.028225806451612902,0.6909249555418535,1.0,8/18,25.65%,CNOT1;WDR43;REST;TAF5L;CNOT2;ELAVL1;TAF6L;HMGA2
prerank,negative regulation of GTPase activity (GO:0034260),-0.5093645717996987,-1.5605935218900266,0.01834862385321101,0.6826213062417499,1.0,7/22,8.37%,LRCH1;DAB2IP;RDX;SH3BP4;CPEB2;LRRK2;F11R
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5496518845055877,1.5595444829235812,0.0075107296137339056,0.8195168888038762,1.0,19/72,14.97%,FGF20;FGF9;FGFRL1;FGFR2;FGFR1;FGF10;POLR2B;TIA1;FLRT2;FRS2;FLRT1;HNRNPM;KL;RBFOX2;POLR2K;TIAL1;SETX;FGFBP1;CBL
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6077425663592368,-1.5560973212040472,0.05732484076433121,0.686231484378729,1.0,6/11,23.57%,RAPGEF6;TJP1;F11R;RAB1A;RAP2C;RAB1B
prerank,regulation of myotube differentiation (GO:0010830),0.630025360784191,1.55509215456205,0.02053915275994865,0.8429183095454431,1.0,8/24,12.36%,HDAC3;TMEM119;DMPK;XBP1;HDAC5;SIK1;HDAC4;HDAC1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.6524752322958224,1.5542614423808934,0.025065963060686015,0.8381314241956322,1.0,9/19,11.98%,CAMK2B;CUL7;CDKL5;OBSL1;DBN1;LRP8;DHX36;DBNL;IL1RAPL1
prerank,tRNA aminoacylation (GO:0043039),0.5813207540164996,1.5534511862374931,0.02026221692491061,0.8322836472691201,1.0,17/37,12.81%,FARSB;YARS1;AIMP2;WARS1;YARS2;GATB;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;AARS1;EPRS1;SARS1;NARS1;HARS1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6272075721828054,1.5522211897954763,0.03713188220230474,0.8310518745183589,1.0,5/21,7.92%,SFRP1;STK36;DCDC2;RAB34;TUBD1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.670817867596827,1.5520078603626004,0.02510460251046025,0.8214186356843998,1.0,7/16,15.32%,PPIF;SLC25A33;COX7A2;VCP;AK4;UQCC2;NUPR1
prerank,regulation of catecholamine secretion (GO:0050433),0.6096852272052871,1.550038770185162,0.01591187270501836,0.8252485522680137,1.0,3/29,0.87%,FGF20;SYT3;SYT10
prerank,response to hexose (GO:0009746),0.6200729307387782,1.5495299861805925,0.0266497461928934,0.8182072309125078,1.0,7/25,13.32%,LPL;GPLD1;SELENOS;TCF7L2;SELENOT;IRS2;ZBED3
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.7202518359992487,1.5482923152116956,0.0345821325648415,0.8165752888099643,1.0,3/11,3.32%,EXOSC3;EXOSC2;FBL
prerank,acylglycerol metabolic process (GO:0006639),-0.42142543172835234,-1.5482719305273012,0.006896551724137931,0.7061597599328507,1.0,13/37,12.91%,DGKH;CAV1;DGKB;GK5;MGLL;DGKE;DGKZ;ABHD6;ABHD2;DGKD;DGKG;LMF1;PGS1
prerank,fatty acid metabolic process (GO:0006631),0.5194341916626937,1.547731182166763,0.005128205128205128,0.8102640153114882,1.0,26/115,15.47%,SLC27A6;FASN;ALOX5AP;NDUFAB1;LPL;MLYCD;SLC27A4;THEM4;PON2;XBP1;LPIN1;PON3;ACOT11;SGPL1;LPIN3;MSMO1;GPAM;ELOVL4;CROT;CPT2;ACADSB;LPIN2;MECR;PTGS2;ACSL6;ABCD2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3692659620550782,-1.5472099423894918,0.0,0.6944448022159271,1.0,29/63,23.88%,ANO4;GABRB1;SLC12A7;SLC26A2;GABRG2;CLCN3;SLC25A3;SLC37A3;ANO6;ANO1;SLC20A1;SLC25A14;GABRA5;SLC12A4;SLC5A6;SLC5A5;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;GABRA1;SLC25A30;GLRA3;SLC25A11;SLC12A8
prerank,substantia nigra development (GO:0021762),0.5725305380273961,1.5471350424572199,0.01527614571092832,0.8051511384082921,1.0,8/37,8.88%,FGF9;NDRG2;SIRT2;INA;CALM3;ATP5PF;SEC16A;YWHAH
prerank,regulation of mitotic spindle organization (GO:0060236),0.5873072663320866,1.5468147644698815,0.02494061757719715,0.7976264163029322,1.0,14/35,21.48%,PSRC1;FSD1;RAE1;CEP97;DRG1;CHMP3;MAP9;GPSM2;VPS4B;NUMA1;EML3;HNRNPU;TPR;CHMP4B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.49765401382696883,-1.5464407403027036,0.05220883534136546,0.6818265181918343,1.0,10/18,22.86%,PREPL;RIMS2;SYN1;LRRK2;DTNBP1;NLGN1;SLC4A8;RAB5A;RAB3GAP1;SNAPIN
prerank,small GTPase mediated signal transduction (GO:0007264),-0.34725436996785125,-1.545548119872343,0.0,0.6703528761739276,1.0,35/103,16.21%,RAPGEF5;RAPGEF6;KRAS;ARHGEF18;RALBP1;RB1;RAB18;ARHGAP18;RREB1;PLCE1;ABR;USP28;PRKD1;TIAM2;NRAS;TNK2;RRAGC;RHEB;NUCB1;RGL1;USP8;RASGRP3;RALB;ARL3;TP53;RIT1;PLD2;SHC3;ARHGAP1;ARHGAP31;JUN;RGL2;ARFIP2;PLK2;DNMT1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.45880939509664015,-1.5449059701887848,0.014778325123152709,0.6581267203020837,1.0,8/26,13.21%,CACNA1D;CAB39;ATP1B3;AKAP9;ACTN2;VAMP2;ATP1B1;NEDD4L
prerank,digestive tract morphogenesis (GO:0048546),0.6928937445890628,1.5446668795092717,0.0319001386962552,0.8038540876937004,1.0,6/14,11.29%,STRA6;FGFR2;NIPBL;BBS7;SOX11;PDGFRA
prerank,mucosal immune response (GO:0002385),-0.5407310867723619,-1.544305491568289,0.05555555555555555,0.646574637446732,1.0,3/15,14.64%,RNASE3;DEFA6;RPL39
prerank,acidic amino acid transport (GO:0015800),-0.4956492541490022,-1.5406715964988291,0.036101083032490974,0.6482290642064441,1.0,5/17,5.58%,SLC6A6;GJA1;ARL6IP5;SLC25A13;LRRC8D
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6531721646722005,1.5406242329649715,0.03146374829001368,0.824986802960848,1.0,4/18,4.44%,BAX;CHCHD10;FZD9;ZNF205
prerank,positive regulation of double-strand break repair (GO:2000781),0.5702270933947852,1.540105979529659,0.018779342723004695,0.8189543831170887,1.0,10/39,9.77%,SPIRE2;KDM4D;FOXM1;PARP1;ACTR2;MGMT;SLF2;FUS;WRAP53;MRNIP
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5678580119599991,1.5394673832100367,0.018433179723502304,0.814135415465014,1.0,18/42,12.81%,FARSB;YARS1;AIMP2;WARS1;YARS2;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;EARS2;AARS1;EPRS1;SARS1;TARS2;NARS1;HARS1
prerank,mitochondrial fusion (GO:0008053),0.6566441338914644,1.5390918425493187,0.02571041948579161,0.80754519542983,1.0,8/18,13.20%,BAX;FIS1;USP30;MIEF2;MFN1;MFN2;AFG3L2;GDAP1
prerank,regulation of dopamine secretion (GO:0014059),0.6231266739941157,1.5390356738992956,0.02402022756005057,0.7985299517223122,1.0,3/25,0.87%,FGF20;SYT3;SYT10
prerank,positive regulation of integrin activation (GO:0033625),-0.6043610031629592,-1.5374800883410458,0.04938271604938271,0.6466735964898324,1.0,5/11,18.46%,FERMT2;PLEK;RASIP1;SRC;P2RY12
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.72893334193021,1.5350967433905134,0.028315946348733235,0.8183746097372749,1.0,1/11,0.14%,PLA2G5
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.46819024722120617,-1.5338239051235685,0.030303030303030304,0.6484591407589304,1.0,6/23,21.26%,LAMP1;CADM1;LGALS9;NECTIN2;PIK3R6;PVR
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.34531297693037183,-1.5334788670330923,0.0,0.6366480162497282,1.0,23/87,10.84%,PARD3;SMAD4;FERMT2;ARHGEF18;PTPRK;PXN;FMOD;TWSG1;FNTA;NLK;APPL1;SIRT1;CLDN5;SMAD1;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2;F11R;UBB;ZFYVE9;DUSP22
prerank,endothelial cell proliferation (GO:0001935),-0.5079807245046927,-1.53286296118926,0.05429864253393665,0.6268424370973483,1.0,8/17,23.62%,BMPER;ERN1;TEK;CD34;PRKX;BMP4;DLG1;SEMA5A
prerank,neural tube development (GO:0021915),0.6617925093393329,1.530400371818445,0.03221288515406162,0.8441951202153006,1.0,8/15,19.15%,ARL13B;ALDH1A2;DVL1;PTCH1;SOX11;TGFB1;PKD2;SOX4
prerank,neurotransmitter uptake (GO:0001504),0.7158190293876316,1.5293782793059993,0.0380818053596615,0.8423704890161275,1.0,5/12,13.89%,SLC29A1;ATP1A2;GLUL;SNAP25;SLC1A3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6949453108875236,1.529228084142043,0.05475504322766571,0.8342263840867659,1.0,4/12,6.18%,GMPS;ADSL;PAICS;GART
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3499075753846729,-1.5284906619571428,0.0,0.6314905388739825,1.0,46/87,22.59%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;RPS26;RPS27;RPL10A;RPS10;RPL7A;SEC61A1;RPL31;RPL36A;SEC61B;SRP14;RPL29
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.6019483867357166,1.5282928712203425,0.03132832080200501,0.8319073605320784,1.0,8/29,6.42%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;DCP1B;EXOSC8
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4974668368787671,-1.5280858730778564,0.03985507246376811,0.621348371609966,1.0,7/18,9.67%,SMAD4;CD46;HIF1A;TGFB2;LGALS9;CD34;FN1
prerank,lipoxygenase pathway (GO:0019372),0.6783603768299867,1.5269706226559576,0.03276353276353276,0.8330681505383298,1.0,5/14,17.74%,ALOX5AP;PON2;PON3;PTGS2;GPX4
prerank,nucleoside salvage (GO:0043174),0.7366232402012409,1.5266287052211758,0.0475482912332838,0.8267677311469339,1.0,6/10,13.10%,DCK;TK1;TK2;UPP2;UCKL1;HPRT1
prerank,GPI anchor metabolic process (GO:0006505),0.6069398056733737,1.5258910197986089,0.03291139240506329,0.823781142856221,1.0,8/26,10.68%,PIGG;GPLD1;PGAP4;DPM2;PIGM;PIGU;PIGA;PGAP1
prerank,regulation of histone deacetylation (GO:0031063),0.694862375804961,1.5244537147953716,0.03212290502793296,0.825905918198548,1.0,7/13,16.05%,PRMT6;NIPBL;AKAP8L;ZBTB7B;CAMK2D;SAP30BP;CTBP1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5931080797638568,1.5236154041772814,0.026862026862026864,0.8238146985371687,1.0,10/30,10.18%,SFRP2;SFRP1;SH3BP5;NTF3;THY1;DMTN;PIBF1;SH3BP5L;MVP;SRCIN1
prerank,leukotriene metabolic process (GO:0006691),0.6306788624651207,1.5167770987926499,0.037275064267352186,0.8666991690139568,1.0,2/19,0.56%,PLA2G5;ALOX5AP
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.5164516081851105,1.5160263345850444,0.005175983436853002,0.8638556123799671,1.0,33/102,15.66%,CPEB1;GPLD1;SELENOS;PDPK1;NFKB1;ADCY7;PARP1;USF1;XBP1;ZFP36L1;SLC25A33;LPIN1;CAPN10;PIK3R1;SLC30A10;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;RAB10;IRS2;DENND4C;PIK3R2;MYO5A;ENPP1;LPIN2;RAB13;PRKCI;ADCY1;RAB31;RAB8A;RAB8B
prerank,purine-containing compound biosynthetic process (GO:0072522),0.6046509928793883,1.5150405059864502,0.048366013071895426,0.8626876264645275,1.0,6/25,6.18%,GMPS;ADSL;PRPSAP2;DCK;PAICS;GART
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.5816924867195332,1.5138620679459567,0.04059040590405904,0.8628812094831266,1.0,6/30,15.47%,SLC27A6;ELOVL1;SLC27A4;ELOVL4;ACSL6;ABCD2
prerank,somite development (GO:0061053),0.7000624023622454,1.5129335345555748,0.048104956268221574,0.8614558624121262,1.0,3/11,9.55%,SFRP2;PTCH1;SOX11
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.703780685165993,1.5124379275805235,0.05807365439093484,0.856879091205961,1.0,1/12,0.02%,DPYSL4
prerank,megakaryocyte differentiation (GO:0030219),-0.5867932231403025,-1.5119564126899658,0.044642857142857144,0.6762421187502198,1.0,3/11,4.62%,MED1;KIT;UBA5
prerank,epidermis development (GO:0008544),0.5431681519260183,1.511499664527384,0.014755959137343927,0.8553215744875396,1.0,8/56,5.53%,ATP2C1;EDAR;FGFR2;SCEL;PTHLH;EDA2R;ATP2A2;PLOD1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5015566831341893,-1.5075922690998402,0.047619047619047616,0.6823605304786062,1.0,8/17,25.22%,CAV1;ADIPOR1;PRKAB2;PPARD;PRKAA2;ADIPOR2;PPARG;PPARA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3092079739729826,-1.5068036342071311,0.0,0.6738627349516896,1.0,76/168,23.01%,CNOT1;DCP1A;EIF3E;CSDE1;RPS24;PATL1;RPL11;SMG5;RPS15A;RPS23;RPL5;RPL37A;DCPS;RPL6;RPL18A;RPL24;RPS19;NCBP1;RPS20;RPL38;TENT2;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;LSM1;RC3H1;RPL28;RPL22;RPL34;RPS13;RPLP0;PARN;UPF3B;RPL36;RPL10;ERI1;CNOT8;RPL32;RPS28;UPF1;RPS5;RPL15;RPS2;PYM1;RNPS1;RPL39;RPL12;RPL27;RPS17;UPF3A;SMG9;RPS26;RPS27;RPL10A;RPS10;CNOT7;SMG6;ETF1;RPL7A;EXOSC9;EIF4A3;RPL31;NCBP2;PPP2CA;TUT1;RBM8A;HELZ2;RPL36A;TUT4;CNOT2;RPL29;CNOT11
prerank,DNA modification (GO:0006304),0.6159401757682121,1.5065984695015897,0.056338028169014086,0.8845160927246384,1.0,5/22,4.96%,EXOSC3;PARP1;NTHL1;MPG;PARP2
prerank,regulation of immunoglobulin production (GO:0002637),0.6128034867845411,1.5032459684456112,0.03741935483870968,0.9014050758943953,1.0,4/23,6.58%,FCGR2B;EPHB2;XBP1;VAMP3
prerank,positive regulation of receptor internalization (GO:0002092),0.6128458411951444,1.502273440774301,0.029224904701397714,0.9009091308075915,1.0,9/22,16.78%,APLN;NTF3;PICK1;CD63;ARRB1;EGF;MAGI2;AHI1;FMR1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.49975716953970445,-1.5017282806278853,0.04054054054054054,0.683239067082791,1.0,16/19,25.30%,MORC3;TAPT1;HK1;PML;SKP1;ARL2BP;TAF8;BBS4;TAF3;PINK1;HSPA5;HK2;AKT1;SUPT7L;ARL2;BCL3
prerank,autophagosome maturation (GO:0097352),0.5796789199981114,1.5016896805890787,0.0380952380952381,0.8973003631391524,1.0,15/32,16.15%,UBQLN1;CLN3;VPS16;ATP2A2;SNX14;LIX1L;ATG14;CHMP3;VCP;VPS33B;VTI1B;MAP1LC3B;VMP1;STX17;VAMP8
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6185637991311607,1.4965353506383845,0.04041720990873533,0.929239600179565,1.0,8/21,15.68%,PTGER4;IGF1;ZFP36L1;FGF10;SOX9;EGF;MAP2K2;CTSH
prerank,actin filament-based transport (GO:0099515),0.6107943734804597,1.4957320420983031,0.03571428571428571,0.926996423376384,1.0,3/21,5.26%,MYO1A;MYO19;MYO1B
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6472011272110969,1.4953234291845565,0.048209366391184574,0.9216594074974757,1.0,6/16,14.83%,SP7;SOX9;DHX36;NUDT21;SOX6;SOX5
prerank,snRNA 3'-end processing (GO:0034472),0.6329054251344531,1.4946377160902347,0.04221635883905013,0.9185569432259237,1.0,6/19,6.42%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1;EXOSC8
prerank,protein deacylation (GO:0035601),0.6040541853377873,1.4944648454810499,0.045572916666666664,0.9117422420598759,1.0,8/23,12.36%,HDAC3;SIRT2;SIRT7;ABHD10;LYPLAL1;HDAC5;HDAC4;HDAC1
prerank,organelle fusion (GO:0048284),0.6106072999493498,1.4938792285470253,0.04187817258883249,0.9078661655661558,1.0,9/22,16.00%,BAX;FIS1;USP30;MIEF2;MFN1;MFN2;AFG3L2;GDAP1;VPS18
prerank,cardiac muscle contraction (GO:0060048),0.5622561657253669,1.4932460227241071,0.04404761904761905,0.9050177487071814,1.0,8/34,14.61%,TNNI3;TNNC1;TNNI1;ATP1A2;SCN2B;TPM1;CAMK2D;GRK2
prerank,sensory perception of taste (GO:0050909),0.7043659733879408,1.492495066088116,0.05015197568389058,0.9029238607412519,1.0,1/10,1.86%,ASIC1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5164557388459852,1.4906210376358526,0.011578947368421053,0.9091435702588965,1.0,23/87,16.76%,FGF20;FGF9;SFRP1;FGFRL1;FGFR2;FGFR1;ZFP36L1;FGF10;POLR2B;TIA1;FLRT2;FRS2;FLRT1;HNRNPM;KL;RBFOX2;POLR2K;TIAL1;SETX;FGFBP1;CBL;NDNF;ITGB1BP1
prerank,diterpenoid metabolic process (GO:0016101),0.5337761063212413,1.4901861843562245,0.024719101123595506,0.9047209313185582,1.0,15/55,17.19%,LPL;RDH10;STRA6;GPC6;RDH11;GPC1;LRP8;RDH5;RBP1;AKR1B10;GPC4;LRP1;HSPG2;ALDH3A2;APOE
prerank,regulation of lamellipodium organization (GO:1902743),0.6705034260920152,1.4900102975214733,0.06051873198847262,0.898278937554001,1.0,3/14,6.44%,CARMIL2;RAC1;DMTN
prerank,regulation of neuroinflammatory response (GO:0150077),0.6113515526543841,1.489617589111765,0.04922279792746114,0.8937674689002025,1.0,5/19,15.32%,IGF1;IL33;CD200R1;PTGS2;NUPR1
prerank,diacylglycerol metabolic process (GO:0046339),-0.45708280132257656,-1.488383357568912,0.0502092050209205,0.7278927637906255,1.0,11/23,21.92%,DGKH;PLCE1;DGKB;DGKE;DGKZ;DGKD;DGKG;PGS1;DGKQ;DGAT1;LIPE
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5963530551417109,-1.487723454057795,0.06358381502890173,0.7177035798103761,1.0,4/10,9.08%,KAT7;SIRT1;KAT2B;EP300
prerank,regulation of protein kinase A signaling (GO:0010738),0.6309781386319466,1.4854613040071616,0.03689567430025445,0.9169989111246214,1.0,3/20,7.66%,FSHR;TCIM;ADGRV1
prerank,ovarian follicle development (GO:0001541),-0.5384853779640192,-1.4853345087892154,0.07947019867549669,0.7160114271369754,1.0,12/13,44.45%,KIT;CEBPB;VEGFA;EIF2B5;INHBA;EIF2B2;EIF2B4;INHBB;INHA;FOXL2;ANG;LHCGR
prerank,protein localization to mitochondrion (GO:0070585),-0.5922176105118762,-1.4846541286473196,0.07058823529411765,0.7069062996735257,1.0,9/11,21.98%,HK1;LRRK2;PINK1;RALA;HK2;COX18;MAIP1;AKT1;DNAJA1
prerank,positive regulation of cell killing (GO:0031343),0.6690203734180233,1.4838357634972852,0.05049088359046283,0.9214890738155557,1.0,3/13,2.78%,WNT5A;DVL2;RAC1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.43730865495885085,-1.482183791535144,0.043478260869565216,0.7050728392732104,1.0,8/27,9.22%,EGFR;PUM1;EIF4ENIF1;STAT3;RIPK1;AGO2;TP53;LIMD1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.7054606223207024,1.4807736871462092,0.04961240310077519,0.9289717977431953,1.0,2/10,1.42%,CDC42EP5;CDC42EP4
prerank,regulation of pseudopodium assembly (GO:0031272),0.7054606223207024,1.4807736871462092,0.04961240310077519,0.9289717977431953,1.0,2/10,1.42%,CDC42EP5;CDC42EP4
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.6144798346481954,-1.4792431912595316,0.04747774480712166,0.7055172824250611,1.0,6/10,28.14%,HK1;GFPT1;HK2;GFPT2;PFKM;PFKL
prerank,response to cadmium ion (GO:0046686),-0.4476424397468714,-1.4790305983788363,0.039603960396039604,0.6952446740243003,1.0,12/26,13.89%,MAPK8;EGFR;HSF1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;JUN
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6324903488187347,1.478891885032013,0.07866666666666666,0.936762205770089,1.0,1/16,0.02%,DPYSL4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6701254189450842,1.4776309863034496,0.05309734513274336,0.9389188431979546,1.0,3/13,3.62%,APLN;PDPK1;FGFR1
prerank,histone H3 deacetylation (GO:0070932),0.6511818980722807,1.4772892393080748,0.047075606276747506,0.9339866173836291,1.0,6/15,12.36%,HDAC3;SIRT2;SIRT7;PER1;HDAC4;HDAC1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6139668208408542,1.4764763003652872,0.05652759084791386,0.9325546927344931,1.0,4/19,12.83%,IGF1;TNFAIP3;CARD16;GIT1
prerank,regulation of osteoblast proliferation (GO:0033688),0.6267800525273222,1.4758728864950255,0.060209424083769635,0.9294968002645363,1.0,4/17,4.87%,TMEM119;SFRP1;FGFR2;NELL1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.57577159090013,1.4753922785812579,0.044444444444444446,0.9256609630248915,1.0,8/31,6.42%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;DCP1B;EXOSC8
prerank,dicarboxylic acid transport (GO:0006835),-0.4229180023787227,-1.4750882029476282,0.027472527472527472,0.7005160243321648,1.0,7/28,14.41%,GJA1;ARL6IP5;SLC26A7;SLC25A13;SLC25A32;SLC22A6;GIPC1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6508123182302719,1.4747159903546085,0.0535966149506347,0.9234845797829291,1.0,5/15,8.95%,AATK;DDR1;ABL1;SRMS;TEC
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5267930150899777,1.4723955250279113,0.019823788546255508,0.9339502819807782,1.0,17/61,14.52%,IGF1;RAC1;FGF10;RASGEF1A;ARRB1;GPR4;RAPGEF1;PRAG1;IRS2;PIK3CB;ADGRG1;ROBO1;ALS2;AKAP13;LPAR1;AUTS2;LPAR6
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.6375658541811315,1.4717475459177463,0.06648575305291723,0.9317366764091192,1.0,4/16,6.18%,GMPS;ADSL;PAICS;GART
prerank,regulation of wound healing (GO:0061041),0.5470039337367154,1.4708183455734851,0.03841676367869616,0.9319285746843798,1.0,7/42,6.44%,VTN;EPHB2;AJAP1;CASK;ANXA1;TNFAIP3;DMTN
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.5867175380915697,1.4704371664021303,0.042821158690176324,0.9279261375183115,1.0,6/26,6.55%,SIRT2;TNFAIP3;PPM1B;CARD16;DHX58;TRAFD1
prerank,regulation of nuclear division (GO:0051783),0.6089930209322105,1.4702120297865626,0.0492676431424767,0.9227167799147318,1.0,6/20,12.64%,CUL7;OBSL1;CDK13;FBXO5;PRMT5;RCC1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5629402302196512,-1.4699216175478886,0.07120743034055728,0.7109743038878525,1.0,3/11,3.57%,SMAD4;LMNA;GLRX3
prerank,regulation of double-strand break repair (GO:2000779),0.5415086055498577,1.4690487304869648,0.04280618311533888,0.9245293305949918,1.0,14/39,19.07%,SPIRE2;FOXM1;SIRT7;ACTR2;MGMT;SLF2;WRAP53;MRNIP;TWIST1;SPIRE1;UBR5;TERF2IP;FMN2;PPP4C
prerank,xenobiotic transport (GO:0042908),-0.5076387120408324,-1.468650023984013,0.07916666666666666,0.7052708793310767,1.0,4/16,4.18%,ABCG2;GJA1;ABCC1;SLC47A1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5733992370068802,1.4685262456767776,0.04881101376720901,0.9217522905302398,1.0,3/29,2.97%,TNNI3;TNNC1;FGFR2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6221767861036644,1.468420480779242,0.05488621151271754,0.9159435477793056,1.0,4/18,8.86%,ZFP36L1;PRELID1;ABL1;XRCC6
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.6470688974555044,1.467323810005798,0.06789250353606789,0.9174424510342969,1.0,4/14,6.18%,GMPS;ADSL;PAICS;GART
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.70497040497433,1.4662646730629227,0.05224963715529753,0.9189199413856455,1.0,4/10,13.34%,CBARP;BIN1;ATP1A2;VDAC1
prerank,cellular response to insulin stimulus (GO:0032869),0.49159714370756,1.4662530821560527,0.007157464212678937,0.9124720549253201,1.0,42/124,16.91%,CPEB1;GPLD1;SELENOS;PDPK1;PARP1;USF1;SLC27A4;ATP6V0A2;XBP1;ZFP36L1;SLC25A33;LPIN1;CAPN10;PIK3R1;GAB1;ATP6V0E2;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;BAIAP2;RAB10;IRS2;DENND4C;ATP6V1G1;PIK3R2;TCIRG1;MYO5A;ENPP1;LPIN2;ATP6V0A4;RAB13;PRKCI;ATP6V1D;RAB31;FOXC2;RAB8A;RAB8B;ATP6V1B2;SLC27A1;PHIP
prerank,glycolipid biosynthetic process (GO:0009247),0.5538219252816653,1.4641149539327152,0.03985932004689332,0.9220188580695488,1.0,10/38,10.42%,PIGG;A4GALT;PGAP4;ST8SIA3;DPM2;ST3GAL2;PIGM;PIGU;ST3GAL5;PIGA
prerank,arachidonate transport (GO:1903963),0.7009981463806514,1.463223661099175,0.07634730538922156,0.9155215086145542,1.0,3/10,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),0.7009981463806514,1.463223661099175,0.07634730538922156,0.9155215086145542,1.0,3/10,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,pseudouridine synthesis (GO:0001522),0.6639117765905889,1.4620966595480598,0.04428571428571428,0.9171229753232438,1.0,4/13,9.92%,NHP2;TRUB2;PUS10;PUS7
prerank,protein K11-linked ubiquitination (GO:0070979),0.5782436585661308,1.4615050104549667,0.04791154791154791,0.9151030812837848,1.0,13/27,18.58%,CDC23;UBE2S;UBE2E2;CDC16;FZR1;ANAPC2;UBE2A;ANAPC11;ANAPC4;CDC26;UBE2L3;ANAPC10;ANAPC5
prerank,urogenital system development (GO:0001655),0.6807732131101215,1.4605156232659724,0.06743185078909612,0.915888222061563,1.0,3/11,8.35%,EPHB2;ANXA1;SOX9
prerank,ncRNA catabolic process (GO:0034661),0.5751542500471394,1.4593751501730199,0.053217821782178217,0.9178309469064804,1.0,11/28,16.21%,EXOSC3;EXOSC7;EXOSC2;ZCCHC8;EXOSC8;LIN28B;MTREX;SND1;XRN1;DIS3L2;NUDT16L1
prerank,regulation of actomyosin structure organization (GO:0110020),0.6643497944481224,1.4584983799700093,0.07092198581560284,0.9178661171979776,1.0,5/13,14.18%,PTGER4;RAC1;ALMS1;AKAP13;ROCK2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.678769714267646,1.4582544888099167,0.0662739322533137,0.9134661690344329,1.0,5/12,10.28%,DCK;TK1;TK2;UPP2;UCKL1
prerank,regulation of B cell activation (GO:0050864),0.5883380521391446,1.4574228168319214,0.06700379266750948,0.9133098387011472,1.0,3/25,4.85%,FCGR2B;ZFP36L1;TNFAIP3
prerank,actin nucleation (GO:0045010),0.5962283681107322,1.4559980794779386,0.0607661822985469,0.9174933065129403,1.0,4/21,3.87%,SPIRE2;WHAMM;ACTR2;ARPC1A
prerank,cellular senescence (GO:0090398),-0.4365365404522292,-1.4541457736149896,0.028901734104046242,0.7564974111432679,1.0,16/27,38.22%,SMC5;PRKCD;PML;SIRT1;CALR;TBX3;TBX2;HMGA2;NSMCE2;ECRG4;KAT6A;CDKN1A;SMC6;ULK3;HRAS;SRF
prerank,P-body assembly (GO:0033962),-0.5661369490197407,-1.4541341052922974,0.08282208588957055,0.7455970143345728,1.0,4/12,10.42%,EIF4ENIF1;PATL1;LIMD1;RC3H1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5532868636391829,-1.4533410998905827,0.07432432432432433,0.7381763301585954,1.0,7/13,21.33%,CNOT1;TNRC6A;EIF4ENIF1;AGO2;CPEB3;CNOT7;BTG2
prerank,negative regulation of protein processing (GO:0010955),-0.5444821677022574,-1.4532694838359648,0.08157099697885196,0.7280564542555855,1.0,4/12,7.45%,TMEM59;SERPINE2;THBS1;LRRK2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6307112967108968,1.45234133495729,0.08089260808926081,0.9375891761506829,1.0,6/14,13.47%,PARP1;ACTR2;FUS;WRAP53;MRNIP;MMS19
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.6894628374253261,1.4518250945568354,0.08497723823975721,0.9233593496485728,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.6894628374253261,1.4518250945568354,0.08497723823975721,0.9233593496485728,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.6894628374253261,1.4518250945568354,0.08497723823975721,0.9233593496485728,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,regulation of multicellular organism growth (GO:0040014),0.6331191916242619,1.4512543937441484,0.05986394557823129,0.9213914817220111,1.0,4/15,10.71%,IGF1;PTCH1;PPIB;APP
prerank,cellular response to cadmium ion (GO:0071276),-0.45314185845533705,-1.4502431495715016,0.06542056074766354,0.7314339960860641,1.0,12/24,13.89%,MAPK8;EGFR;HSF1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;JUN
prerank,positive regulation of secretion (GO:0051047),0.685561122592879,1.4501818790577998,0.07525325615050651,0.9232011475294747,1.0,2/11,3.79%,GPLD1;XBP1
prerank,response to UV-A (GO:0070141),-0.5325998583908338,-1.4493291303130587,0.07457627118644068,0.7249313295837798,1.0,7/14,28.73%,EGFR;MME;MMP2;AKT1;MMP1;CERS1;CCND1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5966879389091158,1.448923269851332,0.06161745827984596,0.9263334471978963,1.0,9/21,14.68%,MED24;MED12;MED14;MED13;MED4;DHX36;TWIST1;SETX;BCLAF1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4159705184158931,-1.4488413354806013,0.04046242774566474,0.7172609214591215,1.0,20/32,28.54%,HIPK2;FHIT;PML;USP28;SIRT1;HIPK1;JMY;TP53;EP300;MSH2;TMEM109;BAG6;DYRK2;DDIT4;RRP8;BCL3;MYBBP1A;RPS27L;BOK;PDK2
prerank,presynapse organization (GO:0099172),0.6957444918939355,1.4483038603442173,0.060790273556231005,0.9252874241046545,1.0,4/10,14.38%,WNT5A;DVL1;NLGN3;NLGN2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.561363679323804,1.448087402085651,0.06303030303030303,0.9210752608936846,1.0,9/30,14.52%,RAC1;ARRB1;GPR4;PRAG1;ADGRG1;ROBO1;AKAP13;LPAR1;LPAR6
prerank,acylglycerol biosynthetic process (GO:0046463),0.5723441563706921,1.447288779487752,0.05449936628643853,0.9209549310689338,1.0,7/23,12.41%,MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,positive regulation of neuron differentiation (GO:0045666),0.5314769908282688,1.4468889571039292,0.05820721769499418,0.9182772342145064,1.0,11/40,17.05%,FGF20;FGFR1;TCF4;ZEB1;BRINP3;MMD;GPRC5B;SOX11;IMPACT;TCF3;BRINP1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5201802024619937,-1.445479155398885,0.0683453237410072,0.7216669760337724,1.0,7/15,21.33%,CNOT1;TNRC6A;EIF4ENIF1;AGO2;CPEB3;CNOT7;BTG2
prerank,embryonic digestive tract development (GO:0048566),0.6037114705738947,1.4454717999357518,0.07571801566579635,0.9225471864113699,1.0,6/18,11.29%,STRA6;FGFR2;PCSK5;NIPBL;SOX11;PDGFRA
prerank,positive regulation of keratinocyte migration (GO:0051549),0.698417993279445,1.4437704262369684,0.06987577639751552,0.9288669709575585,1.0,2/10,4.88%,EPB41L4B;FGF10
prerank,regulation of protein sumoylation (GO:0033233),0.617767437046923,1.4429431885290775,0.08528198074277854,0.9287202555567778,1.0,7/17,15.02%,GNL3;RWDD3;SAE1;HDAC4;ZMIZ1;PARK7;PIAS3
prerank,triglyceride catabolic process (GO:0019433),0.6101573593507803,1.4424506744174865,0.06729475100942127,0.9264052914613958,1.0,1/19,0.96%,LPL
prerank,ncRNA metabolic process (GO:0034660),0.536291949878469,1.440187063141692,0.050175029171528586,0.9368452933672959,1.0,5/37,4.08%,KHSRP;TARBP2;DGCR8;DDX17;ZCCHC8
prerank,genitalia development (GO:0048806),0.6740836148385476,1.4394938365685273,0.08908045977011494,0.9362840628228585,1.0,2/12,2.18%,WNT5A;STRA6
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5293933886719995,-1.4387619275571892,0.08996539792387544,0.7400878081540609,1.0,6/13,24.20%,GJA1;GJC1;CACNA1C;CACNB2;KCNJ3;KCNQ1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.581091047055303,1.4358376345779853,0.07760814249363868,0.9565868821916582,1.0,5/22,6.42%,EXOSC3;NOP9;EXOSC7;EXOSC2;EXOSC8
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.43042547477343995,-1.4350576283034928,0.07692307692307693,0.7464382433118677,1.0,7/23,5.95%,PIP4P2;INPP5F;MTMR12;MTMR10;OCRL;MTMR3;INPP5K
prerank,digestive tract development (GO:0048565),0.5567198370364004,1.4346951156823118,0.06174334140435835,0.9590756430729315,1.0,8/32,6.59%,STRA6;FGFR2;PCSK5;NIPBL;CHD8;CLMP;BBS7;ZIC3
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6801269869411745,1.4328026637609104,0.0837138508371385,0.9672656172195978,1.0,1/10,0.17%,RNF157
prerank,protein targeting to ER (GO:0045047),-0.3193187115117402,-1.4320275472477346,0.0,0.7494183558450597,1.0,46/99,20.15%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;SRPRB;RPS5;SPCS3;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;SGTA;RPS26;RPS27;RPL10A;RPS10;RPL7A;SGTB;SEC61A1;RPL31
prerank,renal filtration (GO:0097205),0.6833997500305523,1.4317262966385182,0.08006042296072508,0.9695566014378533,1.0,3/10,6.14%,XPNPEP3;SULF1;TMEM63C
prerank,ketone body metabolic process (GO:1902224),0.6814860256014231,1.430309897199628,0.08223201174743025,0.9740162344798045,1.0,4/10,7.50%,HMGCLL1;OXCT1;BDH1;ACAT1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.581633547468043,1.4302945059754146,0.08236808236808237,0.9685341527154608,1.0,5/22,4.88%,EPB41L4B;FGFR2;CASK;ZFP36L1;FGF10
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.6549329275738861,1.430093503391389,0.08507462686567165,0.9644352606383191,1.0,8/12,21.95%,HEXIM1;EAPP;RNF8;RNF168;NELFA;RECQL5;HNRNPU;TCERG1
prerank,positive regulation of protein sumoylation (GO:0033235),0.6814580217887187,1.4299365828832755,0.0962406015037594,0.9600901970731065,1.0,7/10,22.93%,GNL3;RWDD3;SAE1;HDAC4;PIAS3;PIAS1;UBA2
prerank,protein heterotetramerization (GO:0051290),0.6392484080622567,1.4285712332976102,0.09129213483146068,0.9645302337523429,1.0,6/13,18.02%,FARSB;GRIN1;CPSF7;NUDT21;CPSF6;PKD2
prerank,mesenchyme development (GO:0060485),0.6302938852845296,1.428411683059947,0.07346938775510205,0.9602823004075114,1.0,2/15,2.97%,SFRP2;FGFR2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.4321378101249412,-1.428197770627487,0.049019607843137254,0.7553792785890282,1.0,8/24,10.78%,UBE2N;IRAK2;IRAK1;NOD1;RNF34;CYLD;UBB;IKBKG
prerank,cellular response to calcium ion (GO:0071277),0.5045364197653801,1.4277650089307279,0.03556034482758621,0.9594080961243486,1.0,28/67,23.25%,ALOX5AP;SYT3;WNT5A;SYT10;GPLD1;PPIF;CARF;SLC25A24;DMTN;RASGRP2;ADGRV1;CPNE7;CAMK2D;IQGAP1;SYT1;CPNE8;ADCY1;DPEP1;PKD2;PRKAA1;KCNH1;SMPD1;SYT4;SYT11;SYT12;CPNE2;SYT7;SYT2
prerank,regulation of exocytosis (GO:0017157),0.520935034229619,1.4271214713733207,0.07206208425720621,0.9588295744163747,1.0,16/46,17.00%,UNC13D;CPLANE2;ANXA1;RAB12;CPLX1;CHMP3;RAB10;RAB3B;RAB2B;IL1RAPL1;SYT1;RAB13;RAB8A;RAB8B;NSF;RAB21
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5367268787472523,1.4254319693617095,0.0492379835873388,0.9653472246962874,1.0,10/38,10.71%,IL34;SH3BP5;DLG3;THY1;LRP8;GPRC5B;SH3BP5L;MVP;SRCIN1;APP
prerank,mammary gland development (GO:0030879),0.5813766642892124,1.4242603762592116,0.08344549125168237,0.9683348285737421,1.0,6/21,14.04%,APLN;GPAT4;ZBTB7B;WNT4;PRLR;NRG1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6876352895758946,1.423106255668383,0.09422492401215805,0.9710298337277955,1.0,1/10,0.06%,CARMIL2
prerank,histone H4 deacetylation (GO:0070933),0.6822949944706597,1.4229694634440495,0.08469539375928678,0.9667155790778734,1.0,5/10,12.36%,HDAC3;SIRT2;HDAC4;RCOR1;HDAC1
prerank,peptidyl-amino acid modification (GO:0018193),0.6888851402774077,1.4222761785818938,0.09365558912386707,0.9665754610785469,1.0,4/10,13.29%,TTLL4;METAP1;METAP1D;METAP2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5574719952850123,1.4219284680617963,0.07133917396745933,0.9637780786758925,1.0,7/27,10.14%,CRTC1;RBM4B;FBXL12;SIK1;PER1;PPP1CC;USP2
prerank,Golgi ribbon formation (GO:0090161),0.6424942267546563,1.421789718651459,0.08547008547008547,0.9596699603287003,1.0,5/13,15.63%,STX6;TRIP11;STX16;PRMT5;VTI1A
prerank,negative regulation of cation channel activity (GO:2001258),0.565306232996079,1.4211343885104812,0.07462686567164178,0.9591765595203835,1.0,4/26,3.09%,UBQLN1;CBARP;EPHB2;CALM3
prerank,positive regulation of glycolytic process (GO:0045821),0.590458921298359,1.4210884842133857,0.06621621621621622,0.9494447866349692,1.0,6/20,10.71%,SLC4A4;IGF1;ARNT;PRXL2C;ZBTB20;APP
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.590458921298359,1.4210884842133857,0.06621621621621622,0.9494447866349692,1.0,6/20,10.71%,SLC4A4;IGF1;ARNT;PRXL2C;ZBTB20;APP
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6170218334999801,1.4201328378276108,0.09405255878284924,0.9506708679191505,1.0,5/15,17.19%,GPLD1;NRDC;PACSIN3;SNX33;APOE
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5817329807949888,1.4199281944679543,0.08516129032258064,0.9471419796565748,1.0,1/21,0.14%,PLA2G5
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5634607589140769,1.4197769687428217,0.07313997477931904,0.9434732457746481,1.0,8/26,14.28%,EIF2AK3;RORA;CCBE1;SULF1;ARNT;SARS1;PTGS2;TGFB1
prerank,regulation of protein neddylation (GO:2000434),-0.5689556425211351,-1.4195167467720895,0.11818181818181818,0.7809382573969674,1.0,4/10,6.65%,DCUN1D4;RPL11;HIF1A;RPL5
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5994608401334788,1.419481805291773,0.0856760374832664,0.9406937048461581,1.0,9/17,22.65%,RTN2;IGF1;BIN1;ABCA7;APOE;SORL1;NTRK2;GGA3;RTN1
prerank,response to amyloid-beta (GO:1904645),0.5259022033572662,1.4194292740324252,0.05328798185941043,0.9362530698390574,1.0,10/44,10.71%,MMP12;FCGR2B;IGF1;GRIN1;ATP1A3;CDK5;SNX6;GRIN2A;CACNB1;APP
prerank,tyrosine metabolic process (GO:0006570),0.6610166349010128,1.4193790299855396,0.09224011713030747,0.9317781838129038,1.0,1/11,0.55%,HGD
prerank,DNA catabolic process (GO:0006308),0.6491949427412166,1.4184709497210952,0.10134128166915052,0.9334312678181119,1.0,3/11,6.72%,DNASE1L2;FBH1;DFFB
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5135404030718642,-1.4178194574194538,0.11295681063122924,0.7784455524042669,1.0,4/14,12.54%,ATP1B3;AKAP9;ACTN2;ATP1B1
prerank,histone H2A ubiquitination (GO:0033522),0.612712120492761,1.4164634189153047,0.08571428571428572,0.9423372528185239,1.0,7/17,12.70%,RNF8;PCGF1;DDB1;RNF168;CUL4B;KDM2B;UBE2A
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5256110009919098,1.4159679223997133,0.05807200929152149,0.9411615646281128,1.0,10/39,17.25%,MYO1A;CLN3;MYO19;TANC2;MYO1B;MYO5A;BICDL1;HTT;TRAK1;KIF5B
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4261743474082925,-1.4154395392737238,0.06282722513089005,0.7797308363893845,1.0,11/30,9.78%,GJA1;JAM2;PECAM1;TJP1;ACTB;CLDN5;ESAM;DMD;F11R;OCLN;LSR
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5503601355891283,1.415149321042585,0.07398273736128237,0.9374186020591169,1.0,8/29,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;ACAT1;CROT;ACSL6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5503601355891283,1.415149321042585,0.07398273736128237,0.9374186020591169,1.0,8/29,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;ACAT1;CROT;ACSL6
prerank,negative regulation of neuron differentiation (GO:0045665),-0.4323946783091165,-1.4146447000065039,0.07659574468085106,0.7741010340358554,1.0,9/22,24.88%,EIF2AK4;MED1;CALR;REST;BMP7;HES1;DTX1;SOX2;NEPRO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.6683453913737598,1.414599110256763,0.09146341463414634,0.9317571351289298,1.0,7/10,19.29%,MPG;MGMT;ASCC1;ALKBH3;ASCC2;FTO;ALKBH1
prerank,DNA dealkylation (GO:0035510),0.6683453913737598,1.414599110256763,0.09146341463414634,0.9317571351289298,1.0,7/10,19.29%,MPG;MGMT;ASCC1;ALKBH3;ASCC2;FTO;ALKBH1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4542033896110036,-1.4141817235673073,0.06640625,0.7668364523851193,1.0,8/20,17.09%,PDCD4;THBS1;ANO6;PLCG1;SFRP4;ITGA4;PIAS4;RGCC
prerank,negative regulation of histone modification (GO:0031057),0.6369982111800728,1.4138230826385587,0.09718309859154929,0.9324819067773937,1.0,5/14,16.05%,AASS;PRMT6;TWIST1;JARID2;CTBP1
prerank,regulation of blood circulation (GO:1903522),0.5452312124329981,1.4124517331348043,0.07322929171668667,0.9373533916235866,1.0,7/34,11.50%,KCNG2;DMPK;CELF2;DES;BDKRB2;TPM1;CAMK2D
prerank,membrane lipid catabolic process (GO:0046466),0.672387759467058,1.412290076135811,0.0880597014925373,0.9337830341507173,1.0,4/10,10.25%,SMPDL3B;SMPD2;SGPL1;ENPP2
prerank,response to interferon-beta (GO:0035456),-0.44434545832252953,-1.411311442440461,0.06965174129353234,0.7703337015581807,1.0,13/22,23.52%,UBE2K;IFNAR2;STAT1;PLSCR1;IKBKE;AIM2;XAF1;IRGM;NDUFA13;BST2;IFITM2;IFITM1;UBE2G2
prerank,negative regulation of cholesterol transport (GO:0032375),0.6809765998585993,1.4112998991206698,0.08507462686567165,0.936093688935919,1.0,2/10,4.31%,NFKB1;ABCA2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.42579335176295807,-1.4095961006037045,0.06995884773662552,0.7683251909144494,1.0,8/24,16.70%,PECAM1;EZR;F11R;SEMA4D;NT5E;ROCK1;ITGA4;MSN
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5677319268790483,1.4081679682462034,0.08854166666666667,0.9519405213508566,1.0,4/23,12.83%,IGF1;TNFAIP3;CARD16;GIT1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.38427000592558647,-1.406940532069589,0.043010752688172046,0.770079891083272,1.0,13/34,13.78%,LATS1;MFHAS1;PICALM;GPM6B;UBXN2B;GOPC;NSFL1C;TTBK2;ILRUN;ACTN2;MAP1A;NEDD4L;SIN3A
prerank,secretion (GO:0046903),0.620875619890853,1.4064459053450769,0.1016949152542373,0.9590871491800129,1.0,4/14,13.35%,GUCA1B;SLC22A4;FBLN5;PRKCI
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5235032662277871,1.4057380130828896,0.056128293241695305,0.9592914362418413,1.0,7/41,10.90%,SFRP2;TNNI3;TNNC1;FGFR2;SOX11;TPM1;RBPJ
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6526539611530195,1.4056638508574693,0.09370424597364568,0.9552134064466151,1.0,1/12,1.00%,B3GALNT1
prerank,positive regulation of phospholipase activity (GO:0010518),0.5717197106398022,1.405645639243952,0.07632600258732213,0.9508801709073507,1.0,5/22,3.62%,PLA2G5;PDPK1;NTF3;FGFR2;FGFR1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.33574237403904733,-1.405599067086548,0.06578947368421052,0.7672260425711638,1.0,18/65,15.99%,LEF1;FOXP1;KIT;SBNO2;PML;SIRT1;PIR;LGALS9;TGFBR2;EP300;RARA;MT1G;OSTM1;CBFA2T3;THOC5;GLO1;TNFRSF11A;BMP4
prerank,negative regulation of cilium assembly (GO:1902018),0.6435843892520061,1.4049152571917185,0.09298998569384835,0.9509830106123931,1.0,7/12,18.26%,CCP110;TBC1D7;CEP97;TCHP;EVI5L;MAP4;CDK10
prerank,regulation of mitotic nuclear division (GO:0007088),0.49205408650212507,1.4042948687497323,0.055495103373231776,0.9506532865547936,1.0,10/55,9.18%,IGF1;CUL7;LCMT1;EDN3;OBSL1;CDK13;FBXO5;AURKAIP1;EGF;PRMT5
prerank,regulation of cellular protein localization (GO:1903827),0.5136275720849756,1.4040533446366963,0.05442176870748299,0.9477625284967844,1.0,11/45,9.82%,TRIM67;KCNAB2;LCP1;PARP1;HSP90AA1;ABCA2;GPC6;DVL1;GPC1;EGF;VCP
prerank,sensory perception of chemical stimulus (GO:0007606),0.6166544183524603,1.4036314339994784,0.10312075983717775,0.946190303594931,1.0,4/15,10.58%,SYT10;SLC24A4;GNAS;UBR3
prerank,cellular response to pH (GO:0071467),0.6052323270710168,1.403137616399171,0.09641873278236915,0.9452687637693004,1.0,3/17,4.43%,GPLD1;ASIC1;GPR68
prerank,regulation of keratinocyte migration (GO:0051547),0.6585932004978469,1.4028783496221038,0.09379727685325265,0.9426652045668089,1.0,2/12,4.88%,EPB41L4B;FGF10
prerank,glycosphingolipid metabolic process (GO:0006687),0.515291233321136,1.4023825562413306,0.058823529411764705,0.941688145958523,1.0,12/42,14.34%,B3GALNT1;A4GALT;CLN6;ST8SIA3;SMPD2;GBA2;GLB1;ABCA2;ST3GAL5;PSAP;SMPD4;ST6GALNAC6
prerank,regulation of mRNA polyadenylation (GO:1900363),0.5990034455961113,1.401211317634042,0.09029649595687332,0.945122137056133,1.0,9/17,17.69%,CPEB1;CDK9;RNF40;CPSF7;ZC3H14;NUDT21;ZC3H3;CCNT1;CPSF6
prerank,regulation of axon guidance (GO:1902667),0.6683311590209063,1.4009806250935068,0.091324200913242,0.9422684230167139,1.0,5/10,16.03%,ZSWIM6;NRP1;MYCBP2;YTHDF1;ZSWIM8
prerank,regulation of cellular localization (GO:0060341),0.5070796314032463,1.4006655372306005,0.05808656036446469,0.9401061003466741,1.0,19/46,23.26%,TRIM67;UNC13D;PARP1;HSP90AA1;DVL1;BRSK2;BRSK1;CAMK2D;NUMA1;ADCY5;EPHA5;WWC1;LYN;PARD6G;GSN;PPM1F;GOSR1;MAP2;STXBP4
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.39882292518445756,-1.3993976437276943,0.08743169398907104,0.7832790168120712,1.0,22/32,39.57%,SORBS1;ASAH1;CREBL2;ADIPOR1;PRKAB2;CREB1;PRKAA2;ADIPOR2;AKT1;PPARA;AVIL;CEACAM1;SIRT4;MID1IP1;GPER1;ASXL3;EIF6;MLXIPL;FITM2;STAR;C3;PDK4
prerank,neuron projection extension (GO:1990138),0.5324972833008209,1.398929201868318,0.07407407407407407,0.9469679134775956,1.0,14/32,15.89%,HSP90AA1;NRP1;CDK5;TMEM108;CYFIP1;FLRT1;IQGAP1;NLGN3;USP9X;ALCAM;AUTS2;IMPACT;SEMA3A;SLC9A6
prerank,retinoid metabolic process (GO:0001523),0.48722467138546477,1.398681445330576,0.034224598930481284,0.9442916500929679,1.0,16/71,17.19%,LPL;RDH10;STRA6;GPC6;ALDH1A2;RDH11;GPC1;LRP8;RDH5;RBP1;AKR1B10;CYP26B1;GPC4;LRP1;HSPG2;APOE
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5736790326185799,1.3986647594266768,0.09125964010282776,0.94027328622873,1.0,5/21,13.55%,FCGR2B;TNFAIP3;PIBF1;SOX11;PTPN22
prerank,miRNA metabolic process (GO:0010586),0.5773358422878154,1.397977084068477,0.09031413612565445,0.9404858117896348,1.0,7/20,15.03%,KHSRP;TARBP2;DGCR8;DDX17;LIN28B;SND1;DIS3L2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6309810672200762,1.3979331186209036,0.08368794326241134,0.9366950407455674,1.0,3/14,7.22%,APLN;SULF1;GPC1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.4706647430877449,-1.397482096442024,0.0946969696969697,0.7821142206924756,1.0,9/17,22.94%,MAML3;MAML1;STAT1;NOTCH3;KAT2B;EP300;HEYL;PBX1;NOTCH4
prerank,protein heterooligomerization (GO:0051291),0.5967260863145016,1.3969162003552231,0.08660351826792964,0.9393867834771834,1.0,8/17,18.43%,FARSB;GRIN1;KCNC2;CPSF7;NUDT21;CPSF6;PKD2;MAT2A
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.41480262183873096,-1.3964362020723766,0.07602339181286549,0.7777695344637966,1.0,9/25,11.38%,HIPK2;CSNK2A1;PML;RPL11;HSP90AB1;RPL5;PSMF1;TRIM39;GABARAPL2
prerank,regulation of dendrite extension (GO:1903859),0.5869008724891682,1.396136803740212,0.11666666666666667,0.9405899271782959,1.0,3/18,3.59%,RNF157;SYT3;UNC13A
prerank,alanine transport (GO:0032328),-0.5655224904437073,-1.3956131989945908,0.11014492753623188,0.7727236672292153,1.0,5/10,27.20%,SLC6A6;SLC36A4;SLC1A4;SLC6A17;SLC36A1
prerank,respiratory system development (GO:0060541),0.5328655363905043,1.3950728775342092,0.08393285371702638,0.9436981871968629,1.0,4/32,6.59%,FGF9;STRA6;FGFR2;ZIC3
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5903645162297104,1.394784070011483,0.0797872340425532,0.9413314932838733,1.0,2/17,0.87%,UNC13D;SYT10
prerank,isotype switching (GO:0045190),0.6583599675057163,1.3944834456688964,0.10381679389312977,0.9392450340524312,1.0,4/10,15.53%,EXOSC3;RNF8;RNF168;HSPD1
prerank,sodium ion export across plasma membrane (GO:0036376),0.629785415969541,1.394222667997814,0.10662824207492795,0.9369217731993492,1.0,3/13,7.53%,SLC4A4;ATP1A3;ATP1A2
prerank,regulation of exit from mitosis (GO:0007096),0.5254155334101506,1.3937413556818814,0.06971428571428571,0.936085555638363,1.0,16/38,19.74%,CDC23;SIRT2;UBE2S;MAD2L1;CDC16;ANAPC2;CDC14B;PPP1R9B;ANAPC11;ANAPC4;CDC26;UBE2E1;UBE2D1;ANAPC10;ANAPC5;ZW10
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5024034013654408,1.3930501550289747,0.06084070796460177,0.9364567236665113,1.0,8/54,8.20%,AMIGO1;KCNAB2;BIN1;CD63;GNG2;NOS1AP;KCNMA1;KCNJ10
prerank,negative regulation of B cell activation (GO:0050869),0.5786816272300159,1.3926119189071817,0.09752925877763328,0.9351885247321966,1.0,3/21,4.85%,FCGR2B;SFRP1;TNFAIP3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5410208925556557,1.3925696195139736,0.07869249394673124,0.9314684744074683,1.0,8/31,11.06%,BAX;CHCHD10;TFDP1;ZNF205;NMT1;YWHAH;YWHAG;BCL2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.467124292938533,1.392544469136284,0.012282497441146366,0.9277264230995842,1.0,48/129,20.13%,SFRP2;TMEM198;ATP6AP2;SFRP1;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DDX3X;FZD9;FGF10;PPM1B;USP47;PSMB10;PSMD11;XIAP;GPRC5B;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;JUP;AXIN2;ZBED3;CSNK1D;RNF220;TGFB1;LYPD6;PSMD1;USP34;ADGRA2;TNKS;PTK7;UBR5;PSMD6;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;PRDM15;LRRK1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.6283447522806322,1.3921527967367195,0.10502958579881656,0.9262866040391489,1.0,8/13,21.95%,HEXIM1;EAPP;RNF8;RNF168;NELFA;RECQL5;HNRNPU;TCERG1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.6073871016152694,1.391565459929455,0.08390646492434663,0.9260746611302256,1.0,4/16,9.11%,KHSRP;PLEKHN1;ZFP36L1;DHX36
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6023530991902227,1.3914874734980542,0.11081081081081082,0.9227241948266357,1.0,5/17,9.08%,NTF3;NRP1;CDK5;ABL1;BAIAP2
prerank,positive regulation of lipid localization (GO:1905954),0.6468070647847028,1.3892199224615893,0.12318840579710146,0.9331648691686631,1.0,2/11,2.19%,LPL;NFKB1
prerank,regulation of cell cycle process (GO:0010564),0.4711510515373153,1.389197360069271,0.026399155227032733,0.9294765337689198,1.0,34/104,22.08%,CCP110;FSD1;SFRP1;CUL7;CSNK2A2;RAB11FIP4;MYO19;CALM3;OBSL1;CDK13;FLCN;FBXO5;PLK5;SOX9;ENTR1;PRMT5;MAP9;USP19;RCC1;GIT1;SND1;PRPF40A;KLHL13;NUMA1;PIK3C3;KIF20B;CALM1;PIK3R4;YTHDF2;UVRAG;KLHL9;RAB11FIP3;CALM2;CUL9
prerank,T cell homeostasis (GO:0043029),-0.5479617109790008,-1.3890740860388502,0.13166144200626959,0.7905292720874284,1.0,5/10,24.61%,PPP2R3C;FAS;AKT1;NCKAP1L;ZC3H8
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6408929975799392,1.3890269022143733,0.10224089635854341,0.9229958768195877,1.0,4/12,14.41%,IGF1;CHERP;STIMATE;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6408929975799392,1.3890269022143733,0.10224089635854341,0.9229958768195877,1.0,4/12,14.41%,IGF1;CHERP;STIMATE;CAMTA1
prerank,carbohydrate derivative transport (GO:1901264),0.5863777889342192,1.3883223322064173,0.09752747252747253,0.9235933322680276,1.0,4/18,8.89%,SLC29A1;CLN3;SLC25A19;VLDLR
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5187160950404447,-1.3880963877763355,0.10749185667752444,0.7860477654536203,1.0,3/12,5.12%,WAPL;RB1;HDAC8
prerank,regulation of epithelial cell proliferation (GO:0050678),0.47464576836927025,1.3880320647065585,0.044350580781414996,0.9216927789411968,1.0,13/85,8.35%,SFRP2;FGF9;EPB41L4B;SFRP1;IGF1;BMP6;FGFR2;ZFP36L1;FGF10;LAMC1;TCF7L2;MAGED1;SOX9
prerank,negative regulation of blood pressure (GO:0045776),0.6172393845927006,1.3869462775522583,0.10638297872340426,0.9250366790505461,1.0,1/13,0.18%,APLN
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5445540004370115,1.386650608527159,0.09693877551020408,0.9232002572858867,1.0,6/27,13.55%,SELENOS;TNFAIP3;CD200R1;SIRPA;ARRB1;PTPN22
prerank,regulation of secretion (GO:0051046),0.6267621243009769,1.386607256836998,0.10369318181818182,0.9197790151180807,1.0,6/13,16.95%,GPLD1;OPRK1;FGF10;EGF;NRG1;OAS2
prerank,axon development (GO:0061564),0.47641241578244214,1.386534246723211,0.042105263157894736,0.9165632295238563,1.0,28/78,21.89%,AMIGO1;EPHB2;ATL1;FGFR2;NEFH;CDK5;PAK3;BRSK2;CAMSAP2;BAIAP2;RAB10;NTNG2;BRSK1;AFG3L2;APP;ANK3;MAPK8IP3;DOCK7;MAPT;RAB8A;DCC;ZDHHC17;SLITRK1;SLITRK5;SPTBN4;LLGL1;RYK;ARHGAP35
prerank,positive regulation of dendrite extension (GO:1903861),0.5886401068994284,1.3863924723524472,0.11838440111420613,0.9138245846086911,1.0,3/17,3.59%,RNF157;SYT3;UNC13A
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.5041041979078017,-1.3857162257533358,0.10175438596491228,0.7872611464968152,1.0,8/13,18.48%,GOT2;IDH1;IDH2;PHYH;D2HGDH;GPT2;L2HGDH;GOT1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6092552108436633,1.3850868590762324,0.1038781163434903,0.918475768834301,1.0,7/16,17.19%,LRPAP1;ABCA7;IFNGR1;HDAC1;CYP51A1;LRP1;APOE
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.5498845223385396,-1.3849590333530295,0.12573099415204678,0.78211042726249,1.0,7/10,34.87%,MTHFR;MTHFS;MTHFD1;MTHFD1L;MTHFD2;DHFR;TYMS
prerank,organic anion transport (GO:0015711),0.4740202551327593,1.38361513671942,0.05026737967914439,0.924009809699376,1.0,7/76,2.23%,CYB5R2;SLC4A4;SLC4A5;SLC35B2;SLC35B1;SLC25A19;LRRC8A
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5167528359114817,-1.3827593033850287,0.10510510510510511,0.7831479108097641,1.0,5/12,16.21%,TASOR;PPHLN1;APOBEC1;SETDB2;DNMT1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.547748739606895,-1.3814738212368558,0.11711711711711711,0.7801732232109102,1.0,4/11,9.22%,PUM1;STAT3;XPO5;LIMD1
prerank,protein secretion (GO:0009306),0.4923059562343403,1.380813081757875,0.0586283185840708,0.9376889056083235,1.0,20/56,18.19%,PTPRN;ANXA1;PCSK5;TVP23B;MIA3;RAB12;RCN3;RAB10;WLS;RAB3B;PORCN;PARK7;TANGO2;CAMK2G;MON1A;RAB13;RAB8A;RAB8B;MTTP;NECAB3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5309789363262264,1.3798966997582278,0.10144927536231885,0.9397832574055491,1.0,11/32,16.50%,CSNK2A2;LPIN1;CEPT1;GPAT4;LPIN3;PCYT1B;STARD7;LPIN2;CHKB;SLC44A2;SLC27A1
prerank,negative regulation of immune effector process (GO:0002698),-0.5232790298586549,-1.3798831282205102,0.13333333333333333,0.77837320901222,1.0,6/13,13.96%,FER;APPL1;RPS19;RC3H1;GRN;ENPP3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5559562214889959,1.3796436478160086,0.0812807881773399,0.9376702416767805,1.0,10/26,21.10%,SMPDL3B;GPR108;IRF1;LGR4;LRRC14;TLR3;GPS2;FLOT1;BIRC3;APPL2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5523109579788069,1.3790689324107792,0.0983397190293742,0.9376402750512925,1.0,7/24,14.28%,EIF2AK3;RORA;CCBE1;SULF1;ARNT;PTGS2;TGFB1
prerank,cellular response to sterol (GO:0036315),0.6100287278457808,1.3787903204386818,0.11722141823444283,0.9356757333625052,1.0,5/13,8.42%,GPLD1;RORA;MLC1;INSIG1;PTCH1
prerank,regulation of microtubule polymerization (GO:0031113),0.5162059860573801,1.3773872238145264,0.08013937282229965,0.9406835712812629,1.0,19/40,23.06%,PSRC1;RAC1;MAPRE3;GBA2;ABL1;CAMSAP2;PRUNE1;DRG1;CLIP3;MAPT;EML2;TBCD;NUMA1;TUBB4A;RPS3;CAMSAP1;PAK1;MAP2;CDK5RAP2
prerank,response to zinc ion (GO:0010043),-0.42272534757954405,-1.3770969918591913,0.11442786069651742,0.7807825750303622,1.0,13/25,21.70%,SLC30A4;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;D2HGDH;GLRA2;CRIP1;MT2A
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6295991484909041,1.3769753438580608,0.10746268656716418,0.9394941531118615,1.0,6/12,21.25%,HGS;NDRG4;IFT20;CBL;F3;CBLB
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4534737116989543,1.3768181143059697,0.016243654822335026,0.9369432956406911,1.0,49/150,18.99%,SFRP2;SFRP1;SIRT2;TARBP2;EPHB2;GSKIP;TSC2;PDPK1;NTF3;GPD1L;CALM3;PRKRIP1;WARS1;FBLN1;PMEPA1;ERRFI1;THY1;ATG14;DMTN;DVL1;CNKSR3;SIRPA;PID1;CDK5RAP3;TWIST1;MVP;YWHAG;IGFBP3;ENPP1;PARK7;RACK1;PLPP3;ZBED3;TGFB1;FKBP8;PPM1E;IMPACT;SMAD6;ITGB1BP1;SPRY2;GNAQ;DNAJC10;CAMK2N1;RASSF2;TAB1;TERF2IP;TRIM27;CALM1;PRKAG2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.5616625955080885,1.37668061007339,0.10828877005347594,0.934285963485093,1.0,6/20,18.97%,RNF157;APLP1;GRK3;GRK2;MRAP2;GPRASP1
prerank,immunoglobulin mediated immune response (GO:0016064),0.6598332011831939,1.3758003766057012,0.1308411214953271,0.9362156642681982,1.0,1/10,0.85%,FCGR2B
prerank,T cell migration (GO:0072678),-0.5033245865065739,-1.3745976672863351,0.10037174721189591,0.7830252448284015,1.0,5/13,22.72%,CXCL16;S1PR1;MSN;SLC12A2;PIK3CD
prerank,positive regulation of T cell migration (GO:2000406),0.5643762930680263,1.374310113850102,0.09419354838709677,0.9419241991979027,1.0,4/20,10.71%,WNT5A;CXCL12;DOCK8;APP
prerank,positive regulation of nuclear division (GO:0051785),0.5435280633341358,1.3742836596225516,0.10163111668757842,0.9385537047704315,1.0,4/25,9.15%,IGF1;SIRT2;EDN3;EGF
prerank,positive regulation of ossification (GO:0045778),0.5068162392086741,1.373849775858711,0.09639953542392567,0.9376867984828118,1.0,11/39,9.70%,WNT5A;TMEM119;FBN2;BMP6;FZD9;NELL1;ADGRV1;WNT4;ATP2B1;SOX11;KL
prerank,rRNA catabolic process (GO:0016075),0.6037729574392977,1.3735473147754473,0.0970873786407767,0.9361073583404543,1.0,4/16,6.42%,EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6314809667212486,1.3730469130739897,0.10344827586206896,0.9355525903970549,1.0,1/13,1.00%,B3GALNT1
prerank,regulation of T cell migration (GO:2000404),0.5807800642811671,1.3723773937754804,0.10469798657718121,0.9361733498576396,1.0,5/18,10.71%,CXCL12;CD200R1;RIPOR2;DOCK8;APP
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4039817544114396,-1.3721346397365466,0.07865168539325842,0.7852989167367812,1.0,9/26,10.78%,UBE2N;IRAK2;IRAK1;NOD1;IFIH1;CYLD;UBB;ALPK1;IKBKG
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5334790309335358,1.3716411316066828,0.09325153374233129,0.9372456220100337,1.0,6/30,9.79%,SFRP2;CDKN2D;CXCL12;SNAI1;FBXO5;TWIST1
prerank,cellular lipid catabolic process (GO:0044242),0.5390200058669392,1.371617502152273,0.1018867924528302,0.9339412960016718,1.0,6/27,12.41%,SMPDL3B;SIRT2;LPIN1;LPIN3;ENPP2;LPIN2
prerank,regulation of protein polymerization (GO:0032271),0.518604877565777,1.3715426894664149,0.09112709832134293,0.9310033239225894,1.0,11/35,9.63%,ABITRAM;HSP90AA1;MAPRE3;GBA2;ABL1;PAK3;DBN1;TPPP3;CAMSAP2;PRUNE1;DBNL
prerank,glycoprotein catabolic process (GO:0006516),0.580343850480411,1.3714711261829735,0.10195530726256984,0.92794819161546,1.0,4/17,8.34%,MMP12;EDEM1;NGLY1;MANBA
prerank,cytoplasmic translational initiation (GO:0002183),-0.47576977670418297,-1.3702889949705808,0.10305343511450382,0.7851206796883701,1.0,9/17,26.18%,EIF2S2;EIF4B;MCTS1;RBM4;EIF4A2;EIF2D;EIF5;EIF3I;EIF3D
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6112005245333525,1.3697391500627982,0.11005434782608696,0.9348848778401034,1.0,3/15,15.38%,HGD;FAH;QDPR
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5239229073873569,1.369139097683271,0.07665094339622641,0.9351419681707085,1.0,9/35,15.44%,FASN;ALOX5AP;HMGCLL1;FAR2;BDH1;ACAT1;PAM;FAR1;SLC25A1
prerank,regulation of cell junction assembly (GO:1901888),-0.3990054628134555,-1.3678555024753238,0.06666666666666667,0.7879712765901027,1.0,9/27,11.89%,MEF2C;PRKCH;PDLIM5;TJP1;CLDN5;PRKACA;F11R;OCLN;ROCK1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.45116554441870366,-1.3677594046798793,0.09163346613545817,0.7808621720298295,1.0,6/18,13.96%,DOCK2;SBNO2;LBP;PLCG2;DYSF;ENPP3
prerank,base conversion or substitution editing (GO:0016553),-0.5330013542004717,-1.367548820334959,0.13861386138613863,0.7743819220472945,1.0,3/11,13.01%,ADARB2;APOBEC1;METTL3
prerank,photoperiodism (GO:0009648),0.5322288809104662,1.3670394270000816,0.09649122807017543,0.9445256748825603,1.0,7/28,10.14%,CRTC1;RBM4B;FBXL12;SIK1;PER1;PPP1CC;USP2
prerank,positive regulation of cell adhesion (GO:0045785),0.47407678993321567,1.3668768828885947,0.06702127659574468,0.9419875341181453,1.0,13/74,12.46%,SFRP2;EPB41L4B;DUSP26;RAC1;CXCL12;PRKCA;FLCN;RHOD;TPM1;ADGRG1;FBLN2;CD47;ECM2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.47829063423057216,1.3633853814439418,0.059574468085106386,0.9601511580715607,1.0,23/65,19.02%,CPEB1;UBQLN1;SFRP1;SIRT2;STUB1;PICK1;RORA;ZFP36L1;CARD16;FAM162A;TBL2;MDM4;NDRG1;TWIST1;SUV39H1;AK4;EGLN2;PTGS2;NDNF;HP1BP3;MDM2;PGK1;FMN2
prerank,regulation of B cell differentiation (GO:0045577),0.5868997022347044,1.3619723256753566,0.09906291834002677,0.9655914521077789,1.0,3/17,4.02%,SFRP1;XBP1;ZFP36L1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4800195116030889,1.3618176925751933,0.05519480519480519,0.9631753383022964,1.0,11/66,12.83%,WNT5A;LPL;IGF1;GSDMD;TNFAIP3;CARD16;TMEM106A;SIRPA;MALT1;APP;GIT1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4484517087194785,-1.3610547537887088,0.09829059829059829,0.792313229460994,1.0,8/19,11.89%,PRKCH;IKBKB;TJP1;CLDN5;PRKACA;F11R;OCLN;ROCK1
prerank,purine nucleotide catabolic process (GO:0006195),-0.509108149391115,-1.3606516511103863,0.09897610921501707,0.7866258734219086,1.0,8/13,34.72%,NT5C2;NT5E;ITPA;GPX1;PNP;GDA;NT5C;NT5C1A
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6159161175426551,1.3606437798351754,0.11944444444444445,0.9668786798764489,1.0,5/13,11.52%,NFKB1;SCAP;DKK3;ERLIN2;BMP5
prerank,positive regulation of cell differentiation (GO:0045597),0.4393417285422637,1.3602638830530989,0.011033099297893681,0.9656926028555672,1.0,59/237,16.48%,SFRP2;PLA2G5;MAPK9;LPL;TMEM119;SFRP1;IGF1;SP7;FBN2;NFKB1;LRRC8A;BMP6;EDN3;FGFR1;XBP1;GLIPR2;ZFP36L1;NELL1;SNAI1;OLFM1;DDR2;TCF4;ABL1;FBXO5;SUCO;EZH2;ZEB1;RANBP3L;GPC1;RIPOR2;TGFB1I1;WDFY2;BRINP3;WNT4;SOX9;MMD;GPRC5B;SDCBP;DHX36;SOX11;TWIST1;GDNF;IGFBP3;BNIP2;NUDT21;SOX6;AXIN2;RPS6KA3;TGFB1;AAMDC;IMPACT;SOX5;LMO3;TCF3;CTNNBIP1;RPS6KA1;CDS1;MEDAG;AGTR1
prerank,heart contraction (GO:0060047),0.5031674965411678,1.3601321351895417,0.09490740740740741,0.9630582249878468,1.0,6/41,10.81%,TNNI3;TNNC1;TNNI1;ATP1A2;SCN2B;TPM1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5132594962949405,-1.358863694645066,0.11301369863013698,0.7860643993812398,1.0,3/13,9.41%,LEF1;LGALS9;RARA
prerank,regulation of leukocyte migration (GO:0002685),0.5798725786308919,1.3584822568120591,0.12585499316005472,0.9697457298698762,1.0,3/16,6.68%,RAC1;ANXA1;MIA3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.511724801191112,1.358269620109851,0.08963911525029103,0.9678269122591197,1.0,12/40,14.63%,BAX;SLC25A33;PRELID1;ABL1;PPA2;SLC25A36;PID1;VCP;BCL2;PARK7;MAPT;RNF122
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6327642613003072,1.3579781309479302,0.13583815028901733,0.9662436264705139,1.0,5/11,19.47%,ATL1;BNIP1;MOSPD3;VAPB;VCPIP1
prerank,chloride transmembrane transport (GO:1902476),-0.3470230919604653,-1.3575282303027012,0.06363636363636363,0.7840432143258345,1.0,20/48,23.88%,ANO4;GABRB1;SLC12A7;GABRG2;CLCN3;ANO6;ANO1;GABRA5;SLC12A4;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;GABRA1;GLRA3;SLC12A8
prerank,regulation of ion transport (GO:0043269),0.47131441788617845,1.3570927079357442,0.061636556854410204,0.9684399014088048,1.0,13/76,12.73%,FGF20;SYT3;SYT10;NKAIN4;VAMP3;SNX6;SIK1;KCNJ10;YWHAH;PER1;GDNF;ANK3;SYT1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.485876356238229,1.3569510855458071,0.0728476821192053,0.9660469341918153,1.0,11/59,12.08%,NDUFAB1;LPL;CYP27A1;MLYCD;XBP1;ALDH1A2;CYP7B1;HSD17B4;ELOVL4;AMACR;PARK7
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5501521006210601,1.356269778116299,0.1119496855345912,0.9667921296176228,1.0,10/25,17.63%,STUB1;ZYG11B;NGLY1;AUP1;POMT2;KLHL15;VCP;UGGT2;DERL1;OMA1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.29266159359491545,-1.3558664867004335,0.0,0.7836824451535123,1.0,28/94,14.52%,UBE2N;IKBKB;PSMB7;IRAK2;CUL1;IL1R1;RPS6KA5;RBX1;SKP1;IRAK1;NOD1;PSMB2;PSMD7;NFKBIA;PELI1;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;MAP3K8;UBB;TOLLIP;IKBKG;PSMD9;PSMD2;IRAK4;PSMB3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5592235350147986,1.3545449275094115,0.1318242343541944,0.9739583281130016,1.0,8/20,15.76%,GMPS;ADSL;PAICS;GART;AK4;HPRT1;AK3;GMPR2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3872576466719598,-1.353885239014122,0.07303370786516854,0.7847035076168707,1.0,10/28,17.15%,UBE2N;IRAK2;IRAK1;NOD1;OTULIN;CYLD;UBB;IKBKG;IRGM;AAMP
prerank,fatty acid transport (GO:0015908),0.5690916863935765,1.353860211459884,0.11637347767253045,0.9749748087421991,1.0,2/17,3.04%,SLC27A6;SLC27A4
prerank,cardiolipin metabolic process (GO:0032048),0.6102495918267231,1.3534139184852367,0.1502808988764045,0.9744128641368652,1.0,6/13,16.50%,PLA2G5;PTPMT1;CRLS1;HADHB;LCLAT1;SLC27A1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3846927149770328,-1.3533916764363458,0.08743169398907104,0.779470502124167,1.0,6/30,9.55%,CD46;STAT3;TLR4;LGALS9;CD34;PLCG2
prerank,peptide catabolic process (GO:0043171),-0.42076967769502294,-1.3527658577581452,0.12442396313364056,0.7748563908591464,1.0,12/23,23.93%,NPEPPS;LNPEP;LTA4H;ERAP1;TPP1;GGT5;XPNPEP1;ACE;ENPEP;IDE;CHAC2;TRHDE
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5326375265323198,1.352670978651633,0.11875,0.9753679338574188,1.0,5/24,8.37%,CARMIL2;RAC1;ACTR2;PIK3R1;CYFIP1
prerank,activation of adenylate cyclase activity (GO:0007190),0.5158378817487393,1.3511320000775042,0.09250585480093677,0.9812929251756423,1.0,2/35,2.40%,FSHR;ADCY7
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.5079219881117655,-1.3507221102361917,0.11926605504587157,0.77580406432284,1.0,9/12,35.54%,CAV1;IFIH1;RALB;MAVS;IFIT1;DHX9;PQBP1;MUL1;CGAS
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4924129022324833,1.3501814183842982,0.08833522083805209,0.9840239891078465,1.0,12/48,16.59%,GMPS;ADSL;SLC35B2;ADCY7;DCAKD;PANK4;COASY;ACAT1;AK5;ADCY1;NPR2;ADCY5
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.43046624299502523,-1.3499313036707359,0.09881422924901186,0.7723276945615823,1.0,9/17,15.99%,NR3C1;MED1;AR;ATP1A1;URI1;ABHD2;BMP7;SRC;BMP4
prerank,response to glucose (GO:0009749),0.4972897040077481,1.3498126746108416,0.09662398137369034,0.9830950482542509,1.0,12/46,13.42%,LPL;GPLD1;SELENOS;NKX6-1;XBP1;TCF7L2;SELENOT;IRS2;ZBTB20;RACK1;ZBED3;TRA2B
prerank,regulation of smoothened signaling pathway (GO:0008589),0.48585882137583436,1.3489684061523421,0.09587513935340022,0.9850667705920131,1.0,14/50,16.45%,SFRP1;STK36;FGFR2;DCDC2;GLIS2;RORA;RAB34;TUBD1;PTCH1;VCP;RACK1;SUFU;TULP3;MEGF8
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5472419590453887,-1.3487686311147287,0.12615384615384614,0.7702366996055378,1.0,4/10,3.95%,PRKG1;RDX;SERPINE2;PRKCD
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4881067462602084,-1.3485946408052907,0.1267123287671233,0.7643110751116665,1.0,6/14,17.09%,PDCD4;THBS1;ANO6;PLCG1;ITGA4;RGCC
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6372123223028154,1.3484162332806227,0.11861861861861862,0.9852215332589235,1.0,4/11,5.91%,IGF1;TSC2;EIF2AK3;PIK3R1
prerank,sensory perception of smell (GO:0007608),0.6427917035679499,1.3483300155158335,0.1217008797653959,0.9824708437887095,1.0,3/11,10.58%,SYT10;SLC24A4;UBR3
prerank,canonical Wnt signaling pathway (GO:0060070),0.47667630792108945,1.3471816278184796,0.06493506493506493,0.9861716335548181,1.0,15/68,15.29%,SFRP2;WNT2B;WNT5A;SFRP1;DVL2;FZD9;FZD3;TCF7L2;DVL1;WNT4;DIXDC1;PORCN;PLPP3;CSNK1A1;TCF7L1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.44871572338812865,-1.3468802977504117,0.0842911877394636,0.7641220141487653,1.0,4/17,21.26%,LAMP1;CADM1;NECTIN2;PVR
prerank,positive regulation of signaling (GO:0023056),0.5005653357931811,1.3467357922987842,0.10250297973778308,0.9856152171244652,1.0,13/37,18.43%,CDKN2AIP;EDN3;SCRIB;VAMP3;NMU;SOX11;WLS;CLSTN2;SYT1;NSF;ANXA2;ILK;CLSTN3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4602736772176369,-1.346474125529536,0.10256410256410256,0.7589378808530047,1.0,4/16,21.26%,LAMP1;CADM1;NECTIN2;PVR
prerank,regulation of glucose import (GO:0046324),0.5225140070417665,1.346168537983995,0.10774818401937046,0.9857950576145063,1.0,9/30,13.35%,RTN2;IGF1;SELENOS;CAPN10;PIK3R1;PID1;IRS2;ENPP1;PRKCI
prerank,steroid metabolic process (GO:0008202),0.46346312901716974,1.3459553894136147,0.08783068783068783,0.9839304557386777,1.0,13/72,13.04%,CYP27A1;GBA2;CYP7B1;LSS;HSD17B4;GC;RDH5;MSMO1;PRLR;AMACR;STARD3;CYP26B1;CYP51A1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4469910226459884,1.3459287134142606,0.021233569261880688,0.9808650273449401,1.0,52/152,20.13%,SFRP2;TMEM198;ATP6AP2;SFRP1;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DDX3X;FZD9;TNFAIP3;FGF10;PPM1B;USP47;SULF1;PSMB10;PSMD11;XIAP;GPRC5B;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;JUP;AXIN2;ZBED3;CDC73;DISC1;CSNK1D;RNF220;TGFB1;LYPD6;PSMD1;USP34;ADGRA2;TNKS;PTK7;UBR5;PSMD6;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;PRDM15;LRRK1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.46587206290202343,1.3458399603283726,0.0559662090813094,0.9781727426225806,1.0,30/75,21.78%,ATL1;ABITRAM;FGFR2;DCDC2;MINK1;NEFH;CDK5;PAK3;DVL1;BRSK2;BAIAP2;RAB10;NTNG2;BRSK1;AFG3L2;APP;ANK3;DOCK7;FARP1;RAB8A;BTBD3;TBCD;DCC;ZDHHC17;SLITRK1;SLITRK5;MAP6;SPTBN4;LLGL1;RYK
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.49531421704578876,1.3453838334570674,0.08700564971751412,0.9777242718389403,1.0,20/45,22.12%,MAD2L1;HECA;ZFP36L1;FZD3;SCRIB;WEE1;TRIM35;BRINP3;AURKAIP1;CHFR;PTPN3;TGFB1;BCL6;ZWINT;BRINP1;NABP2;ZW10;TOM1L2;ANGEL2;SMAD3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5482521265476725,1.3443092762093611,0.13534822601839686,0.9808666079194512,1.0,10/20,21.65%,VTN;IGF1;NRP1;IGFBP3;NDRG4;LRP1;SERPINE1;SORL1;S100A11;IGFBP5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4782461011220292,1.3407203754553545,0.08234019501625135,1.0,1.0,14/62,12.60%,SFRP2;CDKN2D;PPIF;SELENOS;SYVN1;XBP1;DDX3X;CXCL12;SNAI1;BCL2;RTKN2;PARK7;SOD2;CREB3
prerank,positive regulation of heart rate (GO:0010460),0.5774267414794448,1.3404299509871223,0.13237221494102228,0.9986677190848631,1.0,4/17,10.81%,ADM;EDN3;ATP2A2;TPM1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4281233822219065,-1.3401580880633241,0.13852813852813853,0.7762584188212899,1.0,6/19,7.34%,PRKCE;LBP;IRAK1;TLR4;LGALS9;RAB11FIP2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.49814171378702277,1.340096932858882,0.09824561403508772,0.9974580201471366,1.0,7/41,12.84%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10;ANK3;GABBR1
prerank,sympathetic nervous system development (GO:0048485),0.5951749019893711,1.3395438660530699,0.149519890260631,0.9978757206591744,1.0,6/15,19.15%,FZD3;NRP1;SOX11;GDNF;SEMA3A;SOX4
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5584875670023711,1.3392847783587725,0.12661498708010335,0.9963153948766572,1.0,6/20,18.01%,APLN;SULF1;GPC1;NPTN;SPRY2;PRKD2
prerank,cellular response to interleukin-6 (GO:0071354),-0.4140399756255693,-1.3390897198017744,0.1044776119402985,0.7741044865591368,1.0,7/26,4.13%,SMAD4;ST3GAL6;IL6R;FER;STAT3;STAT1;SBNO2
prerank,regulation of neuron apoptotic process (GO:0043523),0.45515187090199494,1.3388752535849289,0.05555555555555555,0.9956394400626953,1.0,23/96,17.19%,FGF20;CLN3;EPHA7;BAX;NTF3;FZD9;CDK5;SNX6;SLC30A10;DDIT3;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;LANCL1;PRKCI;EGLN2;NUPR1;NDNF;FAIM2;APOE
prerank,mRNA splice site selection (GO:0006376),0.5228651588231911,1.3388026530183328,0.125,0.9928967106521588,1.0,14/30,17.68%,SRSF12;SRSF5;CELF2;CELF1;SRSF9;SF3A1;SRSF1;PSIP1;SETX;LUC7L2;KHDC4;CELF5;YTHDC1;LUC7L3
prerank,cellular response to amyloid-beta (GO:1904646),0.5187250437088395,1.338580981979174,0.10153482880755609,0.9911449992037114,1.0,11/35,16.06%,FCGR2B;IGF1;GRIN1;ATP1A3;CDK5;SNX6;GRIN2A;CACNB1;APP;LRP1;ICAM1
prerank,autophagy of peroxisome (GO:0030242),0.6094915277424211,1.3384929421523102,0.13043478260869565,0.9886179540779506,1.0,7/12,19.00%,TRAPPC8;USP30;SQSTM1;PEX5;MAP1LC3B;PIK3C3;PIK3R4
prerank,release of cytochrome c from mitochondria (GO:0001836),0.577440590668471,1.3383621440484625,0.14664804469273743,0.9863119100759082,1.0,6/17,14.84%,BAX;FIS1;FZD9;BCL2;SOD2;DNM1L
prerank,regulation of viral life cycle (GO:1903900),-0.4256457086181266,-1.3377254410979704,0.11328125,0.7726339765452737,1.0,9/21,21.33%,TSG101;AXL;TRIM25;KPNA6;TRIM5;TRIM14;VPS4A;NECTIN2;HS3ST5
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.550377703595529,1.3376405497165726,0.13219895287958114,0.9875825282894746,1.0,7/21,15.91%,SIRT2;SLC30A10;PARK7;COA8;ABCB7;ABCD2;SIRT5
prerank,protein localization to phagophore assembly site (GO:0034497),0.6212692741168834,1.337565841748551,0.14561664190193166,0.9849045769592432,1.0,6/11,18.15%,TRAPPC8;WIPI1;MFN2;ATG13;STX17;ATG9A
prerank,purine nucleotide biosynthetic process (GO:0006164),0.6112717648002555,1.3372777106011084,0.1564327485380117,0.9835112723144632,1.0,4/12,13.10%,ADSL;PRPSAP2;GART;HPRT1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5096817773182843,1.3367614915202348,0.11084905660377359,0.983517696249744,1.0,6/34,14.67%,WNT5A;EPHB2;XBP1;VAMP3;PTPN22;LACC1
prerank,presynapse assembly (GO:0099054),0.5843260175164812,1.3363757939718028,0.1188118811881188,0.9827432474526269,1.0,5/16,14.38%,WNT5A;DVL1;IL1RAPL1;NLGN3;NLGN2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.47790698084891736,1.3363018126717474,0.08564814814814815,0.9801912892221037,1.0,11/47,20.45%,VTN;BIN1;SERPING1;SPOCK1;SERPINA2;SPOCK2;SERPINE1;SERPIND1;SORL1;TIMP2;SERPINF1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.545180806014603,1.33593739183706,0.1423076923076923,0.9794347916509677,1.0,7/22,19.24%,GPLD1;NRDC;PACSIN3;SNX33;PTPN3;APOE;TIMP2
prerank,neurotransmitter transport (GO:0006836),0.46949992812830127,1.335634952364622,0.08423326133909287,0.9782288755717261,1.0,16/73,14.29%,SLC29A1;PPFIA4;GLS2;CASK;UNC13A;DVL1;ATP1A2;GLUL;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1;SLC6A4;SLC1A3;SLC6A15
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5707460171115326,1.334415426610886,0.14363143631436315,0.9825277628178707,1.0,7/17,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;CXCL17;HMGB1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.503012226542426,1.3332851377527157,0.11374407582938388,0.9866669128249533,1.0,7/35,11.37%,IL10RA;OCIAD2;IL10RB;PIGU;HGS;EGF;LEPROT
prerank,coenzyme A metabolic process (GO:0015936),0.5910241492952188,1.3327745963285265,0.14887640449438203,0.9867435575427734,1.0,5/14,10.94%,DCAKD;PANK4;COASY;ACAT1;CROT
prerank,myelin assembly (GO:0032288),0.6335058630733988,1.3319102027738967,0.1283987915407855,0.9890035105568726,1.0,6/10,21.61%,ABCA2;GPC1;EPB41L3;TENM4;TPPP;CD9
prerank,icosanoid secretion (GO:0032309),0.6087072911722459,1.3311898276398975,0.1529745042492918,0.9903289552696299,1.0,3/12,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.5003228353411338,-1.3311598320027638,0.15140845070422534,0.7922796341039683,1.0,11/12,45.58%,MCM6;CDC7;MCM4;MUS81;MCMDC2;GINS4;CDC45;MCM3;MCM2;MCM7;MCM5
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5669738907294722,1.330337434009618,0.13733333333333334,0.9925147016183516,1.0,5/16,15.47%,CHID1;ADCY7;SIRPA;CUEDC2;ABCD2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.638928250573777,1.3303054156766267,0.15701219512195122,0.9897565918485435,1.0,3/10,6.42%,EMC1;EMC8;MMGT1
prerank,peptide hormone secretion (GO:0030072),0.5265142434350011,1.3301666001106967,0.1084788029925187,0.9876156044650731,1.0,5/26,12.18%,PTPRN;EDN3;ANXA1;PARK7;CAMK2G
prerank,ear morphogenesis (GO:0042471),0.553666497241774,1.3290817181927272,0.13506139154160982,0.991080675555047,1.0,4/20,9.79%,EPHB2;FGFR2;NIPBL;TWIST1
prerank,positive regulation of cell growth (GO:0030307),0.4508178090876249,1.3290342283486838,0.06638566912539515,0.9883803589776796,1.0,21/96,13.92%,SFRP2;RNF157;SYT3;SFRP1;IGF1;CDKN2AIP;EXOSC2;CDKL5;TAF9B;UNC13A;SLC25A33;DDX3X;USP47;DBN1;SDCBP;DBNL;BCL2;EIF4G2;SYT1;RPS6KA3;MAPT
prerank,histone H2A acetylation (GO:0043968),-0.44597508002972136,-1.3284991498471639,0.12698412698412698,0.7956690868013386,1.0,6/16,17.77%,EPC1;TRRAP;NAA40;MSL3;ACTL6A;ING3
prerank,axon extension (GO:0048675),0.5392618899918872,1.328465336177309,0.12298136645962733,0.9890165457828028,1.0,12/23,15.89%,HSP90AA1;NRP1;CDK5;CYFIP1;NLGN3;USP9X;ALCAM;AUTS2;SLIT1;SLIT3;SEMA3A;SLC9A6
prerank,nuclear membrane disassembly (GO:0051081),0.6044949874009526,1.3279195625792082,0.12831241283124128,0.9893377879307229,1.0,4/14,6.66%,LPIN1;PRKCA;NEK9;AKAP8L
prerank,regulation of cell adhesion (GO:0030155),0.44195330113362963,1.3278258274816412,0.04781281790437437,0.9869968103765141,1.0,24/129,11.14%,EPB41L4B;DUSP26;DACT2;EPHA7;EPHB2;PLXNA2;FBLN1;CXCL12;MINK1;PRKCA;FLCN;NUAK1;ABL1;ADAM22;EPHA8;MIA3;RHOD;CXCR4;RIPOR2;DSCAM;PLXNA1;GPR4;TPM1;ADGRG1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5664474259461574,1.3268661028760258,0.12872628726287264,0.9901694059813282,1.0,1/17,0.11%,SFRP2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5066205968676649,1.326844792592605,0.12575574365175332,0.9873969872125614,1.0,8/32,10.71%,SLC4A4;IGF1;ARNT;PID1;PRXL2C;VCP;ZBTB20;APP
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5148780634138886,1.3267557269409747,0.11686746987951807,0.9850593606000347,1.0,10/31,20.88%,TNNI3;TNNC1;FGFR2;TPM1;RBPJ;NRG1;TGFB1;TGFBR1;TGFBR3;SMAD7
prerank,triglyceride metabolic process (GO:0006641),0.48599299152803654,1.3262227755923688,0.11724137931034483,0.9852511399925483,1.0,8/48,12.41%,LPL;MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5336744537059515,1.3255619102060114,0.11734693877551021,0.9863223388086453,1.0,8/27,13.59%,FCGR2B;FBXO7;BRSK2;NTNG2;BRSK1;IL1RAPL1;CAMK2G;DISC1
prerank,regulation of protein autophosphorylation (GO:0031952),0.49832177761111834,1.3249294157920577,0.12,0.9872800676552179,1.0,15/36,18.96%,EPHA7;CALM3;DDX3X;ERRFI1;RAP2A;PPP2R5E;MVP;ENPP1;IMPACT;PPP2R5D;MRE11;RAD50;PPP2R5A;RASSF2;CALM1
prerank,negative regulation of blood coagulation (GO:0030195),0.49389762568097184,1.3241851689907913,0.10810810810810811,0.9887277114030906,1.0,10/38,17.19%,VTN;C1QTNF1;SERPING1;PLAT;PDGFRA;TFPI;F3;F8;SERPINE1;APOE
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.630962015380046,1.3237835299279879,0.14411764705882352,0.9883116861446142,1.0,4/11,11.50%,BIN1;NOS1AP;CACNB1;CAMK2D
prerank,protein methylation (GO:0006479),0.48900793429989986,1.3228924197143712,0.11764705882352941,0.9907136777021355,1.0,19/40,19.80%,LCMT1;PRMT6;ETFBKMT;EZH2;EHMT2;PRMT5;NTMT1;NSD3;PRMT1;EHMT1;GSPT1;FAM98A;ATPSCKMT;PRMT8;PCMT1;NSD1;RAB6A;PRMT2;CARM1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4601652198429621,1.3225960280407285,0.0877005347593583,0.9896468799667646,1.0,23/71,19.04%,ADAMTS7;STUB1;ZYG11B;TNFAIP3;OTUD7A;NGLY1;DDB1;HM13;CAPN2;CUL4B;VCP;CHFR;MALT1;VPS4B;USP9X;RNF41;CTSZ;CTSH;NEDD8;MDM2;OMA1;CTSK;CTSO
prerank,positive regulation of protein processing (GO:0010954),0.5632993117440606,1.3208863563529365,0.12433862433862433,0.9968541326103522,1.0,2/19,4.19%,CLEC3B;CCBE1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.559534258762119,1.3206311265023514,0.12702702702702703,0.9955484029051754,1.0,6/19,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,regulation of amyloid-beta formation (GO:1902003),0.49901239537651115,1.3198592422047204,0.11927710843373494,0.9973298809841636,1.0,16/34,23.04%,RTN2;IGF1;BIN1;ABCA2;ABCA7;IFNGR1;TMED10;ROCK2;APOE;SORL1;NTRK2;ABCG1;GGA3;RTN1;EPHA4;SP1
prerank,positive regulation of cell projection organization (GO:0031346),0.4458668799628366,1.3194586571259337,0.05252317198764161,0.9968110685377846,1.0,41/115,20.96%,CARMIL2;AMIGO1;WNT5A;CAMK2B;DVL2;CUL7;CDKL5;PLXNA2;OBSL1;TENM3;DVL1;PLXNA1;PLK5;RAPGEF1;ROBO2;ROBO1;MAGI2;IL1RAPL1;NDRG4;SETX;ROR2;NPTN;PRKCI;PLPPR5;ARSB;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;SLITRK1;CUX1;SCARB2;CARMIL1;LYN;ATP1B2;PTK2B;MAP6;NTRK2;SCN1B
prerank,regulation of sodium ion transport (GO:0002028),0.5065575252143288,1.3193874138296755,0.12515042117930206,0.9943938680540525,1.0,10/34,11.41%,GPD1L;NKAIN4;CNKSR3;SIK1;YWHAH;PER1;WNK2;ANK3;SLMAP;FGF12
prerank,regulation of chemotaxis (GO:0050920),0.5157442899311027,1.3193251795046488,0.12439024390243902,0.9919765283167463,1.0,10/30,16.26%,USP14;ZSWIM6;CXCR4;MYCBP2;EFNB2;PDGFRA;YTHDF1;TGFB1;ZSWIM8;ADGRA2
prerank,activation of protein kinase B activity (GO:0032148),0.5109954961524544,1.3191528550085596,0.1189873417721519,0.9902430806417071,1.0,4/29,2.60%,WNT5A;IGF1;PDPK1;NTF3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4497742930768116,1.3181731999062467,0.08227848101265822,0.9930813318928408,1.0,31/84,22.71%,ILF3;RTN2;IGF1;PAIP2;BIN1;EIF2AK3;DDX3X;CNOT10;IGF2BP2;EPRS1;DHX36;ABCA7;PUS7;EIF4E2;CNOT9;MALSU1;RACK1;DAPK1;MRPL13;FMR1;APOE;SORL1;SAMD4B;RPS3;YBX1;NTRK2;IGFBP5;SAMD4A;GGA3;RTN1;RPL13A
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5571458862117752,1.3179656971259361,0.1497326203208556,0.9915286000251681,1.0,5/18,11.50%,PPIF;CBARP;BIN1;ATP1A2;CAMK2D
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5352757855823264,1.3173859025437094,0.13486005089058525,0.9921524367882455,1.0,7/22,10.46%,MED24;MED12;MED14;MED13;MED4;DHX36;PSMC5
prerank,mitochondrion morphogenesis (GO:0070584),0.6089615716490918,1.3172068882113603,0.16716417910447762,0.9904674728466036,1.0,5/11,14.84%,FIS1;MYH14;PID1;WASF1;DNM1L
prerank,negative regulation of hormone secretion (GO:0046888),-0.537290379491492,-1.3171966341971164,0.142433234421365,0.8317973151312672,1.0,3/10,18.74%,GJA1;RAB11FIP5;RAB11FIP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5659717675600824,1.3171939095305243,0.14758620689655172,0.9877961347479983,1.0,6/17,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.45915876897658314,1.3169013344364098,0.09663409337676439,0.9867352157668816,1.0,25/65,23.40%,ADAMTSL2;FBN2;PDPK1;STUB1;PMEPA1;SNX6;HTRA3;TGFB1I1;LTBP1;LEMD3;PEG10;FBN1;TGFB1;SMAD6;VASN;MTMR4;SPRY2;SMURF1;TGFBR1;PPM1A;SMAD7;SMAD2;SMAD3;DAND5;FKBP1A
prerank,response to ethanol (GO:0045471),0.5866705799433958,1.3167279352897419,0.16069057104913678,0.985070970857389,1.0,4/14,14.46%,ADCY7;GRIN1;GRIN2A;GLRA1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.48841075873032913,-1.3163454510684245,0.15384615384615385,0.8285854704475628,1.0,4/12,6.44%,LRP6;MBNL1;FBXW4;TGFB2
prerank,neuron projection morphogenesis (GO:0048812),0.43836670801106886,1.3161970768956794,0.05188199389623601,0.985559441902005,1.0,51/137,21.78%,EPHB2;ATL1;ABITRAM;NTF3;FGFR2;DCDC2;TAOK1;CTNND2;MINK1;NEFH;CDK5;SRGAP2;PAK3;DVL1;DBN1;BRSK2;FLRT1;BAIAP2;RAB10;DBNL;NTNG2;BRSK1;AFG3L2;APP;ANK3;ALS2;IQGAP1;DOCK7;FARP1;ALCAM;EPB41L3;IMPACT;CNTNAP2;RAB8A;TRIO;SLC9A6;BTBD3;DCC;ZDHHC17;SLITRK1;GAS7;KIF20B;SHANK1;NRK;SLITRK5;NBL1;MAP6;SPTBN4;MAP4K4;LLGL1;RYK
prerank,positive regulation of proteolysis (GO:0045862),0.4697492674571581,1.3150822894890108,0.09812568908489526,0.9894133184342152,1.0,14/55,17.26%,GPLD1;CLN6;STUB1;NRDC;CCBE1;OGT;RCN3;PACSIN3;AURKAIP1;SNX33;CTSH;APOE;TANK;TNIP1
prerank,regulation of synapse organization (GO:0050807),0.5182032079080395,1.3147822613597389,0.13422007255139057,0.988245108731505,1.0,5/26,6.07%,WNT5A;CLN3;CAMK2B;CDKL5;ABL1
prerank,rRNA modification (GO:0000154),0.5309618798081681,1.3140905364705513,0.13541666666666666,0.9894509142521702,1.0,8/21,19.51%,NHP2;FBL;DIMT1;BUD23;ZCCHC4;TFB1M;METTL5;NSUN4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6224330440317389,1.3140686452776256,0.15648286140089418,0.9869150682179876,1.0,4/11,14.61%,ADM;ARRB1;GRK3;GRK2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.387212078175685,-1.3138550629411616,0.1330049261083744,0.8315264913262304,1.0,10/25,18.44%,KAT7;WDR43;ELL;HTATSF1;EAF2;SCAF8;THOC5;CCNK;CCAR2;ERCC6
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5270206003231952,1.3119202907988992,0.14814814814814814,0.9965025480679811,1.0,6/24,6.13%,SFRP1;RAC1;NRP1;PIK3R1;ABL1;THY1
prerank,regulation of fibroblast migration (GO:0010762),0.5440351762031918,1.311792660779691,0.151797603195739,0.9945985199849127,1.0,11/20,21.29%,CLN3;RAC1;DDR2;ARHGEF7;DMTN;RFFL;TGFB1;ITGB1BP1;ITGB1;APPL2;FGF2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5069929034293497,1.3110277185506514,0.13048933500627352,0.9964596128017773,1.0,9/30,15.20%,ALG5;DPM2;ALG8;UGGT2;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5200226816848668,1.310831742458115,0.1311881188118812,0.9949194408122998,1.0,7/28,9.17%,STMN4;MAPRE3;GBA2;ABL1;CAMSAP2;GAS2L1;PRUNE1
prerank,striated muscle contraction (GO:0006941),0.46715915110437195,1.3098636347493595,0.11576626240352811,0.9979659053551353,1.0,7/53,10.81%,TNNI3;TNNC1;TNNI1;MYH14;ATP1A2;SCN2B;TPM1
prerank,placenta development (GO:0001890),0.5949823139316078,1.3096909171268847,0.15671641791044777,0.9963153202171633,1.0,1/12,1.38%,CUL7
prerank,regulation of lipase activity (GO:0060191),0.5920269682709419,1.3093991791583848,0.15728715728715728,0.9953281752982509,1.0,2/13,4.57%,LPL;PCSK5
prerank,positive regulation of cell communication (GO:0010647),0.5106880405118539,1.3093620446327385,0.13875,0.9929523262786103,1.0,10/28,18.43%,CDKN2AIP;EDN3;NMU;SOX11;WLS;CLSTN2;ANK3;SYT1;ILK;CLSTN3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.533079890506692,-1.3092429599450237,0.15457413249211358,0.8427046488070783,1.0,6/10,27.10%,CSGALNACT1;XYLT1;DSEL;B3GAT2;XYLT2;B3GAT1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5215425825844077,1.3088427260038125,0.12804097311139565,0.993416068477297,1.0,12/25,21.95%,HEXIM1;EAPP;RNF8;CDK13;BRD4;RNF168;CDC73;NELFA;RECQL5;HNRNPU;EAF1;TCERG1
prerank,negative regulation of ATPase activity (GO:0032780),0.5718811213537679,1.3087649704961979,0.1502808988764045,0.9912150170903394,1.0,2/16,1.61%,TNNI3;PPIF
prerank,amino acid import (GO:0043090),-0.42346818401794306,-1.308676646124743,0.14344262295081966,0.8382392428977812,1.0,6/21,5.29%,SLC6A6;SLC16A2;SH3BP4;SLC47A1;SLC7A1;SFXN2
prerank,heart trabecula morphogenesis (GO:0061384),-0.42100779079202766,-1.308223985202188,0.145748987854251,0.8337502738253121,1.0,8/18,13.00%,ADGRG6;TEK;RBP4;TGFB2;ENG;BMPR1A;S1PR1;BMP7
prerank,DNA conformation change (GO:0071103),0.5577621751321559,1.3072444829798384,0.15591397849462366,0.9974671158095267,1.0,8/17,22.00%,HMGB3;ABL1;TOP1;HAT1;TOP3B;TOP3A;TOP2B;HMGB1
prerank,RNA transport (GO:0050658),0.4538517352434358,1.3069771332799065,0.08836206896551724,0.9963745329689428,1.0,33/71,24.91%,SLBP;U2AF1;SRSF2;ZFP36L1;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;KIF5C;THOC7;SIDT1;HNRNPA2B1;THOC1;NUP214;FMR1;SRRM1;NUP153;FLOT1;RTRAF;YBX1;TPR;SARNP;U2AF2;SIDT2;NUP155;SRSF6;ATXN2;RBFOX1;CHTOP;PNPT1
prerank,B cell mediated immunity (GO:0019724),0.6273032316125146,1.3062029995388214,0.17357910906298002,0.9981260016177234,1.0,1/10,0.85%,FCGR2B
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3634564091276096,-1.3059765536402013,0.07236842105263158,0.8357684944075265,1.0,20/37,21.70%,HIPK2;WAC;FHIT;CSNK2A1;PML;RPL11;HSP90AB1;UCHL5;RPL5;CAMLG;DDRGK1;TRIM39;MAP1A;GIPC1;SGTA;CCAR2;BAG6;PDCL3;UBXN1;NOP53
prerank,positive regulation of neutrophil migration (GO:1902624),0.5528491387558069,1.3043418414786487,0.1600547195622435,1.0,1.0,6/18,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,regulation of cell killing (GO:0031341),0.5624183289441269,1.3043154444225937,0.14207650273224043,1.0,1.0,3/16,2.78%,WNT5A;DVL2;RAC1
prerank,lipoprotein localization (GO:0044872),0.6214290776601105,1.3038978447982998,0.14836795252225518,1.0,1.0,5/11,17.86%,MIA3;ZDHHC3;LRP1;VMP1;ZDHHC17
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5780665032146336,1.3037025165964553,0.16810344827586207,1.0,1.0,2/13,4.87%,SFRP2;NRP1
prerank,dendrite morphogenesis (GO:0048813),0.49476238353003366,1.3029876521164194,0.13196125907990314,1.0,1.0,7/35,6.49%,EPHB2;ABITRAM;DCDC2;CTNND2;MINK1;PAK3;DVL1
prerank,positive regulation of chemokine production (GO:0032722),0.4692257682086213,1.301852045391437,0.1320973348783314,1.0,1.0,8/44,13.28%,WNT5A;LPL;IL33;DDX3X;TIRAP;TWIST1;APP;TLR3
prerank,nuclear transport (GO:0051169),0.565281216599224,1.301269104637775,0.1601615074024226,1.0,1.0,5/16,12.27%,NXT2;NXT1;ANP32A;PSIP1;NPM1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4714327525977426,1.3010532708564588,0.1174496644295302,1.0,1.0,12/47,16.69%,KHSRP;NFKB1;ABCA2;SNAI1;ERLIN2;SIRPA;SIK1;WNT4;ROCK2;SLC27A1;ACADL;ACADVL
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.43885982650446964,1.3009226855371043,0.07399794450154162,1.0,1.0,18/113,9.55%,FGF9;MMP12;WNT5A;PTPRN;SFRP1;IGF1;BMP6;FGFR2;XBP1;NRP1;FGF10;PRKCA;LAMC1;TCF7L2;ARNT;SOX9;EGF;SOX11
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.606933070997058,1.300635660775095,0.1606886657101865,1.0,1.0,3/12,5.13%,LPIN1;PRKCA;NEK9
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.43843678246912154,1.3004331205708148,0.07237512742099898,1.0,1.0,8/116,3.71%,FSHR;FCGR2B;PTGER4;SELENOS;ADCY7;ADM;VIPR2;PTHLH
prerank,intraciliary retrograde transport (GO:0035721),-0.5010209378642392,-1.3002705806395725,0.16828478964401294,0.8510882471429931,1.0,8/12,24.23%,IFT43;DYNC2I1;IFT122;IFT140;WDR19;DYNC2LI1;DYNLT2B;DYNC2I2
prerank,protein polyglutamylation (GO:0018095),0.6110222849837166,1.2999133960514493,0.16567164179104477,1.0,1.0,4/11,16.03%,TTLL4;TPGS1;CFAP20;TTLL11
prerank,cardiac atrium morphogenesis (GO:0003209),-0.42713088404984195,-1.2996382670026354,0.14590747330960854,0.8471419901610969,1.0,14/16,55.67%,TGFB2;ENG;NOTCH2;BMP2;HEY2;ZFPM1;DLL4;BMPR2;TBX20;NOG;MYH6;PROX1;GATA4;ISL1
prerank,negative regulation of interferon-beta production (GO:0032688),0.6160602568807397,1.2996050395368777,0.18433179723502305,1.0,1.0,6/10,23.35%,PPM1B;SIRPA;YY1;RELB;PTPRS;REL
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.44362823468111356,1.298834673790738,0.08501594048884166,1.0,1.0,15/86,10.71%,SFRP2;VTN;SFRP1;IGF1;EPHA7;BMP6;NTF3;NRP1;FGF10;ABL1;DMTN;LRP8;TEC;ENPP2;APP
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5023087267832776,1.2968838846400956,0.1393643031784841,1.0,1.0,17/32,24.81%,MMP12;AJAP1;CASK;DMTN;SEMA3E;JAG1;SERPINE1;ITGB1BP1;DLC1;ARHGAP6;NF2;MAP4K4;CLASP2;HOXA7;PTEN;CORO1C;PHLDB2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.428876669520572,-1.2962869540779807,0.13733905579399142,0.8541630893025961,1.0,8/18,13.64%,RNF103;RNF185;AMFR;MAN1B1;EDEM2;OS9;UBB;RNF139
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3863822198120566,-1.2959756474628468,0.12745098039215685,0.8490231850627785,1.0,7/24,8.93%,WASF2;ARHGEF18;TMEFF2;TJP1;INPP5K;F11R;ARHGAP28
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5349414244798624,1.2954880228701362,0.15535248041775457,1.0,1.0,5/23,11.50%,CBARP;NOS1AP;ATP1A2;CACNB1;CAMK2D
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5584496724608037,1.295426359679237,0.17582417582417584,1.0,1.0,2/17,3.12%,PSRC1;MAPRE3
prerank,neuromuscular process controlling balance (GO:0050885),0.5976728372911104,1.2950322886821763,0.16568047337278108,1.0,1.0,2/12,5.21%,CLN3;PCDH15
prerank,response to sterol (GO:0036314),0.6052187603541365,1.294808613029584,0.17391304347826086,1.0,1.0,6/11,21.53%,RORA;ABCA2;INSIG1;TGFB1;TGFBR1;SMAD2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4927066895939996,1.2946001585969018,0.15058823529411763,1.0,1.0,7/32,10.25%,CARMIL2;RAC1;ACTR2;PIK3R1;ARHGEF7;CYFIP1;ENPP2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4728196258639582,1.2944970478198132,0.14685314685314685,1.0,1.0,10/40,9.70%,TMEM119;FBN2;BMP6;FZD9;NELL1;FBXO5;ADGRV1;WNT4;ATP2B1;KL
prerank,sensory organ development (GO:0007423),-0.33222968485131976,-1.294468372047272,0.12962962962962962,0.84847188844017,1.0,21/51,30.11%,HIPK2;SMOC1;RAB18;RBP4;TGFB2;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMCHD1;SMG9;PBX2;PBX1;SOX2;ZDHHC16;FREM2;MEIS3;PAX8;MAFB;CHRDL1
prerank,positive regulation of endocytosis (GO:0045807),0.4721813127912616,1.2943407432748089,0.13124274099883856,1.0,1.0,17/45,22.07%,CALY;VTN;CLN3;CD151;HNRNPK;CLIP3;LRP1;CBL;RAB31;SERPINE1;RAB21;APOE;FLOT1;SMPD1;DAB2;APPL2;B2M
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.47191439881297403,1.2939088127392362,0.15356711003627568,1.0,1.0,15/38,24.20%,KHSRP;HSP90AA1;RAC1;NOS1AP;SIRPA;CD47;ROCK2;PTGS2;PKD2;ASS1;KLF4;ATP2B4;SMAD3;INSR;JAK2
prerank,positive regulation of leukocyte migration (GO:0002687),0.5078392672889582,1.2937807596833752,0.15452261306532664,1.0,1.0,4/27,8.46%,EDN3;THY1;MIA3;JAM3
prerank,mRNA metabolic process (GO:0016071),0.4373478007225366,1.2930836207160792,0.08577405857740586,1.0,1.0,33/90,19.58%,LSM6;TBRG4;SLBP;U2AF1;SRSF2;GEMIN2;PRPF8;DHX15;CNOT10;SRSF5;SF3B2;CELF1;AKAP8L;SRSF9;SF3A1;SRSF1;AURKAIP1;KIN;NUDT12;NUDT21;CPSF3;HNRNPA0;AGO3;HNRNPA2B1;DIS3L2;DDX5;NUDT16L1;SON;CPSF6;PCBP2;NONO;YTHDF2;CSTF3
prerank,regulation of protein localization to membrane (GO:1905475),0.5029285339851188,1.292933170013844,0.15489467162329615,1.0,1.0,13/28,19.44%,CLN3;SLC5A3;CDK5;GPC6;GPC1;VTI1B;GPC4;SPTBN1;STX8;VAMP8;ZDHHC2;MMP14;GPC5
prerank,cell-cell junction maintenance (GO:0045217),-0.5101757855316496,-1.2928279754003436,0.18275862068965518,0.8484748355415996,1.0,3/11,10.41%,FERMT2;TJP1;MYADM
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5407746867191637,1.2920034766447723,0.16094986807387862,1.0,1.0,7/21,12.60%,SELENOS;EIF2AK3;SYVN1;XBP1;DDIT3;PARK7;CREB3
prerank,metanephros development (GO:0001656),0.5115222230977089,1.2918395204651347,0.15489467162329615,1.0,1.0,9/26,18.92%,NIPBL;FGF10;PTCH1;GDNF;ROBO2;CTSH;OSR1;PKD2;FOXD1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5602478250314724,1.2917121226700805,0.16688918558077437,1.0,1.0,6/16,9.68%,DDX17;RBM17;CDK13;SRSF9;SRSF1;HNRNPM
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5940520744564933,1.2913227312650604,0.18607954545454544,1.0,1.0,3/12,4.44%,GRIN1;SLC5A3;ZNF205
prerank,myelin maintenance (GO:0043217),0.6243702365374305,1.2911199798650954,0.17655786350148367,1.0,1.0,4/10,15.47%,MYRF;CXCR4;EPB41L3;ABCD2
prerank,Notch signaling pathway (GO:0007219),-0.31640307572965737,-1.2911090744374398,0.08,0.8489964849664946,1.0,25/59,24.81%,MAML3;MIB1;MAML1;POFUT1;STAT1;NOTCH3;KAT2B;EP300;NCSTN;ADAM10;TRAF7;HES1;APH1A;HEYL;DTX1;NOTCH2;DTX3L;PBX1;JAG2;SORBS2;APH1B;NOTCH4;PSEN2;BMP2;MDK
prerank,neutral amino acid transport (GO:0015804),-0.37913971604611657,-1.2906037461516509,0.12135922330097088,0.8449299529736745,1.0,17/28,39.43%,SLC6A6;SLC3A2;SLC6A9;SLC36A4;CTNS;SLC43A2;SLC38A5;SLC1A4;SLC6A17;SLC36A1;SLC43A1;SLC6A7;LLGL2;SLC38A2;SLC7A8;SLC38A1;SLC7A10
prerank,regulation of fat cell differentiation (GO:0045598),0.44301365523619674,1.2892721476055333,0.12731229597388466,1.0,1.0,19/74,18.38%,SFRP2;WNT5A;LPL;SFRP1;SIRT2;XBP1;RORA;ZFP36L1;WDFY2;ENPP1;RUNX1T1;TGFB1;AAMDC;LMO3;TRIO;CDS1;MEDAG;FTO;GPS2
prerank,phospholipid biosynthetic process (GO:0008654),0.48577769029369994,1.2891600379323893,0.1430274135876043,1.0,1.0,10/36,9.95%,CLN3;PCYT2;AGPAT5;CRLS1;DHDDS;CPNE7;AGPAT3;DPAGT1;GPAM;FADS1
prerank,organic acid transport (GO:0015849),-0.2873277942814446,-1.2890065377576179,0.0975609756097561,0.8450586851533165,1.0,21/94,14.75%,ABCG2;ABCC4;SLC6A6;ATP8B1;SLC25A17;SLC26A7;SLC3A2;SLC7A1;SLCO1C1;LRRC8D;SLC16A1;GOT2;SLC25A32;SLC7A6;SLC7A7;PPARD;SLC22A6;SLC25A14;SLC43A2;SLC16A10;SLC5A6
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.46320098910060453,1.2881363985972583,0.12555555555555556,1.0,1.0,11/52,11.48%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;CNOT10;DCP1B;EXOSC8;RC3H2;CNOT9
prerank,histone H4-K5 acetylation (GO:0043981),-0.4389026221149911,-1.2878937101608088,0.14233576642335766,0.8374416357784782,1.0,8/15,18.09%,KAT7;JADE2;JADE1;KANSL3;JADE3;WDR5;HCFC1;KAT8
prerank,histone H4-K8 acetylation (GO:0043982),-0.4389026221149911,-1.2878937101608088,0.14233576642335766,0.8374416357784782,1.0,8/15,18.09%,KAT7;JADE2;JADE1;KANSL3;JADE3;WDR5;HCFC1;KAT8
prerank,regulation of ERAD pathway (GO:1904292),-0.49740121073269705,-1.2878266921036992,0.16233766233766234,0.8318460878025095,1.0,7/11,21.74%,RNF185;USP13;HERPUD1;RNFT1;BAG6;UBXN1;AQP11
prerank,positive regulation of potassium ion transport (GO:0043268),0.4762618988614666,1.2875289959436007,0.14069767441860465,1.0,1.0,5/38,8.20%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4337033006282538,1.286916834553756,0.062436028659160696,1.0,1.0,16/110,14.65%,FSHR;S1PR2;PTGER4;ADCY7;ADM;PTHLH;GNG2;GNAS;GPR4;LGR4;TBXA2R;PTH1R;ADGRG1;GPR161;LPAR1;ADCY1
prerank,negative regulation of protein polymerization (GO:0032272),-0.3714188154694522,-1.286509361135766,0.1407035175879397,0.8306902166051315,1.0,11/27,17.39%,CYRIB;MAPRE1;SLIT2;PRKCD;KANK3;MYADM;KANK4;TWF2;PFN1;KANK1;TWF1
prerank,regulation of secretion by cell (GO:1903530),0.46055086856725475,1.2862099001290213,0.12555066079295155,1.0,1.0,18/54,17.84%,CPLANE2;ANXA1;VAMP3;RAB12;CPLX1;RAB10;RAB3B;MCTP2;SYT1;RAB13;RHBDF1;RAB8A;RAB8B;VAMP8;NSF;FMR1;RAB21;MCTP1
prerank,protein mannosylation (GO:0035268),0.5209870866985126,1.2860062319466699,0.17108753315649866,1.0,1.0,8/22,18.89%,TMTC4;DPM2;TMTC1;POMT2;DPY19L1;DPY19L3;DPM1;DPY19L4
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3723785771057974,-1.2856228687259916,0.11398963730569948,0.8283753591897396,1.0,3/29,6.13%,CYRIB;LAMP1;CADM1
prerank,peptidyl-asparagine modification (GO:0018196),0.4939288406754869,1.2853453318236152,0.1455223880597015,1.0,1.0,9/31,15.20%,ALG5;DPM2;ALG8;UGGT2;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,ganglion development (GO:0061548),0.6045082182010821,1.2839844813865229,0.18168812589413447,1.0,1.0,4/11,15.56%,FZD3;NRP1;UNC5C;SEMA3A
prerank,GPI anchor biosynthetic process (GO:0006506),0.49791451908286355,1.2836858046459105,0.1607795371498173,1.0,1.0,10/30,18.41%,PIGG;PGAP4;DPM2;PIGM;PIGU;PIGA;PGAP1;PIGK;PIGX;DPM1
prerank,glucan catabolic process (GO:0009251),-0.4516424340345248,-1.2832897338641407,0.175,0.8313761669859372,1.0,5/15,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.4649357489266965,1.282419815035709,0.13697104677060135,1.0,1.0,8/46,9.52%,PLA2G5;GPD1;GPD1L;AGPAT1;AGPAT5;GPAT4;AGPAT3;GPAM
prerank,apoptotic mitochondrial changes (GO:0008637),0.501383978202328,1.2823594449832034,0.164366373902133,1.0,1.0,10/32,15.53%,BAX;THEM4;FIS1;AIFM2;FZD9;BCL2;SOD2;ATG3;DNM1L;HSPD1
prerank,positive regulation of ruffle assembly (GO:1900029),0.57988757040713,1.282196850104336,0.19101123595505617,1.0,1.0,1/13,0.06%,CARMIL2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5037526990434693,1.2819742660748714,0.16313823163138233,1.0,1.0,8/26,15.47%,GRIN1;SLC25A33;SLC5A3;SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,ethanol metabolic process (GO:0006067),0.5792221505755802,1.281798319061177,0.18732394366197183,1.0,1.0,1/12,0.66%,ADH5
prerank,negative regulation of response to external stimulus (GO:0032102),0.431602941942944,1.281528874610039,0.079002079002079,1.0,1.0,14/105,7.34%,SMPDL3B;PTGER4;SIRT2;AJAP1;SELENOS;CASK;RORA;TNFAIP3;PPM1B;CARD16;DHX58;CERS2;TRAFD1;SIRPA
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5355464576629325,1.280235782273527,0.17073170731707318,1.0,1.0,5/21,7.42%,UBE2S;MAD2L1;FZR1;FBXO5;CDC14B
prerank,natural killer cell mediated immunity (GO:0002228),0.5562858131818956,1.2802275722485095,0.17753120665742025,1.0,1.0,6/15,23.73%,PLEKHM2;CEBPG;TUBB;KIF5B;ARL8B;LYST
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5384057897976462,1.2799128905585726,0.17880794701986755,1.0,1.0,9/19,18.22%,SCRIB;MTCL1;DLG3;PATJ;PRKCI;DLG2;PARD3B;ERBIN;SYNJ2BP
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6061954264923691,1.2793135117858168,0.16292974588938713,1.0,1.0,4/10,15.82%,HGS;NDRG4;LRP1;PTPN12
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.614441221793598,1.2790273580029285,0.17559523809523808,1.0,1.0,4/10,18.96%,CBARP;CALM3;FMR1;CALM1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3439435985671275,-1.2787588667894556,0.11188811188811189,0.8429952861053271,1.0,26/39,28.93%,RIOK3;RPS24;RIOK2;NOL11;RPS19;RPS16;RPS6;NOM1;RPS28;RPS5;RPS17;NOB1;RPS27;NOP14;WDR3;METTL17;RRP36;SNU13;RPS14;ERAL1;LTV1;RRP7A;EMG1;RPS27L;SURF6;MRPS7
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5059242382161566,1.2784873687392253,0.16377171215880892,1.0,1.0,10/24,23.37%,ADAMTS7;PTHLH;SOX9;SOX6;TRPS1;SOX5;TGFBR1;MBOAT2;ADAMTS12;EFEMP1
prerank,regulation of cellular respiration (GO:0043457),0.5448042870998868,1.2781454548750024,0.16186556927297668,1.0,1.0,4/17,9.82%,IFNAR1;IL10RB;PRELID1;VCP
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5403964115215836,1.2781344684276952,0.16666666666666666,1.0,1.0,2/18,5.54%,CARMIL2;DDR2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5386917975193865,1.27763729694661,0.17509727626459143,1.0,1.0,5/18,8.54%,FCGR2B;BAX;XBP1;PIK3R1;DDIT3
prerank,regulation of cellular pH (GO:0030641),0.5049801100514214,1.2772220534071452,0.16053921568627452,1.0,1.0,3/29,0.91%,SLC4A4;SLC4A5;CLN3
prerank,protein deneddylation (GO:0000338),0.6017727978363865,1.2769933515540575,0.19530102790014683,1.0,1.0,2/10,8.17%,COPS7A;COPS7B
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5274191288533938,1.2765078603956765,0.1773981603153745,1.0,1.0,9/19,22.65%,RTN2;IGF1;BIN1;ABCA7;APOE;SORL1;NTRK2;GGA3;RTN1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3464787456772054,-1.276254913880411,0.10666666666666667,0.8467595631719859,1.0,18/36,21.74%,WAC;FHIT;RPL11;HSP90AB1;UCHL5;CAMLG;PSMF1;DDRGK1;TRIM39;MAP1A;GABARAPL2;GIPC1;CCAR2;BAG6;UBXN1;PRKCG;NOP53;AQP11
prerank,embryonic axis specification (GO:0000578),-0.45411347765562127,-1.2761088365686293,0.1828358208955224,0.8416607533354193,1.0,4/15,9.15%,TASOR;COBL;CXXC4;TBX3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6049018542915148,1.2747380236883592,0.19126506024096385,1.0,1.0,2/11,4.50%,SELENOS;CXCL12
prerank,ruffle organization (GO:0031529),0.5574107624032336,1.2745431587898017,0.1700960219478738,1.0,1.0,8/16,20.42%,AIF1L;RAC1;CYFIP1;TPM1;PIP5K1A;PLEKHA1;CARMIL1;LIMA1
prerank,positive regulation of phosphorylation (GO:0042327),0.4145179291552062,1.2743103600605805,0.02902902902902903,1.0,1.0,49/240,14.28%,FGF20;FGF9;SLC4A4;HDAC3;TMEM119;MST1R;IGF1;IL34;DVL2;EPHA7;EPHB2;HSP90AA1;RAC1;FGFR2;FGFR1;ERP29;DDR1;NRP1;FGF10;FLCN;DDR2;KNDC1;FBH1;ABL1;ATG14;EPHA8;ARNT;RAP2A;DSCAM;WDFY2;ARRB1;SOX9;PRXL2C;SDCBP;EGF;EPHA10;CLIP3;MUSK;ZBTB20;APP;PDGFRA;LEPR;AXIN2;RACK1;ROR2;NPTN;CSNK1D;ROCK2;TGFB1
prerank,regulation of macrophage activation (GO:0043030),0.48768332230216493,1.2739059805957533,0.16727272727272727,1.0,1.0,4/30,4.92%,WNT5A;FCGR2B;IL33;IL31RA
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5406945306136586,1.2734038362569746,0.19337016574585636,1.0,1.0,4/17,8.35%,AJAP1;MAFG;CD24;SOX9
prerank,synaptic vesicle cycle (GO:0099504),0.4923353462509303,1.2725584654071949,0.1656516443361754,1.0,1.0,6/30,10.56%,SYT10;CDK5;DNAJC5;CPLX1;SNAP25;BRSK1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.44061143113536394,1.272501856098105,0.12781954887218044,1.0,1.0,13/69,13.35%,FGF20;CLN3;NTF3;FZD9;SNX6;SLC30A10;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;PRKCI
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5392638689720051,1.271637465006885,0.17446270543615677,1.0,1.0,6/18,16.48%,EDN3;ABL1;POR;GDNF;PARK7;AGTR1
prerank,error-prone translesion synthesis (GO:0042276),-0.40544065223183334,-1.2714991803412368,0.13679245283018868,0.8530243300926061,1.0,15/21,38.96%,REV3L;RPA1;UBB;REV1;PRIMPOL;RFC2;PCNA;POLE2;POLK;POLI;RPA3;RFC3;MAD2L2;UBA52;RPA2
prerank,regulation of exosomal secretion (GO:1903541),0.5337116433036238,1.2713542406904144,0.1875,1.0,1.0,6/19,12.16%,ATP9A;SNF8;HGS;SDCBP;CHMP3;VPS4B
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4661463993084995,1.271337386618405,0.15455594002306805,1.0,1.0,14/40,17.00%,VTN;NTF3;PICK1;CD63;HNRNPK;ARRB1;EGF;MAGI2;CBL;AHI1;SERPINE1;ANXA2;FMR1;RAB21
prerank,lamellipodium assembly (GO:0030032),0.5031124866202683,1.2712540549938192,0.1761723700887199,1.0,1.0,13/26,20.97%,RAC1;WHAMM;SRGAP2;ARHGEF7;ARHGEF4;DMTN;RHOD;CYFIP1;ABLIM2;ARHGEF6;CCDC88A;CARMIL1;ITGB1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5192840943094078,-1.271187115833041,0.2043343653250774,0.8485838988238374,1.0,3/10,28.86%,BMP4;FZD7;PAX8
prerank,DNA replication initiation (GO:0006270),-0.33535026845262417,-1.2708179735080738,0.09815950920245399,0.8444442919273281,1.0,28/37,45.77%,ORC4;RPA1;PURA;NOC3L;ORC5;MCM6;PRIM2;CDK2;POLA2;PRIM1;LRWD1;POLE2;CDC7;MCM4;DBF4;RPA3;ORC1;CDC34;MCM8;RPA2;CDC45;POLE;MCM3;MCM2;MCM7;POLE3;MCM5;MCM10
prerank,brain development (GO:0007420),0.4171594185394131,1.2701201551726324,0.06389452332657201,1.0,1.0,27/136,16.11%,AATK;AMIGO1;AFF2;POU6F1;EPHA7;SYNJ2;NKX2-2;GRIN1;NIPBL;CHD8;ATXN1;CXCR4;GRIN2A;PTCH1;ZFHX2;CDK5RAP3;SETD1A;ROBO2;ADGRG1;SMARCA1;NDRG4;SOX6;SLC6A4;ZIC2;CNTNAP2;CIC;HSPG2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5119412446388414,-1.2699107520134172,0.20952380952380953,0.8420468673601678,1.0,3/10,6.97%,CTTNBP2NL;INPP5K;THBS1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4528390094463082,1.2698795502108233,0.13864628820960698,1.0,1.0,16/59,15.24%,MED24;BAX;NFKB1;MED12;MED14;CCNC;TCF7L2;MED13;MED4;SOX9;TWIST1;AGO3;SETX;CBFB;BCLAF1;MED23
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.5145683058615174,1.2698309251160427,0.16772554002541296,1.0,1.0,1/23,0.14%,PLA2G5
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.545027224981718,1.2695811792793024,0.19002695417789758,1.0,1.0,4/17,7.15%,EMC1;EMC8;MMGT1;GET1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.37014470213043654,-1.2695588660867445,0.13368983957219252,0.8379746553921318,1.0,10/27,16.58%,WASF2;ARHGEF18;TMEFF2;TJP1;INPP5K;F11R;ARHGAP28;SHANK3;PFN1;MET
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4278250830966308,-1.2695409948083782,0.16417910447761194,0.8326660522839928,1.0,9/18,19.69%,SLC25A13;MSRA;MTHFR;GOT2;FOLH1;MTHFD1;NAALAD2;GOT1;ASPG
prerank,lipid biosynthetic process (GO:0008610),0.44603716817398703,1.2694422215358914,0.11170784103114931,1.0,1.0,16/77,14.55%,NDUFAB1;LPL;MLYCD;PCYT2;XBP1;AGPAT5;GPAT4;LSS;AGPAT3;GPAM;ELOVL4;FADS1;PRLR;CYP51A1;PAM;ACSL6
prerank,actin filament depolymerization (GO:0030042),-0.4913278257840161,-1.2693244212611965,0.20123839009287925,0.8280652703676522,1.0,6/11,23.63%,CFL2;DSTN;TWF2;TWF1;MICAL2;MICAL1
prerank,negative regulation of cartilage development (GO:0061037),0.5832483090140191,1.2685465376031113,0.18892045454545456,1.0,1.0,3/13,8.35%,ADAMTS7;PTHLH;SOX9
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5327247281598991,1.2684643228623305,0.19833564493758668,1.0,1.0,4/17,10.30%,BMP6;PRKCA;CARD16;LY96
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.43334324400720853,1.2684380502441517,0.11437565582371459,1.0,1.0,27/88,19.43%,ILF3;CLN3;PAIP2;NFKB1;EIF2AK3;DDX3X;NELL1;CNOT10;CDK5;IGF2BP2;EPRS1;DHX36;CDK5RAP3;PLAT;PUS7;EIF4E2;CNOT9;MALSU1;RACK1;DAPK1;MRPL13;FMR1;APOE;CAMK2N1;ATRAID;SAMD4B;RPS3
prerank,chromatin disassembly (GO:0031498),0.56512803586581,1.2682433689065187,0.18585298196948682,1.0,1.0,4/14,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,nucleosome disassembly (GO:0006337),0.56512803586581,1.2682433689065187,0.18585298196948682,1.0,1.0,4/14,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.6135170018540063,1.2678565754549025,0.19790104947526238,1.0,1.0,3/10,13.59%,SMARCD3;FZD3;DISC1
prerank,positive regulation of protein deacetylation (GO:0090312),0.5746320804552008,1.2675960905040324,0.18854748603351956,1.0,1.0,6/14,16.05%,NIPBL;AKAP8L;ZBTB7B;NNMT;SAP30BP;CTBP1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4413895016623436,1.2667482486700388,0.13113006396588486,1.0,1.0,14/70,16.50%,PLA2G5;GPLD1;CSNK2A2;LPIN1;CEPT1;GPAT4;LPIN3;PCYT1B;ENPP2;STARD7;LPIN2;CHKB;SLC44A2;SLC27A1
prerank,calcium-mediated signaling (GO:0019722),0.43174806968825297,1.266184995056867,0.11721991701244813,1.0,1.0,15/93,11.16%,TNNI3;PDPK1;EIF2AK3;DMPK;CCR9;ACKR2;FIS1;RCAN2;ATP2A2;DMTN;CXCR4;RCAN3;PPP1R9B;STIMATE;MCTP2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.49727310005318576,1.265650583024076,0.18306351183063513,1.0,1.0,10/29,18.47%,CLN3;CAMK2B;EPHB2;DBN1;APP;NETO1;APOE;MCTP1;ZDHHC2;SHISA9
prerank,glycogen catabolic process (GO:0005980),-0.4398149679767483,-1.2652300506778351,0.19572953736654805,0.8378981932267334,1.0,5/15,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,positive regulation of innate immune response (GO:0045089),0.48713221345425056,1.265197242731412,0.1712907117008444,1.0,1.0,5/30,8.18%,PLA2G5;WNT5A;POLR3D;IFI35;TRIM62
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.4278426173658273,-1.265196756530963,0.17712177121771217,0.8327314600462974,1.0,3/17,1.94%,FERMT2;GJA1;KAT7
prerank,chordate embryonic development (GO:0043009),0.44676703259563993,1.2648475367116156,0.14585635359116023,1.0,1.0,10/55,8.42%,WNT5A;ZNF568;FGFR2;FGFR1;PCSK5;FLCN;SULF1;ALDH1A2;DVL1;PTCH1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5658805075263,1.2647629361779251,0.19220055710306408,1.0,1.0,3/13,11.80%,LCMT1;MAD2L1;DYNC1LI1
prerank,regulation of neuron projection arborization (GO:0150011),0.5631715467828873,1.264338372553889,0.21680216802168023,1.0,1.0,4/15,10.01%,WNT5A;DVL2;DVL1;NTNG2
prerank,neuromuscular process (GO:0050905),0.5520163698267061,1.2636548874140148,0.19390581717451524,1.0,1.0,7/16,19.91%,CLN3;STRA6;MYCBP2;KCNA1;SHANK1;AGTPBP1;PAFAH1B1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5848746718969224,1.262972384442133,0.22189349112426035,1.0,1.0,3/12,5.91%,BAX;XBP1;PIK3R1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4179991188602584,1.2624251213313584,0.07833163784333673,1.0,1.0,27/150,15.02%,FGF20;MYORG;FGF9;MST1R;PDPK1;HSP90AA1;RAC1;FGFR2;THEM4;FGFR1;FGF10;TCF7L2;PIK3R1;GAB1;FRS2;EGF;KL;IRS2;PIK3CB;PIK3R2;MAZ;PDGFRA;PARK7;NRG2;NRG1;TGFB1;F3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5562934113928537,1.2620564064328377,0.20192307692307693,1.0,1.0,3/15,6.02%,IGF1;PPIF;PRELID1
prerank,positive regulation of sodium ion transport (GO:0010765),0.5840922849015318,1.2616539965306426,0.22740524781341107,1.0,1.0,6/12,22.71%,GPD1L;CNKSR3;ANK3;AHCYL1;SCN1B;WNK3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5340016044458608,1.2614756578786055,0.19168900804289543,1.0,1.0,3/18,3.62%,APLN;PDPK1;FGFR1
prerank,nucleotide biosynthetic process (GO:0009165),0.5320410665609335,1.26144524894104,0.19863013698630136,1.0,1.0,5/18,13.10%,ADSL;PRPSAP2;GART;RRM2B;HPRT1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.6138631051796676,1.2614003063299912,0.21148036253776434,1.0,1.0,2/10,1.24%,SFRP1;SP7
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3593272567393921,-1.2612645783778649,0.11917098445595854,0.842132352551218,1.0,13/30,31.17%,NIBAN2;DACH1;GNL3L;STN1;TP53;NAT10;SRC;CTC1;CERS1;TEN1;CDKN1A;TINF2;MEN1
prerank,import into cell (GO:0098657),0.4767238289704195,1.261198116571528,0.15519253208868145,1.0,1.0,11/41,16.50%,IL10RA;SLC29A1;LRRC8A;SLC5A3;SLC22A4;ATP1A2;GLUL;SNAP25;SLC1A3;SLC6A13;SLC27A1
prerank,nucleocytoplasmic transport (GO:0006913),0.4739976244306162,1.2609866801378304,0.1653272101033295,1.0,1.0,11/40,12.27%,SMN1;NXT2;NXT1;GEMIN2;ANP32A;HTATIP2;ATXN1;MALT1;BACH2;NEMF;NPM1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4371860912683535,1.2605514738374495,0.1406926406926407,1.0,1.0,12/69,13.28%,WNT5A;LPL;DDT;EPHB2;IL33;TIRAP;TMEM106A;TWIST1;LY96;APP;IFNGR1;TLR3
prerank,receptor clustering (GO:0043113),0.500879272214009,1.2595362462786923,0.19853836784409257,1.0,1.0,10/27,18.22%,PICK1;SCRIB;DLG3;THY1;DVL1;MUSK;MAGI2;ITGB1BP1;DLG2;SYNJ2BP
prerank,negative regulation of binding (GO:0051100),-0.2886055211294046,-1.2592798544824453,0.04918032786885246,0.8443185557313887,1.0,25/81,16.01%,WAPL;MAPK8;LEF1;CAV1;ACTB;PRKCD;SP100;GNL3L;STYX;CSNK1E;NFKBIA;LRRK2;RALB;ARHGAP28;IFIT2;ILRUN;CAMK1;TMBIM6;ROCK1;DACT1;BTAF1;JUN;HABP4;EFHB;PEX19
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.43775073528668046,1.2590037291541891,0.13071200850159406,1.0,1.0,13/72,11.29%,FSHR;IGF1;NTF3;FGFR1;DCN;PIK3R1;GAB1;SOX9;EGF;IRS2;PIK3CB;MAZ;PDGFRA
prerank,synaptic membrane adhesion (GO:0099560),0.5495085948354775,1.2580112756353,0.2022792022792023,1.0,1.0,6/14,20.04%,LRRC4;GPC6;PTPRF;GPC4;SLITRK1;PTPRS
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.4511810889098715,-1.257458031763993,0.19402985074626866,0.845735942440564,1.0,7/16,20.27%,NAA15;KAT2B;NAA40;EP300;NAA25;NAA60;NAA80
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.500780832355272,1.2573127271631965,0.18982630272952852,1.0,1.0,3/24,9.52%,PLA2G5;CRLS1;GPAM
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5625446395557703,1.2565871547848524,0.19833564493758668,1.0,1.0,3/14,8.35%,ADAMTS7;PTHLH;SOX9
prerank,sterol transport (GO:0015918),-0.42339962669944,-1.2562666984089847,0.2,0.8448570872012763,1.0,6/19,18.43%,OSBPL2;CAV1;OSBPL5;OSBP;ARV1;LDLRAP1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4544544632884649,1.2561219757514304,0.1645422943221321,1.0,1.0,13/47,17.10%,SFRP2;LPL;SFRP1;XBP1;ZFP36L1;ZBTB7B;WDFY2;PTGS2;AAMDC;LMO3;CDS1;MEDAG;SOX13
prerank,regulation of adaptive immune response (GO:0002819),0.5313198038339735,1.25602611191297,0.20639147802929428,1.0,1.0,3/18,5.88%,FCGR2B;ADCY7;IRF1
prerank,regulation of calcium ion import (GO:0090279),0.5187289236967385,1.2559449205958753,0.2094240837696335,1.0,1.0,7/21,22.71%,CXCL12;EGF;SLC30A1;PLPP4;PKD2;TRIM27;WNK3
prerank,phosphatidic acid metabolic process (GO:0046473),0.455127384395576,1.2550007699459818,0.15307262569832403,1.0,1.0,8/48,9.52%,PLA2G5;GPD1;GPD1L;AGPAT1;AGPAT5;GPAT4;AGPAT3;GPAM
prerank,positive regulation of phagocytosis (GO:0050766),0.45640761340327773,1.2543670626224497,0.1621315192743764,1.0,1.0,9/47,16.52%,PLA2G5;FCGR2B;TUB;SIRPA;ABCA7;CD47;IL15RA;RAB31;CAMK1D
prerank,regulation of hydrolase activity (GO:0051336),-0.28979745599173,-1.2540766202765903,0.014285714285714285,0.8480392226611427,1.0,27/71,22.99%,PRKG1;DAB2IP;RDX;RAPGEF6;RALBP1;CAV1;FGD5;OCRL;ARHGAP44;PLXNA4;FGD1;SIPA1L1;TDG;ARHGEF5;PLXNB2;PLXNC1;RASIP1;TBC1D10B;ARHGAP27;CHN2;NF1;WRN;PLXNB1;NGEF;CAMK2A;RAB3GAP1;FGD3
prerank,synaptic vesicle exocytosis (GO:0016079),0.4691042124206068,1.2539950287542196,0.18192352259559674,1.0,1.0,9/40,14.93%,SYT10;UNC13A;CDK5;STX2;DNAJC5;CPLX1;SNAP25;SYT1;STX11
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4495481274653799,1.2536594909833003,0.150609080841639,1.0,1.0,9/57,5.90%,BAX;PPIF;CHCHD10;FIS1;ZNF205;FBXO7;FAM162A;DCN;MIEF2
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5730350484767601,1.2534306837538989,0.18992805755395684,1.0,1.0,1/12,1.28%,IL34
prerank,reticulophagy (GO:0061709),-0.47701751311744756,-1.253078569237368,0.19875776397515527,0.8464485861601853,1.0,7/12,22.06%,ATG2B;UBA5;DDRGK1;ULK2;UFC1;UFL1;UFM1
prerank,negative regulation of neuron death (GO:1901215),0.4238095430337876,1.2529255372267147,0.12331606217616581,1.0,1.0,17/93,13.35%,FGF20;CLN3;NTF3;FZD9;CDK5;FBXO7;SNX6;SLC30A10;CD200R1;INPP5A;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;PRKCI
prerank,metal ion homeostasis (GO:0055065),-0.3409514163354845,-1.2526365740623795,0.14084507042253522,0.8429816786729858,1.0,18/40,30.30%,SLC12A7;CNNM2;CAV1;LETM1;TMTC2;LETM2;FAM20A;SLC12A4;COX11;SELENON;SLC12A9;SLC12A2;SLC12A8;CNNM4;SLC12A6;WFS1;SLC8A1;JPH2
prerank,positive chemotaxis (GO:0050918),0.5395786941037581,1.252513403878873,0.181058495821727,1.0,1.0,4/17,5.37%,TSC2;NRP1;FGF10;SCRIB
prerank,regulation of aerobic respiration (GO:1903715),0.544032930679626,1.2525052878191705,0.20502092050209206,1.0,1.0,5/15,13.28%,SLC25A33;COX7A2;VCP;AK4;UQCC2
prerank,cellular response to fatty acid (GO:0071398),0.571152823412559,1.252499009902112,0.2161764705882353,1.0,1.0,2/12,7.65%,LPL;PID1
prerank,ceramide catabolic process (GO:0046514),-0.4358867123306661,-1.2518918134722632,0.18243243243243243,0.8406945926133805,1.0,13/14,55.84%,ASAH1;GM2A;NAGA;NEU1;NEU3;HEXA;GLA;ACER2;NEU2;ASAH2;NEU4;ACER3;ACER1
prerank,plasma membrane invagination (GO:0099024),0.4924047893519221,1.2518162828343151,0.17857142857142858,1.0,1.0,2/29,0.85%,SPIRE2;FCGR2B
prerank,cellular response to alcohol (GO:0097306),0.4669712203665705,1.251629235198839,0.17936694021101993,1.0,1.0,11/42,16.59%,SFRP1;PTGER4;GPLD1;ADCY7;MLC1;GNG2;PTCH1;JUP;GLRA1;ADCY1;ADCY5
prerank,axonogenesis (GO:0007409),0.4107392786105445,1.2516046207162141,0.041,1.0,1.0,67/237,17.96%,SPTBN5;WNT5A;EPHA7;PDLIM7;EPHB2;ATL1;HSP90AA1;FGFR2;CXCL12;NRP1;NEFH;PRKCA;CDK5;PIK3R1;GAB1;PAK3;EFNB3;EPHA8;BRSK2;CXCR4;GPC1;DSCAM;RAP1GAP;CYFIP1;FRS2;EFNB2;VLDLR;BAIAP2;EPHA10;RAB10;SEMA3D;NTNG2;GDNF;IRS2;GFRA2;BRSK1;AFG3L2;PIK3CB;APP;ROBO2;ANK3;ROBO1;KIF5C;DAG1;NLGN3;DOCK7;B4GALT5;USP9X;FEZ2;NPTN;UNC5D;AUTS2;UNC5C;SLIT1;SLIT3;SEMA3E;SPTBN1;SEMA3A;RAB8A;SLC9A6;EPHA5;KIF5B;USP33;DAB1;DCC;ZDHHC17;SLITRK1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.46005763240633935,1.251070192618648,0.17939814814814814,1.0,1.0,10/43,9.55%,TMEM119;IGF1;FBN2;BMP6;NELL1;DDR2;FBXO5;SUCO;WNT4;SOX11
prerank,glycerol metabolic process (GO:0006071),-0.5029076867408543,-1.251056330771269,0.19696969696969696,0.8384282307459383,1.0,8/10,39.25%,GK5;COQ2;COQ3;GOT1;PGP;GK;ANGPTL3;TKFC
prerank,negative regulation of immune response (GO:0050777),0.41529022008432204,1.250783695996693,0.0859453993933266,1.0,1.0,13/154,6.64%,FSHR;FCGR2B;PTGER4;SIRT2;ADCY7;ADM;VIPR2;PTHLH;TNFAIP3;PPM1B;DHX58;TRAFD1;GNG2
prerank,regulation of interleukin-6 production (GO:0032675),0.42322379788391473,1.250632236962892,0.11322751322751323,1.0,1.0,16/96,13.55%,WNT5A;LPL;SELENOS;IL33;XBP1;TNFAIP3;TIRAP;TMEM106A;CD200R1;SIRPA;ARRB1;TWIST1;APP;CD47;TLR3;PTPN22
prerank,negative regulation of immune system process (GO:0002683),0.5359910598925277,1.2506219320913923,0.20136054421768707,1.0,1.0,2/16,8.35%,FCGR2B;SOX9
prerank,protein-DNA complex disassembly (GO:0032986),0.5427426642680235,1.250511693499191,0.2192513368983957,1.0,1.0,4/16,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,metal ion export (GO:0070839),0.4822300311992724,1.2503258772657795,0.1751207729468599,1.0,1.0,5/31,12.11%,SLC4A4;ATP1A3;KCNT2;ATP1A2;KCND3
prerank,ubiquinone metabolic process (GO:0006743),0.5491186950450522,1.2502318636395773,0.1950207468879668,1.0,1.0,3/15,3.34%,COQ6;COQ8B;AIFM2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.41699994842783666,-1.249547194604711,0.17228464419475656,0.8387745070919023,1.0,7/17,15.52%,AFG1L;COX4I1;COX5A;COX8A;NDUFA4;COX7A2L;COX6A1
prerank,protein homotrimerization (GO:0070207),0.5581634926900714,1.2492111153826213,0.20542082738944364,1.0,1.0,5/14,17.79%,ALOX5AP;ASIC1;SLC1A5;MLKL;SLC1A2
prerank,protein trimerization (GO:0070206),0.5581634926900714,1.2492111153826213,0.20542082738944364,1.0,1.0,5/14,17.79%,ALOX5AP;ASIC1;SLC1A5;MLKL;SLC1A2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6033485364238425,1.24892140558791,0.22076023391812866,1.0,1.0,2/10,6.69%,VTN;ARNT
prerank,neuromuscular junction development (GO:0007528),0.5068517840382176,1.248312801626604,0.18434343434343434,1.0,1.0,7/24,11.13%,CACNB4;UNC13A;PDZRN3;DVL1;MUSK;CACNB1;ANK3
prerank,positive regulation of bone mineralization (GO:0030501),0.46665436516648745,1.2480388242458391,0.1807372175980975,1.0,1.0,9/35,9.70%,TMEM119;FBN2;BMP6;FZD9;NELL1;ADGRV1;WNT4;ATP2B1;KL
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.499565495881817,1.2479823160586383,0.19576059850374064,1.0,1.0,4/26,7.53%,UBQLN1;CBARP;CALM3;ATP1A2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4262029588011994,1.247405319276411,0.1276595744680851,1.0,1.0,10/85,9.16%,MYO1A;DCDC2;MYH14;NIPBL;PCDH15;TIMM13;RIPOR2;ADGRV1;LHFPL3;CCDC50
prerank,regulation of lamellipodium assembly (GO:0010591),0.46723534206103606,1.2470971531320332,0.18377088305489261,1.0,1.0,6/34,8.37%,CARMIL2;RAC1;ACTR2;PIK3R1;DMTN;CYFIP1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5367653704684561,1.246592444129407,0.1989389920424403,1.0,1.0,6/16,15.49%,PARP1;FLCN;PID1;VCP;AK4;ATPSCKMT
prerank,regulation of mRNA stability (GO:0043488),0.4125433579864237,1.2463184004553884,0.09949238578680203,1.0,1.0,54/145,22.24%,KHSRP;EXOSC1;EXOSC3;PSMD4;TBRG4;EXOSC7;EXOSC2;PAIP1;PCBP4;ANP32A;ZFP36L1;PRKCA;IGF2BP2;PSMB10;EXOSC8;CELF1;FUS;PSMD11;HNRNPD;DHX36;PABPC1;GDNF;PSME2;PSMC5;ZC3H14;RC3H2;YTHDF3;NPM1;AXIN2;YTHDF1;CSDC2;ROCK2;XRN1;NUP214;PSMD1;TNPO1;FMR1;THRAP3;PSMD6;FASTKD1;FTO;TENT5A;SAMD4B;YTHDF2;PSMD5;CIRBP;HNRNPU;MAPKAPK2;YBX1;PSMA4;PSMA1;PSMC6;SAMD4A;METTL14
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.42885371580154524,-1.2460964959334633,0.18613138686131386,0.8462244370480576,1.0,5/16,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,membrane raft organization (GO:0031579),0.5471985373793781,1.2460931084509745,0.21349862258953167,1.0,1.0,6/15,22.05%,CLN3;ABCA7;EMP2;ANXA2;FLOT1;NPC1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3927834273771539,-1.2452732649476301,0.15311004784688995,0.8444191120081672,1.0,6/20,9.94%,KCNB2;CHRM3;CAV1;PLCE1;CTTN;SETD3
prerank,heart process (GO:0003015),0.5615955679072214,1.2449302277245025,0.21408839779005526,1.0,1.0,1/14,0.42%,TNNI3
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4605808274891519,1.2445840899726985,0.18663594470046083,1.0,1.0,18/42,25.25%,RAC1;MINK1;THY1;DMTN;SPOCK1;PIK3CB;FBLN2;ECM2;EMP2;TBCD;NDNF;GCNT2;PPM1F;TSC1;CORO1C;JAK2;CX3CL1;ATXN3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5080870353808604,1.2441993341282236,0.2139240506329114,1.0,1.0,10/23,16.45%,GLIS2;PTCH1;VCP;RFX4;ENPP1;GPR161;RACK1;SUFU;TULP3;MEGF8
prerank,chondrocyte differentiation (GO:0002062),0.47539941319936285,1.2438056110945797,0.20395550061804696,1.0,1.0,9/32,17.12%,WNT2B;GPLD1;EIF2AK3;SULF1;SOX9;SOX6;TGFB1;SOX5;OSR1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.36098193937692796,-1.2436834478105079,0.1318181818181818,0.8448896644787321,1.0,13/26,18.80%,SLC39A14;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;SLC39A8;SLC39A12;SLC39A7;SLC39A10
prerank,regulation of NMDA receptor activity (GO:2000310),0.48948320697561837,1.2433581328576517,0.17809867629362214,1.0,1.0,10/32,14.09%,CAMK2B;EPHB2;NEFL;GRIN1;DLG3;GRIN2A;APP;GRIA1;DAPK1;GRIA2
prerank,long-chain fatty acid transport (GO:0015909),0.47795325843612757,1.243296987459809,0.1891566265060241,1.0,1.0,8/30,18.99%,SLC27A6;SLC27A4;CPT2;ABCD2;SLC27A1;APOE;SLC25A20;PRKAG2
prerank,hepaticobiliary system development (GO:0061008),0.5180100426934078,1.243292602045602,0.18972332015810275,1.0,1.0,6/20,12.40%,GFER;XBP1;NIPBL;WNT4;CDK5RAP3;CEBPG
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5685027137343568,1.2427933467961627,0.2086230876216968,1.0,1.0,1/13,0.11%,SFRP2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2563020208496162,-1.242786870496884,0.05,0.8434034191099234,1.0,33/128,15.99%,PARD3;HIVEP1;SMAD4;FERMT2;ARHGEF18;PTPRK;PXN;PDCD4;TWSG1;FNTA;SLC33A1;NLK;APPL1;SIRT1;CLDN5;SMAD1;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2;F11R;UBB;ZFYVE9;DUSP22;ACVR2B;BMP7;ZMIZ2;BMPR1B;JUN;SRC;ITGB5;BMP4
prerank,cognition (GO:0050890),0.4576215202564432,1.2422022568945013,0.16628175519630484,1.0,1.0,11/42,15.65%,METTL23;STRA6;MGAT3;NIPBL;CYFIP1;TTC8;APP;JAKMIP1;LINS1;RP9;SOBP
prerank,I-kappaB phosphorylation (GO:0007252),-0.49437942260548073,-1.2416275858391859,0.20625,0.842681431920431,1.0,3/10,7.06%,DAB2IP;ERC1;TLR4
prerank,regulation of cytoplasmic transport (GO:1903649),0.5885429794401948,1.2414258890331593,0.21888412017167383,1.0,1.0,5/11,14.89%,ATP9A;USP7;CHMP3;MAP2K2;DNAJC13
prerank,ephrin receptor signaling pathway (GO:0048013),0.42449168206851146,1.2414087888587324,0.1612223393045311,1.0,1.0,17/82,10.04%,EPHA7;EPHB2;DNM1;RAC1;GRIN1;ACTR2;ARPC1A;ARHGEF7;PAK3;EFNB3;EPHA8;KALRN;SDCBP;EFNB2;EPHA10;AP2S1;VAV2
prerank,amino acid transmembrane transport (GO:0003333),-0.3189605764286595,-1.2412547373699334,0.1037037037037037,0.8391896046591444,1.0,12/45,10.86%,SLC6A6;SLC16A2;SLC25A13;SLC3A2;SLC47A1;SLC7A1;SFXN2;LRRC8D;SLC7A6;SLC38A11;SLC7A7;SLC36A4
prerank,zinc ion homeostasis (GO:0055069),-0.3439583735001379,-1.2407857310854937,0.10810810810810811,0.8360229990738272,1.0,11/28,12.57%,SLC39A14;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;SLC39A8;SLC39A12
prerank,regulation of tumor necrosis factor production (GO:0032680),0.41269344755063353,1.240764318793921,0.12744090441932168,1.0,1.0,18/112,13.55%,WNT5A;LPL;IGF1;DDT;EPHB2;SELENOS;IL33;TNFAIP3;TIRAP;TMEM106A;SIRPA;TWIST1;LY96;APP;IFNGR1;CD47;TLR3;PTPN22
prerank,neutrophil activation (GO:0042119),-0.4740356711913961,-1.2399502671518752,0.21022727272727273,0.8344661263094506,1.0,2/12,3.95%,KMT2E;PRKCD
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.5464089976932727,1.2398291206115628,0.20781032078103207,1.0,1.0,3/16,3.85%,PDK1;MLYCD;RORA
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.44767655131048945,1.2395795846155788,0.1613958560523446,1.0,1.0,19/57,19.05%,CAMK2B;NPTXR;NEFL;CACNG3;GRIN1;MINK1;DLG3;GRIN2A;APP;GRIA1;DAPK1;NETO1;GRIA2;NLGN2;CACNG4;DLGAP1;DLG2;SHISA9;SHANK1
prerank,monocarboxylic acid transport (GO:0015718),-0.2987978498121642,-1.2394143099549897,0.14678899082568808,0.8316623834964696,1.0,9/51,6.35%,ABCG2;SLCO3A1;ABCC4;ATP8B1;SLC16A2;SLC16A6;SLCO1C1;SLCO2A1;SLC16A1
prerank,regulation of feeding behavior (GO:0060259),-0.48104933987358056,-1.2393869302162728,0.20903954802259886,0.8271016724696826,1.0,3/11,5.04%,EIF2AK4;STAT3;SGIP1
prerank,chromosome organization (GO:0051276),0.4222578516960269,1.2388373391331633,0.11389759665621735,1.0,1.0,23/99,15.29%,COPS7A;HDAC3;CENPT;PARP1;FAM50A;GATAD1;RAE1;TCF7L2;ABL1;DDB1;PHF1;SETD7;EZH2;HDAC5;COPS7B;CUL4B;SUV39H1;HDAC1;AXIN2;EHMT1;NUCKS1;SATB1;TCF7L1
prerank,regulation of amyloid fibril formation (GO:1905906),0.549792392852692,1.238809557146922,0.20480225988700565,1.0,1.0,6/15,17.23%,PFDN4;VBP1;PFDN1;APP;APOE;PFDN2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.524077889863204,1.2386220620177297,0.2018111254851229,1.0,1.0,8/20,16.69%,ABCA2;ERLIN2;SIK1;WNT4;BMP5;SLC27A1;ACADL;ACADVL
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4536498110459287,1.2375693211867362,0.17963386727688788,1.0,1.0,15/43,19.82%,TSC2;PIP4K2B;SLC27A4;SNX5;OGT;ZBTB7B;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;NUCKS1;SORL1;PTPRE;PRKCZ
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.40724978846476256,1.2374253675238598,0.04208416833667335,1.0,1.0,75/248,20.37%,SFRP2;TMEM198;WNT5A;BICC1;ATP6AP2;SFRP1;DVL2;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DKK3;DDX3X;FZD9;CTNND2;CHD8;FGF10;PPM1B;TCF7L2;USP47;KLHL12;PSMB10;DVL1;STK11;PSMD11;XIAP;SOX9;DDIT3;GPRC5B;RBMS3;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;LZTS2;JUP;ZNRF3;HDAC1;AXIN2;KREMEN1;ZBED3;CSNK1D;RNF220;TGFB1;LYPD6;CSNK1A1;PSMD1;INVS;USP34;NKD1;ADGRA2;TNKS;PTK7;UBR5;PSMD6;SOX13;APOE;TLE5;GNAQ;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;MLLT3;PRDM15;LRRK1;DAB2;CDK14
prerank,positive regulation of lipid storage (GO:0010884),0.5103172305129319,1.236558645764295,0.2187902187902188,1.0,1.0,4/21,9.13%,LPL;NFKB1;OSBPL11;PLIN3
prerank,protein polymerization (GO:0051258),0.44007910994812693,1.2362665115629505,0.1732283464566929,1.0,1.0,20/55,21.48%,SPIRE2;RAC1;UBE2S;TPPP3;TTC17;CHMP3;WASF1;MAPT;SPIRE1;TPPP;GPX4;GAS7;ARHGAP6;PSTPIP2;PREX1;FGF13;GSN;DIAPH1;CHMP4A;CHMP4B
prerank,regulation of cation channel activity (GO:2001257),0.42827587144345386,1.2361534729663963,0.14675052410901468,1.0,1.0,32/89,22.20%,CAMK2B;NEFL;CACNG3;CACNB4;GRIN1;MINK1;DLG3;GRIN2A;CACNB1;APP;ANK3;SLMAP;FGF12;CAMK2D;GRIA1;FGF14;DAPK1;NETO1;GRIA2;NLGN2;CACNG4;AHNAK;JPH1;DLG2;SHISA9;CALM1;SHANK1;PTK2B;ITGB1;FGF13;CALM2;GRIA4
prerank,negative regulation of viral transcription (GO:0032897),0.5553724932914916,1.2356487736427382,0.21128798842257598,1.0,1.0,3/13,8.18%,HEXIM1;TRIM11;TRIM62
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5229482361346186,1.2355068231364905,0.22440944881889763,1.0,1.0,5/20,11.50%,TNNI3;CALM3;ATP2A2;ATP1A2;CAMK2D
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4103825198559025,-1.2354932471382685,0.1890909090909091,0.8361448026620892,1.0,6/18,13.78%,LATS1;MDFIC;MFHAS1;ILRUN;RAB23;SIN3A
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4988067501536168,1.234859671475436,0.22860791826309068,1.0,1.0,8/23,18.75%,RAC1;MOSPD2;TIRAP;RIPOR2;JAM3;DNM1L;CAMK1D;MPP1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4334757509099,1.234531433217469,0.17245119305856832,1.0,1.0,12/67,11.29%,AATK;EPHB2;FGFR2;FGFR1;DDR1;DDR2;ABL1;SRMS;PIBF1;TEC;PRLR;PDGFRA
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.49203400282827914,1.2344626132128516,0.21528662420382166,1.0,1.0,1/24,0.17%,RNF157
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5387923640892728,1.2343143173685969,0.20534458509142053,1.0,1.0,1/16,0.85%,FCGR2B
prerank,protein-containing complex disassembly (GO:0032984),0.4463138510448801,1.234017806460428,0.17225950782997762,1.0,1.0,15/54,16.15%,UBQLN1;CLN3;DVL2;VPS16;SNX14;LIX1L;DVL1;CHMP3;VCP;VPS33B;VTI1B;MAP1LC3B;CSNK1A1;STX17;VAMP8
prerank,cellular response to peptide (GO:1901653),0.44917616821588147,1.2337586507971703,0.17362637362637362,1.0,1.0,14/56,13.60%,FCGR2B;IGF1;GRIN1;XBP1;ATP1A3;ZFP36L1;CDK5;SNX6;GRIN2A;TRIM41;CACNB1;APP;PTPN22;LRP1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4698725390800198,1.233476073194249,0.1903030303030303,1.0,1.0,8/33,12.24%,APLN;TNFAIP3;MFN2;TAFA5;TPM1;IGFBP3;NDRG4;SOD2
prerank,sterol metabolic process (GO:0016125),0.4388783368211702,1.2333884188555329,0.1757508342602892,1.0,1.0,12/60,13.04%,CYP27A1;CLN6;SCAP;GBA2;CYP7B1;SOAT1;INSIG1;MSMO1;SC5D;STARD3;CYP26B1;CYP51A1
prerank,negative regulation of defense response (GO:0031348),0.42312341317175045,1.2330425807964005,0.1439153439153439,1.0,1.0,10/77,7.34%,SMPDL3B;PTGER4;SIRT2;SELENOS;RORA;TNFAIP3;PPM1B;DHX58;TRAFD1;SIRPA
prerank,liver development (GO:0001889),0.47127399558479455,1.2323286818477612,0.20627261761158022,1.0,1.0,7/32,12.40%,GFER;ANXA1;XBP1;ZIC3;WNT4;CDK5RAP3;CEBPG
prerank,mitotic spindle assembly (GO:0090307),0.4589690816046903,1.2323262960580013,0.20420070011668612,1.0,1.0,13/42,17.49%,CCDC61;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;STAG2;OFD1;CHEK2;BCCIP
prerank,regulation of cytokinesis (GO:0032465),0.4262177199881876,1.2317169085646458,0.16648648648648648,1.0,1.0,24/78,21.79%,CCP110;FSD1;RAB11FIP4;MYO19;CALM3;FLCN;CDC14B;PLK5;CIT;ENTR1;MAP9;GIT1;SVIL;CSPP1;PRPF40A;KLHL13;PIK3C3;KIF20B;CALM1;PIK3R4;UVRAG;KLHL9;RAB11FIP3;CALM2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5183121349875399,1.231714898124442,0.223841059602649,1.0,1.0,5/19,6.13%,SFRP1;RAC1;NRP1;ABL1;THY1
prerank,macroautophagy (GO:0016236),0.4116806724089189,1.2313144139881713,0.11625514403292181,1.0,1.0,47/118,21.48%,UBQLN1;CLN3;MVB12A;PIP4K2B;CSNK2A2;VPS16;WIPI1;SNF8;SNX14;TOMM20;MTERF3;FUNDC1;LIX1L;SQSTM1;ATG14;MFN1;HGS;MFN2;VTA1;CHMP3;VCP;ATG13;TCIRG1;VPS33B;VPS4B;VTI1B;PIP4K2A;VDAC1;ATG3;MAP1LC3B;VPS39;VPS41;STX17;VAMP8;PIK3C3;STAM2;ARL8B;PRKAA1;PRKAG2;PIK3R4;YOD1;AMBRA1;DYNLL1;UVRAG;VAMP7;CHMP4A;CHMP4B
prerank,regulation of myoblast differentiation (GO:0045661),0.4788452256867352,1.2309934437475254,0.2096969696969697,1.0,1.0,9/32,16.48%,LRRC8A;ZFP36L1;RANBP3L;RIPOR2;SOX9;SRA1;IGFBP3;TGFB1;TRIP4
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4981191962017305,1.230846582972803,0.20463320463320464,1.0,1.0,7/25,11.37%,CCP110;TBC1D7;CEP97;TCHP;RAP1GAP;ARHGAP24;EVI5L
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.42299380932870706,1.2305135833872032,0.17703862660944206,1.0,1.0,12/73,13.28%,WNT5A;LPL;DDT;EPHB2;IL33;TIRAP;TMEM106A;TWIST1;LY96;APP;IFNGR1;TLR3
prerank,ribosomal large subunit assembly (GO:0000027),-0.37328521713537977,-1.2304337437474122,0.16831683168316833,0.8495485794306905,1.0,18/24,36.64%,RPL11;RPL5;RPL6;RPL24;RPL3;RPLP0;RPL10;TRAF7;MRPL20;FASTKD2;NOP53;RPF2;NOP2;BOP1;RRS1;RSL24D1;NLE1;PPAN
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.38075460573766073,-1.2301893504595016,0.17551020408163265,0.8457151179457961,1.0,6/23,7.61%,LATS1;SMAD4;BCL9;TRIM33;ITGA3;ENG
prerank,regulation of regulated secretory pathway (GO:1903305),0.4704019278261621,1.230069629006707,0.20355029585798817,1.0,1.0,3/34,0.87%,UNC13D;SYT3;SYT10
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5977897572382209,1.2300290060999444,0.23293768545994065,1.0,1.0,3/10,12.01%,SELENOS;PID1;ENPP1
prerank,negative regulation of signal transduction (GO:0009968),0.4048607970510211,1.2298455873621126,0.05823293172690763,1.0,1.0,49/249,14.49%,SFRP2;RNF157;APLN;DLK1;SMPDL3B;GPR108;SFRP1;TCIM;TSC2;PIP4K2B;CSNK2A2;SLC27A4;GLIS2;DKK3;BRAP;TNFAIP3;CARD16;SULF1;DCN;SRMS;EZH2;TMBIM1;HGS;GPC1;PID1;ARRB1;PTCH1;LRPAP1;EGF;LGR4;VCP;PIK3CB;IGFBP3;BCL2;MAZ;LEPROT;BMP5;ENPP1;NDRG4;CD47;LRRC14;RACK1;CYP26B1;PIP4K2A;SUFU;TNS2;LRP1;PIP4K2C;TULP3
prerank,female gamete generation (GO:0007292),0.4795950186254691,1.2295340823322582,0.2130952380952381,1.0,1.0,2/29,6.03%,FSHR;SPO11
prerank,myelination (GO:0042552),0.44713782876272673,1.2293340459050264,0.18692660550458715,1.0,1.0,13/46,17.90%,AMIGO1;SIRT2;MYRF;ARHGEF10;MARVELD1;CXCR4;GPC1;PLLP;B4GALT5;EPB41L3;ABCD2;TPPP;BCAS1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4993477076584808,1.2284776424686565,0.2220795892169448,1.0,1.0,7/22,15.77%,HEXIM1;EEF1E1;CHD5;CDK5RAP3;RPS15;ATR;DDX5
prerank,regulation of heart contraction (GO:0008016),0.418371026920515,1.228453972891405,0.16457023060796647,1.0,1.0,13/90,11.50%,APLN;KCNG2;DMPK;CALM3;ATP1A3;ATP2A2;ITPR1;CELF2;ATP1A2;DES;ATP2B1;TPM1;CAMK2D
prerank,cellular response to dsRNA (GO:0071359),-0.4266692342272521,-1.2284391791417397,0.1840277777777778,0.847481611204752,1.0,11/15,35.54%,RIOK3;CAV1;IFIH1;RALB;MAVS;IFIT1;DHX9;PQBP1;PDE12;MUL1;CGAS
prerank,cGMP-mediated signaling (GO:0019934),0.5517640449949734,1.2280470327113808,0.2316546762589928,1.0,1.0,4/13,18.87%,KCNC2;HTR2C;APOE;PDE9A
prerank,regulation of protein kinase B signaling (GO:0051896),0.4031592242134037,1.2280264217807533,0.08853118712273642,1.0,1.0,34/193,14.28%,FGF20;MYORG;FGF9;MST1R;TSC2;PDPK1;HSP90AA1;RAC1;FGFR2;THEM4;FGFR1;FGF10;FLCN;TCF7L2;PIK3R1;GAB1;RCN3;DDIT3;FRS2;EGF;KL;IRS2;PIK3CB;PIK3R2;MAZ;PDGFRA;MAGI2;PARK7;DAG1;RACK1;NRG2;NRG1;RNF41;TGFB1
prerank,protein O-linked mannosylation (GO:0035269),0.5098334836103279,1.2273588492915934,0.23387096774193547,1.0,1.0,4/18,9.40%,TMTC4;DPM2;TMTC1;POMT2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43620245131093427,1.2270072817898516,0.1772972972972973,1.0,1.0,14/60,15.24%,MED24;BAX;NFKB1;MED12;MED14;CCNC;TCF7L2;MED13;MED4;SOX9;DHX36;AGO3;CBFB;MED23
prerank,peptide biosynthetic process (GO:0043043),-0.2521566511287998,-1.226951340386413,0.08333333333333333,0.8483560846898792,1.0,55/153,18.40%,RPS24;ABCF1;AGO2;RPL11;RPS15A;RPS23;RPL5;DMD;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;SRBD1;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;GGT5;RPLP0;EEF1A1;RPL36;RPL10;RPL32;RPS28;RPS5;MRPL42;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;MRPS21;RPS26;RPS27;RPL10A;MRPL52;DARS1;RPS10;PCSK1;MRPS18A;MRPS15;RPL7A;MRPS33;MRPS18C
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3290252565683209,-1.226401625844058,0.18045112781954886,0.8457605120195212,1.0,14/40,16.75%,RAD23B;HIPK2;LATS1;CSNK2A1;GNA12;PML;RPL11;RPL5;AXIN1;TRIM39;UBQLN4;RNF139;SGTA;UFL1
prerank,steroid hormone biosynthetic process (GO:0120178),-0.34852333831129606,-1.2263893340660421,0.16184971098265896,0.8412780231709974,1.0,14/29,42.34%,MED1;AKR1B1;STARD3NL;FDX1;TSPO;SRD5A3;FDXR;HSD17B7;HSD17B8;DHCR7;STAR;SRD5A1;HSD17B2;TSPOAP1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5684267647105928,1.2255823329858324,0.23851851851851852,1.0,1.0,6/11,16.87%,ZFP36L1;BARD1;DHX36;CDC73;ZC3H3;AHCYL1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5154352548283487,1.2255075457377247,0.2210242587601078,1.0,1.0,6/20,11.50%,BAX;FIS1;RAP1GDS1;ATP2A2;BCL2;CAMK2D
prerank,negative regulation of calcium ion transport (GO:0051926),0.5466441429852734,1.2253373911631888,0.21617852161785217,1.0,1.0,4/15,9.62%,CBARP;ATP1A2;PACSIN3;SLC30A1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5907650091338497,1.2250107254195586,0.24814264487369986,1.0,1.0,1/10,0.49%,NHP2
prerank,regulation of T cell differentiation (GO:0045580),0.4786677766596861,1.2246191198243208,0.19366626065773446,1.0,1.0,8/33,17.44%,XBP1;PRELID1;ABL1;CLPTM1;ZMIZ1;CBFB;FANCA;TCF7
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5654198395895342,1.224314740617067,0.23453237410071942,1.0,1.0,5/12,17.23%,PFDN4;VBP1;PFDN1;APOE;PFDN2
prerank,cellular response to estrogen stimulus (GO:0071391),0.551754863228318,1.2242013099140063,0.24581005586592178,1.0,1.0,4/14,12.53%,WBP2;SFRP1;SRA1;NCOA4
prerank,vasculature development (GO:0001944),0.5354037014028575,1.2229086825798152,0.2189265536723164,1.0,1.0,4/16,11.29%,STRA6;ERRFI1;STK11;PDGFRA
prerank,sphingolipid catabolic process (GO:0030149),0.5298550086025611,1.2222535470503757,0.2348804500703235,1.0,1.0,6/15,19.67%,SMPD2;SGPL1;ENPP2;SMPD4;SMPD1;PDXDC1
prerank,actin filament organization (GO:0007015),0.4052070466127679,1.2221340466542423,0.12284263959390863,1.0,1.0,29/151,17.61%,MYO1A;CARMIL2;SPIRE2;LCP1;MYO19;RAC1;WHAMM;NEB;MYO1B;DMTN;DBN1;RHOD;GAS2L1;PPP1R9B;BAIAP2;RHOBTB3;TPM1;MYO5A;MPRIP;ZBED3;EFS;SVIL;EMP2;FAT1;SPIRE1;VILL;TMOD2;RUFY3;ABI1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5281075373661,1.2218104095176643,0.2220744680851064,1.0,1.0,6/17,19.75%,ANXA1;ARRB1;SSC5D;PTPN22;ANXA4;KLF4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.48205554485506613,1.2214906229833298,0.20024570024570024,1.0,1.0,10/27,19.82%,TSC2;PIP4K2B;SLC27A4;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;PTPRE;PRKCZ
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.42093557473894705,1.221030172097416,0.1761546723952739,1.0,1.0,17/80,14.58%,CARMIL2;CCP110;CDC42EP5;CDC42EP4;RAC1;ACTR2;NRP1;PIK3R1;RIPOR2;CYFIP1;ENTR1;ARAP1;HTT;FAM98A;AUTS2;PLPPR5;CEP120
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5669534322844576,1.2209362632264416,0.23555555555555555,1.0,1.0,5/11,15.47%,SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,striated muscle tissue development (GO:0014706),-0.3504425908014188,-1.2208163851061986,0.18041237113402062,0.8566371467581867,1.0,9/29,16.25%,MEF2C;PGM5;MYL6;CAV1;RBP4;SGCD;BMP7;SIX1;NDUFV2
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.38603268424018067,-1.220726515073884,0.1862348178137652,0.8478496657137599,1.0,8/20,11.39%,BCKDHB;IVD;MCCC2;HIBCH;MCCC1;ACAD8;ALDH6A1;BCKDHA
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.38603268424018067,-1.220726515073884,0.1862348178137652,0.8478496657137599,1.0,8/20,11.39%,BCKDHB;IVD;MCCC2;HIBCH;MCCC1;ACAD8;ALDH6A1;BCKDHA
prerank,regulation of cilium assembly (GO:1902017),0.42745853880889206,1.2206149706185343,0.18797814207650274,1.0,1.0,22/62,18.26%,CCP110;DCDC2;CDKL5;TBC1D7;SGSM3;TBC1D13;CEP97;TCHP;ENTR1;TBC1D20;USP6NL;EVI5L;IFT20;HTT;RABGAP1;TBC1D24;ATG3;CEP120;TBC1D9B;TBC1D22B;CCDC88A;CDK10
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5909394854639556,1.2201394024598784,0.20933734939759036,1.0,1.0,2/10,10.25%,PLA2G5;ENPP2
prerank,embryonic eye morphogenesis (GO:0048048),0.5710706962249749,1.219547713240319,0.23795180722891565,1.0,1.0,5/11,12.67%,FBN2;MFAP2;MFAP5;KDM2B;FBN1
prerank,cell-substrate junction assembly (GO:0007044),-0.3388994855406163,-1.219397022021375,0.16463414634146342,0.8482575839833997,1.0,15/33,15.19%,DST;SORBS1;FERMT2;PTPRK;ITGA6;TAOK2;CTTN;TESK2;ACTN1;FN1;PLEC;ACTN2;LAMA3;ITGB4;SRC
prerank,response to exogenous dsRNA (GO:0043330),-0.40323955927400057,-1.2193822929274893,0.20930232558139536,0.8438736441633728,1.0,11/18,35.54%,CAV1;SLC3A2;IFIH1;RALB;MAVS;IFIT1;TICAM1;DHX9;PQBP1;MUL1;CGAS
prerank,positive regulation of immune effector process (GO:0002699),0.4754301196338872,1.2192256700536204,0.20300751879699247,1.0,1.0,3/27,5.93%,PLA2G5;XBP1;DHX58
prerank,macrophage activation involved in immune response (GO:0002281),-0.4357171877277592,-1.2180968677387394,0.24305555555555555,0.8439907539011192,1.0,5/13,13.96%,SBNO2;LBP;PLCG2;DYSF;GRN
prerank,regulation of intracellular pH (GO:0051453),0.46703588827236847,1.2177843639483912,0.21027479091995221,1.0,1.0,3/34,0.91%,SLC4A4;SLC4A5;CLN3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.42408763436400865,1.2172242162182456,0.1891891891891892,1.0,1.0,18/68,16.33%,MLYCD;THEM4;PTHLH;ENTPD7;ACOT9;ACOT11;GPAT4;MFN1;ACAT1;CROT;AK4;ENPP1;HPRT1;ABHD14B;AK3;ACSL6;GMPR2;SULT1A1
prerank,negative regulation of response to wounding (GO:1903035),0.5132154082829841,1.2169835543737664,0.25609756097560976,1.0,1.0,8/19,22.67%,AJAP1;CASK;CERS2;GIT1;SERPINE1;PTPRS;FGF2;EPHA4
prerank,regulation of interferon-beta production (GO:0032648),0.4424210286086591,1.2169391024209761,0.1947608200455581,1.0,1.0,16/46,20.04%,HSP90AA1;POLR3D;DDX3X;TIRAP;PPM1B;IRF1;DHX58;TRIM56;SIRPA;IRF3;YY1;TLR3;OAS2;RELB;FLOT1;PTPRS
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5087180233978518,1.2163778894431994,0.24899598393574296,1.0,1.0,2/20,3.12%,PSRC1;MAPRE3
prerank,response to calcium ion (GO:0051592),0.41340871407122076,1.216174377076891,0.16769547325102882,1.0,1.0,32/102,21.79%,ALOX5AP;SYT3;WNT5A;SYT10;GPLD1;PPIF;CALM3;CARF;SLC25A24;DMTN;RASGRP2;KCNMA1;ADGRV1;PEF1;CPNE7;CAMK2D;IQGAP1;SYT1;CPNE8;ADCY1;DPEP1;AHCYL1;PKD2;PRKAA1;CALM1;KCNH1;SMPD1;SYT4;PDCD6;SYT11;SYT12;CALM2
prerank,protein N-linked glycosylation (GO:0006487),0.4220534534331247,1.2160268557252558,0.19155844155844157,1.0,1.0,17/66,15.20%,ALG5;TMEM258;ALG6;MGAT3;DPM2;MGAT4B;ALG1;ALG8;DPAGT1;MGAT4C;UGGT2;ALG9;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,regulation of peptide hormone secretion (GO:0090276),0.41984340478532944,1.2157617502452656,0.17926565874730022,1.0,1.0,12/67,17.24%,CACNA2D2;KCNG2;PICK1;ITPR1;PRKCA;KCNC2;SNAP25;HTR2C;UQCC2;RFX3;CLOCK;EIPR1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.25228256861267073,-1.215683560456566,0.0,0.8480974170315206,1.0,41/153,12.83%,RICTOR;MAPK8;HIPK2;LATS1;PRKCH;CSNK1G3;CAB39;ERN1;MORC3;CSNK2A1;IKBKB;MARK2;STK38L;NLK;PRKCE;PRKCD;RIPK1;RPS6KA5;CSNK1G1;PRKD1;MARK1;CSNK1E;MKNK1;HIPK1;PRKACA;LRRK2;CSNK1G2;TGFBR2;NEK6;IKBKE;TTBK2;MAP3K10;MAP3K13;STK32A;LMTK2;VRK3;CAMK1;ROCK1;MAP3K12;AKT3;PRKX
prerank,regulation of trophoblast cell migration (GO:1901163),-0.43602715347043236,-1.2147948342199217,0.20618556701030927,0.8468625172764898,1.0,6/14,19.11%,GJA1;AGO2;CALR;SYDE1;ARHGDIB;VEGFA
prerank,regulation of insulin secretion (GO:0050796),0.40554183915897807,1.2145213422238808,0.15657620041753653,1.0,1.0,21/101,17.24%,CACNA2D2;KCNG2;SFRP1;LRRC8A;PICK1;ITPR1;CAPN10;PRKCA;TCF7L2;BRSK2;KCNC2;SNAP25;IRS2;UQCC2;NLGN2;RFX3;CLOCK;TRH;ADCY5;EPHA5;EIPR1
prerank,sensory perception of sound (GO:0007605),0.4138474655123199,1.2142518015416937,0.1537645811240721,1.0,1.0,10/88,9.16%,MYO1A;DCDC2;MYH14;NIPBL;PCDH15;TIMM13;RIPOR2;ADGRV1;LHFPL3;CCDC50
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5300308877242227,1.2140304566720825,0.22641509433962265,1.0,1.0,3/16,7.50%,FASN;MLYCD;ACAT1
prerank,macrophage differentiation (GO:0030225),0.5435404805678008,1.2136107288579092,0.23121387283236994,1.0,1.0,2/13,4.92%,PARP1;IL31RA
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.49115559353869465,1.2131850724858246,0.23289473684210527,1.0,1.0,5/23,9.57%,COPS7A;PARP1;DDB1;COPS7B;CUL4B
prerank,regulation of mast cell degranulation (GO:0043304),0.5491648771041588,1.2127443921350534,0.24787535410764872,1.0,1.0,1/14,0.21%,UNC13D
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4907217226284686,1.2117734210963982,0.24183006535947713,1.0,1.0,7/23,10.18%,SH3BP5;ERRFI1;THY1;SNX6;SH3BP5L;MVP;SRCIN1
prerank,glial cell differentiation (GO:0010001),0.4679310355759539,1.2116087300124818,0.220873786407767,1.0,1.0,7/28,9.55%,MYRF;PICK1;FGF10;CDK5;GPC1;SOX9;SOX11
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.44092735507541037,1.2113109392936041,0.21034870641169853,1.0,1.0,14/49,15.32%,UBQLN1;BAX;PPIF;EIF2AK3;FIS1;PTPMT1;DDX3X;DDIT3;BCL2;RTKN2;RACK1;BCLAF1;DNM1L;NUPR1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.49547429833426515,1.2112793708830305,0.2351421188630491,1.0,1.0,9/22,17.19%,MAPRE3;GBA2;ABL1;CAMSAP2;PRUNE1;PARK7;AKAP13;MAPT;APOE
prerank,protein localization to cell-cell junction (GO:0150105),-0.42676027671142835,-1.211077718524433,0.22393822393822393,0.8556633422281475,1.0,5/15,9.78%,ARHGEF18;TJP1;ACTB;F11R;LSR
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5361518017902045,1.2110112323982072,0.26420454545454547,1.0,1.0,2/13,2.68%,SELENOS;IL33
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.435462772758936,1.210838932728506,0.20246085011185683,1.0,1.0,13/50,16.81%,CDKN2D;DDX3X;CARD16;USP47;RFFL;XIAP;CAAP1;PARK7;DNAJB6;LAMTOR5;RPS6KA3;RPS6KA1;DPEP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.47629479167448424,1.210524751512312,0.21648216482164823,1.0,1.0,11/28,21.10%,TSC2;PIP4K2B;SLC27A4;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;PTPRE;PRKCZ;APPL2
prerank,positive regulation of developmental growth (GO:0048639),0.4386983308453768,1.2104974024150368,0.2080989876265467,1.0,1.0,11/49,17.44%,RNF157;SYT3;CDKL5;UNC13A;DBN1;PPIB;DBNL;SYT1;MAPT;SMURF1;RUFY3
prerank,dendritic cell differentiation (GO:0097028),-0.3717693922439654,-1.2104904378445671,0.1853448275862069,0.8533768222308785,1.0,3/22,7.89%,AXL;LGALS9;TGFBR2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5492887602749621,1.2103714110030666,0.24495677233429394,1.0,1.0,5/13,7.71%,SAR1A;SEC16A;BRSK2;SEC16B;INSIG1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.48677274256435493,1.2103220669341297,0.2196029776674938,1.0,1.0,3/25,5.62%,B3GALNT1;HS2ST1;NDST2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4036486311356744,-1.2103216011681281,0.22093023255813954,0.8496549899451429,1.0,7/17,12.54%,GJA1;ATP1A1;GJC1;GJD3;CACNA1C;PRKACA;ATP1B1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.39959748755855096,1.2099837559425026,0.1206896551724138,1.0,1.0,22/152,14.65%,FSHR;S1PR2;PTGER4;ADCY7;ADM;VIPR2;PTHLH;OPRK1;GPR37;GNAS;GPR4;LGR4;TBXA2R;PTH1R;ADGRG1;GPR161;GABBR1;CHRM2;LPAR1;PSAP;AKAP12;ADCY1
prerank,fatty acid elongation (GO:0030497),0.540138142362761,1.209914941617022,0.26453488372093026,1.0,1.0,7/13,27.49%,ELOVL1;ELOVL4;ELOVL6;HACD2;HACD1;HACD3;HACD4
prerank,positive regulation of neuron death (GO:1901216),0.4487435455331399,1.209854837774605,0.19750283768444948,1.0,1.0,7/46,8.84%,WNT5A;FCGR2B;EPHA7;BAX;CDK5;DDIT3;EFNB2
prerank,endomembrane system organization (GO:0010256),0.40257241341934713,1.2095723006938521,0.10887096774193548,1.0,1.0,50/178,16.00%,SPTBN5;REEP4;CUL7;A4GALT;ATL1;DNM1;TJAP1;UBXN2A;EIF2AK3;DMPK;BNIP1;TRAPPC8;OBSL1;TLCD1;SQSTM1;SEC16A;ARHGEF7;MIA3;SNX10;TRIP11;SEC16B;ATP8B2;LMAN2L;ARHGAP21;TOR1B;HOOK3;TBC1D20;PLEKHM2;USP6NL;ANK3;RAB30;ALS2;SNX33;VPS33B;LEMD3;TANGO2;TMED10;SERP1;COG3;HTT;CSNK1D;SMPD4;VMP1;DNM1L;DNAJC13;CSNK1A1;SPTBN1;VAPB;STX17;VPS18
prerank,regulation of sequestering of triglyceride (GO:0010889),0.5332361100413802,1.2093674150732878,0.2325268817204301,1.0,1.0,3/15,9.13%,LPL;OSBPL11;PLIN3
prerank,peptidyl-methionine modification (GO:0018206),0.5612199096635141,1.209001418270395,0.2503681885125184,1.0,1.0,4/12,13.29%,METAP1;NAA30;METAP1D;METAP2
prerank,central nervous system myelination (GO:0022010),0.5720852602154531,1.2089090721108504,0.2511013215859031,1.0,1.0,4/11,15.23%,MYRF;ABCA2;B4GALT5;TENM4
prerank,retinol metabolic process (GO:0042572),0.5330639162382305,1.208789722392407,0.22344827586206897,1.0,1.0,2/14,6.30%,RDH10;RDH11
prerank,histone H2A monoubiquitination (GO:0035518),0.5290727456461571,1.2084949460850765,0.24528301886792453,1.0,1.0,6/17,10.68%,PCGF1;DDB1;PCGF6;RNF168;CUL4B;KDM2B
prerank,positive regulation of organelle assembly (GO:1902117),0.44887549115897873,1.2080065403765772,0.20070011668611434,1.0,1.0,14/44,18.16%,CCP110;LCP1;PIP4K2B;ENTR1;SDCBP;GPSM2;PIP4K2A;HTT;PIP4K2C;CEP120;CNOT6;NUMA1;IL5;CCDC88A
prerank,C4-dicarboxylate transport (GO:0015740),-0.42422451085851604,-1.2078423173149733,0.23024054982817868,0.8540211000687143,1.0,9/14,36.89%,SLC25A13;LRRC8D;SLC25A14;SLC25A30;SLC25A11;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4556069241663562,1.2076309609926985,0.20681551116333724,1.0,1.0,9/34,18.58%,IGF1;CDC23;EDN3;CDC16;EGF;ANAPC11;ANAPC4;PHIP;ANAPC5
prerank,negative regulation of kinase activity (GO:0033673),0.4313225734233545,1.2074209328498295,0.1940463065049614,1.0,1.0,24/62,21.66%,TARBP2;GSKIP;TSC2;PDPK1;PRKRIP1;WARS1;THY1;DVL1;YWHAG;IRS2;PARK7;MAPT;PPM1E;ITGB1BP1;GNAQ;CAMK2N1;PPP2R5A;TAB1;TRIM27;PRKAG2;RTRAF;HNRNPU;NPRL2;PPM1F
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5162448628092356,1.207244405245249,0.24360699865410498,1.0,1.0,6/17,12.59%,ALG6;ALG1;ALG8;DHDDS;DPAGT1;ALG9
prerank,mitochondrial membrane organization (GO:0007006),0.4625827384423081,1.2069106984991471,0.21445497630331753,1.0,1.0,9/32,13.79%,APOOL;PPIF;MICOS10;MFN1;MFN2;APOO;RCC1L;BCL2;MTX3
prerank,regulation of protein kinase C signaling (GO:0090036),0.5395416286575264,1.206337921241803,0.24335664335664337,1.0,1.0,3/14,7.66%,WNT5A;GPD1L;ADGRV1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5329614793983785,1.206165180315752,0.2496570644718793,1.0,1.0,3/13,13.39%,SYT10;SYT1;SCAMP5
prerank,calcium ion homeostasis (GO:0055074),0.4107898694881465,1.205491006620784,0.17547568710359407,1.0,1.0,15/95,13.21%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;GRIN1;CXCL12;ATP2A2;ATP2B1;SLC24A4;SLC30A1;PTH1R;HTR2C;NPTN
prerank,ERBB2 signaling pathway (GO:0038128),0.4655515655438876,1.205467111478682,0.2235722964763062,1.0,1.0,11/31,18.11%,HSP90AA1;STUB1;PRKCA;PIK3R1;GAB1;EGF;NRG2;CUL5;NRG1;PTPN12;ERBIN
prerank,Wnt signaling pathway (GO:0016055),0.4113047023299514,1.2049201962859026,0.17908902691511386,1.0,1.0,21/92,15.56%,SFRP2;WNT2B;WNT5A;SFRP1;DVL2;DDX3X;FZD9;FZD3;TCF7L2;KLHL12;DVL1;CD24;WNT4;WLS;DIXDC1;PORCN;GPC4;PLPP3;CSNK1A1;TCF7L1;USP34
prerank,oligodendrocyte differentiation (GO:0048709),0.5003609778255403,1.204801745290203,0.24254215304798962,1.0,1.0,6/19,17.10%,MYRF;CDK5;SOX9;SOX6;TPPP;SOX13
prerank,endocardial cushion morphogenesis (GO:0003203),-0.39933825523566624,-1.2042280669243879,0.23348017621145375,0.8621204422063647,1.0,10/18,24.63%,TGFB2;NOS3;ACVR1;ENG;BMPR1A;TGFBR2;BMP4;HEYL;TBX2;BMP2
prerank,regulation of lipid catabolic process (GO:0050994),-0.40313919879691873,-1.2039365410206864,0.24302788844621515,0.8587603218125024,1.0,5/19,21.92%,LONP2;PDE3B;ALK;BSCL2;ADRA2A
prerank,cholesterol homeostasis (GO:0042632),0.4223866147008738,1.2038896783303523,0.20065430752453653,1.0,1.0,20/64,22.93%,LPL;XBP1;RORA;ABCA2;CNBP;CYP7B1;SOAT1;CD24;INSIG1;EPHX2;APOE;MTTP;TTC39B;ABCA5;LIMA1;EHD1;NPC2;ABCG1;NPC1;IL18
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.4673991524350234,-1.2031138008402695,0.23952095808383234,0.8575316853261865,1.0,4/11,16.21%,TASOR;PPHLN1;SETDB2;DNMT1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.346311600924631,-1.203040505847183,0.20689655172413793,0.8535731270587243,1.0,13/29,16.11%,RAD23B;GTF2H1;ERCC5;RBX1;CHD1L;MNAT1;CUL4A;RPA1;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5664354597829356,1.2028874667725227,0.26166902404526166,1.0,1.0,4/12,7.40%,CCT8;GNL3;CCT6A;WRAP53
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.46874035981780937,1.2026536147885654,0.24754901960784315,1.0,1.0,12/29,20.76%,PAIP1;FUS;PABPC1;GDNF;AXIN2;FMR1;THRAP3;DHX34;TENT5A;CIRBP;HNRNPU;YBX1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.5746981736895918,1.2024679858565184,0.26015037593984963,1.0,1.0,2/11,5.61%,XBP1;TMEM106A
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.5737674905486604,1.201390240748529,0.2554517133956386,1.0,1.0,1/10,1.59%,SIRT2
prerank,negative regulation of cell development (GO:0010721),0.4836513370085424,1.201282858237117,0.2275064267352185,1.0,1.0,8/25,23.92%,IGF1;PTHLH;HOOK3;FBN1;SORL1;APPL2;B2M;FBXW7
prerank,RNA processing (GO:0006396),0.3923404141848493,1.2003993850864139,0.12727272727272726,1.0,1.0,46/176,14.92%,KHSRP;LSM6;DDX17;RBM3;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;DHX15;USB1;SRSF5;SF3B2;SF3B1;RBM39;CELF2;DHX8;ATXN1;CELF1;HNRNPK;AKAP8L;FUS;MPHOSPH10;SRSF9;SF3A1;PRPF6;SRSF1;AURKAIP1;PPP1R9B;PABPC4;KIN;HNRNPD;LIN28B;RBMS1;NUDT21;RBMS2;DHX16;HNRNPA0;HNRNPH3;SETX;HNRNPL;NOVA1;HNRNPA2B1;RP9;THOC1
prerank,mesenchymal cell differentiation (GO:0048762),0.4316323699149743,1.200259539238885,0.22197558268590456,1.0,1.0,13/51,15.77%,WNT5A;CUL7;DDX17;FGFR2;FGFR1;SNAI1;RANBP3L;WNT4;SOX9;RBPJ;ROCK2;TGFB1;DDX5
prerank,negative regulation of platelet activation (GO:0010544),-0.411939788820524,-1.2000549894336576,0.25622775800711745,0.8597014123677331,1.0,5/16,6.80%,PRKG1;SERPINE2;PRKCD;THBD;NOS3
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4118026579823836,-1.1998660095783917,0.22377622377622378,0.8560923534122464,1.0,7/17,32.79%,LGALS9;RARA;CEBPB;CD86;SYK;HAVCR2;FCER1G
prerank,mitochondrial transport (GO:0006839),0.4359842625648442,1.199813145812935,0.1937290033594625,1.0,1.0,13/53,13.20%,PPIF;BCS1L;HSP90AA1;FIS1;SLC25A24;TOMM20;FBXO7;TIMM13;MFN2;AIP;BCL2;STARD3;GDAP1
prerank,sterol homeostasis (GO:0055092),0.42056129531540576,1.199672924897877,0.20218579234972678,1.0,1.0,20/65,22.93%,LPL;XBP1;RORA;ABCA2;CNBP;CYP7B1;SOAT1;CD24;INSIG1;EPHX2;APOE;MTTP;TTC39B;ABCA5;LIMA1;EHD1;NPC2;ABCG1;NPC1;IL18
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.37714129022290405,-1.1996051018346452,0.1752136752136752,0.852854251098555,1.0,11/21,34.12%,LIMCH1;GPM6B;SLK;ROCK1;ACTG1;DAPK3;RHOA;PEAK1;MACF1;EPHA3;CLASP1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4970498311298456,1.1995729432057012,0.24868421052631579,1.0,1.0,7/22,16.78%,CBARP;CACNB4;NOS1AP;CACNB1;PDE4B;AHNAK;FMR1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4852780371299372,-1.1985892203085013,0.260752688172043,0.852198539433699,1.0,5/10,28.19%,CD34;KDR;HIF1AN;CEACAM1;RRAS
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5665622197151896,1.1983361951480156,0.2562225475841874,1.0,1.0,5/11,15.94%,UBN1;RBBP4;ASF1A;ATRX;HAT1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5024162686353839,1.1969530827842045,0.26104417670682734,1.0,1.0,7/19,17.00%,CD63;CCBE1;DCN;PIK3CB;ROBO1;ADAMTS3;SPRY2
prerank,positive regulation of organelle organization (GO:0010638),0.46667917336478415,1.1962144184170567,0.24166666666666667,1.0,1.0,9/32,21.24%,PLA2G5;ANXA1;KATNBL1;ANXA2;PFDN2;FYCO1;RAB3GAP2;UVRAG;ATL3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4568373022243455,-1.1960426435687734,0.22910216718266255,0.8572386483985583,1.0,6/11,20.23%,MBTPS2;TP53;HSPA5;CEBPB;ATF4;CREB3L1
prerank,external encapsulating structure organization (GO:0045229),0.3936538688501529,1.1958196735955706,0.11581067472306143,1.0,1.0,46/205,16.49%,ADAMTSL2;MMP12;MMP17;VTN;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;DDR2;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;MFAP5;APP;ST7;ADAM12;COL1A2;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;PXDN;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1
prerank,negative regulation of defense response to virus (GO:0050687),0.5612236033190505,1.195687506677059,0.2675438596491228,1.0,1.0,2/10,5.04%,TARBP2;PPM1B
prerank,myeloid dendritic cell activation (GO:0001773),-0.4585977861803002,-1.1956631665349624,0.2686084142394822,0.8544461764469508,1.0,2/12,7.89%,DOCK2;TGFBR2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.44205434187651305,1.1956309414392112,0.22058823529411764,1.0,1.0,6/45,10.71%,WNT5A;LPL;GSDMD;TMEM106A;MALT1;APP
prerank,vesicle transport along microtubule (GO:0047496),0.48011230419840834,1.1955979484720693,0.24124513618677043,1.0,1.0,13/23,26.29%,CLN3;KIF3A;BICDL1;HTT;TRAK1;KIF5B;FYCO1;KIFAP3;PAFAH1B1;KIF3B;DYNC1H1;FBXW11;KIF5A
prerank,regulation of gastrulation (GO:0010470),0.5300875562182734,1.1954517973112615,0.25444596443228457,1.0,1.0,7/14,24.81%,DAG1;RACK1;TENM4;PHLDB1;OSR1;CLASP2;PHLDB2
prerank,potassium ion transport (GO:0006813),0.39938407203269344,1.1952688560066698,0.16529774127310062,1.0,1.0,19/120,15.89%,KCNG2;KCNAB2;KCNA4;KCNC1;NALCN;KCNK2;KCNMA1;ATP1A2;KCNC2;KCNJ10;SLC24A4;KCNQ4;KCND3;KCNH5;SLC1A3;KCNA1;KCNQ2;SLC9A7;SLC9A6
prerank,positive regulation of neurogenesis (GO:0050769),0.4229264196187948,1.1952377461008954,0.20498915401301518,1.0,1.0,21/68,20.85%,AMIGO1;CUL7;SMARCD3;CDKL5;PLXNA2;FZD3;OBSL1;PLXNA1;SOX11;ROBO2;ROBO1;IL1RAPL1;NPTN;DISC1;SNW1;PLXNB3;SLITRK1;CUX1;SERPINF1;MAP6;NTRK2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4955214230597296,1.1938786969098485,0.2709424083769634,1.0,1.0,3/22,6.13%,FCGR2B;UBASH3A;THY1
prerank,response to alcohol (GO:0097305),0.47975457900551594,1.1937386139536033,0.253416149068323,1.0,1.0,10/27,21.76%,GRIN1;ABCA2;GRIN2A;TGFB1;GLRA1;SLIT3;TGFBR1;TGFBR3;SMAD2;SDF4
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5693998541784585,1.1937234293886763,0.2716049382716049,1.0,1.0,1/10,0.80%,WNT5A
prerank,cellular response to misfolded protein (GO:0071218),0.5056261377451303,1.1929110480250755,0.26459143968871596,1.0,1.0,6/20,10.84%,STUB1;AUP1;POMT2;KLHL15;VCP;UGGT2
prerank,negative regulation of protein kinase activity (GO:0006469),0.40829241489245494,1.1927573357743122,0.1909282700421941,1.0,1.0,26/88,18.99%,DUSP26;TARBP2;GSKIP;TSC2;PDPK1;SH3BP5;PRKRIP1;WARS1;ABL1;THY1;DVL1;SH3BP5L;CDK5RAP3;MVP;YWHAG;SRCIN1;PARK7;NPM1;PPM1E;ITGB1BP1;GNAQ;CAMK2N1;SORL1;TAB1;TRIM27;PRKAG2
prerank,regulation of water loss via skin (GO:0033561),-0.41249053305016736,-1.1925641917703182,0.20945945945945946,0.8572856963550494,1.0,6/15,34.08%,LSR;MET;HRNR;CLDN1;UGCG;ALOX12
prerank,establishment of skin barrier (GO:0061436),-0.41249053305016736,-1.1925641917703182,0.20945945945945946,0.8572856963550494,1.0,6/15,34.08%,LSR;MET;HRNR;CLDN1;UGCG;ALOX12
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4212223426492429,-1.1923665542795983,0.23214285714285715,0.8537612182440112,1.0,6/15,23.62%,PRKD1;TMSB4X;THBS1;MET;HSPB1;SEMA5A
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.29054711436417885,-1.1919732346289518,0.16666666666666666,0.8511202908364329,1.0,20/72,12.74%,ELF1;AXL;IFNAR2;IKBKB;IRAK2;STAT1;RIPK1;IRAK1;HSP90AB1;HIPK1;OTULIN;CYLD;TRIM44;TAX1BP1;PTPRC;IKBKG;LIFR;MADD;TNFRSF1A;CDC37
prerank,neuron migration (GO:0001764),0.4303920270430895,1.1916051481369372,0.23986486486486486,1.0,1.0,20/48,21.28%,RAC1;DCDC2;CDKL5;FGFR1;NRP1;CDK5;TUBB2A;SPOCK1;LRP12;USP9X;DISC1;AUTS2;PEX13;SEMA3A;NDNF;TUBGCP2;PAFAH1B1;DCX;NTRK2;FGF13
prerank,extracellular structure organization (GO:0043062),0.39217591437759075,1.1912928313924773,0.12588116817724068,1.0,1.0,46/204,16.49%,ADAMTSL2;MMP12;MMP17;VTN;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;DDR2;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;MFAP5;APP;ST7;ADAM12;COL1A2;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;PXDN;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5386050068202254,1.1907393341606824,0.2633863965267728,1.0,1.0,5/13,12.59%,ALG6;ALG1;ALG8;DPAGT1;ALG9
prerank,ganglioside metabolic process (GO:0001573),0.4916939279088823,1.1905985031192197,0.2506426735218509,1.0,1.0,5/20,14.34%,CLN6;ST8SIA3;ABCA2;ST3GAL5;ST6GALNAC6
prerank,regulation of epithelial cell migration (GO:0010632),-0.29272384789505135,-1.190529462807527,0.136986301369863,0.8520894330629303,1.0,16/51,15.19%,PTPRG;DAB2IP;BMPER;DOCK1;RREB1;PRKCE;HIF1A;TGFB2;ADIPOR1;PLCG2;DUSP10;PTPN23;PLCG1;PFN1;CAPN7;SRC
prerank,chemical homeostasis (GO:0048878),0.4276238191934754,1.1903533703581572,0.22355507088331517,1.0,1.0,13/61,15.48%,SLC4A4;SLC4A5;USF1;NR1D2;DDX3X;TLCD1;RBP1;IRS2;WNK2;ZBTB20;TLCD3B;AQP4;ACOX3
prerank,cAMP metabolic process (GO:0046058),0.5353401198365364,1.1900589909991308,0.26770538243626063,1.0,1.0,4/13,16.59%,ADCY7;PTHLH;ADCY1;ADCY5
prerank,secondary alcohol metabolic process (GO:1902652),0.44205184971035205,1.1896108924010684,0.23201856148491878,1.0,1.0,6/42,7.49%,CYP27A1;CLN6;SCAP;IDH3B;GBA2;SOAT1
prerank,signal release from synapse (GO:0099643),0.43298506872190534,1.1896064925288918,0.2488479262672811,1.0,1.0,9/43,12.73%,SYT10;UNC13A;CDK5;DVL1;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1
prerank,cellular response to purine-containing compound (GO:0071415),-0.4802763677195183,-1.1895790220991254,0.2553846153846154,0.8515741217893952,1.0,7/10,37.91%,P2RY1;RYR2;GSTM2;SLC8A1;TRPM2;P2RY6;CASQ2
prerank,positive regulation of histone deacetylation (GO:0031065),0.5474112369194671,1.1895724156495122,0.263768115942029,1.0,1.0,6/12,18.01%,NIPBL;AKAP8L;ZBTB7B;SAP30BP;CTBP1;PRKD2
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.47945845710965884,-1.1893667186965902,0.24183006535947713,0.8483399566672271,1.0,5/10,21.34%,GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.45609819269366486,1.1892705433591302,0.24516908212560387,1.0,1.0,10/32,18.42%,CUL7;CDKL5;OBSL1;KNDC1;RAP2A;YWHAH;IL1RAPL1;GORASP1;CUX1;ADGRB3
prerank,regulation of ossification (GO:0030278),0.44838372473539484,1.1891084372691654,0.24106113033448673,1.0,1.0,10/36,14.82%,WNT5A;SFRP1;ANKH;DDR2;SOX9;SOX11;TWIST1;RBPJ;ENPP1;SMAD6
prerank,autophagy of mitochondrion (GO:0000422),0.44485055669638873,1.1888097832010933,0.22379269729093051,1.0,1.0,15/38,19.40%,FIS1;FUNDC2;USP30;WIPI1;FBXO7;FUNDC1;SQSTM1;ATG14;ATG2A;ATG13;ATG3;MAP1LC3B;ATG9A;CTSK;AMBRA1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.39365158814334,-1.188711601093114,0.20512820512820512,0.8467188622990317,1.0,4/19,23.38%,LRP6;MANF;VEGFA;NR4A2
prerank,epithelial to mesenchymal transition (GO:0001837),0.432782953451966,1.1883699841111826,0.2383654937570942,1.0,1.0,12/47,15.77%,WNT5A;CUL7;DDX17;FGFR1;SNAI1;OLFM1;WNT4;SOX9;RBPJ;ROCK2;TGFB1;DDX5
prerank,positive regulation of growth (GO:0045927),0.42004090022568735,1.1881247293649275,0.2176795580110497,1.0,1.0,12/64,12.97%,SFRP2;SFRP1;CDKN2AIP;EXOSC2;TAF9B;SLC25A33;DDX3X;USP47;SDCBP;BCL2;EIF4G2;RPS6KA3
prerank,regulation of chromosome organization (GO:0033044),-0.3749405664757045,-1.187429782814012,0.2028301886792453,0.8471215136231465,1.0,7/22,17.46%,WAPL;RB1;HDAC8;SMG5;CENPV;UPF1;SMG6
prerank,regulation of steroid metabolic process (GO:0019218),0.4823383890458873,1.1873612059064977,0.25475285171102663,1.0,1.0,9/23,21.43%,STUB1;RORA;ABCA2;EPHX2;ACADL;ACADVL;APOE;TTC39B;ABCG1
prerank,interstrand cross-link repair (GO:0036297),0.43054040570270785,1.187001658525252,0.22048997772828507,1.0,1.0,13/53,15.12%,RNF8;USP1;FANCE;FANCG;RNF168;VCP;DCLRE1A;FANCM;POLN;FAAP100;ATR;FANCA;NUCKS1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4053787828004384,-1.1867376562719674,0.21908127208480566,0.8456411569606407,1.0,2/16,10.73%,CYRIB;PTPRC
prerank,regulation of endocytosis (GO:0030100),0.42180682298000827,1.186683064760785,0.24363233665559247,1.0,1.0,21/61,20.27%,CALY;TSC2;CD151;ABL1;PACSIN3;LRPAP1;RAB5B;ABCA7;CLIP3;AP2S1;SNX33;SCAMP5;LRP1;RUFY1;RIT2;APOE;MCTP1;ZFYVE16;FLOT1;SMPD1;DAB2
prerank,insulin secretion (GO:0030073),0.4976926759532284,1.18665672148395,0.24702774108322326,1.0,1.0,5/19,12.18%,PTPRN;ANXA1;SELENOT;PARK7;CAMK2G
prerank,positive regulation of signal transduction (GO:0009967),0.38638604280874295,1.1862251322586703,0.11434302908726178,1.0,1.0,59/238,18.56%,MYORG;VTN;ATP6AP2;SFRP1;IGF1;STK36;BAX;CDKN2AIP;BMP6;NTF3;FGFR2;DCDC2;GRIN1;XBP1;CD63;RWDD3;CCBE1;SNX5;AGPAT1;RAB34;TNFAIP3;NRP1;PRKCA;SULF1;PIK3R1;DMTN;ARNT;TMEM108;ZBTB7B;SMARCB1;TUBD1;WLS;LY96;RBPJ;ROBO1;ZMIZ1;NLGN3;NPTN;PRKCI;CDC73;EMP2;DISC1;HTT;ADAMTS3;NLGN2;F3;LMO3;MN1;SNW1;JAG1;ITGB1BP1;PHIP;LANCL2;ILK;SORL1;PRKD2;PKD2;GPS2;TGFBR1
prerank,organelle disassembly (GO:1903008),-0.33759930321091647,-1.185802020400694,0.2057142857142857,0.8449076467145347,1.0,12/33,16.75%,GBF1;ATG2B;MCTS1;KLC1;UBA5;DDRGK1;EIF2D;MTIF2;ULK2;ZFAND1;UFC1;UFL1
prerank,regulation of protein kinase activity (GO:0045859),0.4025822435830545,1.1856948241267795,0.18789144050104384,1.0,1.0,31/106,20.58%,TARBP2;GSKIP;TSC2;PDPK1;PRKRIP1;MAPRE3;SMG8;WARS1;DDR2;THY1;DVL1;MMD;XRCC6;MRNIP;YWHAG;JTB;ALS2;IQGAP1;PARK7;PPM1E;DAXX;ITGB1BP1;GNAQ;CAMK2N1;RASSF2;TAB1;TRIM27;PRKAG2;RTRAF;UVRAG;PTK2B
prerank,modification-dependent protein catabolic process (GO:0019941),0.390559918177639,1.1856085426491287,0.13380281690140844,1.0,1.0,61/193,18.58%,UBQLN1;CDC23;RNF8;UBE2S;SPSB1;STUB1;SYVN1;XBP1;MAD2L1;CDC16;RNF215;FZR1;FBXL14;FBXO7;SQSTM1;ANAPC2;DDB1;FBXO45;RFFL;PSMD11;ARRB1;UBA1;UBE3B;RNF40;RNF168;KLHL15;RNF11;CHFR;UBR3;RC3H2;ZNRF3;NTAN1;RNF19A;UBE2A;ANAPC11;WDR91;ANAPC4;RNF19B;CDC26;ANKIB1;PCYOX1;RNF217;FEM1C;CBL;TRPC4AP;UBE2E1;UBE2D1;NDFIP2;ARIH2;NEDD8;UBE2L3;FBXO22;SMURF1;TOPORS;USP33;TTC3;MDM2;PPP1R11;ANAPC10;RNF111;ANAPC5
prerank,cellular metal ion homeostasis (GO:0006875),0.4020462738844462,1.1853928581307145,0.19852941176470587,1.0,1.0,18/102,14.06%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;ATP1A3;CXCL12;ATP2A2;KCNMA1;ATP1A2;ATP2B1;SLC24A4;SLC30A1;PTH1R;HTR2C;NPTN;SLC41A1
prerank,actin filament polymerization (GO:0030041),0.4602794043976776,1.1850777537356116,0.26700251889168763,1.0,1.0,11/29,21.44%,SPIRE2;RAC1;TTC17;WASF1;SPIRE1;GAS7;ARHGAP6;PSTPIP2;PREX1;GSN;DIAPH1
prerank,cell part morphogenesis (GO:0032990),0.5294337794653147,1.1846575763870026,0.2733812949640288,1.0,1.0,5/13,14.84%,FIS1;MYH14;PID1;WASF1;DNM1L
prerank,cellular response to catecholamine stimulus (GO:0071870),0.47891366805171476,1.1844797205097601,0.2635561160151324,1.0,1.0,4/23,6.64%,APLP1;SIRT2;ABL1;GNG2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.40866353695853486,1.1843943174556801,0.21858500527983105,1.0,1.0,31/76,24.51%,HDAC3;UBQLN1;PHF23;GNL3;STUB1;TBC1D7;RWDD3;SAE1;MYCBP2;XIAP;CDK5RAP3;HDAC4;MALT1;PIAS3;UBE2D1;NDFIP2;DERL1;UBE2L3;TANK;TNIP1;DCUN1D5;BIRC3;PIAS1;SMAD7;COMMD1;UBA2;FKBP1A;FBXW7;UBE3A;TRAF6;CRY1
prerank,positive regulation of DNA repair (GO:0045739),0.4344245846147518,1.1842235697311394,0.23488372093023255,1.0,1.0,18/46,22.00%,SPIRE2;FOXM1;PARP1;RNF8;FGF10;MGMT;SLF2;WRAP53;RNF168;CEBPG;EYA2;SPIRE1;FMN2;UIMC1;RPS3;EYA1;NPAS2;HMGB1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.37615201741041415,-1.1840226307984385,0.22821576763485477,0.8472745882966666,1.0,4/21,7.55%,CACNA1D;FLNA;CACNA2D1;AKAP9
prerank,regulation of vesicle-mediated transport (GO:0060627),0.4062834772565841,1.1839122463812148,0.19348054679284962,1.0,1.0,26/91,17.00%,CPLANE2;TSC2;ATP9A;USP7;NRP1;ABL1;RAB12;PACSIN3;RAB5B;CPLX1;CHMP3;RAB10;AP2S1;MBTPS1;SCFD1;RAB3B;SYT1;RAB13;MAP2K2;DNAJC13;RAB8A;RAB8B;RUFY1;NSF;RIT2;RAB21
prerank,vitamin transport (GO:0051180),-0.34929661718806715,-1.183837023035553,0.1958762886597938,0.844211948631926,1.0,9/29,23.43%,ABCG2;TCN2;SLC35F3;SLC25A32;SLC52A1;SLC5A6;CUBN;SLC19A2;SLC2A10
prerank,nuclear body organization (GO:0030575),0.5594856819191428,1.183420143190807,0.2857142857142857,1.0,1.0,3/12,7.40%,AFF2;USPL1;WRAP53
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5481937976581854,1.182850494215438,0.2758132956152758,1.0,1.0,6/13,14.40%,PRPF8;SRSF12;PRPF6;SART3;USP4;AAR2
prerank,regulation of developmental growth (GO:0048638),0.4609977494064976,1.1820449672191207,0.2419753086419753,1.0,1.0,6/29,10.71%,IGF1;NIPBL;OLFM1;ABL1;MUSK;APP
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4521616327112883,-1.1818727349907205,0.26006191950464397,0.8471266389349517,1.0,2/11,3.85%,STAT3;STAT1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4434386576166044,-1.1817726621949585,0.2459546925566343,0.8437246949697813,1.0,10/12,52.74%,INPP5K;PPP1R3B;AKT1;PPP1R3C;PPP1R3F;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.46838174789177833,-1.1816524823210144,0.28362573099415206,0.8404848117166541,1.0,5/10,18.19%,FEM1B;THOC5;WDR76;CCAR2;ETAA1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5329349549612059,1.1814365471746657,0.2695035460992908,1.0,1.0,3/12,22.93%,IL33;NUPR1;IL18
prerank,positive regulation of cilium assembly (GO:0045724),0.5059839945884557,1.181307894174606,0.2557510148849797,1.0,1.0,6/18,18.16%,CCP110;WRAP73;ENTR1;HTT;CEP120;CCDC88A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.44667075696822545,1.181185463229306,0.2431466030989273,1.0,1.0,11/35,18.68%,VTN;RAC1;SMAP1;HNRNPK;LRPAP1;PIK3CB;CBL;SNAP91;SERPINE1;RAB21;FLOT1
prerank,positive regulation of inflammatory response (GO:0050729),0.4016211170318883,1.181137639447005,0.20403825717321997,1.0,1.0,17/86,17.69%,WNT5A;LPL;PTGER4;DDT;IL33;IFI35;GPRC5B;GPR4;APP;CD47;TLR3;NUPR1;VAMP8;AGTR1;SERPINE1;TNIP1;SNX4
prerank,acyl-CoA metabolic process (GO:0006637),0.44500533458204183,1.1809841036848718,0.24820143884892087,1.0,1.0,8/35,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;MCEE;OGDH;ACSL6
prerank,establishment of protein localization to extracellular region (GO:0035592),0.44452832379101365,1.1807475159611311,0.25350467289719625,1.0,1.0,19/39,24.57%,TVP23B;MIA3;RAB12;RCN3;RAB10;RAB3B;TANGO2;MON1A;RAB13;RAB8A;RAB8B;MTTP;NECAB3;STEAP3;ARFGAP3;COPG1;OLFM2;ABCA1;SEL1L
prerank,ribosomal small subunit assembly (GO:0000028),-0.41180970882133877,-1.180729368155083,0.24621212121212122,0.8398520459183283,1.0,12/16,35.04%,RPS19;RPS28;RPS5;RPS27;RPS14;ERAL1;RRP7A;RPS27L;MRPS7;PRKDC;MRPS11;XRCC5
prerank,monocyte chemotaxis (GO:0002548),-0.33671749627498965,-1.1807054056204906,0.18556701030927836,0.8361793933723288,1.0,7/32,18.94%,FLT1;IL6R;CCL15;RPS19;PTPRO;TNFRSF11A;CCL13
prerank,gland development (GO:0048732),0.4182847040048109,1.1806702463488439,0.22306034482758622,1.0,1.0,12/59,14.04%,GFER;STRA6;FGFR2;ANXA1;XBP1;DKK3;FGF10;WNT4;SOX9;CDK5RAP3;CEBPG;NRG1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.42827570846591784,-1.1801336204269568,0.23484848484848486,0.8344545973186248,1.0,8/14,38.46%,CACNA2D1;SLC24A2;TRPV2;TRPV4;SLC8A1;SLC8A2;TRPM2;SLC8A3
prerank,mitotic metaphase plate congression (GO:0007080),0.42346780500523323,1.1798026251634384,0.23960612691466082,1.0,1.0,7/51,13.49%,PSRC1;CDC23;KPNB1;PIBF1;CHMP3;VPS4B;CENPC
prerank,peroxisomal membrane transport (GO:0015919),0.463879052553692,1.17968547523062,0.25400739827373614,1.0,1.0,11/27,16.83%,FIS1;PXMP4;PEX1;PEX5;PXMP2;GDAP1;PEX7;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,aminoglycan biosynthetic process (GO:0006023),0.4270916619070618,1.179589159600929,0.22998872604284104,1.0,1.0,13/49,20.33%,B3GALNT1;HS2ST1;SLC35D2;GPC6;NDST2;GPC1;HS6ST2;GPC4;HSPG2;EXT2;GPC5;HS3ST1;GCNT2
prerank,response to leucine (GO:0043201),-0.4732044211231925,-1.1795040391305356,0.29941860465116277,0.8291895935096874,1.0,6/10,33.98%,UBR1;LARS1;SESN2;RRAGD;KLHL22;SESN3
prerank,cellular response to leucine (GO:0071233),-0.4732044211231925,-1.1795040391305356,0.29941860465116277,0.8291895935096874,1.0,6/10,33.98%,UBR1;LARS1;SESN2;RRAGD;KLHL22;SESN3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5157066485486362,1.1793279520033688,0.2656675749318801,1.0,1.0,4/16,10.42%,PIGG;DPM2;PIGM;PIGA
prerank,negative regulation of B cell proliferation (GO:0030889),0.5569424411659624,1.1790131902255503,0.28156748911465895,1.0,1.0,1/11,0.85%,FCGR2B
prerank,monocarboxylic acid metabolic process (GO:0032787),0.39118154588452086,1.1790122000853696,0.19057377049180327,1.0,1.0,23/117,13.45%,FASN;LPL;IGF1;SLC27A4;THEM4;GBA2;ACOT11;PCCB;ALDH1A2;ABAT;SGPL1;MSMO1;GPAM;ALDH4A1;DLAT;CROT;AMACR;SLC6A8;ACADSB;PCCA;CYP26B1;VDAC1;MECR
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4099385057227375,-1.1789482889403493,0.24475524475524477,0.8271946829133204,1.0,11/16,31.96%,CAV1;TRIM25;EXOC7;EXOC2;TRIM5;TRIM14;NECTIN2;HS3ST5;FUCA2;TRIM21;TRIM68
prerank,negative regulation of leukocyte activation (GO:0002695),0.5211452057559556,1.1789226810570799,0.25416666666666665,1.0,1.0,2/15,4.92%,FCGR2B;IL31RA
prerank,fatty acid catabolic process (GO:0009062),0.41401465004731575,1.178806205535315,0.23010752688172043,1.0,1.0,21/67,16.83%,SLC27A4;ACAD10;LPIN1;PCCB;HADHB;ACAT1;HSD17B4;LPIN3;MCEE;CROT;CPT2;EHHADH;LPIN2;PCCA;MECR;PEX13;ECHDC1;ABCD2;ACADL;ACADVL;ALDH3A2
prerank,stabilization of membrane potential (GO:0030322),0.5180747587278942,1.1787387161496372,0.2994428969359331,1.0,1.0,2/16,5.33%,CHCHD10;KCNK2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5102625689125222,1.1786694637850137,0.28344370860927154,1.0,1.0,5/17,9.82%,SELENOS;SYVN1;HM13;AUP1;VCP
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5458617065336389,1.1784064672287453,0.2943786982248521,1.0,1.0,3/12,9.95%,ELOVL1;HSD17B4;FADS1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.4154568727300949,-1.1783664347824223,0.23809523809523808,0.8254866241257625,1.0,5/15,11.10%,RAPGEF3;BAG3;ANP32B;TP53;CAMK1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38408688351633974,1.1782310304096537,0.062,1.0,1.0,80/390,14.32%,FGF20;FGF9;MST1R;IGF1;EPHA7;SIRT2;GPLD1;EPHB2;FGFRL1;DNM1;TSC2;NTF3;EIF2AK3;HSP90AA1;RAC1;FGFR2;SH2D2A;COL4A6;ATP6V0A2;FGFR1;GRIN1;ACTR2;ARPC1A;DDR1;NRP1;FGF10;POLR2B;IL31RA;ANGPTL1;DDR2;SULF1;PIK3R1;GAB1;SRMS;ARHGEF7;PAK3;EFNB3;EPHA8;TIA1;ATP6V0E2;KALRN;CYFIP1;BDKRB2;FLRT2;SDCBP;FRS2;EFNB2;FLRT1;BAIAP2;EPHA10;RAPGEF1;PLAT;HNRNPM;KL;MVP;AP2S1;MUSK;VAV2;SHC4;PRLR;IRS2;GFRA2;PIK3CB;RBFOX2;ATP6V1G1;PIK3R2;TCIRG1;PDGFRA;POLR2K;TIAL1;ATP6V0A4;GIT1;SETX;ROR2;EFS;FGFBP1;BLNK;NRG1;ROCK2;ATP6V1D
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4547720021907101,1.1781594133186077,0.25181598062953997,1.0,1.0,3/31,1.68%,SYT3;SYT10;CBARP
prerank,COPII-coated vesicle budding (GO:0090114),0.4132076408323429,1.1780979777369405,0.21536796536796537,1.0,1.0,28/68,20.40%,TRAPPC10;SCAP;SAR1A;KLHL12;SEC16A;MIA3;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;VAPB;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5444957098350806,1.177821704061726,0.27927927927927926,1.0,1.0,3/11,14.28%,IL34;PRKCA;TGFB1
prerank,regulation of T cell chemotaxis (GO:0010819),0.5524502424665472,1.1777454118485553,0.27565084226646247,1.0,1.0,1/11,0.80%,WNT5A
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.47453950492844565,1.1766302998211065,0.2607626076260763,1.0,1.0,6/25,7.87%,KHSRP;GEMIN2;PRPF8;SF3B1;MPHOSPH10;PRPF6
prerank,regulation of transposition (GO:0010528),0.5353018807270935,1.176216317645921,0.2913616398243045,1.0,1.0,1/13,1.78%,SIRT7
prerank,mesoderm development (GO:0007498),-0.3982493802562556,-1.1761461428844078,0.2396694214876033,0.8292840836750545,1.0,7/18,19.11%,TBX3;TIE1;MESD;IKZF1;TBX1;BMX;VEGFA
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3195907780589709,-1.1754988112731406,0.15819209039548024,0.827778651694012,1.0,8/33,10.21%,PTPRG;DAB2IP;PTPRM;SLIT2;SP100;ADIPOR1;THBS1;DUSP10
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5511813200755505,1.1751952409719217,0.2706222865412446,1.0,1.0,3/12,7.42%,UBE2S;FZR1;CDC14B
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.37983091649764794,-1.1751882402151022,0.23580786026200873,0.8252262606754882,1.0,8/20,19.51%,CNOT1;TNRC6A;HELZ;AGO2;LIMD1;CNOT8;CNOT7;NRDE2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.26883668038095326,-1.1751577830197362,0.16666666666666666,0.821807638956514,1.0,27/70,19.67%,CRADD;DAB2IP;IL6R;CASP8AP2;BAG3;APPL1;RIPK1;MCL1;DEDD;BCL2L1;TGFB2;HIPK1;DELE1;FAS;BCL2L2;TNFRSF1A;NGF;GABARAP;DDX47;TNFRSF1B;SORT1;P2RX7;MLLT11;TNFSF12;GSK3A;DIABLO;CASP3
prerank,histone acetylation (GO:0016573),-0.2713892547289729,-1.1749349633485395,0.09722222222222222,0.8190753450177319,1.0,29/69,23.87%,EPC1;TRRAP;LEF1;KAT7;MBIP;JADE2;KAT2B;TAF12;NAA40;EP300;JADE1;JADE3;WDR5;MSL3;ACTL6A;TAF5L;KAT6B;DR1;ING3;BRCA2;KAT8;PHF20L1;ING5;NAA60;APBB1;RUVBL1;TRIM16;SUPT7L;TAF6L
prerank,synapse organization (GO:0050808),0.3957066954605778,1.1739965398355003,0.1864754098360656,1.0,1.0,27/125,14.94%,PPFIA4;LRRC4;CHCHD10;CACNB4;UNC13A;CTNND2;OBSL1;PDZRN3;CDK5;GPC6;PAK3;DVL1;DSCAM;CYFIP1;DBNL;MUSK;CACNB1;APP;ANK3;PTPRF;NLGN3;GPC4;SPOCK2;FARP1;MAPT;NLGN2;SEMA3E
prerank,spermatid development (GO:0007286),0.451029197286394,1.1736785313629532,0.2506203473945409,1.0,1.0,6/32,15.75%,IQCG;SYCP3;RNF8;CDYL;ACRBP;GALNTL5
prerank,dendritic spine morphogenesis (GO:0060997),0.5191957872715264,1.1732331711905357,0.2773109243697479,1.0,1.0,3/15,6.37%,EPHB2;CTNND2;PAK3
prerank,lipoprotein transport (GO:0042953),0.5666025764086254,1.172995141643475,0.2781954887218045,1.0,1.0,4/10,17.86%,MIA3;LRP1;VMP1;ZDHHC17
prerank,organonitrogen compound catabolic process (GO:1901565),0.4218424149515895,1.1729598540320305,0.2388888888888889,1.0,1.0,9/57,10.25%,PLA2G5;ADO;CLN6;SMPD2;RENBP;ANPEP;UCHL3;SGPL1;ENPP2
prerank,cellular response to interferon-gamma (GO:0071346),0.3995125155191671,1.1727977416265676,0.22233820459290188,1.0,1.0,21/88,18.03%,WNT5A;CAMK2B;GBP3;IRF1;GBP7;SIRPA;TRIM62;IFNGR2;EPRS1;IFNGR1;IRF3;CAMK2D;CAMK2G;CD47;DAPK1;GBP6;AQP4;ICAM1;OAS2;CCL25;JAK1
prerank,intestinal absorption (GO:0050892),-0.43125020531708996,-1.1727364001155465,0.23509933774834438,0.8225892543120461,1.0,5/13,33.22%,F11R;ADRA2A;KCNQ1;SLC26A6;UGCG
prerank,cellular response to metal ion (GO:0071248),0.39388359042512633,1.1727157080992996,0.18640576725025745,1.0,1.0,31/123,19.12%,ALOX5AP;MAPK9;SYT3;WNT5A;SYT10;GPLD1;PPIF;ADCY7;BMP6;CARF;SLC25A24;DMTN;RASGRP2;ADGRV1;CPNE7;ANK3;CAMK2D;IQGAP1;SYT1;CPNE8;KCNA1;SLC41A1;GLRA1;ADCY1;DAXX;DPEP1;DLG2;PKD2;PRKAA1;KCNH1;SMPD1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5324641883204815,1.1718489664161815,0.28680981595092025,1.0,1.0,1/12,0.85%,FCGR2B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5043106404814842,1.1715503518450936,0.28249336870026526,1.0,1.0,5/17,15.23%,IL34;BIN1;CXCR4;TGFB1;TENM4
prerank,spindle assembly (GO:0051225),0.4088363611022811,1.1713866956717873,0.24838012958963282,1.0,1.0,21/67,17.49%,HDAC3;CCDC61;MAPRE3;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;RCC1;HAUS3;CSNK1D;STAG2;OFD1;CHEK2;NUMA1;TNKS;TUBGCP2;BCCIP
prerank,actin cytoskeleton reorganization (GO:0031532),0.4121930150605774,1.1705815143241098,0.24156692056583243,1.0,1.0,21/63,19.17%,S1PR2;ATP2C1;WHAMM;ANXA1;MINK1;NRP1;FGF10;CAPN10;GAB1;DMTN;BRSK2;RAP2A;ANTXR1;EFS;AUTS2;FARP2;PTK7;THSD7B;PIP5K1A;CDC42BPB;NRK
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.40970051381446704,-1.1699498365383154,0.21405750798722045,0.827937324794415,1.0,3/13,7.57%,STAT3;STAT1;TYK2
prerank,protein neddylation (GO:0045116),-0.42984047046800644,-1.169738932484685,0.26480836236933797,0.8251725397487544,1.0,3/13,4.49%,DCUN1D4;UBA3;RBX1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4204505690044643,1.1694372066074488,0.24130190796857465,1.0,1.0,17/54,21.21%,CLN6;HS2ST1;SLC35D2;GLB1;GPC6;NDST2;GPC1;HS6ST2;HGSNAT;GPC4;HSPG2;EXT2;GPC5;GUSB;HS3ST1;GCNT2;CHST9
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.48416322215177193,1.1687517205616147,0.26040268456375837,1.0,1.0,3/21,4.16%,SMARCD3;FZD9;FZD3
prerank,embryonic limb morphogenesis (GO:0030326),-0.3174800569299631,-1.1684621639353936,0.20754716981132076,0.8260224140887548,1.0,9/34,11.93%,LRP6;MBNL1;RARG;WDPCP;FBXW4;TGFB2;CACNA1C;TBX3;INTU
prerank,sodium ion transmembrane transport (GO:0035725),0.40500206570145303,1.168417107906861,0.23870967741935484,1.0,1.0,17/84,16.34%,SLC4A4;ASIC1;NALCN;ATP1A3;SLC6A11;SCN7A;ATP1A2;SLC24A4;SCN2B;SCN1A;SLC6A8;SLC6A4;SLC6A15;SLC6A12;SLC9A7;SLC9A6;SLC6A13
prerank,skeletal system development (GO:0001501),0.3859793688626109,1.1684007819191042,0.19390862944162437,1.0,1.0,37/148,20.33%,WNT5A;PTGER4;IGF1;BMP6;EIF2AK3;FGFR2;FGFR1;PTHLH;ANKH;PCSK5;SULF1;HAPLN4;TRIP11;SOX9;GNAS;PPIB;CDH11;SOX11;PTH1R;BMP5;COL1A2;SOX6;FBN1;AKAP13;RPS6KA3;SUFU;TRPS1;SOX5;BMP1;TGFBR1;WWOX;SOX4;MMP14;PAPSS1;CHD7;EVC;MMP16
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.4234450052222346,1.1679189955824083,0.24829157175398633,1.0,1.0,9/44,12.08%,CYP27A1;PSAT1;CYP7B1;INSIG1;HSD17B4;MSMO1;SC5D;AMACR;PARK7
prerank,regulation of cell differentiation (GO:0045595),0.3839880528788869,1.1678973467223726,0.19939271255060728,1.0,1.0,37/148,18.56%,DDX17;MCRIP1;BIN1;NTF3;EDN3;FGFR2;FGFR1;NR1D2;PTHLH;ZFP36L1;CDK9;CASZ1;CD24;SIK1;ZFHX2;YWHAH;CDK5RAP3;FADS1;YWHAG;GDNF;ST7;DAG1;SPOCK2;RPS6KA3;UQCC2;CBFB;EMP2;TGFB1;TRPS1;BCL6;RPS6KA1;DDX5;PHLDB1;TRIP4;OCIAD1;GPS2;TGFBR1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5038276511500698,1.1674027656447636,0.28184281842818426,1.0,1.0,9/18,19.31%,CLN3;ABCA2;CDK5;VTI1B;SPTBN1;STX8;VAMP8;ZDHHC2;MMP14
prerank,protein targeting to mitochondrion (GO:0006626),0.41525976196307507,1.167275411650943,0.25692137320044295,1.0,1.0,11/52,13.20%,DNLZ;HSP90AA1;FIS1;TOMM20;FBXO7;TIMM13;PMPCA;MFN2;AIP;TIMM29;GDAP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.42791309209312206,-1.1670330041661483,0.29372937293729373,0.8270828304513267,1.0,5/13,17.64%,IRAK2;IRAK1;UNC93B1;IRAK4;PIK3AP1
prerank,purine-containing compound catabolic process (GO:0072523),-0.438412529578727,-1.1669467631102866,0.24561403508771928,0.8239856619632786,1.0,8/13,34.72%,NT5C2;NT5E;ITPA;GPX1;PNP;GDA;NT5C;NT5C1A
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5530847877751616,1.1665561073719497,0.2879019908116386,1.0,1.0,1/10,0.80%,WNT5A
prerank,histone deacetylation (GO:0016575),0.4349254243302957,1.1662613562269002,0.23885714285714285,1.0,1.0,10/43,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;PER1;HDAC4;RCOR1;MTA2;HDAC1
prerank,negative regulation of wound healing (GO:0061045),0.45775503694432956,1.1658625216915064,0.2785276073619632,1.0,1.0,8/28,21.41%,VTN;AJAP1;CASK;TFPI;SERPINE1;APOE;FGF2;CLASP2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.40619960415865364,1.1654260174307423,0.23283261802575106,1.0,1.0,24/74,22.12%,SFRP2;SFRP1;MCRIP1;GLIPR2;SNAI1;OLFM1;EZH2;TGFB1I1;SDCBP;TWIST1;BMP5;DAG1;AXIN2;TGFB1;VASN;PHLDB1;SPRY2;TGFBR1;DAB2;GCNT2;SMAD7;CLASP2;SMAD2;SMAD3
prerank,regulation of autophagosome maturation (GO:1901096),0.5311466842647647,1.165240211528075,0.3051094890510949,1.0,1.0,2/13,1.37%,CLN3;PHF23
prerank,endocrine system development (GO:0035270),0.47521880143390627,1.1652336693529943,0.2989821882951654,1.0,1.0,3/21,8.19%,STRA6;DKK3;WNT4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4567501896865952,1.1650572504259429,0.275092936802974,1.0,1.0,5/28,9.77%,KDM4D;SIRT7;ACTR2;WRAP53;MRNIP
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3852572453451924,1.1646121361758703,0.1967380224260958,1.0,1.0,21/142,13.68%,WNT5A;CLN3;PTGER4;CCR9;ACKR2;FIS1;FZD9;C1QTNF1;ABL1;CXCR4;HCRTR2;ATP1A2;CD24;BDKRB2;ATP2B1;SELENOT;TBXA2R;HCRTR1;PDGFRA;NPTN;LPAR1
prerank,positive regulation of cellular process (GO:0048522),0.37550155389690576,1.1641314261596392,0.053,1.0,1.0,98/565,15.68%,FGF20;SFRP2;PLA2G5;FGF9;S1PR2;FASN;WNT5A;FCGR2B;EPB41L4B;SFRP1;MST1R;IGF1;DUSP26;IL34;DVL2;FOXM1;SIRT2;TUB;EAPP;MYRF;CDKN2AIP;TBRG4;BMP6;NTF3;EDN3;RAC1;EXOSC2;TSPAN31;FGFR2;TAF9B;FGFR1;GRIN1;PTHLH;XBP1;ZFP36L1;SLC25A33;MLC1;DDX3X;CXCL12;AGPAT1;CDC123;FGF10;IL31RA;CDK13;CAPN10;PRKCA;FLCN;USP47;CNBP;FBXO5;CELF1;EZH2;RHOD;SIRPA;SOX9;SDCBP;EFNB2;DHX36;EGF;HDAC4;ABCA7;SOX11;GDNF;PRLR;IRS2;COX17;TPM1;BCL2;ADGRG1;TCIRG1;MAZ;PDGFRA;RTKN2;BMP5;EIF4G2;CD47;NPM1;HDAC1;AXIN2;UBE2A;PRMT1;RPS6KA3;EMP2;LRP1;FAM98A;MAPT;NRG1;CSPP1;TGFB1;BCLAF1;KMT2D;IL15RA;TENM4;NUPR1;FAF1;CNOT6;RPS6KA1;CTSH
prerank,negative regulation of DNA binding (GO:0043392),-0.3539329860515928,-1.164023566986955,0.2222222222222222,0.830157589966737,1.0,11/28,26.63%,LEF1;SP100;NFKBIA;ILRUN;SIN3A;JUN;HABP4;MDFI;SUMO3;HMGA2;HEY2
prerank,eye morphogenesis (GO:0048592),0.49335340397705296,1.1636144318281345,0.296875,1.0,1.0,9/19,19.22%,FBN2;NIPBL;TENM3;MFAP2;MFAP5;FBN1;COL5A2;NKD1;AGTPBP1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.44927514735836815,1.1633327017309518,0.2746987951807229,1.0,1.0,6/32,11.97%,TFDP1;CDK5;NPAT;BRD4;FBXO5;BACH1
prerank,response to interleukin-1 (GO:0070555),0.4038789912418882,1.1621711239090815,0.23554603854389722,1.0,1.0,12/73,12.26%,SFRP1;ADAMTS7;GBP3;NFKB1;ANXA1;PRKCA;SIRPA;SOX9;USP10;HDAC4;APP;CD47
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.43733474942447453,-1.1619719938907553,0.2901023890784983,0.8331805045341336,1.0,3/13,21.26%,CYRIB;NECTIN2;PVR
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42339547237954545,-1.161827510004387,0.2568493150684932,0.8302167709152638,1.0,7/13,25.22%,NFIB;PPARD;REST;NFATC4;BMP4;PPARG;PPARA
prerank,inositol lipid-mediated signaling (GO:0048017),0.4224383228204227,1.1613495215998269,0.24830699774266365,1.0,1.0,16/50,19.07%,IGF1;PLCH1;FGFR1;OGT;PLCL2;PIK3R1;ADAP2;IRS2;PIK3CB;PIK3R2;PDGFRA;PI4KB;PIK3C2B;PIK3C3;PITPNM2;KCNH1
prerank,positive regulation of macrophage activation (GO:0043032),0.5043210586866214,1.1612435396363983,0.28591160220994477,1.0,1.0,2/17,2.68%,WNT5A;IL33
prerank,regulation of glycolytic process (GO:0006110),0.4033209697802443,1.1610255812020513,0.26543878656554715,1.0,1.0,21/68,19.14%,SLC4A4;IGF1;OGT;RAE1;ARNT;PRXL2C;HDAC4;NUP188;PGAM1;ZBTB20;APP;NUP210;GIT1;NUP88;NUP214;NUPR1;NUP153;RANBP2;PRKAA1;PRKAG2;NUP35
prerank,bile acid and bile salt transport (GO:0015721),-0.3592280573014225,-1.1609936715824654,0.22596153846153846,0.8296930849790263,1.0,3/24,4.79%,ABCC4;ATP8B1;SLCO1C1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4280457181538518,1.1609314415060703,0.2748267898383372,1.0,1.0,7/44,12.84%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10;WNK2;GABBR1
prerank,positive regulation of calcium ion import (GO:0090280),0.5448308195590281,1.1608566184401086,0.2916053019145803,1.0,1.0,1/12,4.50%,CXCL12
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.38621245236350304,1.1600190508353616,0.18960244648318042,1.0,1.0,30/138,15.88%,GUCA1B;MST1R;EPHA7;EPHB2;NTF3;FGFR2;FGFR1;DDR1;IL31RA;ANGPTL1;DDR2;SRMS;EPHA8;BDKRB2;FRS2;EPHA10;RAPGEF1;MUSK;SHC4;GFRA2;PIK3CB;PDGFRA;PTPRF;ROR2;EFS;BLNK;ACVR1B;TRIO;NPR2;AHI1
prerank,regulation of mitotic cell cycle (GO:0007346),0.3802762115722218,1.1599856651413578,0.20202020202020202,1.0,1.0,59/171,22.12%,CUL7;CDC23;PSMD4;UBE2S;MAD2L1;HECA;CDC16;OBSL1;FZR1;CDK13;PRKCA;CDK9;SCRIB;ANAPC2;FBXO5;PSMB10;DDB1;TRIM35;PSMD11;BRINP3;SIK1;SRA1;SDCBP;RNF40;PRMT5;CDK5RAP3;USP2;PSME2;PSMC5;TMEM8B;APP;IQGAP1;PTPN3;RCC1;ANAPC11;ANAPC4;CDC26;TGFB1;PSMD1;UBE2E1;UBE2D1;PSMD6;BRINP1;MDM2;MEIS2;ANAPC10;CDK10;ANAPC5;USP22;KIF20B;PSMD5;CDK11B;HNRNPU;PSMA4;ANGEL2;PSMA1;PSMC6;CUL9;SMAD3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.39430314046041903,1.1599830644960178,0.22792607802874743,1.0,1.0,14/101,9.15%,PSRC1;WNT5A;MST1R;IL34;TCIM;INCENP;EDN3;CALM3;MAPRE3;FGFR1;DDX3X;EZH2;CD24;EGF
prerank,regulation of bone mineralization (GO:0030500),0.4121447086517998,1.15995648976383,0.25,1.0,1.0,13/55,12.01%,TMEM119;FBN2;BMP6;FZD9;ANKH;NELL1;DDR2;ADGRV1;WNT4;ATP2B1;KL;TWIST1;ENPP1
prerank,negative regulation of macrophage activation (GO:0043031),0.5098010408742285,1.1599416404135152,0.28591749644381226,1.0,1.0,2/16,4.92%,FCGR2B;IL31RA
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4786155026202298,1.1599258738886715,0.29028132992327366,1.0,1.0,5/21,9.16%,HS2ST1;EXTL3;SULF1;GPC1;HS6ST2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5223074365169558,1.1598730223048608,0.28917378917378916,1.0,1.0,5/14,12.60%,SELENOS;SYVN1;XBP1;PARK7;CREB3
prerank,global genome nucleotide-excision repair (GO:0070911),-0.34622845400589186,-1.159832120422945,0.2237442922374429,0.8300936460133331,1.0,11/26,16.11%,RAD23B;USP45;GTF2H1;RBX1;CHD1L;CUL4A;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,actin filament bundle organization (GO:0061572),0.44582508221221273,1.159758172789547,0.26634382566585957,1.0,1.0,8/33,15.37%,LCP1;AIF1L;MYO1B;DMTN;RHOD;BAIAP2;ADD2;PAWR
prerank,negative regulation of cell aging (GO:0090344),0.49821303870035993,1.1596117415096518,0.26944444444444443,1.0,1.0,4/16,9.79%,FOXM1;FBXO5;SLC30A10;TWIST1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.34582349696909304,-1.1595095857580595,0.2,0.8277729229477456,1.0,8/24,7.89%,SMAD4;PARVA;NRP2;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.4755083720381951,-1.1594599871249236,0.3029411764705882,0.8246108742207491,1.0,6/10,25.53%,RARG;RARB;RARA;TBX1;PPARG;RXRB
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3813273909686379,1.1589727851171492,0.19436052366565962,1.0,1.0,49/172,19.00%,PLA2G5;CLN3;GPD1;PIP4K2B;CSNK2A2;GPD1L;SYNJ2;PCYT2;LPIN1;CEPT1;AGPAT1;AGPAT5;CRLS1;INPP5E;PIK3R1;GPAT4;PLEKHA3;CPNE7;AGPAT3;LPIN3;GPAM;PCYT1B;PITPNM3;PIK3CB;PIK3R2;STARD7;LPIN2;PI4KB;PIP4K2A;LCLAT1;PIP4K2C;PTDSS1;FAR1;FIG4;DDHD2;SACM1L;CHKB;CDS1;PIK3C2B;SLC44A2;MTMR4;RUFY1;SLC27A1;PIK3C3;PTDSS2;PITPNM2;PIP5K1A;PLEKHA1;PIK3R4
prerank,regulation of mitochondrion organization (GO:0010821),0.42359674645976564,1.158964014012014,0.2648709315375982,1.0,1.0,14/47,17.63%,SIRT7;CSNK2A2;MYO19;PRMT6;FIS1;FLCN;MIEF2;SQSTM1;PID1;VDAC1;MAPT;DNM1L;PARL;OMA1
prerank,regulation of response to external stimulus (GO:0032101),0.38742974158933957,1.1589558249781773,0.2261048304213772,1.0,1.0,27/121,16.48%,GUCA1B;WNT5A;FCGR2B;EPHB2;USP14;NR1D2;ANXA1;TIRAP;METAP1;BRD4;IRF1;DHX58;CELF1;CXCR4;NMT1;XIAP;LRP8;EFNB2;PDGFRA;PARK7;METAP2;PTPN22;PTGS2;BCL6;LACC1;ADGRA2;AGTR1
prerank,negative regulation of organelle assembly (GO:1902116),0.44477306610858774,1.15822037498829,0.27251461988304093,1.0,1.0,10/35,15.32%,CCP110;PHF23;TBC1D7;MDM1;CEP97;TCHP;SCFD1;EVI5L;FEZ2;NUPR1
prerank,kinetochore organization (GO:0051383),0.5250877236154233,1.1579208396421388,0.302158273381295,1.0,1.0,2/13,13.49%,CENPT;CENPC
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5421586949875603,1.157433744136053,0.3159420289855073,1.0,1.0,3/11,8.35%,WNT5A;FGFR2;SOX9
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5037478877638415,1.1572706157708559,0.3091655266757866,1.0,1.0,2/17,4.57%,LPL;PCSK5
prerank,myeloid cell differentiation (GO:0030099),-0.3084619319864294,-1.1570566865944751,0.21428571428571427,0.8289949458254003,1.0,18/47,29.03%,HIPK2;MFHAS1;NCOA6;KMT2E;KIT;UBA5;RPS19;PRKX;UFL1;IKZF1;KAT8;CASP3;PRDX3;RPS14;INHBA;SLC25A5;KAT6A;TAL1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.4240582018102512,-1.156683125790746,0.2676923076923077,0.8269892581331733,1.0,7/13,26.97%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5550816854859684,1.1563096146748688,0.3007518796992481,1.0,1.0,4/10,13.44%,CAMK2B;APP;NPTN;NETO1
prerank,central nervous system neuron development (GO:0021954),0.5209181887841857,1.156275575314708,0.3087621696801113,1.0,1.0,8/15,23.89%,HSP90AA1;GBA2;B4GALT5;MAPT;NTRK2;ARHGAP35;MAP2;PTEN
prerank,lipoprotein catabolic process (GO:0042159),0.5385528999323178,1.156143672314012,0.3010279001468429,1.0,1.0,2/11,2.89%,ABHD10;LYPLAL1
prerank,protein K63-linked ubiquitination (GO:0070534),0.4319112069580426,1.155976012949066,0.2615558060879369,1.0,1.0,14/41,22.05%,RNF8;UBE2S;STUB1;UBE2E2;TRIM56;RNF168;UBE2V2;RNF152;HECTD1;ARIH2;TRIM27;TRAF3IP2;UBE2V1;TRAF2
prerank,positive regulation of embryonic development (GO:0040019),0.48274514680757896,1.1553404703085792,0.2891566265060241,1.0,1.0,8/19,21.38%,WNT4;RACK1;B4GALT5;ZBED3;NR2C2;TENM4;OSR1;CFL1
prerank,negative regulation of peptidase activity (GO:0010466),0.41627665166705663,1.1551464691313882,0.2742857142857143,1.0,1.0,11/47,20.45%,VTN;SERPING1;SPOCK1;PARK7;SERPINA2;SPOCK2;LRP1;SERPINE1;SERPIND1;TIMP2;SERPINF1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4224344672103705,1.154971780500438,0.28321678321678323,1.0,1.0,16/40,22.12%,GLIPR2;SNAI1;OLFM1;TCF7L2;EZH2;TGFB1I1;SDCBP;TWIST1;AXIN2;TGFB1;JAG1;TGFBR1;DAB2;GCNT2;SMAD2;SMAD3
prerank,regulation of cation transmembrane transport (GO:1904062),0.4478558061891408,1.1548542635492336,0.2786683107274969,1.0,1.0,6/29,16.89%,KCNAB2;CD63;SLMAP;FGF12;DPP10;SLC30A5
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4491402508853912,1.154762857863013,0.27951807228915665,1.0,1.0,1/29,0.14%,PLA2G5
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.39134993162471776,1.1546154920612735,0.23173277661795408,1.0,1.0,20/100,14.97%,FSHR;IGF1;TSC2;PIP4K2B;NTF3;FGFR1;DCN;PIK3R1;GAB1;SOX9;EGF;TWIST1;IRS2;PIK3CB;MAZ;PDGFRA;PIP4K2A;ROR2;PIP4K2C;CBL
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.3753049962164433,-1.1545604272668506,0.27413127413127414,0.8307481607809891,1.0,4/18,8.15%,MTUS1;IL6R;SLIT2;SLC8B1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.4428921305153157,1.1544829187090593,0.28484107579462103,1.0,1.0,11/33,18.57%,NHP2;ZBTB48;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3366130127981288,-1.1538907132640541,0.22772277227722773,0.8294682219471656,1.0,7/27,17.46%,NIBAN2;DACH1;SMG5;TOM1L1;RGCC;PDGFA;SMG6
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4793860097979926,1.1533149569542966,0.2921646746347942,1.0,1.0,9/18,18.37%,KMT2B;SETD7;EHMT2;SETD1A;SUV39H1;EHMT1;KMT2D;ASH1L;KMT2A
prerank,regulation of metal ion transport (GO:0010959),0.49746237333091253,1.1532921574393435,0.3042291950886767,1.0,1.0,4/16,12.18%,CAMK2B;SLC30A10;BCL2;CAMK2G
prerank,regulation of organelle organization (GO:0033043),0.39882905289703635,1.1526643648327155,0.2528977871443625,1.0,1.0,15/80,11.49%,CLN3;CPLANE2;SIRT7;ZEB2;PRMT6;FIS1;TAOK1;SAR1A;MIEF2;SQSTM1;CAMSAP2;CAPN2;PDE4DIP;USP6NL;MYO5A
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.47199589910548373,1.1524113338454407,0.29224904701397714,1.0,1.0,10/23,22.71%,S1PR2;CALM3;EGF;APP;TGFB1;CEMIP;CALM1;PRKAG2;CALM2;WNK3
prerank,rRNA transcription (GO:0009303),-0.39471895922225064,-1.1522792619382938,0.26811594202898553,0.831493089727165,1.0,5/17,3.81%,SPIN1;BRF1;CAVIN1;GTF3C3;GTF3C2
prerank,nitric oxide metabolic process (GO:0046209),-0.41715977237175844,-1.152082440143685,0.27364864864864863,0.8288192877027771,1.0,7/14,26.97%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR
prerank,cellular response to arsenic-containing substance (GO:0071243),0.513942754090191,1.152075869421463,0.28995756718529,1.0,1.0,4/15,9.82%,PPIF;DDX3X;DHX36;VCP
prerank,regulation of biomineral tissue development (GO:0070167),0.45243684716850874,1.151925629704315,0.30514705882352944,1.0,1.0,8/26,14.28%,ANKH;DDR2;FBXO5;SOX9;TWIST1;ENPP1;ROCK2;TGFB1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4157745750978834,1.1517097648642391,0.27464008859357697,1.0,1.0,7/51,12.75%,WNT5A;LPL;GSDMD;TMEM106A;MALT1;APP;TMED10
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.4846562161523821,1.1517004662346397,0.29483695652173914,1.0,1.0,6/18,25.18%,IGF1;CD24;RPS3;HMGB1;IL18;IGFBP2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5170676028775821,1.1516373580793853,0.3323615160349854,1.0,1.0,7/13,27.49%,ELOVL1;ELOVL4;ELOVL6;HACD2;HACD1;HACD3;HACD4
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5216904026118131,1.1512525907233417,0.2986822840409956,1.0,1.0,7/13,23.03%,FBN2;FSTL1;LTBP1;FBN1;GREM2;NBL1;DAND5
prerank,positive regulation of axon extension (GO:0045773),0.47399056042204374,1.1512456929806942,0.312987012987013,1.0,1.0,8/22,17.44%,CDKL5;NRP1;DBN1;DSCAM;DBNL;MAPT;MEGF8;RUFY3
prerank,cellular response to oxygen levels (GO:0071453),0.5497092126402093,1.1511678118500372,0.3147590361445783,1.0,1.0,4/10,10.79%,ATP6V0A2;PICK1;NDUFS2;ATP6V1G1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5142295619405484,1.1503710074597218,0.31977559607293127,1.0,1.0,4/13,13.54%,EDEM1;ERLEC1;BRSK2;UBE2J1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5187340951610883,1.150330728753058,0.3169705469845722,1.0,1.0,4/13,7.54%,EDEM1;SAR1A;SEC16A;SEC16B
prerank,regulation of receptor internalization (GO:0002090),0.43304673880070677,1.1501440095025366,0.28180737217598095,1.0,1.0,11/35,18.68%,NTF3;PICK1;CD63;ARRB1;LRPAP1;SDCBP;EGF;MAGI2;AHI1;FMR1;FLOT1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.34237698735311184,-1.149476817532926,0.22916666666666666,0.8337968591725581,1.0,13/25,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ADPGK;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,protein targeting to peroxisome (GO:0006625),0.44555361854326325,1.1491971590098309,0.3037667071688943,1.0,1.0,12/29,16.83%,FIS1;ZFAND6;PXMP4;PEX1;PEX5;PXMP2;GDAP1;PEX7;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.4749562655299806,1.1490463055562574,0.3006451612903226,1.0,1.0,9/22,24.09%,DUSP18;PPM1B;PPM1E;PPP5C;PPP2CB;PPM1A;PPM1F;DUSP16;PPM1D
prerank,positive regulation of type I interferon production (GO:0032481),0.3985901028879097,1.148818166491412,0.2643312101910828,1.0,1.0,21/73,17.30%,NFKB1;HSP90AA1;POLR3D;STAT6;NFKB2;DDX3X;IRF1;DHX58;TRIM56;DHX33;XRCC6;DHX36;POLR3E;IRF3;POLR2K;TLR3;PTPN22;MRE11;HSPD1;OAS2;POLR3K
prerank,amino acid import across plasma membrane (GO:0089718),-0.3535315223763953,-1.148760443631243,0.23043478260869565,0.8327205250756674,1.0,6/24,4.67%,SLC6A6;SLC16A2;SLC3A2;SLC47A1;SLC7A1;SLC6A9
prerank,negative regulation of cellular catabolic process (GO:0031330),0.40396658437382216,1.1486208794986421,0.27323008849557523,1.0,1.0,17/63,19.24%,IL10RA;SIRT2;GPLD1;NELL1;RRAGA;WDR6;CDK5RAP3;BCL2;LEPR;EIF4G2;PTPN3;PTPN22;NUPR1;EIF4G3;SORL1;ATRAID;TIMP2
prerank,axon guidance (GO:0007411),0.3768155202018371,1.1484346674530512,0.18036072144288579,1.0,1.0,50/201,17.72%,SPTBN5;WNT5A;EPHA7;PDLIM7;EPHB2;RAC1;PLXNA2;CXCL12;NRP1;PRKCA;PIK3R1;GAB1;EFNB3;EPHA8;CXCR4;GPC1;DSCAM;RAP1GAP;PLXNA1;CYFIP1;FRS2;EFNB2;VLDLR;TMEFF1;EPHA10;SEMA3D;GDNF;IRS2;GFRA2;PIK3CB;ROBO2;ROBO1;KIF5C;DAG1;FEZ2;NPTN;ALCAM;UNC5D;UNC5C;SLIT1;SLIT3;SEMA3E;SPTBN1;SEMA3A;PLXNB3;EPHA5;KIF5B;USP33;DAB1;DCC
prerank,protein glycosylation (GO:0006486),0.3849502350883053,1.1483445213800605,0.21486761710794297,1.0,1.0,28/125,15.81%,ALG5;B3GALNT1;C1GALT1C1;ST8SIA3;TMEM258;ALG6;MGAT3;ST3GAL2;OGT;MGAT4B;ALG1;PLOD1;ST3GAL3;ALG8;ST3GAL5;POMGNT1;DPAGT1;MGAT4C;POMT2;ALG9;B4GALT5;SERP1;COG3;DAD1;RPN2;GALNT18;GALNTL5;TRAK1
prerank,cellular calcium ion homeostasis (GO:0006874),0.38256383474456124,1.148018634521273,0.2463917525773196,1.0,1.0,23/133,13.21%,TNNI3;CLN3;BAX;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;FZD9;CXCL12;ATP2A2;PDZD8;HCRTR2;ATP2B1;SLC24A4;SLC30A1;AFG3L2;PTH1R;HCRTR1;BCL2;CAMK2D;HTR2C;NPTN
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.35086411180813903,-1.1479655913345355,0.2545454545454545,0.8321098635154552,1.0,9/24,19.49%,TOMM70;EIF2AK4;STAT1;TRIM44;AIM2;SIN3A;MAVS;DTX3L;PARP9
prerank,regulation of immune effector process (GO:0002697),0.425204016382176,1.1473766808463723,0.2706155632984901,1.0,1.0,3/41,5.04%,VTN;FCGR2B;SERPING1
prerank,defense response to tumor cell (GO:0002357),0.5591605014502488,1.1473322867157287,0.30303030303030304,1.0,1.0,5/10,19.75%,PLK5;RBMS3;DAPK1;DLEC1;KLF4
prerank,protein O-linked glycosylation (GO:0006493),0.3927709881113276,1.1472606333844897,0.24557752341311134,1.0,1.0,24/96,19.34%,TMTC4;C1GALT1C1;GALNT16;B3GLCT;DPM2;ST3GAL2;OGT;PLOD1;GALNT4;ST3GAL3;TMTC1;POMGNT1;POMT2;B4GALT5;GALNTL6;GXYLT1;GALNT14;GALNT15;GALNT18;TRAK1;GXYLT2;DPM1;B3GALNT2;TET1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4682383541003774,-1.1469858232976593,0.3050314465408805,0.8318751170620896,1.0,3/10,7.64%,PARD3;DGKH;DGKD
prerank,glutamate metabolic process (GO:0006536),0.4819393156944868,1.14675085316712,0.33511348464619495,1.0,1.0,6/19,13.26%,GLS2;FPGS;OAT;GLUL;GCLC;DGLUCY
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5265142121448414,1.146544594089577,0.2971830985915493,1.0,1.0,3/12,10.71%,CXCL12;DOCK8;APP
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.4646747728286364,-1.1464489767114792,0.32448377581120946,0.8302723396026748,1.0,5/10,22.33%,CST3;TNFRSF1A;TNFRSF1B;EMILIN1;DPP4
prerank,protein maturation (GO:0051604),0.3882147678202897,1.1462717034887855,0.25103734439834025,1.0,1.0,26/95,21.26%,NDUFAB1;XPNPEP3;CPXM1;CLN3;STUB1;PCSK5;OGT;SDE2;PCSK2;CIAO2A;PTCH1;AFG3L2;CPXM2;METAP2;MMS19;ADAMTS3;F3;CASP2;HSPD1;SORL1;MMP14;NFU1;PCSK6;MMP16;NAA35;ISCA1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.46234584468690665,1.1462663665344386,0.3045751633986928,1.0,1.0,5/21,14.18%,MAFG;ZFP36L1;ERRFI1;CBFB;ROCK2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.31939724272887215,-1.1462274380870978,0.21511627906976744,0.8278488590612264,1.0,16/35,26.31%,MFHAS1;DAB2IP;PHLPP1;EZR;LGALS9;CYLD;DUSP10;MAP3K4;EMC10;VEGFA;DUSP1;DLG1;SASH1;ZC3H12A;BMP2;GADD45B
prerank,detection of mechanical stimulus (GO:0050982),0.48303434214471136,1.1460002615650773,0.3193504736129905,1.0,1.0,5/19,24.29%,PKD2L2;JUP;PKD2;CSRP3;CDH2
prerank,exit from mitosis (GO:0010458),0.522401351700329,1.1459167616487078,0.3028571428571429,1.0,1.0,2/12,2.85%,SIRT7;UBE2S
prerank,endocardial cushion development (GO:0003197),-0.35800561768154304,-1.145800405167378,0.24056603773584906,0.8259734527802088,1.0,10/21,24.63%,TGFB2;NOS3;ACVR1;ENG;BMPR1A;BMP4;HEYL;CRELD1;TBX2;BMP2
prerank,plasma membrane organization (GO:0007009),0.40560930367610315,1.1455920666125439,0.28182807399347115,1.0,1.0,21/61,21.80%,CLN3;A4GALT;BIN1;WHAMM;TLCD1;CXCR4;STX2;PACSIN3;ABCA7;ANK3;SNX33;SERP1;EPB41L3;SPTBN1;ABCD2;NSF;ARL8B;SMPD1;CHMP4A;SYT11;MYH9
prerank,pinocytosis (GO:0006907),0.5432867850089412,1.1455755009400712,0.3092485549132948,1.0,1.0,5/10,20.61%,SNX5;RAB34;SNX33;CARMIL1;MAPKAPK2
prerank,positive regulation of telomere maintenance (GO:0032206),0.4316705462291559,1.1455354037036751,0.29333333333333333,1.0,1.0,11/31,19.61%,GNL3;PKIB;HNRNPD;DHX36;ATRX;HNRNPA2B1;MRE11;RAD50;TNKS;NABP2;PPP1R10
prerank,regulation of myelination (GO:0031641),0.4600341036761615,1.1454645268185466,0.2986198243412798,1.0,1.0,3/25,2.65%,SIRT2;MYRF;EIF2AK3
prerank,regulation of cellular metabolic process (GO:0031323),0.42175952914216797,1.1453218042234787,0.29228998849252014,1.0,1.0,7/45,8.80%,FASN;FOXM1;STUB1;ABCA2;AGPAT1;PID1;SSH1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.40062100208909823,-1.1452236967162686,0.2490272373540856,0.8216610731486869,1.0,3/17,3.26%,BRWD1;STAT3;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),-0.40062100208909823,-1.1452236967162686,0.2490272373540856,0.8216610731486869,1.0,3/17,3.26%,BRWD1;STAT3;IRS1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.49302051322729956,1.1451800863687058,0.2950138504155125,1.0,1.0,7/16,23.73%,PLEKHM2;CEBPG;TUBB;KIF5B;ARL8B;VAMP7;LYST
prerank,skeletal muscle tissue development (GO:0007519),0.4418821127616295,1.1450888924237759,0.2920245398773006,1.0,1.0,2/32,4.00%,MYORG;MYH14
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.34614251108707805,-1.145013202578085,0.25980392156862747,0.8192943007774737,1.0,13/23,38.00%,AXL;TLR4;LGALS9;RARA;VSIR;INHBA;ZC3H12A;CD274;HAVCR2;LAPTM5;NR1H4;INHA;C1QBP
prerank,calcium ion import into cytosol (GO:1902656),-0.405340092529648,-1.1449378129890975,0.2874015748031496,0.8164894275602665,1.0,8/15,38.46%,CACNA2D1;SLC24A2;TRPV2;TRPV4;SLC8A1;SLC8A2;TRPM2;SLC8A3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4251696346955546,1.1446594251563909,0.2926267281105991,1.0,1.0,5/40,6.02%,IGF1;BAX;PPIF;FAM162A;PRELID1
prerank,calcium ion import (GO:0070509),-0.3436216240101264,-1.143749756833544,0.26285714285714284,0.8171508515123502,1.0,16/28,31.29%,MICU1;CACNA1D;CACNA1C;CACNA1G;MCU;MCUR1;TRPC4;CACNB2;MCUB;MAIP1;SMDT1;CACNA1B;TRPV4;MICU3;SLC8A1;CACNA1H
prerank,telomere maintenance via telomerase (GO:0007004),0.4491326173719368,1.1434642455205746,0.28983688833124216,1.0,1.0,10/28,18.57%,NHP2;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.31431176952691264,-1.1434440154951226,0.2222222222222222,0.8150801463969998,1.0,13/36,15.17%,CRADD;DAB2IP;RB1;CSNK2A1;TPD52L1;CYLD;TRIM39;FAS;TMBIM6;MADD;SGMS1;DAPK2;TRAF7
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.4447847039838327,1.142886639480135,0.29652605459057074,1.0,1.0,10/29,18.57%,NHP2;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5231644996648623,1.1428851624312997,0.32294617563739375,1.0,1.0,4/12,15.47%,MLYCD;TWIST1;IRS2;ABCD2
prerank,ERBB signaling pathway (GO:0038127),0.403904796696725,1.1424734313576543,0.26731601731601734,1.0,1.0,17/64,15.82%,PDPK1;HSP90AA1;STUB1;PRKCA;PIK3R1;GAB1;SLC30A10;SOX9;EGF;MVP;IQGAP1;NRG2;CUL5;NRG1;TGFB1;CBL;PTPN12
prerank,positive regulation of leukocyte activation (GO:0002696),0.488605108882208,1.1423806670329517,0.31283422459893045,1.0,1.0,2/18,2.68%,WNT5A;IL33
prerank,regulation of mRNA catabolic process (GO:0061013),0.38194128432315305,1.1423454656583893,0.23439099283520984,1.0,1.0,31/121,17.01%,KHSRP;EXOSC1;EXOSC3;PSMD4;EXOSC7;EXOSC2;PCBP4;ANP32A;ZFP36L1;PRKCA;IGF2BP2;PSMB10;EXOSC8;PSMD11;HNRNPD;DHX36;PABPC1;PSME2;PSMC5;ZC3H14;RC3H2;YTHDF3;YTHDF1;CSDC2;XRN1;NUP214;PSMD1;TNPO1;ZC3HAV1;FMR1;PSMD6
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5299110801656306,1.1422084082757382,0.3193033381712627,1.0,1.0,5/11,17.83%,PCBP4;IGF2BP2;ZNF445;NOVA1;PCBP2
prerank,regulation of leukocyte activation (GO:0002694),-0.4099032932596851,-1.142078324223694,0.2783171521035599,0.8162536239571625,1.0,8/14,35.71%,MFHAS1;PLSCR1;GPR137B;SHPK;GPER1;CD74;CD200;MIF
prerank,regulation of protein phosphorylation (GO:0001932),0.3727396951121151,1.1420233066940058,0.15915915915915915,1.0,1.0,50/256,14.90%,FGF20;FGF9;HDAC3;TMEM119;IL34;KDM4D;DVL2;EPHA7;EPHB2;EIF2AK3;HSP90AA1;RAC1;SMG8;WARS1;ERP29;FBLN1;FGF10;FLCN;KNDC1;FBH1;BRD4;ABL1;ATG14;AKAP8L;RAP2A;SIRPA;WDFY2;PID1;ARRB1;SOX9;PPP2R5E;CDK5RAP3;CLIP3;MUSK;APP;IGFBP3;LEPR;PARK7;NPM1;AXIN2;RACK1;PLPP3;NPTN;ZBED3;CSNK1D;ROCK2;TGFB1;FKBP8;IMPACT;PPP2R5D
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.47183001863155305,1.142019693879076,0.29404466501240695,1.0,1.0,5/23,9.82%,SELENOS;SYVN1;SEC16A;AUP1;VCP
prerank,negative regulation of phosphorylation (GO:0042326),0.38918648712774795,1.1417575555080421,0.2760416666666667,1.0,1.0,27/85,20.74%,CDKN2D;EPHB2;PRKRIP1;WARS1;FBLN1;ATG14;SIRPA;PID1;CDK5RAP3;HDAC4;IRS2;IGFBP3;PARK7;GIT1;PLPP3;ZBED3;MAPT;TGFB1;FKBP8;IMPACT;NUPR1;DNAJC10;TERF2IP;DYNLL1;LYN;HNRNPU;NPRL2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3985124963670673,1.1416795656777485,0.27360515021459225,1.0,1.0,18/69,19.07%,IGF1;SIRT2;PLCH1;FGFR1;ZFP36L1;OGT;PLCL2;PIK3R1;IRS2;PIK3CB;PIK3R2;PDGFRA;PI4KB;PIK3C2B;PIK3C3;PITPNM2;PLEKHA1;KCNH1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.44565571581964203,1.1409924048951767,0.2900378310214376,1.0,1.0,6/28,15.53%,FGF10;THY1;SIRPA;XRCC6;CD47;HSPD1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.4078256515942324,1.14066540916799,0.2894736842105263,1.0,1.0,13/56,17.34%,SPIRE2;CUL7;INCENP;CIT;JTB;MYH10;ANK3;RTKN;SNX33;ROCK2;SPTBN1;SPIRE1;SON
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.33383778362402095,-1.1406645038219203,0.25316455696202533,0.8179484777075956,1.0,10/30,15.08%,CACNA1D;GJA1;CACNA2D1;ATP1A1;GJC1;KCNJ2;CACNA1C;CACNA1G;NEDD4L;SNTA1
prerank,positive regulation of lyase activity (GO:0051349),-0.4258372492613482,-1.1405367128516128,0.2956204379562044,0.8153414198535245,1.0,7/14,28.05%,CACNA1D;NOS3;CACNA1C;NF1;NOS1;FXN;ISCU
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3859395406879314,1.140403734805587,0.24842105263157896,1.0,1.0,22/98,17.19%,FASN;NTF3;IFNAR1;IL10RB;PICK1;CD63;AGPAT1;SCRIB;PRELID1;VAMP3;PID1;ARRB1;EGF;MAGI2;RNF41;TGFB1;AHI1;AGTR1;NSF;ANXA2;FMR1;APOE
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4718564906964186,1.1401046355079383,0.3116036505867014,1.0,1.0,3/21,5.54%,HKDC1;G6PC3;TKT
prerank,central nervous system development (GO:0007417),0.36899854522485376,1.1398976094082167,0.16449348044132397,1.0,1.0,51/250,18.16%,AATK;AMIGO1;AFF2;ATP6AP2;SH3GL3;POU6F1;EPHA7;MYRF;SYNJ2;GBA2;NKX2-2;GLIS2;GRIN1;NIPBL;CHD8;CDK5;DHX30;ATXN1;HAPLN4;ADAM22;ZIC3;CXCR4;GRIN2A;SPOCK1;SOX9;PTCH1;ZFHX2;CDK5RAP3;SOX11;JARID2;POU6F2;COX7B;SETD1A;ROBO2;ADGRG1;SMARCA1;NDRG4;SOX6;RPS6KA3;ZIC2;CNTNAP2;CIC;AHI1;HSPG2;ADGRA2;TPPP;ALDH3A2;TUBGCP2;MEIS2;PKD2;ATN1
prerank,extracellular matrix assembly (GO:0085029),0.46227840020061794,1.1397607577270175,0.31352718078381797,1.0,1.0,7/23,14.59%,MFAP4;TNXB;NTNG2;FBLN5;LAMB1;TGFB1;PXDN
prerank,cellular response to interleukin-4 (GO:0071353),0.5443934048233807,1.1394388645328866,0.3191489361702128,1.0,1.0,2/10,3.79%,STAT6;XBP1
prerank,negative regulation of lipid storage (GO:0010888),-0.375934723486161,-1.1388742149935878,0.24675324675324675,0.817569402480573,1.0,10/19,32.33%,ABHD5;NFKBIA;PPARD;NR1H3;NR1H2;PPARG;PPARA;ITGB3;PNPLA2;PTPN2
prerank,establishment of spindle localization (GO:0051293),0.526413211777908,1.1386509894185914,0.3220338983050847,1.0,1.0,7/14,24.58%,KPNB1;ZBED3;MAP4;CFL1;CLASP2;LLGL1;DYNC1H1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5141210560010645,1.1385823825340955,0.3385269121813031,1.0,1.0,3/13,9.60%,GLS2;GLUL;ALDH4A1
prerank,positive regulation of protein modification process (GO:0031401),0.37355319964495154,1.1385030720275289,0.19698492462311556,1.0,1.0,53/203,21.29%,FGF20;FGF9;HDAC3;TMEM119;IL34;DVL2;HSP90AA1;RAC1;CALM3;TAOK1;ERP29;DDX3X;FGF10;FLCN;KNDC1;FBH1;ABL1;ATG14;NOS1AP;RAP2A;WDFY2;ARRB1;SOX9;NNMT;CLIP3;MUSK;APP;LEPR;AXIN2;RACK1;NPTN;CSNK1D;ROCK2;TGFB1;CAMTA1;ASPSCR1;DAXX;FMR1;ILK;PPP2R5A;TERF2IP;FLOT1;CALM1;SMPD1;PELI2;DLC1;RAB3GAP2;DAB2;LYN;ACVR2A;NTRK2;PTBP1;FGF2
prerank,triglyceride homeostasis (GO:0070328),0.4506754843806702,1.1384660697650664,0.31909547738693467,1.0,1.0,3/26,3.85%,LPL;XBP1;RORA
prerank,neurotransmitter secretion (GO:0007269),0.4152902266720164,1.138434987770349,0.3083140877598152,1.0,1.0,9/44,12.73%,SYT10;UNC13A;CDK5;DVL1;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5221250447091283,1.1381369043189566,0.30945558739255014,1.0,1.0,4/12,12.71%,EPHB2;HSP90AA1;MYCBP2;B4GALT5
prerank,negative regulation of secretion by cell (GO:1903531),0.42588223882088583,1.1380163400088155,0.3064327485380117,1.0,1.0,12/38,21.57%,ANXA1;ERP29;VAMP3;SLC30A1;IL1RAPL1;CYP51A1;RHBDF1;VAMP8;TRH;APOE;SYT4;SYT11
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.46011503489300404,1.1378946660611868,0.3153153153153153,1.0,1.0,4/23,7.60%,DNASE1L2;FBH1;DFFB;KPNB1
prerank,positive regulation of protein acetylation (GO:1901985),0.5256325378462328,1.1378553856308025,0.3304964539007092,1.0,1.0,3/12,4.16%,TAOK1;DDX3X;DIP2B
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.2880449848887194,-1.137793166630544,0.2403846153846154,0.8179001885944615,1.0,25/52,24.63%,ME3;ME2;MTHFR;GCLM;MTHFS;GOT2;SLC25A32;IDH1;ACLY;MTHFD1;IDH2;PHYH;D2HGDH;ACOT8;GPT2;L2HGDH;GOT1;MTHFD1L;ALDH5A1;HOGA1;MTRR;ALDH1L1;ALDH1L2;MDH1;ALDH18A1
prerank,keratinocyte differentiation (GO:0030216),0.4477063317166968,1.137591435008956,0.30097087378640774,1.0,1.0,3/29,3.76%,WNT5A;SCEL;ANXA1
prerank,RNA metabolic process (GO:0016070),0.381543871654654,1.1373165388910218,0.24922760041194644,1.0,1.0,36/127,17.85%,LAGE3;DDX17;TBRG4;EXOSC7;RNASE1;RBM3;DDX3X;POLR2B;RBM39;CELF2;DHX8;ATXN1;HNRNPK;MPHOSPH10;PABPC4;HNRNPD;DHX36;HNRNPM;MTREX;RBFOX2;RBMS1;RBMS2;POLR2K;HNRNPA0;AGO3;HNRNPH3;SETX;HNRNPL;SND1;NOVA1;HNRNPA2B1;THOC1;TP53RK;FASTKD1;PCBP2;FTO
prerank,positive regulation of chromosome organization (GO:2001252),0.4996219269613607,1.1372979585026577,0.3286118980169972,1.0,1.0,7/15,19.61%,GNL3;DHX36;ATRX;MRE11;RAD50;RAD21;PPP1R10
prerank,neuropeptide signaling pathway (GO:0007218),0.4050288967443981,1.1372318871876204,0.2965821389195149,1.0,1.0,9/58,14.46%,LTB4R2;OPRK1;HCRTR2;GPR37;GPR149;NMU;NXPH2;HCRTR1;GLRA1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4399259722880158,1.137029322022085,0.30241423125794153,1.0,1.0,9/26,24.17%,HSP90AA1;TMEM106A;NOS1AP;PTGS2;PKD2;ASS1;KLF4;SMAD3;INSR
prerank,negative regulation of secretion (GO:0051048),0.5417101826350647,1.1369564179666656,0.34234234234234234,1.0,1.0,4/10,16.15%,VAMP3;EGF;NRG1;VAMP8
prerank,regulation of macrophage chemotaxis (GO:0010758),0.46717265799285346,1.136772694313468,0.3009198423127464,1.0,1.0,2/21,1.32%,IL34;DDT
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.47674782020703943,1.1366807990256884,0.3228454172366621,1.0,1.0,10/18,26.38%,UNC13A;GRIK5;GRIA2;NAPA;UNC13B;CDH8;GRIK2;GRIK1;GRID1;SLC17A6
prerank,lymphocyte proliferation (GO:0046651),-0.3538351070591744,-1.1365721538309062,0.2560386473429952,0.8188386102070859,1.0,6/22,16.70%,MEF2C;ELF4;PTPRC;LMBR1L;HELLS;MSN
prerank,response to hydrogen peroxide (GO:0042542),0.4147232550834057,1.136245111737115,0.2947247706422018,1.0,1.0,13/45,19.43%,APTX;PPIF;ANXA1;TNFAIP3;ABL1;SIRPA;OSER1;PARK7;SETX;IMPACT;STK25;PLEKHA1;RPS3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4403121698927526,1.1359280247918773,0.32116788321167883,1.0,1.0,8/31,17.91%,ARRDC4;UBE2S;FZR1;CDC14B;UBE2L3;TOPORS;GORASP1;DCUN1D5
prerank,spliceosomal complex assembly (GO:0000245),0.4142797032307222,1.1352065479478286,0.3035107587768969,1.0,1.0,17/46,18.52%,SMN1;SRSF5;SF3B1;CELF2;CELF1;SRSF9;SF3A1;PRPF6;SRSF1;SETX;LUC7L2;KHDC4;CELF5;YTHDC1;LUC7L3;GCFC2;SRPK1
prerank,cellular amide metabolic process (GO:0043603),0.3832873580449402,1.1351206608259294,0.266597510373444,1.0,1.0,19/102,14.55%,CPXM1;MLYCD;SMPD2;THEM4;ABCA2;FPGS;ACOT9;ACOT11;PCCB;THOP1;GPAT4;DNPEP;SGPL1;NNMT;CPXM2;PCCA;PLPP3;NIT1;ACSL6
prerank,actin filament bundle assembly (GO:0051017),0.4365738041166576,1.134978040845365,0.29890643985419196,1.0,1.0,8/33,15.37%,LCP1;AIF1L;MYO1B;DMTN;RHOD;BAIAP2;ADD2;PAWR
prerank,protein complex oligomerization (GO:0051259),0.38922362525272114,1.1349483068386483,0.2622601279317697,1.0,1.0,26/85,22.77%,TRMT61B;GSDMD;MPP2;KCNC1;ATL1;LRRC8A;FUS;TIFA;KCNC2;CPSF7;HGSNAT;ALS2;NUDT21;NACC2;PRMT1;DNM1L;PRMT8;CPSF6;PKD2;MAT2A;OXA1L;EHD1;ATL3;EHD3;WDCP;OPA1
prerank,positive regulation of protein polymerization (GO:0032273),0.3989789866366215,1.134532956043534,0.2870967741935484,1.0,1.0,9/65,9.23%,PSRC1;CDC42EP5;CDC42EP4;BIN1;HSP90AA1;RAC1;TPPP3;BAIAP2;DRG1
prerank,cellular response to glucose starvation (GO:0042149),0.4186085002032528,1.134264819587343,0.30158730158730157,1.0,1.0,15/41,19.00%,EIF2AK3;XBP1;PICK1;NUAK2;NUAK1;ATG14;BRSK2;TBL2;SIK1;BRSK1;IMPACT;PIK3C3;PRKAA1;PRKAG2;PIK3R4
prerank,lamellipodium organization (GO:0097581),0.4400288593891234,1.13414590636777,0.31,1.0,1.0,13/29,20.97%,RAC1;WHAMM;ARHGEF7;ARHGEF4;DMTN;RHOD;CYFIP1;ABLIM2;WASF1;ARHGEF6;CCDC88A;CARMIL1;ITGB1
prerank,regulation of macrophage differentiation (GO:0045649),0.4976144289172765,1.1340654198142117,0.31843575418994413,1.0,1.0,2/15,5.06%,IL34;PRKCA
prerank,angiogenesis involved in wound healing (GO:0060055),-0.45650112372641966,-1.1339295080387,0.32679738562091504,0.82400119182673,1.0,7/11,25.44%,CD34;KDR;ADIPOR2;VEGFA;GATA2;MCAM;ITGB3
prerank,organic hydroxy compound transport (GO:0015850),-0.3077142178776101,-1.1333415588480071,0.21568627450980393,0.8229077771662172,1.0,6/36,6.35%,ABCC4;ATP8B1;RALBP1;SLCO1C1;RBP4;SLC16A1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.2985661448916064,-1.132589045612574,0.23741007194244604,0.8224927493700064,1.0,16/39,18.82%,LATS1;DAB2IP;RDX;TJP1;EZR;TIE1;PARP10;ROCK1;VPS11;HCFC1;SPTY2D1;IRGM;MSN;PINK1;ANKRA2;GFAP
prerank,regulation of spindle assembly (GO:0090169),0.4592590330518957,1.1325594603872082,0.31639135959339265,1.0,1.0,10/25,21.48%,CEP97;DRG1;CHMP3;GPSM2;VPS4B;NUMA1;EML3;HNRNPU;TPR;CHMP4B
prerank,sulfur compound catabolic process (GO:0044273),0.4272817212196733,1.1322206547850355,0.2980209545983702,1.0,1.0,9/38,16.81%,ADO;MLYCD;GLB1;DCN;ACAT1;OMD;ARSB;LUM;DPEP1
prerank,positive regulation of translational initiation (GO:0045948),0.4754590639675099,1.1322142151263408,0.32837837837837835,1.0,1.0,7/18,24.24%,DDX3X;CDC123;YTHDF3;YTHDF1;YTHDF2;KHDRBS1;UHMK1
prerank,regulation of humoral immune response (GO:0002920),0.4146139951031129,1.1319498760049187,0.27314285714285713,1.0,1.0,3/44,5.04%,VTN;FCGR2B;SERPING1
prerank,extracellular matrix organization (GO:0030198),0.36845090685572024,1.1318354933223722,0.191,1.0,1.0,77/276,21.42%,ADAMTSL2;MMP12;MMP17;VTN;LCP1;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;P4HA1;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;PLOD1;DDR2;CD151;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;FLRT2;MFAP5;CAPN2;PPIB;P4HA2;APP;ST7;ADAM12;COL1A2;CRTAP;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;TGFB1;PXDN;P3H2;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1;CAPNS1;COL11A1;BMP1;TGFBR1;SCUBE1;FLOT1;COL5A3;COL8A2;CTSK;TIMP2;MMP14;QSOX1;LOXL1;MMP16;ITGAV;ITGB1;ADAMTSL5;FGF2;GFOD2;GSN
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5002824462638508,1.130318008903869,0.34560906515580736,1.0,1.0,5/14,15.48%,HSD17B4;CROT;AMACR;EHHADH;ACOX3
prerank,protein modification by small protein conjugation (GO:0032446),0.36823052450190735,1.130269596370815,0.147,1.0,1.0,101/361,20.24%,ARRDC4;RNF157;CUL7;CDC23;SELENOS;RNF138;ASB5;MSL2;RNF8;UBE2S;SPSB1;STUB1;TRIM7;DTX3;SYVN1;USP7;SAE1;CDC16;LZTR1;TRIM11;BRAP;PDZRN3;RAE1;SDE2;FBXO7;FBH1;DDB1;BARD1;RTF1;FBXO45;UCHL3;RRAGA;TRIM35;FBXW5;MYCBP2;NFX1;ARRB1;TRIM62;UBA1;RNF40;RNF168;RNF103-CHMP3;CDK5RAP3;UBE2V2;TRIM41;TRIM17;CUL4B;VCP;NUP188;CHFR;UBE2Z;UBR3;PEX5;ZNRF3;RNF152;NUP210;RACK1;UBE2A;ANAPC11;NUP88;USP9X;CDC73;CUL5;PCNP;RNF220;PEX13;ATG3;RNF41;CBL;PIAS3;NUP214;TRPC4AP;KLHL13;UBE2E1;UBE2D1;VPS18;ZSWIM8;DERL1;ARIH2;NEDD8;UBE2L3;EIPR1;SMURF1;TOPORS;MDM2;FBXO9;DCUN1D5;URM1;KLHL20;NUP153;RNF111;HLTF;RANBP2;TRIM27;NUP35;VCPIP1;RNF38;DTX2;PIAS1;SUMO2;EYA1
prerank,Golgi organization (GO:0007030),0.38812343775468566,1.129809710136739,0.25906735751295334,1.0,1.0,37/112,19.74%,SPTBN5;CUL7;TJAP1;UBXN2A;TRAPPC8;OBSL1;STX6;SEC16A;ARHGEF7;TRIP11;STX16;SEC16B;ATP8B2;PLK5;LMAN2L;PRMT5;ARHGAP21;TBC1D20;PLEKHM2;USP6NL;RAB30;TANGO2;VTI1B;TMED10;COG3;HTT;CSNK1D;VMP1;CSNK1A1;STX17;VTI1A;STK25;GORASP1;VCPIP1;STX5;FAM174B;ZW10
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.46090744478261436,1.1298075459666324,0.3278271918678526,1.0,1.0,6/24,18.05%,FIS1;MTCL1;MIEF2;ANK3;ITGB1BP1;CEMIP
prerank,base-excision repair (GO:0006284),0.4156050587769079,1.129717597881478,0.2997787610619469,1.0,1.0,7/48,6.98%,LIG1;PARP1;NTHL1;PRMT6;MPG;USP47;LIG3
prerank,acute-phase response (GO:0006953),-0.43052825813156503,-1.1294804668551188,0.3053691275167785,0.8295396277895931,1.0,3/12,7.50%,IL6R;LBP;PLSCR1
prerank,negative regulation of metabolic process (GO:0009892),0.4111908560497557,1.1294121222497422,0.30467899891186073,1.0,1.0,13/54,15.42%,FIS1;NRDC;FLCN;PLCL2;ACOT11;STK11;ADAMTS5;DDIT3;LGR4;RBPJ;DOCK7;NOVA1;FOXC2
prerank,protein import (GO:0017038),0.38986361844791695,1.129165449062937,0.288117770767613,1.0,1.0,29/84,21.10%,MMP12;TSC2;HSP90AA1;NXT2;FIS1;NXT1;KPNB1;NUP188;PXMP4;PEX5;IPO11;SNX33;E2F3;PXMP2;NUP88;GDAP1;PEX13;IPO7;NUP214;TNPO1;ABCD2;RAB8B;ALDH3A2;APOE;NUP153;PPP1R10;HEATR3;TPR;APPL2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42839727718981263,1.1290318999582156,0.31153388822829964,1.0,1.0,11/34,21.65%,SMPDL3B;GPR108;TNFAIP3;LGR4;LY96;LRRC14;TLR3;GPS2;PTPRS;LYN;RAB7B
prerank,regulation of postsynapse organization (GO:0099175),0.45168241812361287,1.128996093617932,0.3251833740831296,1.0,1.0,7/28,11.98%,WNT5A;FCGR2B;CDKL5;TANC2;CDK5;SRCIN1;IL1RAPL1
prerank,response to metal ion (GO:0010038),-0.2721863565115556,-1.1288799860778287,0.1891891891891892,0.8282697399071381,1.0,17/67,13.35%,SEC31A;CAV1;GPHN;SLC25A13;ANXA11;HIF1A;TRPC3;MTF1;TRPC1;THBS1;PLSCR1;ITPR3;SLC30A4;MT1A;MT1X;NEDD4L;D2HGDH
prerank,regulation of microtubule nucleation (GO:0010968),0.5458985659750472,1.1288199194094197,0.33775811209439527,1.0,1.0,5/10,22.51%,ARHGEF7;GIT1;EML2;MECP2;PAK1
prerank,fatty acid biosynthetic process (GO:0006633),0.39779515926979775,1.1286209662781914,0.29791894852135814,1.0,1.0,9/63,14.71%,NDUFAB1;LPL;MLYCD;ELOVL1;XBP1;ELOVL4;FADS1;PTGS2;EPHX2
prerank,filopodium assembly (GO:0046847),0.49559872553705,1.1285635846204287,0.33787465940054495,1.0,1.0,4/16,8.63%,S1PR2;SRGAP2;ARHGEF4;PPP1R9B
prerank,endoplasmic reticulum organization (GO:0007029),0.3954034925199567,1.128489220795249,0.2766415500538213,1.0,1.0,23/72,19.98%,REEP4;ATL1;EIF2AK3;BNIP1;SEC16A;MIA3;GET1;SEC16B;MOSPD3;LMAN2L;RAB10;TOR1B;APP;SERP1;ZBED3;SMPD4;DNM1L;SEC61G;VAPB;ALDH3A2;VCPIP1;STX5;TOR1AIP2
prerank,folic acid metabolic process (GO:0046655),-0.37965198831616476,-1.1281265802554898,0.28270042194092826,0.8276956418635061,1.0,10/18,29.29%,MTHFR;MTHFS;SLC25A32;MTHFD1;MTHFD1L;MTRR;ALDH1L1;ALDH1L2;MTHFD2;DHFR
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.478241903030288,1.1270935419412893,0.35278154681139756,1.0,1.0,5/17,11.30%,GPLD1;NRP1;MIA3;EFNB2;ROBO1
prerank,second-messenger-mediated signaling (GO:0019932),0.3892705588808783,1.1265786455232683,0.30810234541577824,1.0,1.0,16/82,17.84%,PDPK1;EIF2AK3;EDN3;CCR9;ACKR2;RCAN2;CXCR4;RCAN3;INPP5A;PPP1R9B;MCTP2;NDNF;AGTR1;APOE;HRH1;MCTP1
prerank,superoxide anion generation (GO:0042554),-0.41430675238459164,-1.1256914080046632,0.30491803278688523,0.8325531777519082,1.0,11/13,56.85%,NOX1;CYBA;NCF2;ALOX12;CYBB;NOX4;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,aorta development (GO:0035904),0.49658636942900647,1.1255761688021093,0.33841886269070737,1.0,1.0,6/14,18.02%,ROBO2;ROBO1;LRP1;HECTD1;JAG1;PKD2
prerank,regulation of chromosome segregation (GO:0051983),-0.3821671583439179,-1.1255560192371001,0.2862595419847328,0.8300386394813285,1.0,3/16,1.76%,SMC5;PUM1;CSNK2A1
prerank,ribosome assembly (GO:0042255),-0.28697889254816744,-1.1249617692184866,0.21296296296296297,0.8289161926103796,1.0,35/47,38.75%,EIF2A;RPL11;RPL5;RPL6;RPL24;RPS19;EFL1;RPL3;RPLP0;RPL10;RPS28;RPS5;TRAF7;RPS27;MRPL20;NOP53;RPF2;RPS14;ERAL1;RRP7A;RPS27L;NOP2;MRPS7;BOP1;EIF6;DHX37;MRPS11;MRPL22;RRS1;RSL24D1;NLE1;PPAN;MPV17L2;C1QBP;PWP2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.42915073608030885,1.1247878073833164,0.31845597104945716,1.0,1.0,11/33,19.43%,PPIF;ANXA1;TNFAIP3;ABL1;SIRPA;OSER1;PARK7;SETX;IMPACT;PLEKHA1;RPS3
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3769917584689063,-1.1247660186046087,0.2798507462686567,0.826628358428919,1.0,12/16,44.80%,RPA1;PURA;BLM;RECQL;MCM6;WRN;MCM4;MCMDC2;TWNK;RAD51;MCM2;MCM7
prerank,glycoprotein biosynthetic process (GO:0009101),0.3912564578593354,1.1247483480684768,0.28888888888888886,1.0,1.0,14/79,13.65%,ALG5;B3GALNT1;IGF1;ST8SIA3;ST3GAL2;ALG1;TMEM106A;CHST10;ST3GAL3;ST3GAL5;B4GALT5;SERP1;COG3;DAD1
prerank,cellular response to UV-A (GO:0071492),-0.4352652263052818,-1.1246457487748966,0.31563421828908556,0.8240959106879031,1.0,4/11,25.35%,MME;MMP2;MMP1;CERS1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4671374866144411,1.1243457972430064,0.32588699080157685,1.0,1.0,6/20,12.60%,SMAD9;XBP1;CARF;CHD6;RBPJ;CREB3
prerank,phasic smooth muscle contraction (GO:0014821),0.5499430608224094,1.1242116478743653,0.3492537313432836,1.0,1.0,2/10,10.19%,EDN3;GDNF
prerank,negative regulation of translation (GO:0017148),0.3848801685317204,1.1239914694472573,0.29947089947089944,1.0,1.0,31/87,22.71%,ILF3;CPEB1;PAIP2;EIF2AK3;DDX3X;CNOT10;IGF2BP2;CELF1;EPRS1;DHX36;PUS7;EIF4E2;CNOT9;MALSU1;YTHDF3;RACK1;DAPK1;YTHDF1;ROCK2;MRPL13;FMR1;FTO;SAMD4B;YTHDF2;RPS3;YBX1;TPR;IGFBP5;SAMD4A;METTL14;RPL13A
prerank,activation of GTPase activity (GO:0090630),0.3869995803309568,1.1238585914242172,0.27936507936507937,1.0,1.0,20/89,14.05%,MTSS2;NTF3;SLC27A4;TBC1D7;SGSM3;RUNDC1;ARHGEF10;TBC1D13;SCRIB;SYDE2;RAP1GAP;ARHGAP42;RAP1GAP2;RABGAP1L;ARHGAP24;USP6NL;EVI5L;DOCK7;RABGAP1;ARHGAP29
prerank,regulation of axonogenesis (GO:0050770),0.4075836818301848,1.1236054080673452,0.3160322952710496,1.0,1.0,23/51,24.29%,AMIGO1;PLXNA2;THY1;PAK3;EFNB3;BRSK2;MCF2;PLXNA1;BRSK1;ROBO2;ROBO1;PLXNB3;RUFY3;SLITRK1;CHN1;MAP6;NTRK2;ARHGAP35;PAK1;EPHA4;LRP4;PTEN;CDH2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.502268063753597,1.1234784685720534,0.3402061855670103,1.0,1.0,1/14,0.80%,WNT5A
prerank,negative regulation of protein metabolic process (GO:0051248),0.40950856324047086,1.1234202295404252,0.31839080459770114,1.0,1.0,13/48,19.02%,PFDN4;SIRT2;AZIN2;NFKB1;MAD2L1;VBP1;PFDN1;MDM4;CYP51A1;APOE;PFDN2;BANP;FMN2
prerank,phospholipid homeostasis (GO:0055091),0.5178638649492522,1.123238845503578,0.3302891933028919,1.0,1.0,2/11,7.81%,TLCD1;RCN3
prerank,protein localization to synapse (GO:0035418),0.5155448850741884,1.1231917084280643,0.3357142857142857,1.0,1.0,1/12,0.27%,MPP4
prerank,mitochondrial fission (GO:0000266),0.4935474313493464,1.1230706131898098,0.3086253369272237,1.0,1.0,5/16,14.84%,DNM1;FIS1;MTFR1L;GDAP1;DNM1L
prerank,primary alcohol metabolic process (GO:0034308),0.44428805708086017,1.1228659369998428,0.3227040816326531,1.0,1.0,4/25,7.45%,IGF1;RDH10;RDH11;GDPD3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5360927519705404,1.1227196792142686,0.34992458521870284,1.0,1.0,1/10,0.85%,FCGR2B
prerank,regulation of programmed necrotic cell death (GO:0062098),0.45672472928291397,1.1223075881063,0.3161290322580645,1.0,1.0,8/20,18.94%,HSP90AA1;STUB1;OGT;SDCBP;NUPR1;MLKL;FLOT1;BIRC3
prerank,kidney development (GO:0001822),0.3927143531134009,1.1222544344947913,0.29265658747300216,1.0,1.0,16/65,19.15%,STRA6;GREB1L;PCSK5;NIPBL;FGF10;SULF1;WNT4;GDNF;ROBO2;PYGO2;PYGO1;CTSH;AGTR1;OSR1;TGFBR1;SOX4
prerank,positive regulation of ERAD pathway (GO:1904294),-0.40073989565151136,-1.1222056706090107,0.30714285714285716,0.8287321327516068,1.0,9/13,21.77%,CAV1;RNF185;USP13;HERPUD1;RNFT1;SGTA;BAG6;NFE2L2;UBQLN2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.35962981831142354,-1.122200234163559,0.3017241379310345,0.8258559842873417,1.0,5/20,13.21%,CAB39;PRKCE;GOPC;ACTN2;NEDD4L
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4284525099245624,1.1221460309988038,0.3172737955346651,1.0,1.0,5/33,6.02%,IGF1;PPIF;FZD9;FLCN;PRELID1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.516984082265525,1.1221296261445592,0.33284457478005863,1.0,1.0,7/12,25.15%,ARHGEF7;CLIP3;EML2;TBCD;TUBB4A;MAP2;STMN1
prerank,cellular component disassembly (GO:0022411),0.40159987463387714,1.121896717150415,0.2935153583617747,1.0,1.0,15/53,21.42%,MMP12;LCP1;MMP11;LAMC1;ADAMTS5;CAPN2;CAPNS1;BMP1;SCUBE1;FLOT1;CTSK;TIMP2;MMP14;MMP16;GSN
prerank,quinone biosynthetic process (GO:1901663),0.4933942929243117,1.1216702212829206,0.3268698060941828,1.0,1.0,2/14,2.22%,COQ6;COQ8B
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4713029414222998,1.1214880235853932,0.34620505992010653,1.0,1.0,4/20,7.75%,BBS10;HSP90AA1;NDUFAF1;PSMG3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4305029218309131,1.121252326693568,0.31398104265402843,1.0,1.0,6/33,11.01%,IGF1;SIRT2;ZFP36L1;PIK3R1;PIK3CB;PIK3R2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4174904773801952,1.1209295980817602,0.33451957295373663,1.0,1.0,16/39,24.95%,AJAP1;CASK;FBLN1;DMTN;SPOCK1;SEMA3E;TBCD;JAG1;ITGB1BP1;GCNT2;NF2;MAP4K4;HOXA7;AP1AR;CORO1C;CX3CL1
prerank,regulation of intracellular transport (GO:0032386),0.4267200472366447,1.120907407450244,0.3037214885954382,1.0,1.0,10/38,16.13%,LCP1;ATP9A;MLC1;CAPN10;NEFH;SCFD1;TTC21B;NUP214;ATPSCKMT;NUMA1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.42459157265835823,-1.1204191056028974,0.3152542372881356,0.8286330526047826,1.0,5/13,19.19%,NIBAN2;DAB2IP;EPN2;CADM4;EMILIN1
prerank,nuclear export (GO:0051168),0.3860996538052808,1.1203341951275771,0.30425531914893617,1.0,1.0,30/80,23.13%,U2AF1;SRSF2;RAE1;SRSF5;ATXN1;SRSF3;THOC3;SRSF9;RANBP3L;SRSF1;NUP188;MALT1;STRADB;NEMF;THOC7;TGFB1;THOC1;NUP214;XPO6;SMURF1;SRRM1;XPO7;NUP153;RANBP3;TPR;SARNP;U2AF2;NUP155;SRSF6;CSE1L
prerank,cholesterol efflux (GO:0033344),0.4693193965522245,1.1201740684331607,0.3368560105680317,1.0,1.0,8/20,23.97%,SOAT1;ABCA7;APOE;ABCA5;NPC2;ABCG1;NPC1;ABCA1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.505058041389546,1.1200402013809343,0.33841886269070737,1.0,1.0,4/14,10.40%,GPLD1;DDB1;NNMT;IRS2
prerank,extracellular matrix disassembly (GO:0022617),0.40123967704697866,1.1198066953315495,0.29545454545454547,1.0,1.0,15/53,21.42%,MMP12;LCP1;MMP11;LAMC1;ADAMTS5;CAPN2;CAPNS1;BMP1;SCUBE1;FLOT1;CTSK;TIMP2;MMP14;MMP16;GSN
prerank,negative regulation of mRNA processing (GO:0050686),0.494263907388591,1.1190292128168216,0.352112676056338,1.0,1.0,4/15,7.02%,PCBP4;SRSF12;BARD1;SRSF9
prerank,positive regulation of metabolic process (GO:0009893),0.37870264734212183,1.1189302691616143,0.29690721649484536,1.0,1.0,22/103,17.63%,FASN;HDAC3;STAT6;LPIN1;AGPAT1;OGT;ALMS1;MFAP2;ZBTB7B;CXCR4;MFN2;GNAS;PRLR;PIGA;CPT2;LEPR;EHMT1;ESRRG;CAMK1D;ACADL;KDM6B;OMA1
prerank,endothelial cell development (GO:0001885),-0.3392905835046263,-1.1188625317949654,0.23783783783783785,0.830721788660714,1.0,8/25,16.70%,RDX;RAPGEF3;PECAM1;COL18A1;EZR;MYADM;MET;MSN
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.455124243540071,-1.118855402780716,0.3363914373088685,0.8278873689159758,1.0,2/10,1.89%,PRKCH;MED1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3405012407321081,-1.1188166697632151,0.27979274611398963,0.8251475161685091,1.0,6/27,4.67%,ARL6IP5;SLC25A13;SLC3A2;SLC47A1;SLC7A1;SLC6A9
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4197460577203822,1.1183005307325717,0.3289630512514899,1.0,1.0,5/37,8.75%,SIRT2;NFKB1;ABCA2;LRPAP1;SDCBP
prerank,negative regulation of cell population proliferation (GO:0008285),0.35899975695329905,1.1180561432014364,0.182,1.0,1.0,96/351,22.51%,SFRP2;CDKN2D;WNT5A;SFRP1;SIRT2;GPLD1;TSC2;CHERP;CGRRF1;GNRH1;PTHLH;WARS1;TFDP1;FBLN1;TNFAIP3;NELL1;RBBP4;FLCN;CLMN;IRF1;DLG3;ALDH1A2;CELF1;EEF1E1;MAGED1;STK11;HGS;CHD5;TGFB1I1;IFIT3;PODN;MFN2;IFI35;SOX9;WDR6;MDM4;SOX11;WNK2;KDM2B;APP;IGFBP3;ADGRG1;IGFBP7;BMP5;NACC2;E2F3;MAGI2;SPEG;NDRG4;SOD2;NPM1;AXIN2;ROR2;TNS2;CDC73;FGFBP1;RNF41;TGFB1;SLURP1;P3H2;SMAD6;DIS3L2;MN1;NUPR1;CTNNBIP1;CTBP1;ADAMTS1;ITGB1BP1;ABI1;CAMK2N1;PKD2;ATRAID;CDK10;PDCD5;ATP8A2;SOX4;DLC1;KLF4;MTSS1;LYN;FTH1;CTCF;PTK2B;TGFBR3;S100A11;NF2;APPL2;DLG5;TES;IGFBP5;PRKRA;PEX2;B2M;ERBB4;ITGA1;PAK1
prerank,camera-type eye development (GO:0043010),0.4463278145072836,1.117465370485031,0.3241206030150754,1.0,1.0,3/25,5.55%,FBN2;STRA6;TENM3
prerank,regulation of cytoplasmic translation (GO:2000765),0.48869244548653257,1.1170531735831122,0.3511659807956104,1.0,1.0,3/14,9.11%,CPEB1;CNBP;DHX36
prerank,purine ribonucleotide transport (GO:0015868),0.4823618377225526,1.1169734020903477,0.3384615384615385,1.0,1.0,3/16,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,inner ear morphogenesis (GO:0042472),0.45796268603485707,1.1166959239531793,0.35255570117955437,1.0,1.0,3/22,8.35%,EPHB2;FGFR2;SOX9
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.38525853379485303,-1.1165324055244552,0.3024054982817869,0.8296437158895522,1.0,10/15,35.24%,SAMHD1;STAT2;METTL3;CNOT7;USP18;NLRC5;ISG15;PTPN2;CACTIN;MUL1
prerank,positive regulation of axonogenesis (GO:0050772),0.4159471726095531,1.1161248800566108,0.3279445727482679,1.0,1.0,12/43,17.96%,AMIGO1;CDKL5;PLXNA2;DBN1;PLXNA1;DBNL;ROBO2;ROBO1;MAPT;PLXNB3;RUFY3;SLITRK1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5017968908151214,1.1157184466350825,0.32968536251709984,1.0,1.0,3/15,7.08%,NHP2;CCT8;CCT6A
prerank,negative regulation of cell communication (GO:0010648),0.4536257604438906,1.1156094809297623,0.32639791937581275,1.0,1.0,4/21,14.46%,BRAP;SRMS;IGFBP3;GLRA1
prerank,regulation of membrane depolarization (GO:0003254),0.48027060710337677,1.1151279328439945,0.3473132372214941,1.0,1.0,6/18,20.96%,GPD1L;SCN2B;CAMK2D;PTPN3;SMAD7;SCN1B
prerank,retinal metabolic process (GO:0042574),0.5277707949101755,1.1146042108504792,0.35198821796759944,1.0,1.0,2/12,6.30%,RDH10;RDH11
prerank,cellular response to nutrient levels (GO:0031669),0.39464675609471334,1.1145898593739494,0.3130434782608696,1.0,1.0,11/62,9.95%,LPL;SFRP1;XBP1;WIPI1;FLCN;ATG14;RRAGA;GAS2L1;EHMT2;RIPOR1;FADS1
prerank,transition metal ion transport (GO:0000041),0.4139046229352418,1.1145783992555816,0.3407755581668625,1.0,1.0,11/35,21.53%,CP;ATP2C1;SLC30A10;SLC30A9;SLC30A1;COX17;HEPH;SLC30A5;SLC11A2;FTH1;ATOX1
prerank,tRNA modification (GO:0006400),0.39118092876659233,1.1143548244476926,0.3268186753528773,1.0,1.0,17/62,19.95%,TRMT61B;DTWD1;ANKRD16;TRDMT1;TYW1;PUS10;AARS1;WDR6;PUS7;TRMT1;METTL2A;METTL2B;TPRKB;QTRT2;URM1;ALKBH1;WDR4
prerank,DNA biosynthetic process (GO:0071897),0.4794363244997336,1.114116021133332,0.3446866485013624,1.0,1.0,3/16,13.72%,CDKN2D;POLH;POLD3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4715348679796042,1.113844807823182,0.3531746031746032,1.0,1.0,8/17,21.43%,SCAP;ABCA2;ERLIN2;KPNB1;MBTPS1;APOE;PRKAA1;ABCG1
prerank,negative regulation of histone methylation (GO:0031061),0.5319592033064446,1.1138146105024345,0.3717201166180758,1.0,1.0,3/10,10.02%,AASS;PHF1;JARID2
prerank,mitochondrion disassembly (GO:0061726),0.4202954528254355,1.1137694744061617,0.33726415094339623,1.0,1.0,13/34,19.40%,FIS1;FUNDC2;USP30;WIPI1;FBXO7;FUNDC1;SQSTM1;ATG2A;ATG3;MAP1LC3B;ATG9A;CTSK;AMBRA1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.39707771064884234,1.1133794695706465,0.3310734463276836,1.0,1.0,11/56,9.77%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.39707771064884234,1.1133794695706465,0.3310734463276836,1.0,1.0,11/56,9.77%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.44289188399389723,1.1129263711117743,0.3353960396039604,1.0,1.0,12/27,24.07%,SYT3;SYT10;SYT1;ARL8B;SYT4;VAMP7;SYT11;SYT12;SDF4;SYT7;SYT2;PPP3CB
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4231646670969924,1.1128340260624634,0.33727810650887574,1.0,1.0,6/33,16.76%,SFRP2;EPHA8;JAM3;FOXC2;SERPINE1;ITGB1BP1
prerank,regulation of protein catabolic process (GO:0042176),0.3803475575036156,1.1128299689446541,0.3011422637590862,1.0,1.0,29/99,19.51%,WNT5A;SIRT2;AZIN2;ASB5;MAD2L1;FZR1;SNF8;TNFAIP3;DDB1;BARD1;HGS;MDM4;VCP;CYP51A1;WDR91;EGLN2;RNF41;FAF1;CHEK2;NKD1;NSF;TIPARP;SMURF1;MDM2;SORL1;ZDHHC2;BANP;FMN2;STX5
prerank,regulation of RNA metabolic process (GO:0051252),0.3960357151507547,1.112209841043242,0.3266888150609081,1.0,1.0,26/59,23.97%,AFF2;FAM50A;PCBP4;IGF2BP2;CELF1;FUS;RC3H2;HNRNPH3;HNRNPL;TRA2B;NOVA1;HNRNPLL;GRSF1;AHNAK;CLK4;OAS2;SON;PCBP2;BRDT;YTHDF2;MITF;PTBP1;CLK2;RRP1B;SNRNP70;CLK1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3988794726965243,1.1115222530394235,0.3248898678414097,1.0,1.0,13/56,13.22%,CDC23;UBE2E2;ANXA1;TFDP1;DDX3X;CDC16;FGF10;BRD4;FBXO5;CDC25A;VPS4B;ANAPC11;ANAPC4
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4168926293453697,1.1114149082581088,0.3260340632603406,1.0,1.0,8/38,9.77%,NDUFAB1;NDUFA7;NDUFAF1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.28155093305897694,-1.1104169138515205,0.25984251968503935,0.8460969814561284,1.0,14/47,13.27%,EXOC6B;EXOC1;PREPL;VPS35L;GOPC;KIF13A;BLZF1;OSBPL5;ARL3;VAMP2;GCC2;BBS2;GOLGA7;EXOC2
prerank,muscle cell development (GO:0055001),0.4374800048569103,1.1103790692730464,0.34239802224969096,1.0,1.0,3/30,3.12%,IGF1;BIN1;NEB
prerank,sulfur amino acid catabolic process (GO:0000098),0.5346735279594502,1.1102494379385188,0.35693215339233036,1.0,1.0,1/10,1.95%,ADO
prerank,histone monoubiquitination (GO:0010390),0.44391499449104144,1.1100559595394943,0.33205619412515963,1.0,1.0,8/24,15.71%,PCGF1;DDB1;RNF40;RNF168;CUL4B;KDM2B;CDC73;UBE2E1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5334453321578438,1.1099879385135039,0.34418604651162793,1.0,1.0,4/10,13.57%,CPEB1;DHX36;NUDT21;CDC73
prerank,peptidyl-proline hydroxylation (GO:0019511),0.5129108756720451,1.1097257179192161,0.34672619047619047,1.0,1.0,5/11,14.63%,P4HA1;P4HA2;CRTAP;EGLN2;P3H2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3737530522817888,1.1096744864465824,0.3095723014256619,1.0,1.0,6/117,3.71%,FSHR;PTGER4;ADCY7;ADM;VIPR2;PTHLH
prerank,regulation of transmembrane transport (GO:0034762),-0.31327210037222625,-1.1096567934146941,0.2616279069767442,0.8454264123167576,1.0,6/31,13.21%,CTTNBP2NL;SLC2A1;ACTB;KCNJ2;OCLN;NEDD4L
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4309279106488738,1.1096056716824734,0.3522012578616352,1.0,1.0,7/32,18.96%,PDPK1;CALM3;THY1;HTT;PKD2;CEMIP;CALM1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4865678942668276,1.1095593885744406,0.3382949932341001,1.0,1.0,5/15,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.500635592807426,1.1095462678360024,0.34449093444909346,1.0,1.0,9/14,26.22%,PKIB;HTT;PKIG;PRKAR1A;ATP2B4;PKIA;PRKAR1B;PRKAR2A;RAPGEF2
prerank,transepithelial transport (GO:0070633),0.4902908310471435,1.1094313364560686,0.3528610354223433,1.0,1.0,2/15,1.59%,BEST1;GPLD1
prerank,response to fatty acid (GO:0070542),0.4761057180079973,1.1092507151211066,0.363758389261745,1.0,1.0,4/17,15.21%,LPL;PID1;SOX9;PPP5C
prerank,protein deacetylation (GO:0006476),0.41833388769371055,1.1091114422882788,0.3256880733944954,1.0,1.0,9/41,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;HDAC4;RCOR1;MTA2;HDAC1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.5141483446256436,1.1090370013684592,0.3784977908689249,1.0,1.0,1/11,0.80%,WNT5A
prerank,positive regulation of rRNA processing (GO:2000234),0.5230472131775443,1.1086537754801697,0.36053412462908013,1.0,1.0,3/10,8.48%,SIRT7;DIMT1;BUD23
prerank,cellular response to interferon-beta (GO:0035458),-0.3968979377149801,-1.108494142024343,0.3025830258302583,0.8462232388839305,1.0,7/14,23.52%,UBE2K;STAT1;AIM2;IRGM;NDUFA13;IFITM2;UBE2G2
prerank,negative regulation of protein catabolic process (GO:0042177),0.41073192472991504,1.1080657580635078,0.33064516129032256,1.0,1.0,12/40,19.24%,SIRT2;AZIN2;MAD2L1;NELL1;MDM4;CDK5RAP3;PTPN3;CYP51A1;ATRAID;BANP;FMN2;TIMP2
prerank,regulation of lymphocyte activation (GO:0051249),-0.41419224112921726,-1.1077274856632555,0.3344370860927152,0.845840973745268,1.0,9/12,54.28%,PAG1;KAT2A;DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5278123492361224,1.1077106021229448,0.36268656716417913,1.0,1.0,4/10,12.69%,FZD9;DCN;BCL2;RACK1
prerank,regulation of biosynthetic process (GO:0009889),0.509346215728701,1.1070902740788644,0.375,1.0,1.0,1/11,4.06%,SLC25A33
prerank,regulation of endopeptidase activity (GO:0052548),0.3909815803532216,1.1067490341163393,0.335946248600224,1.0,1.0,14/59,20.45%,VTN;NRDC;SERPING1;PRELID1;SPOCK1;PSME2;HDAC1;SERPINA2;SPOCK2;SERPINE1;SERPIND1;BIRC3;TIMP2;SERPINF1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3595639874425649,1.1065720967120267,0.215,1.0,1.0,78/348,19.80%,FGF20;FGF9;MAPK9;WNT5A;EPB41L4B;TMEM119;IGF1;EPHB2;BMP6;NTF3;EIF2AK3;IL33;WARS1;PICK1;ERP29;CD63;DDX3X;SNF8;C1QTNF1;FGF10;FUBP1;SCRIB;OLFM1;VAMP3;CELF1;ZBTB7B;NOS1AP;HGS;SEC16B;PID1;ARRB1;SOX9;RBMS3;DHX36;EGF;SOX11;TWIST1;CALCOCO1;MUSK;ATF2;PIK3CB;APP;RBPJ;ANK3;MAZ;ROBO1;IFNGR1;MAGI2;PARK7;TADA3;AGO3;LAMTOR5;TLR3;PTPN22;FAM98A;ROCK2;TGFB1;EPHX2;F3;MED23;CTSH;AHI1;NSF;ANXA2;FMR1;UBR5;SPRY2;OSR1;CAMK2N1;TGFBR1;PDCD5;MPHOSPH8;PRKAA1;FOXD1;RPS3;MITF;KLF4;GABPA
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5054053500888911,1.1065086463912799,0.35964912280701755,1.0,1.0,2/12,4.89%,LPL;TIRAP
prerank,positive regulation of response to external stimulus (GO:0032103),0.3655967869335548,1.1063895488145092,0.28804902962206336,1.0,1.0,22/128,17.26%,WNT5A;LPL;PTGER4;DDT;BMP6;IL33;USF1;POLR3D;PRKCA;DHX58;IFI35;GPRC5B;GPR4;LY96;APP;USP15;CD47;TLR3;TGFB1;AGTR1;SERPINE1;TNIP1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3365408088891526,-1.1063760488798413,0.3173913043478261,0.8472122381019955,1.0,8/22,30.79%,PDE3B;ALK;BSCL2;CCDC3;ADRA2A;CEACAM1;GPER1;ASXL3
prerank,glycerolipid catabolic process (GO:0046503),-0.36385553659068354,-1.1062135282894132,0.3031674208144796,0.8449191640659957,1.0,6/19,8.66%,GPCPD1;PNPLA6;MGLL;ABHD6;ABHD2;GDPD1
prerank,response to amino acid (GO:0043200),0.4255941627900738,1.1061789873413124,0.35066505441354295,1.0,1.0,8/31,14.46%,CPEB1;GRIN1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.42438732419072156,1.1059789100247575,0.3344988344988345,1.0,1.0,5/35,6.98%,LIG1;PARP1;NTHL1;MPG;LIG3
prerank,fatty acid oxidation (GO:0019395),0.39518812260691183,1.1056559262216248,0.33370786516853934,1.0,1.0,15/57,16.83%,ADH5;ACAD10;HADHB;ACAT1;HSD17B4;CROT;CPT2;EHHADH;MECR;PEX13;ECHDC1;ABCD2;ACADL;ACADVL;ALDH3A2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5071894106976538,1.1056293715106904,0.36538461538461536,1.0,1.0,2/12,9.21%,GALT;EXTL2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3757588204470862,1.1054624731387728,0.3103802672147996,1.0,1.0,23/108,17.54%,SFRP2;ATP6AP2;SFRP1;GSKIP;TSC2;FGFR2;DCDC2;CTNND2;TNFAIP3;SULF1;WLS;APP;RACK1;KREMEN1;CBFB;CDC73;DISC1;LRP1;TCF7L1;CTNNBIP1;NKD1;PTK7;GNAQ
prerank,regulation of neutrophil migration (GO:1902622),0.5310361472568912,1.1052137538427342,0.36229749631811486,1.0,1.0,2/10,8.46%,RAC1;JAM3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.415961719704489,1.1051756777424295,0.3445867287543655,1.0,1.0,16/39,22.71%,GPD1L;YWHAH;SCN2B;WNK2;ANK3;SLMAP;FGF12;CAMK2D;PTPN3;FGF14;NETO1;OSR1;SCN1B;HECW2;FGF13;WNK3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.515678883801935,1.1048809702092748,0.3776435045317221,1.0,1.0,2/11,4.16%,SIRT2;FZD3
prerank,blood vessel endothelial cell migration (GO:0043534),0.4489988474767259,1.1044429375804425,0.3527080581241744,1.0,1.0,6/22,13.57%,GPLD1;NRP1;MIA3;EFNB2;ROBO1;EMP2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.41748906855177464,1.1039752076283913,0.3416666666666667,1.0,1.0,13/35,16.93%,WBP2;DDX17;PMEPA1;CALCOCO1;RBFOX2;ZMIZ1;TADA3;NCOA4;EGLN2;DDX5;TRIP4;DAXX;UBR5
prerank,protein ADP-ribosylation (GO:0006471),0.43147209332349484,1.103891376204328,0.3366214549938348,1.0,1.0,10/28,18.69%,SIRT2;PARP1;PARP2;PARP14;PARP16;SIRT5;ZC3HAV1;TNKS;TIPARP;PARP11
prerank,positive regulation of protein phosphorylation (GO:0001934),0.35672868868649116,1.103674443313269,0.208,1.0,1.0,53/348,12.69%,FGF20;SFRP2;FGF9;S1PR2;HDAC3;VTN;TMEM119;IGF1;IL34;DVL2;ARAF;BMP6;NTF3;HSP90AA1;RAC1;CALM3;MAPRE3;ERP29;DDX3X;NRP1;FGF10;CDK9;FLCN;DDR2;KNDC1;FBH1;ABL1;ATG14;RAP2A;WDFY2;ARRB1;LRP8;SOX9;MMD;SDCBP;XRCC6;TEC;EGF;CLIP3;MRNIP;MUSK;JTB;ENPP2;APP;LEPR;ALS2;CNOT9;BMP5;IQGAP1;PARK7;DOCK7;AXIN2;RACK1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4835117769746142,1.1036425130734497,0.3494475138121547,1.0,1.0,4/16,10.88%,LRRC8A;RANBP3L;RIPOR2;IGFBP3
prerank,response to organic cyclic compound (GO:0014070),0.3967403845404319,1.103617694154115,0.3261608154020385,1.0,1.0,4/52,4.31%,CDKN2D;SFRP1;ANXA1;ABCA2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.38048837978464917,1.1035646122846583,0.31851851851851853,1.0,1.0,18/80,17.91%,ARRDC4;HDAC3;UBQLN1;PHF23;STUB1;TBC1D7;MYCBP2;PEF1;XIAP;CDK5RAP3;MALT1;FANCM;UBE2D1;NDFIP2;DERL1;UBE2L3;TOPORS;DCUN1D5
prerank,regulation of lymphocyte proliferation (GO:0050670),0.4855909683079104,1.1035551111581154,0.3499308437067773,1.0,1.0,3/16,13.55%,FGF10;SOX11;PTPN22
prerank,cobalamin metabolic process (GO:0009235),-0.3656767762134826,-1.1034770256205346,0.2968197879858657,0.8506689858941547,1.0,3/17,5.76%,MMAA;ABCC1;TCN2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.36950392211242905,1.1032460960357173,0.3091095189355169,1.0,1.0,18/124,10.55%,SFRP2;WNT5A;SFRP1;DVL2;PSMD4;RAC1;FZD9;FZD3;TCF7L2;PSMB10;DVL1;GNG2;PSMD11;WNT4;AP2S1;PSME2;PSMC5;DAAM1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.4454274597512423,-1.1031239776857373,0.3488372093023256,0.8488640216663043,1.0,4/10,26.68%,SLC8B1;HOMER3;EFHB;CD84
prerank,regulation of phosphate metabolic process (GO:0019220),0.4838830788049932,1.1026577709548515,0.3737931034482759,1.0,1.0,4/16,10.29%,SIRT2;BARD1;CD24;PGAM1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4261255648893639,-1.102597130167293,0.35947712418300654,0.8479022276140685,1.0,6/12,16.92%,KAT7;TIPIN;NBN;WRNIP1;METTL4;BLM
prerank,protein import into peroxisome matrix (GO:0016558),0.5050204364978441,1.1024053025263836,0.3483309143686502,1.0,1.0,6/12,22.02%,PEX1;PEX5;PEX7;PEX13;PEX5L;PEX2
prerank,positive regulation of hormone secretion (GO:0046887),0.4658228122073628,1.1023428035232672,0.36213991769547327,1.0,1.0,5/17,21.27%,EDN3;SOX11;VAMP8;SNX4;VAMP7
prerank,protein import into peroxisome membrane (GO:0045046),0.4508232002103718,1.1020398021738689,0.35621761658031087,1.0,1.0,9/22,16.83%,FIS1;PXMP4;PEX5;PXMP2;GDAP1;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,arachidonic acid metabolic process (GO:0019369),-0.3107675170876135,-1.1013116563567174,0.2867132867132867,0.8490847902475219,1.0,19/35,40.01%,PNPLA8;PTGES3;MGLL;DAGLB;CYP1B1;PTGES;GPX1;TBXAS1;HPGDS;EPHX1;CYP2U1;PLA2G4A;CYP2A6;ALOX12;PLA2G4C;FAAH;PTGES2;CYP2S1;CBR1
prerank,regulation of small molecule metabolic process (GO:0062012),0.4314027545696817,1.1012958034547877,0.35294117647058826,1.0,1.0,9/28,18.70%,PDK1;MLYCD;RORA;EPHX2;ACADL;ACADVL;APOE;NCOR2;TTC39B
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4518855547992577,1.1011697122811115,0.3524904214559387,1.0,1.0,6/22,14.77%,ISCA2;NUBP2;NUBP1;CIAO2A;MMS19;ABCB7
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.354769554110475,1.101134080652154,0.167,1.0,1.0,90/509,15.32%,FSHR;FGF20;MYORG;FGF9;HDAC3;HEXIM1;WNT5A;MST1R;IGF1;SLC35B2;TCIM;BAX;PDPK1;MAP3K14;NTF3;ATP2C1;HSP90AA1;EDAR;RAC1;FGFR2;THEM4;FIS1;FGFR1;DDX3X;EDA2R;FGF10;TIRAP;CARD16;SLC38A9;FLCN;TCF7L2;TMEM106A;DCN;BRD4;PIK3R1;DHX58;GAB1;EPHA8;NOS1AP;RRAGA;DHX33;CHD5;CC2D1A;ADGRV1;TIFA;GPR37;IFI35;TRIM62;SOX9;DDIT3;GPRC5B;FRS2;DHX36;EGF;CDK5RAP3;SOX11;WLS;KL;MALT1;IRS2;PIK3CB;APP;USP15;PIK3R2;BCL2;TFG;MAZ;RPS15;PDGFRA;NFAT5;RTKN2;IQGAP1;PARK7;PLEKHG5;RACK1;LAMTOR5;AKAP13;NRG2;ROR2;TLR3;LPAR1;NRG1;ROCK2;TGFB1;BCLAF1;DNM1L;CBL;F3;PPP5C;NUPR1
prerank,Golgi localization (GO:0051645),0.5190452032028732,1.1006895497745732,0.3538011695906433,1.0,1.0,7/11,22.64%,ARHGAP21;RIPOR1;HOOK3;STK25;UVRAG;TBCCD1;COPG1
prerank,protein lipidation (GO:0006497),0.39005561200727745,1.1002680980609134,0.3263736263736264,1.0,1.0,11/59,11.53%,PIGG;GPLD1;PGAP4;WIPI1;DPM2;PIGM;PIGU;ZDHHC3;GLUL;PIGA;PORCN
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.43794293752151636,1.100263857292112,0.3611111111111111,1.0,1.0,2/29,1.12%,SFRP2;SFRP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.43516093570783687,1.0995718530168332,0.3567901234567901,1.0,1.0,7/28,18.05%,FIS1;MTCL1;MIEF2;DMTN;ANK3;ITGB1BP1;CEMIP
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4151048795654333,1.099420475609273,0.343030303030303,1.0,1.0,8/34,15.77%,WNT5A;SIRT2;RORA;FLCN;ENPP1;RUNX1T1;TGFB1;TRIO
prerank,negative regulation of inflammatory response (GO:0050728),0.3624112870378187,1.0991974496409118,0.2980866062437059,1.0,1.0,14/182,7.34%,FSHR;SMPDL3B;PTGER4;IGF1;SELENOS;ADCY7;ADM;VIPR2;PTHLH;RORA;TNFAIP3;GNG2;CD200R1;SIRPA
prerank,wound healing (GO:0042060),0.3853524010929777,1.0990746801084743,0.3286334056399132,1.0,1.0,20/62,23.69%,MMP12;WNT5A;EPB41L4B;IGF1;FGF10;MIA3;TPM1;PPL;PDGFRA;NRG1;ARL8B;TGFBR1;SMPD1;FGF2;SYT11;MYH9;SMAD3;PAK1;SYT7;PRCP
prerank,regulation of mRNA processing (GO:0050684),0.4218265640937879,1.0989998095635576,0.33212996389891697,1.0,1.0,14/32,19.61%,ZFP36L1;SLTM;RBM39;SRSF3;HNRNPK;TIA1;KHDRBS2;PTCD2;SAFB2;YTHDC1;AHCYL1;SON;SRPK1;CDK11B
prerank,positive regulation of vasoconstriction (GO:0045907),-0.41070331548113287,-1.0986022490601093,0.3333333333333333,0.8548747618070197,1.0,2/13,4.65%,CAV1;ADRA1B
prerank,mRNA stabilization (GO:0048255),0.40488313446692037,1.0985970779025156,0.35046728971962615,1.0,1.0,14/40,21.35%,PAIP1;TIRAP;FUS;PABPC1;GDNF;HNRNPA0;AXIN2;THRAP3;TENT5A;CIRBP;HNRNPU;MAPKAPK2;YBX1;ANGEL2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5210302403385934,1.0985071417872474,0.3556851311953353,1.0,1.0,5/11,16.38%,AUP1;POMT2;VCP;UGGT2;DERL1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3527080350973092,1.0983459811613274,0.115,1.0,1.0,179/834,18.38%,SFRP2;APLN;METTL23;CAMTA2;MMP12;HDAC3;LAGE3;WNT5A;PTPRN;WBP2;HSF2;IGF1;MED24;SP7;DVL2;MPND;FOXM1;SIRT2;GNL3;SIRT7;DDX17;EAPP;CRTC1;NFKB1;SMARCD3;BMP6;PARP1;ZEB2;IL33;USF1;NR2F2;FGFR2;MLXIP;NKX6-1;MED12;MED14;GLIS2;SMAD9;STAT6;NR1D2;GRIN1;HTATIP2;XBP1;ACTR2;RORA;TFDP1;NFKB2;DDX3X;LPIN1;CCNC;OGT;CHD8;POU2F1;RFX5;CDK13;CDK9;FLCN;MRTFA;NPAT;TCF4;TCF7L2;TFCP2;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;DVL1;ZIC3;CASZ1;AKAP8L;ARNT;SMARCB1;TEAD1;HDAC5;MOSPD1;ZBTB38;PID1;MED4;DBP;PRPF6;ARRB1;SLC30A9;SOX9;SMARCD1;GCN1;DDIT3;CRTC3;DPF2;LPIN3;XRCC6;PER1;ECD;DHX36;ATMIN;HDAC4;SOX11;TWIST1;CALCOCO1;NKRF;TCEA1;GDNF;ATF2;SSBP4;BRD8;APP;TAF6;JUP;RBPJ;GLIS1;RFX4;PIK3R2;NFAT5;IRF3;BMP5;YY1;SMARCA1;ZMIZ1;E2F3;NFIX;PARK7;ZNF462;PEG3;NPM1;HDAC1;CEBPG;LPIN2;CREB3;CREB3L4;RPS6KA3;SETX;TLR3;ZBED3;ABHD14B;CDC73;FOXJ3;ATRX;AUTS2;TGFB1;MED21;RGMA;BCLAF1;KMT2D;RFX3;NR2C2;TCF3;SSBP2;FOXC2;THAP3;RPS6KA1;AHI1;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;SERPINE1;TNKS;KDM6B;ITGB1BP1;THRAP3;PHIP;CDK7;OSR1;TNIP1;GABPB1;GABPB2;MEIS2;TBL1XR1;PRKD2;PKD2;RNF111;KMT2A;BCL11B;GPS2
prerank,regulation of innate immune response (GO:0045088),0.39089349656787986,1.0981395974582115,0.3281423804226919,1.0,1.0,10/57,8.14%,FCGR2B;POLR3D;TNFAIP3;TIRAP;IRF1;DHX58;TRAFD1;XIAP;IFI35;LRP8
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5228226939411733,1.0981072078926069,0.38125,1.0,1.0,4/10,14.79%,ERRFI1;MVP;ENPP1;IMPACT
prerank,glycosaminoglycan catabolic process (GO:0006027),0.38787631739080186,1.0969671396513967,0.34509371554575524,1.0,1.0,15/55,19.84%,LYVE1;GLB1;GPC6;DCN;GPC1;HGSNAT;GPC4;OMD;TGFB1;ARSB;LUM;HSPG2;CEMIP;GPC5;GUSB
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4412557281906788,1.0967518243533463,0.3460122699386503,1.0,1.0,4/24,8.54%,EPHA7;BAX;CDK5;DDIT3
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3632499896452547,1.0967148271806353,0.2984771573604061,1.0,1.0,33/151,22.16%,FSHR;PLA2G5;DDT;FGFR2;GLIPR2;NRP1;FGF10;TIRAP;PRKCA;SLC30A10;ARRB1;PRXL2C;ABCA7;APP;PDGFRA;NDRG4;HTR2C;ROR2;PTPN22;TGFB1;ICAM1;SPRY2;APOE;CCL25;PRKD2;PRKCZ;GCNT2;PTK2B;NTRK2;FGF2;MTURN;HMGB1;ERBB4
prerank,potassium ion transmembrane transport (GO:0071805),0.36449385912067067,1.0966641435313629,0.3169230769230769,1.0,1.0,20/135,15.89%,KCNG2;KCNAB2;KCNA4;KCNC1;NALCN;ATP1A3;KCNK2;KCNT2;ATP1A2;KCNC2;KCNJ10;SLC24A4;KCNQ4;KCND3;KCNH5;SLC1A3;KCNA1;KCNQ2;SLC9A7;SLC9A6
prerank,piRNA metabolic process (GO:0034587),-0.3500376789751319,-1.0963637902102281,0.3281853281853282,0.8592394439989248,1.0,19/19,65.04%,TDRKH;MYBL1;TEX15;EXD1;PIWIL2;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,lipid oxidation (GO:0034440),-0.4122570729854984,-1.096015036877685,0.35014836795252224,0.8575720852163067,1.0,3/12,22.13%,ADIPOR1;ADIPOR2;PPARGC1A
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5138980653384854,1.0955558788923374,0.3911764705882353,1.0,1.0,3/11,11.33%,SIRT7;SMARCB1;IPPK
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5069855391252197,1.0951106933682402,0.3622159090909091,1.0,1.0,8/12,24.84%,SIRT7;TGFB1;NUP214;TPR;IFI27;KHDRBS1;UHMK1;PTPN14
prerank,adenine nucleotide transport (GO:0051503),0.4684360486797916,1.095082277407718,0.3522884882108183,1.0,1.0,3/17,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,regulation of muscle contraction (GO:0006937),0.43461520891906463,1.095027651701954,0.3388746803069054,1.0,1.0,6/26,13.93%,TNNC1;TNNI1;ATP1A2;TPM1;CHRM2;KCNA1
prerank,regulation of axon extension (GO:0030516),0.4138975015320389,1.0946256252283333,0.35495283018867924,1.0,1.0,10/37,17.44%,CDKL5;DIP2B;OLFM1;ABL1;DBN1;DBNL;MAPT;SEMA3A;APOE;RUFY3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5087004510434776,1.0943490601069044,0.3709923664122137,1.0,1.0,4/10,24.80%,ZBTB7B;CBFB;HMGB1;RUNX1
prerank,lipid homeostasis (GO:0055088),0.39284998768019297,1.09416200029411,0.3464052287581699,1.0,1.0,11/57,12.73%,USF1;NR1D2;XBP1;DDX3X;ABCA2;TLCD1;RCN3;RBP1;IRS2;ZBTB20;TLCD3B
prerank,regulation of histone methylation (GO:0031060),0.4956295233117607,1.0936795675874054,0.3669985775248933,1.0,1.0,5/13,19.34%,AASS;NNMT;JARID2;NSD1;TET1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.35521392578484506,1.0935006585160674,0.228,1.0,1.0,92/341,18.15%,UBQLN1;MVB12A;CDC23;SIRT2;SPSB3;KCTD5;PSMD4;UBXN2A;RNF8;UBE2S;SPSB1;STUB1;SYVN1;XBP1;MAD2L1;UCHL1;CDC16;RNF215;FZR1;FBXL14;TNFAIP3;OTUD7A;FBXO7;COP1;SQSTM1;ANAPC2;PSMB10;DDB1;FBXO45;RFFL;TGFB1I1;FBXW5;PSMD11;RMND5A;ARRB1;UBA1;DDIT3;TRIM9;UBE3B;RNF40;RNF168;KLHL15;RNF11;VCP;CHFR;PSME2;PSMC5;UBR3;RC3H2;ZNRF3;NTAN1;VPS4B;RNF19A;KCTD2;UBE2A;ANAPC11;USP9X;WDR91;ANAPC4;RNF19B;PCNP;ZFAND2A;CDC26;ANKIB1;RNF122;RNF217;FEM1C;CBL;PSMD1;TRPC4AP;FAF1;UBE2E1;UBE2D1;ZSWIM8;NDFIP2;CLOCK;ARIH2;NEDD8;UBE2L3;PSMD6;FBXO22;SMURF1;TOPORS;USP33;TTC3;MDM2;PPP1R11;PCBP2;TBL1XR1;KLHL20;ANAPC10;RNF111
prerank,regulation of osteoblast differentiation (GO:0045667),0.37651536974643657,1.0930785255133264,0.3177966101694915,1.0,1.0,15/82,9.79%,TMEM119;IGF1;FBN2;BMP6;FGFR2;NELL1;DDR2;FBXO5;SUCO;RANBP3L;WNT4;SOX9;PTCH1;SOX11;TWIST1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.4337945035817101,-1.0928833390084458,0.344311377245509,0.8646128434455822,1.0,5/11,13.21%,PICALM;GPM6B;GOPC;ACTN2;NEDD4L
prerank,intracellular protein transmembrane transport (GO:0065002),0.40765849548258015,1.0927971644169356,0.34183082271147164,1.0,1.0,14/42,22.02%,DNLZ;RTN2;SEC61A2;TOMM20;PEX1;PEX5;PEX7;SEC61G;HSPD1;SEC62;TIMM44;SEC63;TIMM23;PEX2
prerank,regulation of actin nucleation (GO:0051125),0.5057143659637139,1.0926295207616517,0.38639652677279307,1.0,1.0,2/12,3.83%,WHAMM;PICK1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3883913481122695,1.0926005149205449,0.36231884057971014,1.0,1.0,14/52,18.18%,CLN3;EPHB2;PDPK1;ATP2C1;PIK3R1;SQSTM1;CLIP3;RACK1;PRKCI;LRP1;DPP10;SPTBN1;KIF5B;ZDHHC2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3489081180862456,-1.092457277060971,0.3073770491803279,0.8632377712308078,1.0,10/20,20.48%,MICU1;LETM1;SLC8B1;MCU;MCUR1;SPG7;MCUB;MAIP1;SMDT1;STOML2
prerank,regulation of chemokine production (GO:0032642),0.40500543262528305,1.0923289611590472,0.3565426170468187,1.0,1.0,3/36,2.68%,WNT5A;LPL;IL33
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.42723041146707835,1.091718931064089,0.35396039603960394,1.0,1.0,7/27,16.50%,PCYT2;LPIN1;CEPT1;LPIN3;LPIN2;CHKB;SLC27A1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5013773922488979,1.0908543893040936,0.38724035608308605,1.0,1.0,6/12,18.69%,PARP1;PARP2;PARP16;TNKS;TIPARP;PARP11
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.43333003178010954,1.0907564101804568,0.35862913096695226,1.0,1.0,6/26,21.06%,IGF1;CHERP;STIMATE;CAMTA1;PTBP1;ATP2B4
prerank,regulation of cell motility (GO:2000145),0.3621350911006066,1.090539635723123,0.3278520041109969,1.0,1.0,21/121,14.28%,FGF20;FGF9;RAC1;PLXNA2;MGAT3;FBLN1;MINK1;FGF10;ABL1;PLXNA1;EGF;TWIST1;PRAG1;SRCIN1;ENPP2;CFAP20;SPOCK2;NRG2;NRG1;ROCK2;TGFB1
prerank,protein localization to cilium (GO:0061512),0.4246852539188505,1.0904303893133243,0.3691194209891435,1.0,1.0,12/32,20.65%,TUB;TCTN1;SNX10;IFT20;CSNK1D;ATP6V1D;TULP3;TTC21B;INVS;WDR35;RABEP1;EHD1
prerank,cardiac muscle tissue development (GO:0048738),-0.279530360869481,-1.0903616237768992,0.29245283018867924,0.8671497178606434,1.0,13/50,17.79%,SMAD4;GJA1;MAML1;RBP4;SMAD1;BMPR1A;CACNA1G;SGCD;BMP7;TBX18;BMP4;NDUFV2;NOTCH2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4083235492104396,1.090298381549111,0.37023809523809526,1.0,1.0,8/37,13.73%,DNASE1L2;EXOSC7;ENTPD7;DFFB;PABPC4;HNRNPD;MTREX;SND1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4966259095185045,1.0902948469909948,0.363103953147877,1.0,1.0,5/12,24.12%,FBLN1;DMTN;ITGB1BP1;AP1AR;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4966259095185045,1.0902948469909948,0.363103953147877,1.0,1.0,5/12,24.12%,FBLN1;DMTN;ITGB1BP1;AP1AR;CORO1C
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.49400307303530244,1.0899486284401985,0.3888888888888889,1.0,1.0,4/13,15.32%,FCGR2B;EIF2AK3;USP19;NUPR1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4124784219420314,-1.0897228066596836,0.3258426966292135,0.8663021438256514,1.0,4/12,13.23%,MTPN;CFL2;PLEK;PIK3CA
prerank,positive regulation of DNA binding (GO:0043388),0.41439085237753664,1.0895365799395482,0.3759305210918114,1.0,1.0,7/31,14.28%,IGF1;SIRT2;EGF;TWIST1;PARK7;CEBPG;TGFB1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.40471385408074145,1.0894484227091041,0.36495535714285715,1.0,1.0,12/46,15.42%,NRDC;FLCN;PLCL2;ACOT11;STK11;ADAMTS5;DDIT3;LGR4;RBPJ;DOCK7;NOVA1;FOXC2
prerank,DNA duplex unwinding (GO:0032508),-0.27615051525929357,-1.0892776094157874,0.2636363636363636,0.8648996872170253,1.0,20/50,20.55%,RAD23B;GTF2H1;ASCC3;RBX1;CHD1L;CUL4A;RPA1;NBN;PURA;UBB;GTF2H5;GTF2H2;XPC;ERCC3;BLM;SUPV3L1;RECQL;RTEL1;MCM6;WRN
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3772902479888166,1.089211410694215,0.33297872340425533,1.0,1.0,24/78,20.88%,UBQLN1;SIRT2;STUB1;FZR1;ZYG11B;COP1;BBS7;DVL1;VCP;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;MDM2;PIAS1;SUMO2;DAB2;SMAD7
prerank,AMP metabolic process (GO:0046033),0.4990583514375586,1.0889825307878378,0.3791606367583213,1.0,1.0,3/13,13.69%,ADSL;AK4;AK3
prerank,phagosome maturation (GO:0090382),0.40993269972042035,1.0888710200574556,0.36938031591737547,1.0,1.0,13/35,22.41%,ATP6V0A2;RAB34;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;RAB31;ATP6V1B2;RAB7A;ATP6V1C1;PIKFYVE;RAB43
prerank,proteolysis (GO:0006508),0.35571743614129564,1.0886461728812273,0.28,1.0,1.0,45/252,17.64%,MMP12;MMP17;XPNPEP3;CPXM1;CLN3;ATG4A;CUL7;ADAMTS7;CASP7;PCSK5;OGT;SDE2;CAPN10;PCSK2;ANPEP;THOP1;UFSP2;CAPN5;HTRA3;LAP3;ADGRV1;HM13;LRP8;PTCH1;CAPN2;PLAT;MBTPS1;ADAM33;MALT1;AFG3L2;CPXM2;CNDP2;SUFU;METAP2;ADAMTS3;CTSZ;F3;CASP2;CTSH;NEDD8;PSMD6;PARL;CAPN15;MDM2;BMP1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.44183568060695205,1.0884604502524007,0.3719115734720416,1.0,1.0,6/22,13.92%,NTF3;TMEM108;RAPGEF1;MAGI2;WASF1;MAPT
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4113710420948786,-1.0883549073247736,0.3498452012383901,0.8652099997839404,1.0,7/12,30.58%,INPP5K;REST;JUN;PSMC3;HMGA2;TARDBP;TFAP4
prerank,COPII vesicle coating (GO:0048208),0.3856159563441654,1.088046061643229,0.33881578947368424,1.0,1.0,24/61,20.40%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,vesicle coating (GO:0006901),0.3856159563441654,1.088046061643229,0.33881578947368424,1.0,1.0,24/61,20.40%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3856159563441654,1.088046061643229,0.33881578947368424,1.0,1.0,24/61,20.40%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,negative regulation of cell adhesion (GO:0007162),0.3763514749319562,1.087833536740577,0.36542669584245074,1.0,1.0,18/72,16.76%,DACT2;EPHB2;PLXNA2;FBLN1;ADAM22;DMTN;MIA3;RIPOR2;DSCAM;PLXNA1;SPOCK1;JAM3;TGFB1;TBCD;JAG1;SERPINE1;PLXNB3;ITGB1BP1
prerank,protein insertion into ER membrane (GO:0045048),0.41011542201414747,1.0873297221577611,0.3700234192037471,1.0,1.0,13/37,22.54%,EMC1;EMC8;MMGT1;GET1;APP;SERP1;EMC7;SEC61G;ALDH3A2;STX5;EMC4;TRAM2;EMC2
prerank,focal adhesion assembly (GO:0048041),-0.3383967414145003,-1.0872863550912593,0.30917874396135264,0.865885994074022,1.0,7/21,5.56%,SORBS1;FERMT2;PTPRK;TAOK2;CTTN;TESK2;ACTN1
prerank,vasculogenesis (GO:0001570),0.417674119198292,1.0872805433023802,0.378698224852071,1.0,1.0,3/32,2.42%,TNNI3;CUL7;ADM
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.38544413220001666,-1.086940357910592,0.32950191570881227,0.864348220157527,1.0,5/14,16.21%,SMAD4;KMT2E;PAXIP1;WDR5;DNMT1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.43640124165261124,1.0864000381696268,0.37150127226463103,1.0,1.0,6/26,13.22%,CDC23;LCMT1;CDC16;FBXO5;ANAPC11;ANAPC4
prerank,acute inflammatory response (GO:0002526),-0.33669450855028527,-1.0863553954325205,0.32432432432432434,0.8635021885456657,1.0,4/23,7.72%,IL6R;LBP;PLSCR1;ANO6
prerank,positive regulation of MAPK cascade (GO:0043410),0.3549361849900054,1.0862488635145011,0.28815261044176704,1.0,1.0,38/245,14.28%,FSHR;PLA2G5;MST1R;IGF1;IL34;DDT;EDN3;FGFR2;FGFR1;TAOK1;GLIPR2;NRP1;FGF10;TIRAP;PRKCA;TMEM106A;EPHA8;EZH2;SLC30A10;DHX33;CD24;GPR37;ARRB1;PRXL2C;EGF;ABCA7;APP;KLHDC10;PDGFRA;ROBO1;IQGAP1;NDRG4;HTR2C;ROR2;PTPN22;LPAR1;ROCK2;TGFB1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4695904008732699,1.0861499318274945,0.36675461741424803,1.0,1.0,3/18,7.08%,NHP2;CCT8;CCT6A
prerank,positive regulation of DNA recombination (GO:0045911),0.42330249690592303,1.0857876547708862,0.36523929471032746,1.0,1.0,8/27,19.64%,PARP1;ACTR2;FUS;WRAP53;MRNIP;MMS19;HMCES;KMT5B
prerank,synapse assembly (GO:0007416),0.3804824672873943,1.0852372804921442,0.35782747603833864,1.0,1.0,12/67,14.38%,WNT5A;LRRC4;OBSL1;CDK5;DVL1;DSCAM;DBNL;GABRB3;NLGN3;SPOCK2;FARP1;NLGN2
prerank,regulated exocytosis (GO:0045055),0.3565005937255305,1.0851871142505722,0.32961460446247465,1.0,1.0,42/173,21.80%,MAGED2;SYT3;CLEC3B;SYT10;IGF1;APOOL;CHID1;CD63;SERPING1;CDK5;SPARC;DNAJC5;CPLX1;EGF;RAB10;APLP2;SNAP25;APP;BRPF3;VTI1B;SYT1;TMED10;NHLRC2;GTPBP2;PSAP;TGFB1;RAB31;STEAP2;F8;SERPINE1;PHACTR2;CALM1;QSOX1;PROS1;SYT4;LYN;VAMP7;SYT11;SYT12;CD9;SDF4;MYH9
prerank,phagosome acidification (GO:0090383),0.42733950361505413,1.0851558029237527,0.36295369211514394,1.0,1.0,9/26,22.03%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2;RAB7A;ATP6V1C1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.44916726415503877,1.0849409607665792,0.3712021136063408,1.0,1.0,5/20,15.44%,FASN;FAR2;HSD17B4;FAR1;SLC25A1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4221078264490099,-1.0849305830269254,0.3449367088607595,0.8653286349940412,1.0,1/12,3.43%,ZBTB1
prerank,regulation of necroptotic process (GO:0060544),0.4349991546843143,1.0845507248352717,0.36075949367088606,1.0,1.0,5/23,8.75%,HSP90AA1;STUB1;FZD9;OGT;SDCBP
prerank,blood vessel morphogenesis (GO:0048514),0.3891996895169953,1.0845368773428832,0.36129753914988816,1.0,1.0,8/54,10.90%,TNNI3;CUL7;STRA6;ADM;CCBE1;NRP1;EFNB2;RBPJ
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4090108038220255,1.084464954578566,0.36160188457008247,1.0,1.0,7/37,16.06%,AMIGO1;TENM3;IGSF21;IL1RAPL1;ALCAM;TENM4;ICAM1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3973037800736209,1.0837342756375852,0.35722543352601155,1.0,1.0,14/45,18.33%,SIRT7;NFKB1;DIMT1;PIK3R1;BUD23;LIN28B;SETX;TGFB1;MAP2K2;HNRNPLL;DDX5;GRSF1;ZC3H18;RBM22
prerank,regulation of acute inflammatory response (GO:0002673),-0.35956043956043954,-1.0835804724831612,0.316,0.8669637418843162,1.0,15/18,64.07%,PTGES;OSMR;IL6ST;ADAM8;KLKB1;NLRP3;IL4;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B
prerank,membrane organization (GO:0061024),0.35546987026034493,1.0834481529388862,0.30992978936810434,1.0,1.0,50/227,15.44%,WNT5A;CLN3;REEP4;DVL2;A4GALT;DNM1;AZIN2;BIN1;UBXN2A;ATP2C1;DMPK;SYNJ2;ACTR2;PICK1;ARPC1A;SAR1A;GAPVD1;TLCD1;NAPG;VAMP3;PLEKHA3;HGS;MFN2;MOSPD3;ARRB1;ATP10B;FNBP1;EGF;CHMP3;TOR1B;DNAJC6;AP2S1;TMEM43;ANK3;VPS33B;LEMD3;VPS4B;VTI1B;SYT1;SERP1;IGF2R;PRKCI;CHRM2;MTCH1;USO1;DNM1L;STX11;CBL;SPTBN1;VAPB
prerank,tetrapyrrole metabolic process (GO:0033013),-0.35525876319312133,-1.0832902135003113,0.31343283582089554,0.8650628685543029,1.0,3/18,5.76%,MMAA;ABCC1;TCN2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.43009746205154387,1.0832769797208464,0.3753180661577608,1.0,1.0,6/25,12.16%,MVB12A;VTA1;CHMP3;VCP;LEPROT;VPS4B
prerank,regulation of phagocytosis (GO:0050764),0.3901824656552456,1.0826050017448876,0.36579841449603623,1.0,1.0,9/53,16.52%,PLA2G5;FCGR2B;TUB;SIRPA;ABCA7;CD47;RACK1;IL15RA;CAMK1D
prerank,regulation of monocyte chemotaxis (GO:0090025),0.43176712361384134,1.0825879852555005,0.361323155216285,1.0,1.0,9/24,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;LYN;NBL1;CXCL17;HMGB1
prerank,sensory perception (GO:0007600),0.3905856189921387,1.0823306198026703,0.3728620296465222,1.0,1.0,6/45,9.25%,TMEM150C;OPRK1;PCDH15;ADGRV1;GNAS;TTC8
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5162878003525637,1.0821454743291208,0.4006024096385542,1.0,1.0,5/11,20.27%,SFRP1;CSNK1D;NKD1;MLLT3;DAB2
prerank,sodium ion transport (GO:0006814),0.3727871059701069,1.082137808274897,0.34810126582278483,1.0,1.0,15/85,16.34%,SLC4A4;ASIC1;NALCN;SLC6A11;SCN7A;CATSPER3;ATP1A2;SLC24A4;SCN2B;SCN1A;SLC6A8;SLC6A4;SLC6A15;SLC6A12;SLC6A13
prerank,regulation of cilium movement (GO:0003352),-0.43988243241483027,-1.0820802623695946,0.38011695906432746,0.866231598119088,1.0,9/10,52.11%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.42265264126684865,1.0820684991171126,0.35768261964735515,1.0,1.0,8/27,17.10%,NHP2;TOE1;RNASE1;LACTB2;CPSF3;RPP30;XRN1;ZC3H12C
prerank,acylglycerol homeostasis (GO:0055090),0.4528186432009148,1.0819006416801524,0.37866666666666665,1.0,1.0,2/20,3.85%,LPL;RORA
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4830654899721935,1.0817568020971031,0.38082191780821917,1.0,1.0,4/15,9.82%,SELENOS;SYVN1;AUP1;VCP
prerank,mRNA 3'-end processing (GO:0031124),0.372721581700407,1.0817202475870398,0.35927505330490406,1.0,1.0,25/78,19.58%,RPRD2;SLBP;U2AF1;SRSF2;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;CPSF7;PABPC1;APP;CSTF2T;NUDT21;CPSF3;THOC7;CDC73;THOC1;GRSF1;AHCYL1;SRRM1;CPSF6;FIP1L1;MTPAP;CSTF3
prerank,nervous system development (GO:0007399),0.34818758252529386,1.0815443976860997,0.242,1.0,1.0,77/429,16.97%,PCDHA2;DPYSL4;PCDHA11;SH3GL3;MST1R;APLP1;EPHB2;CHERP;NTF3;ZEB2;GBA2;GLIS2;NINJ2;FZD9;SDHA;OBSL1;RAPGEFL1;NELL1;CDK5;IGF2BP2;DHX30;ATXN1;ALDH1A2;HAPLN4;ADAM22;EFNB3;DVL1;ZIC3;CXCR4;KALRN;TEAD1;DSCAM;ADGRV1;SPOCK1;DPF2;VLDLR;HDAC4;DBNL;NDUFS2;JARID2;GDNF;POU6F2;COX7B;GFRA2;RBFOX2;ROBO2;ROBO1;FGF12;MOBP;SOX6;NLGN3;SPOCK2;RPS6KA3;FEZ2;CYP51A1;RBM45;FARP1;CHRM2;LSAMP;LPAR1;NRG1;ZIC2;TGFB1;NLGN2;PPP2R5D;NR2C2;ACVR1B;KCNQ2;TRAK1;AHI1;BTBD3;ITM2B;ADGRA2;TMOD2;JAG1;ALDH3A2;MSI1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3950762255740643,1.081525707358747,0.3777267508610792,1.0,1.0,10/44,16.81%,CDKN2D;DDX3X;CARD16;USP47;XIAP;DNAJB6;LAMTOR5;RPS6KA3;RPS6KA1;DPEP1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3746334307558635,1.0813332865156537,0.36764705882352944,1.0,1.0,22/84,17.95%,WNT5A;GPLD1;ASB5;HSP90AA1;NRDC;FZR1;SNF8;TNFAIP3;DDB1;BARD1;PACSIN3;VCP;SNX33;EGLN2;RNF41;FAF1;NKD1;NSF;TIPARP;APOE;SMURF1;SORL1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.436901693177131,1.0807272737433413,0.3840304182509506,1.0,1.0,6/26,12.71%,ALG6;ST3GAL2;TKT;ALG8;RRM2B;B4GALT5
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3579678760479813,1.0806997944191696,0.3438133874239351,1.0,1.0,41/148,18.99%,HEXIM1;PDPK1;PIP4K2B;CSNK2A2;TAF9B;USP7;BRPF1;TAF4;CDK5;RBBP4;TBP;NUAK1;BARD1;STK11;CHD5;RFFL;EHMT2;MDM4;PRMT5;CDK5RAP3;USP2;TAF6;RPS15;MTA2;BRIP1;HDAC1;RMI1;ATR;EHMT1;PIP4K2A;MRE11;CHEK2;RAD50;TP53RK;DAXX;MDM2;TOP3A;RBBP8;PRKAA1;BANP;PRKAG2
prerank,N-terminal protein amino acid modification (GO:0031365),0.4737800280590736,1.0805203187047672,0.36827195467422097,1.0,1.0,4/14,13.29%,METAP1;NTMT1;METAP1D;METAP2
prerank,zinc ion transport (GO:0006829),0.4411758231010505,1.080446360307061,0.3795336787564767,1.0,1.0,7/21,16.89%,SLC30A10;SLC39A1;SLC30A9;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3634837893883815,1.080445750903025,0.3450413223140496,1.0,1.0,19/107,11.57%,UBQLN1;BAX;SELENOS;EIF2AK3;SYVN1;ERLEC1;ATP2A2;ITPR1;PIK3R1;SEC16A;BRSK2;RCN3;DDIT3;CDK5RAP3;VCP;MBTPS1;PIK3R2;BCL2;USP19
prerank,protein oxidation (GO:0018158),-0.4117449207436926,-1.080405250483416,0.36507936507936506,0.868941005058996,1.0,5/11,30.99%,SUMF1;LOX;PRDX3;CHCHD4;TMX3
prerank,spliceosomal snRNP assembly (GO:0000387),0.4108639591859588,1.080401694191714,0.3960739030023095,1.0,1.0,10/38,14.40%,COIL;SMN1;GEMIN2;PRPF8;SRSF12;PRPF6;PRMT5;SART3;USP4;AAR2
prerank,dopamine metabolic process (GO:0042417),-0.36106706378893816,-1.080353962738482,0.3269230769230769,0.866358713810678,1.0,6/18,27.01%,MAOA;TGFB2;MAOB;GCH1;PRKN;DRD2
prerank,negative regulation of gene expression (GO:0010629),0.34987252399028484,1.0801969119305177,0.289,1.0,1.0,74/302,19.88%,SFRP2;APLN;ILF3;FCGR2B;LSM6;SFRP1;PTGER4;IGF1;PAIP2;ANXA7;NFKB1;AEBP2;EIF2AK3;CREBZF;ERP29;DDX3X;CNOT10;IGF2BP2;RBBP4;FLCN;OLFM1;PHF1;CELF1;EZH2;SFMBT2;WNT4;ATP2B1;EPRS1;RBMS3;DHX36;SOX11;LGR4;NUDT12;PUS7;JARID2;RBL2;APP;ROBO1;EIF4E2;CNOT9;YY1;MALSU1;PARK7;HDAC1;AGO3;RACK1;NPTN;PARP14;DAPK1;PTPN22;MAPT;ROCK2;TGFB1;MAP2K2;MRPL13;DIS3L2;SHQ1;NDFIP2;NUDT16L1;FMR1;TIPARP;APOE;TLE5;PPP1R11;MECP2;MPHOSPH8;NCOR2;PRKAA1;TRIM27;SAMD4B;YTHDF2;RPS3;KLF4;DNMT3A
prerank,steroid biosynthetic process (GO:0006694),0.3799154681863619,1.0801280814457295,0.3631346578366446,1.0,1.0,10/56,13.04%,CYP27A1;CYP7B1;LSS;INSIG1;HSD17B4;MSMO1;SC5D;PRLR;AMACR;CYP51A1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5202468530447639,1.0798969485706527,0.36990595611285265,1.0,1.0,3/10,7.29%,MIA3;CD200R1;RIPOR2
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3654274006352799,-1.0798166397384583,0.35,0.8652730128772551,1.0,5/16,16.21%,SMAD4;BCOR;PAXIP1;WDR5;DNMT1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.39552053615517524,1.0792940385217134,0.3583138173302108,1.0,1.0,16/46,20.87%,DUSP26;EPHB2;FBLN1;FLCN;CNKSR3;SIRPA;WNK2;LMO3;ITGB1BP1;SPRY2;TNIP1;CAMK2N1;SYNJ2BP;RANBP9;LYN;PTPRR
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2786164602622634,-1.0791524056045765,0.2894736842105263,0.8646045940866952,1.0,11/47,7.14%,DAB2IP;EGFR;IGF1R;ARL6IP5;TAOK2;EPHB1;PHLPP1;TGFB2;NBR1;EIF2AK2;LGALS9
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5182927602451911,1.0787086971362836,0.3878437047756874,1.0,1.0,2/10,5.61%,GALNT16;GALNT4
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4970302243326534,1.0783629474061511,0.3938953488372093,1.0,1.0,4/12,9.91%,CLCN2;ABCA2;KPNB1;MBTPS1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4073764605571863,1.0782406576317796,0.3882783882783883,1.0,1.0,3/33,5.06%,IL34;ZFP36L1;PRKCA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.354091646012081,1.0773227189188643,0.3521695257315843,1.0,1.0,59/173,22.69%,SPTBN5;WHAMM;KDELR3;TRAPPC8;SAR1A;ANK1;TEX261;KLHL12;SEC16A;MIA3;TRIP11;SEC16B;PEF1;ERGIC2;DCTN6;LMAN2L;COPZ2;NRBP2;TBC1D20;SCFD1;CAPZA1;PGAP1;DCTN4;TFG;ANK3;DYNC1LI1;GRIA1;VTI1B;TMED10;COG3;NRBP1;TRAPPC6B;USO1;CTSZ;MCFD2;SPTBN1;VAPB;STX17;VTI1A;F8;COG8;NSF;GORASP1;SEC24D;CNIH1;STX5;PROS1;DYNLL1;ZW10;BCAP29;PDCD6;SPTBN4;ATL3;VAMP7;NAPA;ARFGAP3;ACTR10;COPG1;GOSR1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3608723746788158,1.0767380548569134,0.3597497393117831,1.0,1.0,18/107,14.06%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;CXCL12;ATP2A2;SLC30A10;SLC30A9;ATP2B1;SLC24A4;SLC30A1;PTH1R;SLC39A6;HTR2C;NPTN;SLC41A1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4709634085773913,1.076725689732157,0.3994413407821229,1.0,1.0,3/15,3.87%,WHAMM;ACTR2;ARPC1A
prerank,axonal transport of mitochondrion (GO:0019896),0.5154482261158579,1.0766432021226298,0.39642324888226527,1.0,1.0,5/11,22.77%,NEFL;MAPT;TRAK1;ACTR10;OPA1
prerank,regulation of lipid storage (GO:0010883),0.44339071960600984,1.076451505159976,0.38636363636363635,1.0,1.0,2/22,2.19%,LPL;NFKB1
prerank,regulation of neuron differentiation (GO:0045664),0.36683849306035277,1.0763521771385849,0.37124463519313305,1.0,1.0,14/76,10.08%,BIN1;NTF3;FGFR1;TCF4;CASZ1;ZEB1;BRINP3;MMD;GPRC5B;ZFHX2;YWHAH;CDK5RAP3;SOX11;YWHAG
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.228761117448451,-1.0760792943368465,0.23076923076923078,0.8715066919101468,1.0,28/149,10.78%,SLCO3A1;PRKCH;UBE2N;MTPN;IKBKB;CAV1;AR;FER;IRAK2;STAT3;RIPK1;RPS6KA5;PRKD1;IRAK1;NOD1;TRIM25;ERC1;NFKBIA;PSMA6;TLR4;EIF2AK2;LGALS9;EP300;DDRGK1;MAP3K13;UBB;AIM2;IKBKG
prerank,ubiquinone biosynthetic process (GO:0006744),0.47115731797456356,1.0759662539476322,0.3732590529247911,1.0,1.0,2/15,2.22%,COQ6;COQ8B
prerank,presynaptic endocytosis (GO:0140238),0.43065171550315773,1.0758109693993767,0.39575530586766544,1.0,1.0,5/24,14.38%,SYNJ2;CDK5;NLGN3;SYT1;NLGN2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3565530273207568,1.0753964805473006,0.3917525773195876,1.0,1.0,16/121,10.25%,VTN;IGF1;IL34;BMP6;NTF3;NRP1;FGF10;IL31RA;DLG3;ABL1;LRP8;PIBF1;GPRC5B;TEC;SRCIN1;ENPP2
prerank,regulation of protein secretion (GO:0050708),0.3596908000777326,1.0751523275546206,0.3645833333333333,1.0,1.0,21/119,17.24%,CACNA2D2;KCNG2;IGF1;BMP6;PICK1;ERP29;ITPR1;PRKCA;KCNC2;SNAP25;MYH10;TMED10;CYP51A1;UQCC2;TGFB1;DNM1L;RHBDF1;RFX3;CLOCK;APOE;EIPR1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.47969450397253943,1.0751159113508613,0.3884180790960452,1.0,1.0,2/14,7.27%,IGF1;CD200R1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.301177862158112,-1.0741550692358386,0.34057971014492755,0.8747548388452729,1.0,13/35,22.05%,MEF2C;FLT1;CAV1;PTPRM;STAT1;THBS1;AIMP1;CAV2;SCG2;RGCC;NF1;ATOH8;PPARG
prerank,lymphocyte differentiation (GO:0030098),-0.2554928216655547,-1.0740289382247339,0.3026315789473684,0.8724431420655904,1.0,16/68,15.12%,AXL;TOX;KAT7;KIT;KLF6;DCAF1;GPR89B;GPR89A;PLCG2;MSH2;PTPRC;LMBR1L;NHEJ1;TPD52;PTPRJ;ITGA4
prerank,positive regulation of interleukin-6 production (GO:0032755),0.374126705092397,1.073906075236447,0.37486338797814206,1.0,1.0,9/68,13.28%,WNT5A;LPL;IL33;XBP1;TIRAP;TMEM106A;TWIST1;APP;TLR3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.44181319341940123,1.073846434810367,0.37858032378580325,1.0,1.0,1/22,0.80%,WNT5A
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.32438806021894445,-1.0736336003940228,0.29850746268656714,0.8682497212573996,1.0,12/24,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,canonical glycolysis (GO:0061621),-0.32438806021894445,-1.0736336003940228,0.29850746268656714,0.8682497212573996,1.0,12/24,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,regulation of protein localization to cell surface (GO:2000008),0.41196449403819096,1.073314205114039,0.3792697290930506,1.0,1.0,8/33,11.92%,KCNAB2;GPD1L;ABCA2;EGF;ABCA7;LEPROT;SNX33;RIC3
prerank,extracellular transport (GO:0006858),-0.41423233139292104,-1.073294189318967,0.3618421052631579,0.8666718105685063,1.0,11/12,52.40%,TSG101;SPEF2;ARRDC1;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,protein ubiquitination (GO:0016567),0.3474932817105118,1.0732880243087295,0.233,1.0,1.0,138/471,22.23%,ARRDC4;RNF157;CUL7;CDC23;PSMD4;SELENOS;RNF138;FBXW10;ASB5;MSL2;RNF8;UBE2S;SPSB1;STUB1;TRIM7;DTX3;UBE2E2;UBE2QL1;FBXL12;SYVN1;USP7;CDC16;LZTR1;TRIM11;BRAP;FBXL14;PDZRN3;SDE2;FBXO7;FBH1;KLHL12;THOP1;FBXO31;PSMB10;DDB1;BARD1;RTF1;FBXO45;UCHL3;RRAGA;TRIM35;FBXW5;PSMD11;MYCBP2;RMND5A;NFX1;ARRB1;TRIM62;UBA1;UBE3B;RNF40;RNF168;RNF103-CHMP3;UBE2V2;TRIM41;TRIM17;CUL4B;RNF11;VCP;CHFR;UBE2Z;PSME2;PSMC5;UBR3;BCL2;PEX5;RC3H2;ZNRF3;RNF152;RNF19A;RACK1;UBE2A;ANAPC11;USP9X;CBFB;UBE2J1;CDC73;CUL5;RNF19B;PCNP;RNF220;PEX13;ATG3;RNF41;ANKIB1;RNF122;RNF217;CBL;PSMD1;TRPC4AP;KLHL13;UBE2E1;UBE2D1;VPS18;ZSWIM8;DERL1;ARIH2;TNKS;NEDD8;UBE2L3;UBR5;PSMD6;EIPR1;FBXO22;SMURF1;TOPORS;MDM2;FBXO9;KLHL20;RNF111;HLTF;USP22;TRIM27;ZNRF2;RNF167;PELI2;VCPIP1;RNF38;PSMD5;DTX2;FANCL;RAD18;KLHL9;FBXO28;PSMA4;TRIP12;HECW2;CNOT4;COMMD1;PSMA1;TRIM26;PSMC6;UBE2V1;PEX2;TRAF2;CUL9;TAF1;PJA2
prerank,regulation of Golgi organization (GO:1903358),0.46034728380935364,1.0732671148886255,0.39893617021276595,1.0,1.0,8/17,23.46%,CAMSAP2;PDE4DIP;USP6NL;MYO5A;MAP2K2;STX5;EHD3;MAP2K1
prerank,Rap protein signal transduction (GO:0032486),0.5115356605342064,1.073231073244479,0.40801186943620177,1.0,1.0,3/10,9.43%,SGSM3;RAP2A;RAPGEF1
prerank,regulation of striated muscle contraction (GO:0006942),0.4251601441340605,1.0731385954618926,0.3888888888888889,1.0,1.0,8/27,21.79%,TNNI1;CALM3;ATP1A2;GRK2;ASB3;CALM1;SMAD7;CALM2
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.36074380440736736,-1.0727719116925836,0.36101083032490977,0.8658107995465095,1.0,5/18,11.28%,OGA;SAMHD1;DERA;FUCA1;BPGM
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.49887043668845665,1.0726900781311075,0.40649149922720246,1.0,1.0,3/10,14.83%,SOX9;SOX6;SOX5
prerank,positive regulation of immune system process (GO:0002684),0.45989238018256107,1.0726582570127698,0.39705882352941174,1.0,1.0,3/16,10.63%,ANXA1;MIA3;PIK3CB
prerank,epithelial tube morphogenesis (GO:0060562),-0.29103476117818894,-1.0725066929089682,0.3469387755102041,0.8639816816103033,1.0,11/32,16.72%,MEF2C;SLIT2;ACVR1;COL4A1;RHOB;PRKX;RASIP1;BMP4;HES1;MET;PODXL
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.46053688725910297,1.0718838064168852,0.40852819807427787,1.0,1.0,4/17,8.02%,CASK;FSTL1;SULF1;XIAP
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4187393934352923,1.0718647506337058,0.38471177944862156,1.0,1.0,4/28,9.15%,DLK1;TCIM;ARRB1;EGF
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3738766218635562,-1.0713440202285767,0.34057971014492755,0.8649493456961823,1.0,4/15,15.99%,PRKCH;MED1;SFRP4;BMP4
prerank,mRNA transport (GO:0051028),0.36319297729924904,1.0712850522035104,0.36468129571577845,1.0,1.0,37/101,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;ZFP36L1;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;KIF5C;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;FMR1;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,cellular response to acid chemical (GO:0071229),0.4167266613607566,1.0712199438393974,0.3853779429987608,1.0,1.0,7/27,14.46%,CPEB1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,regulation of vasculature development (GO:1901342),0.42950034940115567,1.0711906476266158,0.39223057644110276,1.0,1.0,3/26,3.79%,SFRP1;WARS1;HTATIP2
prerank,Golgi to endosome transport (GO:0006895),-0.38587515471813366,-1.0710409379079695,0.34108527131782945,0.8632917942233568,1.0,7/16,16.65%,GBF1;VPS13A;RAB14;VPS13C;EPS15;KIF16B;SORT1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3673857443968431,1.0708176519572234,0.38195173137460653,1.0,1.0,29/87,21.59%,DUSP26;FOXM1;EPHB2;UCHL1;FBLN1;FLCN;CNKSR3;SIRPA;CDK5RAP3;ABCA7;WNK2;PIK3CB;PIK3R2;DAG1;LMO3;ITGB1BP1;SPRY2;APOE;TNIP1;CAMK2N1;SORL1;SYNJ2BP;SMPD1;RANBP9;PRDM15;LYN;IGBP1;PTPRR;FOXO1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3546600354868743,-1.070576899372549,0.3157894736842105,0.8621330378570894,1.0,6/16,11.38%,GBF1;TAPT1;VAPA;LRRK2;DDRGK1;GABARAPL2
prerank,calcium import into the mitochondrion (GO:0036444),-0.43488932244139133,-1.070214335933778,0.38170347003154576,0.8607162706466023,1.0,6/10,20.10%,MICU1;MCU;MCUR1;MCUB;MAIP1;SMDT1
prerank,organophosphate biosynthetic process (GO:0090407),0.40339892642597824,1.0700200972739082,0.3919239904988123,1.0,1.0,15/37,23.07%,MOCS2;PCYT2;AGPAT5;TKT;AGPAT3;GPAM;FADS1;IPPK;IPMK;IP6K1;PIP5K1A;MOCS1;FGF2;TPI1;GNPAT
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.36952867412368984,-1.0699949624255995,0.3657587548638132,0.8588057342650811,1.0,4/17,10.39%,CD46;STAT3;TLR4;MSH2
prerank,regulation of neuroblast proliferation (GO:1902692),0.4794515119690588,1.0698578711894782,0.40252454417952316,1.0,1.0,3/15,13.59%,SMARCD3;FZD3;DISC1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4276266976262923,1.069384373760079,0.3843236409608091,1.0,1.0,3/25,5.76%,BAX;PPIF;FAM162A
prerank,response to ATP (GO:0033198),-0.35607929814525763,-1.0692688843481424,0.41245136186770426,0.8586526317543994,1.0,6/18,19.02%,HSP90B1;TRPC3;ABCC9;P2RX7;P2RY12;DGKQ
prerank,chromatin organization (GO:0006325),0.35750505417527495,1.0690270158351332,0.3475609756097561,1.0,1.0,35/132,17.49%,HDAC3;KDM4D;MPND;SMARCD3;FAM50A;SMARCC2;GATAD1;SNAI1;RBBP4;PHF1;SETD7;EZH2;SMARCB1;HDAC5;SOX9;SMARCD1;HDAC4;JARID2;TOP1;SUV39H1;SMARCA1;MTA2;NPM1;HDAC1;EHMT1;ATRX;BAZ2B;CHD1;NUCKS1;SATB1;TCF7L1;KDM6B;DAXX;HP1BP3;PWWP3A
prerank,regulation of viral transcription (GO:0046782),0.3982402369673056,1.0689870465372802,0.3818393480791618,1.0,1.0,6/39,8.18%,HEXIM1;TARBP2;TRIM11;POLR2B;CDK9;TRIM62
prerank,aminoglycan catabolic process (GO:0006026),0.42112850953278624,1.0688029170433893,0.3938618925831202,1.0,1.0,8/28,19.84%,GLB1;GPC6;GPC1;HGSNAT;GPC4;HSPG2;GPC5;GUSB
prerank,covalent chromatin modification (GO:0016569),0.47464769772220794,1.0684049883855842,0.39777468706536856,1.0,1.0,6/14,19.44%,SIRT7;PARP2;PARK7;HDAC1;CHD1;SETD5
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.41542140837086106,1.068379820440824,0.398505603985056,1.0,1.0,9/30,16.70%,DDX3X;TNFAIP3;TMBIM1;RFFL;BMP5;PARK7;ICAM1;SERPINE1;FAIM2
prerank,RNA splicing (GO:0008380),0.36315141745532153,1.0680148408790162,0.3761658031088083,1.0,1.0,27/95,19.19%,KHSRP;LSM6;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;DHX15;USB1;SF3B2;SF3B1;DHX8;FUS;MPHOSPH10;PRPF6;PPP1R9B;DHX16;HNRNPH3;TRA2B;NOVA1;RP9;SRRM1;LUC7L3;SRPK1;NONO;BCAS2;RSRC1
prerank,erythrocyte differentiation (GO:0030218),-0.2843413771307033,-1.0680137323046452,0.2878787878787879,0.8598296016998315,1.0,16/44,24.13%,HIPK2;MFHAS1;MED1;KMT2E;KIT;UBA5;RPS19;UFL1;ABCB10;IKZF1;SH2B3;VEGFA;CASP3;RPS14;NCKAP1L;INHBA
prerank,protein transport (GO:0015031),0.34604751367639314,1.06799930040203,0.3083083083083083,1.0,1.0,85/332,18.52%,ARRDC4;IL10RA;ARL4C;ATP6V0A2;SGSM3;PICK1;ERP29;KIF3A;SAR1A;RUNDC1;RAB24;DNAJC27;RAB34;TBC1D13;NAPG;STX6;TVP23B;SNX6;MIA3;VPS26B;ATP6V0E2;STX16;RAB12;RCN3;STX2;LMAN2L;RAB5B;YWHAH;VLDLR;CHMP3;RAB10;COPZ2;ARL5B;RABGAP1L;WLS;SCFD1;RAB3B;ATP6V1G1;USP6NL;ANK3;TCIRG1;AP3B1;EVI5L;SNX33;VPS33B;TLK1;TANGO2;MON1A;NPM1;ATP6V0A4;TMED10;RAB13;SCAMP5;LRP1;RABGAP1;ATP6V1D;VMP1;USO1;SCAMP1;AP4M1;STX11;RAB31;SPTBN1;STX8;STX17;RAB8A;RAB8B;GGA2;TXNIP;ATP6V1B2;RUFY1;NSF;SYNRG;RAB21;APOE;MTTP;TBC1D9B;SNX4;TBC1D22B;ZDHHC17;LRP1B;NECAB3;RAB6A;SGSM2;TOM1
prerank,nucleotide catabolic process (GO:0009166),-0.3599440271375928,-1.0676134262899748,0.34375,0.8585269194727833,1.0,9/16,30.67%,NT5C2;SAMHD1;DERA;NT5E;ITPA;GPX1;PNP;GDA;NT5C
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.33542661590884154,-1.0675758607080608,0.37551020408163266,0.8561329693768179,1.0,10/22,16.11%,RAD23B;GTF2H1;RBX1;CHD1L;CUL4A;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5094899647450114,1.0675292024605443,0.4057315233785822,1.0,1.0,3/10,10.95%,GPLD1;IRS2;PTH1R
prerank,inorganic cation transmembrane transport (GO:0098662),0.3477428181571221,1.0675279766285337,0.33,1.0,1.0,44/268,16.34%,KCNG2;SLC4A4;KCNAB2;KCNA4;KCNC1;ASIC1;NALCN;SLC24A5;ATP2C1;ATP1A3;SLC6A11;ATP2A2;KCNK2;SCN7A;SLC30A10;ATP6V0E2;ATP1A2;KCNC2;SLC39A1;KCNJ10;SLC24A4;TRPM3;SCN2B;KCNQ4;SLC30A1;SCN1A;SLC6A8;SLC39A6;KCND3;ATP6V0A4;KCNH5;SLC6A4;SLC1A3;KCNA1;SLC41A1;SLC6A15;SLC30A3;ABCB7;TRPC4AP;SLC6A12;KCNQ2;SLC9A7;SLC9A6;SLC6A13
prerank,anterograde axonal transport (GO:0008089),0.40638631839590045,1.0674963596682765,0.3793103448275862,1.0,1.0,11/37,17.51%,NEFL;KIF3A;AP3B1;KIF5C;BLOC1S2;MAPK8IP3;TRAK1;DLG2;RAB21;KIF5B;AP3B2
prerank,platelet degranulation (GO:0002576),0.35426418010135835,1.0674359757914442,0.3824130879345603,1.0,1.0,17/118,14.28%,MAGED2;CLEC3B;IGF1;APOOL;CHID1;CD63;SERPING1;SPARC;EGF;APLP2;APP;BRPF3;VTI1B;NHLRC2;GTPBP2;PSAP;TGFB1
prerank,central nervous system neuron differentiation (GO:0021953),0.4098410597853035,1.0673012744907273,0.3775633293124246,1.0,1.0,12/33,23.00%,GBA2;KNDC1;CHD5;SPOCK1;MAPT;FAIM2;SOX4;AGTPBP1;MDGA2;NTRK2;RYK;MAP2
prerank,positive regulation of cell population proliferation (GO:0008284),0.3445586394307388,1.0672239477843586,0.281,1.0,1.0,62/423,14.28%,FGF20;SFRP2;FGF9;S1PR2;WNT5A;TMEM119;SFRP1;MST1R;IGF1;IL34;FOXM1;EAPP;TBRG4;BMP6;NTF3;EDN3;TSPAN31;FGFR2;FGFR1;PTHLH;XBP1;SLC25A33;FZD9;CDC123;FGF10;IL31RA;CDK13;LAMC1;DDR2;TCF7L2;CNBP;FBXO5;EZH2;PID1;SOX9;SDCBP;EFNB2;EGF;HDAC4;SOX11;GDNF;PRLR;IRS2;COX17;RBPJ;BCL2;TCIRG1;MAZ;PDGFRA;RTKN2;BMP5;CD47;NPM1;HDAC1;UBE2A;PRMT1;LAMB1;PRKCI;EMP2;FAM98A;NRG1;TGFB1
prerank,positive regulation of viral genome replication (GO:0045070),0.41121957867250003,1.066740082483329,0.3907203907203907,1.0,1.0,5/29,9.95%,TARBP2;DDX3X;DDB1;PPIH;PABPC1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4500560851838517,1.0666744441336555,0.38026315789473686,1.0,1.0,8/19,21.48%,CEP97;DRG1;CHMP3;VPS4B;EML3;HNRNPU;TPR;CHMP4B
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4905908189269385,1.0661836675368552,0.43162393162393164,1.0,1.0,4/13,11.92%,GPD1L;ABCA7;SNX33;RIC3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4784367647125819,1.0660687072067125,0.3899018232819074,1.0,1.0,3/14,8.79%,SCRIB;RAP2A;PATJ
prerank,phospholipid translocation (GO:0045332),-0.3144576972781759,-1.0659345564887919,0.36231884057971014,0.8588589688435608,1.0,10/28,13.16%,ATP8B1;ATP10A;ABCC1;PLSCR2;ABCA4;TMEM30A;PLSCR1;ANO6;ATP11C;ATP11A
prerank,regulation of synapse assembly (GO:0051963),0.39428228999630704,1.0658457295350243,0.39953271028037385,1.0,1.0,15/46,19.44%,EPHB2;GPC6;MUSK;CLSTN2;APP;ROBO2;IL1RAPL1;NLGN3;GPC4;NLGN2;SLIT1;IL1RAP;SLITRK1;CLSTN3;SETD5
prerank,inhibitory synapse assembly (GO:1904862),0.4995754401502671,1.0656827722992641,0.41184971098265893,1.0,1.0,2/11,9.74%,WNT5A;GABRB3
prerank,glial cell development (GO:0021782),0.42277120852146144,1.0655930775168063,0.3980222496909765,1.0,1.0,7/25,19.15%,MYRF;PICK1;SOX11;APP;TPPP;MXRA8;SOX4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.33940824933213964,-1.0652238274763588,0.33587786259541985,0.8586182477363155,1.0,4/20,7.06%,PRKCE;LBP;IRAK1;TLR4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.37040474569543436,1.0649752426142507,0.39786096256684494,1.0,1.0,14/70,11.01%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,alcohol catabolic process (GO:0046164),0.5089517854708667,1.0649032815310289,0.4090909090909091,1.0,1.0,1/10,1.82%,CYP27A1
prerank,regulation of T cell activation (GO:0050863),0.38974255753113585,1.0646063460189936,0.3876146788990826,1.0,1.0,7/42,15.53%,PRELID1;ABL1;THY1;SIRPA;CD47;PTPN22;HSPD1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.2648802846004567,-1.0646049105651778,0.330188679245283,0.8580115706088782,1.0,22/54,22.62%,MEF2C;ANGPT1;NUS1;SIRT1;PRKD1;HIF1A;TMSB4X;NOS3;THBS1;KDR;AKT3;PLCG1;ANGPT2;RGCC;HSPB1;VEGFA;NF1;ATP5F1B;AKT1;PPARG;GATA2;STAT5A
prerank,glycerophospholipid catabolic process (GO:0046475),0.42167732091602095,1.0645039169134625,0.39039408866995073,1.0,1.0,8/27,20.14%,PLA2G5;PRDX6;GDPD3;ENPP2;SMPD4;GDE1;PLA2G7;ABHD16A
prerank,regulation of response to biotic stimulus (GO:0002831),0.4221463738985336,1.0643384959404738,0.40025575447570333,1.0,1.0,6/28,8.14%,FCGR2B;TIRAP;IRF1;DHX58;XIAP;LRP8
prerank,response to hydroxyurea (GO:0072710),-0.41290383750725357,-1.0639770596600537,0.35331230283911674,0.8574211715735639,1.0,5/11,16.92%,KAT7;SPIDR;DDI2;RTF2;BLM
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4189070488489476,1.063959791164413,0.4082624544349939,1.0,1.0,11/31,19.89%,ANK1;SCRIB;MTCL1;DLG3;RAP2A;PRKCI;DLG2;PARD3B;ERBIN;SYNJ2BP;MYO9A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.46514277883981986,1.0639003428797145,0.4042253521126761,1.0,1.0,4/15,11.29%,FGFR2;NIPBL;TWIST1;PDGFRA
prerank,ion homeostasis (GO:0050801),0.41483830161624136,1.0634680743982936,0.41075794621026895,1.0,1.0,2/30,0.31%,SLC4A4;SLC4A5
prerank,cell differentiation in hindbrain (GO:0021533),0.5092797857142539,1.06299785526643,0.41353383458646614,1.0,1.0,3/11,19.22%,KNDC1;FAIM2;AGTPBP1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3025441572974311,-1.0628976385982607,0.3393939393939394,0.8582601818881245,1.0,16/33,24.89%,LATS1;AR;KDM4C;UBA5;CALR;RNF6;EP300;DDRGK1;AXIN1;ESR1;UFL1;KCTD6;KLK2;UFM1;NCOA2;HDAC6
prerank,autophagosome assembly (GO:0000045),0.3814546065285208,1.0627019119286254,0.39373601789709173,1.0,1.0,21/52,22.68%,UBQLN1;UBXN2A;TRAPPC8;WIPI1;ATP2A2;ATG14;MFN2;ATG2A;ATG13;ATG3;MAP1LC3B;VMP1;STX17;PIK3C3;SMURF1;ATG9A;AMBRA1;RAB7A;ATG16L2;RAB43;WIPI2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3478175840179307,1.0625524408515337,0.337361530715005,1.0,1.0,47/214,20.87%,FSHR;PLA2G5;DUSP26;DDT;EPHA7;EPHB2;FGFR2;GLIPR2;FBLN1;NRP1;FGF10;TIRAP;PRKCA;FLCN;SLC30A10;CNKSR3;SIRPA;ARRB1;PRXL2C;ABCA7;WNK2;APP;PDGFRA;NDRG4;HTR2C;ROR2;PTPN22;TGFB1;LMO3;ICAM1;ITGB1BP1;SPRY2;APOE;TNIP1;CAMK2N1;ZDHHC17;CCL25;PRKD2;SYNJ2BP;RANBP9;PRKCZ;GCNT2;LYN;PTK2B;TGFBR3;NTRK2;PTPRR
prerank,protein localization to chromatin (GO:0071168),-0.36106660192376794,-1.0625514768422322,0.3436293436293436,0.8568744791199494,1.0,3/18,1.11%,WAPL;TASOR;PPHLN1
prerank,cAMP biosynthetic process (GO:0006171),0.5071985673759353,1.062485683024261,0.422680412371134,1.0,1.0,3/10,16.59%,ADCY7;ADCY1;ADCY5
prerank,phospholipid transport (GO:0015914),-0.27392165052059214,-1.0617141064308113,0.30973451327433627,0.8569334655738483,1.0,11/52,8.39%,ATP8B1;ATP10A;OSBPL2;PITPNA;ABCC1;ABCA4;PITPNC1;TMEM30A;SCARB1;SCP2;OSBPL5
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.4957318604067286,1.0616013145135983,0.41389728096676737,1.0,1.0,11/11,50.46%,MALT1;PRKCQ;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;NFKBID
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.5196252066872215,1.0615633518576921,0.38552437223042835,1.0,1.0,3/10,7.40%,CCT8;CCT6A;WRAP53
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3680830234411922,1.061499304434401,0.3833157338965153,1.0,1.0,29/76,24.35%,SIRT2;STUB1;ZYG11B;COP1;BBS7;DVL1;CDK5RAP3;VCP;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;SMURF1;MDM2;PIAS1;SUMO2;DAB2;SMAD7;TAF1;KEAP1;PTEN;FBXW7;TRIB2
prerank,positive regulation of exocytosis (GO:0045921),0.40572817157513585,1.0613321303210814,0.38372093023255816,1.0,1.0,6/35,12.16%,UNC13D;SNF8;HGS;SDCBP;RAB2B;VPS4B
prerank,cardiac muscle cell contraction (GO:0086003),-0.3433075677725193,-1.0609203211897562,0.35269709543568467,0.8568032057941523,1.0,7/19,13.23%,CACNA1D;CACNA2D1;ATP1A1;KCNJ2;CACNA1C;CACNA1G;PIK3CA
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3984354007111137,1.0604800165750243,0.40736342042755347,1.0,1.0,7/37,12.24%,APLN;FGF9;IGF1;MFN2;TAFA5;TPM1;SOD2
prerank,cell cycle checkpoint signaling (GO:0000075),0.4982252131924792,1.0602280247875309,0.4060693641618497,1.0,1.0,5/12,19.74%,WEE1;CHFR;ZWINT;NABP2;ZW10
prerank,positive regulation of response to wounding (GO:1903036),0.43306369467509465,1.060208817829066,0.3934010152284264,1.0,1.0,3/24,6.44%,VTN;ANXA1;DMTN
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.41772150768483385,1.0601538953883376,0.4027603513174404,1.0,1.0,4/27,11.29%,WNT5A;IGF1;DDR2;PDGFRA
prerank,regulation of tissue remodeling (GO:0034103),0.44946190044279427,1.059935002777072,0.4103967168262654,1.0,1.0,7/18,24.80%,DDR2;SUCO;LEPR;TGFB1;IL18;SYT7;RUNX1
prerank,receptor catabolic process (GO:0032801),0.42650595443850287,1.0599017951520735,0.4129032258064516,1.0,1.0,12/24,24.74%,MVB12A;VLDLR;AP2S1;ZNRF3;TGFB1;SMURF1;GPRASP1;PIK3R4;UVRAG;SH3GLB1;MYLIP;RNF43
prerank,copper ion transport (GO:0006825),0.4975686389334164,1.0597893855614218,0.42296511627906974,1.0,1.0,6/11,23.36%,COX17;STEAP2;SLC11A2;ATOX1;STEAP3;SLC31A1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3727962400917253,1.05942291504615,0.39087947882736157,1.0,1.0,20/66,22.07%,SFRP2;SFRP1;NR2F2;FGFR2;CASK;SULF1;MAGED1;SPARC;SOX9;ROBO1;CDC73;TGFB1;NUPR1;APOE;SYNJ2BP;KRIT1;MTSS1;TGFBR3;PEX2;B2M
prerank,import into nucleus (GO:0051170),0.3703645511749768,1.0591555047178964,0.4150743099787686,1.0,1.0,22/73,21.10%,MMP12;TSC2;SMN1;NXT2;NXT1;GEMIN2;HTATIP2;KPNB1;NUP188;BACH2;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;NUP153;PPP1R10;GEMIN5;HEATR3;TPR;APPL2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3639564031060196,1.0590247726559214,0.39316239316239315,1.0,1.0,5/78,3.12%,PSRC1;CDKN2D;HEXIM1;NR2F2;MAPRE3
prerank,maturation of SSU-rRNA (GO:0030490),-0.2946741975444534,-1.0588180443595432,0.3767123287671233,0.8608961746315438,1.0,17/34,24.91%,RIOK3;RIOK2;NOL11;RPS19;RPS16;RPS28;HEATR1;NAT10;NOB1;NGDN;NOP14;WDR3;RRP36;SNU13;RPS14;TSR2;UTP3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.41090398372744513,-1.058805927130979,0.41522491349480967,0.8584607273642852,1.0,6/11,41.67%,MAVS;TICAM1;TYROBP;ITGB2;SPI1;ITGAM
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3674914461652731,1.0587909613585673,0.4036208732694356,1.0,1.0,14/71,11.01%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3993015352251589,-1.0581289374405205,0.38636363636363635,0.8581305690814222,1.0,4/12,10.73%,ELF1;ELF2;RC3H1;PTPRC
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.35645909364455003,1.0579456415235038,0.3888888888888889,1.0,1.0,28/95,20.88%,ADAMTSL2;PDPK1;ZEB2;STUB1;DKK3;PMEPA1;FLCN;SNX6;STK11;HTRA3;TGFB1I1;SDCBP;SOX11;LEMD3;PEG10;TGFB1;SMAD6;VASN;MTMR4;SNW1;SPRY2;SMURF1;RNF111;TGFBR1;PPM1A;DAB2;TGFBR3;SMAD7
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2987288060745281,-1.0576143251747268,0.37142857142857144,0.8573229581200646,1.0,16/29,30.78%,CAV1;RIPK1;PML;THBS1;TNFSF10;CYLD;PPP2R1B;LTBR;TNFSF12;BCL10;INHBA;RET;BID;PAK2;DEDD2;GPER1
prerank,regulation of neuron migration (GO:2001222),0.4216656298474433,1.057436327846566,0.41379310344827586,1.0,1.0,7/26,18.75%,CAMK2B;NIPBL;SRGAP2;NTNG2;ADGRG1;SEMA3A;KIF20B
prerank,positive regulation of microtubule polymerization (GO:0031116),0.42175739980774773,1.0571092805927187,0.40443896424167697,1.0,1.0,8/28,19.43%,PSRC1;RAC1;DRG1;GIT1;MAPT;NUMA1;MECP2;RPS3
prerank,protein processing (GO:0016485),0.35653777226816236,1.0570597514104894,0.38809034907597534,1.0,1.0,20/102,17.63%,XPNPEP3;CPXM1;CLN3;MYRF;PCSK5;OGT;SDE2;PCSK2;HM13;PTCH1;AFG3L2;CPXM2;PRSS12;METAP2;ADAMTS3;F3;CASP2;CTSH;PARL;OMA1
prerank,glycerolipid metabolic process (GO:0046486),-0.3987414391624464,-1.0570225697464084,0.3667711598746082,0.8567651293773236,1.0,6/11,28.66%,DGKB;DGKZ;DGKG;DGKQ;PLA2G15;PGP
prerank,protein localization to cell surface (GO:0034394),0.4106688088442509,1.0568216406194786,0.4246575342465753,1.0,1.0,10/26,17.32%,FGF10;PIGU;JAM3;RIC3;FBLN5;PIGK;EMP2;USP4;GGA2;SMURF1
prerank,regulation of RNA splicing (GO:0043484),0.36902508637223314,1.0568083425945871,0.40261153427638735,1.0,1.0,30/69,23.97%,AFF2;FAM50A;RBM39;PIK3R1;SRSF3;CELF1;HNRNPK;FUS;TIA1;KHDRBS2;HNRNPH3;SETX;HNRNPL;TRA2B;HNRNPLL;GRSF1;AHNAK;YTHDC1;CLK4;SON;RBM22;SRPK1;BRDT;PTBP1;CLK2;U2AF2;RRP1B;KHDRBS1;SNRNP70;CLK1
prerank,response to UV-B (GO:0010224),0.49181299808579465,1.055764417460828,0.4171511627906977,1.0,1.0,2/12,6.84%,MFAP4;STK11
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2421246631366614,-1.0553197684434223,0.3466666666666667,0.8595034592600932,1.0,24/75,27.40%,SLC12A7;ATP1B3;SLC9A2;SLC39A14;CACNA2D1;ATP1A1;KCNJ2;SLC24A2;ABCC9;SLC39A8;ATP1B1;SLC39A12;SLC12A4;SLC12A9;SLC39A10;SLC12A2;KCNJ3;KCNK9;HCN2;TRPV2;SLC12A8;KCNJ12;SLC12A6;TRPV4
prerank,regulation of monocyte differentiation (GO:0045655),0.47250462602257903,1.0552488736570658,0.41274238227146814,1.0,1.0,2/14,4.02%,IL34;ZFP36L1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.2933054787047043,-1.0550300120727625,0.375886524822695,0.8579859065829994,1.0,16/34,24.25%,FLT1;DAB2IP;ERN1;NUS1;PRKD1;SEMA6A;MT1G;RAMP2;KDR;PIK3CA;VEGFC;HSPB1;VEGFA;NR4A1;VEGFB;PGF
prerank,positive regulation of kinase activity (GO:0033674),0.3547014079268161,1.0550213182791772,0.39384615384615385,1.0,1.0,24/107,17.15%,MST1R;EPHA7;EPHB2;FGFR2;MAPRE3;FGFR1;DDR1;DDR2;EPHA8;MMD;XRCC6;EPHA10;MRNIP;MUSK;JTB;PDGFRA;ALS2;IQGAP1;ROR2;MAPT;MRE11;RAD50;DAXX;EPHA5
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4212547021767474,1.0545708198272015,0.417201540436457,1.0,1.0,5/25,10.71%,RAC1;ABCA2;LRPAP1;SDCBP;APP
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.35288731093671405,1.0541106716532165,0.4010204081632653,1.0,1.0,42/124,23.00%,IQCG;STMN4;RAC1;GPRIN1;CDK5;EPHA8;TMEM108;TTC17;CYFIP1;PPP1R9B;GDNF;APP;TPM1;LRP12;BLOC1S2;BICDL1;DOCK7;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;CNTNAP2;ARMC2;APOE;MAP4;PKD2;ATCAY;ODF2;PLEKHA1;KIFAP3;CARMIL1;ATXN10;LIMA1;LYN;ATP1B2;EHD1;RYK;HMGB1;CAMSAP1;FAM161A;MAP2
prerank,positive regulation of synaptic transmission (GO:0050806),0.36762736740090707,1.0536215096763188,0.39744952178533477,1.0,1.0,21/72,20.58%,MPP2;EPHB2;CACNG3;SQSTM1;ZDHHC3;GRIN2A;NMU;CLSTN2;APP;NLGN3;SYT1;NPTN;NLGN2;ADCY1;CACNG4;FMR1;ZDHHC2;CLSTN3;FLOT1;PRKCZ;PTK2B
prerank,excitatory postsynaptic potential (GO:0060079),0.442776229366122,1.053536461643146,0.4106910039113429,1.0,1.0,3/19,8.22%,MPP2;GRIN1;GRIN2A
prerank,lipid transport (GO:0006869),-0.23923663392475408,-1.0532602419546624,0.3055555555555556,0.8610408165140336,1.0,17/97,9.63%,SLCO3A1;ABCC4;ATP8B1;OSBPL2;PITPNA;SLC25A17;CERT1;LBP;SLCO1C1;ABCA4;PITPNC1;SLCO2A1;SCARB1;GOT2;SCP2;OSBPL5;PPARD
prerank,ganglioside biosynthetic process (GO:0001574),0.46574088790114054,1.053052716864276,0.43091655266757867,1.0,1.0,5/15,14.34%,ST8SIA3;ST3GAL2;ST3GAL5;B4GALT5;ST6GALNAC6
prerank,dendritic spine organization (GO:0097061),0.41901020375470177,1.052941968849305,0.409261576971214,1.0,1.0,4/26,6.37%,EPHB2;PICK1;CTNND2;PAK3
prerank,monocarboxylic acid catabolic process (GO:0072329),0.43296352994962023,1.0528730804477093,0.40764331210191085,1.0,1.0,5/21,14.99%,LPIN1;LPIN3;LPIN2;CYP26B1;FAH
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3091026575265006,-1.0526944029507908,0.3392857142857143,0.8603376453446885,1.0,17/30,23.49%,WAC;FHIT;RPL11;HSP90AB1;UCHL5;STYX;CAMLG;DDRGK1;TRIM39;MAP1A;GIPC1;SGTA;CCAR2;BAG6;UBXN1;NOP53;SVIP
prerank,regulation of viral genome replication (GO:0045069),0.3713881494362829,1.052491674899973,0.412348401323043,1.0,1.0,12/56,18.52%,ILF3;TARBP2;DDX3X;DDB1;PPIH;PABPC1;SHFL;VAPB;ZC3HAV1;OAS2;TNIP1;SRPK1
prerank,positive regulation of GTPase activity (GO:0043547),0.34604444845455823,1.052405476745277,0.3881644934804413,1.0,1.0,36/188,14.05%,SFRP1;MTSS2;NTF3;CDKL5;SLC27A4;TBC1D7;SGSM3;RUNDC1;RAP1GDS1;RGS10;ARHGEF10;TBC1D13;SCRIB;FLCN;SYDE2;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RAP1GAP;ARHGAP42;DOCK8;RAP1GAP2;RAPGEF1;RABGAP1L;ARHGAP24;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;DOCK7;RACK1;RABGAP1;ARHGAP29
prerank,L-amino acid transport (GO:0015807),-0.3044167480368675,-1.0523866953995336,0.3567567567567568,0.8587356409282,1.0,6/28,10.89%,ARL6IP5;SLC25A13;SLC3A2;SLC7A1;SLC36A4;CTNS
prerank,histone H3-K9 demethylation (GO:0033169),0.4889259908809265,1.0522027537932115,0.4020771513353116,1.0,1.0,2/11,2.24%,KDM4D;KDM7A
prerank,cellular response to unfolded protein (GO:0034620),-0.3090164953392847,-1.0520217514181829,0.37962962962962965,0.8573928254820209,1.0,10/26,19.09%,DAB2IP;ERN1;BAG3;HSF1;TM7SF3;TMBIM6;HSPA14;ABCB10;HSPA5;HSPA13
prerank,nerve growth factor signaling pathway (GO:0038180),0.506188378864173,1.0518432081529718,0.4351145038167939,1.0,1.0,3/10,11.88%,NTF3;RAPGEF1;MAGI2
prerank,cation transport (GO:0006812),0.34835041733618566,1.0518314248092009,0.3838383838383838,1.0,1.0,17/166,9.53%,KCNG2;SLC4A4;CLN3;KCNA4;KCNC1;ASIC1;GRIN1;SLC22A4;SCN7A;TMEM63C;CATSPER3;KCNMA1;ATP1A2;SLC39A1;KCNJ10;TRPM3;KCNQ4
prerank,histone H3 acetylation (GO:0043966),-0.28629177773242614,-1.0515167178234124,0.37037037037037035,0.8565596184586936,1.0,18/40,23.87%,LEF1;KAT7;MBIP;JADE2;KAT2B;TAF12;JADE1;JADE3;WDR5;TAF5L;KAT6B;DR1;BRCA2;ING5;NAA60;TRIM16;SUPT7L;TAF6L
prerank,sprouting angiogenesis (GO:0002040),-0.2590505166744871,-1.0514410566925168,0.336283185840708,0.8543987877523627,1.0,15/51,12.02%,BMPER;ANGPT1;PARVA;RSPO3;SLIT2;PIK3R3;TEK;EPHB4;THBS1;ENG;OTULIN;RNF213;RAMP2;KDR;JMJD6
prerank,detection of calcium ion (GO:0005513),0.4758209014134114,1.0514055941614104,0.4263456090651558,1.0,1.0,4/13,21.79%,CALM3;SYT1;CALM1;CALM2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.36430744156948586,1.0513532921482978,0.4033970276008493,1.0,1.0,14/73,11.01%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,epithelium development (GO:0060429),0.35265104898676897,1.0512466087283847,0.399581589958159,1.0,1.0,22/107,18.84%,ANXA7;FGFR2;FGF10;ERRFI1;ALDH1A2;DVL1;RCN3;WNT4;SOX9;PTCH1;SOX11;DAG1;NDRG4;HNRNPH3;VDAC1;TGFB1;AHI1;ACADVL;OSR1;ANXA4;PKD2;PGK1
prerank,actin crosslink formation (GO:0051764),0.4895995838550284,1.0511937242477005,0.4152542372881356,1.0,1.0,3/12,9.08%,LCP1;GAS2L1;BAIAP2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4268840458407892,1.0509704514019909,0.40512820512820513,1.0,1.0,3/21,7.87%,FGF9;IGF1;MFN2
prerank,positive regulation of cytokine production (GO:0001819),0.3395882149965033,1.0509296831616244,0.365,1.0,1.0,49/292,15.76%,WNT5A;LPL;PTGER4;NFKB1;EIF2AK3;IL33;POLR3D;STAT6;ANXA1;XBP1;RORA;NFKB2;CCBE1;AGPAT1;TIRAP;SCRIB;TMEM106A;SULF1;IRF1;DHX58;ARNT;ZBTB7B;DHX33;DDIT3;PIBF1;XRCC6;DHX36;POLR3E;TWIST1;MALT1;APP;IRF3;PARK7;POLR2K;CEBPG;TMED10;LAMTOR5;TLR3;SCAMP5;PTPN22;ROCK2;PTGS2;TGFB1;LACC1;F3;MRE11;SPTBN1;HSPD1;PDE4B
prerank,regulation of establishment of cell polarity (GO:2000114),0.4565590390885635,1.0507679266437011,0.4214876033057851,1.0,1.0,11/16,26.59%,RIPOR2;RACK1;ROCK2;RUFY3;KIF20B;KRIT1;PTK2B;GSN;RAP1B;SHTN1;ARFGEF1
prerank,regulation of cell population proliferation (GO:0042127),0.3364281821770419,1.050714500191491,0.273,1.0,1.0,136/691,19.15%,FGF20;SFRP2;FGF9;S1PR2;CDKN2D;SFRP1;MST1R;IGF1;IL34;FOXM1;SIRT2;GPLD1;GNL3;EAPP;TSC2;TBRG4;CHERP;BMP6;NTF3;EDN3;TSPAN31;CGRRF1;FGFR2;TNFRSF9;GNRH1;STAT6;FGFR1;PTHLH;WARS1;XBP1;ZFP36L1;SLC25A33;CDC123;FGF10;IL31RA;CDK13;RBBP4;CLMN;TCF7L2;CNBP;IRF1;DLG3;NUAK1;FBXO5;ALDH1A2;CELF1;EZH2;EEF1E1;STK11;HGS;CHD5;TGFB1I1;IFIT3;PODN;XIAP;IFI35;SOX9;WDR6;PPP1R9B;SDCBP;EFNB2;XRCC6;MDM4;EGF;HDAC4;SOX11;GDNF;PRLR;IRS2;WNK2;RBFOX2;COX17;APP;JUP;IGFBP3;BCL2;ADGRG1;TCIRG1;IGFBP7;MAZ;PDGFRA;RTKN2;BMP5;NACC2;MAGI2;SPEG;SOD2;CD47;NPM1;HDAC1;AGO3;AXIN2;UBE2A;PRMT1;ROR2;TNS2;CDC73;EMP2;FGFBP1;FAM98A;NRG1;RNF41;TGFB1;SLURP1;BCL6;P3H2;SMAD6;KMT2D;DIS3L2;NUPR1;CNOT6;CTSH;CTBP1;JAG1;ADAMTS1;AGTR1;ITGB1BP1;PHIP;CAPNS1;HP1BP3;MDM2;ABI1;CAMK2N1;MEIS2;PKD2;CCDC88A;CDK10;S100A13;MECP2;TGFBR1;PDCD5;ATP8A2;KIF20B;KCNH1;KSR1;SOX4
prerank,negative regulation of nervous system development (GO:0051961),0.4491247100654083,1.050690750511691,0.43513513513513513,1.0,1.0,6/17,22.07%,HOOK3;ROBO2;SLIT1;SORL1;APPL2;B2M
prerank,bile acid metabolic process (GO:0008206),0.41638733432722697,1.050670066462085,0.40914709517923364,1.0,1.0,5/27,11.00%,CYP27A1;GBA2;CYP7B1;HSD17B4;AMACR
prerank,regulation of cardiac muscle contraction (GO:0055117),0.39843624476128714,1.0505539601193796,0.4092526690391459,1.0,1.0,3/34,4.76%,TNNI3;CALM3;ATP2A2
prerank,positive regulation of viral life cycle (GO:1903902),-0.32747228031046444,-1.0501211444078105,0.36363636363636365,0.8560691663264363,1.0,9/22,17.98%,TSG101;AXL;P4HB;KPNA6;LGALS9;VPS37B;CHMP2B;LGALS1;VPS4A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4316994570867574,1.0499802545514125,0.40625,1.0,1.0,4/23,13.29%,GUCA1B;METAP1;NMT1;METAP2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4972242616864677,1.0497690307196978,0.42877906976744184,1.0,1.0,4/10,19.20%,ERLEC1;INSIG1;UBE2J1;YOD1
prerank,ceramide metabolic process (GO:0006672),0.3820973236903331,1.0497394035714978,0.43115124153498874,1.0,1.0,10/49,14.34%,CLN6;SMPD2;ABCA2;CERS2;SGPL1;SPTSSA;TLCD3B;PLPP3;SMPD4;ST6GALNAC6
prerank,androgen receptor signaling pathway (GO:0030521),0.4898658823577106,1.049688239521702,0.416793893129771,1.0,1.0,5/11,16.74%,DDX17;PMEPA1;ZMIZ1;DDX5;DAXX
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.34865148330716456,1.0493224007292472,0.39152371342078707,1.0,1.0,31/151,18.27%,ASL;MOCS2;CSNK2A2;ELOVL1;GSTT1;TYW1;ST3GAL2;LPIN1;PCSK5;CEPT1;GPAT4;CERS2;SGPL1;LPIN3;ELOVL4;PCYT1B;SPTSSA;STARD7;LPIN2;B4GALT5;PLPP3;PAM;VAPB;CHKB;SLC44A2;SLC27A1;ALDH3A2;APOE;TNIP1;PRKD2;ASS1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3884928845643366,1.0492400940350715,0.4014002333722287,1.0,1.0,20/44,22.51%,SFRP1;RAC1;ARHGEF10;NRP1;ABL1;TPM1;ARHGEF10L;CD47;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;EVL;NF2;PPM1F;PFN2;PAK1
prerank,chloride transport (GO:0006821),-0.24403046305764028,-1.0491832969033055,0.328125,0.8563179028443909,1.0,27/74,23.88%,ANO4;GABRB1;SLC12A7;SLC4A10;SLC26A7;GABRG2;CLCN3;CLCN6;ANO6;ANO1;GABRA5;SLC12A4;CLIC5;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;TTYH3;GABRA1;GLRA3;TTYH1;FXYD1;SLC12A8
prerank,negative regulation of signaling (GO:0023057),0.4178672485535714,1.0491445919820277,0.40568475452196384,1.0,1.0,4/25,14.46%,BRAP;SRMS;IGFBP3;GLRA1
prerank,protein modification by small protein removal (GO:0070646),0.34296691741384067,1.0491429308173277,0.3711133400200602,1.0,1.0,82/252,22.12%,CCP110;COPS7A;OTULINL;PSMD4;IL33;TAF9B;USP14;USPL1;USP7;USP30;UCHL1;JOSD2;USP1;USP38;OGT;TNFAIP3;OTUD7A;USP24;TOMM20;USP47;PSMB10;USP42;BARD1;UCHL3;HGS;PSMD11;ACTR8;CDC25A;COPS7B;USP32;USP10;MDM4;ABRAXAS2;VCP;USP2;PSME2;PSMC5;SENP5;USP11;USP15;USP3;USP19;YY1;TADA3;USP40;USP9X;USP4;PSMD1;USP34;USP35;UBE2D1;USP48;USP31;NEDD8;EIF3F;PSMD6;TNIP1;STAM2;USP33;MDM2;TAB1;TGFBR1;USP22;BIRC3;USP50;YOD1;UIMC1;VCPIP1;USP37;PSMD5;JOSD1;INO80;NFRKB;SENP7;SMAD7;PSMA4;SMAD2;PSMA1;PSMC6;OTUD6B;TRAF2;SMAD3
prerank,negative regulation of apoptotic process (GO:0043066),0.33935569772627555,1.048627154762149,0.333,1.0,1.0,84/444,17.41%,FGF20;RNF157;CDKN2D;HDAC3;WNT5A;CLN3;SFRP1;IGF1;TCIM;PPIF;ARAF;NFKB1;CSNK2A2;NTF3;BNIP1;TAF9B;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;FZD9;FZD3;NUAK2;IL31RA;MGMT;PRKCA;CARD16;USP47;PRDX5;PIK3R1;PRELID1;SQSTM1;BAG1;BARD1;SNX6;HNRNPK;SLC30A10;ZFAND6;IFIT3;XIAP;SOX9;NRBP2;UBE2Z;MALT1;GDNF;PRLR;KDM2B;BCL2;MAZ;BNIP2;PARK7;SOD2;DNAJB6;NPM1;HDAC1;LAMTOR5;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;TXNDC5;SMAD6;CBL;MRE11;NUPR1;CASP2;HSPD1;RPS6KA1;CTSH;AHI1;NDNF;FAIM2;DPEP1;PHIP;SPRY2;MTDH;OSR1;APOE;SON;DFFA;TOPORS
prerank,membrane fusion (GO:0061025),0.3997551774805721,1.0484425754551878,0.4161640530759952,1.0,1.0,10/33,16.55%,DNM1;UBXN2A;NAPG;VAMP3;VPS33B;VTI1B;USO1;DNM1L;STX11;NSF
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.48275450783076573,1.0483711244789151,0.407514450867052,1.0,1.0,6/12,26.39%,STX2;SNAP25;STX11;SNAP47;SNAP23;STX1A
prerank,establishment of protein localization to membrane (GO:0090150),-0.2548439072693688,-1.0477679303252163,0.2926829268292683,0.8582175741525193,1.0,15/66,15.42%,PARD3;EGFR;SYNE3;TAOK2;REEP1;ZDHHC20;NACA;RAB3IP;VPS37B;ZDHHC15;BRAF;NECTIN3;GOLGA7;VPS37C;FRMPD1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3812178118198668,1.0471647913283901,0.4157303370786517,1.0,1.0,12/47,17.19%,NFKB1;RBM4B;RBM3;METAP1;CYFIP1;SSH1;PUM3;APP;WDR91;TGFB1;AGTR1;APOE
prerank,glycolipid metabolic process (GO:0006664),0.3795997006646211,1.0470636411093088,0.4184971098265896,1.0,1.0,10/47,14.34%,B3GALNT1;SMPD2;GBA2;GLB1;ABCA2;ST3GAL2;PGAP1;PSAP;SMPD4;ST6GALNAC6
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3854214309715219,1.0469127655514083,0.41685393258426967,1.0,1.0,8/48,6.44%,CUL7;RAC1;CDKL5;OBSL1;NRP1;ABL1;ARHGEF7;DMTN
prerank,regulation of coagulation (GO:0050818),0.49920997500549896,1.0466612128847843,0.42301943198804187,1.0,1.0,1/11,1.72%,EPHB2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4563879060707854,1.0464398110751068,0.43029490616621985,1.0,1.0,7/16,16.48%,DDX17;RBFOX2;TADA3;NCOA4;EGLN2;DDX5;TRIP4
prerank,cellular macromolecule catabolic process (GO:0044265),0.37582799104578585,1.0464257861404793,0.4238258877434135,1.0,1.0,9/49,10.46%,DNASE1L2;EXOSC7;NGLY1;DFFB;RAB12;MANBA;PABPC4;HNRNPD;MTREX
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3946607638059098,1.045669538907647,0.42409638554216866,1.0,1.0,10/37,15.32%,BAX;FIS1;FBH1;DDIT3;BCL2;NACC2;RACK1;BCLAF1;DNM1L;NUPR1
prerank,negative regulation of axonogenesis (GO:0050771),0.4117762200550247,1.0455929213602877,0.4189189189189189,1.0,1.0,11/27,23.89%,DIP2B;THY1;EFNB3;MCF2;RUFY3;DCC;PTPRS;FGF13;MAP2;LRP4;PTEN
prerank,regulation of defense response (GO:0031347),0.3634338620556898,1.0454956795246666,0.413903743315508,1.0,1.0,18/76,17.19%,WNT5A;FCGR2B;NR1D2;ANXA1;TIRAP;BRD4;IRF1;DHX58;CELF1;XIAP;LRP8;PARK7;PTPN22;PTGS2;BCL6;LACC1;AGTR1;APOE
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.3767457822676261,-1.04546585087171,0.3674911660777385,0.8627690452072468,1.0,4/14,7.77%,PRKG1;MEF2C;SLIT2;BMPR1A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3420708697062014,-1.0451500665875473,0.3900414937759336,0.8613541299709451,1.0,12/18,33.13%,SIRT1;HIF1A;TRAP1;PINK1;HSPB1;NFE2L2;AKT1;PRKN;MAPK7;BAG5;NME5;HTRA2
prerank,t-circle formation (GO:0090656),-0.43475834322126927,-1.0450486335411513,0.41411042944785276,0.8545875356339023,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.43475834322126927,-1.0450486335411513,0.41411042944785276,0.8545875356339023,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.43475834322126927,-1.0450486335411513,0.41411042944785276,0.8545875356339023,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,apical protein localization (GO:0045176),-0.4186683308534567,-1.044866225313074,0.40683229813664595,0.8528252359853,1.0,4/10,15.14%,ATP8B1;ACTB;GOPC;MAL
prerank,hemopoiesis (GO:0030097),0.35585495625123953,1.0447660260599176,0.4063157894736842,1.0,1.0,8/87,5.45%,SFRP2;WNT2B;WNT5A;SFRP1;FGFR2;TIRAP;CDK13;FLCN
prerank,maintenance of protein location in nucleus (GO:0051457),-0.33628566078443944,-1.0447530578742124,0.38181818181818183,0.8508303389225338,1.0,10/20,14.38%,MORC3;PML;SKP1;SP100;SUN2;ARL2BP;TAF8;RANGAP1;BBS4;TAF3
prerank,ribosomal subunit export from nucleus (GO:0000054),0.47752963442891816,1.0446176938950729,0.42424242424242425,1.0,1.0,5/13,18.76%,NOP9;RPS15;NPM1;NUP88;ABCE1
prerank,cellular response to BMP stimulus (GO:0071773),0.3670741191237182,1.0443578763036143,0.4281081081081081,1.0,1.0,22/66,22.96%,SFRP1;ADAMTS7;BMP6;SMAD9;SOX9;USP15;BMP5;USP9X;TGFB1;RGMA;SMAD6;RGMB;DDX5;MEGF8;SMURF1;ZFYVE16;TGFBR3;ACVR2A;SMAD7;SMAD2;SMAD3;ADAMTS12
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4661523928143666,1.0442823664156493,0.4452054794520548,1.0,1.0,4/15,12.08%,MAD2L1;ABL1;FBXO5;PARK7
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3411649240969512,1.044158356239308,0.379,1.0,1.0,77/314,18.01%,UBQLN1;CDC23;SIRT2;SPSB3;KCTD5;PSMD4;SELENOS;UBXN2A;UBE2S;SPSB1;STUB1;EDEM1;FBXL12;SYVN1;MAD2L1;UCHL1;CDC16;FZR1;FBXL14;FBXO38;COP1;ERLIN2;ANAPC2;FBXO5;FBXO31;PSMB10;DDB1;FBXO45;RFFL;FBXW5;PSMD11;RMND5A;ARRB1;DDIT3;TRIM9;JKAMP;AUP1;RNF103-CHMP3;CUL4B;KLHL15;VCP;PSME2;PSMC5;UBR3;USP19;NEMF;KCTD2;UBE2A;ANAPC11;ANAPC4;UBE2J1;CUL5;PCNP;ZFAND2A;CDC26;RNF122;FEM1C;PSMD1;FAF1;UBE2E1;UBXN4;RNF121;UBE2D1;ZSWIM8;CLOCK;DERL1;DMAC2;PSMD6;SMURF1;TOPORS;MDM2;DNAJC10;FBXO9;PCBP2;TBL1XR1;KLHL20;ANAPC10
prerank,generation of neurons (GO:0048699),0.3419505852714425,1.0440150763599292,0.40703517587939697,1.0,1.0,28/190,14.07%,WNT2B;WNT5A;RAC1;DCDC2;CDKL5;FGFR1;FZD3;NRP1;CDK5;TUBB2A;BRSK2;WNT4;CIT;SPOCK1;PRUNE1;NRBP2;SOX11;BRSK1;LRP12;SMARCA1;IL1RAPL1;DOCK7;MYEF2;USP9X;DISC1;MAPT;AUTS2;PEX13
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.475037107475037,1.04349595919605,0.4156028368794326,1.0,1.0,5/13,16.67%,PLXNA2;NRP1;PLXNA1;SEMA3A;PLXNB3
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4171718236379957,-1.0434343233953134,0.36942675159235666,0.8524417541553744,1.0,4/10,13.00%,LRP6;PHACTR4;LIN7C;BMP7
prerank,positive regulation of neuron projection development (GO:0010976),0.359357213927249,1.0432904193911159,0.40764331210191085,1.0,1.0,31/85,20.96%,WNT5A;CAMK2B;TENM3;DBN1;PLK5;LRP8;VLDLR;DHX36;RAPGEF1;DBNL;BMP5;MAGI2;NDRG4;SETX;ROR2;NPTN;PRKCI;PLPPR5;ARSB;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;SCARB2;LYN;ATP1B2;PTK2B;NTRK2;SCN1B
prerank,regulation of cell cycle phase transition (GO:1901987),0.35594094529481773,1.042970438555868,0.4107142857142857,1.0,1.0,30/91,22.19%,TCIM;CDC23;PSMD4;UBE2S;MAD2L1;CDC16;FZR1;ANAPC2;FBXO5;PSMB10;DDB1;PSMD11;PSME2;PSMC5;ANAPC11;ANAPC4;CDC26;MN1;PSMD1;UBE2E1;UBE2D1;PSMD6;ANAPC10;ANAPC5;PSMD5;PSMA4;ATP2B4;PSMA1;PSMC6;TAF1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4516913579007187,1.0427308684319554,0.4394141145139814,1.0,1.0,5/16,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,regulation of activated T cell proliferation (GO:0046006),0.40369880104177425,1.0425661287079764,0.40636474908200737,1.0,1.0,3/30,7.55%,IGF1;SCRIB;CD24
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.48691783998732463,1.042518156437767,0.43831640058055155,1.0,1.0,5/12,18.58%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.48691783998732463,1.042518156437767,0.43831640058055155,1.0,1.0,5/12,18.58%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.48691783998732463,1.042518156437767,0.43831640058055155,1.0,1.0,5/12,18.58%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,protein import into nucleus (GO:0006606),0.3681594233954042,1.042333773940567,0.43013100436681223,1.0,1.0,22/66,21.25%,MMP12;TSC2;NXT2;NXT1;KPNA3;KPNB1;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;NUP153;RANBP2;KPNA1;NUP35;PPP1R10;HEATR3;TPR;APPL2;CBLB
prerank,regulation of nervous system process (GO:0031644),0.4458131089946885,1.0422131012131581,0.4445927903871829,1.0,1.0,6/18,16.30%,NPTXR;TMEM108;APP;HTR2C;ROCK2;DLGAP1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3416450116391918,-1.042079892440491,0.37358490566037733,0.8543352539185407,1.0,6/18,23.73%,JAM2;SLC39A8;ROCK1;ITGA4;PODXL2;CX3CR1
prerank,mitotic DNA replication (GO:1902969),0.5011533560313521,1.0417647452825733,0.4362017804154303,1.0,1.0,1/10,1.55%,LIG1
prerank,defense response to fungus (GO:0050832),0.44101043719654026,1.0415986809347502,0.4473324213406293,1.0,1.0,2/17,7.78%,RNASE7;FAM3A
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5023781298225978,1.0414759189275287,0.4294478527607362,1.0,1.0,5/10,19.44%,DIP2B;FLCN;PARK7;PRKAA1;SETD5
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4206991440720749,1.0413928153026595,0.43455497382198954,1.0,1.0,7/24,19.22%,PARP1;TTLL4;TPGS1;CFAP20;TTLL11;AGBL4;AGTPBP1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.35684184037016503,1.0409031049440949,0.41281512605042014,1.0,1.0,30/84,21.19%,DDX17;RBM3;PCBP4;SRSF12;PRDX6;RBM39;CELF2;SRSF3;CELF1;HNRNPK;TIA1;SRSF9;KHDRBS2;RBFOX2;HNRNPL;TRA2B;NOVA1;CELF5;DDX5;YTHDC1;SNW1;FMR1;THRAP3;SON;SRPK1;CIRBP;HNRNPU;TRA2A;PTBP1;RBM7
prerank,anion transport (GO:0006820),0.40077073423596066,1.0407428957235896,0.42206235011990406,1.0,1.0,4/33,7.43%,SLC17A5;LRRC8A;VDAC2;SLC13A4
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3381914887141219,1.0405219951464533,0.4004004004004004,1.0,1.0,76/308,21.53%,HDAC3;WNT5A;TMEM119;PTGER4;IL33;NKX6-1;STAT6;XBP1;GLIPR2;LPIN1;AGPAT1;OGT;ALMS1;SNAI1;OLFM1;MFAP2;FBXO5;EZH2;ZBTB7B;CXCR4;TGFB1I1;MFN2;SOX9;LRPAP1;SDCBP;GNAS;EGF;PPIB;ABCA7;SOX11;TWIST1;GDNF;PRLR;TBXA2R;CPT2;LEPR;SOX6;AXIN2;B4GALT5;EHMT1;ZBED3;SCAMP5;LRP1;TGFB1;ESRRG;SOX5;RFX3;NR2C2;ACVR1B;NUMA1;VAMP8;SERPINE1;SLC27A1;ACADL;KDM6B;APOE;OMA1;BMP1;SNX4;SORL1;HMCES;S100A13;TGFBR1;FLOT1;FOXD1;ELOVL6;KMT5B;NCOA3;PLA2R1;DAB2;GCNT2;APPL2;VAMP7;FGF2;CFL1;SMAD2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4150585132888511,1.0404315129929291,0.43462017434620176,1.0,1.0,5/26,4.88%,UBE2E2;ANXA1;TFDP1;DDX3X;FGF10
prerank,alpha-amino acid catabolic process (GO:1901606),0.4084080219200133,1.0404184163807824,0.44563918757467147,1.0,1.0,5/29,14.99%,HGD;ACAT1;ALDH4A1;ACADSB;FAH
prerank,regulation of telomere maintenance (GO:0032204),0.4140919576239128,1.0403074775290202,0.42336683417085424,1.0,1.0,10/26,21.36%,GNL3;USP7;HNRNPD;DHX36;ATRX;MRE11;RAD50;TERF2IP;PPP1R10;SMG1
prerank,epithelial structure maintenance (GO:0010669),-0.4113199484254679,-1.0401879245755048,0.40175953079178883,0.8581634405542611,1.0,2/11,17.38%,RBP4;STRAP
prerank,negative regulation of response to stimulus (GO:0048585),0.3686264402457403,1.0400530175135376,0.41345093715545755,1.0,1.0,9/60,10.88%,FCGR2B;CASK;BRAP;THY1;FBXO5;SRMS;SLC30A10;TWIST1;IGFBP3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.39803584458054586,1.0398249299918425,0.42118537200504413,1.0,1.0,12/29,22.97%,TARBP2;DGCR8;PUS10;LIN28B;ZC3H7B;AGO3;HNRNPA2B1;ZC3H7A;SMAD2;PRKRA;SMAD3;AGO4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.44887736442989906,1.03982277877089,0.45417789757412397,1.0,1.0,7/18,18.01%,CRTC1;LRP8;CRTC3;ADCY1;CAMK1D;EPHA5;PRKD2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.40609522463327485,-1.0397229439217297,0.3746031746031746,0.857370353888648,1.0,1/12,3.02%,IL1R1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4220939406636887,1.0396832054848222,0.4287548138639281,1.0,1.0,6/24,12.69%,SELENOS;SYVN1;XBP1;PARK7;CREB3;RACK1
prerank,regulation of neuron projection development (GO:0010975),0.3457000985005443,1.0394595219349048,0.41194331983805665,1.0,1.0,52/163,20.96%,WNT5A;CAMK2B;CDKL5;TANC2;CDK5;FBXO7;TENM3;KNDC1;PAK3;DBN1;BRSK2;CAMSAP2;PLK5;SPOCK1;EFNB2;RAPGEF1;PRAG1;NTNG2;SRCIN1;BRSK1;DENND5A;MAGI2;IL1RAPL1;NDRG4;CAMK2G;SETX;ROR2;NPTN;PRKCI;DISC1;LPAR1;PLPPR5;ARSB;SEMA3A;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;RUFY3;DCC;CCDC88A;ITM2C;SCARB2;PTPRS;LYN;ATP1B2;PTK2B;CHN1;NTRK2;SCN1B
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.40365585686814326,1.0391496123554005,0.4204685573366215,1.0,1.0,12/32,22.35%,DUSP26;CALM3;MAGI2;TGFB1;CAMTA1;PPP2R5A;CALM1;SMPD1;DLC1;PTBP1;CALM2;ITGA1
prerank,smooth muscle tissue development (GO:0048745),0.48824132506909623,1.0391422118384959,0.4209770114942529,1.0,1.0,2/10,8.42%,STRA6;PTCH1
prerank,gastrulation (GO:0007369),-0.3667305864455749,-1.0390092643153501,0.3917910447761194,0.8571962147608768,1.0,1/15,0.19%,TASOR
prerank,L-serine metabolic process (GO:0006563),0.499141955016249,1.0388041258326077,0.43051359516616317,1.0,1.0,1/10,2.30%,PSAT1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4992534940697301,1.038775884977092,0.43377001455604075,1.0,1.0,3/10,13.55%,TIRAP;IFI35;PTPN22
prerank,cell-cell junction assembly (GO:0007043),0.36876261062259313,1.0387394708297981,0.4489571899012075,1.0,1.0,18/63,17.22%,GJB2;CTNND2;PRKCA;CLDN11;FLCN;JAM3;PATJ;CDH11;GJB6;CLDN12;JUP;TLN2;CDH18;EPB41L3;TBCD;CDH20;CDH19;CDH7
prerank,ERAD pathway (GO:0036503),0.3603792533757787,1.0383775809746023,0.44105263157894736,1.0,1.0,20/83,16.38%,UBQLN1;SELENOS;STUB1;EDEM1;SYVN1;ERLEC1;ERLIN2;BRSK2;RCN3;JKAMP;AUP1;RNF103-CHMP3;POMT2;VCP;UGGT2;USP19;UBE2J1;UBXN4;RNF121;DERL1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4214719616608168,1.0381358885228702,0.44040150564617314,1.0,1.0,6/26,16.13%,PSRC1;RAC1;DRG1;KATNB1;MAPT;NUMA1
prerank,lymphocyte mediated immunity (GO:0002449),-0.3970619432224639,-1.0373537845482979,0.3954248366013072,0.8595915575616335,1.0,3/12,17.35%,CD46;MSH2;GNL1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4095058490291413,1.03710604464968,0.4226190476190476,1.0,1.0,8/31,10.18%,CAMK2B;TANC2;CDK5;DBN1;LRP8;DHX36;DBNL;SRCIN1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.34482114792947816,1.0363041960437747,0.4226069246435845,1.0,1.0,21/140,16.59%,PTGER4;CCR9;ACKR2;FIS1;GRIN1;C1QTNF1;ABL1;CXCR4;CD24;BDKRB2;SELENOT;GPR4;TBXA2R;PDGFRA;HTR2C;NPTN;LPAR1;LPAR6;JPH1;AGTR1;ADCY5
prerank,microtubule bundle formation (GO:0001578),0.38293376579393834,1.0362557557329175,0.43815028901734104,1.0,1.0,4/42,7.37%,PSRC1;MTCL1;TPPP3;GAS2L1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3400337907295447,1.0361921064597415,0.4344344344344344,1.0,1.0,85/264,22.27%,RAVER2;LSM6;DDX17;LSM7;COIL;SMN1;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;CDK13;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;HNRNPK;FUS;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;HNRNPD;PRMT5;PPIH;CPSF7;HNRNPM;PABPC1;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CPSF3;HNRNPA0;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;DDX5;YTHDC1;SNW1;SRRM1;PRPF40B;PCBP2;RBM22;GCFC2;SRPK1;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;PTBP1;SART1;SRRM2;ISY1;GTF2F2;HNRNPUL1;METTL14;PNN
prerank,regulation of inflammatory response (GO:0050727),0.3381829387580752,1.036183171899973,0.4161616161616162,1.0,1.0,32/190,17.26%,SMPDL3B;WNT5A;LPL;PTGER4;DDT;SELENOS;IL33;NR1D2;ANXA1;RORA;TNFAIP3;BRD4;VAMP3;CELF1;SNX6;CD200R1;SIRPA;XIAP;IFI35;GPRC5B;GPR4;APP;PARK7;CD47;TLR3;PTGS2;BCL6;LACC1;AGTR1;SERPINE1;APOE;TNIP1
prerank,regulation of lymphocyte migration (GO:2000401),-0.41637883689785543,-1.0358858604650982,0.4107142857142857,0.8615597934495923,1.0,6/10,27.01%,JAM2;SLC8B1;STK10;MSN;AKT1;WASL
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.38857609717324093,1.0357969078130191,0.4276018099547511,1.0,1.0,11/42,12.36%,RNF8;SMARCC2;CHD8;RBBP4;ACTR6;SMARCB1;ACTR8;ARID1B;SMARCA1;MTA2;HDAC1
prerank,nuclear pore complex assembly (GO:0051292),-0.40762538603378135,-1.0356196200636618,0.4199395770392749,0.8600811291032284,1.0,5/10,21.50%,NUP205;NUP93;NUP107;NDC1;TMEM170A
prerank,neuron projection organization (GO:0106027),0.4516796800317623,1.0355579362811913,0.4399441340782123,1.0,1.0,4/15,15.47%,PICK1;ATP1A3;APP;ABCD2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.35664999461517777,1.0353577269276875,0.4172813487881981,1.0,1.0,22/84,18.58%,CDC23;PSMD4;UBE2S;MAD2L1;CDC16;FZR1;ANAPC2;FBXO5;FBXO31;PSMB10;PSMD11;PSME2;PSMC5;ANAPC11;ANAPC4;CDC26;PSMD1;UBE2E1;UBE2D1;PSMD6;ANAPC10;ANAPC5
prerank,positive regulation of response to stimulus (GO:0048584),0.39212699966830683,1.0353500567365512,0.4432624113475177,1.0,1.0,4/40,6.71%,WNT5A;FCGR2B;CDKN2AIP;EEF1E1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.44695140062003463,1.035276231906789,0.4491758241758242,1.0,1.0,3/17,13.55%,UBASH3A;THY1;PTPN22
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3411005603756989,1.0351007140893147,0.42943548387096775,1.0,1.0,37/159,21.72%,AMIGO1;FGFRL1;LRRC4;ATP2C1;OBSL1;CLDN11;GPC6;TENM3;IGSF21;DSCAM;CDH11;CLDN12;IGSF11;ROBO2;ROBO1;PTPRF;IL1RAPL1;GPC4;NPTN;ALCAM;UNC5D;CDH18;TENM4;ICAM1;PLXNB3;CDH20;CDH19;CDH7;CDH4;SLITRK1;CNTN2;PTPRS;NEXN;CDH9;ITGB1;PCDHB16;CDH10
prerank,cartilage development (GO:0051216),0.37301411262861234,1.0350813462149984,0.4474885844748858,1.0,1.0,9/49,17.12%,WNT2B;GPLD1;SULF1;TRIP11;SOX9;SOX6;TGFB1;SOX5;OSR1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4100010828972362,1.0349937317019162,0.4362745098039216,1.0,1.0,8/28,18.18%,EPHB2;ABL1;SQSTM1;APP;YTHDF1;ADCY1;APOE;ZDHHC2
prerank,mRNA processing (GO:0006397),0.3376076476916848,1.0348314777203935,0.4264264264264264,1.0,1.0,95/287,22.27%,RAVER2;LSM6;LSM7;RPRD2;TBRG4;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;CELF1;HNRNPK;AKAP8L;FUS;THOC3;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;AURKAIP1;KIN;HNRNPD;PPIH;CPSF7;HNRNPM;PABPC1;GTF2H3;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CCNH;CPSF3;HNRNPA0;THOC7;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;THOC1;DDX5;YTHDC1;SNW1;CDK7;SON;SRRM1;PRPF40B;CPSF6;PCBP2;RBM22;GCFC2;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;SARNP;PTBP1;SART1;SRRM2;ISY1;TCERG1;GTF2F2;HNRNPUL1;METTL14;PNN
prerank,positive regulation of exosomal secretion (GO:1903543),0.45332124537999796,1.034554032676976,0.43679775280898875,1.0,1.0,4/15,12.16%,SNF8;HGS;SDCBP;VPS4B
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.35129442190743815,-1.034523175060199,0.42083333333333334,0.8610258919207581,1.0,5/17,7.09%,ARL6IP5;TAOK2;RNF13;TGFB2;EIF2AK2
prerank,regulation of catabolic process (GO:0009894),0.4401941371613708,1.0344759271068675,0.4438573315719947,1.0,1.0,7/18,20.97%,SNF8;HGS;FAF1;CHEK2;MDM2;ZDHHC2;ITGB1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.45582355882420134,1.0344658425928226,0.4317241379310345,1.0,1.0,6/14,21.40%,AK4;AK5;ENPP1;AK3;CMPK1;AK1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.455254695684495,1.0344587701937178,0.452,1.0,1.0,5/16,21.10%,ERLIN2;SOX9;ACADL;ACADVL;APPL2
prerank,transcription by RNA polymerase III (GO:0006383),-0.3085721757363302,-1.0342839468652123,0.36597938144329895,0.8594845395068307,1.0,14/27,25.75%,BRF1;GTF3C3;GTF3C2;ELL;POLR3GL;ICE1;SNAPC1;CRCP;POLR3H;GTF3C1;GTF3C5;ZC3H8;GTF3C4;POLR3G
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.46876682264123115,1.0342052264579327,0.43263473053892215,1.0,1.0,6/12,19.58%,ABCA2;ABCA7;TMED10;ROCK2;APOE;RANBP9
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.35005104312818924,-1.033890824598068,0.4090909090909091,0.8584043391739754,1.0,6/17,14.29%,CACNA1D;CACNA2D1;KCNJ2;CACNA1C;CACNA1G;CACNB2
prerank,nuclear envelope organization (GO:0006998),0.42822218845689697,1.0334269466687191,0.4186046511627907,1.0,1.0,5/20,11.77%,REEP4;DMPK;TOR1B;TMEM43;LEMD3
prerank,phosphatidylserine metabolic process (GO:0006658),0.39588844892886577,1.0332222915869043,0.44376528117359415,1.0,1.0,1/32,0.14%,PLA2G5
prerank,cell differentiation in spinal cord (GO:0021515),0.48593615433239323,1.0328435460021237,0.4229607250755287,1.0,1.0,4/10,20.79%,SOX6;SOX13;SOX4;MDGA2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3949686353798526,1.0322200394459489,0.43825665859564167,1.0,1.0,8/33,14.38%,LRRC4;NTF3;GRIK5;LRP8;NRG3;PSMC5;NLGN3;NLGN2
prerank,motor neuron axon guidance (GO:0008045),0.44615208803894646,1.0322117657192154,0.43169398907103823,1.0,1.0,6/15,22.67%,RAC1;TMEFF1;SLIT1;SEMA3A;CHN1;EPHA4
prerank,negative regulation of transposition (GO:0010529),0.4489592561266118,1.032086176630771,0.46657381615598886,1.0,1.0,1/16,1.78%,SIRT7
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.47105740519457784,1.0319718225966834,0.4388185654008439,1.0,1.0,6/12,21.65%,FGF9;TPM1;DOCK7;ADAMTS1;DOCK5;IGFBP5
prerank,negative regulation of translational initiation (GO:0045947),-0.373643740629822,-1.031918553130228,0.4019607843137255,0.8619629427539611,1.0,5/13,9.38%,EIF3E;EIF2AK4;AGO2;EIF2AK1;RBM4
prerank,myoblast differentiation (GO:0045445),0.46150721705276426,1.0316878062736532,0.4444444444444444,1.0,1.0,6/14,16.44%,IGF1;DDX17;TCF7L2;NRG1;DDX5;JAG1
prerank,activation of protein kinase activity (GO:0032147),0.3451379447151095,1.0314515585684472,0.43460350154479915,1.0,1.0,29/106,21.24%,WNT5A;IGF1;PDPK1;ADCY7;NTF3;TAOK1;MINK1;TIRAP;ABL1;PAK3;STK11;PIBF1;MALT1;PRLR;STRADB;PARK7;TLR3;EMP2;NRG1;ADCY1;ADCY5;ITGB1BP1;CCDC88A;PRKAR1A;NRK;PTK2B;PAK5;MAPKAP1;MAP4K4
prerank,regulation of translation (GO:0006417),0.33745368534958264,1.031167288388956,0.42354124748490946,1.0,1.0,41/173,16.78%,ILF3;MIF4GD;PAIP2;RBM4B;EIF2AK3;RBM3;PAIP1;DDX3X;CNOT10;IGF2BP2;METAP1;EIF1B;CYFIP1;EPRS1;HNRNPD;DHX36;PUM3;PUS7;APP;ZCCHC4;SHFL;EIF4E2;CNOT9;EIF4G2;NEMF;MALSU1;YTHDF3;EIF1;NPM1;RACK1;RPS6KA3;GSPT1;DAPK1;YTHDF1;PRR16;IMPACT;MRPL13;RPS6KA1;MTG2;EIF4G3;FMR1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4429518882823804,1.0308560705503786,0.43741765480895917,1.0,1.0,2/16,9.75%,CLDN11;CLDN12
prerank,positive regulation of histone modification (GO:0031058),0.3978650288310804,1.0307819848697606,0.4555160142348754,1.0,1.0,10/33,19.34%,NIPBL;CDK9;AKAP8L;ZBTB7B;ARRB1;SART3;SAP30BP;CTBP1;FMR1;TET1
prerank,embryonic organ morphogenesis (GO:0048562),0.38039271929378454,1.0307215689232356,0.4305717619603267,1.0,1.0,8/42,12.67%,FBN2;FGFR2;NIPBL;MFAP2;MFAP5;SOX11;PDGFRA;FBN1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.36346142317603897,-1.0306870526218945,0.41479099678456594,0.8634520154171856,1.0,3/14,5.38%,ANKRD17;PUM1;ZDHHC5
prerank,phospholipid dephosphorylation (GO:0046839),-0.2785518258190336,-1.0304982771890416,0.4065040650406504,0.8618236682630009,1.0,7/37,5.95%,PIP4P2;INPP5F;MTMR12;MTMR10;OCRL;MTMR3;INPP5K
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2447878216211309,-1.0304982396277222,0.4421052631578947,0.8595851652285516,1.0,11/56,10.62%,IRAK2;LBP;IRAK1;NOD1;HSP90B1;UNC93B1;TLR4;CTSL;PLCG2;UBB;ALPK1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3075278169979449,-1.0304589071763701,0.4246575342465753,0.857485625558561,1.0,8/25,12.54%,ATP1B3;SLC6A9;DMD;AKAP9;TCAF1;ACTN2;NDUFA4;ATP1B1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.33003027393020795,-1.0302532183812239,0.3974358974358974,0.8559643627731731,1.0,11/22,37.78%,SORBS1;CREBL2;PPARD;CREB1;AKT1;PPARG;PPARA;SIRT4;DISP3;MLXIPL;ANGPTL3
prerank,programmed necrotic cell death (GO:0097300),0.4371740543042134,1.0298681960583291,0.43089430894308944,1.0,1.0,7/18,20.53%,PPIF;LY96;TLR3;DNM1L;MLKL;IPMK;ITPK1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.49105263337641575,1.0298579018597251,0.46656976744186046,1.0,1.0,2/11,2.08%,GSKIP;PDK1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3662258177388489,1.0296700947225366,0.43921139101861995,1.0,1.0,23/61,22.00%,GNL3;APLF;RNF8;USP7;FGF10;WRAP53;RNF168;DHX36;CEBPG;USP9X;ATRX;EYA2;MRE11;RAD50;PRKD2;MECP2;UIMC1;RPS3;PPP1R10;EYA1;FGF2;NPAS2;HMGB1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3776006752735687,1.0294601512919903,0.461283185840708,1.0,1.0,15/46,18.63%,RAC1;LAMC3;NRP1;LAMC1;PIK3R1;SRGAP2;VAMP3;NTNG2;SRCIN1;ANTXR1;LAMB1;RADIL;ATRN;ILK;MEGF9
prerank,positive regulation of interferon-beta production (GO:0032728),0.3980742320846287,1.0288692807940825,0.46722288438617404,1.0,1.0,8/33,13.28%,HSP90AA1;POLR3D;DDX3X;IRF1;DHX58;TRIM56;IRF3;TLR3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4733747811511363,1.0288012121968302,0.45652173913043476,1.0,1.0,2/13,4.65%,WNT5A;AGPAT1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.33821646886623447,1.028664279545684,0.40904522613065325,1.0,1.0,29/198,14.71%,PLA2G5;DUSP28;DUSP18;XYLB;HKDC1;LPL;EPHA7;G6PC3;EPHB2;PLCH1;PIP4K2B;TAOK1;AGPAT1;CDK5;PPA2;PLPPR2;INPP5A;ACYP2;TOP1;PIK3CB;NUDT3;IPPK;ENPP1;HDHD2;PLPP3;PIP4K2A;PLPPR5;TGFB1;EPHX2
prerank,tRNA methylation (GO:0030488),0.392281987508209,1.0286282015650055,0.4392857142857143,1.0,1.0,7/34,12.90%,TRMT61B;TRDMT1;WDR6;PRORP;TRMT1;METTL2A;METTL2B
prerank,cellular response to hypoxia (GO:0071456),0.34381989502760935,1.028257202174599,0.4525993883792049,1.0,1.0,29/126,17.57%,CPEB1;UBQLN1;SFRP1;SIRT2;PSMD4;STUB1;RORA;ZFP36L1;CARD16;FAM162A;PSMB10;ARNT;PSMD11;TBL2;MDM4;NDRG1;TWIST1;PSME2;PSMC5;SUV39H1;AK4;BACH1;EGLN2;PTGS2;PSMD1;NDNF;PSMD6;HP1BP3;MDM2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.48045335411824974,1.0281260343141925,0.45481481481481484,1.0,1.0,3/11,6.98%,FBH1;FBXO5;LIG3
prerank,positive regulation of defense response (GO:0031349),0.3497756115713771,1.02810263006301,0.4386339381003202,1.0,1.0,15/89,17.26%,WNT5A;LPL;PTGER4;DDT;IL33;POLR3D;IFI35;GPRC5B;GPR4;APP;CD47;TLR3;AGTR1;SERPINE1;TNIP1
prerank,oligosaccharide metabolic process (GO:0009311),0.37294423568900725,1.028062845209437,0.44560185185185186,1.0,1.0,6/46,8.34%,MAN2C1;ST8SIA3;ST3GAL2;ST3GAL3;ST6GAL2;MANBA
prerank,negative regulation of neurogenesis (GO:0050768),0.3930543683642066,1.0280548913892888,0.45066991473812423,1.0,1.0,12/34,23.89%,THY1;EFNB3;MCF2;YWHAH;HOOK3;GORASP1;RUFY3;SORL1;APPL2;B2M;LRP4;PTEN
prerank,regulation of T cell mediated immunity (GO:0002709),-0.42697433708151616,-1.0279934950541634,0.41566265060240964,0.8605611013519989,1.0,2/10,15.98%,ZBTB1;TNFRSF1B
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.42607879031229806,1.027645653359193,0.45740498034076016,1.0,1.0,6/20,18.56%,UBQLN1;HSP90AA1;ZMIZ1;DAXX;DCUN1D5;TGFBR1
prerank,negative regulation of biosynthetic process (GO:0009890),0.4443841400602718,1.0276098774010958,0.44505494505494503,1.0,1.0,5/16,15.47%,SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,regulation of plasminogen activation (GO:0010755),0.4733364534269296,1.0275283764940466,0.4287812041116006,1.0,1.0,3/12,16.49%,CLEC3B;CTSZ;SERPINE1
prerank,regulation of cell communication (GO:0010646),0.3871572366402898,1.0272483663818939,0.4258823529411765,1.0,1.0,8/35,14.61%,ANXA1;NCLN;YWHAG;GRK3;IGFBP7;CAMK2D;MTCH1;GRK2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4150308115770976,1.0272159762286328,0.4441687344913151,1.0,1.0,5/23,11.06%,TFDP1;NMT1;YWHAH;YWHAG;BCL2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4150308115770976,1.0272159762286328,0.4441687344913151,1.0,1.0,5/23,11.06%,TFDP1;NMT1;YWHAH;YWHAG;BCL2
prerank,regulation of macrophage cytokine production (GO:0010935),0.4577008972881846,1.0272152186661005,0.44778254649499283,1.0,1.0,4/13,14.28%,WNT5A;GPRC5B;CUEDC2;TGFB1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3715825577914038,1.0271093790034933,0.42777155655095184,1.0,1.0,14/52,16.69%,CUL7;KDELR3;EDEM1;SYVN1;XBP1;WIPI1;EXTL3;EXTL2;SERP1;PARP16;CTDSP2;VAPB;FKBP14;ACADVL
prerank,regulation of mRNA metabolic process (GO:1903311),0.4789530782502113,1.0268854098505247,0.4419970631424376,1.0,1.0,5/11,19.61%,SLTM;PTCD2;SAFB2;SRPK1;CDK11B
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.32896917813242893,1.0268455348651675,0.318,1.0,1.0,339/1668,18.38%,SFRP2;METTL23;CBX8;CAMTA2;MMP12;HDAC3;HEXIM1;TEAD3;LAGE3;WNT5A;PTPRN;ZSCAN12;ZMYM5;WBP2;HSF2;POU6F1;ZNF418;IGF1;MED24;DUSP26;SP7;DVL2;ZNF23;MPND;FOXM1;BAX;SIRT2;ZBTB48;SIRT7;POU5F2;DDX17;CRTC1;NFKB1;ZNF25;KDM7A;ZBTB46;SMARCD3;AASS;HMGB3;ZNF568;MAMLD1;PKNOX2;CC2D1B;AEBP2;BMP6;PARP1;ZEB2;CREBZF;IL33;USF1;NR2F2;FGFR2;MLXIP;TEF;NKX6-1;MED12;TAF9B;NKX2-2;MAFG;SMARCC2;MED14;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;GRIN1;PCGF1;ZNF8;ZFP82;HTATIP2;XBP1;ACTR2;RORA;TFDP1;MIER2;NFKB2;CARF;DDX3X;MXI1;ABCA2;ZNF205;LPIN1;SNF8;NIPBL;CCNC;OGT;CHD8;VGLL3;POU2F1;RFX5;CDK13;SNAI1;SLTM;CDK9;ZNF692;FLCN;MRTFA;NPAT;TCF4;TCF7L2;TFCP2;ZNF276;BBS7;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;ATXN1;DVL1;ZNF35;ZIC3;CASZ1;HNRNPK;EZH2;AKAP8L;FUS;ARNT;ZBTB7B;RTF1;ZEB1;SMARCB1;CHD5;TEAD1;HDAC5;PCGF6;MOSPD1;MXD1;RAI1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;PID1;MED4;ZKSCAN5;DBP;NFX1;PRPF6;ARRB1;TSHZ2;SLC30A9;SOX9;SRA1;SMARCD1;PTCH1;EHMT2;DDIT3;BRD3;PGBD1;CRTC3;SDCBP;DPF2;LPIN3;ZFHX2;XRCC6;PER1;ECD;ARID1B;DHX36;MDM4;ATMIN;ZSCAN20;HDAC4;ARID4A;SOX11;TWIST1;CALCOCO1;PSIP1;PRRX1;NKRF;GTF2H3;TCEA1;HOXB8;USP2;GDNF;ATF2;POU6F2;SSBP4;RCOR1;PSMC5;ZBTB20;BRD8;ZNF445;KDM2B;APP;TAF6;JUP;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SUV39H1;PIK3R2;SARS1;BACH2;MAZ;NFAT5;IRF3;CAMK2D;JAZF1;BMP5;ZNF471;YY1;SMARCA1;NACC2;ZMIZ1;MTA2;E2F3;NFIX;BRIP1;BACH1;PARK7;ZNF462;PEG3;SOX6;SOD2;CCNH;NPM1;TADA3;TIAL1;HDAC1;CEBPG;LPIN2;ZFP2;AGO3;CREB3;CREB3L4;ZNF383;RPS6KA3;USP9X;PROX2;SETX;SUFU;TLR3;ZBED3;CBFB;ABHD14B;CDC73;FOXJ3;ATRX;ZHX2;EBF1;AUTS2;ZIC2;TGFB1;MED21;RGMA;TRPS1;ESRRG;CAMTA1;BCL6;BAZ2B;BCLAF1;ZNF292;IMPACT;SMAD6;SOX5;KMT2D;PIAS3;CHD1;NUCKS1;TTC21B;RFX3;NR2C2;MED23;SATB1;TCF7L1;TCF3;SSBP2;FOXC2;CIC;HSPD1;THAP3;RPS6KA1;DDX5;TRAK1;AHI1;GTF2IRD1;MAF;SAFB2;UBE2D1;CTBP1;HOXC8;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;SERPINE1;TNKS;CBX5;KDM6B;ITGB1BP1;THRAP3;CBX7;PHIP;ZFP37;CDK7;KDM3B;MTDH;SOX13;ZBTB41;OSR1;HSBP1;APOE;ZFP90;TNIP1;TLE5;TCF7;NSD1;MDM2;GABPB1;GABPB2;ANXA4;RAD21;MEIS2;TBL1XR1;PRKD2;PKD2;RELB;ZNF177;PHF12;RBBP8;RNF111;ATN1;PRKAR1A;MECP2;CUX1;KMT2A;BCL11B;GPS2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.28008905106813586,-1.0266791835274132,0.3969465648854962,0.8624211919962069,1.0,8/38,10.47%,CACNA1D;CTNNA3;CAV1;CACNA2D1;KCNJ2;CACNA1C;AKAP9;CACNA1G
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.35226408756366256,-1.0266142675172254,0.43214285714285716,0.8603723311307755,1.0,4/16,10.48%,PDS5B;RB1;PDS5A;MAU2
prerank,negative regulation of cell death (GO:0060548),-0.2386577098565202,-1.026404402394117,0.3275862068965517,0.8587866006774536,1.0,26/88,18.27%,MECOM;FERMT2;CCN2;ATG5;BNIP3L;PRKD1;BECN1;NCK1;DCPS;LRRK2;ADNP2;CD34;TM7SF3;IKBKG;DUS2;BMP7;CCN3;NENF;BNIP3;TNFRSF1B;BMP4;PINK1;KANK2;CCN5;TMEM109;CCN1
prerank,heart development (GO:0007507),0.34385430359302604,1.0263617576157649,0.4432048681541582,1.0,1.0,32/150,20.60%,APLN;PDLIM2;TNNI3;POU6F1;DVL2;CACYBP;PDLIM7;TSC2;STRA6;PCSK5;NIPBL;SOX9;FLRT2;ADAP2;FGF12;BMP5;NDRG4;FBN1;AKAP13;TGFB1;FOXC2;MEGF8;KDM6B;OSR1;PKD2;TGFBR1;SCUBE1;SOX4;KDM6A;DLC1;CHD7;TGFBR3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.48202070934375935,1.0261350297742704,0.4413489736070381,1.0,1.0,2/11,4.89%,TNFAIP3;TIRAP
prerank,epidermal cell differentiation (GO:0009913),0.38238747369103615,1.0255275990813402,0.4429223744292237,1.0,1.0,7/41,18.58%,WNT5A;SCEL;ANXA1;HDAC1;TXNIP;JAG1;PIP5K1A
prerank,response to cholesterol (GO:0070723),0.44109190187363917,1.0253439605391887,0.4511173184357542,1.0,1.0,4/17,8.42%,GPLD1;MLC1;ABCA2;PTCH1
prerank,osteoclast differentiation (GO:0030316),-0.3236943493932102,-1.0243326947661002,0.3891625615763547,0.8627857672659586,1.0,6/22,15.91%,FOXP1;SBNO2;OSTM1;GLO1;SRC;TNFRSF11A
prerank,regulation of type I interferon production (GO:0032479),0.3493049875663622,1.0239356346011854,0.4497354497354497,1.0,1.0,16/84,13.55%,NFKB1;POLR3D;STAT6;NFKB2;TNFAIP3;TIRAP;IRF1;DHX58;TRIM56;DHX33;XRCC6;DHX36;POLR3E;IRF3;POLR2K;PTPN22
prerank,cellular response to reactive oxygen species (GO:0034614),0.3606602092272078,1.023848640527133,0.4318181818181818,1.0,1.0,14/59,14.79%,MAPK9;PPIF;ANXA1;TNFAIP3;PRDX5;ABL1;SIRPA;TPM1;PDGFRA;OSER1;PARK7;SETX;MAPT;IMPACT
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.39351134063842746,1.0237397005484181,0.46511627906976744,1.0,1.0,9/33,19.75%,CDKN2D;WEE1;PLK5;RBL2;NACC2;CDC73;PKD2;PRMT2;KLF4
prerank,smooth muscle cell differentiation (GO:0051145),-0.38226387969138753,-1.0236761238132428,0.4150326797385621,0.8626225038072396,1.0,11/12,38.03%,MEF2C;TMEM204;TBX18;BMP4;MRTFB;HEY2;GATA6;EDNRB;MYOCD;APLNR;HEY1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.40616274510313394,1.02356561745317,0.445679012345679,1.0,1.0,6/24,10.02%,AEBP2;CREBZF;RBBP4;PHF1;EZH2;JARID2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.48760017646434983,1.0233687520093875,0.4498525073746313,1.0,1.0,3/11,12.54%,UBQLN1;PARK7;LANCL1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2567448547255401,-1.0233280535718647,0.42452830188679247,0.8614729300372594,1.0,19/55,18.83%,CRADD;DAB2IP;CAV1;RIPK1;PML;GSDME;BECN1;BCL2L1;TPD52L1;TP53;TNFSF10;CYLD;TRIM39;FAS;TRAF7;LTBR;SIAH1;ING5;TNFSF12
prerank,nucleosome organization (GO:0034728),0.3624735547816742,1.0232150527271964,0.44929116684841874,1.0,1.0,21/55,21.68%,SMARCD3;RNF8;SMARCC2;ASF1A;ACTR6;SMARCB1;SOX9;SMARCD1;SART3;NPM1;ATRX;DAXX;BRDT;INO80;CTCF;SMARCD2;NAP1L4;ZNHIT1;VPS72;H3-3A;SRCAP
prerank,sensory perception of light stimulus (GO:0050953),0.34796343125539475,1.0230695136624384,0.4632352941176471,1.0,1.0,10/87,14.68%,GPR179;BEST1;RDH10;PCDH15;ADGRV1;OAT;POU6F2;ZIC2;CRYBB3;EML2
prerank,positive regulation of cell junction assembly (GO:1901890),0.3699823348569347,1.0228917882048425,0.45936794582392776,1.0,1.0,18/56,21.66%,SFRP1;EPHB2;RAC1;NRP1;ABL1;THY1;CLSTN2;IL1RAPL1;NLGN3;NLGN2;CNTNAP2;IL1RAP;CLSTN3;NPHP1;FLOT1;DLG5;MAP4K4;PPM1F
prerank,regulation of translational initiation (GO:0006446),0.3564694577708907,1.022212024857146,0.4589989350372737,1.0,1.0,15/63,16.78%,MIF4GD;PAIP2;EIF2AK3;PAIP1;DDX3X;CDC123;EIF1B;EIF4G2;YTHDF3;EIF1;NPM1;YTHDF1;IMPACT;EIF4G3;FMR1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2488634840202565,-1.0220810182975244,0.38461538461538464,0.8628129035688299,1.0,17/53,17.42%,RAD23B;DAB2IP;TMF1;GNA12;HSP90AB1;UCHL5;PRKACA;PSMC2;PSMF1;DDRGK1;UBB;GABARAPL2;UBQLN4;OSBPL7;UFL1;PINK1;PSMC3
prerank,mitotic recombination (GO:0006312),-0.3551276060878187,-1.0220014298467204,0.40942028985507245,0.8608603094753172,1.0,9/15,32.35%,SMC5;TEP1;RAD52;RAD51D;DMC1;NSMCE2;RAD54B;ERCC1;SMC6
prerank,regulation of blood coagulation (GO:0030193),0.4031291896525858,1.0219351922941136,0.4398976982097187,1.0,1.0,6/27,17.19%,VTN;EPHB2;DMTN;TFPI;SERPINE1;APOE
prerank,negative regulation of innate immune response (GO:0045824),0.3886901494753604,1.021814864930791,0.44,1.0,1.0,7/34,12.01%,TNFAIP3;SERPING1;DHX58;TRAFD1;FAM3A;USP15;YTHDF3
prerank,bone development (GO:0060348),0.38026407624568487,1.0217468236665723,0.44815668202764974,1.0,1.0,8/39,12.92%,PTGER4;FGFR2;SULF1;RANBP3L;GNAS;PPIB;CYP26B1;AKAP13
prerank,regulation of centriole replication (GO:0046599),0.43970633630030453,1.0215949049457642,0.456,1.0,1.0,5/17,17.13%,MDM1;ALMS1;NPM1;SPICE1;CEP76
prerank,histone modification (GO:0016570),0.3470231390846083,1.0212978012815424,0.4603501544799176,1.0,1.0,32/109,20.24%,SIRT2;INCENP;SIRT7;PRMT6;MIER2;PARP2;EZH2;HDAC5;EHMT2;NTMT1;HDAC4;RCOR1;BRD8;TAF6;NSD3;USP3;MTA2;PARK7;HDAC1;UBE2A;PRMT1;EHMT1;EYA2;PRMT8;NSD1;TBL1XR1;SGF29;USP22;PRMT2;CARM1;MIER1;EYA1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2132457829431794,-1.0212096756316091,0.39473684210526316,0.8588950735955695,1.0,21/104,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,cellular response to lectin (GO:1990858),-0.2132457829431794,-1.0212096756316091,0.39473684210526316,0.8588950735955695,1.0,21/104,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.36596770393165357,1.0208896676711379,0.44431946006749157,1.0,1.0,9/55,17.07%,FOXM1;SIRT2;RAC1;SLC25A33;PID1;RNF41;SIRT5;AGTR1;PARL
prerank,positive regulation of catalytic activity (GO:0043085),-0.26772418225474715,-1.020867147887936,0.4358974358974359,0.8577665093274082,1.0,10/37,16.62%,XRCC4;MAPK8;CAV1;PHACTR4;NCSTN;MSH2;IGF2;NHEJ1;ABL2;APH1A
prerank,carbohydrate catabolic process (GO:0016052),0.37812866197219785,1.0207992814511428,0.44565217391304346,1.0,1.0,6/38,11.10%,HKDC1;MAN2C1;MANBA;PGAM4;PGAM1;ENO2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4110264691388503,-1.0207646353113256,0.40412979351032446,0.8559088763609943,1.0,5/10,17.42%,THRA;PSMC2;TP53;ESR1;PSMC3
prerank,methylguanosine-cap decapping (GO:0110156),-0.4271751769542367,-1.0207461749660731,0.4526627218934911,0.853831653887656,1.0,4/10,10.39%,DCP1A;PATL1;DCPS;LSM1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3716524596894031,1.0205296693864265,0.44772727272727275,1.0,1.0,7/46,8.27%,DNLZ;FIS1;TOMM20;FBXO7;TIMM13;MFN2;AIP
prerank,eye development (GO:0001654),-0.2498476706045785,-1.0204181264281904,0.3958333333333333,0.8526072470214148,1.0,14/54,16.73%,HIPK2;SMOC1;COL5A1;RAB18;RBP4;TGFB2;CACNA1C;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMG9;PBX2
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4271898605404899,-1.0203447471177878,0.43952802359882004,0.8507084712890197,1.0,4/10,6.32%,DROSHA;TSN;AGO2;TSNAX
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.46836235794605574,1.0203032967277363,0.460545193687231,1.0,1.0,1/12,1.59%,GPLD1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.3756989024721751,-1.0202859871469763,0.4051094890510949,0.8487650108901597,1.0,4/13,7.29%,LATS1;FLNA;NFKBIA;GOPC
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3865689513261744,1.0194429204017157,0.4528301886792453,1.0,1.0,8/38,12.69%,TSC2;THEM4;FLCN;DDIT3;PIK3CB;MAGI2;DAG1;RACK1
prerank,atrial septum morphogenesis (GO:0060413),-0.4006232789289035,-1.0193041450568365,0.43548387096774194,0.8496015318942427,1.0,5/10,31.43%,TGFB2;ACVR1;NOTCH2;HEY2;ZFPM1
prerank,negative regulation of reproductive process (GO:2000242),0.43164930246568595,1.0191394501591426,0.4791386271870794,1.0,1.0,2/17,5.67%,IGF1;SULF1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3775208773815724,1.0185200049922711,0.434052757793765,1.0,1.0,7/38,10.96%,BMP6;POLR3D;PRKCA;DHX58;IFI35;LY96;USP15
prerank,actin polymerization or depolymerization (GO:0008154),0.3696707813250974,1.0181969262193185,0.47171945701357465,1.0,1.0,17/50,21.98%,SPIRE2;RAC1;TTC17;WASF1;SVIL;SPIRE1;VILL;ABI1;GAS7;ARHGAP6;PSTPIP2;EVL;PREX1;CFL1;GSN;DIAPH1;ENAH
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.43730037296072377,1.0178940269409185,0.4568062827225131,1.0,1.0,3/18,13.72%,LIG1;LIG3;POLD3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4042751162154056,1.0175198395589293,0.44609665427509293,1.0,1.0,6/26,13.35%,IGF1;CAPN10;PIK3R1;CLIP3;IRS2;PRKCI
prerank,RNA stabilization (GO:0043489),0.39169139527559144,1.0175136576090644,0.4603174603174603,1.0,1.0,12/33,20.76%,TRDMT1;PAIP1;FUS;DHX36;PABPC1;GDNF;AXIN2;THRAP3;TENT5A;CIRBP;HNRNPU;YBX1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.40381649596059466,1.0173966384071473,0.44621026894865523,1.0,1.0,7/27,11.84%,GPD1L;YWHAH;SCN2B;SLMAP;FGF12;CAMK2D;PTPN3
prerank,RNA catabolic process (GO:0006401),0.3683740688401098,1.0172594126076813,0.4663625997719498,1.0,1.0,11/46,16.21%,LSM6;EXOSC7;CNOT10;PABPC4;HNRNPD;NUDT12;MTREX;AGO3;SND1;DIS3L2;NUDT16L1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3322484901424889,1.0170410495354676,0.461,1.0,1.0,91/336,20.64%,WDHD1;XRCC2;APTX;LIG1;BAX;SIRT7;CDKN2AIP;PARP1;APLF;RNF8;PAXX;UBE2E2;TAOK1;NIPBL;PARP2;MGMT;USP47;ASF1A;FBH1;SLF2;ABL1;FBXO31;DDB1;BARD1;PHF1;SETD7;TDP1;FBXO45;STK11;FANCG;ZBTB38;XIAP;PLK5;UBA1;DDIT3;USP10;RNF168;KIN;CUL4B;MRNIP;VCP;CASP9;GTF2H3;ATF2;POLH;MTREX;BRSK1;SUV39H1;ENDOV;USP3;BCL2;ALKBH3;IRF3;YY1;BACH1;PARK7;NPM1;UBE2A;ATR;SETX;MMS19;HELB;BCL6;FANCA;MRE11;CASP2;CHEK2;RAD50;CBX5;FMR1;UBR5;TANK;TOPORS;NABP2;SUSD6;PWWP3A;DCUN1D5;HMCES;RBBP8;FMN2;RECQL5;ALKBH1;RPS3;VCPIP1;KMT5B;INO80;FANCL;UVRAG;LYN;MAPKAPK2;RAD18
prerank,negative regulation of cell growth (GO:0030308),0.343062237280088,1.0166162520728157,0.4696813977389517,1.0,1.0,12/121,8.63%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;CGRRF1;DDX3X;DIP2B;FLCN;STK11;TCHP;PPP1R9B
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.40623583655266876,1.016596474702134,0.44328552803129073,1.0,1.0,9/22,21.95%,EAPP;CDK13;BRD4;CDC73;THOC1;CCNT1;CCNT2;HMGN1;TCERG1
prerank,adherens junction organization (GO:0034332),-0.26557327820980625,-1.0165877042715583,0.4,0.8557538532663588,1.0,16/48,21.26%,FERMT2;CADM2;TJP1;ACTB;CDH6;CADM1;CDH1;CSK;RAMP2;NECTIN3;NECTIN1;PIP5K1C;CADM3;NECTIN2;DCHS1;PVR
prerank,regulation of urine volume (GO:0035809),0.5003887476536322,1.016527415308818,0.4727272727272727,1.0,1.0,1/10,2.42%,ADM
prerank,negative regulation of hemostasis (GO:1900047),0.4651409496917609,1.0165165404579062,0.4670571010248902,1.0,1.0,4/12,17.19%,VTN;TFPI;SERPINE1;APOE
prerank,regulation of ion transmembrane transport (GO:0034765),-0.27336029065716305,-1.0163189101376213,0.4117647058823529,0.8543652862665151,1.0,10/33,25.98%,CHRM3;KCNJ2;AKAP9;ANO6;NEDD4L;P2RX7;KCNJ3;KCNQ1;KCNJ12;WNK1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4038586480530725,-1.0162663077374448,0.4608433734939759,0.8503610868454776,1.0,3/11,9.38%,TNRC6A;AGO2;RBM4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4038586480530725,-1.0162663077374448,0.4608433734939759,0.8503610868454776,1.0,3/11,9.38%,TNRC6A;AGO2;RBM4
prerank,regulation of ruffle assembly (GO:1900027),0.41445048880274715,1.01615582549559,0.4540880503144654,1.0,1.0,1/23,0.06%,CARMIL2
prerank,negative regulation of cyclase activity (GO:0031280),0.4517187340311718,1.015989124841895,0.4578146611341632,1.0,1.0,2/14,7.66%,LTB4R2;ADGRV1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4049394527504141,-1.0157478962014568,0.4382716049382716,0.8498858273690159,1.0,4/11,6.81%,YBX3;RIPK1;SLC25A4;PELI1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4336298290565989,1.0156511032193942,0.44715447154471544,1.0,1.0,3/15,9.31%,REEP4;ATL1;RAB10
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3432944502332178,1.0156343333138755,0.46290491118077326,1.0,1.0,25/113,16.68%,LCP1;BAX;PARP1;HSP90AA1;STUB1;WARS1;DDX3X;TIRAP;SLF2;DDB1;TPPP3;DHX33;CUL4B;VCP;GTF2H3;PSMC5;PARK7;RACK1;ATR;NRG1;TGFB1;FAF1;TERF1;IL5;TPPP
prerank,cytosolic calcium ion transport (GO:0060401),-0.2995602246805667,-1.0153972353969518,0.39473684210526316,0.8488493485683631,1.0,19/28,32.09%,MICU1;CACNA2D1;CACNA1C;ITPR3;SLC35G1;MCU;MCUR1;ADRA1A;MCUB;ATP2B3;MAIP1;SMDT1;ATP2A3;RYR2;MICU3;SLC8A1;JPH2;JPH4;SLC8A2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4218324380125317,1.0152746900950576,0.46838709677419355,1.0,1.0,5/21,12.27%,BRD4;FBXO5;CDC25A;VPS4B;NPM1
prerank,regulation of telomere capping (GO:1904353),0.4024199003192276,1.0151569767244077,0.46437994722955145,1.0,1.0,6/23,17.42%,PKIB;USP7;HNRNPD;RAD50;TNKS;NABP2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.39531005065783,1.0148618220336336,0.44878048780487806,1.0,1.0,3/32,6.13%,PDPK1;GRIN1;THY1
prerank,negative regulation of viral process (GO:0048525),0.3565429723180983,1.0147015613120678,0.461283185840708,1.0,1.0,12/57,18.85%,ILF3;HEXIM1;TRIM11;TRIM35;TRIM62;CHMP3;SHFL;ZC3HAV1;OAS2;TNIP1;SRPK1;TRIM27
prerank,regulation of B cell proliferation (GO:0030888),0.3743455654021084,1.014554759577426,0.45538818076477405,1.0,1.0,5/44,11.06%,FCGR2B;EPHB2;TIRAP;IRS2;BCL2
prerank,iron-sulfur cluster assembly (GO:0016226),0.40660444471686924,1.0145478557041976,0.4665012406947891,1.0,1.0,6/24,14.77%,ISCA2;NUBP2;NUBP1;CIAO2A;MMS19;ABCB7
prerank,regulation of cell migration (GO:0030334),0.32834093541149256,1.0139453670546346,0.46646646646646645,1.0,1.0,91/382,21.29%,FGF20;CARMIL2;SFRP2;FGF9;CLN3;CAMK2B;SFRP1;IGF1;EPHB2;ELP6;FAM83H;NTF3;RAC1;PLXNA2;MGAT3;ANXA1;XBP1;CXCL12;MINK1;FGF10;PRKCA;SNAI1;FLCN;SULF1;CD151;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;RHOD;RFFL;PODN;PLXNA1;SDCBP;EGF;RIPOR1;SEMA3D;NTNG2;SRCIN1;ENPP2;TPM1;MAZ;PDGFRA;ROBO1;MAGI2;YTHDF3;DAG1;SOD2;RACK1;ROR2;LAMB1;RNF41;ROCK2;TGFB1;SLURP1;ARSB;SEMA3E;F3;SEMA3A;CTSH;NKD1;JAG1;SERPINE1;PLXNB3;DPEP1;SPRY2;RUFY3;MCTP1;SORL1;CEMIP;AMOT;TGFBR1;MMP14;MITF;CARMIL1;DLC1;DAB2;NEXN;GCNT2;PTK2B;TBCCD1;NF2;SMAD7;SRGAP1;ITGB1;APPL2;SGK3;DLG5;MAP4K4;FGF2
prerank,histone H4 acetylation (GO:0043967),-0.259825986202546,-1.0135237144257754,0.3786407766990291,0.8521905842795547,1.0,22/47,22.96%,EPC1;TRRAP;LEF1;KAT7;JADE2;NAA40;EP300;JADE1;KANSL3;JADE3;WDR5;MSL3;HCFC1;ACTL6A;ING3;BRCA2;KAT8;ING5;NAA60;APBB1;RUVBL1;TRIM16
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.44975611849107777,1.0133984006339012,0.46629213483146065,1.0,1.0,3/15,10.40%,GPLD1;ADM;IRS2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.29330738473059587,-1.012900129892399,0.44,0.8518995180948681,1.0,7/30,7.61%,LATS1;SMAD4;BCL9;TWSG1;TRIM33;ITGA3;ENG
prerank,positive regulation of protein localization to membrane (GO:1905477),0.34584651917487225,1.0126262126180157,0.4673684210526316,1.0,1.0,23/98,18.57%,EPHB2;PDPK1;FIS1;TFDP1;SLC5A3;MTCL1;MIEF2;PIK3R1;SQSTM1;NMT1;YWHAH;CLIP3;YWHAG;BCL2;ANK3;PRKCI;LRP1;DPP10;SPTBN1;ITGB1BP1;KIF5B;CEMIP;PDCD5
prerank,mRNA destabilization (GO:0061157),0.3759137879311838,1.0122723899209385,0.46926713947990545,1.0,1.0,10/38,15.03%,KHSRP;PLEKHN1;ZFP36L1;CELF1;DHX36;RC3H2;YTHDF3;YTHDF1;ROCK2;DIS3L2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3503906748956246,1.0119538458108068,0.48891235480464623,1.0,1.0,15/85,10.61%,IGF1;FOXM1;EPHB2;SGSM3;LZTR1;OGT;FGF10;FLCN;SQSTM1;RASGEF1A;MFN2;RALGPS1;RAPGEF1;IRS2;DENND4C
prerank,regulation of protein localization (GO:0032880),0.3576551687632273,1.0118970844976252,0.4758771929824561,1.0,1.0,11/58,12.69%,TRIM67;PARP1;HSP90AA1;STX6;DVL1;MMD;TRIM17;RABGAP1L;PLEKHM2;DNAJB6;RACK1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.43292094904438794,1.0118779570517658,0.4616457461645746,1.0,1.0,4/16,12.86%,FLCN;RRAGA;GPR137C;LAMTOR5
prerank,positive regulation of gene expression (GO:0010628),0.32782989496216924,1.011854991394469,0.462,1.0,1.0,94/442,19.80%,FGF20;FGF9;MAPK9;WNT5A;EPB41L4B;TMEM119;WBP2;PTGER4;IGF1;EPHB2;BMP6;EIF2AK3;IL33;RBM3;WARS1;ERP29;DDX3X;SNF8;C1QTNF1;AGPAT1;FGF10;FUBP1;SF3B1;OLFM1;TBP;PIK3R1;CELF1;ZBTB7B;NOS1AP;HGS;SEC16B;PID1;SOX9;HNRNPD;RBMS3;DHX36;EGF;SOX11;TWIST1;CALCOCO1;MUSK;ATF2;PIK3CB;APP;RBPJ;ZCCHC4;ANK3;MAZ;ROBO1;IFNGR1;YTHDF3;PARK7;POLR2K;NPM1;TADA3;AGO3;LAMTOR5;SETX;TLR3;SCAMP5;YTHDF1;PTPN22;FAM98A;ROCK2;PRR16;TGFB1;MAP2K2;EPHX2;F3;HNRNPLL;MED23;CTSH;DDX5;POLR1A;FMR1;UBR5;SPRY2;OSR1;CAMK2N1;S100A13;RBM22;METTL5;TGFBR1;PDCD5;FLOT1;PRKAA1;TAF1B;FOXD1;SOX4;RPS3;MITF;KLF4;CIRBP;GABPA
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41580532748973403,-1.0117576356510887,0.46153846153846156,0.853235425241676,1.0,4/10,17.43%,PCGF5;PRMT7;IGF2;KDM1B
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.37043959817364175,1.0117107619333474,0.4618055555555556,1.0,1.0,11/42,19.07%,PARP1;ACTR2;FBH1;FUS;WRAP53;KLHL15;MRNIP;MMS19;HELB;TERF2IP;PPP4C
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3400101354560653,1.0115830578148286,0.4629822732012513,1.0,1.0,12/95,10.30%,WNT5A;FCGR2B;SIRT2;SELENOS;NFKB1;XBP1;TNFAIP3;TIRAP;CARD16;SIRPA;TRIM41;LY96
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3489004493722658,1.011553099738073,0.46881720430107526,1.0,1.0,14/75,17.48%,RNF157;GUCA1B;GNG7;METAP1;NMT1;ZDHHC3;PPP1R9B;RIC8B;GIT1;METAP2;ROCK2;TULP3;MRAP2;USP33
prerank,negative regulation of phosphatase activity (GO:0010923),-0.3056054890506856,-1.0112800427363628,0.43577981651376146,0.8525931150792597,1.0,7/25,19.70%,URI1;TGFB2;SEMA4D;PTPA;BOD1L1;SH3RF2;ZCCHC9
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4014205654747785,-1.0110918828017574,0.4559748427672956,0.8511056236412494,1.0,5/11,24.20%,ATP1A1;KCNJ2;ATP1B1;KCNJ3;KCNQ1
prerank,regulation of protein processing (GO:0070613),0.4235628523869406,1.0110330079305785,0.47074468085106386,1.0,1.0,2/21,4.19%,CLN3;CCBE1
prerank,neuron apoptotic process (GO:0051402),0.43224948405677116,1.0110094469055038,0.47395171537484115,1.0,1.0,5/19,11.06%,CDK5;FAM162A;CIT;APP;BCL2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.39712375178735243,1.0105621806739495,0.4607594936708861,1.0,1.0,6/28,9.63%,ABITRAM;GBA2;CXCL12;PAK3;DBN1;DBNL
prerank,regulation of proteolysis (GO:0030162),0.37082636396920293,1.0102308478879558,0.46524663677130046,1.0,1.0,7/48,9.66%,CLN3;CLN6;STUB1;OGT;CDK5;AURKAIP1;PLAT
prerank,organelle fission (GO:0048285),0.4121000415655978,1.0102224482548818,0.45603015075376885,1.0,1.0,6/24,14.84%,DNM1;FIS1;SEC16B;MTFR1L;GDAP1;DNM1L
prerank,positive regulation of secretion by cell (GO:1903532),0.3493601098273294,1.0102113079057804,0.45387062566277836,1.0,1.0,11/70,14.84%,UNC13D;IGF1;BMP6;EDN3;SOX11;MYH10;RAB2B;TMED10;TGFB1;GRK2;DNM1L
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.33174763436716415,1.0100235090311394,0.4794794794794795,1.0,1.0,82/241,23.06%,RAVER2;LSM6;LSM7;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;HNRNPK;FUS;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;HNRNPD;PPIH;CPSF7;HNRNPM;PABPC1;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CPSF3;HNRNPA0;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;DDX5;YTHDC1;SNW1;SRRM1;PRPF40B;PCBP2;RBM22;GCFC2;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;PTBP1;SART1;SRRM2;ISY1;GTF2F2;HNRNPUL1;METTL14;PNN;U2AF2;ZCRB1;SRSF6;ZMAT5
prerank,response to peptide (GO:1901652),0.3803826140198026,1.0098145655647004,0.46545454545454545,1.0,1.0,3/33,3.76%,MMP12;STAT6;ANXA1
prerank,positive regulation of DNA replication (GO:0045740),-0.3441382521388801,-1.0096534279570888,0.41729323308270677,0.8530678451028852,1.0,4/16,7.16%,EGFR;KAT7;BCAR3;STN1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4797084525437295,1.0095809939990263,0.472992700729927,1.0,1.0,3/11,7.40%,CCT8;CCT6A;WRAP53
prerank,aerobic electron transport chain (GO:0019646),0.3493119026005011,1.0095206133804466,0.4738562091503268,1.0,1.0,11/68,10.37%,NDUFAB1;UQCRC1;NDUFA7;NDUFAF1;SDHA;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;COX7B
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.397322315199902,1.00946990759306,0.4556500607533414,1.0,1.0,5/29,10.40%,IGF1;FGF10;RASGEF1A;RAPGEF1;IRS2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4552093551320638,1.009334939558424,0.4643356643356643,1.0,1.0,2/13,7.66%,LTB4R2;ADGRV1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.40955262364334205,1.008866044671553,0.4685929648241206,1.0,1.0,5/25,14.46%,MPP2;GRIN1;GRIN2A;NLGN3;GLRA1
prerank,hexose metabolic process (GO:0019318),0.3717411104570035,1.0085431560651221,0.4668218859138533,1.0,1.0,2/39,2.71%,GALT;GALK1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3425502775546698,1.0081473760933664,0.4702194357366771,1.0,1.0,34/96,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4489384594814106,1.0081448253648626,0.453015427769986,1.0,1.0,6/14,22.83%,HDAC5;TBXA2R;ITGB1BP1;KLF4;STARD13;MEOX2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3895200196428651,1.0074968227112464,0.46958637469586373,1.0,1.0,7/29,17.91%,ARRDC4;ABL1;FBXO5;PARK7;UBE2L3;TOPORS;DCUN1D5
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4125621173672004,1.0074026905950693,0.46055979643765904,1.0,1.0,7/23,19.74%,WEE1;PLK5;CDK5RAP3;CHFR;ZWINT;NABP2;ZW10
prerank,mesenchyme morphogenesis (GO:0072132),-0.3411058783784041,-1.0073798723893959,0.43873517786561267,0.857406945060183,1.0,5/17,7.77%,TGFB2;NOS3;ACVR1;ENG;BMPR1A
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.38381746847695536,1.0073375783684535,0.4781582054309327,1.0,1.0,14/37,22.71%,S1PR2;SIRT2;CALM3;DMTN;EGF;APP;TGFB1;SPRY2;CEMIP;CALM1;PRKAG2;SMAD7;CALM2;WNK3
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.2940960652302024,-1.0073264573238199,0.4444444444444444,0.8555457543949884,1.0,6/29,6.64%,FLT1;KIT;IRS1;PRKD1;TEK;DGKZ
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.25550211761331765,-1.0071936080665873,0.39166666666666666,0.8538885172274545,1.0,13/48,11.74%,HIPK2;FNIP2;MCL1;PML;USP28;SIRT1;BCL2L1;HIPK1;TP53;EP300;IKBKE;MSH2;BCL2L2
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.27707777218131246,-1.0070233031100484,0.42771084337349397,0.8523559292925743,1.0,6/32,7.94%,MEF2C;PREPL;RIMS2;SYN1;LRRK2;DTNBP1
prerank,neuron projection development (GO:0031175),0.3338767705906536,1.0066505973817432,0.4818913480885312,1.0,1.0,53/168,23.00%,STMN4;EPHB2;NTF3;GPRIN1;TAOK1;CTNND2;MINK1;NEFH;CDK5;SRGAP2;PAK3;EPHA8;DBN1;TMEM108;CAMSAP2;ADGRV1;PPP1R9B;DBNL;GDNF;APP;LRP12;ALS2;BLOC1S2;MAPK8IP3;BICDL1;DOCK7;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;EPB41L3;CNTNAP2;TRIO;SLC9A6;APOE;MAP4;ATCAY;GAS7;KIF20B;SHANK1;NRK;ATXN10;LYN;NBL1;EHD1;MAP4K4;RYK;HMGB1;CAMSAP1;PAK1;EPHA4;MAP2
prerank,neurogenesis (GO:0022008),0.3657930900671234,1.005436688873901,0.46674445740956827,1.0,1.0,15/43,23.94%,ANXA1;CXCR4;CIT;SPOCK1;NDUFS2;LPAR1;MAPT;TRAK1;BTBD3;BTBD1;BTBD2;RYK;METTL14;CDK5RAP2;FAT4
prerank,organic substance transport (GO:0071702),0.3370984092079026,1.0054312998261197,0.4984583761562179,1.0,1.0,33/120,24.23%,ARRDC4;PICK1;KIF3A;SLC22A4;ABCA2;MIA3;RCN3;LMAN2L;CHMP3;ABCA7;SLC50A1;VPS33B;ABCA6;SCAMP5;SLC6A4;SLC18A1;SCAMP1;ABCD2;TXNIP;RUFY1;SNX4;LRP1B;TOM1;ABCA5;CMTM6;ABCG1;RAB7A;MYH9;SPNS2;ABCA9;PLEKHA8;ABCA1;PEX3
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.38518091145527916,-1.0054029756319067,0.45714285714285713,0.8551643918151443,1.0,6/13,42.43%,LAMP1;SYK;SPHK2;ITGB2;ITGAM;FGR
prerank,glutamine family amino acid metabolic process (GO:0009064),0.387906877984614,1.0052024063150051,0.4994054696789536,1.0,1.0,7/33,13.26%,GLS2;FPGS;OAT;GLUL;ALDH4A1;GCLC;DGLUCY
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.38911885595151596,-1.005122035734736,0.41914191419141916,0.8539588790120854,1.0,10/12,30.20%,ACO2;ACO1;IDH1;ACLY;IDH2;IDH3A;IREB2;SIRT4;GLUD1;IDH3G
prerank,fibrinolysis (GO:0042730),0.45419235139779035,1.0046664072573668,0.4797202797202797,1.0,1.0,2/13,16.49%,PLAT;SERPINE1
prerank,hippo signaling (GO:0035329),0.3981348757808253,1.0040362250021575,0.4818523153942428,1.0,1.0,3/26,7.26%,TEAD3;DVL2;TEAD1
prerank,gliogenesis (GO:0042063),-0.34991877665931626,-1.0038888963041548,0.4259927797833935,0.8556371923369152,1.0,5/15,13.01%,NFIB;RELN;TGFB2;CDK6;METTL3
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2630963257571732,-1.003542037267985,0.43410852713178294,0.8546290355639065,1.0,6/42,7.91%,DROSHA;IL6R;RNASE3;LBP;TLR4;RPS19
prerank,early endosome to Golgi transport (GO:0034498),0.47778812553598604,1.0033848021360565,0.4822485207100592,1.0,1.0,6/11,25.21%,TRAPPC10;RAB6A;STX5;EHD3;SURF4;LMAN1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3924759203367081,1.0030284558995872,0.4778645833333333,1.0,1.0,8/25,24.17%,HSP90AA1;NOS1AP;PTGS2;PKD2;ASS1;KLF4;SMAD3;INSR
prerank,negative regulation of cell motility (GO:2000146),0.34003424909179863,1.002881810849669,0.5145833333333333,1.0,1.0,41/108,26.16%,SFRP2;SFRP1;FBLN1;FLCN;SULF1;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;PODN;TPM1;ROBO1;MAGI2;DAG1;RNF41;SLURP1;JAG1;SERPINE1;PLXNB3;DPEP1;MCTP1;MITF;DLC1;NF2;SMAD7;SRGAP1;DLG5;IGFBP5;EPHA4;DPYSL3;PTEN;ADARB1;CX3CL1;NAV3;DUSP3;AFDN;VCL;CLIC4;GTPBP4;RECK
prerank,vascular process in circulatory system (GO:0003018),-0.38238397560643034,-1.0019538753142165,0.47202797202797203,0.8553005900016766,1.0,6/13,14.83%,SCPEP1;NOS3;GCLM;ROCK1;NPR1;ACE
prerank,regulation of tube diameter (GO:0035296),-0.38238397560643034,-1.0019538753142165,0.47202797202797203,0.8553005900016766,1.0,6/13,14.83%,SCPEP1;NOS3;GCLM;ROCK1;NPR1;ACE
prerank,mitochondrion organization (GO:0007005),0.3315702896299824,1.0019469140891801,0.49294354838709675,1.0,1.0,44/165,20.13%,BAX;DNM1;CHCHD10;BCS1L;PARP1;MSTO1;FIS1;AIFM2;USP30;MYH14;SLC25A33;TOMM20;FBXO7;TIMM13;MIEF2;SLC25A36;MFN1;COX7A2;FANCG;PID1;MFN2;AIP;MTFR1L;AFG3L2;PTCD2;PARK7;GDAP1;WASF1;MTX3;DNM1L;HSPD1;TFB1M;TRAK1;SIRT5;MTX2;VPS13D;OMA1;GABPB1;ATCAY;AGTPBP1;OXA1L;GABPA;TIMM44;TIMM22
prerank,amide biosynthetic process (GO:0043604),0.36619563703899627,1.0018143402615058,0.4965986394557823,1.0,1.0,8/47,13.94%,ASL;SMPD2;PCSK5;CERS2;SPTSSA;TLCD3B;PAM;SMPD4
prerank,regulation of gene expression (GO:0010468),0.32181190659679015,1.001502718714792,0.499,1.0,1.0,204/903,19.85%,FGF20;SFRP2;APLN;FGF9;KHSRP;AFF2;MAPK9;WNT5A;EPB41L4B;TMEM119;SFRP1;IGF1;DVL2;EPHB2;ANXA7;NFKB1;BMP6;FAM50A;EIF2AK3;IL33;EDN3;PCBP4;NR1D2;PCGF1;PTHLH;WARS1;ERP29;RORA;NFKB2;ZFP36L1;DDX3X;PSPC1;ZNF205;TRIM11;SNF8;C1QTNF1;NELL1;FGF10;IGF2BP2;FUBP1;FLCN;OLFM1;NPAT;CNBP;ABL1;ATXN1;PHF1;ATG14;DVL1;ZNF35;CELF1;CASZ1;HNRNPK;EZH2;FUS;ZBTB7B;NOS1AP;MAGED1;ZNF711;HGS;HDAC5;SIRPA;ADNP;SEC16B;ZBTB38;ASCC1;PID1;ZKSCAN5;ACTR8;NFX1;SFMBT2;WNT4;SOX9;DDIT3;PER1;HNRNPD;RBMS3;DHX36;EGF;PRMT5;HDAC4;TRIM17;SOX11;SAP30L;TWIST1;CALCOCO1;MUSK;FADS1;ZC3H7B;RBL2;GDNF;ATF2;POU6F2;CAVIN4;PIK3CB;APP;NSD3;RBPJ;SART3;ANK3;MAZ;ROBO1;FOXN3;IFNGR1;YY1;NUDT21;BACH1;PARK7;ZNF462;PEG3;SOX6;TADA3;HDAC1;AGO3;RACK1;HNRNPH3;LAMTOR5;HNRNPL;SUFU;PARP14;TLR3;TRA2B;PTPN22;C1D;ATRX;FAM98A;MAPT;NOVA1;ROCK2;TGFB1;ESRRG;MAP2K2;TULP3;BCL6;EPHX2;KMT2D;F3;HNRNPLL;ZUP1;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;CTSH;GRSF1;AHNAK;GTF2IRD1;CHEK2;HNRNPDL;YTHDC1;NDFIP2;SBNO1;CLOCK;MEGF8;TRIP4;KDM6B;DAXX;UBE2L3;UBR5;CLK4;TIPARP;ZFP37;SPRY2;ZC3H7A;SOX13;OSR1;APOE;HP1BP3;SON;TLE5;TCF7;NFXL1;NSD1;CAMK2N1;PCBP2;PHF12;ATRAID;MECP2;GCFC2;NONO;TGFBR1;TERF2IP;PDCD5;PRKAA1;TRIM27;FOXD1;NUP35;SOX4;BRDT;YAF2;YTHDF2;RPS3;KDM6A;MITF;CDK11B;KLF4;WWC1;CARM1;GABPA;NFIA
prerank,protein autoubiquitination (GO:0051865),0.3538284270075818,1.0011536746003973,0.4824945295404814,1.0,1.0,11/61,14.63%,RNF157;RNF8;STUB1;NFX1;TRIM17;RNF11;UBE2A;RNF19B;RNF220;RNF41;RNF122
prerank,regulation of presynapse organization (GO:0099174),0.4211871218653152,1.0011111100390913,0.47644683714670255,1.0,1.0,5/18,17.96%,GPC6;APP;IL1RAPL1;GPC4;SLITRK1
prerank,regulation of presynapse assembly (GO:1905606),0.4211871218653152,1.0011111100390913,0.47644683714670255,1.0,1.0,5/18,17.96%,GPC6;APP;IL1RAPL1;GPC4;SLITRK1
prerank,membrane assembly (GO:0071709),0.3780356802333277,1.0009506407852968,0.4807228915662651,1.0,1.0,15/34,24.29%,UBXN2A;TLCD1;STX2;ANK3;IL1RAPL1;NLGN3;EMP2;NLGN2;SPTBN1;ANXA2;FLOT1;CHMP4B;LRP4;PTEN;NRXN2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.212853550824455,-1.0009140782975054,0.4,0.8565159329346306,1.0,21/105,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.43339385960202453,1.0007301482169266,0.45934959349593496,1.0,1.0,4/16,11.29%,NRP1;ABL1;PLAT;PDGFRA
prerank,regulation of DNA repair (GO:0006282),0.3666184381207941,1.000557376958326,0.47254004576659037,1.0,1.0,19/44,21.98%,SIRT7;RNF8;USP1;FGF10;CDK9;WRAP53;RNF168;UBE2V2;POLH;CEBPG;AXIN2;EYA2;UBR5;UIMC1;RPS3;EYA1;TRIP12;NPAS2;UBE2V1
prerank,negative regulation of viral release from host cell (GO:1902187),0.447340870714539,1.0001465680576573,0.4826629680998613,1.0,1.0,6/13,22.47%,TRIM11;TRIM35;CHMP3;MID2;TRIM26;TRIM8
prerank,regulation of interleukin-1 production (GO:0032652),0.43692828944882656,0.9997766799679877,0.4899057873485868,1.0,1.0,3/15,12.75%,ANXA1;SIRPA;TMED10
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.4345915195719733,0.9997622991434394,0.48567530695770805,1.0,1.0,4/16,14.34%,A4GALT;ST8SIA3;ST3GAL5;ST6GALNAC6
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3201465251606338,0.9995034519719923,0.51,1.0,1.0,214/1082,18.38%,PSRC1;SFRP2;METTL23;ILF3;CAMTA2;MMP12;HDAC3;LAGE3;WNT5A;PTPRN;WBP2;HSF2;SFRP1;IGF1;MED24;SP7;DVL2;MPND;FOXM1;SIRT2;ZBTB48;SIRT7;DDX17;MYRF;CRTC1;NFKB1;SMARCD3;CHCHD10;BMP6;PARP1;ZEB2;EIF2AK3;IL33;USF1;NR2F2;FGFR2;MLXIP;NKX6-1;MAPRE3;MED12;SMARCC2;MED14;GLIS2;STAT6;NR1D2;GRIN1;HTATIP2;XBP1;ACTR2;RORA;TFDP1;KMT2B;NFKB2;DDX3X;BRPF1;LPIN1;SNX5;CCNC;OGT;CHD8;POU2F1;IL31RA;RFX5;SNAI1;CDK9;FLCN;MRTFA;NPAT;TCF4;TCF7L2;ASF1A;TFCP2;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;DVL1;ZIC3;CASZ1;TRIM56;AKAP8L;ARNT;ANKRD49;ZNF711;SMARCB1;DHX33;TEAD1;TGFB1I1;HDAC5;MOSPD1;RAI1;ZBTB38;PID1;MED4;DBP;PRPF6;ARRB1;WNT4;SLC30A9;SOX9;SMARCD1;DDIT3;CRTC3;DPF2;LPIN3;XRCC6;YWHAH;PER1;HNRNPD;ECD;ARID1B;DHX36;EGF;ATMIN;HDAC4;SOX11;TWIST1;CALCOCO1;NKRF;TCEA1;GDNF;ATF2;SSBP4;PSMC5;BRD8;APP;TAF6;NSD3;JUP;RBPJ;GLIS1;RFX4;PIK3R2;MAZ;NFAT5;IRF3;BMP5;YY1;SMARCA1;ZMIZ1;E2F3;NFIX;PARK7;ZNF462;PEG3;NPM1;TADA3;HDAC1;CEBPG;LPIN2;CREB3;CREB3L4;RPS6KA3;SETX;TLR3;ZBED3;MMS19;ABHD14B;FOXJ3;ATRX;AUTS2;ZIC2;TGFB1;MED21;RGMA;ESRRG;MAP2K2;BCLAF1;THOC1;KMT2D;RGMB;RFX3;NR2C2;TCF3;SSBP2;FOXC2;THAP3;RPS6KA1;AHI1;CHEK2;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;TRIP4;SERPINE1;TNKS;KDM6B;ITGB1BP1;THRAP3;PHIP;CDK7;OSR1;APOE;ZFP90;TNIP1;NSD1;GABPB1;GABPB2;MEIS2;TBL1XR1;ILK;PRKD2;PKD2;RNF111;KMT2A;BCL11B;GPS2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.43763321290141277,0.9994320730837833,0.47919655667144906,1.0,1.0,3/14,10.20%,STAT6;PIK3R1;PRLR
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.37128029504263294,0.9987891551399232,0.4902186421173763,1.0,1.0,7/41,13.71%,IL34;DLG3;LRP8;GPRC5B;EGF;SRCIN1;DOCK3
prerank,cellular response to UV (GO:0034644),0.34655389516436963,0.9987501331983244,0.4753747323340471,1.0,1.0,14/76,12.82%,MFAP4;PARP1;SDE2;CARD16;USP47;DDB1;STK11;CDC25A;DHX36;CUL4B;CASP9;YY1;NPM1;ATR
prerank,cellular potassium ion homeostasis (GO:0030007),0.4518728838569107,0.9986887235829169,0.47293447293447294,1.0,1.0,3/13,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3468802642264339,0.998569619222269,0.4835164835164835,1.0,1.0,11/69,10.37%,NDUFAB1;UQCRC1;NDUFA7;NDUFAF1;SDHA;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;COX7B
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.43735949333732543,0.9982530888308251,0.48575305291723203,1.0,1.0,3/16,10.90%,IGF1;FGFR2;RBPJ
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2947523684030145,-0.9979644597597641,0.42857142857142855,0.862691554641469,1.0,5/25,5.21%,FOXO3;MED1;STAT3;STAT1;HIF1A
prerank,intermediate filament organization (GO:0045109),0.43764712150829155,0.9978820599938187,0.4865951742627346,1.0,1.0,4/17,16.80%,NEFL;DES;DNAJB6;BFSP2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3425531694236147,0.9976462015852366,0.49580712788259956,1.0,1.0,18/90,17.63%,HDAC3;STAT6;LPIN1;OGT;ALMS1;MFAP2;ZBTB7B;CXCR4;MFN2;GNAS;PRLR;CPT2;LEPR;EHMT1;ESRRG;ACADL;KDM6B;OMA1
prerank,negative regulation of programmed cell death (GO:0043069),0.3235949752269432,0.99728890669561,0.515,1.0,1.0,74/355,19.02%,RNF157;HDAC3;WNT5A;CLN3;SFRP1;IGF1;TCIM;PPIF;ARAF;NFKB1;BNIP1;TAF9B;AIFM2;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;NUAK2;IL31RA;MGMT;USP47;PRDX5;PIK3R1;PRELID1;SQSTM1;BAG1;BARD1;HNRNPK;ZFAND6;IFIT3;XIAP;SOX9;UBE2Z;MALT1;GDNF;PRLR;PSMC5;BCL2;BNIP2;PARK7;NPM1;HDAC1;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;TXNDC5;SMAD6;CBL;MRE11;NUPR1;CASP2;HSPD1;RPS6KA1;CTSH;AHI1;FAIM2;DPEP1;PHIP;SPRY2;MTDH;OSR1;SON;TOPORS;ANXA4;GPX4;KLHL20;BAG4;PRKAA1;BIRC3;FMN2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3736806091559062,0.9972823684980163,0.48928571428571427,1.0,1.0,8/38,15.94%,CENPT;UBN1;RBBP4;ASF1A;NPM1;CENPC;ATRX;HAT1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3672109742069456,-0.9966585537025296,0.4276315789473684,0.8644125254333678,1.0,6/12,25.44%,NFKBIA;NR1H3;NR1H2;PPARG;PPARA;ITGB3
prerank,polarized epithelial cell differentiation (GO:0030859),0.4592758437409913,0.9964177078060745,0.5007072135785007,1.0,1.0,3/13,9.31%,SCRIB;RAP2A;RAB10
prerank,positive regulation of protein kinase activity (GO:0045860),0.33195985926092914,0.9958841787087925,0.5112474437627812,1.0,1.0,33/148,19.17%,IL34;INCENP;HSP90AA1;CALM3;MAPRE3;TAOK1;DDX3X;MINK1;DDR2;DLG3;PAK3;EZH2;STK11;LRP8;MMD;GPRC5B;XRCC6;MRNIP;SRCIN1;JTB;STRADB;ALS2;IQGAP1;EMP2;PARP16;MAP2K2;SLC27A1;DAXX;CCDC88A;RASSF2;CALM1;PRKAG2;NRK
prerank,regulation of interleukin-4 production (GO:0032673),-0.33012763129845296,-0.9958224574427215,0.4322033898305085,0.8648428908737302,1.0,9/21,32.79%,LEF1;LGALS9;RARA;CEBPB;CD86;SYK;ZFPM1;HAVCR2;FCER1G
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.45157353093121455,0.9955456387027212,0.47564469914040114,1.0,1.0,3/13,14.06%,NOP9;RCL1;BMS1
prerank,neuron maturation (GO:0042551),0.4285867338194055,0.9953461338286596,0.4922879177377892,1.0,1.0,7/18,18.42%,PICK1;EPHA8;APP;B4GALT5;MTCH1;FARP2;ADGRB3
prerank,peptidyl-lysine modification (GO:0018205),0.3370690053166775,0.9948459736722216,0.5125,1.0,1.0,29/99,20.92%,NDUFAB1;SIRT2;SIRT7;USPL1;SAE1;RAE1;PLOD1;ETFBKMT;HDAC4;NUP188;SENP5;VPS33B;PARK7;NUP210;NUP88;PIAS3;NUP214;ATPSCKMT;SIRT5;TOPORS;NUP153;RANBP2;NUP35;PIAS1;LOXL1;SUMO2;EYA1;SENP7;TPR
prerank,positive regulation of cell cycle process (GO:0090068),0.3374979443824946,0.9947582710013531,0.5005213764337852,1.0,1.0,20/91,20.92%,IGF1;SIRT2;EDN3;MAD2L1;CDC14B;CIT;EGF;GPSM2;USP19;DYNC1LI1;SVIL;ATRX;CSPP1;CEP120;NUMA1;PHIP;RAD21;KIF20B;INO80;TPR
prerank,protein homooligomerization (GO:0051260),0.33553683642581517,0.9947580646517536,0.5175619834710744,1.0,1.0,22/114,18.02%,ALOX5AP;TRMT61B;GSDMD;MPP2;ASIC1;ATL1;ALDH1A2;FUS;TK1;TIFA;KCNC2;ALS2;NACC2;SOD2;PRMT1;HPRT1;SLC1A5;AQP4;PRMT8;MLKL;SLC1A2;PKD2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.32931784559135296,0.9945313820964709,0.508577194752775,1.0,1.0,40/170,19.43%,KHSRP;AFF2;IGF1;EDN3;PCBP4;PTHLH;ZFP36L1;TRIM11;NELL1;IGF2BP2;FUBP1;NPAT;HNRNPK;ZNF711;SIRPA;ADNP;HNRNPD;TRIM17;GDNF;CAVIN4;ZNF445;APP;SART3;ZNF462;PEG3;C1D;NOVA1;ROCK2;ZUP1;HNRNPDL;MTMR4;MEGF8;KDM6B;APOE;PCBP2;ATRAID;FLOT1;TRIM27;SCARB2;KDM6A
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2243763232166904,-0.9944886150216795,0.5,0.8665635590298955,1.0,36/88,24.63%,ANGPT1;CAV1;PTPRM;STAT1;SIRT1;PRKD1;NRAS;NRP2;TEK;HIF1A;AGGF1;THBS1;AIMP1;TIE1;ECM1;KDR;CAV2;AKT3;SCG2;BMP4;VEGFC;RGCC;TNFSF12;EMC10;VEGFA;NF1;PDCL3;AKT1;ATOH8;STAT5A;NR4A1;PIK3CD;VEGFB;SEMA5A;PGF;BMP2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4545196910366816,0.9942827218905942,0.48068669527896996,1.0,1.0,5/12,23.25%,UNC13A;SYT1;UNC13B;SYT7;SYT2
prerank,chromatin remodeling (GO:0006338),0.33964904733931933,0.9942725381748362,0.4782157676348548,1.0,1.0,25/100,16.74%,KDM4D;MPND;SMARCD3;SMARCC2;GATAD1;CHD8;RBBP4;SMARCB1;HDAC5;ACTR8;SOX9;SMARCD1;ARID1B;HDAC4;JARID2;TOP1;SMARCA1;MTA2;NPM1;HDAC1;ATRX;BAZ2B;SATB1;KDM6B;DAXX
prerank,negative regulation of myoblast differentiation (GO:0045662),0.455965411099963,0.9941887963824763,0.4764621968616263,1.0,1.0,3/13,14.28%,SOX9;SRA1;TGFB1
prerank,positive regulation of dendritic spine development (GO:0060999),0.4189222881670301,0.9938850744981782,0.49017038007863695,1.0,1.0,9/20,21.20%,CAMK2B;DBN1;LRP8;DHX36;DBNL;FMR1;APOE;SHANK1;DLG5
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3184151034792204,-0.9936793869192724,0.45739910313901344,0.8670954627438452,1.0,4/20,20.32%,AKR1B1;STARD3NL;FDX1;TSPO
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.361558828168554,0.9933158048758894,0.5079365079365079,1.0,1.0,10/45,11.68%,RBM4B;RBM3;METAP1;ATG14;CYFIP1;PER1;PUM3;ZC3H7B;APP;NUDT21
prerank,positive regulation of cell death (GO:0010942),0.35412083103556796,0.9932729432039844,0.5116279069767442,1.0,1.0,11/59,16.74%,WNT5A;FCGR2B;HTATIP2;CELF1;EFNB2;AXIN2;LRP1;MAPT;FAF1;SLC6A13;DAXX
prerank,sulfate transport (GO:0008272),-0.3597640639594698,-0.993153746599295,0.4870848708487085,0.8665399593502621,1.0,6/14,22.89%,SLC26A7;SLC26A2;SLC26A11;SLC25A14;SLC25A30;SLC25A11
prerank,T cell activation involved in immune response (GO:0002286),0.4605670898697426,0.9929049072926801,0.5162241887905604,1.0,1.0,1/12,0.97%,LCP1
prerank,response to estrogen (GO:0043627),0.38349083594447136,0.9926214596207815,0.4927710843373494,1.0,1.0,6/31,15.00%,WBP2;SFRP1;CD24;SRA1;NCOA4;KMT2D
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3826846396543362,0.9925437892326783,0.5105067985166872,1.0,1.0,2/29,2.68%,FASN;ELOVL1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4061245667603208,0.9924340938050619,0.4766977363515313,1.0,1.0,3/22,9.49%,ALDH1A2;GC;RBP1
prerank,embryonic heart tube development (GO:0035050),-0.3571914005637371,-0.9922182660406094,0.44280442804428044,0.8671799783217478,1.0,8/14,32.34%,IFT122;ACVR1;HES1;SOX17;CITED2;TBX2;RYR2;SOX18
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.39880375672272067,-0.9917441827723161,0.4556213017751479,0.866651886784971,1.0,6/10,44.31%,PODXL;DPP4;WNK1;SKAP1;FERMT3;ADA
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3750721037461124,-0.9915926216709735,0.4528985507246377,0.8651412050783033,1.0,8/13,32.88%,DDO;MTHFS;GOT2;ACOT8;GOT1;GAD1;GLUD1;QPRT
prerank,positive regulation of glucose import (GO:0046326),0.4077209746152224,0.9914724447996673,0.4993548387096774,1.0,1.0,5/21,13.35%,IGF1;CAPN10;PIK3R1;IRS2;PRKCI
prerank,intracellular cholesterol transport (GO:0032367),-0.3540434774531348,-0.9914496736099896,0.4664179104477612,0.8635600978476695,1.0,7/15,22.89%,LRP6;OSBPL2;SERAC1;OSBP;VPS4A;LDLRAP1;STARD4
prerank,mitotic spindle organization (GO:0007052),0.3304402673334035,0.9913278738818178,0.5202839756592292,1.0,1.0,35/153,19.91%,B9D2;CENPT;CCDC61;INCENP;TAOK1;MAD2L1;STAG1;ARHGEF10;NEK9;WRAP73;KPNB1;DCTN6;PIBF1;PPP1CC;ABRAXAS2;VCP;MAP9;CEP126;GPSM2;DYNC1LI1;SPICE1;RCC1;CENPC;STAG2;ZWINT;OFD1;CHEK2;TNKS;BCCIP;MAP4;MECP2;RANBP2;DYNLL1;ZW10;PAFAH1B1
prerank,regulation of ATP metabolic process (GO:1903578),0.3548746940624601,0.9910202273707,0.4859075535512965,1.0,1.0,16/54,19.14%,FIS1;SLC25A33;OGT;RAE1;COX7A2;NUP188;PGAM1;AK4;NUP210;NUP88;UQCC2;NUP214;NUP153;RANBP2;PRKAG2;NUP35
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.35956110724130597,-0.9909893295458878,0.46511627906976744,0.8609085894933146,1.0,2/14,3.81%,ABCG2;ABCC1
prerank,heme catabolic process (GO:0042167),-0.35956110724130597,-0.9909893295458878,0.46511627906976744,0.8609085894933146,1.0,2/14,3.81%,ABCG2;ABCC1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.43593768769718455,0.9908817440612728,0.48068669527896996,1.0,1.0,2/15,4.50%,NTF3;CXCL12
prerank,protein deubiquitination (GO:0016579),0.32410672189786593,0.9908066063962905,0.5255255255255256,1.0,1.0,69/242,20.05%,CCP110;OTULINL;PSMD4;IL33;TAF9B;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;OGT;TNFAIP3;OTUD7A;USP24;TOMM20;USP47;PSMB10;USP42;BARD1;UCHL3;HGS;PSMD11;ACTR8;CDC25A;USP32;USP10;MDM4;ABRAXAS2;VCP;USP2;PSME2;PSMC5;USP11;USP15;USP3;USP19;YY1;TADA3;USP40;USP9X;USP4;PSMD1;USP34;USP35;UBE2D1;USP48;USP31;NEDD8;EIF3F;PSMD6;TNIP1;STAM2;USP33;MDM2;TAB1;TGFBR1;USP22;BIRC3;USP50;YOD1;UIMC1;VCPIP1;USP37;PSMD5;JOSD1;INO80;NFRKB
prerank,epithelial cell morphogenesis (GO:0003382),0.4217527871154637,0.9903709014261116,0.4828060522696011,1.0,1.0,2/17,6.62%,DACT2;COL22A1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.457891980970885,0.9901587466787117,0.4970674486803519,1.0,1.0,3/12,8.12%,SDE2;FBXO31;PLK5
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.30704732796440487,-0.9900660968409065,0.42105263157894735,0.8616022171104794,1.0,5/24,11.10%,MEF2A;MEF2C;SPAG9;RBM4;CAMK1
prerank,positive regulation of vacuole organization (GO:0044090),0.4773845611755333,0.9900454898758083,0.5181818181818182,1.0,1.0,6/10,23.41%,PIP4K2B;PIP4K2A;PIP4K2C;ANXA2;RAB3GAP2;SH3GLB1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4327027943194962,0.9899794595955707,0.5061058344640434,1.0,1.0,5/16,13.96%,OGT;ARHGAP24;PIK3CB;ALS2;AUTS2
prerank,negative regulation of bone mineralization (GO:0030502),-0.3513826119523414,-0.9899427181305995,0.4490566037735849,0.8600014057705273,1.0,3/13,10.35%,BCOR;ECM1;SRGN
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.36725697583678896,0.9899067107973323,0.4942263279445728,1.0,1.0,9/38,16.70%,SFRP1;DDX3X;TNFAIP3;TMBIM1;RFFL;BMP5;ICAM1;SERPINE1;FAIM2
prerank,positive regulation of hydrolase activity (GO:0051345),0.33088661466617536,0.9897827828380487,0.5249237029501526,1.0,1.0,24/137,12.69%,SFRP1;CDKL5;TBC1D7;CALM3;SGSM3;RAP1GDS1;RGS10;FLCN;MTCL1;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RCN3;RAP1GAP;DOCK8;RAPGEF1;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;RACK1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4175281312715766,0.9897412068469363,0.48891786179921776,1.0,1.0,3/18,11.06%,PPIF;THEM4;BCL2
prerank,regulation of phospholipase C activity (GO:1900274),0.4266770096184348,0.9896843781612367,0.4684065934065934,1.0,1.0,4/15,11.29%,NTF3;FGFR1;ABL1;PDGFRA
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.33901856447559087,0.9895877729393673,0.5374868004223865,1.0,1.0,24/85,21.82%,WNT5A;DVL2;PSMD4;RAC1;FZD3;PSMB10;DVL1;PSMD11;AP2S1;PSME2;PSMC5;DAAM1;MAGI2;ROR2;PSMD1;PSMD6;SMURF1;PRICKLE2;PSMD5;PSMA4;FZD2;PSMA1;RYK;PSMC6
prerank,histone mRNA metabolic process (GO:0008334),-0.2971911364040807,-0.9894009482317674,0.46153846153846156,0.8596285696030674,1.0,15/27,26.25%,NCBP1;TENT2;CPSF2;LSM1;SNRPB;SNRPD3;ERI1;UPF1;NCBP2;TUT1;TUT4;SNRPG;SNRPE;SNRPF;SSB
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.44341461372423197,0.9893581728496214,0.4860335195530726,1.0,1.0,3/13,12.22%,BAX;VDAC2;BLOC1S2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4155060962580339,0.9893161905291353,0.48652482269503544,1.0,1.0,5/16,16.60%,PARP1;DHX36;HNRNPA2B1;TERF1;TNKS
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.33867808660857424,0.9888378203251896,0.5179704016913319,1.0,1.0,25/87,20.72%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;SLC25A33;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;SDHAF3;COX17;UQCC2;COA8;COX16;NDUFB4;NDUFA6;DMAC2;OMA1;NDUFA2;OXA1L;NDUFB3;NDUFA12
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3193874911262069,-0.9887325137133733,0.4653846153846154,0.8595206974238249,1.0,4/19,10.83%,ABHD5;IRS1;PRKCD;DAGLB
prerank,negative regulation of telomere maintenance (GO:0032205),0.4302289578001716,0.9884923719530166,0.48255813953488375,1.0,1.0,7/15,23.45%,PARP1;RAD50;TERF1;TNKS;TERF2IP;PINX1;ATM
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3554762080927636,0.9880195137563318,0.5148741418764302,1.0,1.0,7/46,12.17%,IGF1;TNFAIP3;TCF7L2;MFN2;XRCC6;IGFBP3;NDRG4
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4043817894017018,0.987883031662835,0.4968944099378882,1.0,1.0,5/24,16.68%,STMN4;TPPP3;KATNB1;MAPT;TPPP
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4088488860717175,0.9878514048981639,0.48930817610062893,1.0,1.0,2/22,3.10%,CDKN2D;PRKRIP1
prerank,platelet aggregation (GO:0070527),-0.2667650955665064,-0.9873977432423431,0.4423076923076923,0.8615737749971352,1.0,13/33,20.86%,FLNA;ACTB;ACTN1;STXBP3;PLEK;FN1;TLN1;ACTG1;HSPB1;P2RY12;MYL9;FIBP;MYL12A
prerank,macromolecule catabolic process (GO:0009057),0.39043877954295336,0.987345004058168,0.4981549815498155,1.0,1.0,7/26,20.44%,MVB12A;CLN6;UCHL3;TGFB1;SMURF1;PIK3R4;UVRAG
prerank,regulation of protein ubiquitination (GO:0031396),0.3337548894395659,0.9870709648073586,0.5266393442622951,1.0,1.0,27/108,19.43%,HDAC3;UBQLN1;PHF23;SIRT7;HSP90AA1;STUB1;TBC1D7;OGT;TNFAIP3;SQSTM1;MYCBP2;XIAP;ARRB1;CDK5RAP3;MALT1;PARK7;USP4;UBE2D1;NDFIP2;DERL1;DAXX;UBE2L3;SPRY2;TGFBR1;BIRC3;SOX4;RPS3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2825223585058334,-0.9870363574462336,0.4577114427860697,0.8606683647016516,1.0,10/29,19.16%,UBE2K;SAMHD1;IFNAR2;STAT2;HSP90AB1;CDC37;METTL3;MAVS;CNOT7;USP18
prerank,positive regulation of tissue remodeling (GO:0034105),0.46459073541925405,0.9861029803541914,0.5056360708534622,1.0,1.0,3/10,22.93%,TMBIM1;ROCK2;IL18
prerank,fatty acid beta-oxidation (GO:0006635),0.3614532992655819,0.9856249328555248,0.5125,1.0,1.0,15/51,16.69%,ACAD10;HADHB;ACAT1;HSD17B4;CROT;AMACR;CPT2;EHHADH;MECR;ECHDC1;ABCD2;ACOX3;ETFA;ACADL;ACADVL
prerank,positive regulation of dendrite development (GO:1900006),-0.38551112772197527,-0.9854798915124544,0.46105919003115264,0.8632864937891246,1.0,6/10,16.87%,DAB2IP;COBL;ZDHHC15;BMP7;ALK;PACSIN1
prerank,iron ion transport (GO:0006826),0.3510413713086706,0.9854643725105035,0.4971687429218573,1.0,1.0,15/47,22.42%,CP;ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ABCB7;HEPH;ATP6V1B2;SLC11A2;FTH1;STEAP3;ATP6V1C1;RAB11B
prerank,ceramide transport (GO:0035627),0.45089817732616,0.9854584741160692,0.5104166666666666,1.0,1.0,3/12,13.84%,ABCA2;PLEKHA3;PSAP
prerank,negative regulation of ossification (GO:0030279),0.40469741932774767,0.9853814287544732,0.4759556103575832,1.0,1.0,5/23,14.82%,SFRP1;SOX9;RBPJ;ENPP1;SMAD6
prerank,blood circulation (GO:0008015),0.35815643143613873,0.9853736208117123,0.49547511312217196,1.0,1.0,9/49,16.76%,TNNI3;EDN3;CXCL12;SERPING1;BDKRB2;GCLC;ROCK2;AGTR1;ITGB1BP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3449344575822077,0.9850615981688415,0.5144076840981857,1.0,1.0,13/72,13.72%,COPS7A;LIG1;USP7;POLR2B;DDB1;LIG3;COPS7B;CUL4B;GTF2H3;TCEA1;POLR2K;CCNH;POLD3
prerank,carboxylic acid catabolic process (GO:0046395),0.45761964218881623,0.9850181080039004,0.49037037037037035,1.0,1.0,2/12,4.80%,PON3;RENBP
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4777796062967314,0.9847757171780906,0.5222551928783383,1.0,1.0,2/10,8.54%,EIF2AK3;DDIT3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.37859277195459795,0.9844493133811906,0.4939759036144578,1.0,1.0,8/32,15.16%,TAOK1;FZR1;CDC14B;CDK5RAP3;MRNIP;BRSK1;FOXN3;MRE11
prerank,keratan sulfate metabolic process (GO:0042339),0.3822062710929068,0.9843764310253718,0.49754901960784315,1.0,1.0,7/31,15.67%,SLC35D2;GLB1;ST3GAL2;ST3GAL3;B4GALT5;OMD;LUM
prerank,mRNA export from nucleus (GO:0006406),0.3320356329025392,0.9838707274973286,0.5273477812177503,1.0,1.0,35/102,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;DDX19A;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,double-strand break repair (GO:0006302),0.32508224830370236,0.9838093629979144,0.5430597771023303,1.0,1.0,35/158,16.27%,KDM4D;XRCC2;APTX;RNF138;PARP1;APLF;HELQ;RNF8;PAXX;PARP2;PALB2;FBH1;BARD1;TDP1;LIG3;IFFO1;ACTR8;RNF168;XRCC6;SEM1;UBE2V2;VCP;MDC1;DCLRE1A;YY1;BRIP1;POLN;RMI1;TDP2;SETX;NUCKS1;MRE11;PPP5C;CHEK2;RAD50
prerank,aortic valve morphogenesis (GO:0003180),0.37943278190576457,0.9837645117633399,0.4970344009489917,1.0,1.0,10/30,16.44%,SNAI1;SOX9;TWIST1;ROBO2;ROBO1;ROCK2;TGFB1;SMAD6;SLIT3;JAG1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4106191676871644,0.9836984025912829,0.4980891719745223,1.0,1.0,2/21,3.64%,EPHA7;GRIN1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3262435648410632,0.9836011400127422,0.5482897384305835,1.0,1.0,32/161,17.38%,SFRP2;WNT5A;BICC1;SFRP1;DVL2;PSMD4;DKK3;CHD8;TCF7L2;KLHL12;PSMB10;DVL1;STK11;PSMD11;SOX9;DDIT3;RBMS3;PSME2;PSMC5;LZTS2;ZNRF3;HDAC1;AXIN2;KREMEN1;CSNK1A1;PSMD1;INVS;NKD1;PSMD6;SOX13;APOE;TLE5
prerank,response to interleukin-6 (GO:0070741),0.48270845018680364,0.9834469438814648,0.495398773006135,1.0,1.0,2/10,7.65%,NFKB1;PID1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.26768326867461906,-0.9834460112485999,0.49324324324324326,0.8671293220163058,1.0,16/36,27.17%,EGFR;CAV1;NUS1;HIF1A;SCARB1;NOS3;NOSTRIN;NOSIP;GCH1;AKT1;DDAH2;CYGB;TERT;SPR;WASL;S100A1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.46371119770689945,0.9834294454290389,0.5079825834542816,1.0,1.0,6/11,18.62%,ABCA2;SOAT1;ABCA7;ITM2B;NECAB3;ITM2C
prerank,regulation of fatty acid oxidation (GO:0046320),0.4281879468544733,0.9833198305958042,0.5034106412005457,1.0,1.0,6/16,21.10%,MLYCD;SOX9;ACADL;ACADVL;PRKAG2;APPL2
prerank,transport along microtubule (GO:0010970),-0.3683109425801004,-0.9823977908277032,0.45666666666666667,0.8681957815524357,1.0,4/13,7.51%,COPG2;SPG11;BAG3;APBA1
prerank,heterochromatin organization (GO:0070828),-0.34407750217698985,-0.9823132636706291,0.4423791821561338,0.8664679645942607,1.0,6/14,15.01%,MECOM;SIRT1;EZH1;SETDB2;PRDM16;SMCHD1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.41795925301909054,0.9823109161253472,0.5234899328859061,1.0,1.0,1/17,0.24%,S1PR2
prerank,positive regulation of lipid transport (GO:0032370),0.4436755429355712,0.9822706203021497,0.5174927113702624,1.0,1.0,3/12,17.19%,PRELID1;LRP1;APOE
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.31677939195838595,0.9820756008950664,0.572,1.0,1.0,108/497,19.43%,SFRP2;ILF3;HDAC3;HEXIM1;WNT5A;SFRP1;PAIP2;CIART;FOXM1;SIRT2;SELENOS;ZNF568;EIF2AK3;CREBZF;NR2F2;PRMT6;SMARCC2;GLIS2;NR1D2;DKK3;DDX3X;PSPC1;NIPBL;CHD8;POU2F1;CNOT10;CDK5;IGF2BP2;MTERF3;TCF7L2;USP47;SFMBT1;IRF1;ATXN1;SNX6;EZH2;ZEB1;HDAC5;PCGF6;ZBTB38;SFMBT2;WNT4;SOX9;DDIT3;EPRS1;DPF2;XRCC6;PER1;DHX36;HDAC4;ARID4A;TWIST1;PUS7;NKRF;JARID2;RCOR1;RBFOX2;RBPJ;SUV39H1;EIF4E2;FOXN3;CNOT9;NACC2;MALSU1;ENPP1;HDAC1;BCL7A;RACK1;ATR;TSC22D4;EHMT1;GCLC;CIPC;DAPK1;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;BCL6;BCLAF1;MRPL13;RFX3;CIC;CTBP1;CLOCK;SNW1;TERF1;CBX5;DAXX;FMR1;MBD1;SOX13;TLE5;MDM2;LANCL2;PHF12;MECP2;GCFC2;NONO;MPHOSPH8;NCOR2;FOXD1;PRMT2;UIMC1;SAMD4B;YAF2;RPS3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.45113042290157307,0.9820346905563547,0.4862119013062409,1.0,1.0,4/12,16.44%,CD24;IQGAP1;MAGI2;JAG1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.41839073695774087,0.9811113277191711,0.5238095238095238,1.0,1.0,6/19,14.84%,CSNK2A2;FBXO7;PARK7;VDAC1;HTT;DNM1L
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4583869935631911,0.9808317502961684,0.48333333333333334,1.0,1.0,2/11,2.21%,SLC25A19;DCK
prerank,mitotic nuclear division (GO:0140014),0.342963682784243,0.9805907251445952,0.5306781485468245,1.0,1.0,19/71,21.48%,CCDC61;UBE2S;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;STAG2;ZWINT;OFD1;CHEK2;BCCIP;ZW10;INO80;CLASP2;CHMP4B
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.45681620069421464,0.9802722513693679,0.5007342143906021,1.0,1.0,4/11,14.28%,FRS2;EFNB2;SOX6;TGFB1
prerank,positive regulation of developmental process (GO:0051094),0.325801988264696,0.9799693069462776,0.537525354969574,1.0,1.0,42/164,19.65%,WNT5A;TMEM119;CAMK2B;DVL2;EDN3;FIS1;FGFR1;XBP1;DCN;MIEF2;ANAPC2;FBXO5;ARHGEF7;DVL1;LRP8;SOX9;VLDLR;GDNF;ENPP2;BMP5;DAG1;SOX6;B4GALT5;RPS6KA3;ZBED3;SOX5;DNM1L;NR2C2;ACVR1B;RPS6KA1;SPIRE1;NUMA1;PHLDB1;FMR1;APOE;BMP1;SORL1;HMCES;FOXD1;SHANK1;KMT5B;NCOA3
prerank,positive regulation of cellular catabolic process (GO:0031331),0.32755006964103645,0.9799687841308272,0.5244897959183673,1.0,1.0,32/132,18.85%,SLC4A4;KHSRP;IGF1;GPLD1;HSP90AA1;NRDC;FLCN;DCN;ARNT;STK11;PACSIN3;PRXL2C;LIN28B;TWIST1;IRS2;ZBTB20;PIK3CB;APP;RNF152;SNX33;DAPK1;FAF1;ABCD2;TPCN1;GRSF1;ZC3HAV1;ZSWIM8;MTDH;APOE;ZC3H18;PRKAA1;TRIM27
prerank,cellular response to growth factor stimulus (GO:0071363),0.3265548949850491,0.9799184600395997,0.5469387755102041,1.0,1.0,40/151,21.10%,WNT5A;CLEC3B;SFRP1;SIRT2;ADAMTS7;MTSS2;PDPK1;BMP6;SMAD9;ANXA1;ZFP36L1;NRP1;PLK5;WNT4;SOX9;RAPGEF1;IQGAP1;MAGI2;SOX6;RACK1;SETX;MAPT;TGFB1;SOX5;ACVR1B;PTPN12;NDNF;ITGB1BP1;SPRY2;PRKD2;TGFBR1;PDCD5;WWOX;KLF4;MAPKAPK2;EHD1;ACVR2A;NTRK2;SMAD7;APPL2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.43678590617082486,0.9795915576460603,0.5126050420168067,1.0,1.0,5/15,15.82%,MVB12A;EGF;RBPJ;RHBDF1;PTPN12
prerank,establishment of protein localization to organelle (GO:0072594),0.3439015375867137,0.9795219369201401,0.5257510729613734,1.0,1.0,13/72,15.33%,IL10RA;MMP12;TSC2;NXT2;NXT1;KPNB1;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1
prerank,epithelial cell differentiation (GO:0030855),0.3338033008739853,0.9795087262320186,0.5026567481402763,1.0,1.0,20/88,22.16%,ANXA7;FGFR2;ANXA1;FSTL1;SCRIB;RAB10;HDAC1;HNRNPH3;VDAC1;MAF;JAG1;ACADVL;KDM6B;ANXA4;SCUBE1;PGK1;DAB2;CTSB;PTER;ERBB4
prerank,regulation of DNA recombination at telomere (GO:0072695),0.416615805505908,0.9794821069787485,0.5033921302578019,1.0,1.0,6/19,18.57%,POLR2B;POLR2K;ATRX;TERF1;DAXX;TERF2IP
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.416615805505908,0.9794821069787485,0.5033921302578019,1.0,1.0,6/19,18.57%,POLR2B;POLR2K;ATRX;TERF1;DAXX;TERF2IP
prerank,hemidesmosome assembly (GO:0031581),-0.38645858804997096,-0.9786774489224549,0.49514563106796117,0.8746869664483112,1.0,5/11,13.49%,DST;ITGA6;PLEC;LAMA3;ITGB4
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3748536197580324,0.9785550864872159,0.5112426035502958,1.0,1.0,6/33,6.65%,UBE2E2;ANXA1;TFDP1;DDX3X;FGF10;EZH2
prerank,organelle organization (GO:0006996),0.3182492971001644,0.9785081636950356,0.5815815815815816,1.0,1.0,109/388,21.64%,SPTBN5;IQCG;CENPT;CUL7;ATL1;TJAP1;BIN1;CHCHD10;UBXN2A;BCS1L;PARP1;EIF2AK3;MSTO1;BNIP1;TRAPPC8;KIF3A;SAR1A;SLC25A33;ANK1;OBSL1;RAB34;TNFAIP3;MAST3;MIEF2;THY1;SEC16A;SLC25A36;ARHGEF7;DMTN;MIA3;TRIP11;PDZD8;TTC17;NCKIPSD;SEC16B;FANCG;ATP8B2;PACSIN3;DES;LMAN2L;AUP1;ARHGAP21;CHMP3;TOR1B;TBC1D20;TPM1;PLEKHM2;PEX1;USP6NL;KIF5C;RAB30;PTCD2;YTHDF3;PARK7;TANGO2;VPS4B;TMED10;COG3;PRKCI;SNX11;PEX7;YTHDF1;HTT;CSNK1D;MTX3;SMPD4;PRPF40A;VMP1;DNM1L;CSNK1A1;RAB31;ARMC2;VAPB;ABCD2;STX17;TFB1M;SIRT5;VPS18;NUMA1;MTX2;PHIP;VPS13D;APOE;GORASP1;GABPB1;KLHL20;PKD2;ZFYVE16;ODF2;CDC42BPB;AGTPBP1;KIFAP3;YTHDF2;FAM174B;FGD4;RANBP9;ZW10;GABPA;TOR1AIP2;PAK5;DYNC2H1;ATL3;RHOU;CFL1;CLASP2;DIAPH1;CHMP4A;CHMP4B;RAB7A
prerank,modulation of chemical synaptic transmission (GO:0050804),0.33062303436474627,0.9784258637794827,0.5280082987551867,1.0,1.0,19/107,12.73%,CLN3;NPTXR;LRRC4;NTF3;UNC13A;CDK5;GRIK5;TMEM108;ATP1A2;LRP8;CPLX1;NMU;NRG3;CLSTN2;PSMC5;APP;MCTP2;NLGN3;SYT1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.28513057520416696,-0.9782860076371168,0.47150259067357514,0.8737790657044575,1.0,16/29,30.25%,SORBS1;CREBL2;SCARB1;CREB1;NR1H3;CNEP1R1;SREBF1;ELOVL5;CTDNEP1;NR1H2;AKT1;PPARA;SLC45A3;MFSD2A;SIRT4;MID1IP1
prerank,cellular glucose homeostasis (GO:0001678),0.36441601111858396,0.9779569766377794,0.5069605568445475,1.0,1.0,9/41,15.12%,HKDC1;LRRC8A;XBP1;PIK3R1;ZBTB20;PIK3R2;RACK1;TRA2B;NUCKS1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.42535941108219344,0.9779350528519356,0.5268361581920904,1.0,1.0,3/15,14.38%,CLN3;ZDHHC3;NLGN2
prerank,regulation of cellular component size (GO:0032535),-0.27960127664173073,-0.9777340305999916,0.46706586826347307,0.8734226331288607,1.0,8/30,8.61%,PICALM;RDX;MTPN;RIN3;RARG;EPS8;EZR;RAB22A
prerank,regulation of lipid metabolic process (GO:0019216),0.33129379506667245,0.9777011156156702,0.5448785638859557,1.0,1.0,28/88,24.05%,FASN;HDAC3;SMARCD3;NR1D2;RORA;CHD9;CERS2;LSS;ABCA7;GPAM;SC5D;IRS2;CYP51A1;PSAP;TBL1XR1;GPS2;NCOR2;PRKAG2;ELOVL6;CARM1;GGPS1;NPC2;ID2;NCOA1;SP1;RXRA;TGS1;NFYA
prerank,O-glycan processing (GO:0016266),0.35188587343226124,0.977674815161929,0.5279299014238773,1.0,1.0,10/54,17.94%,C1GALT1C1;ST3GAL2;GALNT4;ST3GAL3;POMGNT1;B4GALT5;GXYLT1;GALNT14;GALNT15;GXYLT2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3178442064666493,0.9776404141491811,0.5584677419354839,1.0,1.0,30/182,14.47%,SFRP2;APLN;SFRP1;IGF1;ANXA7;NFKB1;ERP29;FLCN;OLFM1;CELF1;SFMBT2;WNT4;LRPAP1;SDCBP;RBMS3;SOX11;RBL2;APP;ROBO1;YY1;PARK7;HDAC1;AGO3;RACK1;PARP14;PTPN22;MAPT;ROCK2;TGFB1;MAP2K2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3554083668832757,0.9775394961940178,0.5105908584169454,1.0,1.0,15/49,23.46%,PTGER4;LCMT1;DDX3X;PMEPA1;JAM3;PEX5;PARK7;IMPACT;SMAD6;SORL1;PPM1A;PRKCZ;HMGB1;RPL13A;IAPP
prerank,positive regulation of catabolic process (GO:0009896),0.3475159815467507,0.9774387769246536,0.5212649945474372,1.0,1.0,19/65,21.64%,WNT5A;ASB5;FZR1;SNF8;TNFAIP3;DDB1;BARD1;VCP;EGLN2;RNF41;NKD1;NSF;TIPARP;SMURF1;SORL1;STX5;HECW2;FOXO1;RAB7A
prerank,regulation of kinase activity (GO:0043549),0.33267022555817216,0.9771525935111458,0.5347368421052632,1.0,1.0,20/89,17.15%,MST1R;EPHA7;EPHB2;FGFR2;SMG8;FGFR1;DDR1;DDR2;EPHA8;EPHA10;MUSK;RBL2;IRS2;PDGFRA;ROR2;EMP2;MAPT;MRE11;RAD50;EPHA5
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.43151518884535733,0.9771147970167977,0.49259757738896365,1.0,1.0,6/15,22.25%,ENTPD7;AK4;AK5;CMPK1;AK1;ENTPD5
prerank,embryonic skeletal system development (GO:0048706),0.36616039220971164,0.9768924529358304,0.4975903614457831,1.0,1.0,7/35,17.12%,WNT5A;PCSK5;SULF1;SOX11;PDGFRA;MEGF8;OSR1
prerank,artery development (GO:0060840),0.3878058673783521,0.9768319224074675,0.5147625160462131,1.0,1.0,8/23,20.88%,STRA6;NRP1;ROBO2;ROBO1;HECTD1;PKD2;TGFBR1;SMAD7
prerank,atrioventricular valve development (GO:0003171),-0.34405941802380835,-0.9764927285958304,0.4807017543859649,0.8750626804234217,1.0,4/14,7.89%,TGFB2;ACVR1;BMPR1A;TGFBR2
prerank,regulation of potassium ion transport (GO:0043266),0.3747178353009866,0.9763347398949723,0.5242130750605327,1.0,1.0,5/31,17.25%,KCNAB2;CD63;ANK3;DPP10;KIF5B
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.2696890377659741,-0.9762445056234826,0.510752688172043,0.873917427364926,1.0,7/34,5.16%,FLT1;DAB2IP;KIT;IRS1;PRKD1;PIK3R3;TEK
prerank,cellular response to heat (GO:0034605),0.3690406043600696,0.9761719350523327,0.5253456221198156,1.0,1.0,11/35,20.92%,TCIM;HSP90AA1;STUB1;DHX36;VCP;MAPT;DAXX;HSBP1;CLPB;PDCD6;TPR
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4583752972725629,0.9759674731972885,0.48554913294797686,1.0,1.0,5/11,23.40%,CALM3;PKD2;CALM1;CALM2;FKBP1A
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4583752972725629,0.9759674731972885,0.48554913294797686,1.0,1.0,5/11,23.40%,CALM3;PKD2;CALM1;CALM2;FKBP1A
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2666799939332593,-0.9759414619836624,0.5255474452554745,0.8728802189183987,1.0,11/39,15.19%,MAML3;MAML1;STAT3;KAT2B;TGFB2;NOS3;EP300;EPN2;CCN3;POGLUT1;SRC
prerank,cellular response to retinoic acid (GO:0071300),0.35632782175552014,0.9758869340534587,0.523094688221709,1.0,1.0,14/42,25.33%,WNT5A;ZNF35;BRINP3;SOX9;SETX;SNW1;PTK7;BRINP1;LYN;PTK2B;ATM;WNT5B;WNT6;RORB
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3462242779185804,0.9753352531198312,0.5277161862527716,1.0,1.0,9/59,13.21%,AMIGO1;OBSL1;TENM3;IGSF21;DSCAM;IGSF11;ROBO2;ROBO1;NPTN
prerank,sphingolipid biosynthetic process (GO:0030148),0.3411725363592162,0.9751282376714662,0.5402792696025779,1.0,1.0,17/71,19.12%,A4GALT;ST8SIA3;ELOVL1;SMPD2;CERS2;SGPL1;ST3GAL5;ELOVL4;SPTSSA;TLCD3B;PLPP3;SMPD4;VAPB;ALDH3A2;PRKD2;ELOVL6;SMPD1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3723314136676745,0.9750353203172979,0.5162064825930373,1.0,1.0,8/32,12.75%,RBM4B;RBM3;METAP1;CYFIP1;PUM3;PGAM1;APP;TMED10
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.40203826261245723,0.9749468389326422,0.5034106412005457,1.0,1.0,5/20,14.28%,IGF1;TWIST1;PARK7;LAMTOR5;TGFB1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3042448740018437,-0.9747348133220053,0.4956896551724138,0.8745345930197101,1.0,10/24,30.03%,NIBAN2;DACH1;ZRANB3;MSH2;BLM;RTEL1;MSH6;H1-0;CDKN1A;ERCC1
prerank,RNA export from nucleus (GO:0006405),0.33025488727322694,0.9746614643526927,0.5295336787564767,1.0,1.0,34/100,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,proteasome assembly (GO:0043248),0.46054210462833717,0.9744892683720275,0.5222551928783383,1.0,1.0,5/11,21.96%,PSMD4;PSMD11;POMP;PSMD5;OTUD6B
prerank,cellular iron ion homeostasis (GO:0006879),-0.2427104703082346,-0.9740245901641341,0.4954128440366973,0.8746813335469221,1.0,8/55,4.52%,ABCG2;SMAD4;ATP6V1A;CUL1;GLRX3;SLC39A14;ACO1;SKP1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.36131984830247554,0.9733892175421028,0.5183867141162515,1.0,1.0,4/40,6.52%,GSDMD;RNASE7;TIRAP;GBP7
prerank,protein localization to kinetochore (GO:0034501),0.4287994917707942,0.973355286607731,0.514246947082768,1.0,1.0,1/14,0.88%,CENPT
prerank,synaptic vesicle recycling (GO:0036465),0.37718273818970494,0.9730031163570836,0.5370595382746051,1.0,1.0,6/31,14.38%,SYNJ2;CDK5;NLGN3;SYT1;TBC1D24;NLGN2
prerank,organophosphate ester transport (GO:0015748),-0.2948873327843391,-0.9727296121427464,0.4956140350877193,0.8764983290190053,1.0,6/24,8.39%,OSBPL2;PITPNA;PITPNC1;SCARB1;SCP2;OSBPL5
prerank,cholesterol metabolic process (GO:0008203),0.34287611923957567,0.9725746144946554,0.5323819978046103,1.0,1.0,10/68,13.04%,CYP27A1;CLN6;SCAP;GBA2;LSS;SOAT1;INSIG1;MSMO1;STARD3;CYP51A1
prerank,positive regulation of autophagy (GO:0010508),-0.21861037081835635,-0.9725149439205042,0.5106382978723404,0.8751961521957033,1.0,24/81,16.81%,WAC;EIF2AK4;TFEB;FOXO3;TMEM59;BNIP3L;SH3BP4;EPM2A;SIRT1;PRKD1;LRRK2;KDR;IKBKG;ROCK1;GNAI3;PAFAH1B2;PRKAA2;BNIP3;TRIM5;TRIM65;PLK2;IRGM;UFL1;PINK1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3596154211864931,0.972503938598762,0.528169014084507,1.0,1.0,4/41,7.34%,IGF1;SELENOS;TNFAIP3;SIRPA
prerank,protein localization to cell junction (GO:1902414),0.4020939515268878,0.9724922191064924,0.5112219451371571,1.0,1.0,6/22,19.05%,MPP4;KIF3A;JAM3;NLGN2;JAK1;SHANK1
prerank,Rho protein signal transduction (GO:0007266),0.3519037249502218,0.9724254520896187,0.5161649944258639,1.0,1.0,13/53,16.48%,CDC42EP5;CDC42EP4;CTNNAL1;RHOD;RIPOR1;ADGRG1;RTKN;COL1A2;PLEKHG5;ARHGAP29;ROCK2;EPS8L1;AGTR1
prerank,limb development (GO:0060173),0.3810924715368725,0.9723538783305521,0.5404411764705882,1.0,1.0,8/28,21.30%,PCSK5;FGF10;PTCH1;ZNRF3;KREMEN1;MEGF8;CHD7;GLI3
prerank,potassium ion import across plasma membrane (GO:1990573),-0.25258386441572056,-0.9723278928741508,0.5,0.8737882410673311,1.0,15/41,27.28%,SLC12A7;ATP1B3;ATP1A1;KCNJ2;ABCC9;ATP1B1;SLC12A4;SLC12A9;SLC12A2;KCNJ3;KCNK9;HCN2;SLC12A8;KCNJ12;SLC12A6
prerank,negative regulation of cellular process (GO:0048523),0.3118085470986006,0.9722469357028023,0.607,1.0,1.0,89/521,15.34%,PSRC1;SFRP2;CDKN2D;FCGR2B;SFRP1;DACT2;FOXM1;SIRT2;GPLD1;EPHB2;SIRT7;CDKN2AIP;TSC2;CHERP;EIF2AK3;CGRRF1;CASK;PLXNA2;GNRH1;PTHLH;WARS1;DDX3X;FBLN1;RBBP4;FLCN;CLMN;IRF1;DLG3;SRGAP2;FBXO5;ALDH1A2;ADAM22;VAMP3;CELF1;MIA3;EEF1E1;STK11;HGS;CHD5;RIPOR2;TGFB1I1;SIRPA;IFIT3;TCHP;DSCAM;PODN;IFI35;PLXNA1;LRPAP1;WDR6;PPP1R9B;ORC6;MDM4;SOX11;WNK2;APP;TAF6;IGFBP3;BCL2;ADGRG1;IGFBP7;BMP5;NACC2;MAGI2;MALSU1;ENPP1;SPEG;PARK7;VPS4B;SOD2;NPM1;AXIN2;RACK1;ROR2;TNS2;CDC73;PARP16;FGFBP1;RNF41;TGFB1;SLURP1;BCL6;P3H2;IMPACT;SMAD6;SLIT3;DIS3L2;NUPR1;ACVR1B
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.37152159113078603,0.972220936718113,0.5191387559808612,1.0,1.0,14/35,23.86%,CALM3;NUAK1;PPP1R2;PPP6R3;MAGI2;HTT;PPP1R11;TIPRL;CALM1;CALM2;ITGA1;PPP4R4;FKBP1A;TSC1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3870581574753858,-0.9718298727217787,0.5028735632183908,0.8732448238061926,1.0,5/10,29.77%,SIRT1;NOC2L;KLF15;TAF7;THAP7
prerank,protein catabolic process (GO:0030163),0.3420472132578936,0.971785022567129,0.5200445434298441,1.0,1.0,9/59,9.82%,CLN6;HSP90AA1;NGLY1;DDB1;UCHL3;RAB12;MANBA;CUL4B;VCP
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.43610329833016265,0.9717212036936296,0.5139911634756995,1.0,1.0,3/13,9.21%,MGAT3;RENBP;EXTL2
prerank,positive regulation of phospholipid transport (GO:2001140),0.45840520034767723,0.9716848427722062,0.5172932330827068,1.0,1.0,3/10,17.19%,PRELID1;ABCA7;APOE
prerank,negative regulation of cellular component organization (GO:0051129),0.33738484488586296,0.9716281800532897,0.535752401280683,1.0,1.0,16/74,19.82%,CARMIL2;LCMT1;BMP6;DDX3X;PACSIN3;ABCA7;PEX5;SNX33;DNAJB6;SCAMP5;IMPACT;SPRY2;MCTP1;SORL1;CARMIL1;PRKCZ
prerank,muscle tissue morphogenesis (GO:0060415),-0.3289829510457345,-0.971588489371302,0.4864864864864865,0.8720171021266881,1.0,6/16,31.43%,BMP4;TBX1;EFEMP2;BMP2;HEY2;ZFPM1
prerank,glycerophospholipid metabolic process (GO:0006650),0.33446039137298744,0.9714989848261328,0.5471898197242842,1.0,1.0,17/75,19.91%,PIGG;CLN3;GPLD1;DPM2;PIGM;CRLS1;PRDX6;GDPD3;CPNE7;PIGA;SMPD4;FAR1;GDE1;PIGX;PIP5K1A;PLA2G7;PAFAH1B1
prerank,multivesicular body assembly (GO:0036258),0.38037616758239223,0.9713265843000193,0.5248138957816377,1.0,1.0,6/30,12.16%,MVB12A;SNF8;HGS;VTA1;CHMP3;VPS4B
prerank,ventricular septum morphogenesis (GO:0060412),-0.2771064344961522,-0.9712269553271671,0.44680851063829785,0.871159626477167,1.0,9/27,17.44%,SMAD4;SLIT2;TGFB2;ACVR1;BMPR1A;TGFBR2;BMP4;HES1;HEYL
prerank,regulation of DNA metabolic process (GO:0051052),0.35788073252062524,0.9710127956288346,0.54292343387471,1.0,1.0,16/44,21.98%,SIRT7;WDR18;USP1;CDK9;HNRNPD;UBE2V2;POLH;HELB;THOC1;NUCKS1;TERF2IP;MPHOSPH8;KPNA1;SUB1;SMG1;UBE2V1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.37718387187664165,-0.970966253827026,0.471875,0.8700309498265861,1.0,5/11,16.70%,RDX;EZR;VPS11;PTPN23;MSN
prerank,negative regulation of glycolytic process (GO:0045820),0.4581095591812253,0.9707560646877412,0.5279878971255674,1.0,1.0,3/10,15.32%,HDAC4;GIT1;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4581095591812253,0.9707560646877412,0.5279878971255674,1.0,1.0,3/10,15.32%,HDAC4;GIT1;NUPR1
prerank,mitochondrial genome maintenance (GO:0000002),0.45168349311627726,0.9704663841220345,0.5152394775036284,1.0,1.0,3/11,6.34%,PARP1;SLC25A33;SLC25A36
prerank,catecholamine biosynthetic process (GO:0042423),-0.3794746235845206,-0.9696401319734191,0.48148148148148145,0.8717673309292455,1.0,3/11,23.97%,TGFB2;GCH1;DDC
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.36783775384411754,0.9691132599541871,0.5331781140861467,1.0,1.0,3/33,7.26%,APLN;GNL3;TEAD1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.31507692215287453,-0.9689596764676309,0.497907949790795,0.871765106976836,1.0,10/19,29.29%,MTHFR;MTHFS;SLC25A32;MTHFD1;MTHFD1L;MTRR;ALDH1L1;ALDH1L2;MTHFD2;DHFR
prerank,nuclear pore organization (GO:0006999),-0.3434033425458432,-0.9687957914157427,0.5084175084175084,0.8703529037831133,1.0,6/14,21.50%,NUP205;NUP93;NUP107;NUP133;NDC1;TMEM170A
prerank,regulation of apoptotic process (GO:0042981),0.31145687818414614,0.9687503796318044,0.655,1.0,1.0,146/676,19.55%,SFRP2;RNF157;HDAC3;WNT5A;CLN3;SFRP1;IGF1;GLS2;TCIM;BAX;GPLD1;PPIF;ARAF;LCMT1;NFKB1;BIN1;NTF3;HSP90AA1;PLEKHN1;SLC27A4;BNIP1;TAF9B;AIFM2;ANP32A;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;FZD9;NUAK2;IL31RA;MGMT;CDK5;SCRIB;FLCN;OLFM1;USP47;PRDX5;FAM162A;PIK3R1;PRELID1;ABL1;SQSTM1;USP42;BAG1;BARD1;ARHGEF7;ARHGEF4;HNRNPK;EEF1E1;MAGED1;ZFAND6;KCNMA1;KALRN;TRIM35;IFIT3;CALHM2;MCF2;XIAP;PLK5;LRP8;SOX9;SRA1;NDRG1;CLIP3;VCP;CASP9;VAV2;UBE2Z;MALT1;GDNF;PRLR;IGFBP3;BCL2;RTKN;BNIP2;IRF3;TMEM219;HS1BP3;PARK7;NPM1;HDAC1;TNFRSF25;PLEKHG5;LANCL1;RACK1;AKAP13;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;DAPK1;ANKRD13C;HTT;MTCH1;EGLN2;MTCH2;TXNDC5;BCL6;RNF122;BCLAF1;SMAD6;DNM1L;CBL;SHQ1;MRE11;NUPR1;PAWR;FAF1;CASP2;HSPD1;RPS6KA1;CTSH;TRIO;AHI1;ARHGEF6;FAIM2;DAXX;DPEP1;PHIP;SPRY2;MTDH;OSR1;SON;DFFA;TOPORS;OMA1;ANXA4;KLHL20;RASSF2;BAG4;PDCD5;PRKAA1;RSL1D1;BIRC3;FMN2;PRMT2;SMPD1;SOX4;DDX42;PLEKHG2;RPS3;FGD4
prerank,nucleic acid-templated transcription (GO:0097659),-0.25656810689238996,-0.96838413412255,0.5447154471544715,0.8696059545849691,1.0,25/42,35.73%,EPC1;MEF2A;RRAGC;CREBL2;POLR3A;RNPS1;MED20;DTX1;PWP1;FUBP3;NR4A2;POLR2H;BCL3;TERT;POLR2G;POLR2F;POLR2C;PAX8;POLR2E;HOXD3;POLR2J;XAB2;NFKBIB;POLR2D;E2F1
prerank,negative regulation of cell migration (GO:0030336),0.3227232621008261,0.968353061579158,0.5746421267893661,1.0,1.0,53/137,25.62%,SFRP2;SFRP1;RAC1;FLCN;SULF1;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;PODN;TPM1;IGFBP3;ADGRG1;ROBO1;MAGI2;DAG1;NDRG4;LRP1;RNF41;SLURP1;JAG1;SERPINE1;PLXNB3;ITGB1BP1;DPEP1;MCTP1;MITF;DLC1;EVL;ATP1B2;NF2;PTPRR;SMAD7;SRGAP1;DLG5;FGF2;CLASP2;IGFBP5;PFN2;HOXA7;EPHA4;DPYSL3;PTEN;ADARB1;CORO1C;PHLDB2;CX3CL1;NAV3;DUSP3;AFDN;VCL;CLIC4
prerank,visual perception (GO:0007601),0.33060301585627355,0.9683418223834732,0.5341745531019979,1.0,1.0,9/84,14.68%,GPR179;BEST1;RDH10;ADGRV1;OAT;POU6F2;ZIC2;CRYBB3;EML2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.28527885622065363,-0.9682998070735946,0.46875,0.8679486613845196,1.0,5/27,5.16%,FLT1;KIT;IRS1;PRKD1;TEK
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3842717264558154,-0.9682177090028924,0.5015197568389058,0.8663610333602232,1.0,5/11,11.48%,ATP6V1A;CAV1;ATG7;ATP6AP1;FAS
prerank,positive regulation of nervous system process (GO:0031646),0.40993902154840434,0.967919337444427,0.5323834196891192,1.0,1.0,5/18,16.68%,MYRF;NLGN2;TENM4;ATPSCKMT;TPPP
prerank,negative regulation of phagocytosis (GO:0050765),0.4130429239828577,0.9678125535012989,0.5080862533692723,1.0,1.0,4/17,12.69%,FCGR2B;SIRPA;CD47;RACK1
prerank,bicellular tight junction assembly (GO:0070830),-0.24301840815258152,-0.9673635126966708,0.509090909090909,0.8667637749786223,1.0,7/46,10.64%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;RAMP2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3639575904670721,0.9672783849400137,0.528169014084507,1.0,1.0,10/35,23.08%,ATP2C1;CDH11;CDH18;CDH20;CDH19;CDH7;CDH9;PCDHB16;CDH10;CDH8
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.37736811217408,-0.9672666755133914,0.5080385852090032,0.8652200111403553,1.0,4/11,15.99%,EGFR;RIPK1;TP53;BMP4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4059601986712613,0.9671598619922824,0.5218543046357615,1.0,1.0,1/18,1.59%,GPLD1
prerank,positive regulation of mRNA processing (GO:0050685),0.4001727266865848,0.9663384913296712,0.5294888597640891,1.0,1.0,9/21,20.65%,RBM3;PRDX6;DHX36;TRA2B;CDC73;SNW1;THRAP3;CIRBP;TRA2A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3407038308768804,0.9661018095315087,0.5546218487394958,1.0,1.0,10/66,10.21%,CDKN2D;UBE2E2;ANXA1;TFDP1;DDX3X;FGF10;WEE1;PLK5;RBL2;PSME2
prerank,glycine metabolic process (GO:0006544),-0.3632938743324303,-0.9660552184588436,0.5,0.8669095774662954,1.0,8/12,52.14%,RIDA;AMT;GCSH;SHMT2;GCAT;GLDC;SHMT1;GLYAT
prerank,circulatory system development (GO:0072359),0.32928486969128035,0.9658889027516179,0.5813715455475946,1.0,1.0,24/118,19.43%,PDLIM2;TNNI3;POU6F1;DVL2;CACYBP;PDLIM7;TSC2;STRA6;PCSK5;STK11;SOX9;ADAP2;FGF12;FBN1;AKAP13;TGFB1;FOXC2;HSPG2;KDM6B;OSR1;PKD2;TGFBR1;SOX4;KDM6A
prerank,proteasomal protein catabolic process (GO:0010498),0.3172573682542472,0.9656821892519626,0.5718592964824121,1.0,1.0,46/201,17.98%,SIRT2;SPSB3;KCTD5;PSMD4;UBXN2A;SPSB1;STUB1;SYVN1;UCHL1;ERLEC1;COP1;PSMB10;DDB1;FBXO45;BRSK2;RFFL;FBXW5;PSMD11;RCN3;RMND5A;ARRB1;DDIT3;TRIM9;CUL4B;VCP;PSME2;PSMC5;KCTD2;UBE2A;PCNP;ZFAND2A;RNF41;RNF122;FEM1C;PSMD1;FAF1;ZSWIM8;CLOCK;DERL1;PSMD6;SMURF1;TOPORS;MDM2;PCBP2;TBL1XR1;KLHL20
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.38818394195470407,0.9656668491462155,0.5303225806451612,1.0,1.0,3/23,5.69%,BAX;HSP90AA1;TIMM13
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2237812966270984,-0.9655764273175887,0.5405405405405406,0.8663472137281956,1.0,19/70,15.67%,LNPEP;IKBKB;PSMB7;TAPBP;PSMB2;SEC22B;PSMD7;CALR;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;IKBKG;TAP2;PSMD9;PSMD2;PSMB3;ITGB5
prerank,regulation of stem cell proliferation (GO:0072091),0.4083418832363738,0.9651976538337066,0.5419532324621733,1.0,1.0,4/17,12.58%,ZFP36L1;FBLN1;SOX11;AGO3
prerank,cell-cell junction organization (GO:0045216),-0.213781440122518,-0.9649933562323026,0.5873015873015873,0.8661498520185346,1.0,18/79,16.07%,CADM2;LIMS2;TJP1;PKP4;CLDN5;CDH6;GJC1;CADM1;TGFB2;ARVCF;CDH1;CSK;OCLN;MYADM;NECTIN3;NECTIN1;TLN1;CADM3
prerank,intracellular protein transport (GO:0006886),0.3145138506069557,0.9649627909314835,0.6086086086086087,1.0,1.0,93/304,22.84%,MMP12;ARL4C;RTN2;TSC2;BCS1L;CACNG3;NXT2;NXT1;SGSM3;PICK1;ERP29;SAR1A;RUNDC1;RAB24;SNF8;DNAJC27;TBC1D13;NAPG;STX6;SEC16A;SNX6;VPS26B;RANBP3L;STX16;KPNB1;STX2;RAB5B;YWHAH;COPZ2;ARL5B;RABGAP1L;WLS;CLIP3;NUP188;KATNB1;SCFD1;USP6NL;STRADB;AP3B1;EVI5L;IPO11;VPS33B;E2F3;TLK1;NPM1;TMED10;NUP88;RABGAP1;IPO7;TGFB1;USO1;AP4M1;STX11;RAB31;NUP214;STX8;TNPO1;STX17;TRAK1;GGA2;XPO6;NSF;SYNRG;AP4E1;RAB21;SMURF1;TBC1D9B;TBC1D22B;XPO7;SORL1;NUP153;RAB6A;SGSM2;RANBP3;STX5;PPP1R10;AP4S1;OXA1L;RAB3GAP2;PDCD6;EHD1;HEATR3;TPR;APPL2;NAPA;RAB7A;ARFGAP3;GGA3;SIL1;RAB43;HERC2;SNX27;NUP155
prerank,inositol phosphate catabolic process (GO:0071545),0.44620808018619346,0.964853672652655,0.5184659090909091,1.0,1.0,3/12,10.73%,SYNJ2;INPP5A;NUDT3
prerank,positive regulation of intracellular transport (GO:0032388),0.36465759025195793,0.9648151281881965,0.5249709639953543,1.0,1.0,13/38,20.92%,MLC1;CAPN10;STK11;RIPOR1;TBC1D20;PGAP1;NUMA1;EIPR1;RUFY3;SORL1;KIF20B;EHD1;TPR
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.36319284928872697,0.9646312743787984,0.5379229871645275,1.0,1.0,11/40,16.78%,SIRT7;USP1;CDK9;ABL1;FBXO5;UBE2V2;CASP9;POLH;MAPT;BCLAF1;FMR1
prerank,male meiosis I (GO:0007141),0.4229698728016328,0.9643742792276296,0.5167336010709505,1.0,1.0,4/16,21.14%,SYCP3;FOXJ3;BRDT;FOXJ2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.32557336915511575,0.9642169862387359,0.5746421267893661,1.0,1.0,37/119,21.36%,PIGG;TMEM150A;PGAP4;PIP4K2B;SYNJ2;DPM2;PIGM;INPP5E;PIK3R1;PIGU;PLEKHA3;PITPNM3;PIGA;PIK3CB;PIK3R2;PI4KB;PIP4K2A;PIP4K2C;FIG4;SACM1L;CDS1;PIK3C2B;MTMR4;RUFY1;SLC27A1;PIK3C3;IP6K1;PITPNM2;DPM1;PIP5K1A;PLEKHA1;PIK3R4;IMPA1;INPP4A;PIGB;FGF2;SMG1
prerank,gene silencing by miRNA (GO:0035195),-0.27882780575337884,-0.9641523372212719,0.510752688172043,0.866624397057965,1.0,7/32,9.38%,CNOT1;TNRC6A;PUM1;XPO5;AGO2;LIMD1;RBM4
prerank,maturation of LSU-rRNA (GO:0000470),0.3806259459339249,0.9638877363944878,0.5462610899873257,1.0,1.0,8/26,21.09%,NHP2;DDX18;MRPL1;RPL7L1;LAS1L;NSA2;RSL1D1;RPL7
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.41442972839619324,0.9631691631238507,0.53125,1.0,1.0,4/17,12.24%,APLN;TAFA5;TPM1;SOD2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3805227002343652,0.9629543751752555,0.5393120393120393,1.0,1.0,3/26,5.02%,PTGER4;RAC1;ALMS1
prerank,electron transport chain (GO:0022900),0.41852944511838197,0.962715003993839,0.5160390516039052,1.0,1.0,3/15,6.76%,CYB561;SDHA;POR
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4307127843666585,0.961955930092452,0.5332390381895332,1.0,1.0,3/14,7.02%,PCBP4;SRSF12;SRSF9
prerank,regulation of cellular response to stress (GO:0080135),0.32424988760145085,0.9615766740842897,0.5801447776628749,1.0,1.0,36/115,21.55%,CLN3;CAMK2B;HSP90AA1;AIFM2;DNAJC7;RAE1;NUAK1;ABL1;BAG1;NUP188;CASP9;HSPH1;CAMK2D;USP19;CAMK2G;DNAJB6;NPM1;NUP210;ATR;NUP88;MAPT;ROCK2;NUP214;NUPR1;CHORDC1;HSBP1;NUP153;BAG4;RANBP2;RSL1D1;NUP35;MAPKAPK2;TPR;SMG1;NPAS2;DNAJC2
prerank,negative regulation of catabolic process (GO:0009895),0.3505179959042132,0.9615219574114693,0.52894438138479,1.0,1.0,11/47,19.02%,SIRT2;AZIN2;MAD2L1;MDM4;HDAC4;GIT1;CYP51A1;NUPR1;PRKAA1;BANP;FMN2
prerank,negative regulation of receptor binding (GO:1900121),0.469075598030616,0.9612436785152702,0.5232383808095952,1.0,1.0,2/10,11.35%,ATP2A2;PTPRF
prerank,homotypic cell-cell adhesion (GO:0034109),-0.2551657608754887,-0.9611757549804022,0.5606060606060606,0.8730166119817315,1.0,14/39,20.86%,FLNA;ACTB;ACTN1;MEGF11;STXBP3;PLEK;FN1;TLN1;ACTG1;HSPB1;P2RY12;MYL9;FIBP;MYL12A
prerank,melanocyte differentiation (GO:0030318),-0.3840190391903784,-0.9610169869696681,0.5170278637770898,0.871668438741377,1.0,3/11,3.29%,MEF2C;KIT;USP13
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.34627568088893107,0.9607844423134296,0.5578002244668911,1.0,1.0,20/51,22.51%,SFRP1;RAC1;ARHGEF10;NRP1;ABL1;TPM1;ARHGEF10L;CD47;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;EVL;NF2;PPM1F;PFN2;PAK1
prerank,mitochondrial protein processing (GO:0034982),0.44937969512213505,0.9604287136706632,0.5370101596516691,1.0,1.0,4/11,19.78%,PMPCA;AFG3L2;OMA1;IMMP1L
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.4221229802281049,0.9604262527782745,0.5223274695534507,1.0,1.0,2/14,7.21%,CARD16;RFFL
prerank,positive regulation of establishment of protein localization (GO:1904951),0.41079691890519865,0.9604072037019923,0.5131926121372031,1.0,1.0,3/18,7.40%,CCT8;CCT6A;WRAP53
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3154800715655553,0.9603295173828635,0.6177062374245473,1.0,1.0,54/259,16.17%,S1PR2;TMEM138;B9D2;AIF1L;CPLANE2;STK36;RAC1;IFT52;WHAMM;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;MINK1;CLUAP1;NRP1;TCTN1;BBS7;INPP5E;SRGAP2;ARHGEF7;ARHGEF4;DMTN;SNX10;RAP2A;RHOD;CDC14B;CCDC28B;CYFIP1;PIBF1;PPP1R9B;SDCBP;CFAP54;TTC8;CEP126;CC2D2A;IFT80;ABLIM2;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;EMP2;DISC1;ATP6V1D;TMEM216;RFX3;OFD1;RAB8A;RAB8B;AHI1;ARHGEF6
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.40620021747428425,0.9601116385268728,0.5297297297297298,1.0,1.0,4/19,10.71%,NFKB1;TMEM106A;EGF;APP
prerank,tight junction assembly (GO:0120192),-0.23530802921515817,-0.9600897351664881,0.5225225225225225,0.8724426168214386,1.0,8/49,10.64%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;LSR;RAMP2
prerank,homologous chromosome segregation (GO:0045143),0.4002573317230141,0.959998872780152,0.5203145478374837,1.0,1.0,3/20,19.02%,SIRT7;CENPC;FMN2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3844201332634704,-0.9599425460780939,0.5016501650165016,0.8710421881505426,1.0,4/11,13.21%,CAB39;CAV1;ACTN2;NEDD4L
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.2899635762535521,-0.9599168895024567,0.49,0.8693166447769727,1.0,11/24,21.51%,MBTPS2;HIF1A;TP53;HSF1;HSPA5;CEBPB;ATF4;VEGFA;NFE2L2;CREB3L1;SESN2
prerank,regulation of cartilage development (GO:0061035),0.40822014039070026,0.9598002810552919,0.5285714285714286,1.0,1.0,6/18,17.64%,PTHLH;SOX9;SOX6;TRPS1;SOX5;BMP1
prerank,negative regulation of lyase activity (GO:0051350),0.41557160315455527,0.9597625438857377,0.5337837837837838,1.0,1.0,2/16,7.66%,LTB4R2;ADGRV1
prerank,iron ion homeostasis (GO:0055072),-0.23836980585308556,-0.9594992334646826,0.5533980582524272,0.8686545636106039,1.0,8/58,4.52%,ABCG2;SMAD4;PICALM;ATP6V1A;CUL1;GLRX3;ACO1;SKP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.34089249881244593,0.9594193245873842,0.5382907880133185,1.0,1.0,4/51,4.57%,IL34;EDN3;CXCL12;MOSPD2
prerank,telomere maintenance via recombination (GO:0000722),-0.36868112916022444,-0.9594188968393891,0.5146579804560261,0.8670629750602193,1.0,3/11,10.15%,SMC5;TEP1;RAD51D
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.42654184180044297,0.9592935168162436,0.5241935483870968,1.0,1.0,6/14,21.40%,AK4;AK5;AK3;CMPK1;ME1;AK1
prerank,positive regulation of filopodium assembly (GO:0051491),0.3813958442061318,0.9592088038323542,0.5177215189873418,1.0,1.0,6/24,16.78%,NRP1;PIK3R1;RIPOR2;ARAP1;PLPPR5;FMR1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.33055276077806617,0.9591711521983824,0.5636942675159236,1.0,1.0,10/76,11.26%,CDC42EP5;CDC42EP4;BIN1;NTF3;NRP1;CDK5;ABL1;BAIAP2;KATNBL1;GPSM2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.35040860547182184,0.9588283601011903,0.5432525951557093,1.0,1.0,4/43,7.34%,IGF1;SELENOS;TNFAIP3;SIRPA
prerank,apoptotic DNA fragmentation (GO:0006309),0.41460147782692985,0.958523496973962,0.5317679558011049,1.0,1.0,5/16,22.00%,DFFB;KPNB1;DFFA;KPNA1;HMGB1
prerank,regulation of cell death (GO:0010941),-0.2116237806543595,-0.9584365776573303,0.5106382978723404,0.8681089789414768,1.0,25/94,18.27%,FERMT2;CCN2;ATG5;RILPL1;BNIP3L;EPHB1;PRKD1;BECN1;CDKN1B;NCK1;LRRK2;ADNP2;UBB;DUS2;BMP7;PRODH;CCN3;CHRNA7;BNIP3;CRYAB;TNFRSF1B;BMP4;CCN5;TMEM109;CCN1
prerank,response to interferon-gamma (GO:0034341),0.33465411170203935,0.9582050151153475,0.5632563256325632,1.0,1.0,10/67,14.55%,WNT5A;GBP3;GBP7;SIRPA;EPRS1;SHFL;CD47;DAPK1;GBP6;AQP4
prerank,nucleosome assembly (GO:0006334),0.37052445149881164,0.9581751798034969,0.5408415841584159,1.0,1.0,9/31,16.74%,UBN1;RBBP4;ASF1A;SOX9;SART3;NPM1;ATRX;HAT1;DAXX
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.22069757712192026,-0.9580869275140249,0.5925925925925926,0.8672938645508097,1.0,19/91,10.91%,ABCG2;SMAD4;ATP6V1A;CUL1;GLRX3;SLC39A14;ACO1;SKP1;NDFIP1;ATP6AP1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;SLC39A8
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23282297598115403,-0.9577488474369542,0.5728155339805825,0.8664663942544555,1.0,17/51,17.46%,NEK7;CCT3;GNL3L;SMG5;STN1;FBXO4;TCP1;PARN;NAF1;CCT5;NAT10;SRC;MAP3K4;CCT7;PNKP;CCT2;SMG6
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.3684585026373215,-0.9574560674137088,0.5017543859649123,0.8654721705668513,1.0,6/12,31.29%,AKR1B1;STARD3NL;FDX1;TSPO;FDXR;CACNA1H
prerank,myeloid cell development (GO:0061515),-0.3288708312243934,-0.957396096931469,0.5,0.8638542122074838,1.0,8/18,24.04%,FOXP1;MED1;KIT;SRC;ABCB10;SH2B3;NRROS;NCKAP1L
prerank,positive regulation of cell division (GO:0051781),0.36280838009149863,0.9573774944602214,0.5498241500586166,1.0,1.0,6/38,14.14%,SIRT2;FGFR2;CDC14B;CIT;SVIL;CSPP1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.30921191917816054,0.9572487253370849,0.66,1.0,1.0,87/417,19.37%,SFRP2;ILF3;HDAC3;HEXIM1;WNT5A;SFRP1;CIART;FOXM1;SIRT2;ZNF568;CREBZF;NR2F2;PRMT6;SMARCC2;GLIS2;NR1D2;DKK3;PSPC1;NIPBL;CHD8;POU2F1;CDK5;MTERF3;TCF7L2;USP47;SFMBT1;IRF1;ATXN1;SNX6;EZH2;ZEB1;HDAC5;PCGF6;ZBTB38;SFMBT2;WNT4;SOX9;DDIT3;DPF2;XRCC6;PER1;HDAC4;ARID4A;TWIST1;NKRF;JARID2;RCOR1;RBFOX2;RBPJ;SUV39H1;FOXN3;NACC2;HDAC1;BCL7A;TSC22D4;EHMT1;GCLC;CIPC;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;BCL6;BCLAF1;RFX3;CIC;CTBP1;CLOCK;SNW1;CBX5;DAXX;MBD1;SOX13;TLE5;MDM2;LANCL2;PHF12;MECP2;GCFC2;NONO;MPHOSPH8;NCOR2;FOXD1;PRMT2;UIMC1;YAF2
prerank,cellular protein localization (GO:0034613),0.3107546221563576,0.9568510383839207,0.6356356356356356,1.0,1.0,73/285,18.60%,WNT5A;ARL4C;CPLANE2;SGSM3;TRAPPC8;PICK1;ERP29;CD63;SAR1A;RUNDC1;RAB24;WIPI1;NIPBL;DNAJC27;FGF10;TBC1D13;NAPG;STX6;PIGU;SNX6;VPS26B;RRAGA;RAP2A;HGS;STX16;MFN2;STX2;RAB5B;JAM3;YWHAH;COPZ2;ARL5B;RABGAP1L;WLS;SCFD1;USP6NL;ATG13;AP3B1;EVI5L;VPS33B;RIC3;TLK1;NPM1;AXIN2;TMED10;FBLN5;COG3;PIGK;EMP2;RABGAP1;USP4;USO1;EPB41L3;CNTNAP2;AP4M1;STX11;RAB31;STX8;STX17;AHI1;GGA2;NSF;SYNRG;RAB21;SMURF1;TBC1D9B;TBC1D22B;ARMCX3;ATG9A;AMOT;RAB6A;SGSM2;NPHP1
prerank,regulation of dendrite development (GO:0050773),0.356088523371089,0.9568118545223904,0.5509964830011723,1.0,1.0,11/37,18.42%,CDKL5;KNDC1;DBN1;RAP2A;CAMSAP2;LRP8;VLDLR;BMP5;CAMK1D;DCC;ADGRB3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.34781695073232927,0.9565540801708907,0.5461711711711712,1.0,1.0,16/45,24.20%,CAMK2B;IRF1;TRIM62;IFNGR2;IFNGR1;IRF3;CAMK2D;CAMK2G;ICAM1;OAS2;JAK1;TRIM26;B2M;TRIM8;MID1;JAK2
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3968083520093536,-0.9564880996629016,0.5151515151515151,0.8627919316093939,1.0,4/10,45.27%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3968083520093536,-0.9564880996629016,0.5151515151515151,0.8627919316093939,1.0,4/10,45.27%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,response to retinoic acid (GO:0032526),0.3339567785463248,0.9560340335977229,0.5544554455445545,1.0,1.0,10/59,17.05%,CDKN2D;WNT5A;ZNF35;BRINP3;SOX9;SETX;CTSH;SNW1;PTK7;BRINP1
prerank,RNA 3'-end processing (GO:0031123),0.33144265995976047,0.9559060938028446,0.5610810810810811,1.0,1.0,14/69,12.56%,RPRD2;U2AF1;SRSF2;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;LIN28B;CPSF7;CSTF2T;NUDT21;CPSF3;THOC7
prerank,lipoprotein biosynthetic process (GO:0042158),0.4494766482920604,0.9556582193521864,0.5424739195230999,1.0,1.0,4/11,17.19%,WIPI1;PORCN;PIK3C3;APOE
prerank,chromosome condensation (GO:0030261),0.36646794166142804,0.9550910706438603,0.5480093676814989,1.0,1.0,4/36,6.72%,INCENP;CSNK2A2;AKAP8L;DFFB
prerank,aerobic respiration (GO:0009060),0.3975655124514379,0.9549968376627302,0.5530799475753604,1.0,1.0,4/20,9.89%,UQCRC1;NDUFS7;MDH2;MTFR1L
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.32900187702982536,0.954883899841833,0.5609243697478992,1.0,1.0,20/80,22.00%,CDKN2D;EPHA7;FIS1;DDX3X;CARD16;USP47;XIAP;MALT1;DNAJB6;LAMTOR5;RPS6KA3;DAPK1;RPS6KA1;DPEP1;PDCD5;KLF4;PDCD6;IGBP1;PPM1F;HMGB1
prerank,Notch signaling involved in heart development (GO:0061314),0.44966012133028144,0.9545642489917524,0.5487106017191977,1.0,1.0,3/11,16.44%,SNAI1;RBPJ;JAG1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3995839539725008,0.9544187340359734,0.5448634590377113,1.0,1.0,2/20,2.96%,HEXIM1;NR2F2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3828023912235753,0.9542125521564865,0.5387596899224806,1.0,1.0,2/25,6.13%,PDPK1;THY1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.36613151417027007,0.9541774576432528,0.5480295566502463,1.0,1.0,3/31,6.58%,EPHB2;XBP1;VAMP3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.43509979413162136,0.9541390830395355,0.5454545454545454,1.0,1.0,5/13,18.18%,EPHB2;SQSTM1;APP;ADCY1;ZDHHC2
prerank,neuronal action potential (GO:0019228),0.39352167381098957,0.9541102996797572,0.5382619974059663,1.0,1.0,5/22,13.93%,MYH14;SCN7A;SCN1A;ANK3;KCNA1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.44824560558102694,0.9540053105242984,0.5279770444763271,1.0,1.0,5/10,22.67%,NELL1;CDK5RAP3;ANXA2;ATRAID;EPHA4
prerank,positive regulation of mitochondrial translation (GO:0070131),0.41922182729421054,0.9536538418726859,0.5251396648044693,1.0,1.0,3/14,13.28%,TRUB2;RCC1L;UQCC2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3516728383053799,0.9533699267584271,0.5554259043173863,1.0,1.0,3/39,4.88%,SFRP2;NRP1;FGF10
prerank,protein autophosphorylation (GO:0046777),0.31532325149970325,0.9532740285417819,0.5985772357723578,1.0,1.0,22/157,11.50%,AATK;CAMK2B;PDPK1;EIF2AK3;FGFR2;CDKL5;FGFR1;TAOK1;HTATIP2;DDR1;MINK1;DDR2;ABL1;SRMS;EPHA8;STK11;SIK1;TEC;MUSK;WNK2;PDGFRA;CAMK2D
prerank,lysosome localization (GO:0032418),0.3687350968793195,0.9531443405414998,0.5521844660194175,1.0,1.0,12/37,21.80%,KXD1;RAB34;FLCN;PLEKHM2;VPS33B;BLOC1S2;FAM98A;KIF5B;S100A13;ARL8B;MAP6;MYH9
prerank,regulation of mitochondrial translation (GO:0070129),0.38192997767179737,0.9530851442270066,0.5222363405336722,1.0,1.0,6/21,19.29%,TRUB2;RCC1L;MALSU1;UQCC2;MTG2;ALKBH1
prerank,positive regulation of B cell proliferation (GO:0030890),0.3691358563520555,0.9530128306281649,0.555,1.0,1.0,4/29,11.06%,EPHB2;TIRAP;IRS2;BCL2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3461085070126571,0.9529415729066644,0.5517241379310345,1.0,1.0,17/51,21.24%,NTF3;TAOK1;MINK1;SRGAP2;DBN1;DBNL;ALS2;WASF1;EPB41L3;CNTNAP2;TRIO;SLC9A6;GAS7;KIF20B;NRK;NBL1;MAP4K4
prerank,regulation of cell-cell adhesion (GO:0022407),0.3551370150292274,0.9524165331771555,0.5506402793946449,1.0,1.0,10/39,20.88%,EPHA7;MINK1;TENM3;CD47;TGFB1;JAG1;ZDHHC2;NF2;PTPRR;SMAD7
prerank,negative regulation of cell cycle process (GO:0010948),0.33716066142115564,0.9523084378442529,0.5542035398230089,1.0,1.0,16/61,20.54%,CCP110;TFDP1;RBBP4;FBXO5;EZH2;PCGF6;AURKAIP1;EHMT2;EHMT1;TERF1;CBX5;RBBP8;YAF2;PPP1R10;E2F6;TOM1L2
prerank,cellular response to mechanical stimulus (GO:0071260),0.34418289645942896,0.9521654702975715,0.5501138952164009,1.0,1.0,6/46,8.35%,PTGER4;NFKB1;MAP3K14;TMEM150C;IRF1;SOX9
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.38128412728299754,-0.9521326288672648,0.5098591549295775,0.8728915553818213,1.0,8/10,61.89%,GNB1;SAG;PDE6A;CNGB1;PDE6G;PDE6B;RHO;GNAT1
prerank,serine family amino acid catabolic process (GO:0009071),-0.38271680443950856,-0.9517902068602382,0.5172413793103449,0.8720628013754209,1.0,8/10,53.10%,AMT;CBS;GCSH;THNSL2;SHMT2;GLDC;SHMT1;DAO
prerank,regulation of lipid kinase activity (GO:0043550),0.44462914341123394,0.951756157788602,0.5522174535050072,1.0,1.0,5/11,17.99%,PIK3R1;RBL2;PIK3R2;WDR91;PPP2R5A
prerank,amino sugar metabolic process (GO:0006040),-0.3947059846605113,-0.9516659976854951,0.5329341317365269,0.8706203789921321,1.0,7/10,31.54%,CSGALNACT1;ST3GAL1;GFPT1;GFPT2;ST6GAL1;SLC35A3;FN3K
prerank,positive regulation of RNA splicing (GO:0033120),0.3739570424332484,0.9516316080593323,0.5472392638036809,1.0,1.0,11/29,20.65%,RBM3;PRDX6;PIK3R1;SETX;TRA2B;HNRNPLL;SNW1;THRAP3;RBM22;CIRBP;TRA2A
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3762594789165894,0.95137387906563,0.53875,1.0,1.0,6/26,17.19%,NOS1AP;POR;GDNF;PIK3CB;PARK7;APOE
prerank,negative regulation of coagulation (GO:0050819),0.41991967346350756,0.9510958695830004,0.5402777777777777,1.0,1.0,4/14,17.19%,VTN;TFPI;SERPINE1;APOE
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.42403054691857023,0.9508061993432787,0.5445544554455446,1.0,1.0,6/16,21.70%,SNF8;VTA1;LEPROT;CHMP4A;CHMP4B;LEPROTL1
prerank,homeostasis of number of cells (GO:0048872),0.44041699425139585,0.9507410400373738,0.5336194563662375,1.0,1.0,1/12,0.50%,OCIAD2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3597579689479799,0.9503932631884544,0.5663615560640732,1.0,1.0,11/39,17.80%,TMEM150A;PIP4K2B;PIK3R1;PIK3CB;PIK3R2;PI4KB;PIP4K2A;PIP4K2C;PIK3C2B;PIK3C3;IP6K1
prerank,regulation of centrosome duplication (GO:0010824),0.37952251158558065,0.9502593562112737,0.5616264294790343,1.0,1.0,10/29,21.48%,ALMS1;FBXW5;CHMP3;VPS4B;NPM1;SPICE1;CEP120;CEP76;TMEM67;CHMP4B
prerank,Golgi inheritance (GO:0048313),-0.37852722354908946,-0.9500709800235451,0.5235109717868338,0.8731256411331932,1.0,2/11,1.81%,GBF1;YWHAZ
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.33616270376864316,0.9497276233260855,0.5550611790878754,1.0,1.0,11/57,11.40%,TAOK1;FZR1;SDE2;FBXO31;CDC14B;CDK5RAP3;MRNIP;ATF2;MDC1;BRSK1;FOXN3
prerank,type I interferon signaling pathway (GO:0060337),-0.24526782557665844,-0.9494832630223835,0.515625,0.8712211430518226,1.0,17/41,24.05%,IP6K2;SAMHD1;IFNAR2;STAT2;STAT1;IRAK1;SP100;TYK2;IFIT2;XAF1;IRF9;IFIT1;GBP2;BST2;IFITM2;IFITM1;EGR1
prerank,cellular response to type I interferon (GO:0071357),-0.24526782557665844,-0.9494832630223835,0.515625,0.8712211430518226,1.0,17/41,24.05%,IP6K2;SAMHD1;IFNAR2;STAT2;STAT1;IRAK1;SP100;TYK2;IFIT2;XAF1;IRF9;IFIT1;GBP2;BST2;IFITM2;IFITM1;EGR1
prerank,histone mRNA catabolic process (GO:0071044),-0.34226927942491014,-0.9494305145331376,0.5209790209790209,0.8696142994098086,1.0,7/15,26.25%,TENT2;LSM1;ERI1;UPF1;TUT1;TUT4;SSB
prerank,melanosome organization (GO:0032438),-0.282144000412751,-0.9489405558935526,0.5581395348837209,0.8692005478205042,1.0,10/26,27.87%,AP3D1;KIF13A;DTNBP1;HPS4;AP1M1;BLOC1S5;RAB29;SNAPIN;HPS1;RAB38
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.36977186923747124,-0.9488626062031441,0.5,0.8676872033390435,1.0,2/11,6.43%,RIPK1;UNC93B1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3037719746655199,0.9487882131935458,0.802,1.0,1.0,344/1646,19.91%,PSRC1;SFRP2;ILF3;CAMTA2;HDAC3;HEXIM1;TEAD3;WNT5A;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SFRP1;IGF1;MED24;SP7;DVL2;ZNF23;CIART;TCIM;FOXM1;SIRT2;ZBTB48;POU5F2;DDX17;MYRF;NFKB1;ZNF25;KDM7A;ZBTB46;SMARCD3;HMGB3;ZNF568;MAMLD1;PKNOX2;CC2D1B;AEBP2;ZEB2;CREBZF;USF1;NR2F2;MLXIP;TEF;NKX6-1;MAPRE3;PRMT6;MED12;NKX2-2;MAFG;SMARCC2;MED14;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;PCGF1;ZNF8;ZFP82;HTATIP2;DKK3;RORA;TFDP1;KMT2B;NFKB2;CARF;PSPC1;BRPF1;MXI1;ABCA2;ZNF205;SNF8;NIPBL;SNX5;CCNC;OGT;CHD8;VGLL3;POU2F1;IL31RA;RFX5;SNAI1;CDK5;SLTM;MTERF3;ZNF692;NPAT;TCF4;TCF7L2;USP47;SFMBT1;TFCP2;ZNF276;BBS7;CNBP;BRD4;IRF1;MED13;ABL1;ATXN1;FBXO5;PHF1;DVL1;ZNF35;ZIC3;SNX6;CASZ1;TRIM56;HNRNPK;EZH2;FUS;ARNT;ZBTB7B;ANKRD49;MAGED1;ZNF711;ZEB1;SMARCB1;CHD5;TEAD1;TGFB1I1;HDAC5;PCGF6;MXD1;RAI1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ASCC1;MED4;ZKSCAN5;ACTR8;DBP;NFX1;SFMBT2;ARRB1;TSHZ2;WNT4;SOX9;SRA1;SMARCD1;DDIT3;BRD3;PGBD1;DPF2;ZFHX2;XRCC6;YWHAH;PER1;HNRNPD;ARID1B;DHX36;MDM4;EGF;PRMT5;ATMIN;ZSCAN20;HDAC4;ARID4A;SOX11;SAP30L;TWIST1;CALCOCO1;FADS1;PSIP1;PRRX1;NKRF;JARID2;HOXB8;ATF2;POU6F2;RCOR1;PSMC5;ZBTB20;ZNF445;RBFOX2;KDM2B;NSD3;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SUV39H1;BACH2;MAZ;NFAT5;FOXN3;IRF3;CAMK2D;ZNF471;YY1;SMARCA1;NACC2;ZMIZ1;E2F3;NFIX;BRIP1;BACH1;PEG3;POLR2K;SOX6;SOD2;CCNH;NPM1;TADA3;TIAL1;HDAC1;CEBPG;BCL7A;ZFP2;CREB3;CREB3L4;ZNF383;RPS6KA3;TSC22D4;EHMT1;PROX2;GCLC;SUFU;CIPC;CBFB;MMS19;FOXJ3;ATRX;ZHX2;EBF1;RUNX1T1;NRG1;ZIC2;TGFB1;MED21;TRPS1;ESRRG;CAMTA1;MAP2K2;TULP3;BCL6;BAZ2B;BCLAF1;ZNF292;SMAD6;SOX5;THOC1;KMT2D;RGMB;PIAS3;CHD1;NUCKS1;TTC21B;RFX3;NR2C2;MED23;SATB1;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;FOXC2;CIC;HSPD1;RPS6KA1;DDX5;TRAK1;GTF2IRD1;MAF;CHEK2;SAFB2;CTBP1;SBNO1;HOXC8;CLOCK;SNW1;CCNT1;TRIP4;CBX5;DAXX;MBD1;UBE2L3;THRAP3;PHIP;ZFP37;KDM3B;MTDH;SOX13;ZBTB41;OSR1;APOE;ZFP90;HP1BP3;TLE5;TCF7;NFXL1;NSD1;MDM2;LANCL2;ANXA4;RAD21;MEIS2;TBL1XR1;ILK;RELB;ZNF177;PHF12;RBBP8;RNF111;PRKAR1A;MECP2;CUX1;KMT2A;BCL11B;GCFC2;NONO;TGFBR1;TERF2IP;MPHOSPH8;USP22;NCOR2;CHD2;FOXD1;KLF13;PRMT2;NUP35;SOX4;ZIC4;BRDT;UIMC1;YAF2;SETD5;MITF;CDK11B;PPM1A;KLF4;MLLT3;WWC1;CARM1;GABPA;NFIA;PRDM15;PIAS1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3193995045734106,-0.9486664211730177,0.5508771929824562,0.8664633852200985,1.0,9/16,39.62%,TIPIN;RAD9B;HUS1;CLSPN;DNA2;ORC1;TIMELESS;RAD9A;CDC45
prerank,regulation of programmed cell death (GO:0043067),0.311166971088846,0.9485916126381657,0.6046511627906976,1.0,1.0,28/161,13.35%,GLS2;BAX;LCMT1;NTF3;HSP90AA1;AIFM2;ANP32A;HTATIP2;CDK5;PRELID1;ABL1;USP42;MAGED1;PLK5;LRP8;SOX9;SRA1;NDRG1;VCP;MALT1;PSMC5;IGFBP3;RTKN;IRF3;TMEM219;HS1BP3;TNFRSF25;DAPK1
prerank,negative regulation of cytokine production (GO:0001818),0.3114736261771661,0.9485112342948644,0.6070707070707071,1.0,1.0,22/163,13.55%,FCGR2B;PTGER4;CHID1;SELENOS;ADCY7;RAC1;ANXA1;TNFAIP3;DHX58;CD200R1;SIRPA;ARRB1;DDIT3;PIBF1;ATP2B1;CUEDC2;LGR4;SSC5D;SARS1;IRF3;NPTN;PTPN22
prerank,ether lipid metabolic process (GO:0046485),0.4238239592204714,0.94848862488778,0.5379113018597997,1.0,1.0,8/14,23.07%,PEDS1;AGMO;PEX7;FAR1;PLA2G7;PAFAH1B1;NCEH1;GNPAT
prerank,regulation of receptor binding (GO:1900120),0.45813580673087395,0.9484349858425432,0.5509893455098934,1.0,1.0,4/10,22.07%,ATP2A2;PTPRF;GREM2;B2M
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4454162296975703,0.9482929064667274,0.5660112359550562,1.0,1.0,4/12,16.69%,ERLIN2;PIBF1;ACADL;ACADVL
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3276489499178165,0.9479863584034341,0.5866523143164694,1.0,1.0,25/78,21.06%,CLN3;EPHB2;PDPK1;CDK5;PIK3R1;SQSTM1;TMBIM1;PID1;CLIP3;VTI1B;PRKCI;LRP1;TGFB1;DPP10;SPTBN1;STX8;VAMP8;MRAP2;KIF5B;PPP2R5A;ZDHHC2;MMP14;DAB2;ITGB1;ATP2B4
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.30710967674656947,0.9478863537338844,0.721,1.0,1.0,145/572,22.43%,CBX8;HDAC3;HEXIM1;ZMYM5;POU6F1;DUSP26;FOXM1;SIRT2;SIRT7;NFKB1;ZNF25;AASS;ZNF568;BMP6;PARP1;ZEB2;IL33;NR2F2;FGFR2;NKX6-1;TAF9B;GLIS2;NR1D2;PCGF1;ZNF8;MIER2;MXI1;ZNF205;NIPBL;CHD8;SNAI1;ZNF692;FLCN;TCF7L2;CNBP;ATXN1;EZH2;ZBTB7B;RTF1;ZEB1;HDAC5;MOSPD1;MXD1;ZBTB5;CC2D1A;NFX1;SOX9;PTCH1;EHMT2;DDIT3;SDCBP;DPF2;PER1;MDM4;HDAC4;SOX11;TWIST1;USP2;KDM2B;RBPJ;GLIS1;SUV39H1;SARS1;MAZ;JAZF1;YY1;NACC2;MTA2;NFIX;BACH1;PEG3;HDAC1;USP9X;SUFU;CBFB;CDC73;ATRX;ZHX2;TRPS1;BCL6;IMPACT;NR2C2;SATB1;TCF3;FOXC2;DDX5;GTF2IRD1;UBE2D1;CTBP1;SNW1;CBX5;CBX7;ZFP37;MTDH;SOX13;OSR1;HSBP1;ZFP90;TLE5;NSD1;MDM2;MEIS2;TBL1XR1;ZNF177;PHF12;ATN1;MECP2;CUX1;GPS2;NCOR2;TRIM27;WWOX;MITF;PHF21A;PPM1A;KLF4;WWC1;DNMT3A;MIER1;E2F6;DAB2;GLIS3;HNRNPU;CTCF;ZNF219;IGBP1;ZBTB32;SMAD7;TPR;NFATC3;GLI3;ZNF431;VPS72;SMAD2;TCERG1;CIR1;HMGB1;PEX2;SMAD3;MTA1;TAF1;HOXA7;IFI27;ID2;N4BP2L2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.33614787029402415,-0.9474717094079933,0.5408163265306123,0.8680562359460264,1.0,2/14,6.01%,SHLD2;PAXIP1
prerank,negative regulation of autophagy (GO:0010507),0.3380418734517402,0.9472819930929233,0.5508379888268157,1.0,1.0,11/54,16.63%,IL10RA;SIRT2;RRAGA;WDR6;NRBP2;BCL2;LEPR;EIF4G2;PTPN22;NUPR1;EIF4G3
prerank,regulation of immune response (GO:0050776),0.3155927459929801,0.9471146184201105,0.6059365404298874,1.0,1.0,10/135,8.14%,FCGR2B;GPR108;NPDC1;ADCY7;TIRAP;IRF1;DHX58;CD200R1;XIAP;LRP8
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.31709139309385465,-0.9470669166911186,0.5291479820627802,0.8674707695004261,1.0,9/18,26.33%,KAT2B;RPS13;TMBIM6;PTBP2;ESR1;RPS26;NRDE2;ZC3H12A;TERT
prerank,regulation of cell aging (GO:0090342),0.44776255029945755,0.9470217438062618,0.5377777777777778,1.0,1.0,2/11,5.98%,FOXM1;NUAK1
prerank,regulation of cholesterol esterification (GO:0010872),0.45998285813634054,0.9467314449795793,0.5517241379310345,1.0,1.0,4/10,21.43%,ABCA2;AGTR1;APOE;ABCG1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.31025935172032193,0.9466963600085134,0.6151515151515151,1.0,1.0,51/184,21.84%,CCP110;CDC23;SIRT2;PSMD4;HSP90AA1;UBE2S;MAD2L1;ZFP36L1;CDC16;FZR1;ALMS1;ANAPC2;FBXO5;PSMB10;DDB1;CDC14B;PSMD11;PLK5;TUBA1A;PPP1R9B;YWHAG;PSME2;PSMC5;ANAPC11;ANAPC4;KCNH5;HAUS3;CSNK1D;CDC26;TUBB;PSMD1;OFD1;UBE2E1;UBE2D1;PSMD6;CEP76;ANAPC10;TUBB4A;ANAPC5;ODF2;PSMD5;DYNLL1;ZW10;PAFAH1B1;INO80;PSMA4;HECW2;APPL2;PSMA1;PSMC6;CNTRL
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4175591991677927,0.9466730254962706,0.553314121037464,1.0,1.0,4/14,10.53%,SCAP;SAR1A;MIA3;TBC1D20
prerank,response to molecule of bacterial origin (GO:0002237),0.3271616173456664,0.9466420748118668,0.5815217391304348,1.0,1.0,11/69,14.82%,FCGR2B;SIRT2;IFNAR1;TNFAIP3;TIRAP;CD24;LY96;HNRNPA0;RPS6KA3;PTPN22;SMAD6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3648046017164365,0.9463911409050534,0.5523809523809524,1.0,1.0,11/32,22.83%,ANXA1;HDAC5;TBXA2R;FGFBP1;PTGS2;FOXC2;ITGB1BP1;KLF4;STARD13;FGF2;MEOX2
prerank,ncRNA transcription (GO:0098781),0.42162044893933814,0.9462077086321483,0.5356622998544396,1.0,1.0,2/13,3.66%,SIRT7;USPL1
prerank,regulation of viral release from host cell (GO:1902186),0.3881663022404789,0.9460992806944769,0.5523560209424084,1.0,1.0,5/21,9.28%,TRIM11;DDB1;TRIM35;TRIM62;CHMP3
prerank,innate immune response (GO:0045087),-0.18640772426104615,-0.9458966734453232,0.5714285714285714,0.8689404138751021,1.0,59/217,24.26%,ANKRD17;SETD2;MFHAS1;CAPZA2;IKBKB;FER;RNASE3;PML;LBP;IRAK1;TNK2;TRIM25;SP100;IFIH1;RNF135;TLR4;OTULIN;CYLD;PLCG2;POLR3A;CXCL16;ALPK1;IKBKG;TRIM39;ADAM15;DEFA6;PYDC1;IRAK4;S100B;RPL39;MAVS;AKAP1;SRC;SERINC3;RNF187;TRIM5;IRGM;SKP2;TRIM14;IFIT1;PGLYRP1;GCH1;NRROS;TBK1;FYN;CYBA;BST2;IFITM2;NUB1;ATAD3A;STYK1;PPARG;IFITM1;BCL10;PIK3CD;NLRC5;CX3CR1;TRIM59;TRIM28
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45019053193607383,0.9458137858186362,0.5659259259259259,1.0,1.0,4/10,20.66%,COMT;SMOX;ALDH7A1;SLC44A1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4499763188992841,0.9457533484973156,0.5579710144927537,1.0,1.0,2/11,11.23%,ANXA1;RC3H2
prerank,myelination in peripheral nervous system (GO:0022011),0.42665871904082453,0.9454928818417385,0.5625879043600562,1.0,1.0,2/13,4.84%,SIRT2;ARHGEF10
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.37595518619306234,-0.9448186690364743,0.5315315315315315,0.8701165080895517,1.0,5/11,9.20%,CD46;THBS1;LGALS9;BMPR1A;CD34
prerank,histone H2B ubiquitination (GO:0033523),0.45111031478613056,0.944817764376234,0.5468277945619335,1.0,1.0,4/10,15.71%,RNF8;RNF40;CDC73;UBE2E1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.4222388300703196,0.9443963416073335,0.5626822157434402,1.0,1.0,4/13,18.96%,HSP90AA1;FPGS;QDPR;CALM1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4078499619799062,0.9440189434319554,0.5509383378016086,1.0,1.0,4/17,15.88%,NKX6-1;SOX9;RFX3;AHI1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.22792786741530613,-0.9440044482839074,0.6626506024096386,0.8705668121743667,1.0,18/63,18.83%,CAV1;ITGA6;AR;RIPK1;PML;FEM1B;SP100;ACVR1;THBS1;TNFSF10;CYLD;FAS;MADD;SCG2;SRC;BMP4;LTBR;TNFSF12
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4016326644065181,0.9437289323896182,0.536745406824147,1.0,1.0,4/18,12.16%,BRD4;FBXO5;CDC25A;VPS4B
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.367752247412037,0.9436144164425491,0.548854041013269,1.0,1.0,16/32,27.10%,TAOK1;CAMSAP2;CLIP3;KATNB1;EML2;TBCD;TUBB4A;FGF13;CLASP2;CAMSAP1;MAP2;NAV3;STMN1;ARHGEF2;HDGFL3;APC
prerank,positive regulation of ion transport (GO:0043270),0.3465023386601288,0.9432780883213335,0.5890257558790594,1.0,1.0,14/48,22.71%,GPD1L;CNKSR3;ATP2B1;CRACR2A;GDNF;RAB3B;ANK3;VAMP8;AHCYL1;KIF5B;SNX4;SCN1B;VAMP7;WNK3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3809897811137393,-0.9432189077924749,0.5272727272727272,0.8709205266084007,1.0,5/10,22.77%,ATP5F1C;ATP5PO;ATP5PD;VPS9D1;ATP5F1D
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3035782465302007,0.9427478538577792,0.767,1.0,1.0,198/807,22.43%,SFRP2;ILF3;CBX8;HDAC3;HEXIM1;WNT5A;ZMYM5;POU6F1;SFRP1;DUSP26;CIART;FOXM1;SIRT2;SIRT7;NFKB1;ZNF25;AASS;ZNF568;BMP6;PARP1;ZEB2;CREBZF;IL33;NR2F2;FGFR2;NKX6-1;PRMT6;TAF9B;SMARCC2;GLIS2;NR1D2;PCGF1;ZNF8;DKK3;MIER2;PSPC1;MXI1;ZNF205;NIPBL;CHD8;POU2F1;SNAI1;CDK5;MTERF3;ZNF692;FLCN;TCF7L2;USP47;SFMBT1;PRDX5;CNBP;IRF1;ATXN1;SNX6;EZH2;ZBTB7B;RTF1;ZEB1;HDAC5;PCGF6;MOSPD1;MXD1;ZBTB5;ZBTB38;NFX1;SFMBT2;WNT4;SOX9;PTCH1;EHMT2;DDIT3;SDCBP;DPF2;XRCC6;PER1;MDM4;HDAC4;ARID4A;SOX11;TWIST1;NKRF;JARID2;USP2;RCOR1;RBFOX2;KDM2B;RBPJ;GLIS1;SUV39H1;SARS1;MAZ;FOXN3;JAZF1;YY1;NACC2;MTA2;NFIX;BACH1;PEG3;HDAC1;BCL7A;USP9X;TSC22D4;EHMT1;GCLC;SUFU;CIPC;CBFB;CDC73;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;TRPS1;BCL6;BCLAF1;IMPACT;RFX3;NR2C2;SATB1;TCF3;FOXC2;CIC;DDX5;GTF2IRD1;UBE2D1;CTBP1;CLOCK;SNW1;CBX5;DAXX;MBD1;CBX7;ZFP37;MTDH;SOX13;OSR1;HSBP1;ZFP90;TLE5;NSD1;MDM2;LANCL2;MEIS2;TBL1XR1;ZNF177;PHF12;ATN1;MECP2;CUX1;GPS2;GCFC2;NONO;MPHOSPH8;NCOR2;TRIM27;WWOX;FOXD1;PRMT2;UIMC1;YAF2;MITF;PHF21A;PPM1A;KLF4;WWC1;DNMT3A;MIER1;E2F6;DAB2;GLIS3;HNRNPU;CTCF;ZNF219;IGBP1;PHC2;ZBTB32;SMAD7;TPR;GLI3;ZNF431;VPS72;SMAD2;FOXO1;PPM1F;TCERG1;CIR1;HMGB1;PEX2;SMAD3;MTA1;TAF1;SPINDOC;HOXA7;IFI27;ID2;N4BP2L2
prerank,organic cation transport (GO:0015695),0.3940931248889368,0.9426049222223315,0.5614035087719298,1.0,1.0,2/19,4.21%,SLC25A19;SLC22A4
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.38637566968318326,-0.942565032562949,0.5393939393939394,0.8709201490858526,1.0,2/10,9.41%,LGALS9;RARA
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3835854012603837,0.9422202813668875,0.560853199498118,1.0,1.0,4/24,12.01%,IGF1;SELENOS;IRS2;ENPP1
prerank,negative regulation of growth (GO:0045926),0.3170580928212582,0.9421119239401903,0.6041237113402061,1.0,1.0,11/121,8.63%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;CGRRF1;DDX3X;FLCN;STK11;TCHP;PPP1R9B
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.3270609555626573,-0.9420456586858255,0.5145985401459854,0.8706536218253921,1.0,7/15,23.72%,GGACT;GOT2;GGT5;PRODH;SARDH;HOGA1;CHAC2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.31160159230155104,-0.9418625524720048,0.5375494071146245,0.8694434418177186,1.0,5/20,6.32%,DROSHA;PUM1;TSN;AGO2;TSNAX
prerank,carnitine metabolic process (GO:0009437),0.43922614336808097,0.941771985225092,0.5463483146067416,1.0,1.0,4/12,16.67%,CROT;CPT2;BBOX1;ACADL
prerank,autonomic nervous system development (GO:0048483),0.4037245847065022,0.9417434588519871,0.5550964187327824,1.0,1.0,5/17,19.15%,NRP1;SOX11;GDNF;SEMA3A;SOX4
prerank,hyaluronan catabolic process (GO:0030214),0.3981925644860827,0.9415841835741767,0.5446071904127829,1.0,1.0,5/18,21.29%,LYVE1;TGFB1;CEMIP;GUSB;FGF2
prerank,nuclear membrane organization (GO:0071763),0.39837376310571493,0.9414892907517612,0.5427069645203679,1.0,1.0,4/19,10.12%,UBXN2A;AKAP8L;TOR1B;TMEM43
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.31119593503468207,0.9413632852042474,0.649949849548646,1.0,1.0,36/186,17.38%,SFRP2;WNT5A;BICC1;SFRP1;DVL2;PSMD4;TSC2;DKK3;CHD8;TCF7L2;KLHL12;PSMB10;DVL1;STK11;PSMD11;SOX9;DDIT3;RBMS3;PSME2;PSMC5;LZTS2;ZNRF3;HDAC1;AXIN2;RACK1;KREMEN1;LRP1;CSNK1A1;PSMD1;CTNNBIP1;INVS;NKD1;PSMD6;SOX13;APOE;TLE5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3781635117231216,0.9409384649157934,0.5407124681933843,1.0,1.0,6/25,17.56%,IGF1;SOX11;TWIST1;PARK7;TGFB1;NSD1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.31649942463950675,0.9406312807065863,0.601427115188583,1.0,1.0,37/118,22.67%,SFRP1;MYO19;FGFR2;WARS1;HTATIP2;TANC2;TNFAIP3;CDK5;KNDC1;PAK3;BRSK2;PDZD8;SPARC;RAP2A;PID1;SRCIN1;GDNF;BRSK1;DAG1;EMP2;MAPT;TGFB1;BCL6;ADGRA2;PHLDB1;PHIP;RUFY3;ADGRB3;CHN1;HECW2;FGF2;CFL1;CLASP2;ARHGAP35;CAMSAP1;PAK1;EPHA4
prerank,cellular response to lipid (GO:0071396),0.3072511090368509,0.9400983533890926,0.6545820745216515,1.0,1.0,34/191,17.05%,WNT5A;LPL;SFRP1;GPLD1;SELENOS;NFKB1;XBP1;RORA;ATP1A3;TNFAIP3;CARD16;ZNF35;SIRPA;ATP1A2;PID1;INSIG1;BRINP3;SOX9;TRIM41;LY96;TFPI;NCOA4;GIT1;SETX;CDC73;ROCK2;ADCY1;PDE4B;SNW1;SERPINE1;ADCY5;PTK7;UBE2L3;BRINP1
prerank,protein-containing complex subunit organization (GO:0043933),0.31492084568758555,0.9400567276281054,0.5969072164948453,1.0,1.0,34/109,22.05%,CHCHD10;NDUFAF1;KPNA3;NAPG;LAMC1;DMTN;VAMP3;TEAD1;SOX9;EPRS1;MDM4;PPIH;CAPZA1;AFG3L2;ADD2;WASF1;DNM1L;FANCA;IL1RAP;TUBGCP2;MDM2;TSPAN4;KMT2A;SHANK1;NUP35;KIFAP3;MITF;RANBP9;ZW10;PTK2B;GEMIN5;TPR;LLGL1;TRAF2
prerank,B cell homeostasis (GO:0001782),-0.38004429111995097,-0.9395891122663764,0.5290519877675841,0.8736278461821285,1.0,3/10,8.32%,MEF2C;PPP2R3C;CAMLG
prerank,cilium organization (GO:0044782),0.3088708244172518,0.9395088732130438,0.6508577194752775,1.0,1.0,40/209,15.88%,CCP110;TMEM138;B9D2;IQCG;CPLANE2;STK36;IFT52;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;CLUAP1;TCTN1;BBS7;INPP5E;SNX10;TTC17;CDC14B;CCDC28B;PIBF1;CFAP54;TTC8;CEP126;CC2D2A;IFT80;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;DISC1;ATP6V1D;TMEM216;RFX3;ARMC2;OFD1;RAB8A;RAB8B;AHI1
prerank,regulation of transport (GO:0051049),0.3582232741169243,0.9392398083399377,0.5631641086186541,1.0,1.0,7/36,11.38%,NRP1;GAPVD1;CDK5;ICA1L;MBTPS1;SCFD1;LEPR
prerank,detection of visible light (GO:0009584),-0.3334910745920664,-0.9386933768366199,0.5035211267605634,0.8744095576868004,1.0,4/16,24.03%,ABCA4;GNA11;CEP250;RP1
prerank,regulation of autophagy (GO:0010506),0.30703484189186897,0.9386360982942926,0.6344410876132931,1.0,1.0,49/216,17.48%,IL10RA;UBQLN1;SIRT2;PIP4K2B;CSNK2A2;ATP6V0A2;UCHL1;SNX5;ITPR1;CDK5;SLC38A9;FLCN;DCN;ABL1;SNX6;VPS26B;ATP6V0E2;STK11;RRAGA;DDIT3;WDR6;USP10;PIK3CB;ATP6V1G1;PIK3R2;ATG13;BCL2;LEPR;RNF152;EIF4G2;LAMTOR5;PIP4K2A;VDAC1;DAPK1;PTPN22;PSAP;MAPT;ATP6V1D;PIP4K2C;DNM1L;NUPR1;TPCN1;RAB8A;MTMR4;ATP6V1B2;EIF4G3;MTDH;CAPNS1;USP33
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.2334519899440922,-0.9383321815651655,0.6111111111111112,0.8736080250643905,1.0,13/43,22.64%,MEF2C;ACVR1;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;HES1;CCDC39;SOX17;MICAL2;TBX2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.35871252559597006,0.9380000298871684,0.5613207547169812,1.0,1.0,14/33,23.92%,TCIM;EZH2;PLK5;PSME2;CDC73;MN1;INO80;ATP2B4;APPL2;TAF1;ID2;STXBP4;PTEN;FBXW7
prerank,mitotic sister chromatid segregation (GO:0000070),0.32037261937492145,0.9377982993818422,0.6066597294484911,1.0,1.0,9/98,9.28%,PSRC1;CDC23;CSNK2A2;NIPBL;AKAP8L;WRAP73;KPNB1;PIBF1;CHMP3
prerank,cell-matrix adhesion (GO:0007160),0.3177608125686445,0.9370404704003887,0.6178608515057114,1.0,1.0,15/95,13.57%,VTN;LYVE1;THBS3;RAC1;WHAMM;CD63;DDR1;THY1;ARHGEF7;RHOD;TMEM8B;ITGBL1;ECM2;FBLN5;EMP2
prerank,regulation of cytokine production (GO:0001817),0.3129923006500056,0.9359361581206043,0.6160164271047228,1.0,1.0,16/126,14.57%,FCGR2B;PTGER4;IL33;ANXA1;AGPAT1;IGF2BP2;TRIM56;SIRPA;ATP2B1;PER1;LGR4;IRF3;CD47;NPTN;SCAMP5;BCL6
prerank,vascular transport (GO:0010232),0.32234722744468225,0.9358692472279402,0.6105263157894737,1.0,1.0,16/81,16.50%,SLC4A4;SLC29A1;SLC27A4;SLC5A3;ABCA2;SLC16A12;SLC7A2;ATP1A2;SLC22A8;SLC2A3;LEPR;LRP1;SLC1A3;SLC1A5;SLC6A13;SLC27A1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.37301825553351686,-0.9357543364196697,0.5189873417721519,0.8788417848608939,1.0,2/10,3.56%,ARL6IP5;SLC25A13
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3921883020115626,0.9355989722416261,0.5517241379310345,1.0,1.0,5/19,21.92%,IL34;JAM3;CAMK1D;MPP1;CXCL17
prerank,cilium movement (GO:0003341),-0.24219795761130536,-0.9355765636280259,0.6307692307692307,0.8775998769602825,1.0,37/47,54.44%,DNAAF5;ODAD1;DNAH9;CFAP251;CCDC39;DNHD1;SPEF2;SPEF1;DNAH11;GAS8;RSPH9;CFAP61;DNAH5;ZBBX;CFAP70;CABYR;CFAP53;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;SPA17;DNAAF2;ODAD4;TEKT2;CFAP100;DNAH17;CFAP206;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5;DNAH1
prerank,myotube differentiation (GO:0014902),0.4024295367551639,0.9354638189866353,0.5467914438502673,1.0,1.0,6/17,19.07%,IGF1;ADAMTS5;ADAM12;MYEF2;ADGRB3;KCNH1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.321500430134237,-0.9347402561127769,0.5852713178294574,0.8779973098834299,1.0,2/16,4.71%,ST3GAL4;IRAK1
prerank,connective tissue development (GO:0061448),0.35204537155146853,0.9347175658841973,0.5762514551804424,1.0,1.0,6/35,14.83%,XBP1;SULF1;TRIP11;SOX9;SOX6;SOX5
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.4078206383645149,0.9346272361771146,0.5610425240054869,1.0,1.0,3/15,17.37%,SRM;SMOX;MOXD1
prerank,positive regulation of insulin secretion (GO:0032024),0.3505966164012865,0.934200591825747,0.5721153846153846,1.0,1.0,7/36,16.41%,GPLD1;LRRC8A;CAPN10;TCF7L2;IRS2;NLGN2;TRH
prerank,membrane repolarization during action potential (GO:0086011),-0.34581975783820246,-0.9341963364452693,0.5514950166112956,0.8776071068669762,1.0,3/13,12.54%,ATP1A1;KCNJ2;ATP1B1
prerank,C-terminal protein amino acid modification (GO:0018410),0.44378178386762235,0.9339908677943535,0.56732223903177,1.0,1.0,2/11,2.01%,GPLD1;LCMT1
prerank,DNA repair (GO:0006281),0.3046632509367595,0.9339599034417682,0.6836836836836837,1.0,1.0,57/284,15.30%,CDKN2D;WDHD1;XRCC2;APTX;LIG1;PARP1;APLF;RNF8;PRMT6;USP1;MPG;PARP2;MGMT;USP47;ASF1A;FBH1;MLH1;ABL1;DDB1;BARD1;TDP1;LIG3;FANCE;FANCG;ASCC1;ACTR8;SLC30A9;RNF168;UBE2V2;CUL4B;VCP;GTF2H3;MDC1;POLH;DCLRE1A;ENDOV;USP3;ALKBH3;FANCM;BRIP1;BACH1;POLN;PARK7;NPM1;FAAP100;TDP2;UBE2A;PMS2;ATR;SETX;MMS19;POLD3;FANCA;NUCKS1;MRE11;PPP5C;ASCC2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2839203925558278,-0.9338204985535807,0.5450643776824035,0.8768915017105218,1.0,8/23,28.54%,SLC12A7;CLCN3;SLC12A4;SLC12A9;SLC12A2;SLC12A8;SLC12A6;PDK2
prerank,positive regulation of protein secretion (GO:0050714),0.3216062359089414,0.9335929077143649,0.6158068057080132,1.0,1.0,13/69,16.41%,IGF1;LRRC8A;BMP6;CAPN10;TCF7L2;WLS;IRS2;MYH10;TMED10;TGFB1;NLGN2;DNM1L;TRH
prerank,intracellular lipid transport (GO:0032365),-0.2905669926579934,-0.9334274807638339,0.5529953917050692,0.8762439099514154,1.0,7/21,19.31%,ACACA;CERT1;PRKAB2;ACACB;PRKAA2;ARV1;ABCD3
prerank,regulation of cell cycle (GO:0051726),0.30282151198342316,0.9334237570867173,0.6837349397590361,1.0,1.0,42/271,11.88%,CDKN2D;SFRP1;FOXM1;SIRT2;TSC2;CSNK2A2;TBRG4;BIN1;WHAMM;FGFR2;FBXL12;FZD9;CDC123;FGF10;CDK5;CDK9;RBBP4;TCF7L2;IRF1;ABL1;FBXO5;BARD1;GADD45GIP1;STK11;GAS2L1;CDC14B;CDC25A;MFN2;XIAP;SIK1;SOX9;SRA1;WDR6;PPP1R9B;SDCBP;RNF40;CDK5RAP3;TMEM8B;TAF6;IQGAP1;EIF4G2;MAGI2
prerank,regulation of protein acetylation (GO:1901983),0.43174605795402565,0.9334002838301839,0.5522388059701493,1.0,1.0,4/12,18.57%,TAOK1;DDX3X;PARK7;TERF2IP
prerank,cellular protein-containing complex assembly (GO:0034622),0.30842965697607655,0.9333698335841856,0.6488933601609658,1.0,1.0,43/159,22.48%,CALY;SRP19;CENPT;BBS10;PSMD4;BIN1;HSP90AA1;NDUFAF1;TBCA;TCF4;VAMP3;COX7A2;PSMD11;PSMG3;VBP1;CHMP3;AP2S1;PDE4DIP;PRLR;CENPC;MAPT;NRG1;TGFB1;SHQ1;HSPD1;POMP;TBCD;VAMP8;DNAAF3;OMA1;GPX4;NUP153;DNAI4;UVRAG;TPR;CHMP4A;CHMP4B;SMAD2;OTUD6B;TRAF2;SMAD3;DNAJB12;GTF2B
prerank,negative regulation of anoikis (GO:2000811),-0.33954690168802454,-0.9333170170474692,0.5672727272727273,0.8748529622342315,1.0,4/14,15.19%,CAV1;MCL1;PIK3CA;SRC
prerank,negative regulation of multicellular organismal process (GO:0051241),0.30932189623702233,0.9328308469323725,0.6754032258064516,1.0,1.0,32/199,15.42%,SFRP2;FCGR2B;SFRP1;PTGER4;ADM;NRDC;FLCN;PLCL2;SFMBT1;ACOT11;STK11;ADAMTS5;SOX9;PTCH1;LRPAP1;DDIT3;ATP2B1;LGR4;RBPJ;ROBO1;IFNGR1;BMP5;DOCK7;CYP51A1;NPTN;SLC6A4;NOVA1;ROCK2;TGFB1;SMAD6;VASN;FOXC2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.44504723382718536,0.9327310780118302,0.5622254758418741,1.0,1.0,1/10,2.58%,BMP6
prerank,cardiac myofibril assembly (GO:0055003),0.41654224200905965,0.9324776953168631,0.5702247191011236,1.0,1.0,3/15,11.29%,NEB;OBSL1;PDGFRA
prerank,polyamine metabolic process (GO:0006595),0.4239011572996041,0.9322656541382045,0.5851216022889842,1.0,1.0,4/13,15.79%,SRM;SMS;SMOX;AMD1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.38587353766070975,0.9320311597605921,0.5738125802310655,1.0,1.0,8/20,18.70%,ABCA2;KPNB1;MBTPS1;EPHX2;ACADL;ACADVL;APOE;TTC39B
prerank,cellular defense response (GO:0006968),0.34522084092447425,0.9318026546728102,0.5842956120092379,1.0,1.0,7/40,20.97%,DCDC2;CCR9;LY96;TCIRG1;LSP1;PTK2B;ITGB1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2972320761791466,-0.9315011228440716,0.5454545454545454,0.8777556045740539,1.0,10/22,19.09%,TSG101;UBAP1;VPS36;VPS37B;MVB12B;TOM1L1;PTPN23;VPS37C;VPS4A;PLAA
prerank,muscle organ development (GO:0007517),0.33731284381443505,0.9312103668526159,0.575083426028921,1.0,1.0,4/54,3.12%,FHL3;POU6F1;IGF1;NEB
prerank,N-glycan processing (GO:0006491),-0.30996017933267966,-0.9311970797696416,0.532319391634981,0.8768714855719004,1.0,9/18,15.89%,MGAT4A;GANAB;GANC;MAN1B1;MAN2A2;FUT8;ST8SIA6;ST8SIA4;ST8SIA2
prerank,keratan sulfate catabolic process (GO:0042340),0.4417416971436063,0.9310531431445408,0.5801749271137027,1.0,1.0,3/11,15.67%,GLB1;OMD;LUM
prerank,regulation of telomerase activity (GO:0051972),-0.2433187364357452,-0.9308195447082994,0.547945205479452,0.8762205292847477,1.0,14/45,17.46%,NVL;NEK7;PTGES3;PARM1;HSP90AB1;TP53;TCP1;PARN;NAF1;SRC;MAP3K4;PNKP;CCT2;SMG6
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4088180294850382,0.9306135280473752,0.5836791147994468,1.0,1.0,7/16,20.65%,RBM3;PRDX6;TRA2B;SNW1;THRAP3;CIRBP;TRA2A
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3994310895548946,0.9305541770492273,0.5655172413793104,1.0,1.0,2/17,11.13%,NOS1AP;ANK3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.37168480662491044,0.9304139945015609,0.5879332477535302,1.0,1.0,9/25,24.80%,ANXA1;MALT1;SPTBN1;PDE4B;PRKD2;RPS3;TRAF2;TRAF6;RUNX1
prerank,multivesicular body organization (GO:0036257),0.3622170150111939,0.9300351544024876,0.5651105651105651,1.0,1.0,6/31,12.16%,MVB12A;SNF8;HGS;VTA1;CHMP3;VPS4B
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3266226551264969,0.9298485519089021,0.6127292340884574,1.0,1.0,16/69,17.58%,UBQLN1;SELENOS;STUB1;EDEM1;SYVN1;ERLIN2;JKAMP;AUP1;RNF103-CHMP3;VCP;USP19;UBE2J1;UBXN4;RNF121;DERL1;DNAJC10
prerank,histone exchange (GO:0043486),0.34827718455587553,0.9297952391893359,0.5734597156398105,1.0,1.0,6/37,13.49%,CENPT;RNF8;RBBP4;ACTR6;NPM1;CENPC
prerank,glycogen metabolic process (GO:0005977),-0.2762380235007917,-0.9297903999187014,0.5759162303664922,0.8770961476933271,1.0,7/27,20.56%,AGL;PYGB;PHKA1;GYS1;PGM2;PHKG2;GYG1
prerank,MAPK cascade (GO:0000165),0.30384082122913103,0.929688502327965,0.677,1.0,1.0,68/295,21.29%,FGF20;FGF9;SPTBN5;CAMK2B;PTGER4;IGF1;ARAF;PSMD4;NFKB1;NEFL;FGFR2;FGFR1;GRIN1;TAOK1;ZFP36L1;MINK1;BRAP;FGF10;IL31RA;PIK3R1;DLG3;PSMB10;RASGEF1A;PSMD11;SOX9;FRS2;EGF;PPP1CC;KL;GDNF;PSME2;IRS2;GFRA2;PSMC5;PIK3CB;PIK3R2;PDGFRA;PTPN3;NRG2;SETX;PDE6D;NRG1;TGFB1;MAP2K2;PSMD1;PPP5C;SPTBN1;CTSH;IL5;RIT2;DLG2;PSMD6;RASA3;MRAS;JAK1;CALM1;KSR1;NRK;RANBP9;PSMD5;RALGDS;MAPKAPK2;ITGAV;SPTBN4;PSMA4;MAP4K4;FGF13;FGF2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.31794899633820445,0.929600482315503,0.6246089676746611,1.0,1.0,14/92,10.63%,WNT5A;EPB41L4B;GPLD1;RAC1;GLIPR2;NRP1;FGF10;PRKCA;ABL1;SPARC;SOX9;EGF;ENPP2;PIK3CB
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.27220355521333506,-0.9295882681198546,0.5523255813953488,0.8759498921255843,1.0,14/27,30.40%,TRRAP;KAT7;KAT2B;EP300;MSL3;KAT6B;KAT8;PHF20L1;BAG6;RUVBL1;TAF6L;KAT6A;KAT5;MRGBP
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3863562749982232,0.9290323770328218,0.5852713178294574,1.0,1.0,6/21,23.45%,MAD2L1;FBXO5;ZWINT;ZW10;TPR;ATM
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.32289039549265514,0.9290319792054839,0.6051502145922747,1.0,1.0,8/75,9.15%,APLN;WNT5A;PDPK1;FGFR1;NRP1;PRKCA;ARNT;EGF
prerank,endoderm formation (GO:0001706),-0.26121951251374054,-0.9289737610357485,0.6,0.8757862671696474,1.0,11/35,19.68%,SETD2;COL4A2;COL8A1;COL6A1;FN1;LAMA3;ITGA4;ITGB5;MMP2;DUSP1;SOX17
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.32924122259147104,-0.9288918342748874,0.5428571428571428,0.8743338137052242,1.0,5/14,22.71%,IKBKG;NECTIN2;RAB29;CD81;BCL10
prerank,phosphate ion transport (GO:0006817),-0.31912938961493903,-0.9287930956661645,0.5547169811320755,0.8729199682565243,1.0,6/16,22.89%,SLC25A3;SLC37A3;SLC20A1;SLC25A14;SLC25A30;SLC25A11
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3502791573885841,0.9287527267884452,0.5882352941176471,1.0,1.0,13/33,22.83%,HDAC5;TBXA2R;JUP;TGFB1;ITGB1BP1;APOE;MECP2;KLF4;STARD13;ATP2B4;FGF2;HMGB1;MEOX2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.35130758441594473,0.9286935074673011,0.5749414519906323,1.0,1.0,6/36,12.36%,EPHB2;NRP1;EGF;PARK7;NLGN3;HDAC1
prerank,positive regulation of transporter activity (GO:0032411),0.4221945537643786,0.9286792755511996,0.5885797950219619,1.0,1.0,5/13,23.82%,KCTD7;KMT2A;WNK3;RXRA;SGK1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3009189441768517,0.9284588619789294,0.7181544633901705,1.0,1.0,50/291,17.05%,CPEB1;MAPK9;WNT5A;LPL;SFRP1;GPLD1;SELENOS;NFKB1;XBP1;RORA;ZFP36L1;TNFAIP3;TIRAP;CARD16;SLC38A9;PRDX5;DMTN;ZNF35;GNG2;RRAGA;SIRPA;PID1;INSIG1;BRINP3;KCNC2;SOX9;SSH1;DHX36;CAPN2;TRIM41;RAPGEF1;VCP;LY96;TPM1;PDGFRA;GIT1;LAMTOR5;SETX;DAPK1;CDC73;MAPT;ROCK2;GLRA1;IMPACT;PDE4B;SNW1;SERPINE1;PTK7;DPEP1;BRINP1
prerank,cellular component assembly (GO:0022607),0.30219728054119904,0.9283882807187053,0.6996996996996997,1.0,1.0,60/253,20.62%,WNT5A;LCP1;AIF1L;CHCHD10;RAC1;NDUFAF1;KPNA3;NEFH;TLCD1;MYO1B;RBBP4;NAPG;LAMC1;DMTN;DVL1;VAMP3;RHOD;TEAD1;SOX9;CYFIP1;EPRS1;BAIAP2;MDM4;PPIH;CAPZA1;AFG3L2;ANK3;YTHDF3;NLGN3;ADD2;WASF1;YTHDF1;TGFB1;NLGN2;VMP1;DNM1L;FANCA;SPTBN1;PAWR;IL1RAP;STK25;TUBGCP2;MDM2;TSPAN4;RAD21;ILK;KMT2A;SHANK1;KIFAP3;YTHDF2;VCPIP1;QSOX1;MITF;RANBP9;ZW10;MYO9A;DCX;LIMA1;PTK2B;GEMIN5
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.39771074410843177,0.9282706730229547,0.5661664392905866,1.0,1.0,4/18,12.17%,SIRT7;EIF2AK3;DHX33;POLR2K
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3718762592778372,0.9282210337290245,0.5668789808917197,1.0,1.0,6/25,10.95%,NRP1;DSCAM;SDCBP;EGF;APP;PTH1R
prerank,pyroptosis (GO:0070269),0.4095148502049219,0.9281235516321965,0.5755102040816327,1.0,1.0,1/15,1.45%,GSDMD
prerank,lipid droplet organization (GO:0034389),-0.29319694268369706,-0.9278738564361583,0.5509259259259259,0.8736531139546105,1.0,7/22,24.02%,RAB18;ZFYVE1;FAF2;BSCL2;CDS2;RAB3GAP1;SQLE
prerank,mitotic cytokinesis (GO:0000281),0.34101245876420055,0.9278471600377927,0.5791245791245792,1.0,1.0,11/47,17.34%,CUL7;INCENP;CIT;JTB;MYH10;ANK3;RTKN;SNX33;ROCK2;SPTBN1;SON
prerank,regulation of establishment of planar polarity (GO:0090175),0.3151800915697518,0.927586218956811,0.6361724500525763,1.0,1.0,12/88,10.55%,WNT5A;DVL2;PSMD4;RAC1;FZD3;PSMB10;DVL1;PSMD11;AP2S1;PSME2;PSMC5;DAAM1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.30135923182937624,-0.9270029340607785,0.5560344827586207,0.8743999837494713,1.0,6/20,17.14%,HSP90AB1;ANO6;NT5E;ENTPD1;TXN;P2RX7
prerank,skeletal system morphogenesis (GO:0048705),0.3410407785975751,0.9269557047814972,0.5845799769850403,1.0,1.0,9/42,18.89%,FBN2;FGFR2;FGFR1;SOX11;PDGFRA;CYP26B1;MEGF8;TGFBR1;WWOX
prerank,cellular response to amino acid stimulus (GO:0071230),0.3527683669553759,0.926860192187828,0.5806060606060606,1.0,1.0,7/33,14.46%,CPEB1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,cellular response to starvation (GO:0009267),0.30695436726096276,0.9267720600545192,0.652834008097166,1.0,1.0,37/147,19.00%,SFRP1;EIF2AK3;XBP1;PICK1;WIPI1;NUAK2;SLC38A9;FLCN;NUAK1;ATG14;ATP6V0E2;RRAGA;BRSK2;GAS2L1;TBL2;SIK1;GCN1;EHMT2;RIPOR1;FADS1;ATF2;BRSK1;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;MAP1LC3B;ATP6V1D;VPS41;IMPACT;ATP6V1B2;PIK3C3;MIOS;USP33;PRKAA1;PRKAG2;PIK3R4
prerank,polyol biosynthetic process (GO:0046173),0.39668108938481067,0.9267552276844905,0.5744400527009222,1.0,1.0,6/16,21.29%,CYP27A1;IPPK;ISYNA1;IPMK;IP6K1;FGF2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3180894161790768,-0.9266230647214183,0.5551470588235294,0.8738663618199664,1.0,8/16,21.39%,ABHD5;SCARB1;DAGLB;NR1H3;CNEP1R1;SREBF1;CTDNEP1;NR1H2
prerank,pharyngeal system development (GO:0060037),-0.31077629239127685,-0.92640565894272,0.5475285171102662,0.8727864384838696,1.0,6/15,17.99%,TGFB2;BMPR1A;BMP7;BMP4;HES1;TBX1
prerank,negative regulation of histone acetylation (GO:0035067),-0.36299706424468486,-0.9262264186267133,0.5660377358490566,0.8716367769950196,1.0,7/11,40.64%,SIRT1;SIN3A;NOC2L;TAF7;THAP7;BRCA1;SPI1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3474734543621021,0.9261405932396868,0.5876777251184834,1.0,1.0,5/37,9.24%,CHID1;ADCY7;SIRPA;PER1;CUEDC2
prerank,transport across blood-brain barrier (GO:0150104),0.3182496130271021,0.9259939680475632,0.6365546218487395,1.0,1.0,16/83,16.50%,SLC4A4;SLC29A1;SLC27A4;SLC5A3;ABCA2;SLC16A12;SLC7A2;ATP1A2;SLC22A8;SLC2A3;LEPR;LRP1;SLC1A3;SLC1A5;SLC6A13;SLC27A1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.4339398377132145,0.9259518473540373,0.556923076923077,1.0,1.0,2/10,10.20%,STAT6;PRLR
prerank,regulation of histone modification (GO:0031056),0.42320589733926506,0.924876655711883,0.5994318181818182,1.0,1.0,5/13,12.08%,CDK9;FLCN;AKAP8L;NNMT;PARK7
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.4204469512140554,0.9246469591494081,0.5730337078651685,1.0,1.0,5/13,21.79%,CALM3;ANK3;CAMK2D;CALM1;CALM2
prerank,neural crest cell differentiation (GO:0014033),-0.3064603634774947,-0.9246287012930667,0.58984375,0.8741290223508845,1.0,3/18,1.20%,LRP6;MEF2C;TAPT1
prerank,lysosome organization (GO:0007040),0.34807200610028544,0.9242467327547742,0.5893491124260355,1.0,1.0,7/36,16.00%,CLN3;CLN6;ATP10B;MBTPS1;HOOK3;ARSB;VPS18
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3878864574250891,0.9235209137219228,0.56951871657754,1.0,1.0,3/19,9.41%,FIS1;DMTN;STIMATE
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.41976909775136734,0.9234345358309302,0.5727136431784108,1.0,1.0,3/12,13.43%,KDELR3;INSIG1;ANKRD13C
prerank,cellular response to fluid shear stress (GO:0071498),0.41904764862906824,0.9230655437776261,0.5527859237536656,1.0,1.0,5/12,19.97%,HDAC3;PKD2;ASS1;KLF4;MTSS1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3251751244799871,0.9229001392075952,0.6209503239740821,1.0,1.0,9/66,11.30%,MST1R;IL34;DVL2;EDN3;FGFR1;EZH2;CD24;EGF;ROBO1
prerank,response to peptide hormone (GO:0043434),0.33618441499055046,0.9228562029163743,0.5958188153310104,1.0,1.0,6/43,6.72%,STAT6;ANXA1;XBP1;ZFP36L1;OGT;ZBTB7B
prerank,positive regulation of telomerase activity (GO:0051973),-0.25887435235760353,-0.9224498590809075,0.6373626373626373,0.8780638631844337,1.0,11/33,17.02%,NVL;NEK7;PTGES3;PARM1;HSP90AB1;TCP1;PARN;NAF1;MAP3K4;PNKP;CCT2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.32042073900818224,0.9224180317940346,0.6195652173913043,1.0,1.0,24/64,25.99%,SFRP1;AJAP1;CASK;MINK1;THY1;PIK3CB;JUP;EMP2;ROCK2;SEMA3E;JAG1;CCL25;PTK2B;NF2;MAP4K4;HOXA7;TSC1;CORO1C;CX3CL1;PTPRA;DUSP3;VCL;SLC9A1;LDB1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.4102782466316378,0.9222453150437331,0.5836972343522562,1.0,1.0,1/14,1.28%,IL34
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.43708488683541397,0.9220868601525012,0.5784883720930233,1.0,1.0,4/10,18.96%,CALM3;NOS1AP;PDE4B;CALM1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.30153750759051584,-0.9218416777757442,0.5665236051502146,0.878074637393388,1.0,11/21,31.33%,BACE2;ERAP1;BACE1;NCSTN;ADAM10;APH1A;PSEN2;SPPL3;ADAM19;RBMX;PSENEN
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4202891590988588,0.9217961060425253,0.5749279538904899,1.0,1.0,7/13,23.66%,KPNA3;KPNB1;RANBP2;KPNA1;NUP35;CBLB;NUP54
prerank,neuron cell-cell adhesion (GO:0007158),0.40308100812164,0.9217112233175959,0.5724233983286908,1.0,1.0,6/14,24.91%,NINJ2;NLGN3;NLGN2;NRXN3;NRXN2;ASTN2
prerank,defense response to bacterium (GO:0042742),-0.1947103367258913,-0.9216004050374449,0.7105263157894737,0.8770457597354421,1.0,19/105,20.09%,ANKRD17;DROSHA;IL6R;ANXA3;PRKCD;RNASE3;LBP;NOD1;TLR4;RPS19;RAB1A;DEFA6;RPL39;MAVS;IRGM;CEBPB;PLA2G6;GBP2;PGLYRP1
prerank,positive regulation of wound healing (GO:0090303),0.3503642732793727,0.9214899089602184,0.5990675990675991,1.0,1.0,7/36,16.49%,VTN;ANXA1;XBP1;DMTN;PLPP3;FOXC2;SERPINE1
prerank,proteoglycan metabolic process (GO:0006029),0.3673062755590907,0.9214436281798857,0.5650557620817844,1.0,1.0,3/26,6.08%,IGF1;SULF1;CHST10
prerank,positive regulation of cellular component organization (GO:0051130),0.3121440565638641,0.9214122203403291,0.6391213389121339,1.0,1.0,25/107,19.43%,CALY;CAMK2B;BAX;WARS1;TIRAP;CD151;SLF2;ANAPC2;FRMPD4;CLIP3;VCP;PLEKHM2;PARK7;RACK1;LRP1;NRG1;TGFB1;ABCB7;FAF1;TPPP;APOE;TGFBR1;FLOT1;SMPD1;RPS3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.40328735080108113,0.9208408165386007,0.5734664764621968,1.0,1.0,3/15,9.21%,MGAT3;RENBP;EXTL2
prerank,cardiac muscle cell action potential (GO:0086001),-0.26785180215658533,-0.9207813532660184,0.5987654320987654,0.8775295048978218,1.0,8/30,12.54%,CACNA1D;CACNA2D1;ATP1A1;KCNJ2;DMD;CACNA1C;CACNA1G;ATP1B1
prerank,peptidyl-arginine modification (GO:0018195),0.4010179608331023,0.9206544002263458,0.564,1.0,1.0,4/15,15.50%,PRMT5;PARK7;PRMT1;PRMT8
prerank,positive regulation of cellular protein localization (GO:1903829),0.32406559406417335,0.9206008125327607,0.6108108108108108,1.0,1.0,16/69,18.71%,GNL3;EIF2AK3;GPD1L;SLC5A3;ENTR1;CDK5RAP3;ABCA7;SNX33;RIC3;PARK7;LAMTOR5;MAPT;TGFB1;NUMA1;CCDC88A;PRKAA1
prerank,response to cAMP (GO:0051591),-0.25660733987806583,-0.9205639348967829,0.5827338129496403,0.8764345142780159,1.0,13/37,25.42%,RAPGEF3;NDUFS4;STAT1;INPP5K;EZR;AKAP9;AHR;SLC5A5;DGKQ;PDE2A;HCN2;KCNQ1;HCN1
prerank,positive regulation of cell migration (GO:0030335),0.3001094784106065,0.920395278885726,0.6963927855711423,1.0,1.0,42/253,15.68%,CARMIL2;VTN;IGF1;EPHB2;ELP6;FAM83H;NTF3;XBP1;GLIPR2;CXCL12;NIPBL;NRP1;FGF10;PRKCA;SNAI1;DDR2;CD151;GAB1;FBXO5;ARHGEF7;DMTN;MIA3;RHOD;SOX9;SDCBP;EGF;RIPOR1;SEMA3D;ENPP2;MAZ;PDGFRA;SOD2;RACK1;ROR2;LAMB1;ROCK2;TGFB1;SEMA3E;F3;ACVR1B;SEMA3A;CTSH
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.31583949607074113,-0.9201317442760384,0.5823754789272031,0.8758696014703482,1.0,9/17,22.77%,ATP5F1C;ATP5PO;ATP5F1E;ATP5PD;STOML2;VPS9D1;ATP5F1B;DMAC2L;ATP5F1D
prerank,positive regulation of cell development (GO:0010720),-0.2612163736379528,-0.9199664352349853,0.6536312849162011,0.8746868142079975,1.0,11/31,23.73%,NIBAN2;TGM2;NUMB;NUMBL;ATP6AP1;OPRM1;MME;BMP4;FAIM;BAD;CX3CR1
prerank,cell chemotaxis (GO:0060326),0.32690045288580666,0.9195975042728658,0.6269487750556793,1.0,1.0,13/60,18.58%,CCR9;ACKR2;CXCL12;NRP1;CXCR4;PDGFRA;PLEKHG5;RAB13;LPAR1;AGTR1;PLXNB3;CCL25;PIP5K1A
prerank,dorsal/ventral pattern formation (GO:0009953),0.39202992581390317,0.919458557623641,0.6025806451612903,1.0,1.0,2/20,8.42%,SFRP1;PTCH1
prerank,neuron fate commitment (GO:0048663),0.40818632682528727,0.9183002909512807,0.5861111111111111,1.0,1.0,14/14,59.22%,TGFBR1;ID2;MYT1L;FOXN4;ISL2;EPOP;ISL1;ASCL1;PAX6;POU4F1;SHH;DLL1;DLL4;POU3F2
prerank,retrograde axonal transport (GO:0008090),0.40291306686846756,0.9180919471587251,0.5886426592797784,1.0,1.0,11/16,27.84%,NEFL;TMEM108;DLG2;KIF5B;PAFAH1B1;ACTR10;DYNC1H1;FBXW11;KIF5A;KIF1A;SOD1
prerank,regulation of defense response to virus (GO:0050688),0.40654215399918003,0.9178237089560606,0.5908460471567267,1.0,1.0,2/14,5.04%,TNFAIP3;PPM1B
prerank,regulation of filopodium assembly (GO:0051489),0.3411454566708139,0.9164945053684896,0.6009334889148191,1.0,1.0,8/38,16.78%,ABITRAM;NRP1;PIK3R1;DMTN;RIPOR2;ARAP1;PLPPR5;FMR1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.338627033613283,0.9164119767112686,0.6102088167053364,1.0,1.0,11/43,19.27%,TAOK1;FZR1;CDC14B;CDK5RAP3;MRNIP;CHFR;BRSK1;FOXN3;MRE11;NABP2;UIMC1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.41167785850855976,0.9163869355681579,0.5636856368563685,1.0,1.0,4/15,10.58%,SCEL;FGFR1;CELF1;UBR3
prerank,cAMP-mediated signaling (GO:0019933),-0.27692445182399267,-0.9162146510061425,0.5633187772925764,0.882371411684863,1.0,5/24,6.44%,RAPGEF3;ADGRG6;PDE7A;RIMS2;CAP2
prerank,potassium ion export across plasma membrane (GO:0097623),0.4141965879854712,0.916041258336032,0.594017094017094,1.0,1.0,2/13,12.11%,KCNT2;KCND3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.31814640894356705,0.9158941448349399,0.6400425985090522,1.0,1.0,14/83,13.58%,CDKN2D;TFDP1;CDK5;NPAT;BRD4;FBXO5;CDC25A;CUL4B;E2F3;BACH1;CCNH;RCC1;GSPT1;CUL5
prerank,regulation of phosphorylation (GO:0042325),0.3058880299447328,0.9158356419645532,0.6656472986748216,1.0,1.0,29/120,19.68%,CDKN2D;KDM4D;SIRT2;PRKRIP1;OGT;RAE1;NRP1;FLCN;BARD1;ATG14;DSCAM;CD24;SDCBP;EGF;NUP188;PGAM1;APP;NUP210;NUP88;EMP2;NUP214;PHIP;ILK;NUP153;CCDC88A;RANBP2;PRKAG2;NUP35;DYNLL1
prerank,RNA biosynthetic process (GO:0032774),0.34848860533744314,0.9157535716319856,0.5793939393939394,1.0,1.0,7/31,14.54%,SMN1;TAF4;TBP;PRMT5;TAF6;SETX;HELB
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.40485521805827895,0.9157178052171646,0.5826446280991735,1.0,1.0,2/15,4.33%,CDC23;CDC16
prerank,regulation of TOR signaling (GO:0032006),0.32476762435975615,0.9154070163290148,0.611597374179431,1.0,1.0,8/67,7.21%,HDAC3;ARAF;TSC2;TBC1D7;SLC38A9;FLCN;RRAGA;RFFL
prerank,regulation of cellular response to heat (GO:1900034),0.3168298312487867,0.914886205712907,0.6407249466950959,1.0,1.0,29/77,24.14%,CAMK2B;HSP90AA1;DNAJC7;RAE1;BAG1;NUP188;HSPH1;CAMK2D;CAMK2G;DNAJB6;NUP210;ATR;NUP88;MAPT;NUP214;CHORDC1;HSBP1;NUP153;BAG4;RANBP2;NUP35;MAPKAPK2;TPR;DNAJC2;HSPB8;NUP155;ATM;NUP54;NUP98
prerank,regulation of stress fiber assembly (GO:0051492),0.3188755341194925,0.9148245520102002,0.6221743810548978,1.0,1.0,27/74,22.51%,SFRP1;PTGER4;RAC1;ARHGEF10;NRP1;ALMS1;PIK3R1;ABL1;TPM1;ARHGEF10L;CD47;ARAP1;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;DLC1;ARHGAP6;EVL;NF2;CLASP2;PPM1F;PFN2;PAK1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.31392163705029813,0.9146751326871649,0.6376050420168067,1.0,1.0,31/85,24.35%,SIRT2;STUB1;ZYG11B;COP1;BBS7;DVL1;VCP;PSMC5;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;NUPR1;HECTD1;ARIH2;FMR1;FBXO22;MDM2;PIAS1;SUMO2;DAB2;SMAD7;PSMC6;TAF1;TMEM259;KEAP1;FBXW7;TRIB2
prerank,protein-containing complex assembly (GO:0065003),0.29861735944644124,0.914482181219964,0.7104208416833667,1.0,1.0,73/259,20.62%,TRAPPC10;GSDMD;CHCHD10;NDUFAF1;KPNA3;CXCL12;CDC123;NAPG;LAMC1;TCF7L2;KLHL12;SEC16A;DMTN;VAMP3;TEAD1;SEC16B;PEF1;SOX9;EPRS1;MDM4;PPIH;DBNL;HGSNAT;PDE4DIP;PPP6R3;TBC1D20;SCFD1;CAPZA1;AFG3L2;TFG;GRIA1;HDAC1;ADD2;AXIN2;PYGO2;TMED10;WASF1;CDC73;CSNK1D;PYGO1;TRAPPC6B;USO1;CTSZ;DNM1L;FANCA;KMT2D;MCFD2;CSNK1A1;TCF7L1;FARP2;F8;IL1RAP;NSF;ITGB1BP1;TUBGCP2;GORASP1;TCF7;MDM2;TSPAN4;PLEKHA7;ANKRD28;KMT2A;SEC24D;SHANK1;CNIH1;KIFAP3;STX5;MITF;RANBP9;ZW10;PDCD6;PTK2B;GEMIN5
prerank,regulation of macroautophagy (GO:0016241),0.3071080548649168,0.9136290104132864,0.6423280423280423,1.0,1.0,17/105,11.03%,UBQLN1;CLN3;TSC2;ATP6V0A2;UCHL1;SNX5;CDK5;SLC38A9;DCN;SNX6;VPS26B;ATP6V0E2;RRAGA;NRBP2;GPSM1;ATP6V1G1;ATG13
prerank,positive regulation of myelination (GO:0031643),0.42976974861032435,0.913582794842817,0.5985611510791367,1.0,1.0,3/11,16.68%,MYRF;TENM4;TPPP
prerank,mRNA modification (GO:0016556),0.3698489427232229,0.9135768058199343,0.5976863753213367,1.0,1.0,3/22,9.92%,TRMT61B;TRUB2;PUS7
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.36133384237686106,0.9134009890787694,0.5942211055276382,1.0,1.0,7/26,24.78%,GPLD1;BRSK2;ADCY5;EPHA5;STXBP4;PPP3CB;NR1D1
prerank,microtubule depolymerization (GO:0007019),0.39585946846475706,0.9132649879174446,0.5825503355704698,1.0,1.0,2/17,9.89%,STMN4;KATNB1
prerank,inositol phosphate metabolic process (GO:0043647),-0.24241276382738125,-0.9129778583297303,0.6060606060606061,0.8890438442875611,1.0,12/46,13.81%,IP6K2;PPIP5K1;OCRL;PLCE1;PLCD3;INPP5D;PLCB3;MINPP1;PLCG2;INPPL1;PLCG1;PLCD1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.37043584777146754,0.9127374075251664,0.5764411027568922,1.0,1.0,5/25,11.50%,CALM3;ATP2A2;NOS1AP;JUP;CAMK2D
prerank,receptor signaling pathway via STAT (GO:0097696),0.3586010481036495,0.9126387765659592,0.6143958868894601,1.0,1.0,3/25,4.92%,IFNAR1;STAT6;IL31RA
prerank,retinoic acid metabolic process (GO:0042573),0.40785107523789244,0.9125131843228464,0.5853994490358126,1.0,1.0,2/14,12.85%,ALDH1A2;CYP26B1
prerank,inflammatory response (GO:0006954),0.29894784573185257,0.912283193949934,0.7028112449799196,1.0,1.0,27/195,18.62%,FCGR2B;PTGER4;LTB4R2;NFKB1;ADM;RAC1;IL10RB;ANXA1;GPR68;PRDX5;CXCR4;HDAC5;IL22;NFX1;BDKRB2;HDAC4;TBXA2R;HNRNPA0;BLNK;TGFB1;ADCY1;HSPG2;AGTR1;HRH1;CCL25;RELB;SCUBE1
prerank,protein alkylation (GO:0008213),0.37101552029943446,0.9113062750843716,0.5961538461538461,1.0,1.0,8/22,19.08%,LCMT1;ETFBKMT;PRMT1;GSPT1;FAM98A;PRMT8;PCMT1;PRMT2
prerank,regulation of establishment of protein localization (GO:0070201),0.41205446143877655,0.910974793513319,0.6075949367088608,1.0,1.0,3/13,14.58%,GAPVD1;SCFD1;CEP120
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3528079090926543,0.9109598236054276,0.5866336633663366,1.0,1.0,4/31,13.04%,MOCS2;LSS;PRLR;CYP51A1
prerank,purine nucleotide metabolic process (GO:0006163),0.3697998795012551,0.910772078233057,0.6144121365360303,1.0,1.0,3/24,6.18%,ADSL;PRPSAP2;GART
prerank,protein polyubiquitination (GO:0000209),0.29713462353282316,0.9107116404598455,0.7422266800401204,1.0,1.0,71/297,19.60%,CDC23;PSMD4;FBXW10;RNF8;UBE2S;SPSB1;STUB1;UBE2E2;UBE2QL1;FBXL12;SYVN1;CDC16;FZR1;FBXL14;TNFAIP3;FBXO38;FBXO7;THOP1;ANAPC2;FBXO31;PSMB10;BARD1;TRIM56;RFFL;FBXW5;PSMD11;RMND5A;TRIM62;UBE3B;RNF168;UBE2V2;CHFR;PSME2;PSMC5;BCL2;RC3H2;RNF152;RNF19A;UBE2A;ANAPC11;ANAPC4;CBFB;UBE2J1;RNF19B;CDC26;RNF41;ANKIB1;RNF217;PSMD1;UBE2E1;UBE2D1;HECTD1;ARIH2;TNKS;UBE2L3;UBR5;PSMD6;FBXO22;SMURF1;TOPORS;TTC3;MDM2;FBXO9;KLHL20;ANAPC10;ANAPC5;TRIM27;ZNRF2;RNF167;PELI2;PSMD5
prerank,regulation of cell growth (GO:0001558),0.2994829972766103,0.9102577343528698,0.7108433734939759,1.0,1.0,32/204,15.62%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;EXOSC2;CGRRF1;TAF9B;SLC25A33;DDX3X;FLCN;NUBP1;USP47;RASGRP2;STK11;TCHP;SPOCK1;PPP1R9B;SDCBP;NRG3;BCL2;CAMK2D;EIF4G2;ENPP1;RACK1;RPS6KA3;EGLN2;TGFB1;BCL6;SLIT3;ACVR1B;RPS6KA1
prerank,response to UV (GO:0009411),0.313489210470478,0.9101935635228495,0.6562173458725182,1.0,1.0,16/95,12.82%,CDKN2D;MFAP4;PARP1;USF1;USP1;SDE2;USP47;CDC25A;DHX36;CASP9;POLH;BRSK1;YY1;NPM1;UBE2A;ATR
prerank,cellular response to osmotic stress (GO:0071470),-0.2855134759879,-0.9101240363140695,0.5854700854700855,0.8945972297657534,1.0,4/21,5.58%,RCSD1;CAB39;YBX3;LRRC8D
prerank,positive regulation of telomere capping (GO:1904355),0.38423451827027716,0.9097564765108295,0.5859154929577465,1.0,1.0,4/17,17.42%,PKIB;HNRNPD;TNKS;NABP2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3184527583328891,0.9094422974817363,0.6343042071197411,1.0,1.0,13/72,16.27%,DNASE1L2;PARP1;RNASE1;FBH1;DCP1B;SPO11;DDB1;CUL4B;GTF2H3;ENPP1;POLD3;MRE11;RAD50
prerank,action potential (GO:0001508),0.33337539745863715,0.909420462943752,0.5993071593533488,1.0,1.0,7/44,13.93%,CLN3;MYH14;SCN7A;YWHAH;SCN1A;ANK3;KCNA1
prerank,tryptophan catabolic process (GO:0006569),-0.3506778809942255,-0.9093719425653931,0.5956112852664577,0.8949744007032064,1.0,11/11,64.96%,KYAT1;AFMID;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,phosphate ion transmembrane transport (GO:0035435),-0.3362753304802552,-0.9093050285952273,0.58,0.8935353464593959,1.0,6/12,22.89%,SLC25A3;SLC37A3;SLC20A1;SLC25A14;SLC25A30;SLC25A11
prerank,heterocycle biosynthetic process (GO:0018130),0.4047013527278091,0.9091932233902762,0.600828729281768,1.0,1.0,1/14,1.75%,MOCS2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3234649669178448,0.9091656971567635,0.6224944320712695,1.0,1.0,16/63,19.80%,BAX;PCBP4;TFDP1;SDE2;CNOT10;FBXO31;MDM4;RBL2;CNOT9;PRMT1;CNOT6;CASP2;CHEK2;MDM2;SOX4;CARM1
prerank,Rac protein signal transduction (GO:0016601),0.38353647879114433,0.9090086667818386,0.5944148936170213,1.0,1.0,5/18,15.66%,RAC1;CYFIP1;DBNL;WASF1;FARP2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.318206905430781,-0.9088272233311963,0.5802919708029197,0.8931421326012408,1.0,7/16,11.55%,WBP4;SFSWAP;DCPS;SNRNP200;DDX23;WBP11;CWC15
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.3418575645399971,0.9083799620979119,0.610917537746806,1.0,1.0,11/37,21.41%,STMN4;MAPRE3;TAOK1;GAS2L1;MAPT;PHLDB1;TPPP;PRKAA1;MAP6D1;MAP6;CLASP2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.21264227896682666,-0.9083242992389376,0.7012987012987013,0.8927922200063494,1.0,18/67,15.67%,IKBKB;PSMB7;TAPBP;PSMB2;SEC22B;PSMD7;CALR;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;IKBKG;TAP2;PSMD9;PSMD2;PSMB3;ITGB5
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4081265632656421,0.9079796862309787,0.5941422594142259,1.0,1.0,5/13,21.26%,ISCA2;CIAO2A;MMS19;NFU1;ISCA1
prerank,amide transport (GO:0042886),-0.26603453321029447,-0.9078369845254298,0.6130653266331658,0.8924117422016523,1.0,9/26,22.30%,ABCG2;CERT1;SLC25A32;TAP2;SLC5A6;GLTP;ABCB9;AQP11;SLC38A5
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4098797610948777,0.9076774332870269,0.5979827089337176,1.0,1.0,4/13,13.69%,ENTPD7;MFN1;AK4;AK3
prerank,regulation of MAP kinase activity (GO:0043405),0.3096600038561317,0.9076308005645718,0.6506777893639207,1.0,1.0,13/92,11.30%,MST1R;IL34;EDN3;FGFR1;UCHL1;SNF8;EZH2;HGS;CD24;EGF;CDK5RAP3;PIK3CB;ROBO1
prerank,cellular response to ketone (GO:1901655),0.34700224759451254,0.9076304258897168,0.6321428571428571,1.0,1.0,7/35,16.59%,SFRP1;PTGER4;GNG2;NCOA4;ROCK2;ADCY1;ADCY5
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4151795886944472,0.9074818846377048,0.5742574257425742,1.0,1.0,6/12,21.48%,SEC61A2;SEC61G;SEC62;SEC63;CHMP4A;CHMP4B
prerank,skin development (GO:0043588),0.3204026269749674,0.9073260940351952,0.6298283261802575,1.0,1.0,11/65,18.79%,WNT5A;DACT2;SCEL;ANXA1;ERRFI1;COL1A2;COL5A2;TXNIP;JAG1;PIP5K1A;COL5A3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3554095887829368,0.9068760704095772,0.6017699115044248,1.0,1.0,5/27,16.48%,GPR4;HTR2C;LPAR1;LPAR6;AGTR1
prerank,cellular response to cytokine stimulus (GO:0071345),0.29285159630394475,0.9067024012760468,0.7987987987987988,1.0,1.0,71/416,18.11%,IL10RA;KHSRP;WNT5A;SFRP1;IL34;ADAMTS7;GBP3;NFKB1;HSP90AA1;IFNAR1;IL10RB;STAT6;ANXA1;XBP1;RORA;ZFP36L1;CXCL12;POU2F1;IL31RA;CDK9;IRF1;PIK3R1;GBP7;ZFAND6;ZEB1;CXCR4;RIPOR2;SIRPA;PID1;IL22;LRP8;TXLNA;SOX9;DOCK8;USP10;IFNGR2;EPRS1;TEC;RAPGEF1;TWIST1;PRLR;PIK3CB;PTPN5;BCL2;NFAT5;LEPR;IFNGR1;COL1A2;IL1RAPL1;CD47;DAPK1;SMPD4;GBP6;PTGS2;TGFB1;AQP4;BCL6;CBL;F3;NPR2;PTPN12;ICAM1;IL1RAP;IL5;OXSR1;TANK;TCF7;CCL25;GREM2;JAK1;ERBIN
prerank,rRNA methylation (GO:0031167),0.3692291366212755,0.906484332836262,0.5961538461538461,1.0,1.0,7/22,19.51%,FBL;DIMT1;BUD23;ZCCHC4;TFB1M;METTL5;NSUN4
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.38224950254008716,0.9064522543043775,0.6201044386422977,1.0,1.0,4/19,9.16%,HS2ST1;EXTL3;NDST2;HS6ST2
prerank,cellular response to chemical stress (GO:0062197),0.3089842853255736,0.9062779156806536,0.6452282157676349,1.0,1.0,15/96,13.10%,SIRT2;SELENOS;PARP1;MGAT3;DDX3X;TXNRD1;SLC25A24;PRDX5;PRDX6;ABL1;STX2;PARK7;SOD2;SOD3;SETX
prerank,stem cell development (GO:0048864),0.39076245100182094,0.9055225029539885,0.5940460081190798,1.0,1.0,4/16,14.04%,KLHL12;PEF1;SOX11;NRG1
prerank,protein tetramerization (GO:0051262),0.3207661890630054,0.9054389601706844,0.6466739367502726,1.0,1.0,16/67,22.07%,FARSB;KCNC1;GRIN1;ALDH1A2;TK1;CPSF7;NUDT21;SOD2;HPRT1;AQP4;CPSF6;PKD2;OXA1L;APPL2;ACOT13;B2M
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.42947546755078364,0.9052377752240465,0.6,1.0,1.0,1/11,1.51%,UQCRC1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.41914233453836025,0.9050872327410702,0.591743119266055,1.0,1.0,4/11,20.46%,PRKCA;ANK3;JAK1;LYN
prerank,cellular response to hormone stimulus (GO:0032870),0.31461672869918256,0.9048009984690997,0.6447507953340403,1.0,1.0,15/69,16.82%,WBP2;SFRP1;XBP1;ATP1A3;ZFP36L1;GAS2L1;ATP1A2;SRA1;BRD8;ROBO2;TFPI;NCOA4;SLIT3;CTSH;UBE2L3
prerank,protein localization to plasma membrane (GO:0072659),0.29952532433878504,0.9045534259472116,0.7027579162410623,1.0,1.0,35/129,18.86%,TMEM150A;PRAM1;ANK1;RAB34;SEC16A;RAP2A;RAB12;ZDHHC3;PTCH1;RAB10;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;RAB13;EMP2;ROCK2;DPP10;EPB41L3;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;PACS1;SMURF1;GORASP1;CCDC88A;ZDHHC2;PIP5K1A;FLOT1;ASB3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3289351129451408,0.9042803610715378,0.608548931383577,1.0,1.0,9/46,15.42%,CLN3;CACNG3;UNC13A;CDK5;ATP1A2;NLGN3;SYT1;NLGN2;CACNG4
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.31583601726611926,0.9040793003711071,0.6356837606837606,1.0,1.0,19/70,19.39%,DACT2;RAC1;ARL13B;LAMC3;NRP1;LAMC1;PIK3R1;SRGAP2;VAMP3;NTNG2;SRCIN1;ANTXR1;LAMB1;RADIL;TBCD;ATRN;ILK;MEGF9;YTHDF2
prerank,axoneme assembly (GO:0035082),-0.2582786225225315,-0.9038793963598413,0.5967741935483871,0.9005442771826412,1.0,19/30,47.98%,TOGARAM1;SPAG1;TTC12;TTLL3;CCDC39;CFAP74;RP1;SPEF1;SPAG16;GAS8;RSPH9;CFAP46;LRGUK;DRC1;SPAG17;JHY;FOXJ1;CCDC65;DNAAF2
prerank,positive regulation of apoptotic process (GO:0043065),0.295259446475742,0.903734674731539,0.77,1.0,1.0,66/293,19.69%,SFRP2;SFRP1;EPHA7;BAX;SIRT2;GPLD1;BIN1;PLEKHN1;SLC27A4;AIFM2;DDX3X;FZD9;CDK5;SCRIB;FLCN;OLFM1;FAM162A;ABL1;SQSTM1;BARD1;ARHGEF7;ARHGEF4;EEF1E1;KCNMA1;KALRN;TRIM35;CALHM2;MCF2;SIK1;DDIT3;CLIP3;CASP9;VAV2;UBE2Z;IGFBP3;PLEKHG5;RACK1;AKAP13;DAPK1;HTT;MTCH1;MTCH2;BCL6;RNF122;BCLAF1;DNM1L;SHQ1;NUPR1;PAWR;FAF1;CASP2;HSPD1;TRIO;ARHGEF6;TLE5;OMA1;RASSF2;TGFBR1;PDCD5;PRMT2;SMPD1;SOX4;PLEKHG2;RPS3;FGD4;DLC1
prerank,protein localization to chromosome (GO:0034502),-0.24800195511805834,-0.9036020549487652,0.64,0.899550331182259,1.0,8/34,14.88%,WAPL;XRCC4;RB1;RPA1;TPP1;MSH2;SLF1;ESR1
prerank,response to muramyl dipeptide (GO:0032495),-0.34393408022288097,-0.9033865375509293,0.5933333333333334,0.8984550898498151,1.0,3/12,9.34%,VIM;NOD1;CHMP5
prerank,histone deubiquitination (GO:0016578),-0.29958679915439257,-0.9031375605177376,0.562992125984252,0.8974112240521357,1.0,4/18,5.34%,TRRAP;BRCC3;ATXN7;USP36
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4018611802949575,0.9030896868823868,0.5949008498583569,1.0,1.0,1/13,0.96%,LPL
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30205231921746817,0.9029186311512576,0.7085889570552147,1.0,1.0,33/144,18.75%,HDAC3;CSNK2A2;FIS1;TFDP1;SAR1A;SAE1;TCF7L2;MTCL1;MIEF2;PIK3R1;SEC16A;NMT1;SEC16B;YWHAH;RIPOR1;YWHAG;JUP;PIK3R2;ATG13;BCL2;ANK3;LEPROT;TGFB1;ARIH2;ITGB1BP1;UBE2L3;UBR5;RUFY3;SORL1;CEMIP;ZDHHC2;RBM22;KIF20B
prerank,positive regulation of mitochondrial fission (GO:0090141),0.37952100128879357,0.9027710371727169,0.5744400527009222,1.0,1.0,5/18,15.72%,FIS1;DCN;MIEF2;DNM1L;SPIRE1
prerank,regulation of isotype switching (GO:0045191),-0.32105437941155607,-0.9024617673696311,0.5778546712802768,0.8976036491010033,1.0,3/14,17.03%,SHLD2;PAXIP1;SLC15A4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3709331974813032,0.9024256597543929,0.6086956521739131,1.0,1.0,2/22,2.96%,HEXIM1;NR2F2
prerank,receptor-mediated endocytosis (GO:0006898),0.29635683219645914,0.9023738232890223,0.6836215666327569,1.0,1.0,27/132,17.96%,FCGR2B;CLN3;PDLIM7;DNM1;ADM;HSP90AA1;TMEM108;SPARC;VLDLR;DNAJC6;AP2S1;GRK3;HSPH1;NLGN3;IGF2R;PI4KB;WASF1;LRP1;GRK2;DNAJC13;RAB31;HSPG2;SNAP91;AP4E1;APOE;SORL1;LRP1B
prerank,cellular amino acid catabolic process (GO:0009063),0.3105689160279926,0.9018415778831463,0.6746113989637306,1.0,1.0,14/87,15.38%,HGD;GLS2;HMGCLL1;AASS;ACAT1;BCAT2;ABAT;GLUL;ALDH4A1;ACADSB;CARNMT1;OGDH;FAH;QDPR
prerank,response to reactive oxygen species (GO:0000302),0.3253531607015143,0.9018322948411965,0.639599555061179,1.0,1.0,13/54,19.43%,MAPK9;PTPRN;APTX;PRDX5;TPM1;PDGFRA;SOD2;MAPT;COA8;STK25;APOE;PKD2;RPS3
prerank,bile acid biosynthetic process (GO:0006699),0.36352496421526875,0.9016779783626189,0.6005089058524173,1.0,1.0,4/24,11.00%,CYP27A1;CYP7B1;HSD17B4;AMACR
prerank,protein import into mitochondrial matrix (GO:0030150),0.3835921771312712,0.9014561559240533,0.6040268456375839,1.0,1.0,2/18,5.24%,DNLZ;TOMM20
prerank,endocytic recycling (GO:0032456),0.3240413804612361,0.9014126437020487,0.6293393057110862,1.0,1.0,17/50,22.69%,ARL4C;RAB11FIP4;SNF8;STX6;ENTR1;RAB13;VPS39;CCDC93;EIPR1;SNX4;EHD1;CMTM6;RAB11FIP3;RAB7A;EHD3;RAB11B;SNX27
prerank,monosaccharide transmembrane transport (GO:0015749),0.3933514728399471,0.9010974941449134,0.5950752393980848,1.0,1.0,2/16,11.43%,SLC5A3;SLC50A1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3084368352115188,0.9010133316505827,0.6548856548856549,1.0,1.0,20/95,18.10%,KDM4D;XRCC2;RNF138;PARP1;HELQ;NIPBL;PALB2;FBH1;LIG3;SEM1;FANCM;YY1;POLN;RMI1;NUCKS1;MRE11;RAD50;NABP2;RAD21;RBBP8
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3173458581545362,-0.9010061375252486,0.5653710247349824,0.8995473302287688,1.0,5/15,24.20%,ATP1A1;KCNJ2;ATP1B1;KCNJ3;KCNQ1
prerank,nitrogen compound transport (GO:0071705),0.2996603031813023,0.9007975624065184,0.7122593718338399,1.0,1.0,28/141,19.36%,ARRDC4;SLC7A11;PICK1;KIF3A;SLC22A4;SLC7A2;MIA3;RCN3;LMAN2L;CHMP3;SLC6A8;VPS33B;SCAMP5;SLC6A4;SLC18A1;SLC6A15;SLC1A5;SCAMP1;SLC6A12;SLC44A2;TXNIP;SLC6A13;RUFY1;SNX4;LRP1B;TOM1;SCARB2;SLC25A47
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.24656258077335058,-0.9007084204149077,0.6226415094339622,0.8986446782899417,1.0,5/33,5.21%,FOXO3;MED1;STAT3;STAT1;HIF1A
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.28960489329837913,-0.9005000168699895,0.6181102362204725,0.8975726630016083,1.0,5/18,15.99%,EGFR;RIPK1;TP53;ESR1;BMP4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3152071143926848,0.9003229983961991,0.6587982832618026,1.0,1.0,16/74,16.91%,IGF1;DDX3X;TNFAIP3;TCF7L2;TMBIM1;RFFL;GDNF;BCL2;BMP5;PARK7;HTT;EYA2;ICAM1;SERPINE1;FAIM2;PHIP
prerank,supramolecular fiber organization (GO:0097435),0.29213809113398953,0.90008539698444,0.776,1.0,1.0,66/333,18.80%,MYO1A;FSD1;COL27A1;STMN4;P4HA1;MFAP4;NEFL;MYO19;RAC1;WHAMM;COL4A6;COL4A5;MYO1B;PLOD1;DDR2;CD151;DBN1;COL22A1;TPPP3;RHOD;CAMSAP2;TNXB;DES;PPP1R9B;PPIB;CLIP3;P4HA2;KATNB1;RHOBTB3;HOOK3;APP;TPM1;CEP126;MYO5A;COL1A2;CRTAP;VPS4B;DNAJB6;MPRIP;USP9X;FBLN5;ZBED3;EMP2;MAPT;ADAMTS3;PXDN;P3H2;COL5A2;FAT1;LUM;GGA2;HSPG2;ITM2B;TMOD2;TPPP;BFSP2;TUBGCP2;RUFY3;COL11A1;MDM2;BMP1;SORL1;CCDC88A;TGFBR1;COL5A3;COL8A2
prerank,postsynaptic membrane organization (GO:0001941),0.383159723851947,0.899635728140767,0.5774456521739131,1.0,1.0,5/17,17.19%,LRRC4;MUSK;NLGN3;NLGN2;APOE
prerank,cellular response to oxidative stress (GO:0034599),0.302417895448681,0.8988578630033183,0.6805696846388606,1.0,1.0,20/118,13.92%,MAPK9;SIRT2;SELENOS;PARP1;MGAT3;TXNRD1;SLC25A24;PRDX5;PRDX6;ABL1;ARNT;STX2;TPM1;PDGFRA;PARK7;SOD2;SOD3;SETX;DAPK1;MAPT
prerank,protein localization to vacuole (GO:0072665),-0.34036077631792655,-0.8987515376746945,0.5331230283911672,0.9000659089748262,1.0,9/13,36.55%,SH3BP4;SZT2;KPTN;MFSD1;CD81;RNF128;GLMP;ATP13A2;RTN4
prerank,regulation of stem cell differentiation (GO:2000736),0.3043924271933323,0.8987460143828467,0.663135593220339,1.0,1.0,25/89,21.82%,SP7;PSMD4;ABL1;PSMB10;PSMD11;PUS7;GDNF;PSME2;PSMC5;SETD1A;PDGFRA;NUDT21;CBFB;PSMD1;TCF3;JAG1;PSMD6;OCIAD1;KMT2A;YTHDF2;PSMD5;HNRNPU;PSMA4;PSMA1;PSMC6
prerank,establishment of mitotic spindle localization (GO:0040001),0.3488605153970741,0.8985649662027152,0.617505995203837,1.0,1.0,10/28,23.06%,MAD2L1;KPNB1;GPSM2;HTT;NUMA1;ZW10;PAFAH1B1;ITGB1;CLASP2;CDK5RAP2
prerank,positive regulation of cation channel activity (GO:2001259),0.3408372065419588,0.8985068008925818,0.6193853427895981,1.0,1.0,8/40,18.96%,EPHB2;CALM3;ANK3;NLGN3;HTT;ATPSCKMT;PKD2;CALM1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3243641017511488,0.8981944462029023,0.6482525366403608,1.0,1.0,14/54,19.80%,BAX;PCBP4;TFDP1;CNOT10;MDM4;RBL2;CNOT9;PRMT1;CNOT6;CASP2;CHEK2;MDM2;SOX4;CARM1
prerank,long-chain fatty acid import into cell (GO:0044539),0.4309981130454873,0.8979632988088329,0.6246290801186943,1.0,1.0,2/10,16.50%,SLC27A4;SLC27A1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.3600955392580545,0.8977426903766171,0.6191677175283733,1.0,1.0,3/25,6.60%,EPHB2;ERRFI1;SNX6
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.27783128531572665,-0.8972687418839738,0.6813725490196079,0.9021222216600433,1.0,5/21,17.61%,MFHAS1;ENSA;PPP1R8;PTPA;BOD1L1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.22996268937404016,-0.8967264259084612,0.6694915254237288,0.9017637713188661,1.0,17/45,24.63%,SLC25A13;MTHFR;GOT2;FOLH1;THAP4;MTHFD1;GLS;NAALAD2;KYAT1;GPT2;GOT1;ASPG;KYAT3;RIMKLB;MTRR;DDAH2;ALDH18A1
prerank,RNA destabilization (GO:0050779),0.37882804997653824,0.8960499918183565,0.6187919463087248,1.0,1.0,9/18,22.24%,CELF1;LIN28B;YTHDF3;YTHDF1;ROCK2;ZC3H18;FTO;YTHDF2;METTL14
prerank,amyloid-beta metabolic process (GO:0050435),-0.3121426539603399,-0.8958830726522317,0.6139705882352942,0.9022108871753339,1.0,9/16,23.66%,BACE2;BACE1;NCSTN;MME;ACE;APH1A;APH1B;PSEN2;IDE
prerank,regulation of actin filament polymerization (GO:0030833),0.3121830888839894,0.8958233627806107,0.664876476906552,1.0,1.0,10/69,9.63%,CDC42EP5;CDC42EP4;ABITRAM;BIN1;GBA2;PAK3;DBN1;SSH1;BAIAP2;DBNL
prerank,linoleic acid metabolic process (GO:0043651),0.38609439560421854,0.8957906048404828,0.596100278551532,1.0,1.0,2/17,9.95%,ELOVL1;FADS1
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.2867334562267087,-0.8957326010314145,0.6043478260869565,0.9009515553383265,1.0,5/19,7.89%,SMAD4;TGFB2;ACVR1;BMPR1A;TGFBR2
prerank,lymphocyte migration (GO:0072676),-0.25233816862511865,-0.8956593797683446,0.6728395061728395,0.8995162296024596,1.0,6/32,25.67%,CCL15;S1PR1;MSN;CCL13;CKLF;RET
prerank,pre-miRNA processing (GO:0031054),0.39671887847875703,0.895436861063351,0.6161473087818697,1.0,1.0,3/14,12.58%,TARBP2;LIN28B;AGO3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.29269944500654627,0.8951093806102373,0.751004016064257,1.0,1.0,45/208,19.94%,WNT5A;SLC35B2;PDPK1;MAP3K14;ATP2C1;EDAR;RORA;EDA2R;TNFAIP3;TIRAP;OTUD7A;PPM1B;CARD16;TMEM106A;BRD4;SQSTM1;ZFAND6;CC2D1A;TIFA;TRIM62;GPRC5B;USP10;PER1;DHX36;WLS;MALT1;TFG;PLEKHG5;LAMTOR5;AKAP13;LPAR1;PPP5C;NDFIP2;SLC44A2;MTDH;TANK;TNIP1;ZDHHC17;S100A13;TERF2IP;TRIM27;BIRC3;PELI2;PPM1A;MIER1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2920929837951538,-0.8947033664164036,0.6192468619246861,0.9002903800521294,1.0,8/19,22.61%,CAT;MAOB;NOX1;PRDX2;CYBA;GPX1;PRDX3;PRDX4
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.392699334754698,0.8943510290192055,0.6126373626373627,1.0,1.0,4/14,22.93%,ANXA1;MALT1;PRKCZ;IL18
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.33306005946573297,0.8943324929319585,0.6227758007117438,1.0,1.0,6/38,8.94%,RORA;TNFAIP3;OTUD7A;PPM1B;USP10;PER1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3603167704882951,0.8940828754374514,0.6480304955527318,1.0,1.0,6/25,24.49%,WNT5A;MALT1;LACC1;TRAF2;B2M;TRAF6
prerank,positive regulation of protein maturation (GO:1903319),0.42216431752538774,0.8940594039115968,0.6070901033973413,1.0,1.0,1/11,4.19%,CCBE1
prerank,UV-damage excision repair (GO:0070914),0.4136857657095309,0.8940257899847566,0.5948644793152639,1.0,1.0,6/12,25.50%,DDB1;CUL4B;POLD3;INO80;POLA1;XPA
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.22367135189327608,-0.8939907111037814,0.6610169491525424,0.9004623610681609,1.0,8/49,9.95%,STAT3;RIPK1;LBP;NOD1;AFAP1L2;TLR4;LGALS9;RAB1A
prerank,V(D)J recombination (GO:0033151),0.4105677981578585,0.8938067800393412,0.6085043988269795,1.0,1.0,3/11,15.29%,LIG1;LIG3;TCF3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.35130901912534496,0.893254449244053,0.6176836861768369,1.0,1.0,9/26,19.64%,OGT;ETFBKMT;SETD1A;SUV39H1;KMT2D;ATPSCKMT;KMT2A;SETD5;KMT5B
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.40107851978350745,0.8931475638262879,0.6037463976945245,1.0,1.0,4/13,14.21%,NNMT;NUDT12;PARP16;PTGS2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3341069601965967,0.8930786806344311,0.6289156626506024,1.0,1.0,7/35,16.60%,CCT8;PKIB;CCT6A;DHX36;ATR;HNRNPA2B1;TNKS
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.42488034585989465,0.8929518355035699,0.5990853658536586,1.0,1.0,4/10,21.08%,ATP1A2;CAMK2D;OSR1;HECW2
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3411303624068772,0.8928390005023028,0.63875,1.0,1.0,8/30,16.55%,RAB34;SEC16A;RAB10;ANK3;RAB31;SPTBN1;GGA2;NSF
prerank,regulation of autophagosome assembly (GO:2000785),0.34209112276781123,0.892804469140489,0.6349583828775267,1.0,1.0,17/33,26.01%,PHF23;PIP4K2B;SCFD1;IFT20;FEZ2;PIP4K2A;PIP4K2C;NUPR1;RAB3GAP2;NPRL2;CHMP4A;CHMP4B;PIKFYVE;SH3GLB1;MTM1;NPRL3;TBC1D14
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3236440228852492,-0.8927964343277415,0.6137184115523465,0.9018574975716166,1.0,4/13,13.21%,CAB39;CAV1;ACTN2;NEDD4L
prerank,recombinational repair (GO:0000725),0.3104340981672905,0.8927123642287745,0.6680942184154176,1.0,1.0,19/77,19.92%,KDM4D;XRCC2;RNF138;PARP1;HELQ;PALB2;FBH1;LIG3;SEM1;YY1;POLN;RMI1;NUCKS1;MRE11;RAD50;NABP2;RBBP8;RECQL5;INO80
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3658259337960409,0.8922035954314224,0.6096938775510204,1.0,1.0,5/23,8.75%,ZEB2;FLCN;STK11;TGFB1I1;SDCBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3658259337960409,0.8922035954314224,0.6096938775510204,1.0,1.0,5/23,8.75%,ZEB2;FLCN;STK11;TGFB1I1;SDCBP
prerank,regulation of T cell proliferation (GO:0042129),-0.2153507144070388,-0.8919540587056429,0.7010309278350515,0.902160985587571,1.0,13/61,30.13%,CD46;SLC7A1;NCK1;SDC4;PTPRC;TNFRSF1B;CEBPB;NCKAP1L;PNP;CD80;CD274;NCK2;CD86
prerank,regulation of cellular senescence (GO:2000772),0.3464132736856925,0.8919312683442323,0.6211180124223602,1.0,1.0,5/28,9.79%,NUAK1;FBXO5;SLC30A10;EEF1E1;TWIST1
prerank,response to thyroid hormone (GO:0097066),-0.3187898810022085,-0.891886409019158,0.5951557093425606,0.9007361654827429,1.0,4/13,10.85%,RDX;MED1;CTSL;LMO2
prerank,respiratory electron transport chain (GO:0022904),-0.32924556124151755,-0.8917370465876848,0.5653710247349824,0.8994757175933514,1.0,11/14,35.18%,GPD2;SLC25A13;SDHB;ETFDH;NDUFA5;PPARGC1A;ETFRF1;ETFB;SLC25A22;UQCRFS1;SLC25A18
prerank,regulation of fibroblast proliferation (GO:0048145),0.32652668022075937,0.8916142335313366,0.6601607347876005,1.0,1.0,4/45,5.54%,WNT5A;SFRP1;IGF1;DDR2
prerank,mitochondrial translation (GO:0032543),0.30108175494970096,0.8911535699319738,0.6985446985446986,1.0,1.0,25/104,20.20%,MRPL36;MTRF1L;MRPL17;NDUFA7;MRPL19;GATB;GADD45GIP1;EARS2;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;HARS1;MRPL3;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;IARS2;MRPS6;OXA1L;MRPS24
prerank,regulation of cellular component organization (GO:0051128),0.29832542720250754,0.8909092516279087,0.7024539877300614,1.0,1.0,33/135,21.11%,WNT5A;BBS10;TSC2;HSP90AA1;NCLN;NUBP1;ABL1;RASGRP2;STK11;CAMSAP2;PACSIN3;SPOCK1;RAB5B;NRG3;RAPGEF1;AP2S1;SETD1A;CAMK2D;PARK7;EGLN2;ROCK2;RUFY1;AGTR1;RIT2;APOE;DCUN1D5;ZFYVE16;SETD5;CDK11B;MLLT3;HNRNPU;PAK5;SGK3
prerank,hexose biosynthetic process (GO:0019319),-0.22667020955020664,-0.8906353372970337,0.7266187050359713,0.9005197088246105,1.0,16/42,24.87%,AKR1B1;SLC25A13;GPI;SLC39A14;RBP4;GOT2;ALDOA;PCK2;GOT1;ATF4;ENO1;PPARGC1A;SLC25A11;CRTC2;MDH1;GAPDH
prerank,positive regulation of TOR signaling (GO:0032008),0.33287394129298614,0.8905479511105395,0.6440281030444965,1.0,1.0,5/40,7.73%,HDAC3;SLC38A9;FLCN;RRAGA;GPR137C
prerank,regulation of protein dephosphorylation (GO:0035304),0.33702291565716624,0.8903060391142511,0.6279904306220095,1.0,1.0,15/37,21.79%,CALM3;PPP1R2;PPP6R3;HTT;PPP1R16A;TGFB1;CAMTA1;PPP2R5A;TIPRL;CALM1;ARPP19;SMPD1;DLC1;PTBP1;CALM2
prerank,secondary palate development (GO:0062009),-0.32918023269644836,-0.8898779346227881,0.6107142857142858,0.9007277475321445,1.0,4/14,7.89%,SMAD4;LEF1;TGFB2;TGFBR2
prerank,in utero embryonic development (GO:0001701),0.3538793104106934,0.8897889555642545,0.632183908045977,1.0,1.0,3/25,5.45%,ZNF568;FGFR2;FLCN
prerank,cellular response to drug (GO:0035690),0.35368230416852064,0.8896869227570147,0.6298619824341279,1.0,1.0,6/25,18.33%,GPLD1;RAP2A;PPM1E;PDE4B;DPEP1;RBM22
prerank,apical junction assembly (GO:0043297),-0.21817262635080392,-0.8896019527374263,0.68,0.8998922104428662,1.0,16/53,29.36%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;RAMP2;CLDN14;RHOC;DLG1;ARL2;RHOA;STRN;CLDN1;PAK2;PKN2
prerank,energy reserve metabolic process (GO:0006112),0.37531565828422103,0.8895629240546975,0.625,1.0,1.0,5/19,18.99%,PID1;LEPR;GBE1;MRAP2;PRKAG2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.35059122412199784,0.8895383606071706,0.6309823677581864,1.0,1.0,5/28,11.06%,BAX;ITPR1;BRSK2;DDIT3;BCL2
prerank,glycolytic process (GO:0006096),0.3446562612802715,0.8894262247973345,0.6260978670012547,1.0,1.0,4/28,11.10%,HKDC1;PGAM4;PGAM1;ENO2
prerank,smooth muscle contraction (GO:0006939),-0.3163713463717481,-0.8892078231812618,0.6148648648648649,0.8992102147029928,1.0,8/14,29.99%,EDNRA;SMTN;TPCN2;ROCK1;ADRA1A;MYH11;ACTA2;SLC8A1
prerank,regulation of signal transduction (GO:0009966),0.2911871209961655,0.889141997852798,0.7625754527162978,1.0,1.0,41/190,18.59%,GSKIP;CDKN2AIP;TSC2;FGFR2;DCDC2;GNG7;CD63;RORA;BRAP;OGT;NCLN;SULF1;SRMS;TMEM108;CD24;ZDHHC3;PTCH1;PRAG1;YWHAG;GDNF;APP;GRK3;RIC8B;IGFBP3;IGFBP7;GIT1;CBFB;MTCH1;TGFB1;TULP3;GRK2;NUCKS1;TCF7L1;FRRS1L;SNW1;ITGB1BP1;USP33;ZDHHC17;ILK;SYNJ2BP;CDC42SE2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.30017646698045614,0.8890316053140915,0.6939203354297694,1.0,1.0,22/110,17.95%,BBS10;BAX;LCMT1;HSP90AA1;WARS1;SAR1A;DDX3X;TIRAP;NCLN;SLF2;VCP;PEX5;PARK7;RACK1;NRG1;TGFB1;IMPACT;FAF1;FARP2;TPPP;APOE;SORL1
prerank,tRNA metabolic process (GO:0006399),0.38051301200931376,0.8886342616987513,0.6062246278755075,1.0,1.0,6/17,20.86%,YARS2;AARS1;SARS1;RPP30;FARS2;DTD1
prerank,positive regulation of transferase activity (GO:0051347),0.29320584760091484,0.8885429603359382,0.7206477732793523,1.0,1.0,27/142,17.95%,ARRDC4;MST1R;EPHA7;PKIB;EPHB2;HSP90AA1;FGFR2;FGFR1;DDR1;DDR2;EPHA8;WRAP53;HNRNPD;EPHA10;MUSK;PDGFRA;ROR2;HNRNPA2B1;TGFB1;MRE11;RAD50;TNKS;UBE2L3;EPHA5;TOPORS;DCUN1D5;SORL1
prerank,regulation of multicellular organismal development (GO:2000026),0.34605566230871926,0.8884417836515478,0.6138364779874214,1.0,1.0,8/25,24.55%,NIPBL;CD24;DHX36;EHMT1;OAS2;TRIP12;INSR;MYSM1
prerank,cellular response to glucose stimulus (GO:0071333),0.3477628739315952,0.8884370125444135,0.6215538847117794,1.0,1.0,10/30,22.61%,PTPRN;XBP1;SELENOT;ZBTB20;RACK1;TRA2B;PRKAA1;SOX4;RAB11B;UNC13B
prerank,negative regulation of protein depolymerization (GO:1901880),0.36456843964165503,0.8874859869574455,0.6333754740834386,1.0,1.0,12/24,27.10%,TAOK1;CAMSAP2;PLEKHH2;KATNB1;LIMA1;FGF13;CLASP2;CAMSAP1;NAV3;ARHGEF2;HDGFL3;APC
prerank,negative regulation of nuclear division (GO:0051784),0.4100725660078133,0.8872411128724003,0.6061946902654868,1.0,1.0,2/11,8.26%,FBXO5;AURKAIP1
prerank,negative regulation of transport (GO:0051051),0.3182170111314831,0.8870458938216508,0.6465909090909091,1.0,1.0,16/51,22.32%,FCGR2B;SIRPA;PACSIN3;EGF;ABCA7;SNX33;RACK1;SCAMP5;NRG1;NDFIP2;MCTP1;ITGAV;SYT11;RAB7A;PPM1F;PXK
prerank,endochondral bone morphogenesis (GO:0060350),0.412164405747595,0.8868742882095592,0.6258992805755396,1.0,1.0,1/11,1.00%,TMEM119
prerank,cristae formation (GO:0042407),0.35071657619805824,0.8867466991724446,0.6354679802955665,1.0,1.0,5/27,10.62%,APOOL;ATP5PF;APOO;ATP5MC3;AFG3L2
prerank,tryptophan metabolic process (GO:0006568),-0.3463170874306711,-0.8867237469162399,0.5973154362416108,0.9037818654971363,1.0,10/11,64.96%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,regulation of response to stress (GO:0080134),0.4248876583229406,0.886603308242924,0.6275964391691394,1.0,1.0,1/10,4.10%,MLC1
prerank,regulation of synapse maturation (GO:0090128),0.42627202169104983,0.8862836559123835,0.6268656716417911,1.0,1.0,2/10,6.19%,CAMK2B;ANAPC2
prerank,tRNA export from nucleus (GO:0006409),-0.2501513308520666,-0.8862707929599332,0.6511627906976745,0.9016888239807238,1.0,12/32,17.56%,NUP160;XPOT;NUP205;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2501513308520666,-0.8862707929599332,0.6511627906976745,0.9016888239807238,1.0,12/32,17.56%,NUP160;XPOT;NUP205;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,lysine metabolic process (GO:0006553),0.40677114933112746,0.8862645710811726,0.600864553314121,1.0,1.0,3/12,18.79%,AASS;OGDH;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.40677114933112746,0.8862645710811726,0.600864553314121,1.0,1.0,3/12,18.79%,AASS;OGDH;ALDH7A1
prerank,negative regulation of cellular senescence (GO:2000773),0.39322468192573495,0.8862209843365728,0.6160458452722063,1.0,1.0,3/13,9.79%,FBXO5;SLC30A10;TWIST1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3900731220337247,0.8861427772445558,0.6338797814207651,1.0,1.0,2/16,7.40%,KDM4D;WRAP53
prerank,negative regulation of JNK cascade (GO:0046329),0.3405542741936365,0.8857550483126356,0.6280487804878049,1.0,1.0,5/31,13.55%,HDAC3;MAPK8IP1;SIRPA;PER1;PTPN22
prerank,sphingolipid metabolic process (GO:0006665),0.2964598975175596,0.885592029258439,0.685031185031185,1.0,1.0,23/108,19.67%,B3GALNT1;ELOVL1;SMPD2;GBA2;GLB1;ABCA2;CERS2;SGPL1;ELOVL4;ENPP2;SPTSSA;TEX2;PLPP3;PSAP;SMPD4;ST6GALNAC6;VAPB;ALDH3A2;GALC;PRKD2;ELOVL6;SMPD1;PDXDC1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.31020041806267173,0.8855621565426662,0.6648822269807281,1.0,1.0,16/72,17.19%,RAC1;NRP1;FLCN;ABL1;RIPOR2;ARRB1;GPR4;PRAG1;ADGRG1;ROBO1;AKAP13;LPAR1;LPAR6;EPS8L1;RIT2;APOE
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3258405412965514,-0.8854229827205345,0.6,0.9021710070634141,1.0,4/12,10.85%,RDX;MED1;CTSL;LMO2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3605898635999477,0.8851787944400765,0.6197916666666666,1.0,1.0,3/21,8.83%,CHPF;DCN;CHSY3
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.36656193093332934,0.8850995542926621,0.6389986824769434,1.0,1.0,4/20,14.28%,NFKB1;HM13;MBTPS1;TGFB1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.319586477973608,0.8849868059563414,0.6651835372636262,1.0,1.0,14/52,16.84%,DDX17;SRSF12;CELF2;CELF1;KHDRBS2;RBFOX2;HNRNPL;TRA2B;NOVA1;CELF5;DDX5;YTHDC1;FMR1;THRAP3
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3389318296689775,-0.8848641672256559,0.5792682926829268,0.9019257033379331,1.0,4/11,15.67%,KIT;KIFC3;CCN3;ITGB5
prerank,positive regulation of JNK cascade (GO:0046330),0.30753713103203417,0.8844984935660207,0.6763754045307443,1.0,1.0,9/70,10.71%,FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;SDCBP;APP
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3537453895343269,0.8844665121230099,0.6066411238825032,1.0,1.0,6/26,15.67%,SLC35D2;ST3GAL2;ST3GAL3;B4GALT5;OMD;LUM
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.30668183644361835,0.8843972665461611,0.6749192680301399,1.0,1.0,16/67,17.79%,ABITRAM;RAC1;DCDC2;CDKL5;SGSM3;TBC1D13;DMTN;TBC1D20;USP6NL;IFT20;RABGAP1;TBC1D24;ATG3;FMR1;TBC1D9B;TBC1D22B
prerank,transferrin transport (GO:0033572),0.33150911693870566,0.8842729281212769,0.6328502415458938,1.0,1.0,10/33,22.42%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2;STEAP3;ATP6V1C1;RAB11B
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.21495960814395562,-0.8842337050856254,0.67,0.9019378636420263,1.0,16/61,14.52%,PSMB7;AZIN1;CAV1;SIRT1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3486557679101748,0.8840638008146295,0.6593548387096774,1.0,1.0,11/24,25.47%,ZFP36L1;ERRFI1;CBFB;ROCK2;NUMA1;CTSK;NCOA3;HOXA7;SRSF6;RUNX1;SGPP1
prerank,negative regulation of cell projection organization (GO:0031345),0.325893269313316,0.883719503989983,0.6651785714285714,1.0,1.0,17/48,23.90%,SPOCK1;EFNB2;YWHAH;PRAG1;DENND5A;LPAR1;SEMA3A;SPRY2;APOE;GORASP1;DCC;ITM2C;PTPRS;EPHA4;DPYSL3;PTEN;MYLIP
prerank,negative regulation of cellular component movement (GO:0051271),-0.3117579446264003,-0.8834890036199587,0.6156583629893239,0.9021308108972078,1.0,3/15,5.70%,FRMD5;ACTN1;SP100
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2148979264542895,-0.8834066665282885,0.7281553398058253,0.9007623684824296,1.0,23/59,27.54%,DAB2IP;IKBKB;IRAK2;RIPK1;ERC1;NFKBIA;TLR4;UBB;IKBKG;ROCK1;TNFRSF1A;RNF31;IRAK1BP1;FAIM;TBK1;AKT1;NFKBIL1;PRDX4;BCL10;BCL3;BIRC2;SHARPIN;TLR7
prerank,anterograde trans-synaptic signaling (GO:0098916),0.28874806711252426,0.883397978928513,0.7703109327983951,1.0,1.0,41/224,18.28%,SYT10;CACNB4;GRIN1;PDE7B;OPRK1;MINK1;CDK5;HCRTR2;GRIN2A;SDCBP;CPLX1;SCN2B;GABRB3;CACNB1;SNAP25;HCRTR1;GRIA1;NLGN3;HTR2C;SYT1;RPS6KA3;CHRM2;SLC1A3;KCNA1;GRIA2;NOVA1;NLGN2;GLRA1;KCNQ2;RPS6KA1;SYN2;DLGAP1;RIT2;DLG2;GPR176;HRH1;SLC1A2;SYNJ2BP;DTNA;PRKAR1A;GABRG3
prerank,negative regulation of protein modification process (GO:0031400),0.3045565114629912,0.8833482110568397,0.688367129135539,1.0,1.0,22/79,19.02%,EPHB2;WARS1;FBLN1;ATG14;SIRPA;PID1;CDK5RAP3;IGFBP3;CDYL;PARK7;CRTAP;PLPP3;ZBED3;MAPT;TGFB1;FKBP8;IMPACT;TPPP;DNAJC10;TERF2IP;PRKAA1;ARPP19
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3894069157781972,0.8833439259483072,0.6372413793103449,1.0,1.0,2/15,4.02%,ANXA1;ZFP36L1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.33669373264846697,0.8832362039033402,0.6480380499405469,1.0,1.0,4/36,8.94%,HDAC3;FOXM1;SIRPA;PER1
prerank,nucleotide-excision repair (GO:0006289),0.2998279797411954,0.8829915195707607,0.6947916666666667,1.0,1.0,17/101,13.72%,COPS7A;LIG1;PARP1;USP7;POLR2B;DDB1;LIG3;COPS7B;SLC30A9;CUL4B;GTF2H3;TCEA1;BRIP1;POLR2K;CCNH;MMS19;POLD3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.34264336905546366,0.8827486322710315,0.6666666666666666,1.0,1.0,7/31,19.75%,CDKN2D;WEE1;RBL2;CDC73;PKD2;PRMT2;KLF4
prerank,regulation of protein metabolic process (GO:0051246),0.32827119752245115,0.8822396915818093,0.6526195899772209,1.0,1.0,14/44,19.75%,SNF8;HGS;SSH1;ABCA7;APP;ROCK2;FAF1;CHEK2;NEDD8;PARL;APOE;MDM2;ZDHHC2;KLF4
prerank,cellular response to organonitrogen compound (GO:0071417),0.3008901581601856,0.8821591746651738,0.7127882599580713,1.0,1.0,16/99,14.79%,CPEB1;SFRP1;XBP1;ZFP36L1;SLC38A9;DMTN;RRAGA;SOX9;SSH1;CAPN2;RAPGEF1;GABRB3;JUP;LAMTOR5;GLRA1;IMPACT
prerank,aortic valve development (GO:0003176),0.33377932695213763,0.881499077331489,0.6445221445221445,1.0,1.0,10/34,16.44%,SNAI1;SOX9;TWIST1;ROBO2;ROBO1;ROCK2;TGFB1;SMAD6;SLIT3;JAG1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.43386444189954393,0.881391532006165,0.6534351145038167,1.0,1.0,3/10,20.88%,MALT1;RC3H2;SMAD7
prerank,negative regulation of macroautophagy (GO:0016242),0.3479682806454772,0.8811799601570629,0.638854296388543,1.0,1.0,13/26,25.37%,PHF23;TSC2;NRBP2;SCFD1;FEZ2;NUPR1;QSOX1;SMG1;CHMP4A;CHMP4B;TSC1;MTM1;CLEC16A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.30348637591011607,0.8811283169597279,0.6919032597266036,1.0,1.0,9/86,10.71%,PSRC1;CDC42EP5;CDC42EP4;BIN1;RAC1;BAIAP2;DRG1;KATNB1;APP
prerank,regulation of JUN kinase activity (GO:0043506),-0.24891543187777268,-0.8810195727567101,0.7109826589595376,0.904729766511943,1.0,14/33,25.25%,DAB2IP;PDCD4;DVL3;MAP3K10;DUSP10;ARHGEF5;TNFRSF11A;MAP3K4;TAOK3;DNAJA1;MAP3K5;PPEF2;SASH1;HIPK3
prerank,synaptic vesicle transport (GO:0048489),0.4128640138741564,0.8808046451875546,0.6259097525473072,1.0,1.0,4/11,17.25%,CDK5;KIF5C;TMEM230;KIF5B
prerank,autophagosome organization (GO:1905037),0.3181415357470166,0.8807692816538396,0.6632882882882883,1.0,1.0,17/50,22.68%,UBQLN1;UBXN2A;WIPI1;ATP2A2;ATG14;ATG2A;ATG13;ATG3;MAP1LC3B;VMP1;PIK3C3;ATG9A;AMBRA1;RAB7A;ATG16L2;RAB43;WIPI2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.2639429023356253,-0.8807296954255407,0.6700507614213198,0.9038319199736783,1.0,8/25,18.27%,SMAD4;UBE2O;ENG;BMPR1A;ACVR2B;BMPR1B;BMP4;CCN1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.24715015509790375,-0.880655163159223,0.6918238993710691,0.9024357919167061,1.0,8/33,11.54%,BMPER;TJP1;CEMIP2;SEMA6A;SMAD1;THBS1;EPN2;PKM
prerank,mitochondrion distribution (GO:0048311),0.4067355695489497,0.8806185130652592,0.6237337192474675,1.0,1.0,5/12,18.33%,MSTO1;MAPT;DNM1L;TRAK1;ATCAY
prerank,indolalkylamine catabolic process (GO:0046218),-0.35065587146174604,-0.8805129763885976,0.6219512195121951,0.9012386605623665,1.0,10/10,64.96%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3153888863199166,0.8803622366512515,0.6600221483942414,1.0,1.0,18/53,21.45%,RNF8;FGF10;FBH1;EEF1E1;WRAP53;RNF168;NACC2;CEBPG;ATR;EYA2;BCLAF1;DDX5;FMR1;UIMC1;RPS3;EYA1;PLA2R1;NPAS2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.3597806284566746,-0.8802864317403949,0.6325301204819277,0.9003084880263889,1.0,3/10,11.48%,RNF13;NBR1;FAS
prerank,protein targeting to lysosome (GO:0006622),0.3651246914769575,0.8801885559233791,0.6357615894039735,1.0,1.0,8/20,22.09%,HGS;NCOA4;AP4M1;SORL1;ZFYVE16;SCARB2;RAB7A;GGA3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.33752257789643414,0.8801210467468097,0.6583924349881797,1.0,1.0,4/36,6.64%,WNT5A;FZD3;TCF7L2;GNG2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.35300376288036717,-0.8797671551763989,0.6034985422740525,0.9000105607946388,1.0,6/10,37.38%,NR1H3;ELOVL5;NR1H2;SLC45A3;MID1IP1;MLXIPL
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.306279675897351,0.8797231795649707,0.6833688699360341,1.0,1.0,15/72,15.93%,FOXM1;BAX;PCBP4;TFDP1;CNOT10;USP10;MDM4;NDRG1;RBL2;CNOT9;PRMT1;ATRX;CNOT6;CASP2;CHEK2
prerank,mononuclear cell differentiation (GO:1903131),-0.26732014219472355,-0.8796977096700214,0.6586538461538461,0.8986638732350335,1.0,8/24,22.05%,AXL;PIR;MT1G;THOC5;BMP4;IKZF1;VEGFA;PPARG
prerank,carbohydrate homeostasis (GO:0033500),-0.2104834344606071,-0.8786292753154243,0.7368421052631579,0.899540161476393,1.0,13/67,14.55%,IGF1R;CYB5R4;STAT3;IRS1;BACE2;RBP4;INPP5K;ADIPOR1;SLC8B1;RPS6;MCU;PRKAA2;ADIPOR2
prerank,negative chemotaxis (GO:0050919),0.3382377905009374,0.8786095028044554,0.65625,1.0,1.0,8/33,15.56%,EPHA7;SEMA3D;ROBO1;UNC5C;SLIT1;SLIT3;SEMA3E;SEMA3A
prerank,DNA double-strand break processing (GO:0000729),0.3717222090690179,0.8785003523811898,0.648074369189907,1.0,1.0,7/18,21.07%,RNF138;BARD1;UBE2V2;MRE11;RAD50;RBBP8;EXD2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3189806591266167,0.8783982517548148,0.660377358490566,1.0,1.0,6/47,6.44%,RAC1;FBLN1;NRP1;ABL1;ARHGEF7;DMTN
prerank,cell projection assembly (GO:0030031),0.35623394754875287,0.878352649575992,0.6172370088719898,1.0,1.0,3/22,8.37%,RAC1;NEFH;CYFIP1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3626544498719465,0.8782164129128106,0.6297229219143576,1.0,1.0,5/22,10.84%,EDEM1;SYVN1;MAN1A2;EDEM3;UGGT2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.29527723979154613,0.8781692690821324,0.711340206185567,1.0,1.0,35/109,24.49%,MAPK9;PSMD4;PDPK1;NFKB1;RAC1;PIK3R1;PSMB10;PSMD11;TEC;VAV2;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;PSMD1;MAP3K1;PSMD6;TAB1;CALM1;PSMD5;LYN;TAB3;PSMA4;NFATC3;PSMA1;PSMC6;PAK1;MAP2K7;PSMA5;SOS1;PPP3CB;VAV3;PSMD14;TRAF6
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2188187580986555,-0.8781685335721392,0.7217391304347827,0.8991024698461455,1.0,14/50,14.52%,PSMB7;AZIN1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3751322203303204,0.8778575226364023,0.6310160427807486,1.0,1.0,9/18,23.15%,RIPOR2;RACK1;ROCK2;RUFY3;KIF20B;KRIT1;PTK2B;LLGL1;RAP1B
prerank,selective autophagy (GO:0061912),0.3132529436756073,0.877657833750808,0.668141592920354,1.0,1.0,11/56,12.08%,UBQLN1;USP30;ARL13B;SQSTM1;ATG14;ATG2A;AUP1;ATG13;PEX5;DYNC1LI1;PARK7
prerank,response to histamine (GO:0034776),-0.3524241285763889,-0.8771726534864661,0.6170886075949367,0.8999306847183787,1.0,2/10,5.29%,GABRB1;GABRG2
prerank,neuron remodeling (GO:0016322),0.4249231889361858,0.8771174585613487,0.635036496350365,1.0,1.0,4/10,18.42%,EPHA8;APP;FARP2;ADGRB3
prerank,purine-containing compound salvage (GO:0043101),0.4030957193783574,0.8768543467150348,0.612094395280236,1.0,1.0,4/12,21.39%,DCK;HPRT1;GMPR2;ADK
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3060126996216938,-0.8767963220809352,0.6292134831460674,0.8977632476546986,1.0,5/15,16.99%,SORBS1;SRC;KCTD13;ITGB5;ZYX
prerank,stress fiber assembly (GO:0043149),-0.3060126996216938,-0.8767963220809352,0.6292134831460674,0.8977632476546986,1.0,5/15,16.99%,SORBS1;SRC;KCTD13;ITGB5;ZYX
prerank,regulation of monooxygenase activity (GO:0032768),0.3527258880994954,0.8766334273231384,0.6444159178433889,1.0,1.0,4/23,10.19%,HSP90AA1;NOS1AP;POR;GDNF
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.22323198508421555,-0.8764522799853217,0.7604166666666666,0.8970427343916527,1.0,13/54,14.51%,UBE2K;IKBKB;RIPK1;HIPK1;OTULIN;CYLD;CASP4;TAX1BP1;IKBKG;MADD;TNFRSF1A;PYDC1;RNF31
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.30327467632967947,0.876355274843893,0.6681222707423581,1.0,1.0,6/63,11.06%,EPHB2;ANXA1;FGF10;TIRAP;IRS2;BCL2
prerank,icosanoid metabolic process (GO:0006690),0.32926386335773367,0.8762697394167177,0.6797687861271676,1.0,1.0,9/40,20.61%,ALOX5AP;PON2;PON3;FADS1;PTGS2;DPEP1;GPX4;PTGS1;MAPKAPK2
prerank,positive regulation of protein transport (GO:0051222),0.3068019860677253,0.8761319913678877,0.6791845493562232,1.0,1.0,10/67,14.84%,CLN3;IGF1;BMP6;ATP2C1;RIPOR1;MYH10;RACK1;TMED10;TGFB1;DNM1L
prerank,antibacterial humoral response (GO:0019731),-0.3039072624534276,-0.8759475998110596,0.5870445344129555,0.896723087056171,1.0,4/16,18.33%,RNASE3;DEFA6;RPL39;PLA2G6
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3634783863555519,0.875887689122179,0.6449934980494149,1.0,1.0,4/20,9.58%,PPIF;NKTR;PPIB;PPIH
prerank,apoptotic nuclear changes (GO:0030262),0.3555921512006578,0.8755870250615375,0.6305483028720626,1.0,1.0,7/24,22.00%,DFFB;KPNB1;CDK5RAP3;DFFA;KPNA1;ACIN1;HMGB1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3378992416230367,0.8753289910055447,0.6396508728179551,1.0,1.0,9/28,22.12%,HDAC3;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;RBM22;TPR;SMAD3
prerank,regulation of JNK cascade (GO:0046328),0.29664416089236606,0.8752053694293302,0.7208333333333333,1.0,1.0,12/101,8.94%,HDAC3;FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;RAP2A;SIRPA;SDCBP;PER1
prerank,determination of left/right symmetry (GO:0007368),0.3281969823232209,0.8751052865698303,0.6405693950177936,1.0,1.0,8/36,23.23%,BBS7;ZIC3;RFX3;OFD1;MEGF8;PKD2;DAND5;KIF3B
prerank,DNA geometric change (GO:0032392),0.35532364976493336,0.8750953061305552,0.6632911392405063,1.0,1.0,7/24,19.19%,HMGB3;ANXA1;DHX36;HNRNPA2B1;MRE11;RAD50;RECQL5
prerank,cardiocyte differentiation (GO:0035051),0.4266223102064765,0.8750262759363537,0.6289592760180995,1.0,1.0,4/10,16.73%,SIK1;AKAP13;NRG1;KDM6B
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.33663299176401623,-0.8750207669831455,0.6357827476038339,0.8972788852447836,1.0,3/12,17.38%,RBP4;TLR4;STRAP
prerank,regulation of intracellular signal transduction (GO:1902531),0.28377485316958084,0.8748668747375242,0.846,1.0,1.0,113/420,22.25%,FSHR;WNT5A;ATP6AP2;ARAF;PDPK1;PIP4K2B;CSNK2A2;RAC1;TAF9B;USP7;TAOK1;PTPMT1;BRPF1;TAF4;MINK1;CDK5;RBBP4;FLCN;SYDE2;ARHGAP20;TBP;NUAK1;ARHGAP19;SRGAP2;SRGAP3;SQSTM1;BARD1;ARHGEF7;PAK3;ARHGEF4;ZFAND6;STK11;RHOD;KALRN;RFFL;CD24;MCF2;RCN3;XIAP;EHMT2;MDM4;PRMT5;ARHGAP21;VAV2;USP2;ARHGAP24;TAF6;PIK3R2;MTA2;BRIP1;ARAP1;HDAC1;RMI1;PLEKHG5;FAM13A;ATR;AKAP13;EHMT1;PIP4K2A;PTPN22;MAPT;ARHGAP29;RNF41;AKAP12;PIP4K2C;MRE11;TRIO;CHEK2;ARHGEF6;RAD50;TP53RK;RIT2;DAXX;MDM2;FBXO9;TOP3A;PRKD2;RBBP8;RASSF2;PRKAR1A;PIP5K1A;PRKAA1;BANP;BIRC3;PRKAG2;NRK;PLEKHG2;FGD4;DLC1;WWC1;MYO9A;STARD13;ARHGAP6;LYN;CHN1;PEX5L;ITGAV;PAK5;NTRK2;NF2;PREX1;SRGAP1;TAF2;MAPKAP1;MAP4K4;RHOU;ARHGAP26;ARHGAP35;TELO2;TRAF2;TAF1;PJA2;ENTPD5
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3483525396066105,0.8747469024433596,0.649167733674776,1.0,1.0,3/23,8.05%,DDX3X;PPM1B;IFI35
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.28863283753249624,-0.8741715401463129,0.6160337552742616,0.8976425018399238,1.0,5/20,8.34%,PICALM;TMEM59;BCL2L1;NUMB;CSK
prerank,positive regulation of protein import (GO:1904591),0.3339879468615161,0.8741576710769583,0.6489493201483313,1.0,1.0,10/30,22.12%,HDAC3;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;RBM22;PDCD5;TPR;SMAD3
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.32508848839072346,0.8738512071003746,0.680622009569378,1.0,1.0,8/39,19.15%,LRRC8A;CAPN10;TCF7L2;SELENOT;IRS2;NLGN2;TRH;SOX4
prerank,mesenchymal cell development (GO:0014031),0.3739248616159176,0.8734746553024766,0.6357615894039735,1.0,1.0,4/18,14.04%,KLHL12;PEF1;SOX11;NRG1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.21723684418214076,-0.873453226641317,0.7352941176470589,0.8977911507929532,1.0,26/53,30.51%,PSMB7;AZIN1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3;PSMC3;PSMD3;PSMD8;BCKDK;ODC1;PSME3;PSMB4;PSMC4;PSMB6;PSME1;PSMB5;PSME4
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.296378839229614,0.8734042576986302,0.7165271966527197,1.0,1.0,22/95,20.33%,CHPF;HS2ST1;SLC35D2;ST3GAL2;GPC6;NDST2;DCN;ST3GAL3;GPC1;CHSY3;HS6ST2;B4GALT5;GPC4;OMD;LUM;HSPG2;EXT2;CEMIP;DSE;GPC5;HS3ST1;GCNT2
prerank,leukocyte tethering or rolling (GO:0050901),-0.2953241674509392,-0.873176103797437,0.6263736263736264,0.8969161032621684,1.0,5/17,23.73%,JAM2;ROCK1;ITGA4;PODXL2;CX3CR1
prerank,cellular protein modification process (GO:0006464),0.2805495236698969,0.8726619914310909,0.942,1.0,1.0,195/982,19.00%,AATK;ILF3;COPS7A;ALG5;MAPK9;B3GALNT1;CAMK2B;DUSP26;CUL7;STK36;SIRT2;SPSB3;ARAF;SIRT7;PSMD4;LCMT1;PDPK1;PDK1;COQ8B;FBXW10;CP;ASB5;ST8SIA3;PARP1;EIF2AK3;DMPK;UBE2S;SPSB1;KCTD7;CDKL5;UBE2E2;FBXL12;HUNK;FGFR1;ANXA1;TAOK1;PICK1;FSTL1;WIPI1;OBSL1;NUAK2;ST3GAL2;MINK1;FBXL14;MAP4K5;PARP2;WSB2;CDK13;PPM1B;PRKCA;CDK5;FBXO7;COP1;CDK9;LAMC1;ALG1;UBXN7;METAP1;NGLY1;PIGU;NUAK1;ABL1;FBXO31;ST3GAL3;PSMB10;DDB1;PAK3;MIA3;UCHL3;STK11;BRSK2;CKAP4;FBXW5;CDC14B;PSMD11;LTBP1;SIK1;COPS7B;MANBA;ST3GAL5;SSH1;PPP2R5E;TEC;FAM20C;PPP1CC;ABCA7;NRBP2;APLP2;CUL4B;PLAT;MBTPS1;PRAG1;PSME2;METAP1D;PPM1H;WNK2;PSMC5;BRSK1;PGAP1;APP;PTPN5;GRK3;MAPK6;IGFBP3;STRADB;IGFBP7;PTPRF;CAMK2D;PORCN;PTPN3;TLK1;PARK7;DCAF5;FBN1;B4GALT5;SERP1;RAB13;COG3;PARP14;LAMB1;METAP2;NEURL2;PRKCI;DAPK1;PIGK;PTPN22;CUL5;PARP16;DAD1;CSNK1D;ATG3;NEK3;NRBP1;ROCK2;TGFB1;KLHL5;GRK2;PPM1E;FEM1C;PPP2R5D;CSNK1A1;CTDSP2;PSMD1;RPN2;PPP5C;PPM1M;KLHL13;ACVR1B;RAB8A;UBE2E1;GALNTL5;PTPN12;SIRT5;CHEK2;ZC3HAV1;CTBP1;MTMR4;MAP3K1;CCNT1;SERPIND1;TP53RK;TNKS;PIK3C3;NEDD8;UBE2L3;STK25;TIPARP;PSMD6;PPP2CB;CDK7;MXRA8;OXSR1;APOE;FBXO22;FBXO9;ILK;KLHL20;PPP2R5A;PRKD2;JAK1;NEK1;CDK10;BTBD1;PTPRE;PTAR1;TAB1;SRPK1;B3GALNT2;TGFBR1;PHKA2;PRKAA1;CDC42BPB;ASB3;PRKAG2;PIK3R4
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3288561539571054,-0.8725850377760958,0.6384364820846905,0.8967286108002708,1.0,3/11,15.99%,TGFB2;BMPR1A;BMP4
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.29971256319430467,0.8724732964420409,0.7167381974248928,1.0,1.0,28/80,25.13%,KDELR3;BNIP1;ATP9A;PICK1;KIF3A;KIF3C;ERGIC2;COPZ2;ATP9B;SCFD1;TMED10;PLPP3;COG3;HTT;NSF;RAB6A;KIFAP3;ZW10;UVRAG;NAPA;ARFGAP3;COPG1;KIF3B;COPA;TMED7;GOLPH3L;ERGIC1;SURF4
prerank,regulation of cellular catabolic process (GO:0031329),0.3068401941514953,0.8723905064597254,0.6826608505997819,1.0,1.0,17/62,17.48%,PIP4K2B;ITPR1;ABL1;RRAGA;DDIT3;USP10;PIK3R2;WDR91;PIP4K2A;DAPK1;PSAP;MAPT;PIP4K2C;NUPR1;RAB8A;MTMR4;USP33
prerank,regulation of platelet activation (GO:0010543),0.3522174216865102,0.8722788929919484,0.6435124508519003,1.0,1.0,4/21,11.29%,C1QTNF1;PRKCA;TEC;PDGFRA
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.41889721400072133,0.872257323105138,0.634393063583815,1.0,1.0,2/10,8.35%,FGFR2;SOX9
prerank,regulation of vasoconstriction (GO:0019229),0.3478897962349584,0.8721292908181902,0.6326781326781327,1.0,1.0,4/27,10.66%,ADM;BDKRB2;ATP2B1;TBXA2R
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.27175472637667225,-0.872097269586963,0.659919028340081,0.8963054261025436,1.0,3/21,1.12%,FOXP1;PRKCH;ELF1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3885096189130978,0.8720688334801341,0.6160458452722063,1.0,1.0,2/14,14.21%,PARK7;PTGS2
prerank,regulation of protein transport (GO:0051223),0.3471838660099121,0.8719510001677097,0.6486161251504212,1.0,1.0,5/27,16.04%,LCP1;GAPVD1;SCFD1;RHBDF1;NDFIP2
prerank,synaptic vesicle endocytosis (GO:0048488),0.3366185668443996,0.8718100761083556,0.6654804270462633,1.0,1.0,8/33,16.22%,DNM1;SYNJ2;CDK5;DNAJC6;NLGN3;SYT1;NLGN2;SNAP91
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.30371920873675007,0.8713938373987922,0.7021276595744681,1.0,1.0,13/77,13.66%,IGF1;PPIF;CSNK2A2;DDX3X;FZD9;TCF7L2;PRELID1;CAAP1;BCL2;MAZ;RTKN2;PARK7;HTT
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2940833350950136,0.871291613564087,0.7312049433573635,1.0,1.0,28/109,20.35%,PLA2G5;PIP4K2B;SYNJ2;INPP5E;PIK3R1;PLEKHA3;PITPNM3;PIK3CB;PGAP1;PIK3R2;PI4KB;PIP4K2A;LCLAT1;PIP4K2C;FIG4;SACM1L;CDS1;PIK3C2B;MTMR4;RUFY1;SLC27A1;PIK3C3;PITPNM2;PIP5K1A;PLEKHA1;PIK3R4;IMPA1;INPP4A
prerank,peptidyl-threonine modification (GO:0018210),0.305728383816853,0.8711163926472781,0.6830065359477124,1.0,1.0,18/66,18.78%,PDPK1;CSNK2A2;GALNT16;PRKCA;CDK5;GALNT4;SBK1;CIT;CAMK2D;GALNTL6;ROCK2;ACVR1B;TNKS;OXSR1;PRKD2;CDK10;TGFBR1;CDC42BPB
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3188815365007392,0.8710944207523016,0.6658905704307334,1.0,1.0,5/42,6.13%,SFRP1;RAC1;NRP1;ABL1;THY1
prerank,positive regulation of programmed cell death (GO:0043068),0.2847331474587537,0.8710661969737481,0.817,1.0,1.0,49/272,16.17%,SFRP2;SFRP1;BAX;GPLD1;BIN1;PLEKHN1;SLC27A4;AIFM2;HTATIP2;DDX3X;FZD9;SCRIB;FLCN;OLFM1;FAM162A;ABL1;SQSTM1;BARD1;ARHGEF7;ARHGEF4;EEF1E1;KCNMA1;KALRN;TRIM35;CALHM2;MCF2;CLIP3;CASP9;VAV2;UBE2Z;IGFBP3;PLEKHG5;RACK1;AKAP13;DAPK1;HTT;MTCH1;MTCH2;BCL6;RNF122;BCLAF1;DNM1L;SHQ1;PAWR;FAF1;CASP2;HSPD1;TRIO;ARHGEF6
prerank,regulation of DNA replication (GO:0006275),-0.2211055748940671,-0.8710571245296469,0.7063492063492064,0.8970142659083306,1.0,7/49,7.16%,WAPL;ANKRD17;EGFR;KAT7;RBBP6;BCAR3;STN1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3226990373196717,0.8708390056950002,0.6719457013574661,1.0,1.0,9/45,14.97%,PDPK1;PIK3R1;GAB1;SLC30A10;SOX9;EGF;IQGAP1;TGFB1;CBL
prerank,regulation of viral entry into host cell (GO:0046596),-0.2496608462740471,-0.8698479062447882,0.6818181818181818,0.8983530684920478,1.0,11/30,22.45%,P4HB;TRIM25;LY6E;LGALS9;LGALS1;TRIM5;TRIM14;NECTIN2;HS3ST5;IFITM2;IFITM1
prerank,mRNA catabolic process (GO:0006402),0.31779357778152023,0.8694296720474732,0.6836027713625866,1.0,1.0,11/44,19.39%,LSM6;CNOT10;NUDT12;AGO3;XRN1;DIS3L2;DDX5;NUDT16L1;THRAP3;DHX34;YTHDF2
prerank,regulation of mitochondrial fission (GO:0090140),0.35143621935669755,0.8693986390158965,0.6395939086294417,1.0,1.0,7/24,15.72%,MYO19;FIS1;DCN;MIEF2;MAPT;DNM1L;SPIRE1
prerank,positive regulation of peptidase activity (GO:0010952),0.36286470138348864,0.8692919196833099,0.6503311258278146,1.0,1.0,6/20,17.20%,PRELID1;RCN3;VCP;PSME2;CTSH;TANK
prerank,regulation of dendritic spine development (GO:0060998),0.36541752467034416,0.869153374274528,0.668848167539267,1.0,1.0,7/19,21.20%,CAMK2B;TANC2;FMR1;APOE;SHANK1;PTPRS;DLG5
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.34192421127909134,-0.868927081059391,0.6286644951140065,0.8988951888948717,1.0,2/11,1.67%,IP6K2;PPIP5K1
prerank,pyruvate metabolic process (GO:0006090),-0.2179785935741448,-0.8688878180234855,0.7520661157024794,0.8975123422134623,1.0,16/52,19.17%,ME3;ME2;HK1;BSG;GPI;PDHX;SLC16A1;PDHA1;PKM;GLO1;ALDOA;PDHB;PCK2;PFKFB2;ENO1;HK2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4212591235662816,0.86885216726677,0.6515151515151515,1.0,1.0,2/10,19.73%,ETFBKMT;OXA1L
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.36801970513823784,0.8688092074026347,0.6382428940568475,1.0,1.0,2/18,7.14%,IL34;CXCR4
prerank,response to X-ray (GO:0010165),0.3833361462429749,0.8684884094534003,0.6589928057553956,1.0,1.0,4/14,15.12%,ANXA1;NIPBL;XRCC6;NUCKS1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3755171500012625,0.8683083612546496,0.6675639300134589,1.0,1.0,3/17,6.44%,SIRT2;CALM3;DMTN
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.351825373594759,0.8682001394531104,0.6666666666666666,1.0,1.0,3/24,7.11%,VTN;ARNT;HGS
prerank,snRNA transcription (GO:0009301),0.3017496059047312,0.8681018968481383,0.6865037194473964,1.0,1.0,26/70,24.79%,RPRD2;USPL1;POU2F1;POLR2B;CDK9;TBP;GTF2A2;SNAPC4;TAF6;POLR2K;GTF2E1;CCNT1;CDK7;NABP2;INTS6;INTS2;CCNT2;INTS7;SNAPC3;GTF2F2;GTF2B;RPAP2;SP1;INTS10;INTS9;INTS13
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3569178215375712,0.8680893082083663,0.6447028423772609,1.0,1.0,6/22,21.79%,CALM3;HTT;VMP1;PKD2;CALM1;CALM2
prerank,postreplication repair (GO:0006301),-0.22868381869376458,-0.8676001474797732,0.6756756756756757,0.8988491036081551,1.0,9/45,10.39%,WDR33;UBE2N;ZBTB1;TRIM25;RPA1;UBB;REV1;PARP10;MSH2
prerank,ceramide biosynthetic process (GO:0046513),0.32487935251391203,0.8675349693915474,0.6520231213872832,1.0,1.0,8/40,14.34%,ST8SIA3;SMPD2;CERS2;ST3GAL5;SPTSSA;TLCD3B;SMPD4;ST6GALNAC6
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.399225722567907,0.8674911417098397,0.637956204379562,1.0,1.0,4/12,20.27%,SFRP1;HDAC1;NCOR2;DAB2
prerank,carnitine shuttle (GO:0006853),-0.3390552430016291,-0.8669734731692357,0.5967213114754099,0.8988243750011959,1.0,4/11,14.02%,ACACA;PRKAB2;ACACB;PRKAA2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.25813709724313116,-0.8668463686267142,0.616580310880829,0.8976371412748846,1.0,11/25,30.30%,CNNM2;CAV1;TMTC2;FAM20A;TRPM7;SELENON;CNNM4;PRKN;WFS1;SLC8A1;JPH2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.34433103894518235,-0.8667371710755584,0.6190476190476191,0.8949609271519149,1.0,4/10,32.25%,MYADM;WNK1;MAPK7;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.34433103894518235,-0.8667371710755584,0.6190476190476191,0.8949609271519149,1.0,4/10,32.25%,MYADM;WNK1;MAPK7;MBP
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.38671240719571,0.8666199737089224,0.6626016260162602,1.0,1.0,5/15,20.15%,EDEM1;RAB10;ZFAND2A;SEC61G;RAB3GAP2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.4043819882760694,0.8666120786741479,0.6363636363636364,1.0,1.0,4/12,16.41%,SRM;SMS;AMD1;TRH
prerank,protein autoprocessing (GO:0016540),0.3703934862202338,0.866375717840694,0.6317934782608695,1.0,1.0,3/17,17.63%,MYRF;AFG3L2;OMA1
prerank,positive regulation of protein metabolic process (GO:0051247),0.2925267682517216,0.866240375518183,0.7340980187695516,1.0,1.0,29/110,21.64%,WNT5A;ASB5;ABCA2;FZR1;SNF8;TNFAIP3;DDB1;BARD1;VCP;APP;PRMT1;EGLN2;RNF41;ROCK2;TGFB1;NKD1;AGTR1;NSF;TIPARP;APOE;SMURF1;SORL1;SLC25A37;STX5;RANBP9;KLF4;HECW2;FOXO1;RAB7A
prerank,RNA methylation (GO:0001510),0.3062905324183275,0.8660484325665861,0.7029702970297029,1.0,1.0,9/60,12.90%,TRMT61B;TRDMT1;FBL;DIMT1;BUD23;WDR6;ZCCHC4;METTL2A;METTL2B
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3311393507946336,0.8659559720876654,0.6420927467300832,1.0,1.0,6/35,10.52%,EPHB2;LZTR1;FLCN;RIPOR2;MFN2;ARHGAP24
prerank,positive regulation of viral process (GO:0048524),0.30548470096118596,0.8656109743529118,0.6841530054644809,1.0,1.0,13/60,18.53%,TARBP2;DDX3X;POLR2B;CDK9;DDB1;PPIH;PABPC1;TBC1D20;POLR2K;VAPB;CCNT1;SRPK1;NELFA
prerank,prostanoid biosynthetic process (GO:0046457),0.3758661914492891,0.865560857972701,0.6570644718792867,1.0,1.0,1/15,0.44%,PRXL2B
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.40006999263103493,0.865485848180527,0.6292466765140325,1.0,1.0,1/11,6.74%,NOS1AP
prerank,non-motile cilium assembly (GO:1905515),0.33871646776406317,0.8654431284617125,0.6616915422885572,1.0,1.0,7/30,14.82%,BBS10;ARL13B;PIBF1;TTC8;DISC1;CSNK1D;TMEM216
prerank,defense response to protozoan (GO:0042832),0.39154238997489765,0.8653158754377271,0.6154970760233918,1.0,1.0,4/12,23.73%,GBP7;GBP6;GBP4;LYST
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.40699233859801387,0.8651660984882905,0.6305916305916306,1.0,1.0,2/11,7.92%,SYNJ2;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.40699233859801387,0.8651660984882905,0.6305916305916306,1.0,1.0,2/11,7.92%,SYNJ2;INPP5A
prerank,cell junction maintenance (GO:0034331),0.38191130711582405,0.8651637306036095,0.6429567642956764,1.0,1.0,2/14,14.38%,CHCHD10;NLGN2
prerank,organelle assembly (GO:0070925),0.28054568577039357,0.8651160329610458,0.853,1.0,1.0,76/384,17.36%,TMEM138;HDAC3;B9D2;UBQLN1;CENPT;CCDC61;CPLANE2;MVB12A;STK36;UBXN2A;IFT52;DCDC2;MAPRE3;ACTR2;KIF3A;ARL13B;WIPI1;ATAT1;DDX3X;SNF8;CLUAP1;ATP2A2;TCTN1;BBS7;INPP5E;ATG14;SNX10;HGS;CDC14B;CCDC28B;PIBF1;ATG2A;CFAP54;AUP1;VTA1;TTC8;CHMP3;DBNL;CEP126;CC2D2A;ATG13;IFT80;ATXN2L;YTHDF3;CYS1;VPS4B;NPM1;CFAP20;RCC1;CPLANE1;IFT20;YTHDF1;CENPC;PDE6D;DISC1;HAUS3;CSNK1D;MAPT;ATG3;MAP1LC3B;ATP6V1D;VMP1;TMEM216;RFX3;OFD1;RAB8A;RAB8B;FARP2;AHI1;CDS1;TMOD2;TNKS;PIK3C3;TUBGCP2;STAM2;DHX29
prerank,response to chemokine (GO:1990868),0.3919697242164609,0.8650062573586553,0.6524216524216524,1.0,1.0,3/13,8.61%,CXCL12;RIPOR2;DOCK8
prerank,protein K48-linked ubiquitination (GO:0070936),0.3129834244046011,0.8647858442866025,0.7084257206208425,1.0,1.0,14/54,17.56%,RNF8;UBE2E2;SYVN1;TNFAIP3;FBXO38;RFFL;RNF152;UBE2A;UBE2E1;UBE2D1;ARIH2;UBR5;TOPORS;TTC3
prerank,protein localization to membrane (GO:0072657),0.28319089672097014,0.8647289410047244,0.7831325301204819,1.0,1.0,60/187,23.66%,TMEM150A;LRRC4;PRAM1;PICK1;ANK1;RAB34;SCRIB;DLG3;THY1;SEC16A;DVL1;RAP2A;HGS;RAB12;ZDHHC3;PTCH1;RAB10;ARL5B;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;MAGI2;RAB13;EMP2;ROCK2;NLGN2;DPP10;EPB41L3;AP4M1;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;DLG2;PACS1;SMURF1;ZDHHC2;SYNJ2BP;PIP5K1A;FLOT1;RABEP1;EHD1;SPTBN4;FGF13;CLASP2;NPC1;EHD3;RAB11B;WNK3;NUP155;AGRN;RAB40B;SH3PXD2B;SH3GLB1;NUP54
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2934942168501289,0.8646874852439178,0.7060702875399361,1.0,1.0,24/93,22.51%,SFRP2;ARAF;NTF3;HSP90AA1;GPD1L;DMTN;CNKSR3;APP;CNOT9;PARK7;DOCK7;RACK1;TGFB1;SPRY2;NSD1;PRKD2;RASSF2;TERF2IP;SMAD7;SPTBN4;ATP2B4;PPM1F;PFN2;PAK1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.35803453212014863,0.8644324289535023,0.6526717557251909,1.0,1.0,5/22,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,T-helper cell differentiation (GO:0042093),0.3846490833838932,0.8639397169607675,0.6522346368715084,1.0,1.0,1/14,1.14%,PTGER4
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.36402841471644704,0.8638174828934445,0.643048128342246,1.0,1.0,5/18,19.73%,BCS1L;COX17;COA8;COX16;OXA1L
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2838236647987619,0.8636682254771797,0.7921686746987951,1.0,1.0,28/190,12.69%,RNF157;PPIF;TSC2;GPD1L;THEM4;TBC1D7;RORA;DDX3X;TNFAIP3;OTUD7A;ITPR1;PPM1B;FLCN;RFFL;IFI35;CIT;DDIT3;USP10;PER1;ABCA7;TWIST1;PIK3CB;PIK3R2;BCL2;RTKN2;MAGI2;DAG1;RACK1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3790391933595525,0.8636440416421377,0.6400560224089635,1.0,1.0,2/14,9.38%,CLN3;ABCA7
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3281166367562489,0.8634000166389526,0.666270783847981,1.0,1.0,13/37,20.74%,IFT52;KIF3A;CLUAP1;KIF3C;TRIP11;IFT80;IFT20;TTC21B;TNPO1;WDR35;KIFAP3;DYNLL1;DYNC2H1
prerank,membrane repolarization (GO:0086009),-0.3084578995335928,-0.8631306494861659,0.6654676258992805,0.9014584336425613,1.0,4/15,12.54%,ATP1B3;ATP1A1;KCNJ2;ATP1B1
prerank,positive regulation of synapse assembly (GO:0051965),0.3472696969057789,0.8630988273039468,0.6768060836501901,1.0,1.0,9/27,22.99%,EPHB2;CLSTN2;IL1RAPL1;NLGN3;NLGN2;IL1RAP;CLSTN3;DLG5;AGRN
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.29350388513256165,0.8628587899272618,0.7353556485355649,1.0,1.0,23/100,17.57%,SIRT2;ARAF;STUB1;USP7;ZYG11B;OGT;COP1;BBS7;DVL1;SDCBP;VCP;PARK7;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;MDM2
prerank,vasoconstriction (GO:0042310),0.40864245597042703,0.8627272629998226,0.6257142857142857,1.0,1.0,1/11,2.70%,EDN3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.28799199375424955,0.8626508101307219,0.757606490872211,1.0,1.0,26/138,15.24%,HDAC3;TEAD3;TAF9B;NR1D2;RORA;TAF4;POLR2B;CDK9;TBP;GTF2A2;TEAD1;HDAC5;NRBF2;GTF2H3;TAF6;RBPJ;MAZ;E2F3;POLR2K;CCNH;HDAC1;NRBP1;ESRRG;GTF2E1;NR2C2;MED23
prerank,regulation of neurotransmitter transport (GO:0051588),0.3656754601584899,0.8626263659520476,0.6486486486486487,1.0,1.0,5/16,18.68%,CPLX1;MCTP2;FMR1;MCTP1;FLOT1
prerank,regulation of endothelial cell migration (GO:0010594),0.29560221148595095,0.8624977153553526,0.7204641350210971,1.0,1.0,23/85,21.29%,WNT5A;GPLD1;RAC1;NR2F2;NRP1;PRKCA;DCN;ABL1;SPARC;GLUL;EGF;PIK3CB;EMP2;ROCK2;FOXC2;ITGB1BP1;APOE;PRKD2;SYNJ2BP;KRIT1;PDCD6;PTK2B;FGF2
prerank,response to iron ion (GO:0010039),0.39707725010374545,0.8624541969617848,0.6409883720930233,1.0,1.0,4/12,22.07%,BMP6;BCL2;SLC11A2;B2M
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.30173011755955015,-0.8619028212520025,0.6704119850187266,0.902654251912036,1.0,3/15,10.40%,ERN1;TSEN2;CSTF2
prerank,heart looping (GO:0001947),-0.21978904107703778,-0.861416925782307,0.8029197080291971,0.9022778050394774,1.0,11/39,22.64%,MEF2C;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;CCDC39;SOX17;MICAL2;TBX2
prerank,neutrophil migration (GO:1990266),-0.21144335264654074,-0.8613172796249049,0.75,0.9010449479338184,1.0,5/58,6.44%,GBF1;PECAM1;BSG;CCL15;TGFB2
prerank,regulation of DNA recombination (GO:0000018),-0.24481470960203666,-0.8613066741256361,0.7443181818181818,0.899602927858911,1.0,11/32,26.22%,SETD2;SHLD2;SPIDR;ZRANB3;MSH2;BLM;SMARCAD1;RTEL1;PPP4R2;MSH6;H1-0
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3320870211856396,0.8607313520173883,0.6674727932285369,1.0,1.0,1/29,1.78%,SIRT7
prerank,regulation of astrocyte differentiation (GO:0048710),0.39655823890083775,0.860636364962231,0.6453900709219859,1.0,1.0,1/12,2.40%,BIN1
prerank,neurotrophin signaling pathway (GO:0038179),0.3596287254037083,0.8605183213361837,0.6657929226736566,1.0,1.0,4/21,11.88%,NTF3;FRS2;RAPGEF1;MAGI2
prerank,GTP metabolic process (GO:0046039),0.37526319272917935,0.8603508680485232,0.6359832635983264,1.0,1.0,4/15,13.69%,ENTPD7;MFN1;AK4;AK3
prerank,dephosphorylation (GO:0016311),0.28668437245750905,0.860229984357353,0.7668024439918534,1.0,1.0,32/147,18.51%,DUSP28;DUSP18;DUSP26;PPM1B;STK11;CDC14B;PLPPR2;SSH1;PPP2R5E;PPP1CC;PPM1H;PTPN5;PTPRF;PTPN3;HDHD2;PLPP3;PTPN22;PLPPR5;EPHX2;PPM1E;PPP2R5D;CTDSP2;PPP5C;PPM1M;PLPP4;PTPN12;PLPP5;MTMR4;PPP2CB;PPP2R5A;PTPRE;TAB1
prerank,mitochondrial translational termination (GO:0070126),0.29548333315141445,0.8601566747085836,0.7291886195995785,1.0,1.0,24/88,22.86%,MRPL36;MTRF1L;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS28;MRPS35
prerank,positive regulation of calcium ion transport (GO:0051928),0.33066633935083456,0.8599396855636006,0.6768867924528302,1.0,1.0,4/36,8.98%,GRIN1;CXCL12;ATP2B1;CRACR2A
prerank,mismatch repair (GO:0006298),0.3363875196080189,0.859869183844843,0.6543665436654367,1.0,1.0,5/27,13.72%,LIG1;MLH1;ABL1;PMS2;POLD3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3020781214199961,0.8593237309628369,0.7089305402425579,1.0,1.0,10/57,16.59%,ADCY7;OPRK1;GPR37;GABBR1;CHRM2;LPAR1;PSAP;AKAP12;ADCY1;ADCY5
prerank,toll-like receptor signaling pathway (GO:0002224),-0.19204451470772238,-0.8590489680134321,0.8627450980392157,0.902964820517603,1.0,13/84,10.78%,IKBKB;IRAK2;RIPK1;LBP;IRAK1;HSP90B1;UNC93B1;TLR4;LGALS9;CTSL;PLCG2;UBB;IKBKG
prerank,regulation of defense response to virus by host (GO:0050691),0.33196880664774187,0.8589418455815986,0.6612903225806451,1.0,1.0,3/30,4.85%,TARBP2;HSP90AA1;TNFAIP3
prerank,DNA metabolic process (GO:0006259),0.2793166233114198,0.8589088003127018,0.8298298298298298,1.0,1.0,62/270,21.07%,WDHD1;XRCC2;LIG1;SIRT7;DNASE1L2;HMGB3;PARP1;NTHL1;USP7;MPG;PARP2;MGMT;TCF7L2;ASF1A;CNBP;DDB1;BARD1;TDP1;DFFB;SMARCB1;LIG3;FANCG;ORC6;XRCC6;UBE2V2;VCP;GTF2H3;POLH;TOP1;ZNF445;ENDOV;USP3;ALKBH3;BACH1;PARK7;NPM1;AXIN2;UBE2A;ATR;MMS19;POLD3;HELB;FANCA;MRE11;RAD50;TERF1;TOP3B;NABP2;PWWP3A;TOP3A;RAD21;RBBP8;TERF2IP;RECQL5;ALKBH1;KMT5B;INO80;FANCL;UVRAG;RAD18;TOP2B;EXD2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2782471208646589,0.858492973525233,0.8908908908908909,1.0,1.0,61/476,12.36%,PSRC1;ILF3;WNT5A;WBP2;SFRP1;IGF1;MED24;FOXM1;ZBTB48;MYRF;NFKB1;SMARCD3;NR2F2;MAPRE3;MED12;SMARCC2;MED14;GLIS2;NR1D2;RORA;KMT2B;BRPF1;SNX5;CHD8;IL31RA;SNAI1;NPAT;TCF4;CNBP;BRD4;IRF1;MED13;ZIC3;CASZ1;TRIM56;ANKRD49;ZNF711;TEAD1;TGFB1I1;RAI1;MED4;WNT4;SOX9;DDIT3;XRCC6;YWHAH;HNRNPD;ARID1B;EGF;ATMIN;HDAC4;SOX11;CALCOCO1;PSMC5;NSD3;MAZ;SMARCA1;ZMIZ1;NPM1;TADA3;HDAC1
prerank,Fc receptor signaling pathway (GO:0038093),0.2886259247592597,0.8584878844261992,0.7425025853154085,1.0,1.0,35/110,24.49%,MAPK9;PSMD4;PDPK1;NFKB1;RAC1;PIK3R1;PSMB10;PSMD11;TEC;VAV2;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;PSMD1;MAP3K1;PSMD6;TAB1;CALM1;PSMD5;LYN;TAB3;PSMA4;NFATC3;PSMA1;PSMC6;PAK1;MAP2K7;PSMA5;SOS1;PPP3CB;VAV3;PSMD14;TRAF6
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.33926251092888166,-0.8583360767169407,0.6137724550898204,0.9031533861420906,1.0,4/11,25.97%,TWSG1;LGALS9;VSIR;CD274
prerank,zinc ion transmembrane transport (GO:0071577),0.3480833691226778,0.8583155849398151,0.6683804627249358,1.0,1.0,6/22,16.89%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,Ras protein signal transduction (GO:0007265),0.28733038981511966,0.8580464828193349,0.7675840978593272,1.0,1.0,32/137,19.09%,CDC42EP5;IGF1;CDC42EP4;CTNNAL1;RAC1;SGSM3;BRAP;RASGRP2;RAP2A;RHOD;KPNB1;CYFIP1;RAPGEF1;RIPOR1;DBNL;ADGRG1;RTKN;GPSM2;COL1A2;PARK7;PLEKHG5;WASF1;ARHGAP29;ROCK2;FARP2;EPS8L1;AGTR1;RIT2;MRAS;RRAS2;USP50;KSR1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.34695047413405833,-0.8579661992404768,0.625,0.9025175411148884,1.0,5/10,32.06%,MTMR3;MTMR9;MFSD2A;MTMR2;PHB2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.36759282239202823,0.8579645867832671,0.6385542168674698,1.0,1.0,2/17,4.62%,NTHL1;MPG
prerank,regulation of rRNA processing (GO:2000232),0.3698308112229014,0.8578537614540326,0.6426630434782609,1.0,1.0,3/16,8.48%,SIRT7;DIMT1;BUD23
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3329497009100808,0.8577723397458885,0.6600985221674877,1.0,1.0,9/31,22.02%,DNLZ;TOMM20;PEX1;PEX5;PEX7;HSPD1;TIMM44;TIMM23;PEX2
prerank,protein monoubiquitination (GO:0006513),-0.2283562666027933,-0.8577427316294437,0.7533333333333333,0.9014831054759279,1.0,11/36,19.24%,WAC;RBX1;TRIM25;UBE2O;PAF1;UBE3D;UBE2D3;DTX3L;HUWE1;UBE2R2;LEO1
prerank,activation of phospholipase C activity (GO:0007202),-0.24380051989726753,-0.857716769353281,0.6972972972972973,0.9000784395306494,1.0,15/29,42.21%,EGFR;EDNRA;PLCG1;ADRA1A;P2RY12;HTR2A;BDNF;CD86;PHB2;P2RY6;LPAR2;HTR2B;ANG;TXK;RASGRP4
prerank,positive regulation of histone acetylation (GO:0035066),0.3475848178033095,0.8573628449691729,0.6770963704630788,1.0,1.0,3/23,8.07%,WBP2;SMARCB1;ARRB1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3797357128054747,0.857192096032878,0.6557142857142857,1.0,1.0,3/15,9.95%,ZFP36L1;DHX36;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3797357128054747,0.857192096032878,0.6557142857142857,1.0,1.0,3/15,9.95%,ZFP36L1;DHX36;PABPC1
prerank,prostanoid metabolic process (GO:0006692),-0.3242955727496133,-0.8569222975332084,0.6397306397306397,0.9003232166745633,1.0,5/13,25.94%,PTGES;PLAA;GSTM1;HPGDS;HPGD
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.29026851009060234,0.856507667644768,0.7252631578947368,1.0,1.0,22/88,22.12%,BAX;WARS1;SNF8;TIRAP;PRKCA;SLF2;HGS;SDCBP;VCP;PARK7;VPS4B;RACK1;NRG1;TGFB1;FAF1;TPPP;FLOT1;RPS3;TPR;RAB7A;PFN2;SMAD3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.38578899481789464,0.8558824835869113,0.6517857142857143,1.0,1.0,2/12,10.19%,SOX9;GDNF
prerank,positive regulation of blood coagulation (GO:0030194),0.36656813396776533,0.8557529330452128,0.6675712347354138,1.0,1.0,4/17,16.49%,USF1;DMTN;F3;SERPINE1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.26880704023191726,-0.8557395261076288,0.6511627906976745,0.9013628756437856,1.0,9/23,23.36%,DAB2IP;DVL3;MAP3K10;ARHGEF5;TNFRSF11A;MAP3K4;TAOK3;MAP3K5;SASH1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.29005455805226976,0.8555959779470372,0.7305699481865285,1.0,1.0,23/94,20.07%,CCP110;B9D2;HSP90AA1;ALMS1;TCTN1;CEP97;TUBA1A;YWHAG;CC2D2A;HAUS3;CSNK1D;TUBB;TMEM216;OFD1;AHI1;CEP76;IQCB1;TUBB4A;NPHP1;ODF2;DYNLL1;PAFAH1B1;TMEM67
prerank,lytic vacuole organization (GO:0080171),0.328053108935744,0.855318852423406,0.6718938480096501,1.0,1.0,6/32,16.00%,CLN3;CLN6;MBTPS1;HOOK3;ARSB;VPS18
prerank,response to steroid hormone (GO:0048545),0.32866210934742934,0.8551798789140981,0.6831922611850061,1.0,1.0,8/31,16.82%,WBP2;ATP1A3;ABCA2;CATSPER3;ATP1A2;TFPI;TGFB1;UBE2L3
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.33001989511574387,0.8549348331713335,0.6884236453201971,1.0,1.0,7/29,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;CXCL17;HMGB1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.34618758411305894,0.8548726625373302,0.6764314247669774,1.0,1.0,5/23,19.11%,ELOVL1;FAR2;ACSL6;FAR1;ELOVL6
prerank,ncRNA export from nucleus (GO:0097064),-0.2373340399243162,-0.8548387515374231,0.7350993377483444,0.9018888924008664,1.0,13/36,17.56%,NUP160;XPOT;NUP205;PHAX;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.28888509164833853,0.8547658836693756,0.7393561786085151,1.0,1.0,21/104,19.09%,CDKN2D;INCENP;CALM3;DDX3X;SNF8;ABL1;THY1;EZH2;HGS;CDC25A;CDK5RAP3;CCNH;PARP16;HTT;MAP2K2;CCNT1;SLC27A1;CDK7;BCCIP;CALM1;KSR1
prerank,plasma membrane tubulation (GO:0097320),0.3916288636189955,0.8547270889858654,0.6705539358600583,1.0,1.0,3/13,11.60%,WHAMM;PACSIN3;SNX33
prerank,receptor metabolic process (GO:0043112),0.3033030979783837,0.8546310884238767,0.7141255605381166,1.0,1.0,16/53,23.41%,MVB12A;DNM1;ADM;GRK3;LRP1;TGFB1;GRK2;RAB31;SMURF1;PIK3R4;UVRAG;ITGB1;CD9;EHD3;RAB11B;SH3GLB1
prerank,cellular response to nitrogen compound (GO:1901699),-0.2809017666070419,-0.8539914930226805,0.6363636363636364,0.9022416434505351,1.0,6/20,16.92%,RIOK3;SPIDR;DDI2;HSF1;RTF2;BLM
prerank,translational termination (GO:0006415),0.29019766493472554,0.8536061959260525,0.7492130115424974,1.0,1.0,26/95,22.86%,MRPL36;MTRF1L;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;GSPT1;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;ABCE1;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS28;MRPS35
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.23147718552761967,-0.8534333309639287,0.7205882352941176,0.9020146735469909,1.0,14/39,23.62%,ANGPT1;PDCD4;TEK;THBS1;ANO6;RAMP2;KDR;PLCG1;SCG2;ITGA4;RGCC;NFE2L2;GATA2;SEMA5A
prerank,epithelial cell development (GO:0002064),0.35087796453008213,0.8532267458337605,0.6707482993197279,1.0,1.0,1/20,1.42%,DACT2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3889147815980074,0.8530129739175517,0.6512968299711815,1.0,1.0,1/13,0.91%,CLN3
prerank,regulation of macrophage migration (GO:1905521),-0.3493545810569926,-0.8528334584589237,0.6264367816091954,0.9018372949520896,1.0,5/10,23.73%,MTUS1;P2RY12;EMILIN1;CD81;CX3CR1
prerank,negative regulation of developmental growth (GO:0048640),0.3332788119394337,0.8524237466951561,0.6707317073170732,1.0,1.0,10/30,23.89%,DIP2B;PTCH1;SLC6A4;NKD1;DCC;WWC1;PTPRS;FGF13;MAP2;PTEN
prerank,transcription preinitiation complex assembly (GO:0070897),0.39248960672023436,0.8523173192824784,0.6675977653631285,1.0,1.0,5/12,22.48%,TBP;GTF2A2;TAF1B;TAF1;GTF2B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.24876541175897426,-0.8522986311898291,0.7317073170731707,0.9015071477250302,1.0,5/27,9.60%,CTNNA3;CAV1;CACNA1C;AKAP9;SRI
prerank,response to organonitrogen compound (GO:0010243),0.3229484539432925,0.8521601377456883,0.6840277777777778,1.0,1.0,7/38,16.38%,SYVN1;ERLEC1;BRSK2;RCN3;VCP;GLRA1;DERL1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3165833254187931,-0.8519386417585836,0.6666666666666666,0.9008457764498995,1.0,5/13,14.40%,RHOT1;HIF1A;LRPPRC;UBB;MAP1S
prerank,glucose import (GO:0046323),0.3867842660768228,0.8517671087007844,0.6766712141882674,1.0,1.0,3/13,16.50%,SLC27A4;SLC2A3;SLC27A1
prerank,acylglycerol catabolic process (GO:0046464),0.33067726714517437,0.8517536709251566,0.686060606060606,1.0,1.0,1/30,0.96%,LPL
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.32549714491419224,0.851302245025462,0.6761083743842364,1.0,1.0,7/31,18.56%,FGFR2;SOX11;TWIST1;PDGFRA;MEGF8;OSR1;TGFBR1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.33849353541826555,-0.8510685144949709,0.6534954407294833,0.9012078031875135,1.0,8/11,53.92%,PLCG2;P2RX4;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.3004378665302039,-0.8509749924834854,0.6655290102389079,0.8999316530195787,1.0,2/15,7.95%,LRP6;ANKRD11
prerank,protein prenylation (GO:0018342),-0.33891481183128774,-0.8507764810317053,0.6618075801749271,0.8989140622053718,1.0,4/10,27.26%,FNTA;RABGGTB;CHM;CHML
prerank,fatty acid transmembrane transport (GO:1902001),-0.27535462189064913,-0.8507665449456271,0.7017543859649122,0.8975124736481324,1.0,5/19,14.02%,SLC2A1;ACACA;PRKAB2;ACACB;PRKAA2
prerank,fat cell differentiation (GO:0045444),-0.20352449868745906,-0.8501500347908723,0.8113207547169812,0.897371783797996,1.0,25/57,30.53%,MED1;BBS9;SIRT1;ERAP1;SENP2;EP300;BBS2;BBS4;TMEM120B;PRDM16;ATF5;BSCL2;CTBP2;TMEM120A;C1QTNF3;PPARG;PPARGC1A;NR4A1;NR4A2;METRNL;HMGA2;CBY1;MAFB;TRIM32;MKKS
prerank,peroxisome organization (GO:0007031),0.3393334818037617,0.8497358602491357,0.675,1.0,1.0,6/25,15.47%,FIS1;SEC16B;PEX1;PEX7;DNM1L;ABCD2
prerank,regulation of dephosphorylation (GO:0035303),-0.30249246264945473,-0.8497092068216279,0.6984126984126984,0.8968627732898682,1.0,6/15,17.46%,MTMR3;SMG5;INPP5K;MTMR9;SRC;SMG6
prerank,inner dynein arm assembly (GO:0036159),-0.3439373286815298,-0.8492090708087839,0.6512345679012346,0.8964998866860326,1.0,2/10,18.77%,DNAAF5;CCDC39
prerank,regulation of primary metabolic process (GO:0080090),0.2808665777453838,0.8491268537268744,0.7584789311408017,1.0,1.0,39/126,24.05%,FASN;HDAC3;PSMD4;SMARCD3;NR1D2;CHD9;PSMB10;CERS2;LSS;PSMD11;ABCA7;GPAM;SC5D;PSME2;IRS2;PSMC5;CYP51A1;PSAP;ROCK2;PSMD1;PSMD6;APOE;TBL1XR1;GPS2;NCOR2;ELOVL6;PSMD5;CARM1;GGPS1;PSMA4;PSMA1;PSMC6;ID2;NCOA1;SP1;PSMA5;RXRA;TGS1;NFYA
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3554441639294465,0.8488401761031493,0.6799485861182519,1.0,1.0,5/19,21.02%,EDN3;INPP5A;NFAT5;HRH1;NFATC3
prerank,phospholipid catabolic process (GO:0009395),0.3403754163323433,0.848625979282718,0.684010152284264,1.0,1.0,6/24,19.12%,PRDX6;GDPD3;ENPP2;SMPD4;GDE1;SMPD1
prerank,neuron differentiation (GO:0030182),0.28087620289444687,0.8485925803024631,0.7977642276422764,1.0,1.0,16/165,12.79%,WNT2B;WNT5A;XBP1;FZD3;CDK5;TENM3;BRSK2;WNT4;SPOCK1;NRBP2;SOX11;BRSK1;SMARCA1;IL1RAPL1;TDP2;MYEF2
prerank,lipid translocation (GO:0034204),0.3477172244155343,0.8485357244052928,0.6790945406125166,1.0,1.0,5/21,10.47%,ATP9A;ATP8B2;ATP10B;ABCA7;ATP9B
prerank,early endosome to late endosome transport (GO:0045022),0.3553354470910813,0.84824295738823,0.6715425531914894,1.0,1.0,6/20,16.63%,SNF8;HOOK3;WDR91;EMP2;STX8;PIK3C3
prerank,protein hydroxylation (GO:0018126),-0.2974742701392611,-0.8482393613150674,0.6703296703296703,0.8971739623435357,1.0,9/15,25.43%,OGFOD1;VIPAS39;P3H3;ASPH;EGLN3;PLOD2;P3H1;PLOD3;HIF1AN
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3052942728127965,-0.8482200616395996,0.674074074074074,0.8943923278864163,1.0,6/15,22.86%,AP3D1;AP3S2;DTNBP1;AP3M2;BLOC1S5;SNAPIN
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3052942728127965,-0.8482200616395996,0.674074074074074,0.8943923278864163,1.0,6/15,22.86%,AP3D1;AP3S2;DTNBP1;AP3M2;BLOC1S5;SNAPIN
prerank,glucose homeostasis (GO:0042593),0.2910274982105721,0.8478677871166215,0.7184873949579832,1.0,1.0,11/83,12.44%,HKDC1;LRRC8A;USF1;TCF7L2;PIK3R1;STK11;SELENOT;PIK3R2;LEPR;PARK7;HECTD4
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2338302536294426,-0.8476759233685199,0.7409638554216867,0.8941603881743401,1.0,19/36,35.73%,CEP63;USP28;TIPIN;DOT1L;NBN;HINFP;ATRIP;ERCC6;RAD9B;HUS1;PRPF19;RHNO1;CLSPN;RAD1;DONSON;SETMAR;DNA2;TIMELESS;E2F1
prerank,neuron development (GO:0048666),0.28375605266928616,0.8476182064631,0.7900608519269777,1.0,1.0,38/141,22.15%,STMN4;GBA2;GPRIN1;XBP1;CDK5;TENM3;EPHA8;TMEM108;PPP1R9B;GDNF;APP;LRP12;BLOC1S2;BICDL1;DOCK7;TDP2;B4GALT5;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;CNTNAP2;TENM4;TBCD;EPHA5;APOE;MAP4;ATCAY;ATP8A2;ATXN10;DCX;LYN;EHD1;NTRK2;RYK;HMGB1;CAMSAP1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.414631325354296,0.8474799943422752,0.68,1.0,1.0,1/10,1.15%,NPTXR
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.35322839896770464,0.8474282213681616,0.665785997357992,1.0,1.0,4/19,15.76%,DCK;HPRT1;POLD3;GMPR2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3478825004432388,0.8474270948127453,0.6734955185659411,1.0,1.0,6/20,20.58%,ZFP36L1;HOXB8;PRMT1;CDC73;MEIS2;PTK2B
prerank,peptidyl-lysine methylation (GO:0018022),0.33374586831983727,0.8469997621839294,0.6620253164556962,1.0,1.0,6/26,15.49%,ETFBKMT;SETD7;EHMT2;SUV39H1;EHMT1;ATPSCKMT
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.288079344424301,0.8469505314358042,0.7658688865764828,1.0,1.0,26/104,22.12%,ADAMTSL2;PDPK1;STUB1;SMAD9;PMEPA1;SNX6;HTRA3;TGFB1I1;LEMD3;MAGI2;PEG10;TGFB1;SMAD6;VASN;UBE2D1;MTMR4;SPRY2;SMURF1;SORL1;TGFBR1;PPM1A;NBL1;ACVR2A;SMAD7;SMAD2;SMAD3
prerank,apoptotic process (GO:0006915),0.27794239017389455,0.8468672116597693,0.8413654618473896,1.0,1.0,39/203,18.33%,BAX;YARS1;TSC2;PARP1;DMPK;BNIP1;AIFM2;CASP7;OGT;CDK5;FAM162A;IRF1;STK11;CXCR4;TCHP;CIT;DPF2;CASP9;APP;BCL2;BNIP2;IRF3;RNF152;TNFRSF25;KREMEN1;VDAC1;DAPK1;BCLAF1;THOC1;MAGI3;PAWR;CASP2;HSPD1;ARHGEF6;AHCYL1;MDM2;DCC;ATN1;ATCAY
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2890801963941655,-0.846180881624482,0.6528301886792452,0.8958291126821069,1.0,4/17,8.99%,WASF2;GMFB;BRK1;ABI2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.294348632875955,0.8455324229718182,0.73068669527897,1.0,1.0,11/73,10.02%,WBP2;AEBP2;CREBZF;RBBP4;SF3B1;TBP;PHF1;EZH2;HDAC5;HDAC4;JARID2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3486397047947142,0.8455241824623895,0.6924083769633508,1.0,1.0,7/22,18.96%,CALM3;DDX3X;RAP2A;MRE11;RAD50;RASSF2;CALM1
prerank,inner mitochondrial membrane organization (GO:0007007),0.30520742672439916,0.8454238423083938,0.702914798206278,1.0,1.0,9/47,13.79%,APOOL;MICOS10;ATP5PF;TIMM13;APOO;ATP5MC3;AFG3L2;TIMM29;MTX3
prerank,regulation of fibrinolysis (GO:0051917),0.3852332998204575,0.8452516735521179,0.6680790960451978,1.0,1.0,1/13,2.95%,USF1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.30409402249345857,-0.8446150014859677,0.7072368421052632,0.8976289809930724,1.0,2/14,2.31%,SPRED1;CAV1
prerank,regulation of cellular component movement (GO:0051270),0.3060632015551455,0.8443413325508895,0.7243367935409458,1.0,1.0,19/49,22.50%,ZSWIM6;ABL1;MYCBP2;EGF;PRAG1;ARAP1;NRG2;YTHDF1;NRG1;ROCK2;ZSWIM8;TGFBR1;LYN;TGFBR3;IGBP1;DIAPH1;CD9;ERBB4;PKN1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.327609716484053,0.8442165766412392,0.6948941469489415,1.0,1.0,5/27,15.53%,THY1;SIRPA;NFAT5;CD47;HSPD1
prerank,histone H3-K4 trimethylation (GO:0080182),0.3918331712988817,0.8440618875174144,0.6647058823529411,1.0,1.0,4/11,18.37%,OGT;SETD1A;KMT2D;KMT2A
prerank,intracellular pH reduction (GO:0051452),0.31837074654314446,0.8438566162205771,0.7016706443914081,1.0,1.0,7/33,16.35%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.2380493166174878,-0.8438406660373197,0.7228260869565217,0.897760656325495,1.0,6/30,10.78%,IKBKB;RIPK1;TLR4;IKBKE;UBB;IKBKG
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.330434642985948,-0.843722798622464,0.640625,0.8965819321367863,1.0,4/11,31.79%,PTPRC;AHR;CEACAM1;HFE
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3326722826496067,-0.8433923229632574,0.6566666666666666,0.8958716933446522,1.0,3/11,7.14%,MEF2C;SIRT1;LGALS9
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28817331760403897,0.8430278373120844,0.7465535524920467,1.0,1.0,15/84,15.42%,WNT5A;GPLD1;PDPK1;RAC1;FGFR1;NRP1;PRKCA;ABL1;SPARC;EGF;PIK3CB;PLPP3;ROCK2;TGFB1;FOXC2
prerank,protein stabilization (GO:0050821),0.2801309997491468,0.8429947929020286,0.8109201213346815,1.0,1.0,37/168,19.15%,DNLZ;IGF1;CCT8;HSP90AA1;TAF9B;SYVN1;USP7;NCLN;NAPG;PIK3R1;BAG1;SEC16A;DVL1;CCT6A;GET1;MDM4;PPIB;USP2;USP19;PARK7;CRTAP;CCNH;PLPP3;USP9X;COG3;ZBED3;COA8;HSPD1;CHEK2;RAB21;CDK7;USP33;GNAQ;RASSF2;BAG4;FLOT1;SOX4
prerank,regulation of protein modification process (GO:0031399),0.3028069165209258,0.8428795491688764,0.7158836689038032,1.0,1.0,8/50,9.42%,KDM4D;WARS1;ABCA2;CDK9;FLCN;ATG14;PPIB;PUM3
prerank,monocyte differentiation (GO:0030224),-0.34606263677969334,-0.8427942855837206,0.6723646723646723,0.8957141452877551,1.0,6/10,22.05%,PIR;MT1G;THOC5;BMP4;VEGFA;PPARG
prerank,negative regulation of neuron projection development (GO:0010977),0.30403059237284635,0.8419563685659569,0.7303867403314918,1.0,1.0,19/56,23.90%,THY1;EFNB3;MCF2;SPOCK1;EFNB2;PRAG1;DENND5A;LPAR1;SEMA3A;APOE;RUFY3;DCC;ITM2C;PTPRS;EPHA4;DPYSL3;LRP4;PTEN;MYLIP
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.38366509375101365,0.8419549895839248,0.6624472573839663,1.0,1.0,2/12,7.68%,EPHB2;MYCBP2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2950421010587246,0.8417431051030405,0.7261774370208105,1.0,1.0,10/58,10.65%,RNF8;PAXX;BARD1;LIG3;IFFO1;RNF168;XRCC6;UBE2V2;MDC1;DCLRE1A
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.29191189198008527,-0.841483283852155,0.7031802120141343,0.8969438596480281,1.0,7/15,23.62%,PRKD1;TMSB4X;KDR;MET;HSPB1;VEGFA;SEMA5A
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3700820601316939,0.8414626861346407,0.664756446991404,1.0,1.0,6/14,23.13%,ATR;ATRX;TNKS;NABP2;TERF2IP;PINX1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4074450542623189,0.8412717879366407,0.6790490341753344,1.0,1.0,2/11,7.08%,CCT8;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4074450542623189,0.8412717879366407,0.6790490341753344,1.0,1.0,2/11,7.08%,CCT8;CCT6A
prerank,primary miRNA processing (GO:0031053),0.39797607627126047,0.8412576417860972,0.6671826625386997,1.0,1.0,5/10,22.12%,DGCR8;PUS10;HNRNPA2B1;SMAD2;SMAD3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.35647033151799484,0.8412144580880212,0.6714659685863874,1.0,1.0,2/18,4.02%,ANXA1;ZFP36L1
prerank,metal ion transport (GO:0030001),-0.19281958572685545,-0.8408689573434956,0.8409090909090909,0.8968543730302028,1.0,25/86,21.81%,CACNA1D;NIPA2;CAV1;MRS2;SLC3A2;CACNA2D1;TRPC3;TRPC1;CACNA1C;NDFIP1;SELENOK;RAMP2;NIPA1;SLC39A8;TRPC4;CHRNA7;TRPM7;TRPC5;MAGT1;FYN;PANX1;TPT1;CALCRL;CACNG8;CAMK2A
prerank,mitochondrion localization (GO:0051646),0.34999407585082765,0.8406665213240282,0.6593264248704663,1.0,1.0,6/19,18.33%,MSTO1;MFN1;MFN2;ZBED3;TRAK1;ATCAY
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4025232237007281,0.8405300977393828,0.6753048780487805,1.0,1.0,11/11,59.78%,RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;LPO;PKD1L3;PKD2L1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.30438131721515,-0.839696230800449,0.6666666666666666,0.8978964477257655,1.0,6/15,25.09%,CSGALNACT1;CSPG4;DSEL;BGN;CSPG5;CHST12
prerank,phosphorylation (GO:0016310),0.27202001281889737,0.8396163459822249,0.905,1.0,1.0,88/384,20.76%,AATK;ILF3;XYLB;MAPK9;CAMK2B;STK36;EPHA7;EPHB2;PDPK1;PDK1;COQ8B;EIF2AK3;DMPK;CDKL5;HUNK;FGFR1;TAOK1;PICK1;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;NUAK1;ABL1;PAK3;STK11;BRSK2;SIK1;GNPTG;TEC;FAM20C;NRBP2;PRAG1;WNK2;TOP1;BRSK1;PIK3CB;APP;GRK3;MAPK6;IGFBP3;STRADB;CAMK2D;TLK1;PRKCI;DAPK1;CSNK1D;NEK3;NRBP1;ROCK2;TGFB1;GRK2;CSNK1A1;ACVR1B;CHEK2;CTBP1;MAP3K1;CCNT1;TP53RK;STK25;CDK7;OXSR1;ILK;PRKD2;JAK1;NEK1;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PGK1;PRKAG2;PIK3R4;NRK;CDKL2;CDK11B;DGKI;PRKCZ;CDK14;LYN;PTK2B;MAPKAPK2;PAK5;ACVR2A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.35159235811521317,0.8393969762721601,0.6706507304116865,1.0,1.0,4/21,16.59%,ADCY7;ADCY1;NPR2;ADCY5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.358339202166695,0.8393363982222166,0.6885026737967914,1.0,1.0,4/18,15.42%,CACNG3;NLGN3;NLGN2;CACNG4
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3245575185903849,0.8390623558206843,0.6908396946564885,1.0,1.0,3/29,4.92%,IFNAR1;STAT6;IL31RA
prerank,regulation of axon regeneration (GO:0048679),-0.3161718106896988,-0.8388731124826825,0.6582278481012658,0.898233345353638,1.0,4/12,16.44%,INPP5F;GRN;SCARF1;RTN4RL1
prerank,stress-activated MAPK cascade (GO:0051403),0.29609229388269104,0.8388202541041775,0.7364425162689805,1.0,1.0,5/61,4.55%,MAPK9;PTGER4;NFKB1;ZFP36L1;MINK1
prerank,carboxylic acid transport (GO:0046942),0.29651839370575467,0.8387376499715093,0.7283813747228381,1.0,1.0,9/55,16.34%,SLC17A5;CLN3;SLC6A11;SLC16A12;PSAP;SLC6A15;SLC1A5;SLC6A12;SLC6A13
prerank,determination of bilateral symmetry (GO:0009855),0.334944537051441,0.8387163263852052,0.6624365482233503,1.0,1.0,2/24,6.59%,BBS7;ZIC3
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3428181062724709,0.8385587614706177,0.6888888888888889,1.0,1.0,3/20,14.34%,ST3GAL2;ST3GAL3;ST6GALNAC6
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.30440870611717774,0.8385079489142143,0.7382022471910112,1.0,1.0,9/52,11.37%,CSNK2A2;TFDP1;SAE1;NMT1;YWHAH;YWHAG;ATG13;BCL2;LEPROT
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4091580025642335,0.8381356089280368,0.6762048192771084,1.0,1.0,1/10,2.64%,ZEB2
prerank,glutamate receptor signaling pathway (GO:0007215),0.31393936769336034,0.8380658514189572,0.7029239766081872,1.0,1.0,12/37,24.56%,CLN3;GRIN1;GRIN2A;APP;GRIA2;FMR1;GNAQ;PTK2B;GRIA4;GRIK2;GRIN3A;GRIK1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3426632302146133,0.838051372005832,0.6745098039215687,1.0,1.0,8/22,20.31%,BARD1;DMTN;INSIG1;PARK7;SUFU;ITGB1BP1;BAG4;CABP1
prerank,chemical synaptic transmission (GO:0007268),0.27245470963260104,0.8380096505209575,0.8717434869739479,1.0,1.0,49/284,18.28%,SYT10;CACNB4;UNC13A;GRIN1;PDE7B;OPRK1;MINK1;CDK5;GRIK5;DVL1;HCRTR2;GRIN2A;SDCBP;DNAJC5;CPLX1;SCN2B;GABRB3;CACNB1;SNAP25;BRSK1;HCRTR1;RIC3;GRIA1;NLGN3;HTR2C;SYT1;RPS6KA3;CHRM2;SLC1A3;KCNA1;TBC1D24;GRIA2;NOVA1;NLGN2;GLRA1;KCNQ2;RPS6KA1;SYN2;DLGAP1;RIT2;DLG2;GPR176;APOE;HRH1;SLC1A2;SYNJ2BP;DTNA;PRKAR1A;GABRG3
prerank,cilium assembly (GO:0060271),0.2723942709628837,0.8376233679283251,0.8858858858858859,1.0,1.0,69/296,20.74%,CCP110;TMEM138;B9D2;CPLANE2;STK36;BBS10;HSP90AA1;IFT52;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;CLUAP1;ALMS1;TCTN1;BBOF1;BBS7;INPP5E;CEP97;SNX10;KIF3C;TRIP11;CDC14B;CCDC28B;TUBA1A;PIBF1;CFAP54;TTC8;YWHAG;CEP126;CC2D2A;IFT80;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;DISC1;HAUS3;CSNK1D;ATP6V1D;TUBB;TMEM216;TTC21B;RFX3;TNPO1;OFD1;RAB8A;RAB8B;AHI1;CEP76;DNAAF3;NEK1;IQCB1;TUBB4A;NPHP1;ODF2;WDR35;KIFAP3;DYNLL1;PAFAH1B1;TMEM67;DCX;LZTFL1;TMEM80;EXOC5;EHD1;DYNC2H1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.24046368227245163,-0.8374696849741883,0.7307692307692307,0.8997407109296883,1.0,6/29,10.78%,IKBKB;RIPK1;TLR4;IKBKE;UBB;IKBKG
prerank,establishment of spindle orientation (GO:0051294),0.32568266366052084,0.8370512614879154,0.6823671497584541,1.0,1.0,10/28,23.06%,MAD2L1;GPSM2;HTT;NUMA1;MAP4;ZW10;PAFAH1B1;ITGB1;LLGL1;CDK5RAP2
prerank,peptidyl-proline modification (GO:0018208),0.3323185970096728,0.8369708789543016,0.6944444444444444,1.0,1.0,5/25,9.58%,PPIF;NKTR;NTMT1;PPIB;PPIH
prerank,post-translational protein modification (GO:0043687),0.2712391738726617,0.8367515337357909,0.887,1.0,1.0,54/332,17.27%,COPS7A;CUL7;SPSB3;PSMD4;FBXW10;CP;ASB5;SPSB1;KCTD7;FBXL12;FSTL1;OBSL1;FBXL14;WSB2;FBXO7;COP1;LAMC1;UBXN7;FBXO31;PSMB10;DDB1;MIA3;UCHL3;CKAP4;FBXW5;PSMD11;LTBP1;COPS7B;FAM20C;APLP2;CUL4B;MBTPS1;PSME2;PSMC5;APP;IGFBP3;IGFBP7;DCAF5;FBN1;RAB13;LAMB1;NEURL2;CUL5;KLHL5;FEM1C;PSMD1;KLHL13;RAB8A;SERPIND1;NEDD8;PSMD6;MXRA8;APOE;FBXO22
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3035546417999631,-0.8362980771748224,0.6915254237288135,0.9007500549467751,1.0,7/14,38.98%,RARA;DENND1B;CD81;CD86;CD74;RSAD2;NOD2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32063860239172565,0.8344563751611201,0.7010550996483002,1.0,1.0,5/34,6.44%,RAC1;NRP1;ABL1;ARHGEF7;DMTN
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.2972219107125951,0.8344419917062029,0.71875,1.0,1.0,12/52,17.25%,EPHB2;PDPK1;PIK3R1;SQSTM1;CLIP3;GPSM2;PRKCI;LRP1;DPP10;SPTBN1;NUMA1;KIF5B
prerank,steroid catabolic process (GO:0006706),0.3887756347741255,0.8343163308198751,0.6681957186544343,1.0,1.0,1/10,8.88%,YWHAH
prerank,regulation of cardiac conduction (GO:1903779),0.30027423111843804,0.8338785349267913,0.7322033898305085,1.0,1.0,6/54,8.60%,DMPK;ATP1A3;ATP2A2;ITPR1;ATP1A2;ATP2B1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.29192185026304734,0.83281553708649,0.7454153182308522,1.0,1.0,11/66,14.28%,HDAC3;CCT8;EIF2AK3;PIK3R1;CCT6A;CDK5RAP3;JUP;PIK3R2;PARK7;LAMTOR5;TGFB1
prerank,snRNA metabolic process (GO:0016073),0.3566297053041957,0.8324297888323627,0.6850068775790922,1.0,1.0,8/17,24.59%,ZCCHC8;MTREX;INTS6;INTS2;RBM7;INTS7;INTS10;INTS9
prerank,ventricular septum development (GO:0003281),0.31525690074840873,0.8323678464713578,0.7263157894736842,1.0,1.0,13/37,23.03%,STRA6;MDM4;SOX11;ROBO2;ROBO1;SLIT3;HECTD1;TGFBR1;SOX4;TGFBR3;SMAD7;MATR3;DAND5
prerank,peptidyl-tyrosine modification (GO:0018212),0.2973293033302117,0.8323119632741199,0.7335562987736901,1.0,1.0,8/56,11.29%,EPHB2;FGFR2;FGFR1;DDR2;ABL1;SRMS;TEC;PDGFRA
prerank,protein phosphorylation (GO:0006468),0.2693177799844515,0.8319930679875156,0.938,1.0,1.0,109/478,20.88%,AATK;ILF3;MAPK9;CAMK2B;CAMK1G;STK36;INCENP;EPHB2;PDPK1;PDK1;COQ8B;CSNK2A2;EIF2AK3;DMPK;FGFR2;CDKL5;HUNK;FGFR1;TAOK1;HTATIP2;PICK1;DDR1;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;MAST3;DDR2;NUAK1;ABL1;SRMS;PAK3;EPHA8;STK11;BRSK2;SBK1;SIK1;CIT;TEC;FAM20C;NRBP2;PRAG1;MUSK;GTF2H3;WNK2;TOP1;BRSK1;APP;GRK3;MAPK6;IGFBP3;USP15;STRADB;PDGFRA;CAMK2D;TLK1;CCNH;ATR;RPS6KA3;TLR3;PRKCI;DAPK1;CSNK1D;NEK3;NRBP1;ROCK2;TGFB1;GRK2;CSNK1A1;ACVR1B;RPS6KA1;CHEK2;CTBP1;MAP3K1;CCNT1;CAMK1D;TP53RK;TNKS;STK25;CDK7;OXSR1;ABI1;ILK;PRKD2;JAK1;NEK1;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PRKAG2;PIK3R4;NRK;CDKL2;CDK11B;PRKCZ;CDK14;LYN;PTK2B;TGFBR3;MAPKAPK2;PAK5;ACVR2A;NTRK2;SMAD7
prerank,regulation of angiogenesis (GO:0045765),0.27221763224654427,0.831626928869512,0.8590130916414904,1.0,1.0,45/192,21.29%,SFRP2;WNT5A;SFRP1;PDPK1;THBS2;WARS1;HTATIP2;XBP1;TNFAIP3;PRKCA;SULF1;DCN;GAB1;SPARC;HGS;GLUL;TWIST1;ATF2;JUP;SARS1;ADAM12;EMP2;ROCK2;SEMA3E;F3;CTSH;HSPG2;ADGRA2;ADAMTS1;SERPINE1;SPRY2;MTDH;PRKD2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;KLF4;PDCD6;SERPINF1;ITGB1;ATP2B4;FOXJ2;FGF2
prerank,transcription by RNA polymerase II (GO:0006366),0.270982729809345,0.8308875223566703,0.8948948948948949,1.0,1.0,85/305,22.77%,HDAC3;TEAD3;RPRD2;NFKB1;SLBP;PARP1;TAF9B;NR1D2;XBP1;RORA;TFDP1;TAF4;POU2F1;POLR2B;CDK13;CDK9;TFCP2;TBP;ZBTB7B;RTF1;TRIP11;GTF2A2;TEAD1;SNAPC4;HDAC5;MED4;NFX1;NRBF2;CPSF7;PRRX1;GTF2H3;TCEA1;TAF6;RBPJ;CSTF2T;MAZ;NUDT21;E2F3;NFIX;POLR2K;CCNH;CPSF3;HDAC1;TSC22D1;SETX;CBFB;CDC73;NRBP1;ESRRG;GTF2E1;SOX5;NR2C2;MED23;DDX5;MAF;SNW1;CCNT1;MBD1;CDK7;NABP2;TBL1XR1;NELFA;NCOR2;INTS6;KLF13;FIP1L1;CSTF3;MLLT3;INTS2;PKNOX1;ELP2;GLIS3;TBPL1;CCNT2;TAF2;RPAP1;EAF1;INTS7;SNAPC3;GTF2F2;TAF1;GTF2B;MED17;BTF3;RPAP2
prerank,metanephric mesenchyme development (GO:0072075),0.3911764330703617,0.8306963576068429,0.6786833855799373,1.0,1.0,3/10,18.02%,WNT4;OSR1;PKD2
prerank,regulation of cholesterol transport (GO:0032374),0.3468577645069728,0.8302383062314453,0.6873417721518987,1.0,1.0,5/20,20.03%,NFKB1;ABCA2;LRP1;TTC39B;ABCA5
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.32376620144175533,0.8300369648058642,0.7057324840764331,1.0,1.0,7/26,19.61%,PRKCA;USP2;APP;MDM2;MEIS2;USP22;PPP1R10
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3293484365113742,0.8299546839690591,0.702075702075702,1.0,1.0,8/26,22.23%,DDX3X;TIRAP;IFI35;TLR3;PTPN22;FLOT1;HMGB1;PJA2
prerank,aminoglycan metabolic process (GO:0006022),0.40354483779285566,0.8289917217705772,0.7014925373134329,1.0,1.0,1/10,2.20%,CLN6
prerank,oxoacid metabolic process (GO:0043436),-0.24338009600219787,-0.8289340218050446,0.7292817679558011,0.9141006359861046,1.0,7/27,18.32%,DDO;BPNT2;MINPP1;THAP4;TPST2;PPA1;BPNT1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3030090465663822,0.8286252719583661,0.7284234752589183,1.0,1.0,10/48,21.79%,PDPK1;CALM3;THY1;CAMK2D;JPH1;CEMIP;CALM1;PTK2B;DIAPH1;CALM2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.20042225751378348,-0.8285261683743184,0.8556701030927835,0.9135557215421862,1.0,19/55,21.52%,PSMB7;CUL1;RBX1;SKP1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;PSMD2;PSMB3;ATF5;PSMC3;AVEN;PSMD3;PSMD8
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.18533692020741166,-0.8283768508981257,0.8870967741935484,0.9124812540968841,1.0,28/86,21.52%,PSMB7;BAG3;RBX1;HIF1A;PSMB2;PSMD7;ELOC;PSMA6;PSMC2;PSMD13;TP53;PSMF1;PSMC1;EP300;LIMD1;UBB;PSMD9;EGLN3;PSMD2;PSMB3;PSMC3;ATF4;VEGFA;ELOB;NFE2L2;PSMD3;HIGD1A;PSMD8
prerank,positive regulation of cell motility (GO:2000147),0.2707644073853477,0.8281386185296958,0.8489425981873112,1.0,1.0,31/205,15.68%,CARMIL2;IGF1;EPHB2;ELP6;FAM83H;NTF3;XBP1;CXCL12;PRKCA;SNAI1;CD151;RHOD;SDCBP;EGF;RIPOR1;SEMA3D;TWIST1;MAZ;PDGFRA;SOD2;CFAP20;RACK1;SPOCK2;ROR2;LAMB1;ROCK2;TGFB1;SEMA3E;F3;SEMA3A;CTSH
prerank,regulation of complement activation (GO:0030449),0.30657733913347784,0.8276431266931129,0.7366589327146171,1.0,1.0,2/40,5.04%,VTN;SERPING1
prerank,histone ubiquitination (GO:0016574),0.34052054790052966,0.8275760712129322,0.6924083769633508,1.0,1.0,6/21,18.64%,RNF8;RNF40;UBE2A;CDC73;UBE2E1;USP22
prerank,regulation of TORC1 signaling (GO:1903432),0.3104715970451756,0.827460295955286,0.7042424242424242,1.0,1.0,6/33,12.86%,FLCN;STK11;RRAGA;GPR137C;RNF152;LAMTOR5
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.27278201810448316,0.8273700483326236,0.8119918699186992,1.0,1.0,36/166,19.78%,IGF1;GPLD1;ZEB2;HSP90AA1;RBM3;DDX3X;ZNF205;DDB1;ARNT;NOS1AP;HNRNPD;NNMT;EGF;IRS2;PTH1R;ZCCHC4;BRPF3;YTHDF3;PARK7;NPM1;PRMT1;YTHDF1;PTGS2;PRR16;FAF1;SLC27A1;FMR1;SLC25A37;PRKD2;PKD2;ASS1;METTL5;ARPP19;SOX4;KLF4;CIRBP
prerank,negative regulation of cell cycle (GO:0045786),0.2852389865792691,0.8270132712160664,0.7494646680942184,1.0,1.0,14/73,17.73%,HEXIM1;NR2F2;MAD2L1;HECA;SCRIB;TRIM35;BRINP3;TAF6;PTPN3;IPO7;TGFB1;NUPR1;BRINP1;CAMK2N1
prerank,translesion synthesis (GO:0019985),-0.2142311886511856,-0.8268751029286551,0.8181818181818182,0.9141605184930613,1.0,29/42,42.88%,REV3L;ZBTB1;TRIM25;RPA1;UBB;REV1;PARP10;PRIMPOL;RFC2;SPRTN;PCNA;POLE2;POLK;POLI;UBE2L6;ISG15;FAAP20;RPA3;RCHY1;RFC3;MAD2L2;UBA52;USP43;POLD2;RPA2;PCLAF;RFC4;POLD4;POLD1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.32194608345759557,-0.8263111931037362,0.6934984520123839,0.9138994587520084,1.0,3/11,9.31%,SEMA6A;THBS1;EPN2
prerank,nuclear membrane reassembly (GO:0031468),0.2946859168471372,0.826300808499493,0.7278761061946902,1.0,1.0,7/54,9.85%,REEP4;SIRT2;UBXN2A;CC2D1B;KPNB1;CHMP3;NUP188
prerank,T cell differentiation in thymus (GO:0033077),0.3678334659435144,0.8261451012599632,0.6853625170998632,1.0,1.0,1/14,4.02%,ZFP36L1
prerank,mRNA methylation (GO:0080009),0.36110856966827076,0.8261200686134108,0.6797752808988764,1.0,1.0,1/15,0.77%,TRMT61B
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37472309547130206,0.8259348354417237,0.6794326241134752,1.0,1.0,6/13,21.48%,PHF23;SCFD1;FEZ2;NUPR1;CHMP4A;CHMP4B
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3854162973616073,0.8257340983679964,0.6968838526912181,1.0,1.0,4/11,18.54%,FBXO7;PARK7;RACK1;NONO
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2827257623762403,-0.8256586868721439,0.7131147540983607,0.9138187840425404,1.0,12/17,50.29%,RB1;BUB3;MTBP;MIS12;ZWILCH;BOD1;KNL1;TTK;SPDL1;CENPA;IK;CDK1
prerank,clathrin coat assembly (GO:0048268),0.3611309452220217,0.8256367969891953,0.7017543859649122,1.0,1.0,2/15,9.83%,CALY;AP2S1
prerank,regulation of vasculogenesis (GO:2001212),-0.29930846005405265,-0.8253830087089753,0.6464646464646465,0.9129662935363542,1.0,6/14,28.19%,CD34;KDR;HIF1AN;CEACAM1;HEY2;RRAS
prerank,protein localization to cell periphery (GO:1990778),0.2728650317525072,0.8253408639190078,0.819672131147541,1.0,1.0,38/133,21.41%,TMEM150A;PRAM1;ANK1;RAB34;SEC16A;RAP2A;RAB12;ZDHHC3;PTCH1;RAB10;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;RAB13;EMP2;ROCK2;DPP10;EPB41L3;AP4M1;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;PACS1;SMURF1;ZDHHC2;PIP5K1A;FLOT1;RABEP1;EHD1;SPTBN4;FGF13;CLASP2
prerank,prostaglandin biosynthetic process (GO:0001516),0.347622091661411,0.82493639810098,0.714095744680851,1.0,1.0,1/18,0.44%,PRXL2B
prerank,anion transmembrane transport (GO:0098656),0.28999086130836466,0.8247863340238988,0.7545945945945945,1.0,1.0,13/67,17.79%,SLC35B1;SLC25A19;LRRC8A;SLC16A12;SLC7A2;SLC13A4;SLC25A38;SLC6A8;SLC1A3;SLC25A1;SLC6A13;SLC27A1;SLC1A2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3329443311869824,0.8245388131091508,0.6935687263556116,1.0,1.0,6/24,18.95%,PDPK1;TNFAIP3;ICAM1;NDNF;SERPINE1;KRIT1
prerank,T cell activation (GO:0042110),-0.19460208591874809,-0.824536095723791,0.8352941176470589,0.9132536594131567,1.0,24/69,32.33%,KIF13B;EIF2AK4;KIT;NCK1;CD44;GPR89B;GPR89A;PTPRC;LMBR1L;NHEJ1;MSN;RAB29;JAG2;DPP4;PIK3CD;RHOH;MDK;DDOST;LFNG;NCK2;NLRC3;CTPS1;CD74;PTPN2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.33255657372049474,0.8242448824887995,0.6761658031088082,1.0,1.0,9/23,20.70%,TUBA1A;HOOK3;KIF5C;TUBA1B;TUBB;KIF5B;CCDC88A;MAP6D1;MAP6
prerank,muscle cell migration (GO:0014812),0.38654687379612584,0.8234961759491103,0.6671732522796353,1.0,1.0,3/10,16.76%,DDR1;PLAT;ITGB1BP1
prerank,long-term synaptic potentiation (GO:0060291),0.3441049355747352,0.8234935454691904,0.7077922077922078,1.0,1.0,5/21,20.58%,MPP2;GRIN2A;NPTN;PRKCZ;PTK2B
prerank,positive regulation of cell cycle (GO:0045787),0.28934847022883886,0.8232262320047076,0.7450331125827815,1.0,1.0,12/62,18.64%,PSRC1;FGFR2;MAPRE3;PRKCA;USP2;APP;USP19;NUPR1;MDM2;MEIS2;PKD2;USP22
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3121724257211967,0.8231095061123062,0.711217183770883,1.0,1.0,8/33,18.95%,PDPK1;TNFAIP3;TCF7L2;NUPR1;ICAM1;NDNF;SERPINE1;KRIT1
prerank,iron ion transmembrane transport (GO:0034755),-0.3297665457424607,-0.8230749324437012,0.7032640949554896,0.914796538495473,1.0,5/10,21.78%,SLC39A14;SLC39A8;SLC40A1;SLC25A28;SCARA5
prerank,response to estradiol (GO:0032355),0.3176972084822839,0.823031295248507,0.7189384800965019,1.0,1.0,2/31,3.76%,SFRP1;ANXA1
prerank,regulation of neuron death (GO:1901214),0.2847318332184996,0.8229783757303073,0.7727759914255091,1.0,1.0,16/82,18.00%,WNT5A;FCGR2B;CDK5;CD200R1;INPP5A;EFNB2;PARK7;LANCL1;EGLN2;MAPT;CTSZ;FAIM2;DAXX;DCC;SORL1;RRAS2
prerank,muscle cell differentiation (GO:0042692),0.31575364085415025,0.822861763708145,0.7043478260869566,1.0,1.0,3/32,5.48%,NEB;RORA;MRTFA
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.30606504157509556,0.8227833326061359,0.7283372365339579,1.0,1.0,11/39,19.22%,ERRFI1;ARHGEF7;HGS;EGF;MVP;PTPN3;CBL;PTPN12;SPRY2;STAM2;EPN1
prerank,vasodilation (GO:0042311),0.37737777175916837,0.8227066554502184,0.6852103120759837,1.0,1.0,2/13,12.24%,KCNMA1;SOD2
prerank,SNARE complex assembly (GO:0035493),0.40058811495009716,0.8224337020751669,0.6947368421052632,1.0,1.0,3/10,20.44%,VAMP3;VAMP8;UVRAG
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3295100899690642,0.8224333766031607,0.726027397260274,1.0,1.0,3/25,6.29%,DNAJC7;DNAJB5;BAG1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.31454693977277753,-0.8222143123858175,0.7225609756097561,0.9150538210105722,1.0,4/12,11.55%,SORBS1;IRS1;SIRT1;IGF2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.2462337687319026,-0.8221738404328379,0.7116279069767442,0.9137441782972276,1.0,7/23,18.61%,ATAD1;SLC24A2;LRRK2;SHANK2;PLK2;GRIK3;PRRT1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.34278485665837477,0.8218725937561534,0.6978233034571063,1.0,1.0,10/21,27.10%,TAOK1;CAMSAP2;KATNB1;FGF13;CLASP2;CAMSAP1;NAV3;ARHGEF2;HDGFL3;APC
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.37563480892221257,0.8218613108997967,0.697289156626506,1.0,1.0,3/11,11.79%,SMARCD1;ARID1B;ZMIZ1
prerank,insulin receptor signaling pathway (GO:0008286),0.28667642621786826,0.8212711157376091,0.7666666666666667,1.0,1.0,15/69,16.91%,GPLD1;ATP6V0A2;PIK3R1;GAB1;ATP6V0E2;BAIAP2;IRS2;ATP6V1G1;PIK3R2;TCIRG1;ATP6V0A4;ATP6V1D;FOXC2;ATP6V1B2;PHIP
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2661110068309249,-0.821232949769263,0.7357723577235772,0.9141275066504729,1.0,7/18,22.51%,PABPN1;MCM3AP;THOC2;NUP93;NUP133;NXF1;ZC3H11A
prerank,cellular response to estradiol stimulus (GO:0071392),0.34726098000566646,0.820970676785417,0.6972833117723156,1.0,1.0,1/18,1.12%,SFRP1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2785085410064269,0.8209219084763606,0.7775489186405767,1.0,1.0,11/87,10.46%,CDKN2D;PSMD4;ZFP36L1;USP47;FBXO5;PSMB10;WEE1;PSMD11;RBL2;PSME2;PSMC5
prerank,carboxylic acid metabolic process (GO:0019752),-0.22366310002567116,-0.8203385111129343,0.75,0.914478418880846,1.0,3/33,2.77%,CSGALNACT1;DDO;SLC2A1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.2648858298485492,-0.8203309280963725,0.6875,0.9131180491840662,1.0,8/18,18.89%,ITGA3;RASIP1;KANK1;KCTD13;ABL2;KCTD10;MET;CCDC125
prerank,magnesium ion transport (GO:0015693),0.378672883727198,0.8200594876928354,0.6913946587537092,1.0,1.0,4/12,14.06%,MMGT1;NIPAL3;NIPAL2;SLC41A1
prerank,Golgi to lysosome transport (GO:0090160),0.385569386266754,0.8200364524008362,0.6998577524893315,1.0,1.0,1/11,0.91%,CLN3
prerank,collagen fibril organization (GO:0030199),0.2813724337509053,0.8197568028720197,0.7987616099071208,1.0,1.0,22/88,18.80%,COL27A1;P4HA1;COL4A6;COL4A5;PLOD1;DDR2;CD151;COL22A1;PPIB;P4HA2;COL1A2;CRTAP;ADAMTS3;PXDN;P3H2;COL5A2;LUM;COL11A1;BMP1;TGFBR1;COL5A3;COL8A2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.21686433214664402,-0.8188770273677353,0.8253012048192772,0.9146062220198954,1.0,10/36,25.40%,LEF1;CD46;ZBTB1;DUSP10;NKAP;VSIR;NCKAP1L;RHOH;MDK;PNP
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.28129106824263134,0.818670657299289,0.7486338797814208,1.0,1.0,4/73,2.67%,SFRP2;ARAF;NTF3;HSP90AA1
prerank,endodermal cell differentiation (GO:0035987),-0.2303924307752565,-0.8185369014127765,0.8333333333333334,0.9138721580410598,1.0,10/31,16.79%,SETD2;COL4A2;COL8A1;COL6A1;FN1;PAF1;LAMA3;ITGA4;ITGB5;MMP2
prerank,"phototransduction, visible light (GO:0007603)",-0.29795477398351794,-0.8183705059226017,0.707641196013289,0.9128262776303067,1.0,6/14,39.15%,ABCA4;GNA11;RP1;GNB1;SAG;PDE6A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.35760643877958664,0.8179457490563715,0.7014285714285714,1.0,1.0,3/13,11.79%,SMARCD1;ARID1B;ZMIZ1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3320617599517634,0.8177641704470527,0.7114882506527415,1.0,1.0,7/20,19.70%,FPGS;CNDP2;GCLC;PTDSS1;SLC27A1;PTDSS2;HAGH
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3742107616115705,0.8176414611290549,0.723943661971831,1.0,1.0,2/12,10.40%,IGF1;IRS2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3637594866743088,0.817605542523826,0.7227586206896551,1.0,1.0,7/14,24.31%,PPP2R2C;PPP5C;PPP2CB;PPP2R2B;PPM1F;PPP2R2A;PPP2R2D
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3106568834171141,0.8173574206567961,0.7327790973871734,1.0,1.0,6/35,11.29%,NTF3;NRP1;CDK5;ABL1;BAIAP2;PDGFRA
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.29164362627638485,-0.8172519511580579,0.7175572519083969,0.913615801633035,1.0,8/16,22.77%,ATP5F1C;ATP5PO;ATP5F1E;ATP5PD;STOML2;ATP5F1B;DMAC2L;ATP5F1D
prerank,microtubule nucleation (GO:0007020),-0.2684994748343108,-0.817063291824532,0.7191489361702128,0.9126158217013282,1.0,5/19,16.85%,TUBGCP5;AKAP9;TUBGCP6;NDE1;SLAIN2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.31886606768383885,0.816858600991532,0.708433734939759,1.0,1.0,2/30,1.24%,SFRP1;SP7
prerank,smoothened signaling pathway (GO:0007224),0.3123418186782585,0.8166946933176221,0.7348837209302326,1.0,1.0,4/32,10.88%,STK36;ARL13B;PTCH1;CC2D2A
prerank,positive regulation of macrophage migration (GO:1905523),0.34692098254180714,0.8166447639039515,0.6968449931412894,1.0,1.0,1/19,1.28%,IL34
prerank,vesicle organization (GO:0016050),0.30151570637617375,0.8166224819947019,0.7424071991001124,1.0,1.0,13/46,19.06%,DNM1;SAR1A;SQSTM1;SNX10;HOOK3;ALS2;SNX33;VPS33B;SNX11;DNAJC13;VPS18;ZFYVE16;USP50
prerank,axonal transport (GO:0098930),0.3103023005245789,0.8163086205699471,0.7207100591715976,1.0,1.0,9/36,19.91%,NEFL;KIF3A;TMEM108;AP3B1;BLOC1S2;MAPT;RAB21;AP3B2;PAFAH1B1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.33348256891625294,0.8162710749093427,0.7076923076923077,1.0,1.0,8/22,21.65%,TNFAIP3;TIRAP;IFI35;PTPN22;FLOT1;LYN;APPL2;RAB7B
prerank,hyaluronan metabolic process (GO:0030212),0.334012091065751,0.8160677181729008,0.7150192554557124,1.0,1.0,5/23,21.29%,LYVE1;TGFB1;CEMIP;GUSB;FGF2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3128811014684611,0.8157661292830586,0.7276029055690073,1.0,1.0,2/31,9.55%,FCGR2B;SOX11
prerank,protein kinase A signaling (GO:0010737),0.3708046684118438,0.8157366842913154,0.7128712871287128,1.0,1.0,1/12,0.97%,LCP1
prerank,regulation of extracellular matrix organization (GO:1903053),0.36122935138750223,0.8155488502926924,0.7262723521320495,1.0,1.0,3/15,13.60%,DDR1;DDR2;LRP1
prerank,positive regulation of phosphatase activity (GO:0010922),0.33830965256547835,0.8153919572064032,0.7179818887451488,1.0,1.0,2/21,3.09%,GPLD1;CALM3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2963936629000204,0.815167664260528,0.7627494456762749,1.0,1.0,16/50,23.13%,SIRT7;OGT;TNFAIP3;ABL1;SQSTM1;FBXO5;ARRB1;PARK7;USP4;SPRY2;SOX4;RPS3;SMAD7;TAF1;U2AF2;PINX1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3003129043364381,0.8148618518152622,0.7428571428571429,1.0,1.0,4/43,8.35%,APLN;GNL3;TEAD1;SOX9
prerank,positive regulation of cellular component movement (GO:0051272),0.32844985404291394,0.8147644780250166,0.7099337748344371,1.0,1.0,6/24,20.46%,STK11;TWIST1;CFAP20;SPOCK2;TGFBR1;LYN
prerank,sulfur amino acid metabolic process (GO:0000096),0.32962154141696764,0.814629878872394,0.6939281288723668,1.0,1.0,4/24,16.81%,ADO;SMS;GCLC;DPEP1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3628228942802397,0.8145578270108622,0.6971830985915493,1.0,1.0,4/14,17.60%,SLC25A33;EARS2;TFB1M;FASTKD1
prerank,cellular response to hydroxyurea (GO:0072711),-0.32581520476890635,-0.8145522313557197,0.6965944272445821,0.9159383801426644,1.0,4/10,16.92%,SPIDR;DDI2;RTF2;BLM
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.2420087658786903,-0.8142104056979035,0.7564766839378239,0.9152435621968045,1.0,10/26,26.56%,ADIPOR1;ERLIN1;PRKAB2;NR1H3;PRKAA2;ADIPOR2;ELOVL5;NR1H2;CEACAM1;SLC45A3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2671081421408469,0.8141949991754054,0.8821752265861027,1.0,1.0,56/234,22.19%,WNT5A;DVL2;STK36;CRTC1;NFKB1;NKX6-1;TFDP1;NFKB2;EDA2R;TIRAP;CARD16;DDR2;SMARCB1;DHX33;HDAC5;LRP8;TRIM62;DDIT3;CRTC3;HDAC4;TRIM41;MALT1;ATF2;APP;JUP;RTKN2;PARK7;NPM1;CEBPG;LAMTOR5;PLPP3;PRKCI;ZIC2;ADCY1;TCF3;CLOCK;IL1RAP;CAMK1D;MTDH;EPHA5;PRKD2;TAB1;TERF2IP;FLOT1;TRIM27;RPS3;PRKCZ;TAB3;FZD2;MID2;RAB7B;TRIM26;UBE2V1;TRAF2;SMAD3;TAF1
prerank,membrane depolarization (GO:0051899),0.3179760102253506,0.814109268026269,0.7258454106280193,1.0,1.0,5/32,10.99%,CACNB4;SCN7A;ABL1;YWHAH;SCN1A
prerank,modified amino acid transport (GO:0072337),0.35872901937075286,0.814038918501772,0.7052489905787349,1.0,1.0,3/15,16.34%,SLC16A12;SLC6A8;SLC6A13
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.3037335686340382,-0.8133114816777522,0.7314487632508834,0.9155702666235909,1.0,4/14,30.01%,IL17D;CD80;CD84;PAEP
prerank,macrophage migration (GO:1905517),-0.3038487364071657,-0.8131556006536304,0.7064516129032258,0.9145214516829668,1.0,7/13,45.75%,P2RY12;CKLF;EDNRB;P2RX4;TAFA4;CCR2;CCL2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.27165792820335233,-0.8131055808813793,0.7529880478087649,0.9132475315942384,1.0,2/18,1.25%,ANKRD17;PUM1
prerank,ion transport (GO:0006811),0.2737422445908164,0.8126104625619806,0.805327868852459,1.0,1.0,15/111,15.89%,SLC17A5;SLC24A5;LRRC8A;GRIN1;SLC20A2;TMEM63C;VDAC2;SLC39A1;SLC24A4;TRPM3;VDAC1;SLC1A3;GLRA1;SLC9A7;SLC9A6
prerank,endothelial cell differentiation (GO:0045446),0.3700589973877588,0.8124847608192544,0.702416918429003,1.0,1.0,4/12,18.62%,FSTL1;JAG1;KDM6B;SCUBE1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.31210156011763024,-0.8120910930199082,0.7133956386292835,0.9138052301482581,1.0,2/11,1.97%,TOMM70;AGK
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.366001027391561,0.8118536033966808,0.7144866385372715,1.0,1.0,5/13,23.45%,EEF1E1;ATR;DDX5;PLA2R1;ATM
prerank,engulfment of apoptotic cell (GO:0043652),0.3576024794249101,0.8117822885261534,0.7014285714285714,1.0,1.0,2/15,10.17%,RAC1;XKR6
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.24015950754669138,-0.8114233336999128,0.7810945273631841,0.9136657554757645,1.0,12/26,32.33%,TLR4;RARA;CDK6;INHBA;GPR137B;CEACAM1;TMEM178A;MAFB;C1QC;ZFPM1;GPR137;PTPN2
prerank,histone lysine demethylation (GO:0070076),0.3243479326011,0.8109329173073059,0.7102922490470139,1.0,1.0,6/25,19.43%,KDM4D;KDM7A;KDM2B;KDM6B;KDM3B;KDM6A
prerank,regulation of focal adhesion assembly (GO:0051893),0.2914769225989332,0.8108704098893261,0.7751412429378531,1.0,1.0,6/54,6.44%,SFRP1;RAC1;NRP1;ABL1;THY1;DMTN
prerank,regulation of integrin activation (GO:0033623),0.3591146846552852,0.8100060869351486,0.7064471879286695,1.0,1.0,3/15,15.66%,PTGER4;JAM3;FARP2
prerank,regulation of organelle assembly (GO:1902115),0.2799157935963065,0.8097353497787286,0.7847147470398278,1.0,1.0,17/72,17.79%,DCDC2;CDKL5;SGSM3;ALMS1;TBC1D13;TBC1D20;USP6NL;ATXN2L;NPM1;SPICE1;IFT20;RABGAP1;TBC1D24;ATG3;CEP76;TBC1D9B;TBC1D22B
prerank,neutrophil degranulation (GO:0043312),0.2604042750600994,0.8096182209627577,0.955,1.0,1.0,65/425,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,hexose transmembrane transport (GO:0008645),0.33547414480105753,0.8095503932122641,0.706111833550065,1.0,1.0,3/21,11.43%,SLC5A3;SLC2A3;SLC50A1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2067029300576862,-0.8094827172002642,0.8394160583941606,0.9158196695934282,1.0,6/45,7.77%,SMAD4;TWSG1;TGFB2;ACVR1;ENG;BMPR1A
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.2983120502858328,-0.809280228036024,0.7230769230769231,0.9148522243614657,1.0,3/13,4.50%,SORBS1;IRS1;SIRT1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.28330823858000814,0.8092135127922472,0.7733188720173536,1.0,1.0,16/65,19.22%,MVB12A;ERRFI1;ARHGEF7;HGS;EGF;MVP;CNOT9;PTPN3;ARAP1;CBL;RHBDF1;PTPN12;SPRY2;STAM2;CCDC88A;EPN1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.32790237804062605,0.809004285542786,0.7318007662835249,1.0,1.0,9/24,20.27%,DMTN;TMBIM1;PID1;TGFB1;MRAP2;ITGB1BP1;PPP2R5A;LZTFL1;DAB2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3537756379359551,0.8087774842925189,0.7298444130127298,1.0,1.0,4/15,15.93%,ATF2;MDC1;MRE11;CHEK2
prerank,positive regulation of T cell activation (GO:0050870),0.2805042770854379,0.8084731667597252,0.7711111111111111,1.0,1.0,7/62,12.26%,ANXA1;XBP1;THY1;SIRPA;DOCK8;ZMIZ1;CD47
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2714207621639772,0.8084700841226483,0.8079748163693599,1.0,1.0,16/101,17.09%,WNT5A;SELENOS;NFKB1;XBP1;TNFAIP3;CARD16;SIRPA;TRIM41;LY96;GIT1;PTPN22;CDC73;TGFB1;PDE4B;SERPINE1;MTDH
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.30138692938114486,0.8081298360104189,0.7636152954808807,1.0,1.0,5/41,12.62%,CHERP;GRIN1;ITPR1;GRIN2A;HTR2C
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3206639208882931,0.808102632398403,0.733921815889029,1.0,1.0,8/26,20.27%,SFRP1;PER1;CNOT9;HDAC1;VPS18;CLOCK;NCOR2;DAB2
prerank,neutrophil activation involved in immune response (GO:0002283),0.25967660315930946,0.8076530689075512,0.954,1.0,1.0,65/428,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3585782283019582,0.807468280656771,0.7468879668049793,1.0,1.0,3/16,16.46%,PRKCA;PRMT5;MRAP2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.32051953799027333,0.8073610311967596,0.7217948717948718,1.0,1.0,6/24,16.45%,NRP1;DSCAM;SEMA3D;SEMA3E;SEMA3A;MEGF8
prerank,organelle transport along microtubule (GO:0072384),0.31008896325722696,0.806790913536256,0.746031746031746,1.0,1.0,9/31,19.91%,CLN3;ARHGAP21;BICDL1;HTT;MAPT;TRAK1;KIF5B;RAB6A;PAFAH1B1
prerank,translation (GO:0006412),0.26382273812946144,0.8063980120015111,0.8796389167502507,1.0,1.0,41/208,17.26%,MRPL36;FARSB;YARS1;AIMP2;NDUFA7;WARS1;RPL22L1;YARS2;GATB;DRG2;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;AARS1;EPRS1;PABPC4;DRG1;MRPL47;MRPL10;RPL35A;RPS25;SARS1;RPS15;NARS1;RPL9;HARS1;GTPBP2;MRPL3;GSPT1;EEF1B2;RPL4;MRPL13;MRRF;RWDD1;MRPL24;RPL23A;RPLP2;TNIP1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3307582984130557,0.8063027367749797,0.7032258064516129,1.0,1.0,7/21,21.66%,GPD1L;DMTN;CNKSR3;RACK1;RASSF2;SMAD7;PPM1F
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.36189913258614714,0.8059682585853528,0.7172995780590717,1.0,1.0,1/14,1.58%,BAX
prerank,cell junction organization (GO:0034330),0.2847070902500454,0.8058539789056544,0.7899891186071817,1.0,1.0,17/71,19.89%,PPFIA4;CTNND2;PAK3;DVL1;CAPZA1;APP;NLGN3;PRKCI;MAPT;TGFB1;NLGN2;VMP1;SEMA3E;RAB8B;ILK;PPFIBP1;MYO9A
prerank,cellular response to interleukin-12 (GO:0071349),0.2955988529051712,0.8058208431792855,0.7588571428571429,1.0,1.0,11/48,18.03%,LCP1;SIRPA;AIP;PSME2;CAPZA1;SOD2;CD47;HNRNPA2B1;HNRNPDL;ANXA2;JAK1
prerank,pulmonary valve morphogenesis (GO:0003184),0.34271131447681996,0.8055760670090223,0.7142857142857143,1.0,1.0,5/17,16.44%,STRA6;ROBO2;ROBO1;SMAD6;JAG1
prerank,regulation of embryonic development (GO:0045995),0.3071300402641875,0.8054818725768581,0.7452380952380953,1.0,1.0,11/34,21.41%,NIPBL;DHX36;DAG1;B4GALT5;EHMT1;ZBED3;NR2C2;PHLDB1;TRIP12;CFL1;CLASP2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3830996081509961,0.8054186597909126,0.7151515151515152,1.0,1.0,1/10,2.68%,IL33
prerank,transition metal ion homeostasis (GO:0055076),0.31190812383595806,0.8051792520643738,0.7253694581280788,1.0,1.0,9/28,23.52%,CP;XIAP;ABCB7;HEPH;NEO1;COMMD1;HMOX2;B2M;FBXL5
prerank,cellular response to light stimulus (GO:0071482),0.2823363164432169,0.8049544241074655,0.7965554359526372,1.0,1.0,9/66,12.82%,PARP1;SDE2;USP47;CDC25A;DHX36;CASP9;YY1;NPM1;ATR
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3751327919834777,0.8049104311184455,0.7034277198211625,1.0,1.0,1/11,1.32%,DDT
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3705907339018473,0.8048430561172628,0.7378640776699029,1.0,1.0,2/13,10.24%,NTHL1;UPP2
prerank,transcription by RNA polymerase I (GO:0006360),-0.2277556200315756,-0.8048130955772711,0.8125,0.9215898047992354,1.0,10/34,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;TTF1;RRN3;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,nucleic acid metabolic process (GO:0090304),0.2824963649862382,0.804629303908883,0.7947598253275109,1.0,1.0,20/69,22.24%,DNASE1L2;POLR2B;HNRNPK;HNRNPD;HNRNPM;RBFOX2;ENPP1;POLR2K;HNRNPA0;HNRNPL;MMS19;HNRNPA2B1;RAD50;PCBP2;RECQL5;HNRNPU;PTBP1;EXD2;GTF2F2;METTL14
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.258657757125841,-0.8043878450037352,0.7620967741935484,0.9209632500926719,1.0,15/20,41.94%,SEMA6A;SEMA7A;SEMA4D;SEMA4B;SEMA3B;SEMA5A;SEMA5B;SEMA6C;SEMA3G;SEMA6B;SEMA4C;SEMA6D;SEMA4A;SEMA4G;SEMA3F
prerank,basement membrane organization (GO:0071711),0.3646024773217488,0.8043638560946984,0.723055934515689,1.0,1.0,4/14,14.59%,FLRT2;NTNG2;LAMB1;PXDN
prerank,regulation of MAPK cascade (GO:0043408),0.2666051225862376,0.8043483027100955,0.8595959595959596,1.0,1.0,39/157,22.00%,ATP6AP2;IGF1;EPHA7;FGFR2;FGFR1;TAOK1;MINK1;FGF10;TMEM106A;PAK3;EPHA8;DHX33;CD24;GPR37;EGF;ABCA7;PIK3R2;IQGAP1;DAG1;ROR2;LPAR1;RNF41;ROCK2;MAP2K2;RIT2;ZDHHC17;KSR1;NRK;PELI2;WWC1;PRDM15;LYN;TGFBR3;PAK5;NTRK2;MAP4K4;FGF2;RYK;HMGB1
prerank,intracellular sterol transport (GO:0032366),-0.29329836083974814,-0.8039316560959511,0.6967509025270758,0.9204218325076278,1.0,6/13,22.89%,OSBPL2;SERAC1;OSBP;ARV1;VPS4A;STARD4
prerank,purine ribonucleotide catabolic process (GO:0009154),0.33254894843984667,0.8039287347958006,0.7322540473225405,1.0,1.0,4/21,13.10%,MLYCD;ACAT1;NUDT3;HPRT1
prerank,cation transmembrane transport (GO:0098655),0.29389901921156636,0.8034751126870124,0.774230330672748,1.0,1.0,5/44,10.15%,SLC25A19;SLC7A2;ATP1A2;TRPM3;SLC25A38
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.36133622792424314,0.8025902177817663,0.7207977207977208,1.0,1.0,2/14,8.62%,WNT5A;GPRC5B
prerank,protein localization to condensed chromosome (GO:1903083),-0.30676515413754485,-0.8024327429892307,0.7013422818791947,0.921777493430087,1.0,9/12,50.29%,BUB3;MTBP;MIS12;ZWILCH;KNL1;TTK;SPDL1;IK;CDK1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3391772440038401,0.8022873037654367,0.7265625,1.0,1.0,5/19,19.39%,SLC35B2;ENPP1;ABHD14B;SULT1A1;PAPSS1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2797198064808604,0.8016263262608504,0.7897545357524013,1.0,1.0,25/69,24.79%,RPRD2;POU2F1;POLR2B;CDK9;TBP;GTF2A2;SNAPC4;TAF6;POLR2K;GTF2E1;CCNT1;CDK7;NABP2;INTS6;INTS2;CCNT2;INTS7;SNAPC3;GTF2F2;GTF2B;RPAP2;SP1;INTS10;INTS9;INTS13
prerank,meiosis I (GO:0007127),0.3269987852793447,0.801521490527423,0.72544080604534,1.0,1.0,4/23,21.14%,SYCP3;FOXJ3;BRDT;FOXJ2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.30670314812247623,-0.801448707971122,0.7324414715719063,0.9221996004310609,1.0,3/12,8.35%,CNOT1;CALR;ASXL1
prerank,calcium ion transmembrane transport (GO:0070588),0.2776247500542964,0.8009332885379375,0.8232217573221757,1.0,1.0,11/86,10.62%,NALCN;SLC24A5;ATP2C1;GRIN1;ATP2A2;PMPCA;GRIN2A;ATP2B1;SLC24A4;TRPM3;AFG3L2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.35337768760409843,0.8008873602934534,0.7152777777777778,1.0,1.0,3/16,11.50%,CALM3;ATP1A2;CAMK2D
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3162810149435812,0.8008783335689277,0.739021329987453,1.0,1.0,5/26,14.97%,ERRFI1;SNX6;EGF;APP;CBL
prerank,negative regulation of T cell activation (GO:0050868),0.30201543744196546,0.8007282547126487,0.7904761904761904,1.0,1.0,3/35,13.55%,FCGR2B;RIPOR2;PTPN22
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2496028863206901,-0.8005716459861671,0.7713178294573644,0.9224179224551704,1.0,12/22,37.72%,PSMB7;PSMB2;PSMA6;PSMB3;NFE2L2;PSMB4;PSMB6;PSMB5;PSME4;PSMB8;PSMB9;PSMA8
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.3714520086174734,0.800469514013954,0.7116212338593975,1.0,1.0,3/11,14.28%,EFNB2;DHX36;TGFB1
prerank,stem cell differentiation (GO:0048863),0.2956261647609754,0.8002917044620995,0.7419354838709677,1.0,1.0,5/39,10.02%,SFRP1;SP7;FGFR2;PSMD11;JARID2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.31517546412846154,0.8002349177879104,0.7257281553398058,1.0,1.0,9/29,17.44%,TCF7L2;HDAC1;AXIN2;PYGO2;CDC73;PYGO1;KMT2D;TCF7L1;TCF7
prerank,cell cycle G2/M phase transition (GO:0044839),0.26576504585341043,0.8002059060521189,0.845213849287169,1.0,1.0,28/129,20.42%,CCP110;FOXM1;LCMT1;HSP90AA1;FBXL12;ALMS1;WEE1;AKAP8L;BRSK2;CDC25A;TUBA1A;YWHAG;BRSK1;CCNH;HAUS3;CSNK1D;TUBB;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;DYNLL1;PAFAH1B1;CDK14;PHLDA1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.16962254176496938,-0.7998841607853125,1.0,0.9222565746411241,1.0,124/306,30.16%,EPC1;MEF2A;KAT7;PTMS;RPS24;ORC4;ST3GAL4;ABCF1;AGO2;RPL11;RRAGC;CREBL2;TIPIN;RPS15A;RPS23;RPL5;EEF2;RPL37A;RPL6;RPL18A;RPA1;RPL24;NBN;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;NT5M;SRBD1;POLR3A;RPS16;REV1;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;EEF1A1;RPL36;RPL10;RPL32;RPS28;UPF1;RPS5;MRPL42;RPL15;RPS2;RNPS1;RPL39;RPL12;RPL27;RPS17;MRPS21;MED20;RPS26;RPS27;RPL10A;GTPBP1;MRPL52;DARS1;BLM;RPS10;MRPS18A;MRPS15;EEF1D;DTX1;RPL7A;MRPS33;ATRIP;MRPS18C;ING5;PWP1;ORC5;TBRG1;MCM6;RAD9B;MRPL27;RPL31;WRN;RFC2;RPL36A;RPL29;HUS1;FUBP3;NR4A2;RPS14;DHPS;INHBA;MRPL9;POLR2H;FAM111A;BCL3;CDK2;RPS6KB2;TSFM;RPL41;POLA2;RPL35;TERT;MRPL51;POLR2G;POLR2F;RHNO1;MRPL32;POLR2C;MRPS14;DUT;POLE2;CLSPN;PAX8;CDC7;MRPS7;KAT5;MCM4;MRPL18;IGHMBP2;MRPL43;IGF2BP3;RAD1
prerank,regulation of interleukin-8 production (GO:0032677),0.2786275783050274,0.7998438247287998,0.7863247863247863,1.0,1.0,13/69,18.01%,ANXA1;TIRAP;ARRB1;DDIT3;SSC5D;PARK7;LAMTOR5;TLR3;PTPN22;F3;SERPINE1;ANXA4;PRKD2
prerank,positive regulation of actin nucleation (GO:0051127),0.372225889591236,0.7993677520835442,0.7332361516034985,1.0,1.0,3/11,13.25%,WHAMM;CYFIP1;WASF1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.37270027954478446,0.7991152801849363,0.7134416543574594,1.0,1.0,2/11,11.06%,TAF9B;BCL2
prerank,regulation of cholesterol efflux (GO:0010874),0.3074394423801566,0.799037771674176,0.7246722288438617,1.0,1.0,9/30,20.03%,ABCA2;PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2;TTC39B;ABCA5
prerank,neural tube closure (GO:0001843),0.3042445205330019,0.798998361785896,0.7576832151300237,1.0,1.0,5/34,10.68%,DVL2;TSC2;SCRIB;DVL1;KDM2B
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3691116979411016,0.7988573335543503,0.7152777777777778,1.0,1.0,4/12,20.48%,LRIF1;CDYL;YTHDC1;HNRNPU
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.32969365270798595,0.7986119959162167,0.7373868046571799,1.0,1.0,4/22,11.33%,EIF2AK3;SMARCB1;DHX33;IPPK
prerank,synaptic vesicle localization (GO:0097479),0.36265651634584917,0.7986117132646547,0.7160839160839161,1.0,1.0,4/13,17.25%,CDK5;KIF5C;TMEM230;KIF5B
prerank,cellular response to virus (GO:0098586),0.30899208727826366,0.7986053108702791,0.7403726708074534,1.0,1.0,3/30,4.15%,BAX;HSP90AA1;DDX3X
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2915295961099471,-0.7982242690356159,0.748,0.9238879182777398,1.0,3/15,11.10%,RAPGEF3;EHD2;CAMK1
prerank,gluconeogenesis (GO:0006094),-0.20916846343218326,-0.798130357292991,0.8493150684931506,0.9226975008852423,1.0,16/39,26.79%,SLC25A13;GPI;SLC39A14;RBP4;GOT2;ALDOA;PCK2;GOT1;ATF4;ENO1;PPARGC1A;SLC25A11;CRTC2;MDH1;GAPDH;ALDOC
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2650611837282662,-0.798114366767942,0.7333333333333333,0.9213836875680984,1.0,11/18,30.31%,DAB2IP;MORC3;TP53;PARP10;MED25;NF1;EMD;B4GALT7;CD300A;NLRC3;TRIM32
prerank,regulation of protein export from nucleus (GO:0046825),0.3257316671873481,0.7979490851638668,0.759020618556701,1.0,1.0,4/23,12.08%,SIRT7;TCF7L2;BARD1;PARK7
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2652656426668285,0.7978867060662385,0.8426966292134831,1.0,1.0,29/128,21.00%,CCP110;FOXM1;LCMT1;HSP90AA1;FBXL12;ALMS1;WEE1;BRSK2;CDC25A;TUBA1A;YWHAG;BRSK1;BACH1;CCNH;HAUS3;CSNK1D;TUBB;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;DYNLL1;PAFAH1B1;CDK14;PHLDA1;TAF2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.30538024947164166,0.7976275882212411,0.767580452920143,1.0,1.0,10/36,20.17%,TFDP1;RBBP4;EZH2;PCGF6;EHMT2;EHMT1;CBX5;RBBP8;YAF2;E2F6
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2924629527776977,0.7976161261693028,0.7614678899082569,1.0,1.0,14/43,22.35%,ERRFI1;ARHGEF7;SNX6;HGS;EGF;MVP;PTPN3;CBL;SPRY2;STAM2;EPN1;CBLB;RAB7A;ITGA1
prerank,positive regulation of histone methylation (GO:0031062),0.3204650436412582,0.7976109366163114,0.7186732186732187,1.0,1.0,7/24,19.34%,OGT;PHF1;JARID2;AUTS2;SNW1;KMT2A;TET1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.273497317499031,0.7968894477008639,0.8102345415778252,1.0,1.0,22/75,21.14%,THBS2;SULF1;DCN;SPARC;HGS;WNT4;ATF2;SARS1;ROCK2;SEMA3E;HSPG2;ADAMTS1;SPRY2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;KLF4;SERPINF1;ATP2B4;FOXJ2
prerank,negative regulation of RNA splicing (GO:0033119),0.33311692152348427,0.7965391960706656,0.7306666666666667,1.0,1.0,3/19,7.02%,PCBP4;SRSF12;SRSF9
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2883282588937678,0.7964356847028725,0.7568493150684932,1.0,1.0,8/48,12.17%,WBP2;SF3B1;ASF1A;TBP;SMARCD1;ARID1B;ZMIZ1;POLR2K
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3381912255269961,0.7960256932288632,0.7456492637215528,1.0,1.0,1/18,1.12%,SFRP1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3690648771598807,0.795898658848874,0.7107913669064748,1.0,1.0,1/12,2.30%,PSAT1
prerank,regulation of AMPA receptor activity (GO:2000311),0.325635248863808,0.7954348006031483,0.7493670886075949,1.0,1.0,7/25,19.05%,CACNG3;MINK1;NLGN3;NLGN2;CACNG4;SHISA9;SHANK1
prerank,neutrophil mediated immunity (GO:0002446),0.25583405171790724,0.7953547285377249,0.962,1.0,1.0,65/432,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3756742400292409,0.7948083642487277,0.6998514115898959,1.0,1.0,3/10,16.66%,CHFR;DIS3L2;NEDD8
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3530381107294396,0.7947480230211378,0.7312588401697313,1.0,1.0,3/15,13.76%,SFRP1;ZNRF3;CSNK1D
prerank,translational elongation (GO:0006414),0.2699189045451337,0.7945385014798814,0.8345549738219895,1.0,1.0,28/101,23.10%,MRPL36;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;NEMF;RACK1;GTPBP2;MRPL3;EEF1B2;CHCHD1;MRPL13;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;EEF2K;GFM2;MRPS28;MRPS35;GFM1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.34644974771409437,0.7941077084208858,0.7413793103448276,1.0,1.0,4/14,21.35%,TIRAP;HNRNPA0;MAPKAPK2;ANGEL2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.25663269081187806,0.7938381767761252,0.935,1.0,1.0,90/366,20.76%,DVL2;RBM4B;RBM3;NR1D2;PCGF1;RORA;NFKB2;PSPC1;ZNF205;METAP1;CNBP;ABL1;ATXN1;FBXO5;PHF1;DVL1;ZNF35;CASZ1;EZH2;FUS;MAGED1;ZBTB38;ASCC1;ZKSCAN5;ACTR8;NFX1;CYFIP1;EHMT2;DDIT3;HNRNPD;PRMT5;PUM3;SOX11;SAP30L;FADS1;ATF2;POU6F2;APP;NSD3;FOXN3;BACH1;SOX6;SUFU;ATRX;ESRRG;TULP3;KMT2D;NUCKS1;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;GTF2IRD1;CHEK2;SBNO1;CLOCK;TRIP4;DAXX;UBE2L3;ZFP37;SOX13;HP1BP3;TCF7;NFXL1;NSD1;PHF12;CCDC88A;GCFC2;NONO;TGFBR1;TERF2IP;NUP35;SOX4;BRDT;YAF2;MITF;USP37;CDK11B;WWC1;CARM1;NFIA;CHD7;UTP4;ZNF219;GEMIN5;YBX1
prerank,myoblast fusion (GO:0007520),0.3685964669220795,0.7938346102683956,0.7171717171717171,1.0,1.0,5/12,21.61%,ADAMTS5;ADAM12;ADGRB3;KCNH1;CD9
prerank,mammary gland epithelium development (GO:0061180),0.3439831651039523,0.793745413267147,0.7359882005899705,1.0,1.0,2/14,8.19%,SCRIB;WNT4
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.34601068577739613,0.7937407883810009,0.7360335195530726,1.0,1.0,3/16,13.25%,CLN3;SHFL;GSPT1
prerank,negative regulation of endocytosis (GO:0045806),0.3191129383774323,0.7936913997744371,0.7458912768647282,1.0,1.0,5/24,13.39%,RAC1;PACSIN3;ABCA7;SNX33;SCAMP5
prerank,limb morphogenesis (GO:0035108),0.3380004143718845,0.7928177116891592,0.7618403247631935,1.0,1.0,5/20,16.45%,PCSK5;NIPBL;PTCH1;CYP26B1;MEGF8
prerank,endosome organization (GO:0007032),0.29567025504267513,0.7927124513987828,0.7704545454545455,1.0,1.0,9/41,16.00%,DNM1;SQSTM1;SNX10;HOOK3;ALS2;SNX33;VPS33B;DNAJC13;VPS18
prerank,regulation of intracellular protein transport (GO:0033157),0.31068877851414345,0.7925766637701588,0.7769784172661871,1.0,1.0,11/32,25.35%,LCP1;SIRT7;RIPOR1;TGFB1;RUFY3;KIF20B;TPR;IFI27;UHMK1;PTPN14;PRR5L
prerank,apoptotic cell clearance (GO:0043277),0.30811230188042954,0.7921457893933255,0.7557997557997558,1.0,1.0,8/30,22.00%,RAC1;ANXA1;XKR6;LRP1;TXNDC5;RHOBTB1;ITGAV;HMGB1
prerank,mesonephros development (GO:0001823),0.36814722491307383,0.7918659088988538,0.7434402332361516,1.0,1.0,2/11,17.12%,FGF10;OSR1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.26492886243792885,0.791846582654432,0.8716904276985743,1.0,1.0,31/132,18.52%,TARBP2;COIL;SMN1;HSP90AA1;GEMIN2;SRSF5;SF3B1;CELF2;CELF1;SRSF9;PRPF6;SRSF1;PRMT5;CPSF7;SART3;RPS15;NUDT21;SETX;LUC7L2;CDC73;KHDC4;SHQ1;CELF5;YTHDC1;RPL23A;DHX29;LUC7L3;CPSF6;BRIX1;GCFC2;SRPK1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.28737375448709285,0.7917686830014895,0.7678983833718245,1.0,1.0,2/43,1.18%,FGF9;IGF1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.30202557457683765,0.7915246137725899,0.7610837438423645,1.0,1.0,3/32,7.08%,CCT8;PKIB;CCT6A
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.2992329912412118,0.7915112049891683,0.7520958083832335,1.0,1.0,8/35,16.67%,RAC1;PLXNA2;NRP1;SEMA3D;SEMA3E;SEMA3A;FARP2;PLXNB3
prerank,mesonephric tubule development (GO:0072164),0.34551698044260365,0.7911355260974029,0.7376586741889986,1.0,1.0,4/15,18.02%,FGFR2;ROBO2;OSR1;PKD2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.23583056170292133,-0.7910411063870786,0.8209606986899564,0.9325694386958527,1.0,9/23,23.18%,STAT1;HSP90AB1;CDC37;NR1H3;IRGM;PARP9;NR1H2;PPARG;NLRC5
prerank,regulation of platelet aggregation (GO:0090330),0.33822234403090934,0.7908636246412147,0.755586592178771,1.0,1.0,3/17,6.44%,C1QTNF1;PRKCA;DMTN
prerank,cyclooxygenase pathway (GO:0019371),-0.31185587611746085,-0.7906848554571644,0.7462235649546828,0.9317732133758,1.0,4/10,24.17%,PTGES3;PTGES;TBXAS1;HPGDS
prerank,negative regulation of lipid catabolic process (GO:0050995),0.34333422819438936,0.7904623242110108,0.7256011315417256,1.0,1.0,1/17,1.59%,GPLD1
prerank,renal system development (GO:0072001),0.2830052194452879,0.7899529477377661,0.7714932126696833,1.0,1.0,9/52,18.56%,STRA6;GREB1L;PCSK5;SULF1;WNT4;PYGO2;PYGO1;AGTR1;TGFBR1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30566625503638106,0.7898848473064521,0.7391304347826086,1.0,1.0,4/29,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,CENP-A containing chromatin organization (GO:0061641),0.30566625503638106,0.7898848473064521,0.7391304347826086,1.0,1.0,4/29,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,microtubule anchoring (GO:0034453),-0.29742453261653246,-0.7891560120099993,0.7443365695792881,0.932996955490468,1.0,3/12,12.21%,BICD1;PCM1;GCC2
prerank,establishment of vesicle localization (GO:0051650),-0.263152610288374,-0.7891263464226211,0.7946428571428571,0.9317010872296542,1.0,5/18,11.67%,CCDC186;SPG11;RAB27A;IKBKG;LIMK2
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2281993443975531,-0.7889335744785646,0.8303030303030303,0.9293500433031281,1.0,20/31,34.94%,GTF2H1;MNAT1;NCBP1;GTF2H5;GTF2H2;ERCC3;RNMT;NCBP2;CMTR1;POLR2H;POLR2G;POLR2F;ERCC2;POLR2C;GTF2F1;RAMAC;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2281993443975531,-0.7889335744785646,0.8303030303030303,0.9293500433031281,1.0,20/31,34.94%,GTF2H1;MNAT1;NCBP1;GTF2H5;GTF2H2;ERCC3;RNMT;NCBP2;CMTR1;POLR2H;POLR2G;POLR2F;ERCC2;POLR2C;GTF2F1;RAMAC;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,macrophage activation (GO:0042116),0.3058238276404237,0.7887820999046041,0.7546511627906977,1.0,1.0,6/34,13.92%,TMEM106A;IFI35;CRTC3;APP;IFNGR1;MAPT
prerank,regulation of calcium ion transport (GO:0051924),0.2857552929349987,0.7887290339665384,0.782312925170068,1.0,1.0,7/54,12.18%,CAMK2B;PACSIN3;ATP2B1;CRACR2A;EGF;BCL2;CAMK2G
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.297154208808991,0.7887052297234173,0.768,1.0,1.0,6/42,13.72%,CDKN2D;USP10;VCP;POLH;POLN;POLD3
prerank,positive regulation of reproductive process (GO:2000243),0.30358660733973764,0.7887051448661438,0.7687651331719129,1.0,1.0,4/31,15.34%,SIRT2;PGAM4;GLRA1;ACVR1B
prerank,negative regulation of catalytic activity (GO:0043086),0.31735246191915795,0.7883330533431778,0.7609254498714653,1.0,1.0,2/24,6.95%,CLN3;TMBIM1
prerank,sphingosine biosynthetic process (GO:0046512),0.36729424697730645,0.7882571772374352,0.7318518518518519,1.0,1.0,1/11,4.31%,ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),0.36729424697730645,0.7882571772374352,0.7318518518518519,1.0,1.0,1/11,4.31%,ABCA2
prerank,regulation of peptidase activity (GO:0052547),0.33287853727403427,0.7879806013292179,0.747675962815405,1.0,1.0,4/19,15.68%,NRDC;RCN3;HDAC1;CTSH
prerank,respiratory chain complex IV assembly (GO:0008535),0.3274469050375595,0.7875070251376967,0.7503337783711616,1.0,1.0,5/21,19.73%,BCS1L;COX17;COA8;COX16;OXA1L
prerank,cortical cytoskeleton organization (GO:0030865),0.2909695880280636,0.7873970442038104,0.7865296803652968,1.0,1.0,7/41,14.73%,LCP1;RAC1;RHOD;RHOBTB3;RAB13;ROCK2;EPB41L3
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.19375111337825612,-0.7870952467676626,0.9615384615384616,0.9311949726595677,1.0,15/62,15.93%,TNRC6A;PUM1;NUP160;STAT3;NUP205;AGO2;LIMD1;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1
prerank,negative regulation of cell differentiation (GO:0045596),0.2610012337332672,0.7870539236522606,0.8966565349544073,1.0,1.0,44/181,22.45%,SFRP2;WNT5A;SFRP1;SIRT2;ADAMTS7;PTHLH;RORA;RANBP3L;ADGRV1;SOX9;SRA1;PTCH1;TWIST1;HOXB8;BMP5;ENPP1;SUFU;CDC73;RUNX1T1;TGFB1;SMAD6;COL5A2;VASN;TRIO;JAG1;SPRY2;OSR1;MEIS2;IQCB1;GPS2;TGFBR1;YTHDF2;ABCA5;HNRNPU;PTK2B;ITGAV;SMAD7;PTBP1;ABCG1;FOXO1;SMAD3;METTL14;ID2;TMEM64
prerank,cardiac ventricle development (GO:0003231),0.3328071811065211,0.7867116665074017,0.76221928665786,1.0,1.0,5/20,23.03%,STRA6;MDM4;HECTD1;MATR3;DAND5
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.28971208141916716,-0.7867007925669468,0.7352941176470589,0.9305110247213244,1.0,7/13,26.59%,TMSB4X;NOS3;PINK1;ENO1;PPARGC1A;PPARA;NOS1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.30538866466741543,0.7866924013071378,0.7534246575342466,1.0,1.0,13/29,23.52%,TRAPPC10;NAPG;COPZ2;VTI1B;COG3;VTI1A;COG8;NSF;RAB6A;NAPA;COPG1;GOSR1;COPA
prerank,response to ionizing radiation (GO:0010212),0.2741535975257996,0.7865337036458013,0.8173913043478261,1.0,1.0,20/70,22.18%,KDM4D;RNF8;ANXA1;COP1;STK11;RNF168;MRNIP;BRSK1;AEN;CLOCK;TANK;NABP2;PRKAA1;SMPD1;UIMC1;INO80;EYA1;INTS7;CLK2;MTA1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.2769009409903753,0.7863913291018654,0.8174946004319654,1.0,1.0,17/67,21.66%,SFRP1;RAC1;NRP1;ABL1;ARHGEF7;DMTN;JUP;FBLN2;ECM2;EMP2;NDNF;CCL25;ILK;CARMIL1;PTK2B;DOCK5;PPM1F
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3651568740925599,0.7857115201810017,0.7280701754385965,1.0,1.0,2/12,11.06%,TAF9B;BCL2
prerank,oogenesis (GO:0048477),-0.28402995450592605,-0.7855722340120902,0.7593984962406015,0.9310404993630331,1.0,1/15,0.24%,MARF1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2723631837824498,0.7847419762259752,0.8141783029001074,1.0,1.0,19/79,21.29%,APLN;CASK;SMAD9;SULF1;HTRA3;HGS;GPC1;LEMD3;SMAD6;UBE2D1;SPRY2;SMURF1;SORL1;PDCD6;NBL1;ACVR2A;SMAD7;ATP2B4;FGF2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3326414536185903,0.7846953557294138,0.7386058981233244,1.0,1.0,3/20,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,ncRNA processing (GO:0034470),0.2573524868970456,0.7845454203370679,0.8876518218623481,1.0,1.0,31/200,14.23%,EXOSC1;EXOSC3;TARBP2;DGCR8;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;ZCCHC8;PUS10;EXOSC8;MPHOSPH10;AARS1;LIN28B;RCL1;ESF1;RPL35A;RPS25;MTREX;SARS1;RPS15;RPL9;AGO3;RPP30;C1D;RPL4;BMS1;HNRNPA2B1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.35830328291105185,0.7842723618719558,0.7474747474747475,1.0,1.0,2/12,14.28%,SELENOS;TGFB1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.19471249191269668,-0.7839238086810789,0.9180327868852459,0.9323843232765845,1.0,15/48,23.18%,SAMHD1;STAT2;SLIT2;PTPRC;METTL3;PYDC1;NR1H3;CNOT7;SH2B3;USP18;OTUD4;CCDC3;NR1H2;PPARG;NLRC5
prerank,protein targeting to membrane (GO:0006612),0.2666530378085666,0.7838485660284832,0.8250265111346765,1.0,1.0,25/83,22.95%,SRP19;FIS1;ZDHHC3;SDCBP;PXMP4;PEX5;PXMP2;GDAP1;PRKCI;PEX13;ATG3;ABCD2;RAB8B;ALDH3A2;SEC62;ZDHHC2;SEC63;RTP4;CHMP4A;CHMP4B;PEX2;SIL1;PIKFYVE;ZDHHC14;ZDHHC21
prerank,regulation of mitochondrial fusion (GO:0010635),0.36867358042237747,0.7838475730537624,0.7381656804733728,1.0,1.0,3/11,17.63%,PID1;VAT1;OMA1
prerank,oligodendrocyte development (GO:0014003),0.34448237951899696,0.7838419843420246,0.7629427792915532,1.0,1.0,3/15,16.68%,MYRF;B4GALT5;TPPP
prerank,positive regulation of bone resorption (GO:0045780),-0.30716641167575043,-0.7838039979591858,0.7514792899408284,0.9312724079645489,1.0,4/11,15.91%,PLEKHM1;ATP6AP1;SPP1;TNFRSF11A
prerank,striated muscle cell differentiation (GO:0051146),0.34566378248121105,0.7837028647405081,0.7545582047685835,1.0,1.0,5/16,16.73%,SIK1;MYEF2;AKAP13;NRG1;KDM6B
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.32001831152337157,0.7835770031766435,0.7555847568988173,1.0,1.0,7/22,25.61%,FBXO38;MALT1;HSPD1;TRAF2;B2M;TRAF6;STX7
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3122675567730791,0.7833424456245144,0.7563131313131313,1.0,1.0,3/24,10.15%,UROD;RSAD1;SLC25A38
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.292200751740313,0.7830857013013082,0.791812865497076,1.0,1.0,16/41,24.14%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;LACC1;NUP214;NUP153;RANBP2;PRKAG2;NUP35;TPR;NUP155;NUP54;NUP98
prerank,ureteric bud development (GO:0001657),0.32969513612613177,0.7830273340063353,0.7448840381991815,1.0,1.0,4/17,18.02%,FGFR2;ROBO2;OSR1;PKD2
prerank,glycine transport (GO:0015816),-0.3202797625981104,-0.7829618840567061,0.7553516819571865,0.9312405878667505,1.0,5/10,27.84%,SLC6A9;SLC38A5;SLC6A17;SLC36A1;SLC6A5
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3163019430160079,0.7829527344004227,0.7455012853470437,1.0,1.0,8/23,23.06%,MAD2L1;GPSM2;HTT;NUMA1;ZW10;PAFAH1B1;ITGB1;CDK5RAP2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.29229684550317686,-0.7828578889895709,0.7793103448275862,0.9300976752410537,1.0,6/13,21.79%,NCK1;DDRGK1;PPP1R15B;UFL1;HSPA5;DNAJB9
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3484649125907332,0.7828544763043599,0.7462482946793997,1.0,1.0,2/15,7.04%,DDX3X;DHX33
prerank,RNA modification (GO:0009451),0.2781189062183177,0.7827645488773746,0.8002219755826859,1.0,1.0,12/54,19.95%,DTWD1;ANKRD16;TRDMT1;AARS1;PUS7;TRMT1;TFB1M;QTRT2;URM1;ALKBH1;NSUN4;WDR4
prerank,response to light stimulus (GO:0009416),0.2811675015634245,0.7826883269955249,0.8207126948775055,1.0,1.0,3/55,4.61%,CDKN2D;USF1;USP1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.34783256408696633,0.7825779705324557,0.748587570621469,1.0,1.0,4/14,16.76%,CD63;DMTN;EMP2;ITGB1BP1
prerank,protein export from nucleus (GO:0006611),0.30765785133538265,0.7822289427248751,0.7797029702970297,1.0,1.0,11/27,23.16%,RANBP3L;STRADB;TGFB1;NUP214;XPO6;SMURF1;XPO7;RANBP3;TPR;CSE1L;DUSP16
prerank,BMP signaling pathway (GO:0030509),0.27649173760216056,0.782184649687766,0.8041575492341356,1.0,1.0,18/62,22.12%,BMP6;SMAD9;USP15;BMP5;USP9X;TGFB1;RGMA;SMAD6;RGMB;DDX5;MEGF8;SMURF1;ZFYVE16;TGFBR3;ACVR2A;SMAD7;SMAD2;SMAD3
prerank,cytoskeleton organization (GO:0007010),0.2645437665157772,0.7821017648634795,0.8584710743801653,1.0,1.0,30/114,21.44%,BIN1;RAC1;ANK1;OBSL1;TNFAIP3;MAST3;THY1;DMTN;PDZD8;RHOD;NCKIPSD;LRCH3;PACSIN3;DES;RHOBTB3;TPM1;PRKCI;PRPF40A;EPB41L3;PHIP;APOE;KLHL20;CDC42BPB;FGD4;RANBP9;RHOBTB1;PAK5;RHOU;CFL1;DIAPH1
prerank,aggrephagy (GO:0035973),0.3109001027425071,0.78156505592185,0.7613219094247246,1.0,1.0,5/27,12.08%,UBQLN1;ARL13B;SQSTM1;DYNC1LI1;PARK7
prerank,peptide metabolic process (GO:0006518),0.27044087930591215,0.7814717462328151,0.821917808219178,1.0,1.0,10/75,11.82%,CPXM1;MGAT3;GSTT1;PCSK5;ANPEP;THOP1;DNPEP;HM13;CPXM2;CARNMT1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.3543496556480569,0.7809485815305114,0.7581329561527581,1.0,1.0,3/13,12.69%,GPR37;PARK7;RACK1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3441230908134783,0.7809390339252318,0.7338709677419355,1.0,1.0,2/15,8.11%,GPLD1;SIK1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3201563473298771,0.7806339126894271,0.7643835616438356,1.0,1.0,2/22,14.28%,ZBTB7B;TGFB1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3194410746429277,0.7806079226428024,0.7651715039577837,1.0,1.0,4/23,14.28%,IGF1;EFNB2;NRG1;TGFB1
prerank,response to unfolded protein (GO:0006986),0.28074313079412494,0.7805544761168962,0.7853042479908151,1.0,1.0,10/48,18.06%,BAX;HSP90AA1;DNAJB5;DDIT3;TOR1B;HSPH1;HSPD1;DERL1;DAXX;PACRG
prerank,negative regulation of locomotion (GO:0040013),0.3601136659603632,0.780510972517981,0.7368421052631579,1.0,1.0,1/12,4.45%,FBLN1
prerank,regulation of microtubule-based process (GO:0032886),-0.20925983041011745,-0.7802445034798047,0.8445945945945946,0.932989259274512,1.0,13/36,24.89%,MARK2;BICD1;MARK4;CYLD;TRIM36;ROCK1;PRKAA2;KLHL42;ATF5;TRAF3IP1;ERBB2;FAM107A;HDAC6
prerank,necroptotic process (GO:0070266),0.3362583532513583,0.77976642097283,0.7558620689655172,1.0,1.0,6/16,20.53%,LY96;TLR3;DNM1L;MLKL;IPMK;ITPK1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.25738765277173636,-0.7791395193929451,0.8237704918032787,0.9334610416816329,1.0,6/18,16.70%,RDX;EZR;VPS11;PTPN23;SRC;MSN
prerank,protein K48-linked deubiquitination (GO:0071108),0.3192740173965511,0.7789986911106344,0.7756410256410257,1.0,1.0,8/23,19.59%,TNFAIP3;OTUD7A;USP34;USP33;USP50;YOD1;VCPIP1;USP37
prerank,primary neural tube formation (GO:0014020),0.29746435247286035,0.7789786132976007,0.7598097502972652,1.0,1.0,3/30,5.37%,DVL2;TSC2;SCRIB
prerank,DNA damage checkpoint signaling (GO:0000077),-0.22978667233409708,-0.7789581005738399,0.8446601941747572,0.9324159216373309,1.0,14/28,31.86%,CEP63;USP28;DOT1L;NBN;HINFP;STK33;ATRIP;ERCC6;HUS1;PRPF19;RHNO1;CLSPN;RAD1;DONSON
prerank,regulation of cytoskeleton organization (GO:0051493),0.2618204852490971,0.7785754210380177,0.8623188405797102,1.0,1.0,29/108,21.89%,CLN3;RAC1;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;KATNBL1;CAPN2;RHOBTB3;IQGAP1;LRP1;MAPT;ROCK2;PHLDB1;TPPP;EPHA5;PFDN2;CCDC88A;CDK10;PRKAA1;MAP6D1;DLC1;RHOBTB1;NEXN;MAP6;DIAPH1;ARHGAP35
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.3504571827344886,0.7784043054521371,0.7468354430379747,1.0,1.0,3/13,14.97%,ERRFI1;SNX6;CBL
prerank,pore complex assembly (GO:0046931),-0.25030800565541567,-0.778144583393566,0.7866108786610879,0.9324198462631532,1.0,9/19,22.04%,NUP205;ANO6;NUP93;NUP107;ADAM10;NDC1;P2RX7;TMEM170A;BAD
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2413151130269808,-0.7780458251557208,0.8436018957345972,0.9313049823141658,1.0,13/24,30.70%,LATS1;TMF1;UCHL5;PRKACA;UBB;PINK1;CTSC;NUB1;GPX1;PSME3;PKD1;PSME1;EFNA1
prerank,calcium ion transport (GO:0006816),0.2644591632858894,0.7779467762863272,0.8575819672131147,1.0,1.0,10/113,8.98%,NALCN;SLC24A5;ORAI2;ATP2C1;CACNG3;ATP2A2;ITPR1;SLC24A4;TRPM3;CRACR2A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.36021193899487514,0.7776370568742728,0.7514204545454546,1.0,1.0,2/13,9.55%,DDIT3;SOX11
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.29746124782365074,0.7771503696860531,0.7645600991325898,1.0,1.0,7/29,16.00%,WBP2;UFSP2;GPAM;CNOT9;CBFB;KMT2D;VPS18
prerank,muscle tissue development (GO:0060537),0.3500722493597165,0.7766244495032653,0.7372060857538036,1.0,1.0,2/13,8.42%,STRA6;PTCH1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.34012106708827516,0.7759851766287063,0.7612994350282486,1.0,1.0,1/16,2.42%,ADM
prerank,regulation of protein import into nucleus (GO:0042306),0.2894832866661254,0.7752256031377031,0.7871581450653984,1.0,1.0,11/36,22.12%,HDAC3;PIK3R1;JUP;PIK3R2;SUFU;TGFB1;UBR5;RBM22;CABP1;TPR;SMAD3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3301686396308741,0.7751905201602963,0.7598944591029023,1.0,1.0,4/18,15.42%,ANXA1;FGFBP1;PTGS2;FOXC2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.32073689920530785,0.7751187270190699,0.7645569620253164,1.0,1.0,2/20,8.19%,SIK1;WNT4
prerank,regulation of G0 to G1 transition (GO:0070316),0.29340838019017085,0.7750211780502734,0.7892271662763466,1.0,1.0,10/38,20.17%,TFDP1;RBBP4;EZH2;PCGF6;EHMT2;EHMT1;CBX5;RBBP8;YAF2;E2F6
prerank,negative regulation of TOR signaling (GO:0032007),0.2910997090356741,0.7745823933977439,0.7737397420867527,1.0,1.0,15/36,25.85%,TSC2;TBC1D7;FLCN;STK11;RNF152;PRKAA1;PDCD6;NPRL2;SESN1;ATM;TSC1;TMEM127;NPRL3;CASTOR2;DEPTOR
prerank,tube closure (GO:0060606),0.29602028240620193,0.7745119810865562,0.7790973871733967,1.0,1.0,3/31,5.37%,DVL2;TSC2;SCRIB
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3156999675951028,0.7743598281460294,0.7800511508951407,1.0,1.0,6/21,18.38%,PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2
prerank,regulation of interleukin-17 production (GO:0032660),0.29516957977282676,0.7743592671574955,0.7748427672955975,1.0,1.0,3/31,14.28%,ZBTB7B;DDIT3;TGFB1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2672793562775768,0.774309534258498,0.8442105263157895,1.0,1.0,20/86,21.53%,BMP6;ZEB2;FLCN;SULF1;STK11;TGFB1I1;SDCBP;SOX11;RBPJ;BMP5;TGFB1;ACVR1B;NUMA1;SNW1;RNF111;TGFBR1;FOXD1;DAB2;ACVR2A;SMAD2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2699152458153145,0.7742509259509609,0.8426124197002142,1.0,1.0,19/68,19.58%,SMN1;SLBP;TBP;PRMT5;CPSF7;GTF2H3;CSTF2T;MAZ;NUDT21;POLR2K;CCNH;CPSF3;SETX;POLR1A;CDK7;POLR3K;TAF1B;FIP1L1;CSTF3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3528453919787359,0.7740999772308278,0.7574893009985735,1.0,1.0,5/13,18.99%,CPSF7;CSTF2T;NUDT21;CPSF6;FIP1L1
prerank,regulation of chromatin organization (GO:1902275),0.3435472382613499,0.773989712105039,0.7446504992867332,1.0,1.0,6/14,20.48%,CDK9;SETD1A;TLK1;SETD5;MLLT3;HNRNPU
prerank,proteoglycan biosynthetic process (GO:0030166),0.3020126514380627,0.7737714643930699,0.7900485436893204,1.0,1.0,3/31,6.08%,IGF1;EXTL3;CHST10
prerank,positive regulation of chromatin organization (GO:1905269),0.3527792771779379,0.7732922171727511,0.7628111273792094,1.0,1.0,6/12,21.66%,ATRX;TERF1;DAXX;TERF2IP;MIER1;H3-3A
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2247454126259232,-0.7730193555687465,0.8670212765957447,0.9379766144835523,1.0,9/30,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;TTF1;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2671330519956412,0.772998271784589,0.8213132400430571,1.0,1.0,23/72,24.49%,PSMD4;MAP3K14;NFKB2;TIRAP;PSMB10;PSMD11;MALT1;PSME2;PSMC5;TLR3;PSMD1;PSMD6;RELB;BIRC3;PSMD5;PSMA4;PSMA1;PSMC6;TRAF2;PSMA5;REL;PSMD14;TRAF6
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3424210509257246,0.7729073199528748,0.7741935483870968,1.0,1.0,4/15,17.45%,ADGRV1;SCN1A;KCNA1;COL11A1
prerank,positive regulation of dephosphorylation (GO:0035306),0.3090838579088402,0.772680697730193,0.7698019801980198,1.0,1.0,9/27,21.79%,CALM3;TGFB1;CAMTA1;PPP2R5A;CALM1;SMPD1;DLC1;PTBP1;CALM2
prerank,cellular response to organic substance (GO:0071310),0.2583894099429484,0.7724215522352071,0.860392967942089,1.0,1.0,17/116,15.82%,KHSRP;CLEC3B;SFRP1;CDK9;CXCR4;PID1;PLK5;PTPN5;ROBO2;NFAT5;IL1RAPL1;PARK7;RACK1;TGFB1;SLIT3;ACVR1B;PTPN12
prerank,carbohydrate biosynthetic process (GO:0016051),0.31401279886581235,0.7718094053459909,0.7674418604651163,1.0,1.0,3/21,14.34%,ST3GAL2;ST3GAL3;ST6GALNAC6
prerank,nucleus organization (GO:0006997),0.27783760569008586,0.771794613589858,0.7757225433526012,1.0,1.0,16/47,24.14%,REEP4;BIN1;DMPK;CHMP3;LEMD3;VPS4B;NUMA1;NUP35;TPR;SUN1;CHMP4A;CHMP4B;NUP155;SYNE1;NUP54;NUP98
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.28726230548090037,0.7717177222622857,0.7974388824214202,1.0,1.0,18/41,25.80%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;NUP214;NUP153;RANBP2;PRKAG2;NUP35;SCARB2;TPR;NUP155;NUP54;NUP98;POM121;SEH1L
prerank,protein localization to microtubule organizing center (GO:1905508),0.3465382633894402,0.7716745162373646,0.7700831024930748,1.0,1.0,4/15,13.76%,SNX10;PIBF1;HOOK3;CSNK1D
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.33443241387611294,0.7715905284023541,0.7615176151761518,1.0,1.0,1/17,2.97%,GPD1L
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3235799041551608,0.7712462206377698,0.756544502617801,1.0,1.0,2/21,6.49%,DVL2;DVL1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.317985174592302,0.7710284715365565,0.7703604806408545,1.0,1.0,4/21,10.62%,FIS1;RAP1GDS1;PDZD8;AFG3L2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.25624926910191254,0.770904051734398,0.9051020408163265,1.0,1.0,42/158,23.40%,SLC35B2;MAP3K14;ATP2C1;EDAR;EDA2R;TIRAP;CARD16;TMEM106A;BRD4;CC2D1A;TIFA;TRIM62;GPRC5B;DHX36;WLS;MALT1;TFG;PLEKHG5;LAMTOR5;AKAP13;LPAR1;PPP5C;NDFIP2;SLC44A2;MTDH;ZDHHC17;S100A13;TERF2IP;TRIM27;BIRC3;PELI2;PPM1A;MIER1;TRAF3IP2;TAB3;MID2;UBE2V1;TRAF2;TRIM8;TNFRSF19;REL;FKBP1A
prerank,negative regulation of angiogenesis (GO:0016525),0.26255278743678867,0.7707239585317467,0.8480340063761955,1.0,1.0,24/84,21.14%,THBS2;SULF1;DCN;SPARC;HGS;ATF2;PIK3CB;SARS1;ROCK2;SEMA3E;HSPG2;ADAMTS1;SERPINE1;SPRY2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;EPN1;KLF4;SERPINF1;ATP2B4;FOXJ2
prerank,striated muscle cell development (GO:0055002),-0.26941879505933053,-0.7707208874127167,0.7774086378737541,0.9403888322262329,1.0,4/14,31.69%,PGM5;TMOD1;LMOD1;SDC1
prerank,histone H4-K16 acetylation (GO:0043984),0.3161787341601453,0.7705641010797992,0.7612323491655969,1.0,1.0,4/19,13.99%,MSL2;OGT;MSL1;KANSL2
prerank,positive regulation of behavior (GO:0048520),0.36541761089635827,0.7705299072652176,0.7633136094674556,1.0,1.0,2/10,12.46%,STRA6;CFAP20
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.3479971010147826,0.7702768304451821,0.7727272727272727,1.0,1.0,6/13,20.92%,BARD1;PARK7;SUFU;NUP153;CABP1;TPR
prerank,positive regulation of binding (GO:0051099),0.26551603188479334,0.7702132654934093,0.8438155136268344,1.0,1.0,14/84,17.48%,VTN;IGF1;KDM4D;SIRT2;TCF7L2;EGF;GPSM1;APP;CEBPG;ADD2;LRP1;DERL1;APOE;USP33
prerank,JNK cascade (GO:0007254),0.28837543624261197,0.7696031636429777,0.7958715596330275,1.0,1.0,3/40,4.55%,MAPK9;PTGER4;MINK1
prerank,protein dephosphorylation (GO:0006470),0.25543808877738294,0.7694826208629222,0.8865248226950354,1.0,1.0,48/135,25.67%,DUSP18;DUSP26;PPP2R2C;PPM1B;STK11;CDC14B;SSH1;PPP2R5E;PPP1CC;PPM1H;PTPN5;PTPRF;PTPN3;TNS2;PTPN22;EYA2;PPM1E;PPP2R5D;CTDSP2;PPP5C;PPM1M;PTPN12;MTMR4;PPP2CB;PPP2R5A;PTPRE;TAB1;PPM1A;PTPRS;EYA1;PTPRR;PPP2R2B;PPM1F;PPP2R2A;RPAP2;DUSP16;PTEN;PPP3CB;PPP2R5C;PPM1D;PPP4R1;PPP2R2D;MTM1;PTPN14;PTPRA;DUSP3;PTPN13;FBXW11
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.32596784888572505,0.7694441771062522,0.7631917631917632,1.0,1.0,3/19,9.11%,CHD8;PRDX5;DHX36
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3043326103748777,0.7688384977838434,0.772554002541296,1.0,1.0,6/24,22.83%,CHERP;ITPR1;HTR2C;PKD2;FGF2;IBTK
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.34681625370408725,0.7686622242859077,0.7547169811320755,1.0,1.0,3/13,15.96%,KHSRP;NUDT21;ZC3HAV1
prerank,glycoprotein metabolic process (GO:0009100),0.275567586893627,0.7683101776622729,0.7959413754227734,1.0,1.0,11/53,17.26%,ST8SIA3;ST3GAL2;MGAT4B;NGLY1;MAN1A2;MANBA;PARK7;B4GALT5;ST6GALNAC6;MAN1C1;TNIP1
prerank,microtubule anchoring at centrosome (GO:0034454),0.3715594890901136,0.7681492758998464,0.7631975867269984,1.0,1.0,3/10,17.04%,KIF3A;HOOK3;NIN
prerank,membrane protein proteolysis (GO:0033619),0.2890236091111601,0.7680772975267586,0.8058823529411765,1.0,1.0,13/37,24.88%,NFKB1;HM13;MBTPS1;AFG3L2;DAG1;TGFB1;CTSH;PARL;NAPSA;MYH9;SPPL2A;TRAF6;CLPP
prerank,negative regulation of insulin secretion (GO:0046676),0.3309940823246611,0.767777816856897,0.789544235924933,1.0,1.0,1/17,1.12%,SFRP1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3285154649410723,0.767663226470429,0.7638121546961326,1.0,1.0,3/16,14.28%,SUCO;WNT4;TGFB1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2903928966788064,0.7676567632342212,0.7990654205607477,1.0,1.0,6/39,11.84%,PPIF;GPD1L;YWHAH;SCN2B;FGF12;PTPN3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.2713252556055944,0.7674203119520638,0.8467309753483387,1.0,1.0,11/67,11.01%,HSP90AA1;RAC1;SH2D2A;NRP1;SULF1;PIK3R1;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.25790964566276436,0.7673754880622433,0.8807339449541285,1.0,1.0,23/125,19.91%,B9D2;CENPT;INCENP;TAOK1;MAD2L1;NEK9;KPNB1;DCTN6;PPP1CC;CEP126;GPSM2;DYNC1LI1;RCC1;CENPC;ZWINT;TNKS;BCCIP;MAP4;MECP2;RANBP2;DYNLL1;ZW10;PAFAH1B1
prerank,protein sumoylation (GO:0016925),0.2794830832537909,0.7673542258856296,0.8101123595505618,1.0,1.0,19/49,24.14%,SAE1;RAE1;NUP188;NUP210;NUP88;PIAS3;NUP214;TOPORS;NUP153;RANBP2;NUP35;PIAS1;SUMO2;EYA1;TPR;NUP155;UBA2;NUP54;NUP98
prerank,calcineurin-mediated signaling (GO:0097720),-0.3191219864756273,-0.7672351162818629,0.7635782747603834,0.9430401639359975,1.0,3/10,15.47%,NFATC1;NFATC2;NFATC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3191219864756273,-0.7672351162818629,0.7635782747603834,0.9430401639359975,1.0,3/10,15.47%,NFATC1;NFATC2;NFATC4
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.20814475481802833,-0.7671443301496023,0.8538461538461538,0.9418414918553821,1.0,16/41,31.15%,PNPLA8;MGLL;SCP2;DAGLB;CYP1B1;ACOT8;FADS2;ELOVL5;DEGS1;GPX1;FADS3;DECR2;EPHX1;SCD;GSTM2;PLA2G4A
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3463552062548979,0.7668663851145083,0.7677053824362606,1.0,1.0,2/13,10.40%,IGF1;IRS2
prerank,protein targeting (GO:0006605),0.256011204897157,0.7667171770164091,0.8603465851172273,1.0,1.0,32/118,22.95%,CACNG3;EDEM1;FIS1;TOMM20;FBXO7;TIMM13;ZFAND6;ZDHHC3;MFN2;AIP;SDCBP;KATNB1;PEX1;GDAP1;PRKCI;ZFAND2A;ATG3;AP4M1;SEC61G;TRAK1;AP4E1;SORL1;ZDHHC2;AP4S1;TIMM44;TIMM22;SEC63;RTP4;TIMM23;PIKFYVE;ZDHHC14;ZDHHC21
prerank,tRNA processing (GO:0008033),0.2718324914105461,0.7666520781060157,0.8164835164835165,1.0,1.0,16/61,21.86%,DTWD1;ANKRD16;TRDMT1;AARS1;SARS1;TRMT1;RPP30;PTCD1;QTRT2;URM1;RTCB;WDR4;RTRAF;FARS2;ZBTB8OS;TRMT6
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.33435094474375343,0.766550673560314,0.7614285714285715,0.9999730942960071,1.0,2/15,10.19%,SOX9;GDNF
prerank,cellular sodium ion homeostasis (GO:0006883),0.34265220331624074,0.7663585983160931,0.7673758865248227,0.9997970093192646,1.0,2/15,7.53%,ATP1A3;ATP1A2
prerank,response to axon injury (GO:0048678),-0.2540806505138359,-0.7662721187406409,0.8278688524590164,0.9417984484377443,1.0,13/18,46.77%,RTN4RL1;P2RY12;DHFR;FLRT3;MORN4;SARM1;TYROBP;P2RX4;NREP;GAP43;APOD;TREM2;MTR
prerank,regulation of GTPase activity (GO:0043087),0.25328256300586294,0.7662543120854292,0.8932527693856999,0.9995215629416214,1.0,27/177,13.79%,SFRP1;CDKL5;PLXNA2;TBC1D7;SGSM3;RAP1GDS1;RGS10;FLCN;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RAP1GAP;PLXNA1;DOCK8;RAPGEF1;VAV2;GPSM1;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;RACK1;ADAP1;RABGAP1
prerank,regulation of receptor recycling (GO:0001919),0.3272802603489648,0.7662484241461606,0.7712328767123288,0.9991044309148067,1.0,4/16,16.65%,SCRIB;VAMP3;NSF;ANXA2
prerank,T cell receptor signaling pathway (GO:0050852),0.25564351973907623,0.7659975283654342,0.8850102669404517,0.9990237915041845,1.0,17/138,11.23%,PSMD4;PDPK1;NFKB1;PRAM1;PIK3R1;THY1;PSMB10;PAK3;PSMD11;TEC;THEMIS;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;RC3H2
prerank,brain morphogenesis (GO:0048854),-0.30046605956971606,-0.7654088323907915,0.7541528239202658,0.9417907184193491,1.0,6/12,30.53%,SHANK3;BBS2;BBS4;SPEF2;VPS51;MKKS
prerank,aromatic amino acid family metabolic process (GO:0009072),0.37128691813845305,0.765251975984483,0.7665198237885462,0.9996389117334471,1.0,2/10,15.38%,ASRGL1;QDPR
prerank,"phagocytosis, engulfment (GO:0006911)",0.2906354966543053,0.7652439317207319,0.796875,0.9992251718822174,1.0,2/36,2.78%,FCGR2B;RAC1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.36276015305010767,0.7651665342102065,0.7759146341463414,0.9984967593865732,1.0,2/10,12.69%,SMPD2;RACK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.36276015305010767,0.7651665342102065,0.7759146341463414,0.9984967593865732,1.0,2/10,12.69%,SMPD2;RACK1
prerank,UV protection (GO:0009650),0.36892345540544036,0.7649101157366356,0.7503692762186115,0.9984422874904246,1.0,1/10,2.32%,MFAP4
prerank,estrogen metabolic process (GO:0008210),0.3360364055005207,0.7647810110925012,0.754874651810585,0.998205698312088,1.0,2/15,16.33%,HSD17B4;SULT1A1
prerank,amino sugar biosynthetic process (GO:0046349),0.346428903373608,0.7645985895910608,0.762043795620438,0.9980530946021372,1.0,2/12,6.77%,RENBP;GNPNAT1
prerank,cholesterol transport (GO:0030301),0.28315139969529524,0.7645632254093271,0.8047673098751419,0.9976812976099451,1.0,11/45,22.05%,STARD5;RELCH;SOAT1;ABCA7;STARD3;APOE;ABCA5;LIMA1;NPC2;ABCG1;NPC1
prerank,regulation of T cell cytokine production (GO:0002724),0.33751114544446736,0.7644784578644901,0.7824858757062146,0.9973815112827018,1.0,5/15,24.49%,MALT1;SMAD7;TRAF2;B2M;TRAF6
prerank,protein localization to nucleus (GO:0034504),0.26021965817375164,0.7641572503014252,0.8694300518134715,0.9974353321431515,1.0,30/102,23.13%,MMP12;TSC2;CHCHD10;NXT2;NXT1;DVL1;KPNB1;ABCA7;TOR1B;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;TOPORS;MDM2;NUP153;BANP;PPP1R10;TOR1AIP2;HNRNPU;HEATR3;TPR;APPL2;PIKFYVE;NUP155;PINX1;CSE1L
prerank,response to progesterone (GO:0032570),0.320834897361169,0.7638042141110084,0.7838926174496644,0.9975044280248195,1.0,2/18,6.78%,WBP2;CATSPER3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.32913529465656544,0.7635452417437933,0.7623497997329773,0.9974406046682824,1.0,6/18,18.25%,HSP90AA1;NELL1;CDK5RAP3;WDR91;FAF1;ATRAID
prerank,receptor internalization (GO:0031623),0.2791624939281754,0.763432166425981,0.8241379310344827,0.9971712160884789,1.0,7/44,15.11%,DNM1;ADM;ARRB1;GRK3;LRP1;GRK2;RAB31
prerank,membrane depolarization during action potential (GO:0086010),0.30587413819018483,0.7631356595416756,0.7820197044334976,0.9971658977956227,1.0,5/26,10.99%,SCN7A;ATP1A2;YWHAH;SCN2B;SCN1A
prerank,regulation of glucose transmembrane transport (GO:0010827),0.32899420099976984,0.7630770025102949,0.7842876165113183,0.9968261670790558,1.0,2/18,9.67%,RTN2;CLIP3
prerank,negative regulation of DNA replication (GO:0008156),-0.2837897170342863,-0.7629158362259719,0.8218390804597702,0.9441559676024586,1.0,2/13,10.10%,WAPL;PDS5A
prerank,eosinophil migration (GO:0072677),-0.2800063191628236,-0.7628726527540186,0.8088737201365188,0.9415771926329813,1.0,11/14,61.17%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.2800063191628236,-0.7628726527540186,0.8088737201365188,0.9415771926329813,1.0,11/14,61.17%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.3414357000820229,0.7628302449372492,0.7656675749318801,0.9967288565653434,1.0,1/14,2.70%,EDN3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3550806725339539,0.762511006792507,0.7623318385650224,0.9967468612480003,1.0,2/11,6.77%,RENBP;GNPNAT1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3490857131153956,0.7620930106031897,0.7609682299546142,0.9969200810315341,1.0,3/12,20.33%,THY1;FLOT1;GCNT2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.3059949211855919,-0.7620689204213732,0.7708333333333334,0.9414922123029584,1.0,4/10,17.54%,SETD2;SETD3;SMYD2;SETD4
prerank,integrated stress response signaling (GO:0140467),0.34137629779423556,0.7619973563325396,0.7867036011080333,0.9966169307580613,1.0,4/14,17.63%,EIF2AK3;DDIT3;IMPACT;OMA1
prerank,cellular response to alkaloid (GO:0071312),-0.26640086042694844,-0.7612080878981073,0.8065843621399177,0.9414469748997664,1.0,11/17,39.42%,TGM2;SPIDR;BLM;CASP3;RYR2;GSTM2;SLC8A1;CASP6;HTR1B;CASQ2;RAD51
prerank,response to interleukin-4 (GO:0070670),0.3639937921465835,0.7609394374293016,0.7819548872180451,0.9976307298484797,1.0,1/10,3.79%,XBP1
prerank,regulation of interleukin-2 production (GO:0032663),0.27839701382957666,0.7608537008146559,0.8286713286713286,0.9973308341179002,1.0,12/43,25.02%,ANXA1;TNFAIP3;MALT1;SPTBN1;PDE4B;PRKD2;TRIM27;RPS3;TRAF2;TRAF6;RUNX1;NAV3
prerank,regulation of response to oxidative stress (GO:1902882),0.3627966345320015,0.7602243937192702,0.7732732732732732,0.9977792433677181,1.0,1/11,3.34%,AIFM2
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.33663309660987234,0.760069833112601,0.7707182320441989,0.9975681128051087,1.0,6/15,23.40%,LEMD3;MAGI2;ACVR1B;ACVR2A;SMAD7;FKBP1A
prerank,gene expression (GO:0010467),0.24739645469779295,0.7599694597442822,0.968,0.9973032141606444,1.0,76/348,19.45%,MRPL36;FARSB;DDX17;DDX19B;SLBP;STUB1;RBM3;NXT1;U2AF1;SRSF2;WARS1;YARS2;RAE1;POLR2B;SRSF5;RBM39;CELF2;DHX8;ATXN1;SRSF3;HNRNPK;MPHOSPH10;THOC3;SRSF9;SRSF1;PABPC4;HNRNPD;DRG1;MRPL10;NUP188;RPL35A;RPS25;SARS1;RPS15;RBMS1;RBMS2;POLR2K;CPSF3;NUP210;RPL9;THOC7;HARS1;HNRNPH3;NUP88;SETX;HNRNPL;MRPL3;GSPT1;MMS19;RPL4;NOVA1;HNRNPA2B1;MRPL13;THOC1;NUP214;PPP5C;HSPD1;MRRF;YTHDC1;MRPL24;UPF2;RPL23A;RPLP2;TNIP1;SRRM1;TOPORS;SORL1;NUP153;SMG7;RANBP2;TAF1B;FIP1L1;NUP35;MRPS6;RPS3;RPL27A
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.26140452405889497,0.7598433107190771,0.8497354497354498,0.9970492411244973,1.0,28/80,25.21%,TRAPPC10;SNX5;STX6;VAMP3;SNX6;VPS26B;STX16;TMEM87B;RHOBTB3;DENND5A;VPS54;VTI1B;VTI1A;RAB6A;SGSM2;TRIM27;STX5;HEATR5A;RAB7A;RAB7B;EHD3;PIKFYVE;GOSR1;DENND2A;GGA1;HEATR5B;SURF4;LMAN1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3034475962374232,0.7596947873076216,0.8041615667074663,0.9968312786676451,1.0,8/27,23.40%,CACNB4;CACNB1;CAMK2D;AHNAK;JPH1;CALM1;CALM2;FKBP1A
prerank,regulation of chromatin binding (GO:0035561),0.3668482225680082,0.7592060188119047,0.7731481481481481,0.9970601521463796,1.0,1/10,1.29%,KDM4D
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3254244190679746,0.7591617811382247,0.7859973579920739,0.9966968359718957,1.0,5/19,15.53%,DDX3X;DHX36;IRF3;TLR3;HSPD1
prerank,skeletal muscle organ development (GO:0060538),0.3018639652459072,0.7590032294126791,0.7807351077313055,0.9964899811985819,1.0,2/26,4.00%,STRA6;MYH14
prerank,cellular response to superoxide (GO:0071451),0.36359828169038416,0.7589991635033221,0.7673410404624278,0.9960775080024376,1.0,2/10,12.47%,SOD2;SOD3
prerank,negative regulation of transferase activity (GO:0051348),0.2993882535181539,0.7583989229221952,0.7957920792079208,0.9964919004548739,1.0,9/28,20.88%,ABL1;FBXO5;IRS2;PARK7;MAPT;TERF1;HNRNPU;NPRL2;SMAD7
prerank,positive regulation of isotype switching (GO:0045830),-0.25947393323477735,-0.7583348542170396,0.7986577181208053,0.944283352573021,1.0,2/15,6.01%,SHLD2;PAXIP1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.32123273981868894,0.7582532628961198,0.7992227979274611,0.9962706174790851,1.0,6/20,20.71%,BAX;CASP9;BCL2;CASP2;DCC;ITGAV
prerank,determination of heart left/right asymmetry (GO:0061371),-0.19096502890108583,-0.7578276122535808,0.937984496124031,0.9437464533271107,1.0,11/42,22.64%,MEF2C;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;CCDC39;SOX17;MICAL2;TBX2
prerank,replication fork processing (GO:0031297),0.2811123785076345,0.7576572353369883,0.8273045507584598,0.996660786492981,1.0,8/38,15.16%,CDK9;FBH1;FANCM;ATR;ATRX;THOC1;NUCKS1;MRE11
prerank,anterior/posterior axis specification (GO:0009948),0.3316887260993975,0.757420764400225,0.7922971114167813,0.9965548490622784,1.0,2/15,9.61%,DDIT3;WLS
prerank,substrate-dependent cell migration (GO:0006929),0.33679844896014544,0.7571844171814919,0.761969904240766,0.9964846619647841,1.0,3/14,8.75%,NRP1;EPHA8;SDCBP
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.34934781507602153,0.7568487906719774,0.7730600292825769,0.9965431888015436,1.0,4/12,21.79%,CALM3;CAMK2D;CALM1;CALM2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3058860724190886,0.7567729456745224,0.7948402948402948,0.99623756978869,1.0,8/26,20.58%,GRIN1;TMEM108;APP;NLGN3;NLGN2;SHANK1;PRKCZ;PTK2B
prerank,defense response to symbiont (GO:0140546),0.25753094931386133,0.7566096439340748,0.8768421052631579,0.9960390567043983,1.0,16/92,16.95%,NDUFAF4;MAP3K14;RNASE1;OPRK1;TTC4;IRF1;TRIM56;IFIT3;BCL2;SHFL;IRF3;TLR3;NT5C3A;AGBL4;MLKL;OAS2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.24509770914067533,0.7563192182211627,0.954954954954955,0.9960121708305261,1.0,79/327,20.76%,DVL2;NR1D2;PCGF1;RORA;NFKB2;PSPC1;ZNF205;CNBP;ABL1;ATXN1;PHF1;DVL1;ZNF35;CASZ1;EZH2;FUS;MAGED1;ZBTB38;ASCC1;ZKSCAN5;ACTR8;NFX1;DDIT3;HNRNPD;PRMT5;SOX11;SAP30L;FADS1;ATF2;POU6F2;NSD3;FOXN3;ZMIZ1;BACH1;SOX6;SUFU;ATRX;ESRRG;TULP3;KMT2D;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;GTF2IRD1;CHEK2;SBNO1;CLOCK;TRIP4;DAXX;UBE2L3;ZFP37;SOX13;HP1BP3;TCF7;NFXL1;NSD1;PHF12;GCFC2;NONO;TGFBR1;TERF2IP;NUP35;SOX4;BRDT;YAF2;MITF;CDK11B;WWC1;CARM1;NFIA;CHD7;UTP4;ZNF219;YBX1
prerank,organophosphate catabolic process (GO:0046434),0.35444828981071874,0.7560329465206255,0.7779456193353474,0.9959799899131546,1.0,1/11,10.25%,ENPP2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.25439779523522954,0.7555995108923184,0.8786307053941909,0.9961723066279201,1.0,28/112,21.53%,WNT5A;CLEC3B;SFRP1;CGN;SMAD9;ZFP36L1;WNT4;SOX9;USP15;COL1A2;ZMIZ1;SOX6;USP9X;TGFB1;SMAD6;SOX5;CBL;SMURF1;TGFBR1;PDCD5;WWOX;PRKCZ;GCNT2;TGFBR3;SMAD7;ITGB1;APPL2;SMAD2
prerank,prostaglandin metabolic process (GO:0006693),0.298092118196874,0.7555274694275609,0.7890137328339576,0.995852768935364,1.0,1/26,0.44%,PRXL2B
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.34998148987612526,0.7554907500716483,0.7542372881355932,0.9954840664057438,1.0,1/11,1.59%,GPLD1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.2905496278591525,0.7550312667804713,0.8095238095238095,0.995680024478701,1.0,6/31,14.82%,RANBP3L;SOX9;PTCH1;TWIST1;SUFU;SMAD6
prerank,nuclear migration (GO:0007097),0.33602903441790155,0.7550093793347217,0.7651296829971181,0.9952953747479094,1.0,5/13,19.91%,CLMN;HOOK3;DOCK7;CEP120;PAFAH1B1
prerank,peptidyl-serine modification (GO:0018209),0.25209670138759804,0.7549705918680474,0.9040404040404041,0.994939607620635,1.0,30/166,16.60%,MAPK9;CAMK1G;PDPK1;CSNK2A2;GALNT16;PARP1;EIF2AK3;DMPK;PARP2;PRKCA;CDK5;MAST3;GALNT4;SBK1;NTMT1;TOP1;BRSK1;CAMK2D;TLK1;ATR;RPS6KA3;PRKCI;CSNK1D;ROCK2;GRK2;CSNK1A1;RPS6KA1;NDNF;CAMK1D;TNKS
prerank,negative regulation of cell junction assembly (GO:1901889),0.3043051246693696,0.7545035010276595,0.7833125778331258,0.9951730695470287,1.0,11/25,24.81%,DMTN;ROBO2;ROCK2;SLIT1;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,mitochondrial translational elongation (GO:0070125),0.25860123191218665,0.7544705433478601,0.868421052631579,0.994799304949928,1.0,23/88,23.10%,MRPL36;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;CHCHD1;MRPL13;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS28;MRPS35;GFM1
prerank,stress granule assembly (GO:0034063),0.3176204199281932,0.7538927672784145,0.7976031957390146,0.9951622179418516,1.0,7/20,19.78%,DDX3X;ATXN2L;YTHDF3;YTHDF1;MAPT;YTHDF2;CIRBP
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2901070674664628,0.7534291129799945,0.8142857142857143,0.9953590419385662,1.0,6/37,13.72%,PARP1;NTHL1;DDB1;CUL4B;GTF2H3;POLD3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.358488490471792,0.7533652403277397,0.7768115942028986,0.995031269991225,1.0,1/10,1.57%,FOXM1
prerank,embryonic organ development (GO:0048568),0.266607138992978,0.7531457325626527,0.8358531317494601,0.9949186660977287,1.0,9/61,14.28%,TEAD3;STRA6;FGFR2;PCSK5;TEAD1;GDNF;RBPJ;NDRG4;TGFB1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2698053916817346,0.7531290158028877,0.8320441988950277,0.9945230034180574,1.0,10/57,12.27%,MRPL36;EBNA1BP2;GLUL;CUL4B;RBIS;RPL35A;RPS25;RPS15;MALSU1;NPM1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.34410086048871924,0.7530555206256414,0.7708333333333334,0.9942130685841125,1.0,2/13,9.15%,PIGU;EGF
prerank,rRNA processing (GO:0006364),0.24866059964536233,0.7523255616726173,0.9035532994923858,0.9947501100109278,1.0,24/172,14.06%,NHP2;LSM6;EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;MRPL1;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;RPL9;C1D;RPL4;BMS1
prerank,positive regulation of transmembrane transport (GO:0034764),0.3448447825608851,0.7520505833569274,0.7816901408450704,0.9947154176938534,1.0,2/13,9.67%,AZIN2;CLIP3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.30424164478655014,-0.7519561665721994,0.7655786350148368,0.9510356369309958,1.0,3/10,12.00%,IVD;ACAD11;ETFDH
prerank,inorganic anion transport (GO:0015698),0.2712586912579462,0.7517978000625488,0.8411111111111111,0.9946592281822223,1.0,7/53,14.46%,BEST1;CLCN2;SLC13A4;CLCN4;CLIC1;ENPP1;GLRA1
prerank,sphingoid metabolic process (GO:0046519),-0.29439157033512764,-0.751058867992042,0.7859649122807018,0.9509306066952646,1.0,3/12,16.39%,KDSR;NAAA;DEGS2
prerank,sodium ion homeostasis (GO:0055078),0.31486988646460556,0.7507642945175894,0.7918313570487484,0.9956018035072703,1.0,2/21,7.53%,ATP1A3;ATP1A2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.270421662629727,-0.7503785892204179,0.7789473684210526,0.9506085722221195,1.0,4/14,14.13%,NUDT5;ENTPD1;ADPRM;ENTPD6
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.270671786567501,-0.7502627093928079,0.8181818181818182,0.9494480787205479,1.0,5/14,31.27%,LGALS9;TGFBR2;CD81;CD55;SYK
prerank,negative regulation of leukocyte migration (GO:0002686),0.3619930944259909,0.7502389753227912,0.7927382753403933,0.9958910462241757,1.0,2/10,11.52%,CD200R1;BMP5
prerank,mitotic nuclear membrane organization (GO:0101024),0.26942934884204384,0.7499288314089638,0.8324022346368715,0.9955126955519531,1.0,7/51,12.64%,REEP4;SIRT2;CC2D1B;KPNB1;CHMP3;NUP188;RCC1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.26942934884204384,0.7499288314089638,0.8324022346368715,0.9955126955519531,1.0,7/51,12.64%,REEP4;SIRT2;CC2D1B;KPNB1;CHMP3;NUP188;RCC1
prerank,positive regulation of B cell activation (GO:0050871),0.26760241583442024,0.7499047744926611,0.8228699551569507,0.9951296126216619,1.0,5/50,11.06%,EPHB2;XBP1;TIRAP;IRS2;BCL2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3523265565358399,0.7498493501736536,0.7754491017964071,0.9947869564336397,1.0,3/10,17.64%,ABCA7;APOE;BMP1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3541806029862888,0.7491841677056351,0.7769461077844312,0.9952197028302804,1.0,1/10,2.67%,HSP90AA1
prerank,positive regulation of T cell proliferation (GO:0042102),0.26450563035246716,0.7489985931820512,0.838452787258248,0.9950675517789003,1.0,3/55,7.55%,IGF1;ANXA1;CD24
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.28975917823224673,0.7489970519107119,0.8196915776986952,0.9946573680272272,1.0,5/34,14.46%,MPP2;GRIN1;GRIN2A;NLGN3;GLRA1
prerank,positive regulation of chemotaxis (GO:0050921),0.2756682111026192,0.7488907419233728,0.819557625145518,0.994389492941949,1.0,9/43,21.66%,EDN3;NRP1;DSCAM;TGFB1;F3;MEGF8;PRKD2;FGF2;PPM1F
prerank,chondroitin sulfate metabolic process (GO:0030204),0.2910012477416512,0.7486289055744914,0.8146341463414634,0.9943336941626771,1.0,7/30,21.21%,CHPF;DCN;CHSY3;ARSB;NDNF;DSE;CHST9
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.33246481156303,0.7477781380508509,0.7965860597439545,0.9950583268419093,1.0,3/14,13.28%,TIRAP;MALT1;TLR3
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.29393229853778063,0.7474653997954223,0.7947434292866082,0.995070568230862,1.0,5/26,15.82%,PDPK1;ZFP36L1;SOX9;IQGAP1;PTPN12
prerank,negative regulation of protein binding (GO:0032091),0.2608326242053254,0.7466469449095603,0.8638799571275455,0.9957454372307921,1.0,16/71,17.95%,BAX;ATP2A2;CARD16;DVL1;LRPAP1;PTPRF;PARK7;RACK1;DISC1;CTSZ;CTNNBIP1;PSME3IP1;ITGB1BP1;TLE5;USP33;SORL1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.25845428063855064,0.7456687976875439,0.8469945355191257,0.9966498200486343,1.0,23/70,24.80%,PSMD4;ABL1;PSMB10;PSMD11;PUS7;PSME2;PSMC5;SETD1A;CBFB;PSMD1;TCF3;PSMD6;KMT2A;YTHDF2;PSMD5;PSMA4;PSMA1;PSMC6;N4BP2L2;PSMA5;YAP1;PSMD14;RUNX1
prerank,positive regulation of nervous system development (GO:0051962),0.2789102226529284,0.7453317256308752,0.8443396226415094,0.9966779310698025,1.0,11/42,21.20%,EPHB2;SOX11;CLSTN2;IL1RAPL1;NLGN3;NLGN2;SNW1;IL1RAP;CLSTN3;SERPINF1;DLG5
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.32766753249009184,0.7452771421886447,0.7871485943775101,0.9963426446672419,1.0,1/17,0.79%,UBQLN1
prerank,protein homotetramerization (GO:0051289),-0.1867749492966576,-0.7452111079097977,0.9421487603305785,0.955039952478875,1.0,15/49,25.90%,SAMHD1;OSBPL2;ACACA;KCNJ2;GLS;ACACB;GBP5;ALDOA;UPB1;MCOLN1;ALDH9A1;APIP;CBR4;HCN1;KCNJ12
prerank,response to amino acid starvation (GO:1990928),0.2592612495599742,0.7450118835772896,0.8435814455231931,0.9962793477137701,1.0,15/72,16.99%,EIF2AK3;SLC38A9;FLCN;ATP6V0E2;RRAGA;GCN1;ATF2;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;ATP6V1D;IMPACT;ATP6V1B2;MIOS
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.30961524769426463,0.744538252776518,0.7911646586345381,0.9964989866998973,1.0,4/18,17.54%,RGS10;CHRM2;GRK2;GNAQ
prerank,cellular protein catabolic process (GO:0044257),0.26706669256513943,0.7442211599136276,0.8509933774834437,0.9964896529580972,1.0,19/59,24.88%,ADAMTS7;RAB12;VLDLR;CAPN2;AP2S1;MALT1;TCIRG1;CTSZ;CTSH;CHEK2;MDM2;CTSK;CTSO;CTSB;RAB7A;ADAMTS12;MYLIP;SIAH2;CLPP
prerank,cellular response to amino acid starvation (GO:0034198),0.25939970478808155,0.7440937280369218,0.8418201516793066,0.9962484085484685,1.0,15/71,16.99%,EIF2AK3;SLC38A9;FLCN;ATP6V0E2;RRAGA;GCN1;ATF2;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;ATP6V1D;IMPACT;ATP6V1B2;MIOS
prerank,T cell mediated immunity (GO:0002456),-0.2798326039180221,-0.7438817483256014,0.8027210884353742,0.9555836935140924,1.0,2/13,6.13%,CD46;CADM1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.21133753298409938,-0.7437903559275052,0.9181286549707602,0.9543896336590323,1.0,9/32,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;RRN3;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,peripheral nervous system development (GO:0007422),0.3072119912742025,0.7437770503667901,0.8022959183673469,0.996259309251676,1.0,3/23,10.19%,NTF3;GPC1;GDNF
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2567951237247454,0.7436844455715789,0.8520130576713819,0.9959676680778302,1.0,24/73,24.80%,PSMD4;ABL1;PSMB10;PSMD11;DHX36;PUS7;PSME2;PSMC5;SETD1A;CBFB;PSMD1;TCF3;PSMD6;KMT2A;YTHDF2;PSMD5;PSMA4;PSMA1;PSMC6;METTL14;PSMA5;YAP1;PSMD14;RUNX1
prerank,endodermal cell fate commitment (GO:0001711),0.35895195093097687,0.7436656152072765,0.7906295754026355,0.9955853836769378,1.0,2/10,13.57%,RTF1;CDC73
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.2535287619872576,0.7434633873299323,0.8813209494324046,0.9954321367044824,1.0,22/101,19.78%,CLN6;HSP90AA1;STUB1;RBM3;DDX3X;OGT;AURKAIP1;HNRNPD;ZCCHC4;YTHDF3;NPM1;YTHDF1;PRR16;TGFB1;FAF1;ASPSCR1;AGTR1;FMR1;METTL5;SOX4;KLF4;CIRBP
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.34068499988630685,0.7425434710663533,0.7795620437956204,0.9962288897268298,1.0,5/12,22.96%,DCN;PIK3CB;SPRY2;ATP2B4;ADAMTS12
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3243250141277189,0.7421885435932133,0.7932432432432432,0.9958676437651535,1.0,8/16,24.81%,DMTN;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3243250141277189,0.7421885435932133,0.7932432432432432,0.9958676437651535,1.0,8/16,24.81%,DMTN;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.33067917707561767,0.7419557464749106,0.7838214783821479,0.9957646967552285,1.0,2/14,5.95%,NRP1;GAB1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.31140246198692595,0.7417097911039364,0.8007968127490039,0.995245086462592,1.0,4/21,10.07%,PARP1;DDB1;CUL4B;GTF2H3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.31140246198692595,0.7417097911039364,0.8007968127490039,0.995245086462592,1.0,4/21,10.07%,PARP1;DDB1;CUL4B;GTF2H3
prerank,membrane lipid metabolic process (GO:0006643),0.30164069729655874,0.7414677157607691,0.8111702127659575,0.9951437240991486,1.0,3/22,11.89%,SMPDL3B;AGMO;TEX2
prerank,negative regulation of protein transport (GO:0051224),0.2954058469365428,0.7412874068692706,0.8134328358208955,0.9949915617987218,1.0,5/25,17.19%,ERP29;CYP51A1;RHBDF1;NDFIP2;APOE
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3452742086610416,0.739542405955631,0.8011363636363636,0.9968107359274667,1.0,1/11,1.57%,FOXM1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2815621612015245,0.7394893426008512,0.8294117647058824,0.9964646577682688,1.0,6/39,13.72%,PARP1;NTHL1;DDB1;CUL4B;GTF2H3;POLD3
prerank,cellular response to glucagon stimulus (GO:0071377),0.3176769893959027,0.7389138038015808,0.806970509383378,0.9968051407166503,1.0,4/17,18.28%,ADCY7;ADCY1;ADCY5;PRKAR1A
prerank,negative regulation of T cell differentiation (GO:0045581),0.35168621164335356,0.738795627042832,0.8,0.996554947802332,1.0,1/10,5.88%,IRF1
prerank,peptide cross-linking (GO:0018149),0.2980311483848057,0.7385944240035215,0.8090322580645162,0.9964021194326259,1.0,3/25,16.28%,ANXA1;ABCA7;NDNF
prerank,protein modification process (GO:0036211),0.25739505843977106,0.7385582627867742,0.8671625929861849,0.996044784758572,1.0,13/76,17.27%,ARAF;LCMT1;PARP1;UBE2S;ABL1;MANBA;PLAT;SERP1;ATG3;RPN2;NEDD8;UBE2L3;FBXO22
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.286869197093763,-0.7384190995459581,0.7781155015197568,0.9601630251521167,1.0,3/11,10.02%,PARP8;PARP6;PARP10
prerank,artery morphogenesis (GO:0048844),0.28462246814096487,0.7383735098146955,0.8312958435207825,0.9958823023780617,1.0,7/30,20.88%,STRA6;NRP1;LRP1;JAG1;PKD2;TGFBR1;SMAD7
prerank,sister chromatid segregation (GO:0000819),-0.20625243377649105,-0.7379225647930577,0.8809523809523809,0.9595376595180949,1.0,23/31,46.52%,LATS1;RB1;NCAPG2;SMC1A;SMC4;MIS12;KIF18A;RAN;TUBG1;CENPK;KLHL22;DSN1;NUSAP1;TOP2A;KNSTRN;SPAG5;KIF18B;KIFC1;NSL1;NDC80;TUBG2;CDCA8;SGO1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.33324609251186954,0.7379185820762406,0.7908309455587392,0.9960873491917057,1.0,2/13,6.77%,RENBP;GNPNAT1
prerank,T cell differentiation (GO:0030217),0.27239829117602804,0.73764909924646,0.8149425287356322,0.9960383495222511,1.0,9/40,21.30%,ANXA1;ZFP36L1;LEPR;PTPN22;SOX13;TCF7;SOX4;CHD7;GLI3
prerank,response to interferon-alpha (GO:0035455),-0.25646911559108065,-0.7362279677870639,0.8512110726643599,0.960483270572016,1.0,3/16,7.09%,AXL;IFNAR2;EIF2AK2
prerank,mitotic cell cycle phase transition (GO:0044772),0.24176346529008313,0.7361511938394263,0.9526209677419355,0.9975834651371155,1.0,41/203,21.48%,CCP110;CDKN2D;CDC23;FOXM1;LCMT1;HSP90AA1;UBE2S;FBXL12;CDC16;ALMS1;WEE1;BRSK2;CDC25A;TUBA1A;CUL4B;YWHAG;BRSK1;E2F3;CCNH;RCC1;GSPT1;CUL5;HAUS3;CSNK1D;TUBB;ACVR1B;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;USP37;DYNLL1;PAFAH1B1;CDK14;PHLDA1;TAF2;CLASP2;CHMP4B
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.2591802010108268,-0.7359143130299969,0.8231046931407943,0.9595890341286545,1.0,4/15,11.54%,BMPER;TJP1;SMAD1;PKM
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.3390540170312354,0.735245584605512,0.7887323943661971,0.9983511477611282,1.0,5/13,22.16%,FGFR2;RBPJ;TGFBR3;FGF2;ERBB4
prerank,RNA interference (GO:0016246),0.3137584999588618,0.7351745956250552,0.8242506811989101,0.9980421343852462,1.0,3/17,12.58%,TARBP2;CELF1;AGO3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2515843377475364,0.7349766503757293,0.9011328527291452,0.9978760466127622,1.0,18/94,17.58%,BAX;GSKIP;PDK1;DDX3X;ITPR1;ABL1;STK11;BRSK2;CD24;DDIT3;CASP9;BCL2;CUL5;CASP2;DDX5;CHEK2;TOPORS;DNAJC10
prerank,regulation of myeloid cell differentiation (GO:0045637),0.25793095360560236,0.7342102700141199,0.8565217391304348,0.9984387069309378,1.0,17/62,21.66%,PRMT6;KMT2B;HOXB8;SETD1A;DPY30;HDAC1;AGO3;PRMT1;CBFB;CDC73;KMT2D;MEIS2;KMT2A;LYN;PTK2B;CNOT4;H3-3A
prerank,dendritic cell chemotaxis (GO:0002407),0.3329148094670099,0.7340636820904125,0.7829232995658466,0.9982319760716645,1.0,14/14,66.74%,CXCR4;HMGB1;TRPM4;CCR7;CXCR2;CCR6;CCR1;CCL5;PIK3CG;CCR2;CCR5;CCL19;GPR183;TRPM2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.3465414467250927,0.7337762491438049,0.808095952023988,0.9981842324519434,1.0,5/11,20.88%,USP15;TGFB1;TGFBR1;TGFBR3;SMAD7
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.26394011813667506,0.7334892497602196,0.8477043673012318,0.9981233976919603,1.0,15/49,22.97%,PRMT6;KMT2B;SETD1A;DPY30;HDAC1;AGO3;PRMT1;CBFB;KMT2D;KMT2A;CNOT4;RAB7B;H3-3A;MTURN;AGO4
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.3490737370174264,0.7334201488054175,0.7865671641791044,0.9978124479418883,1.0,3/10,17.00%,DCN;PIK3CB;SPRY2
prerank,response to nitric oxide (GO:0071731),0.32684888507917476,0.7334171804541127,0.8066378066378066,0.9974115060972328,1.0,3/13,21.59%,KCNC2;DPEP1;FOXO1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.23698811491037847,-0.7330629183802277,0.8600823045267489,0.9620850552347082,1.0,8/21,23.83%,SMAD4;BMPR1A;NUP93;CCN3;BMP4;TGFB3;SLC2A10;SH2B1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.31430595998148525,0.7321441305023547,0.8070866141732284,0.9986278876593772,1.0,3/16,14.54%,FBH1;KLHL15;HELB
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.31037416367497095,0.7321307657332135,0.8231197771587744,0.9982368711177602,1.0,6/18,26.14%,ELOVL1;ACSL6;ELOVL6;HACD2;HACD1;ACSL3
prerank,regulation of brown fat cell differentiation (GO:0090335),0.3120758953947142,0.7320128994426198,0.8008130081300813,0.9979847503098128,1.0,6/16,20.48%,FLCN;ZBTB7B;PTGS2;SOX13;FTO;HNRNPU
prerank,negative regulation of establishment of protein localization (GO:1904950),0.35388402227200944,0.7318296217508888,0.7981927710843374,0.99782888656941,1.0,5/10,25.32%,MAPT;NDFIP2;TERF1;PPM1F;WWP2
prerank,zymogen activation (GO:0031638),0.27241084023559364,0.7316991042064457,0.830607476635514,0.9975890387418054,1.0,7/39,19.31%,GRIN2A;PLAT;PRSS12;CTSH;OMA1;PGK1;MMP14
prerank,signal peptide processing (GO:0006465),0.3459682343995556,0.7313320776561839,0.8017492711370262,0.9976444467856386,1.0,3/11,17.07%,PCSK5;HM13;PARL
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.21073107165237637,-0.7310757370672902,0.9257425742574258,0.9632406416498721,1.0,18/30,36.34%,LBR;HMGCS1;ACLY;FDFT1;ACAA2;ARV1;NSDHL;ACAT2;SQLE;DHCR24;PMVK;IDI1;MVK;HSD17B7;FDPS;PLPP6;DHCR7;EBP
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2699165638715461,0.7310670397720314,0.8543123543123543,0.9975868282853315,1.0,11/44,19.39%,KHSRP;ZFP36L1;CELF1;DHX36;PABPC1;YTHDF3;YTHDF1;ROCK2;ZC3HAV1;FTO;YTHDF2
prerank,regulation of actin filament-based process (GO:0032970),0.25429149578456595,0.7306197860014931,0.8770402611534276,0.9977218416837337,1.0,16/70,19.85%,RAC1;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;RHOBTB3;IQGAP1;LRP1;ROCK2;EPHA5;CCDC88A;CDK10;DLC1;RHOBTB1
prerank,regulation of pH (GO:0006885),0.3432008813979249,0.7303962358355661,0.8005908419497785,0.9975905629900684,1.0,3/11,15.89%,ATP6V0A4;LACC1;SLC9A7
prerank,protein destabilization (GO:0031648),-0.20654094527336658,-0.7300187995687645,0.8536585365853658,0.9632099050580313,1.0,13/32,28.80%,SIRT1;SENP2;SERF2;EP300;RNF139;IRGM;SOX17;KDM8;PRKN;RAD23A;CCDC88C;BTRC;TRIM21
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.2882831951895752,-0.7295343409034476,0.8128342245989305,0.9624949502064996,1.0,7/10,29.78%,NAGK;ST3GAL1;GNPDA2;GNPDA1;AMDHD2;ST6GAL1;NPL
prerank,microglial cell activation (GO:0001774),0.3023958672764988,0.7291422676908097,0.8074454428754814,0.9987406670822342,1.0,3/21,13.92%,APP;IFNGR1;MAPT
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2577651518870859,0.7290159838910126,0.8764769065520945,0.9984859931179317,1.0,22/72,23.46%,PFDN4;TAOK1;CAMSAP2;VBP1;SSH1;PFDN1;CLIP3;PLEKHH2;KATNB1;EML2;TBCD;APOE;PFDN2;TUBB4A;SHANK1;LIMA1;FGF13;CLASP2;PFN2;CAMSAP1;MAP2;IAPP
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3119268179932132,0.7286922087018691,0.8147668393782384,0.9984855159007863,1.0,4/17,16.44%,SNAI1;RBPJ;TGFB1;JAG1
prerank,potassium ion homeostasis (GO:0055075),0.2967729630515294,0.728478050181174,0.8255813953488372,0.9983624453595764,1.0,3/23,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,autophagy of nucleus (GO:0044804),0.3153764037267899,0.7284392719013475,0.8102288021534321,0.9980015016990624,1.0,5/16,18.15%,WIPI1;ATG2A;ATG13;ATG3;ATG9A
prerank,sulfur compound transport (GO:0072348),0.2877524364221101,0.7284202134283857,0.8282208588957055,0.9976191171646336,1.0,3/27,7.43%,SLC35B2;SLC25A19;SLC13A4
prerank,histone H3-K4 methylation (GO:0051568),0.2888769082413799,0.7283367398000047,0.8288177339901478,0.9973160386466481,1.0,7/26,19.43%,KMT2B;OGT;SETD1A;DPY30;KMT2D;KMT2A;KDM6A
prerank,superoxide metabolic process (GO:0006801),-0.2067361664777711,-0.7279536436322265,0.9206349206349206,0.9631531292190696,1.0,6/29,20.59%,CYB5R4;NOS3;NOX1;PRDX2;NRROS;CYBA
prerank,morphogenesis of an epithelium (GO:0002009),0.2860122236822486,0.7278648491548106,0.8146766169154229,0.9975098939715861,1.0,5/25,15.88%,FGFR2;SOX9;KDM2B;DAG1;AHI1
prerank,negative regulation of complement activation (GO:0045916),0.3395393426700546,0.7278490535862544,0.7859281437125748,0.9971238302516232,1.0,1/10,5.04%,SERPING1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.29447140295703533,0.7276665214557899,0.8277634961439588,0.9969601848432319,1.0,8/22,23.04%,ABCA2;IFNGR1;ROCK2;RANBP9;LYN;ABCG1;EPHA4;SP1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24772916847314164,0.7275164633795491,0.8904109589041096,0.9967454065864674,1.0,16/88,17.64%,PSMD4;FBXL12;FBXL14;FBXO38;FBXO31;PSMB10;FBXW5;PSMD11;CUL4B;PSME2;PSMC5;CUL5;PSMD1;DMAC2;PSMD6;FBXO9
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3062163721042186,0.7274874722966521,0.8270481144343304,0.9955692063480961,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3062163721042186,0.7274874722966521,0.8270481144343304,0.9955692063480961,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3062163721042186,0.7274874722966521,0.8270481144343304,0.9955692063480961,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.29356027799005824,0.7273551763492402,0.8322324966974901,0.9953321061178093,1.0,5/23,19.11%,FADS1;PTGS2;EPHX2;GPX4;ELOVL6
prerank,protein localization to Golgi apparatus (GO:0034067),0.28684174395715156,0.727171260846754,0.8230958230958231,0.9951601329557649,1.0,9/27,18.30%,OBSL1;ARL5B;RIPOR1;TMED10;IFT20;CSNK1D;VPS13D;SORL1;RAB6A
prerank,response to ketone (GO:1901654),0.29076163625883344,0.727151501256452,0.8254777070063695,0.9947857008716967,1.0,4/24,14.88%,WBP2;CATSPER3;TGFB1;SLIT3
prerank,cytoplasmic microtubule organization (GO:0031122),0.2606262690720097,0.7269652667213637,0.8665919282511211,0.994613299674819,1.0,12/54,18.16%,FSD1;CAMSAP2;KPNB1;CLIP3;HOOK3;CEP126;VPS4B;MAPT;NUMA1;TPPP;TUBGCP2;CCDC88A
prerank,integrin-mediated signaling pathway (GO:0007229),0.2540489323986979,0.7267284618503166,0.8819148936170212,0.9944992125501726,1.0,19/73,22.29%,PRAM1;FBLN1;NRP1;ABL1;THY1;TEC;ITGBL1;CD47;PLPP3;ADAMTS1;ITGB1BP1;ILK;ERBIN;DAB2;PTK2B;ITGAV;ITGB1;MYH9;ITGA5
prerank,cell proliferation in forebrain (GO:0021846),0.34983805515117966,0.7264039239332013,0.8077496274217586,0.9945160590237667,1.0,3/10,14.58%,HOOK3;DOCK7;CEP120
prerank,endoderm development (GO:0007492),0.3342411973701904,0.7263276999011452,0.8118948824343015,0.994206900840035,1.0,1/13,5.43%,LAMC1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.2643361629607981,-0.7262066756863034,0.8480565371024735,0.9638998266868702,1.0,11/14,60.43%,ATP6AP1;TYROBP;POU4F1;CCR1;TNFSF11;OCSTAMP;CSF1;IL23A;TNF;IL23R;IL12B
prerank,protein K63-linked deubiquitination (GO:0070536),0.2797065066634661,0.7261696764884602,0.8341523341523341,0.9939898601633749,1.0,8/31,19.27%,USP7;TNFAIP3;OTUD7A;ABRAXAS2;USP33;USP50;YOD1;UIMC1
prerank,neural crest cell development (GO:0014032),0.26615115530778843,0.7260487147862197,0.8538812785388128,0.9937286476269045,1.0,9/44,15.56%,KLHL12;PEF1;SOX11;SEMA3D;GDNF;RADIL;NRG1;SEMA3E;SEMA3A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.31203676859757024,0.725654721964566,0.8215767634854771,0.9937983429822086,1.0,3/17,9.79%,SNAI1;RFFL;TWIST1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2437815894164672,0.7256270888837704,0.9084362139917695,0.9934323262985666,1.0,26/122,19.78%,IGF1;NFKB1;IL33;RBM3;XBP1;DDX3X;TMEM106A;HNRNPD;EGF;IRS2;ZCCHC4;HSPH1;BRPF3;YTHDF3;NPM1;PRMT1;YTHDF1;PRR16;FAF1;FMR1;SLC25A37;PRKD2;METTL5;SOX4;KLF4;CIRBP
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3014678007444954,0.7255353860917185,0.8197368421052632,0.9931375503601299,1.0,7/20,20.27%,TMBIM1;PID1;TGFB1;MRAP2;PPP2R5A;LZTFL1;DAB2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.26196948124418323,0.7254663550013096,0.8482446206115515,0.9928226365193193,1.0,10/50,19.43%,TCIM;DDX3X;IFI35;APP;NFAT5;RTKN2;TLR3;ILK;TERF2IP;RPS3
prerank,positive regulation of macroautophagy (GO:0016239),0.265102662342217,0.7254076370390757,0.8518099547511312,0.992494267185727,1.0,16/48,23.41%,TSC2;PIP4K2B;DCN;GPSM1;PIP4K2A;VDAC1;HTT;PIP4K2C;VPS13D;FYCO1;SCOC;RAB3GAP2;UVRAG;SESN1;HSPB8;SH3GLB1
prerank,positive regulation by host of viral transcription (GO:0043923),0.32257198471961135,0.7254020926572303,0.797799174690509,0.992103129409627,1.0,7/15,23.04%,SMARCB1;CHD1;NUCKS1;SNW1;CCNT1;RRP1B;SP1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.29866737363949636,0.7253457191833425,0.8100929614873837,0.9917753114565542,1.0,3/21,7.87%,EPHB2;LZTR1;MFN2
prerank,vitamin D metabolic process (GO:0042359),0.32688822601160805,0.7252881391879967,0.8196480938416423,0.9914426706361535,1.0,1/13,7.83%,GC
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.22252945995754111,-0.7250175032069818,0.9208333333333333,0.9640428109149997,1.0,9/22,28.50%,MFHAS1;MAP3K4;EMC10;VEGFA;SASH1;ZC3H12A;BMP2;GADD45B;SPHK1
prerank,bone morphogenesis (GO:0060349),0.3201086374505662,0.7248567341311359,0.8125,0.9915529430567268,1.0,2/14,12.85%,FGFR2;CYP26B1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.3308870843464697,0.7245810645594212,0.8093093093093093,0.9914884063811465,1.0,3/11,18.96%,HSP90AA1;QDPR;CALM1
prerank,negative regulation of heart contraction (GO:0045822),0.33648609305335464,0.724075955194807,0.7976710334788938,0.9917220391835496,1.0,3/11,20.90%,ATP1A2;GRK2;SPTBN4
prerank,response to acidic pH (GO:0010447),0.3318932478431156,0.7232508442687265,0.8064046579330422,0.9923425318927668,1.0,4/13,25.80%,GPR4;IMPACT;RAB11B;SLC9A1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.236191266638537,0.7230361088086438,0.9506048387096774,0.992214120887998,1.0,13/175,7.67%,SFRP1;ADAMTS7;GBP3;PSMD4;MAP3K14;EDAR;TNFRSF9;ZFP36L1;EDA2R;PSMB10;ZFAND6;PID1;PSMD11
prerank,response to lipopolysaccharide (GO:0032496),0.23800894179854012,0.7227431897245158,0.9295199182839632,0.9921755699243976,1.0,19/138,16.49%,WNT5A;SELENOS;NFKB1;IFNAR1;XBP1;TNFAIP3;TIRAP;CARD16;SIRPA;TRIM41;LY96;HNRNPA0;GIT1;RPS6KA3;PTPN22;CDC73;SMAD6;PDE4B;SERPINE1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.25097461373474156,0.7217757856417615,0.875,0.9929375223714916,1.0,14/75,19.12%,HEXIM1;PKIB;NR2F2;UCHL1;ABL1;CDK5RAP3;PIK3CB;IPO7;PKIG;SPRY2;APOE;SORL1;PRKAR1A;SMPD1
prerank,neutrophil chemotaxis (GO:0030593),-0.18175455755319264,-0.7216243116826835,0.9578947368421052,0.9668074275052536,1.0,4/53,6.44%,GBF1;BSG;CCL15;TGFB2
prerank,cGMP biosynthetic process (GO:0006182),-0.2917505011394093,-0.7215543959675402,0.8450292397660819,0.9656014768945859,1.0,2/10,13.97%,GUCY1A1;NPR1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.24448641581117467,0.7214812211811901,0.9040667361835245,0.992911581362792,1.0,11/93,12.93%,FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;SDCBP;APP;KLHDC10;PRMT1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.20485273609933752,-0.7211186379274334,0.9315789473684211,0.9647771791343611,1.0,10/28,26.41%,DAB2IP;PSMC2;DDRGK1;AXIN1;RNF139;OSBPL7;PSMC3;CTSC;ECSCR;PRKN
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.27423298454241424,0.7209710488207756,0.856140350877193,0.993153441662943,1.0,3/36,7.14%,WNT5A;AGPAT1;CXCR4
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.2732100749289074,0.7208321544384656,0.8455089820359282,0.9929295046743284,1.0,5/34,15.82%,DUSP18;PTPRF;TNS2;PTPN22;PTPN12
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2659214243314571,0.7204741640510532,0.852975495915986,0.9929814922343367,1.0,9/41,20.88%,THY1;ANK3;CD47;PLPP3;DENND6A;JAK1;FLOT1;GCNT2;SMAD7
prerank,B cell proliferation (GO:0042100),-0.24170088253222843,-0.720407743323182,0.84375,0.9643109372177309,1.0,2/17,10.73%,MEF2C;PTPRC
prerank,telomere capping (GO:0016233),0.3109775367856738,0.7197190412223711,0.8079658605974396,0.9934823202547671,1.0,5/16,18.57%,DCLRE1A;MRE11;RAD50;TERF1;TERF2IP
prerank,ether lipid biosynthetic process (GO:0008611),0.3401711382090852,0.7196975917280043,0.8108504398826979,0.9931195892821868,1.0,5/10,23.39%,PEDS1;PEX7;FAR1;GNPAT;CHPT1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.31720815072405106,0.7195094007815069,0.8073770491803278,0.9929508724059181,1.0,4/15,20.27%,SMAP1;PIK3CB;SNAP91;DAB2
prerank,negative regulation of type I interferon production (GO:0032480),0.26555591484259394,0.7194935163081609,0.8593200468933178,0.9925750319919024,1.0,6/40,11.61%,TNFAIP3;PPM1B;DHX58;SIRPA;IRF3;YY1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2946343395078156,0.7191096632959026,0.834419817470665,0.9926262797766566,1.0,4/22,14.98%,IRF1;CBFB;BCL6;FANCA
prerank,regulation of microtubule-based movement (GO:0060632),0.331769474372167,0.7190166305314847,0.7933634992458521,0.9923437290563261,1.0,4/11,23.00%,NEFH;TTC21B;IGBP1;MAP2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3447098040248613,0.7188188298631506,0.790273556231003,0.9921926780686626,1.0,1/10,1.59%,SIRT2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.2819924600837886,0.7188141588093104,0.8288177339901478,0.9918037601245462,1.0,3/27,8.83%,CHPF;DCN;CHSY3
prerank,regulation of muscle cell differentiation (GO:0051147),0.27424382112857865,0.7180149438912329,0.8604651162790697,0.9923473171669742,1.0,5/31,15.29%,FGFR2;CDK9;ABL1;BNIP2;TCF3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2508367221200438,0.7180135199469393,0.8696120689655172,0.9919551553949617,1.0,9/68,12.48%,SLC25A19;FPGS;PCCB;MMAB;FLAD1;NNMT;SLC2A3;ENPP1;PCCA
prerank,endothelial cell migration (GO:0043542),0.2679571577785096,0.7176538621731249,0.8476190476190476,0.9919786076840565,1.0,7/37,16.26%,FSTL1;NRP1;ABL1;PLEKHG5;RAB13;EMP2;ADGRA2
prerank,epithelial cell migration (GO:0010631),0.26627898429216124,0.7176091367408324,0.8428405122235157,0.9916392317709743,1.0,4/37,6.07%,ZEB2;FSTL1;NRP1;ABL1
prerank,regulation of cell size (GO:0008361),0.2928423215676653,0.717373846944016,0.8375314861460957,0.991531828166705,1.0,5/23,14.28%,RAC1;RAP1GAP2;VAV2;LAMTOR5;PRR16
prerank,pulmonary valve development (GO:0003177),0.30325773404093315,0.7168149957758475,0.8212877792378449,0.991776961557229,1.0,5/18,16.44%,STRA6;ROBO2;ROBO1;SMAD6;JAG1
prerank,regulation of protein binding (GO:0043393),0.24268321413658966,0.7167258067687711,0.917864476386037,0.9914895608780935,1.0,25/114,18.68%,VTN;BAX;CARD16;TCF7L2;DVL1;HDAC5;LRPAP1;HDAC4;APP;PARK7;ADD2;RACK1;DISC1;LRP1;CTSZ;CTNNBIP1;PRMT8;PSME3IP1;DERL1;ITGB1BP1;TLE5;USP33;SORL1;BTBD1;FLOT1
prerank,"transcription, DNA-templated (GO:0006351)",0.2351486463681322,0.7163872609466806,0.9568273092369478,0.991485286974485,1.0,56/207,22.75%,NFKB1;SMN1;PARP1;TAF9B;XBP1;TFDP1;SLC25A33;TAF4;POLR2B;CDK9;TBP;ZBTB7B;RTF1;TRIP11;GTF2A2;MED4;NFX1;PRMT5;DRG1;GTF2H3;TCEA1;TAF6;NFIX;POLR2K;CCNH;TSC22D1;SETX;CBFB;MMS19;CDC73;GTF2E1;SOX5;PPP5C;DDX5;MAF;CCNT1;MBD1;CDK7;POLR3K;TOPORS;NELFA;TAF1B;KLF13;MLLT3;PKNOX1;GLIS3;TBPL1;CCNT2;TAF2;RPAP1;EAF1;SNAPC3;GTF2F2;TAF1;GTF2B;BTF3
prerank,proton transmembrane transport (GO:1902600),0.2689246899647292,0.7163078823084322,0.851985559566787,0.9911808212255601,1.0,4/36,12.68%,ATP1A3;ATP6V0E2;ATP1A2;ATP6V0A4
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.2839753094289792,-0.7162835981399807,0.8297872340425532,0.9678811791944947,1.0,1/10,2.31%,CAV1
prerank,secretory granule organization (GO:0033363),0.3422890743893745,0.716007739865355,0.8122137404580153,0.9911399367748027,1.0,4/10,23.97%,VPS33B;BLOC1S2;LYST;ABCA1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.23624044695990262,0.7158388478778652,0.9455095862764884,0.9909521982087584,1.0,29/166,16.30%,HDAC3;TEAD3;TAF9B;NR1D2;RORA;TAF4;POLR2B;CDK9;TBP;GTF2A2;TEAD1;HDAC5;NRBF2;GTF2H3;TAF6;RBPJ;MAZ;E2F3;POLR2K;CCNH;HDAC1;NRBP1;ESRRG;GTF2E1;NR2C2;MED23;TFB1M;POLR1A;SNW1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.30359214053536276,0.7158268432624225,0.8237704918032787,0.9905752768514253,1.0,3/17,14.28%,SUCO;WNT4;TGFB1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2546060497696796,0.7157213167146104,0.8798235942668137,0.9902986891279957,1.0,5/60,7.40%,CCT8;PKIB;HSP90AA1;CCT6A;WRAP53
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2589736902445264,0.7156633680739809,0.8721198156682027,0.989965565556105,1.0,9/46,18.33%,HDAC3;TCF7L2;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;CPSF6;RBM22
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2836453738631087,0.7156444509226833,0.83645443196005,0.9895956557031151,1.0,7/27,20.26%,SNAI1;EEF1E1;TWIST1;ATR;DDX5;MDM2;PLA2R1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3032548191143072,0.715553759997385,0.837431693989071,0.9893028082649173,1.0,1/18,0.91%,CLN3
prerank,positive regulation of cell aging (GO:0090343),-0.28030729149770817,-0.7153101855493292,0.8267477203647416,0.9677023802782225,1.0,2/11,4.50%,LMNA;SIRT1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.30799217294764936,0.7151578657029487,0.8315508021390374,0.9893904209973408,1.0,5/17,22.35%,CALM3;MAGI2;CALM1;CALM2;ITGA1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.28181521283849,0.7149743252735484,0.8427518427518428,0.9892254780936587,1.0,10/30,22.50%,SFRP1;PARK7;HDAC1;DDX5;SAFB2;NCOR2;PRMT2;DAB2;H3-3A;PKN1
prerank,acetyl-CoA metabolic process (GO:0006084),0.3110825510835692,0.7136449581866166,0.8257887517146777,0.9903549669264529,1.0,2/15,7.50%,MLYCD;ACAT1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.29337350915978794,0.712819262632837,0.8191082802547771,0.9909115852450856,1.0,3/24,13.72%,LIG1;LIG3;POLD3
prerank,cellular respiration (GO:0045333),0.2594383378862696,0.7128036510202048,0.8337182448036952,0.9905394822009618,1.0,9/41,19.73%,UQCRC1;SDHA;NDUFS7;MDH2;MTFR1L;ETFA;COQ10A;UQCRC2;OXA1L
prerank,ATP transport (GO:0015867),0.3394425653555216,0.7127450372475813,0.8059467918622848,0.9902084683929191,1.0,3/10,18.60%,SLC25A24;CD47;ABCC6
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.29786156672079434,0.712527434968144,0.8188976377952756,0.9900877705060313,1.0,3/21,11.50%,CALM3;ATP1A2;CAMK2D
prerank,response to glucocorticoid (GO:0051384),0.2849244355300288,0.7123163401039102,0.8444444444444444,0.989933325938652,1.0,2/26,4.02%,ANXA1;ZFP36L1
prerank,cell junction assembly (GO:0034329),0.24404864532723766,0.7123034202724456,0.9193381592554292,0.9895595027473999,1.0,31/100,24.54%,CTNND2;OBSL1;CDK5;FLCN;DSCAM;CDH11;DBNL;CAPZA1;NLGN3;SPOCK2;FARP1;TLN2;CDH18;NLGN2;VMP1;CDH20;CDH19;CDH7;ILK;SLITRK1;MYO9A;CDH9;PCDHB16;CDH10;RYK;SDK1;CDH8;PTEN;NRXN2;CDH2;FLNC
prerank,ribosome biogenesis (GO:0042254),0.2353379873607207,0.7120071955967898,0.9445005045408678,0.9895095226233314,1.0,27/187,14.06%,MRPL36;EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;GLUL;CUL4B;RBIS;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;MALSU1;NPM1;RPL9;C1D;RPL4;BMS1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.24209346287906372,0.7118332036393047,0.9167533818938606,0.9893266792958207,1.0,27/88,21.74%,MYO1B;HGS;ARRB1;RAB10;DNAJC6;CLINT1;SCFD1;APP;MYO5A;TXNDC5;SCAMP1;AP4M1;AP1B1;STEAP2;VAMP8;CCDC93;AP4E1;SORL1;KLHL20;AP4S1;RABEP1;EXOC5;FTH1;VAMP7;COMMD1;NAPA;LLGL1
prerank,B cell receptor signaling pathway (GO:0050853),0.2742830766803984,0.7117209819185049,0.8571428571428571,0.9890717951733556,1.0,4/32,14.04%,BAX;TEC;BCL2;BLNK
prerank,replicative senescence (GO:0090399),0.32064259077204854,0.711510002500514,0.8183139534883721,0.9889334056158344,1.0,5/12,23.45%,ATR;CHEK2;SERPINE1;PLA2R1;ATM
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3087701696650573,0.7104662672441687,0.8414634146341463,0.9897373905347273,1.0,4/16,13.24%,HGS;PIBF1;LEPROT;PARP14
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.23377389004290317,-0.710379266994014,0.8536585365853658,0.9719380266903881,1.0,5/19,19.65%,GNL3L;STN1;NAT10;SRC;CTC1
prerank,chromatin remodeling at centromere (GO:0031055),0.274458093389527,0.7102199219183535,0.8444444444444444,0.989636432111268,1.0,4/31,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.3414437318522599,0.7102071326386747,0.8291925465838509,0.9892614522818205,1.0,4/10,21.46%,CAMK2D;OSR1;HECW2;COMMD1
prerank,actomyosin structure organization (GO:0031032),0.245417883754916,0.7098440057032692,0.906183368869936,0.9892921998436716,1.0,17/75,21.83%,EPB41L4B;MYH14;ARRB1;CIT;MYH10;TPM1;FRMD6;ROCK2;EPB41L3;EPB41L1;TMOD2;CSRP2;CDC42BPB;ITGB1;PDLIM1;MYH9;CSRP3
prerank,positive regulation of vasculature development (GO:1904018),0.2421880152243885,0.7096999298669018,0.9216101694915254,0.9890731702030108,1.0,6/94,5.95%,SFRP2;WNT5A;PDPK1;XBP1;PRKCA;GAB1
prerank,tRNA transport (GO:0051031),0.2706119673782056,0.7095684256836932,0.8608799048751486,0.9888355498535809,1.0,16/35,25.80%,RAE1;TOMM20;NUP188;NUP210;NUP88;NUP214;NUP153;RANBP2;NUP35;YBX1;TPR;NUP155;NUP54;NUP98;POM121;SEH1L
prerank,response to lipid (GO:0033993),0.23668603691086396,0.7092211214554043,0.91701244813278,0.9888250904383791,1.0,14/105,15.68%,CDKN2D;IFNAR1;ANXA1;ABCA2;TIRAP;SOX9;LY96;VPS4B;HNRNPA0;RPS6KA3;PTPN22;TGFB1;SMAD6;CTSH
prerank,long-term memory (GO:0007616),-0.23382892206674222,-0.7092080499437122,0.8903508771929824,0.9719093035183385,1.0,3/19,15.47%,EIF2AK4;CPEB3;NFATC4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.23449032261989217,0.7091998426876936,0.9376915219611849,0.9884599627542211,1.0,37/145,23.13%,CCP110;PSMD4;HSP90AA1;ALMS1;USP47;BRD4;FBXO5;PSMB10;PSMD11;CDC25A;TUBA1A;YWHAG;PSME2;PSMC5;VPS4B;KCNH5;HAUS3;CSNK1D;TUBB;PSMD1;OFD1;PSMD6;CEP76;TUBB4A;MECP2;ODF2;PSMD5;DYNLL1;PAFAH1B1;PSMA4;PSMA1;PSMC6;CNTRL;NINL;CDK5RAP2;PSMA5;PINX1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3109005432294763,0.709191979483579,0.8232044198895028,0.9880817350029873,1.0,3/15,13.57%,EZH2;NPM1;CDC73
prerank,regulation of mast cell activation (GO:0033003),-0.2874686117410235,-0.7080979673980421,0.8195266272189349,0.9718105496915088,1.0,8/10,53.75%,PLSCR1;NECTIN2;CD84;CRLF2;MILR1;CD300LF;TSLP;CD226
prerank,blood vessel diameter maintenance (GO:0097746),0.27270112449241984,0.707641184702181,0.8489208633093526,0.9894455951946468,1.0,6/34,16.76%,EDN3;BDKRB2;GCLC;ROCK2;AGTR1;ITGB1BP1
prerank,renal water homeostasis (GO:0003091),0.28597881422288923,0.7073726548564981,0.8322903629536921,0.9893611570423794,1.0,5/23,18.28%,ADCY7;AQP4;ADCY1;ADCY5;PRKAR1A
prerank,negative regulation of proteolysis (GO:0045861),0.27374203614144926,0.7072001597798524,0.838479809976247,0.9891633284900552,1.0,4/34,11.84%,CLN3;CDK5;PLAT;PTPN3
prerank,establishment of epithelial cell polarity (GO:0090162),-0.22898576018687228,-0.706840301466979,0.8760683760683761,0.9718608389980675,1.0,2/19,6.30%,PARD3;EZR
prerank,copper ion homeostasis (GO:0055070),0.30092672685841204,0.7062229351783296,0.8288043478260869,0.9898813522372449,1.0,5/17,23.36%,XIAP;APP;COMMD1;ATOX1;SLC31A1
prerank,negative regulation of double-strand break repair (GO:2000780),0.2715191338217976,0.7061913626931491,0.8517618469015796,0.9895288826014812,1.0,6/30,16.93%,FBH1;KLHL15;TWIST1;HELB;NUDT16L1;UBR5
prerank,regulation of inclusion body assembly (GO:0090083),-0.2664008362155348,-0.7059629080945371,0.8530465949820788,0.9715133213475677,1.0,8/11,45.87%,SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.28171232609691016,0.7057964040736487,0.842964824120603,0.9895864843800928,1.0,5/28,12.22%,BAX;DDX3X;ZDHHC3;BCL2;BLOC1S2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2518829182231796,0.7057048024489052,0.8824833702882483,0.9893118316915638,1.0,15/59,18.78%,PDPK1;CSNK2A2;PRKCA;CDK5;SBK1;CIT;CAMK2D;ROCK2;ACVR1B;TNKS;OXSR1;PRKD2;CDK10;TGFBR1;CDC42BPB
prerank,protein localization to centrosome (GO:0071539),0.3058646527265578,0.7055156785679306,0.8407894736842105,0.9891247025671895,1.0,4/17,13.76%,SNX10;PIBF1;HOOK3;CSNK1D
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.21494190095483612,-0.705246445826332,0.9227053140096618,0.9710241649053103,1.0,9/26,28.50%,ASAH1;NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR;SPHK1
prerank,defense response to virus (GO:0051607),0.23763236774397062,0.7044840567003824,0.9267015706806283,0.9899450036301174,1.0,18/100,18.76%,NDUFAF4;MAP3K14;RNASE1;OPRK1;TTC4;IRF1;TRIM56;IFIT3;BCL2;SHFL;IRF3;TLR3;NT5C3A;AGBL4;MLKL;OAS2;CLPB;ABCE1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.23897291975474616,0.7040855185072009,0.922996878251821,0.9899840669179153,1.0,25/108,22.12%,BAX;EIF2AK3;FIS1;DDX3X;FAM162A;VCP;CASP9;MALT1;ROBO1;RACK1;DAPK1;MTCH1;MAPT;F3;CASP2;HSPD1;PDCD5;RPS3;DLC1;PDCD6;GSN;PPM1F;HMGB1;TRAF2;SMAD3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.26018905320765395,0.7038761202566347,0.8648018648018648,0.9898239325695851,1.0,7/40,15.12%,CDK9;FBH1;FANCM;ATR;ATRX;THOC1;NUCKS1
prerank,response to muscle stretch (GO:0035994),-0.2478120490074673,-0.7037833015530363,0.8671328671328671,0.9712699749124905,1.0,4/15,29.99%,DMD;PIK3CA;RYR2;SLC8A1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.28388266373033155,-0.7036835208355272,0.8115942028985508,0.970080218027709,1.0,8/10,43.75%,NAF1;NUFIP1;RUVBL1;PIH1D1;RUVBL2;ZNHIT3;TAF9;PIH1D2
prerank,positive regulation of translation (GO:0045727),0.2395696005060982,0.7035725538046507,0.9128586609989373,0.9897651808212001,1.0,19/94,19.78%,RBM3;TRUB2;DDX3X;CDC123;CNBP;RCC1L;HNRNPD;DHX36;ZCCHC4;YTHDF3;NPM1;UQCC2;YTHDF1;PRR16;FMR1;METTL5;SOX4;YTHDF2;CIRBP
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.28368725084614277,-0.7034544797681477,0.8553459119496856,0.9690674909228596,1.0,6/11,26.81%,ASAH1;SIRT1;DGKQ;EGR1;BMP2;FGFR4
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.24061221658387671,-0.7032983822229116,0.875,0.9679503663006044,1.0,8/16,29.29%,NUS1;HIF1A;SCARB1;GCH1;AKT1;TERT;S100A1;DHFR
prerank,regulation of cholesterol storage (GO:0010885),0.31198738510369217,0.703125566874632,0.8340136054421768,0.989849930917998,1.0,1/15,0.96%,LPL
prerank,chromatin assembly or disassembly (GO:0006333),0.32867471623873223,0.703124742510179,0.8132183908045977,0.9894652360812293,1.0,2/11,11.79%,RBBP4;MTA2
prerank,histone H3-K36 demethylation (GO:0070544),0.33339041618397575,0.7030105428029346,0.8284023668639053,0.9892036530351069,1.0,2/10,10.68%,KDM7A;KDM2B
prerank,regulation of cellular biosynthetic process (GO:0031326),0.27589845879174496,0.7025630575844339,0.8567870485678705,0.9893098069452053,1.0,7/28,19.56%,RAC1;NOS1AP;SIRPA;CD47;SIRT5;PRKAG2;MITF
prerank,regulation of microglial cell activation (GO:1903978),-0.2551271999814777,-0.7025043873883574,0.88,0.9675529746622307,1.0,4/15,28.50%,PTPRC;GRN;TTBK1;SPHK1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.24518178023878848,-0.7021336101857836,0.8829787234042553,0.9666212030716578,1.0,6/15,27.32%,ZFYVE27;NGF;SORT1;CASP3;DDIT4;BDNF
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.24589159035297292,0.7020580506270823,0.8968512486427795,0.9894671685657888,1.0,12/73,15.53%,BAX;EIF2AK3;FAM162A;VCP;CASP9;ROBO1;RACK1;MTCH1;MAPT;F3;CASP2;HSPD1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.28477045216933805,-0.7019413781511672,0.8689458689458689,0.9655333466278395,1.0,5/10,29.52%,LGALS9;TGFBR2;CD81;NCKAP1L;CD55
prerank,positive regulation of protein depolymerization (GO:1901881),-0.27104088013184313,-0.7015481832736826,0.8485804416403786,0.9646772220137765,1.0,5/11,31.76%,CFL2;PLEK;SEMA5A;TRPV4;STMN2
prerank,odontogenesis (GO:0042476),0.2662038471889143,0.7012942393586197,0.8754406580493537,0.9899392457274037,1.0,6/35,17.12%,FGFR2;COL1A2;HDAC1;AXIN2;LAMB1;OSR1
prerank,negative regulation of centrosome duplication (GO:0010826),0.3332577856624754,0.7011522335162512,0.8130311614730878,0.9897245799426259,1.0,4/11,23.06%,MDM1;NPM1;TMEM67;CDK5RAP2
prerank,protein localization to organelle (GO:0033365),0.2352739490611325,0.7003438213362267,0.9338085539714868,0.9902295849979944,1.0,30/133,19.51%,TUB;FAM83H;DDX3X;OBSL1;DVL1;TIA1;SNX10;GET1;AUP1;ABCA7;RIPOR1;TOR1B;APP;SERP1;IFT20;COG3;CSNK1D;MTCH2;ATP6V1D;TULP3;SEC61G;TTC21B;ALDH3A2;TOPORS;MDM2;SORL1;RAB6A;WDR35;BANP;STX5
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2552140983856456,-0.699776476870986,0.8859934853420195,0.9652407355251783,1.0,5/13,27.27%,TBC1D10A;ASPH;BAD;PERP;CYFIP2
prerank,regulation of myoblast fusion (GO:1901739),0.330801315067461,0.6989870469422343,0.8347701149425287,0.9913217921967445,1.0,3/11,20.65%,RIPOR2;FLOT1;EHD1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.3354489850569619,0.698692710366541,0.8305597579425114,0.9912501737640711,1.0,3/10,15.57%,UPP2;DPYD;NT5C3A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.30583701073329583,0.6985296347965009,0.8262068965517242,0.9910364696091913,1.0,1/15,2.47%,MLYCD
prerank,relaxation of muscle (GO:0090075),-0.2612648092635864,-0.6975089538860146,0.8636363636363636,0.9661961283006981,1.0,4/13,13.23%,ATP1A1;KCNJ2;ATP1B1;PIK3CA
prerank,manganese ion transport (GO:0006828),0.3124891810603496,0.6973800015912591,0.8286908077994429,0.9919099851598814,1.0,2/14,6.65%,ATP2C1;SLC30A10
prerank,intestinal lipid absorption (GO:0098856),0.3323499874466481,0.697053055230711,0.8423493044822257,0.9918590531909435,1.0,11/11,66.79%,LIMA1;LDLR;CEL;FABP2;ABCG8;NPC1L1;ABCG5;AKR1C1;CD36;SOAT2;UGCG
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2745428523169462,0.6966551143909554,0.8490566037735849,0.9918975109488507,1.0,7/27,20.92%,TIRAP;LY96;HSPD1;MAP3K1;TNIP1;TAB1;TAB3
prerank,positive regulation of immune response (GO:0050778),0.24710232915449012,0.6965859763311502,0.89086859688196,0.9915870024340917,1.0,4/64,8.05%,FCGR2B;POLR3D;XBP1;IFI35
prerank,negative regulation of DNA recombination (GO:0045910),0.2555963263579207,0.6964507040520604,0.8751418842224744,0.9913493698551349,1.0,9/43,18.57%,POLR2B;FBH1;KLHL15;POLR2K;ATRX;HELB;TERF1;DAXX;TERF2IP
prerank,negative regulation of developmental process (GO:0051093),0.24381474632004818,0.6963305150635147,0.8964401294498382,0.9911119212735291,1.0,11/69,17.72%,SFRP1;FOXM1;SFMBT1;THY1;SOX9;VAT1;MAPT;ROCK2;TGFB1;OMA1;DCC
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.27280215851049733,0.6957255383023221,0.866421568627451,0.9913914052491021,1.0,5/27,13.69%,TXNRD1;RRM2B;AK4;AK5;AK6
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.22905327495121244,0.6952246606382703,0.9453441295546559,0.9915493765831461,1.0,18/163,11.23%,PSMD4;PDPK1;NFKB1;PRAM1;PIK3R1;THY1;PSMB10;PAK3;PSMD11;TEC;THEMIS;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;BCL2;RC3H2
prerank,spinal cord development (GO:0021510),-0.2640858384620391,-0.695029084595767,0.8193146417445483,0.967500279126384,1.0,2/12,4.40%,RELN;VIT
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.25084514133616154,-0.694790128136044,0.8754325259515571,0.966487128557119,1.0,5/13,17.80%,RREB1;NAPEPLD;BMP7;SIX1;TFE3
prerank,regulation of collagen biosynthetic process (GO:0032965),0.2871495926663419,0.6947480095617178,0.8506666666666667,0.991677007798665,1.0,3/19,14.28%,SUCO;WNT4;TGFB1
prerank,cellular response to organic cyclic compound (GO:0071407),0.231759716699795,0.6938906552755886,0.9295199182839632,0.9921964666127034,1.0,24/141,18.02%,SFRP1;RORA;ATP1A3;ZFP36L1;CASP7;DMTN;GNG2;ATP1A2;INSIG1;SSH1;RAPGEF1;GABRB3;JUP;TFPI;NCOA4;ROCK2;TGFB1;ADCY1;IMPACT;ADCY5;UBE2L3;TIPARP;HRH1;PKD2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.2222227358866633,-0.693584482666337,0.8869565217391304,0.9651528406954212,1.0,4/21,10.42%,MCL1;BCL2L1;EYA3;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.2222227358866633,-0.693584482666337,0.8869565217391304,0.9651528406954212,1.0,4/21,10.42%,MCL1;BCL2L1;EYA3;EYA4
prerank,regulation of BMP signaling pathway (GO:0030510),0.24202762534165426,0.6934624504988486,0.924892703862661,0.9922418463298174,1.0,19/73,21.53%,SMAD9;FSTL1;SULF1;HTRA3;XIAP;SOX11;RBPJ;LEMD3;SMAD6;UBE2D1;NUMA1;SMURF1;SORL1;FOXD1;PCSK6;NBL1;ACVR2A;SMAD7;SMAD2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2825208049611826,0.6933422153385935,0.8277254374158816,0.991975929533213,1.0,4/20,17.54%,RGS10;CHRM2;GRK2;GNAQ
prerank,negative regulation of chemotaxis (GO:0050922),-0.20195099608189382,-0.6931485525326692,0.926829268292683,0.9643207251732966,1.0,15/31,33.03%,SLIT2;SEMA6A;THBS1;SEMA7A;SEMA4D;ANGPT2;SEMA4B;SEMA3B;SEMA5A;SEMA5B;SEMA6C;PTPN2;SEMA3G;SEMA6B;SEMA4C
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2673858882156289,0.6929968599095285,0.8694074969770254,0.9919757253031608,1.0,3/30,6.29%,DNAJC7;DNAJB5;BAG1
prerank,monoacylglycerol metabolic process (GO:0046462),0.31061502554588954,0.6923521092749361,0.8445378151260504,0.9922955903144031,1.0,1/13,3.44%,MOGAT3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2352793693465737,0.6920295817903162,0.913135593220339,0.9922530557225859,1.0,20/87,20.58%,RAC1;NEB;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;RHOBTB3;PDGFRA;IQGAP1;LRP1;ROCK2;SEMA3E;EPHA5;CCDC88A;CDK10;DLC1;RHOBTB1;PTK2B
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2524347536465609,0.6918942441285039,0.8984018264840182,0.9920184345880441,1.0,8/48,15.42%,PDPK1;FGFR1;ANXA1;PRKCA;FGFBP1;PTGS2;TGFB1;FOXC2
prerank,microvillus organization (GO:0032528),0.3188856483207404,0.6914652941880503,0.8293370944992948,0.992102563589531,1.0,2/13,7.01%,MINK1;RAP2A
prerank,signal transduction in response to DNA damage (GO:0042770),0.24900982094143095,0.6913840406166125,0.9115341545352743,0.9917970389753491,1.0,11/49,18.46%,ABL1;USP10;MDM4;NDRG1;CASP9;BRIP1;ATR;ATRX;CHEK2;CLOCK;TIPRL
prerank,termination of RNA polymerase II transcription (GO:0006369),0.26337818333784707,0.6910202942663531,0.8718861209964412,0.9918055583208136,1.0,7/33,13.10%,SLBP;CPSF7;CSTF2T;MAZ;NUDT21;CPSF3;SETX
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.23047427208173893,0.6909428604721308,0.9438202247191011,0.9915112909691997,1.0,38/140,21.89%,FOXM1;RAC1;FLCN;SYDE2;ARHGAP20;ARHGAP19;SRGAP2;SRGAP3;SQSTM1;ARHGEF7;ARHGEF4;RHOD;KALRN;MCF2;ARHGAP21;VAV2;ARHGAP24;PIK3R2;ARAP1;PLEKHG5;FAM13A;AKAP13;ARHGAP29;TRIO;ARHGEF6;PLEKHG2;FGD4;DLC1;MYO9A;STARD13;ARHGAP6;CHN1;ITGAV;PREX1;SRGAP1;RHOU;ARHGAP26;ARHGAP35
prerank,cochlea morphogenesis (GO:0090103),0.3298417691723744,0.6904818557924612,0.8393939393939394,0.9916154125669745,1.0,1/10,8.35%,SOX9
prerank,melanosome localization (GO:0032400),0.2869241348971902,0.690393721460084,0.8591916558018253,0.9913180623084827,1.0,3/21,11.66%,BBS7;MYO5A;VPS33B
prerank,microtubule polymerization (GO:0046785),0.27386372342060417,0.6902604189051419,0.8632478632478633,0.9910772943414194,1.0,8/28,21.41%,TPPP3;CSNK1D;MAPT;TPPP;TUBGCP2;RANBP9;FGF13;CLASP2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2789048295536733,0.6901838390578067,0.8597168597168597,0.9907751219714596,1.0,4/23,15.32%,SIK1;HDAC4;GIT1;NUPR1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.26167753912873776,0.6900783075788218,0.8682634730538922,0.9905035893953604,1.0,8/35,19.09%,PDE7B;SOX9;HTR2C;ADCY1;EPHA5;APOE;PDE9A;KSR1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.31238217347334046,0.6898565233786129,0.841642228739003,0.9903669828612808,1.0,5/12,23.40%,TRIM11;GSN;MID2;TRIM26;IFITM3
prerank,modulation by symbiont of host process (GO:0044003),0.33456781884245973,0.6895428167072152,0.8361408882082695,0.9903002523225897,1.0,4/10,25.11%,HGS;PGK1;B2M;RPS27A
prerank,sphingosine metabolic process (GO:0006670),0.2979051278146049,0.6894890460286544,0.8466757123473542,0.989985718303808,1.0,2/17,12.87%,ABCA2;PLPP3
prerank,regulation of interferon-alpha production (GO:0032647),0.28192124540337904,0.6891066134680001,0.8695652173913043,0.9900218874461534,1.0,5/23,15.53%,DDX3X;DHX36;IRF3;TLR3;HSPD1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.23788522296671666,0.68889560029769,0.9140708915145005,0.9898613209772701,1.0,22/80,23.04%,SMPD2;RBM3;DDX3X;ABCA2;HNRNPD;ZCCHC4;IFNGR1;YTHDF3;NPM1;RACK1;YTHDF1;ROCK2;PRR16;FMR1;METTL5;SOX4;CIRBP;ABCG1;SAMD4A;METTL14;EPHA4;SP1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.31576790195714677,0.6883458472233549,0.8620199146514936,0.9900604341015604,1.0,2/13,8.41%,SAE1;UBA1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.24146233318942792,0.6880189687361153,0.9196919691969196,0.9900152894268741,1.0,11/64,19.11%,ELOVL1;SLC27A4;HSD17B4;FADS1;CPT2;PTGS2;ACSL6;EPHX2;ACADL;GPX4;ELOVL6
prerank,regulation of histone acetylation (GO:0035065),0.26479711369885894,0.6878707711766293,0.8869257950530035,0.989785299363547,1.0,7/33,19.44%,FLCN;HDAC5;ARRB1;PARK7;CTBP1;KMT2A;SETD5
prerank,microvillus assembly (GO:0030033),0.31071571884552657,0.6878569785295569,0.8462603878116344,0.9894230513657667,1.0,2/14,7.01%,MINK1;RAP2A
prerank,protein acylation (GO:0043543),0.255705018899312,0.6865474723987913,0.8815331010452961,0.990390524229992,1.0,11/38,22.95%,NAT9;ZDHHC3;GLUL;PORCN;CLOCK;ZDHHC17;ZDHHC2;FOXO1;GTF2B;ZDHHC14;ZDHHC21
prerank,regulation of nervous system development (GO:0051960),0.25836043987294594,0.6863693487397516,0.881437125748503,0.9902070084572643,1.0,4/37,15.23%,SIRT2;PRUNE1;DOCK7;TENM4
prerank,relaxation of cardiac muscle (GO:0055119),-0.2528922127671096,-0.6853738035070956,0.8742138364779874,0.9706654365091957,1.0,4/13,13.23%,ATP1A1;KCNJ2;ATP1B1;PIK3CA
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2677434416117921,-0.685208501939858,0.8636363636363636,0.9695622958177103,1.0,6/11,25.30%,CAV1;ADIPOR1;PTPRT;SH2B3;VHL;BCL3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.27484726126605963,0.6851337394822533,0.8699609882964889,0.9910841320792221,1.0,13/24,28.27%,PARP1;XRN1;TERF1;TNKS;HNRNPU;PINX1;HNRNPC;TERF2;TENT4B;ERCC4;TNKS2;HNRNPA1;EXOSC10
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.18682673742948558,-0.6850664517352861,0.9457831325301205,0.968427927679311,1.0,4/33,7.64%,TGFA;AFAP1L2;BCAR3;DGKD
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2269783142646293,0.6847528378089364,0.9511698880976602,0.9910846443685786,1.0,28/136,22.40%,COMMD6;GLIS2;USP7;RWDD3;TNFAIP3;TCF7L2;ARRB1;SIK1;PTCH1;DDIT3;CDK5RAP3;HDAC4;CEBPG;LRRC14;SUFU;NUPR1;CTNNBIP1;ANXA4;PKD2;ERBIN;PRMT2;KLF4;SMAD7;ZNF431;COMMD1;MTURN;TAF1;ID2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.24999450800122114,0.6839919692827234,0.8958097395243488,0.9914850597434876,1.0,7/47,16.48%,GRIN1;SLC5A3;PID1;MAPT;RNF41;TGFB1;AGTR1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3077347571808054,0.682850373611423,0.8492392807745505,0.992226319536854,1.0,3/13,16.33%,ENPP1;ABHD14B;SULT1A1
prerank,cytosolic transport (GO:0016482),0.2292743268166886,0.6825142058865479,0.9380165289256198,0.992193188402377,1.0,36/108,25.14%,CLN3;SNF8;SNX5;STX6;VAMP3;SNX6;VPS26B;STX16;TMEM87B;RHOBTB3;HOOK3;DENND5A;VPS54;VTI1B;WDR91;EMP2;AP4M1;STX8;VTI1A;PIK3C3;KLHL20;RAB6A;TRIM27;STX5;HEATR5A;RAB7A;EHD3;PIKFYVE;GOSR1;CCDC91;DENND2A;EEA1;DOP1B;GGA1;HEATR5B;SNX16
prerank,negative regulation of receptor internalization (GO:0002091),0.3066473509015722,0.682076540711222,0.8287373004354136,0.9922656316324845,1.0,2/12,8.75%,LRPAP1;SDCBP
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.28571051351778254,0.6818460680775719,0.850415512465374,0.9921117162822166,1.0,3/16,20.99%,FANCM;RMI1;TOP2B
prerank,dendrite self-avoidance (GO:0070593),0.2943625962521401,0.6815030400450911,0.8701117318435754,0.9920674863859,1.0,4/16,20.32%,DSCAM;NPTN;CNTN2;NEXN
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2736695958385257,0.6811959684773113,0.8655778894472361,0.9920113690060813,1.0,4/25,16.64%,ITPR1;HTT;MAPT;RIT2
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.22035425136167336,-0.6811120918820575,0.9311926605504587,0.9708563788868418,1.0,4/22,12.41%,TOX;SLC16A2;LRRK2;PTPRZ1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.2779892710226474,-0.6796057489752818,0.8484848484848485,0.9710056608711803,1.0,1/10,1.33%,TGFA
prerank,cellular response to hexose stimulus (GO:0071331),0.2771740217865172,0.679533860909601,0.8670967741935484,0.9932951756893148,1.0,6/23,19.15%,XBP1;ZBTB20;RACK1;TRA2B;PRKAA1;SOX4
prerank,cellular response to radiation (GO:0071478),-0.1846153636917125,-0.6794995630262757,0.9530201342281879,0.9698271307907855,1.0,6/40,9.55%,SIRT1;NET1;SPIDR;SWI5;TP53;RHOB
prerank,signal transduction by p53 class mediator (GO:0072331),0.2661650446834506,0.6794476846482226,0.8883374689826302,0.9929989015010198,1.0,6/30,15.77%,STK11;USP10;MDM4;NDRG1;ATRX;DDX5
prerank,amino acid transport (GO:0006865),0.24492363941407375,0.6790421420172528,0.8998862343572241,0.9930340330807542,1.0,7/49,15.32%,SLC7A11;SLC38A9;SLC7A2;SLC38A10;SLC6A15;SLC1A5;SLC6A12
prerank,regulation of centrosome cycle (GO:0046605),0.2842755511569729,0.678721759743941,0.8673740053050398,0.9929746573469524,1.0,4/21,12.27%,FBXW5;CHMP3;VPS4B;NPM1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.27700625267540624,0.6787121527763177,0.8711734693877551,0.9926085678091483,1.0,7/24,23.40%,CALM3;CAMK2D;JPH1;PKD2;CALM1;CALM2;FKBP1A
prerank,heart morphogenesis (GO:0003007),0.24428885477227286,0.678215433715413,0.9089887640449438,0.9927229772747931,1.0,10/50,20.60%,NIPBL;OLFM1;SOX9;FLRT2;MDM4;MEGF8;TGFBR1;DLC1;CHD7;TGFBR3
prerank,regulation of response to cytokine stimulus (GO:0060759),0.2858831018329266,0.6782076824382801,0.8727034120734908,0.9923531749616447,1.0,5/19,19.75%,WNT5A;CD24;CBFB;TLE5;KLF4
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.28502565948247915,0.6775542449712847,0.8543046357615894,0.9926254416399536,1.0,3/19,11.79%,XBP1;XRCC6;ZMIZ1
prerank,rRNA metabolic process (GO:0016072),0.22508315361180994,0.6772625992076106,0.9512690355329949,0.9925618788782287,1.0,23/160,14.80%,EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;RPL9;C1D;RPL4;MAPT;BMS1;XRN1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23038992869971717,0.6769960769483253,0.9351753453772582,0.9924452938648558,1.0,16/82,19.91%,CCP110;HSP90AA1;ALMS1;TUBA1A;YWHAG;NPM1;KCNH5;HAUS3;CSNK1D;TUBB;OFD1;CEP76;TUBB4A;ODF2;DYNLL1;PAFAH1B1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24438576457882744,0.6750793227986467,0.8950892857142857,0.9939804083287432,1.0,18/48,25.80%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;NUP214;NUP153;RANBP2;PRKAG2;NUP35;TPR;NUP155;NUP54;NUP98;PNPT1;POM121;SEH1L
prerank,response to glucagon (GO:0033762),0.28433507243303063,0.6750475818632294,0.8815104166666666,0.9936312268615137,1.0,8/19,26.14%,ADCY7;ADCY1;ADCY5;PRKAR1A;CRY1;PRKAR1B;ADCY2;PRKAR2A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.30350099808674746,0.6749175888032667,0.8608815426997245,0.9933753561798543,1.0,2/13,12.01%,ENTPD7;ENPP1
prerank,anterior/posterior pattern specification (GO:0009952),0.24117319117002278,0.6737195393971935,0.9121245828698554,0.9941676221207465,1.0,4/53,9.61%,ATP6AP2;PCSK5;DDIT3;WLS
prerank,positive regulation of locomotion (GO:0040017),0.26481496721186215,0.6734460243682694,0.8927250308261405,0.9940732447978367,1.0,4/27,14.28%,TWIST1;CFAP20;SPOCK2;TGFB1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3119262247926839,0.673352983266484,0.8623188405797102,0.9937797291196705,1.0,2/11,12.08%,CAAP1;PARK7
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3134974190299634,0.6733506709371374,0.8448023426061494,0.9934050054539335,1.0,2/12,10.86%,BIN1;JUP
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.24398700904416584,0.673312806414308,0.9080459770114943,0.9930620155103214,1.0,8/50,17.73%,CDKN2D;CDC25A;CDK5RAP3;CCNH;CCNT1;CDK7;BCCIP;CAMK2N1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.247473087342424,0.6731564576176885,0.8882554161915621,0.9928254345627929,1.0,11/46,21.38%,LCP1;AIP;PSME2;CAPZA1;SOD2;HNRNPA2B1;HNRNPDL;ANXA2;JAK1;TALDO1;CFL1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.23078875225084206,0.6723503526976556,0.9389721627408993,0.9932327118061901,1.0,15/76,21.85%,COMMD6;USP7;RWDD3;TNFAIP3;ARRB1;DDIT3;CDK5RAP3;LRRC14;FAF1;ANXA4;ERBIN;PRMT2;KLF4;COMMD1;MTURN
prerank,protein localization to lysosome (GO:0061462),0.2609531079875675,0.6719554567025741,0.8838630806845966,0.9932471888621337,1.0,10/28,23.25%,HGS;NCOA4;LAMTOR5;AP4M1;SORL1;ZFYVE16;SCARB2;RAB7A;GGA3;LMBRD1
prerank,positive regulation of cholesterol transport (GO:0032376),0.2647957276316979,0.6718961918096774,0.890818858560794,0.9929310076268321,1.0,7/27,20.03%,PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2;ABCA5
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2952904148200667,0.6708702010215815,0.8641975308641975,0.9935161542854954,1.0,3/15,20.88%,CUEDC2;TGFB1;SMAD7
prerank,negative regulation of JUN kinase activity (GO:0043508),0.31966029110595423,0.6707707003651843,0.8661538461538462,0.993238502937585,1.0,2/10,13.55%,MAPK8IP1;PTPN22
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2640337283334956,0.6705110158356442,0.8676844783715013,0.9931075621815684,1.0,2/26,4.91%,CHERP;ITPR1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.32062954309971237,0.6698412535079428,0.852017937219731,0.9933858085817906,1.0,1/10,4.50%,CXCL12
prerank,DNA recombination (GO:0006310),0.25456815626370843,0.6696302294053895,0.9010856453558505,0.9932099246698716,1.0,3/37,5.73%,XRCC2;HMGB3;FBH1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2799453439272037,0.6691620124638011,0.8599735799207398,0.9932741333406159,1.0,3/18,15.40%,AQP4;RFX3;OFD1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.21566941834513711,0.6688121446980064,0.997,0.9932447040032395,1.0,68/532,17.01%,IL10RA;LCP1;CAMK2B;IL34;PSMD4;NFKB1;MAP3K14;HSP90AA1;IL33;EDAR;IFNAR1;TNFRSF9;IL10RB;STAT6;ANXA1;RORA;CXCL12;EDA2R;POU2F1;IL31RA;IRF1;PIK3R1;SQSTM1;PSMB10;ZEB1;IFIT3;PSMD11;IL22;IFI35;LRP8;TRIM62;TXLNA;AIP;IFNGR2;TEC;RAPGEF1;TWIST1;PRLR;PSME2;IRS2;PSMC5;CAPZA1;PIK3CB;BCL2;LEPR;IFNGR1;IRF3;CAMK2D;COL1A2;CAMK2G;SOD2;TNFRSF25;PTGS2;HNRNPA2B1;TGFB1;BCL6;CBL;F3;IL15RA;PSMD1;HNRNPDL;ICAM1;IL1RAP;IL5;SLC27A1;ANXA2;OAS2;PSMD6
prerank,protein-DNA complex assembly (GO:0065004),0.2218167081286216,0.6687551543124999,0.9498977505112475,0.9929191644245734,1.0,21/116,17.03%,PSMD4;PARP1;TCF4;ASF1A;PSMB10;DDB1;PSMD11;SOX9;ORC6;CUL4B;GTF2H3;PSME2;PSMC5;SART3;CCNH;NPM1;ATRX;PSMD1;DAXX;PSMD6;CDK7
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.25192364219991215,-0.6685816973474419,0.8819672131147541,0.9782863535913638,1.0,6/12,26.59%,ATP1B3;DMD;ATP1B1;FXYD1;WNK1;NOS1
prerank,negative regulation of viral genome replication (GO:0045071),0.24806644025337224,0.6678016759166319,0.9210836277974087,0.9934631552595653,1.0,7/40,18.61%,ILF3;SHFL;ZC3HAV1;OAS2;TNIP1;SRPK1;MPHOSPH8
prerank,cell projection organization (GO:0030030),0.2593636344300918,0.6677902802502726,0.8978102189781022,0.9930983977297945,1.0,8/30,21.42%,RAC1;NEFH;CYFIP1;NPHP1;ATP1B2;ITGB1;RHOU;GSN
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3167271357161966,0.6676410472341137,0.8392857142857143,0.9928796064350738,1.0,2/10,18.28%,SCRIB;PRKAR1A
prerank,actin filament capping (GO:0051693),-0.2163616836785936,-0.6674915307262725,0.9349593495934959,0.9767034149167181,1.0,5/18,17.39%,CAPZA2;EPS8;TRIOBP;TWF2;TWF1
prerank,barbed-end actin filament capping (GO:0051016),-0.2163616836785936,-0.6674915307262725,0.9349593495934959,0.9767034149167181,1.0,5/18,17.39%,CAPZA2;EPS8;TRIOBP;TWF2;TWF1
prerank,NAD biosynthetic process (GO:0009435),0.2781038960543168,0.6674051246999195,0.8641810918774967,0.9927367403521279,1.0,4/20,14.21%,NNMT;NUDT12;PARP16;PTGS2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.24786751961358391,0.666807792873039,0.8997641509433962,0.9928902922371292,1.0,14/36,25.50%,RAB34;RAB10;ANK3;RAB31;SPTBN1;GGA2;NSF;GORASP1;RAB7A;GGA3;GOLGA4;GOLPH3L;GGA1;AFDN
prerank,positive regulation of cartilage development (GO:0061036),0.28070932181578745,0.6666447355432207,0.8555555555555555,0.99266521131431,1.0,4/17,17.64%,SOX9;SOX6;SOX5;BMP1
prerank,negative regulation of cell activation (GO:0050866),0.2943051636217977,0.6663964758978163,0.886685552407932,0.9925181787976648,1.0,3/14,17.19%,C1QTNF1;PDGFRA;APOE
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.2976624401473187,0.6662589136570141,0.8659217877094972,0.9922666002195005,1.0,2/14,11.13%,WNK2;ANK3
prerank,membrane lipid biosynthetic process (GO:0046467),0.23879181179482972,0.6648217532389734,0.9190371991247265,0.9932412518620819,1.0,11/58,19.11%,ELOVL1;ST3GAL2;CERS2;SGPL1;ELOVL4;SPTSSA;PLPP3;VAPB;ALDH3A2;PRKD2;ELOVL6
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.21911092536267335,-0.6647598643699131,0.9114391143911439,0.9777086329387449,1.0,4/18,14.70%,EZR;CD34;PTPRC;HOMER3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.28094785535582795,0.6647199336804488,0.8844155844155844,0.9929539974628951,1.0,6/19,22.16%,FGFR2;RBPJ;TGFBR1;TGFBR3;FGF2;ERBB4
prerank,lipid modification (GO:0030258),0.24940786891029904,0.6646471261331672,0.8971631205673759,0.9926390818114185,1.0,10/37,21.56%,PLPPR2;PORCN;PLPP3;PLPPR5;EPHX2;PLPP4;PLPP5;DGKI;PLA2G7;MBOAT2
prerank,regulation of endocytic recycling (GO:2001135),0.3074058238995625,0.6643955476989989,0.8466165413533835,0.9924795017968029,1.0,5/11,22.42%,ATP9A;EIPR1;SORL1;EHD1;RAB11B
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.26742049058744466,0.664087859212076,0.8906048906048906,0.992377219788759,1.0,3/23,10.19%,SOX9;EGF;GDNF
prerank,hydrogen peroxide catabolic process (GO:0042744),0.3144488291647865,0.6639843391029429,0.875,0.9920973154872967,1.0,2/11,14.59%,PRDX5;PXDN
prerank,positive regulation of biosynthetic process (GO:0009891),0.2463377477721019,0.6634790910189688,0.9107142857142857,0.9922014535626191,1.0,7/40,17.19%,GRIN1;SLC5A3;SUCO;WNT4;ZBTB20;TGFB1;APOE
prerank,cholesterol biosynthetic process (GO:0006695),0.2564150289276479,0.6629180744929802,0.9126092384519351,0.9923351688953387,1.0,5/31,13.04%,LSS;INSIG1;MSMO1;SC5D;CYP51A1
prerank,erythrocyte development (GO:0048821),-0.27142033873621174,-0.6626866277865933,0.8796561604584527,0.97811509451491,1.0,4/10,24.04%,MED1;ABCB10;SH2B3;NCKAP1L
prerank,modulation by host of viral genome replication (GO:0044827),0.29975329347229723,0.6626805152300521,0.8687845303867403,0.992170512030693,1.0,6/13,22.30%,PPIB;TBC1D20;NUCKS1;FMR1;YTHDC2;IFI27
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.28429625859715413,0.6616232034500463,0.8908594815825375,0.9927555863896564,1.0,2/18,4.31%,HSP90AA1;ABCA2
prerank,camera-type eye morphogenesis (GO:0048593),0.3169964380746524,0.6614554723363463,0.8753799392097265,0.9925415253935085,1.0,2/10,10.68%,TENM3;KDM2B
prerank,ncRNA 3'-end processing (GO:0043628),0.2975322545809537,0.661454492738579,0.8674033149171271,0.9921715275098253,1.0,5/14,21.78%,TOE1;PTCD1;INTS6;INTS2;INTS7
prerank,polyol metabolic process (GO:0019751),0.24352459520347247,0.6613179003997115,0.9091915836101883,0.9919322650649358,1.0,12/46,20.53%,PLCH1;SLC5A3;INPP5A;NUDT3;IPPK;ISYNA1;IPMK;IP6K1;CALM1;IMPA1;INPP4A;ITPK1
prerank,glucose transmembrane transport (GO:1904659),0.28093267756696005,0.6604960662339449,0.8723118279569892,0.9922995689269026,1.0,2/18,11.24%,SLC5A3;SLC2A3
prerank,regulation of microtubule depolymerization (GO:0031114),0.26596580601839237,0.6603743596438326,0.8784119106699751,0.992042179652508,1.0,3/25,9.89%,TAOK1;CAMSAP2;KATNB1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.2469675117986052,0.6587898673015263,0.9004796163069544,0.99305306421041,1.0,11/36,22.00%,NR2F2;DCN;JUP;TGFB1;APOE;SYNJ2BP;MECP2;KRIT1;ATP2B4;FGF2;HMGB1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.31493177839437886,0.6586436822836117,0.8698315467075038,0.9928076269419356,1.0,4/10,26.71%,DCLRE1A;TERF2IP;RIF1;TERF2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.28964334597704333,0.6585606340090792,0.8788732394366198,0.9925186032166949,1.0,4/13,24.80%,ZBTB7B;CBFB;GLI3;RUNX1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.25256644656444666,0.6582068872427091,0.9031862745098039,0.9924773666825806,1.0,5/33,19.43%,UBASH3A;THY1;PTPN22;PRKD2;RPS3
prerank,muscle contraction (GO:0006936),0.22103628416286794,0.657073893467657,0.9559877175025588,0.9930944041520922,1.0,9/126,11.40%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;BDKRB2;TPM1;SLC6A8
prerank,response to laminar fluid shear stress (GO:0034616),0.3107895191035481,0.6566656589772778,0.8790697674418605,0.9930865028721914,1.0,5/10,23.97%,SMAD6;ASS1;KLF4;SMAD7;ABCA1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.29579317011370443,0.6559822052807105,0.8697604790419161,0.9933233525523211,1.0,2/12,18.27%,MIA3;ASS1
prerank,centromere complex assembly (GO:0034508),0.24668941549336199,0.6558233697580785,0.9051008303677343,0.9931042122587537,1.0,4/36,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,nitric oxide mediated signal transduction (GO:0007263),0.2873970315888889,0.6553598829209397,0.8787878787878788,0.9931403519984277,1.0,3/16,17.19%,KCNC2;NDNF;APOE
prerank,RNA polyadenylation (GO:0043631),0.2607620137230309,0.6551139816464798,0.9147582697201018,0.9926212369928722,1.0,9/26,19.58%,PABPC1;APP;CPSF3;CDC73;GRSF1;AHCYL1;FIP1L1;MTPAP;CSTF3
prerank,mRNA polyadenylation (GO:0006378),0.2607620137230309,0.6551139816464798,0.9147582697201018,0.9926212369928722,1.0,9/26,19.58%,PABPC1;APP;CPSF3;CDC73;GRSF1;AHCYL1;FIP1L1;MTPAP;CSTF3
prerank,histone lysine methylation (GO:0034968),0.2503624105808491,0.6549156991181949,0.9175757575757576,0.992439400374995,1.0,8/33,19.43%,KMT2B;EZH2;EHMT2;DPY30;SUV39H1;KMT2D;KMT2A;KDM6A
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2713616328137608,0.6533653380645486,0.8974358974358975,0.9934405368056316,1.0,3/20,14.18%,LCP1;RAB13;ROCK2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.23376780640220388,0.6528644337954906,0.9324009324009324,0.9935178954416332,1.0,4/49,13.24%,IGF1;IL31RA;PIBF1;PARP14
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.3121592850850185,0.6528480868053413,0.8708206686930091,0.9927958292901191,1.0,2/10,9.83%,VLDLR;AP2S1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.3121592850850185,0.6528480868053413,0.8708206686930091,0.9927958292901191,1.0,2/10,9.83%,VLDLR;AP2S1
prerank,regulation of RNA export from nucleus (GO:0046831),0.30709452806494425,0.6525180481185003,0.8914373088685015,0.9927165895497762,1.0,5/11,23.45%,AKAP8L;CPSF6;NUP153;TPR;KHDRBS1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.24568370112349883,-0.6520321872185972,0.9121621621621622,0.9853536000576316,1.0,5/12,26.33%,ESR1;PPARG;ELAVL1;ZC3H12A;TERT
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.2836758946439731,0.6519908879687056,0.897742363877822,0.9928180413851381,1.0,6/18,20.58%,GRIN1;NLGN3;NLGN2;SHANK1;PRKCZ;PTK2B
prerank,response to tumor necrosis factor (GO:0034612),0.21940038827820973,0.6513674740939351,0.9485294117647058,0.9930078878337282,1.0,6/91,7.65%,SFRP1;ADAMTS7;GBP3;ZFP36L1;ZFAND6;PID1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.23727873642638875,0.6513391850279698,0.9379932356257046,0.9926629838598079,1.0,13/54,21.09%,NHP2;EBNA1BP2;MRPL1;RPL35A;MALSU1;NPM1;LAS1L;RPL23A;NSA2;BRIX1;RSL1D1;HEATR3;RPL7
prerank,regulation of interferon-gamma production (GO:0032649),0.22758346149805203,0.651077072646198,0.9359391965255157,0.992526665553742,1.0,9/71,15.76%,SCRIB;SIRPA;DDIT3;CD47;CEBPG;TLR3;PTPN22;HSPD1;PDE4B
prerank,DNA methylation (GO:0006306),0.2636038236963835,0.6503068978724257,0.8851174934725848,0.992838100794548,1.0,4/23,13.81%,PICK1;EHMT2;EHMT1;ATRX
prerank,regulation of adenylate cyclase activity (GO:0045761),0.26782646145836225,0.6497368655803724,0.8982188295165394,0.992963214491565,1.0,2/22,7.66%,LTB4R2;ADGRV1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.25256638325193465,0.6491585861804509,0.9,0.9930885973874165,1.0,2/31,2.90%,BAX;STUB1
prerank,cellular response to leucine starvation (GO:1990253),-0.2605885416383731,-0.6487308935264819,0.9136490250696379,0.9865976859603743,1.0,3/10,13.48%,EIF2AK4;RRAGB;LARS1
prerank,adipose tissue development (GO:0060612),0.30639870455173074,0.647650509751593,0.8688524590163934,0.9939855554949516,1.0,1/11,3.79%,XBP1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.30559599341756166,0.6476236686377955,0.8788774002954209,0.9936439488614853,1.0,1/10,8.54%,DDIT3
prerank,activation of protein kinase A activity (GO:0034199),0.2837321168856387,0.6468522255803447,0.9019073569482289,0.9939175204626148,1.0,4/16,18.28%,ADCY7;ADCY1;ADCY5;PRKAR1A
prerank,B cell activation (GO:0042113),0.22678117968238323,0.6468175782825506,0.9505907626208379,0.993585226120861,1.0,9/68,15.53%,EPHB2;HDAC5;HDAC4;MALT1;BCL2;CEBPG;BLNK;TCF3;HSPD1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.24674441569937505,0.6464424248488609,0.914560770156438,0.9935580647706668,1.0,2/32,7.78%,RNASE7;FAM3A
prerank,activin receptor signaling pathway (GO:0032924),0.2807027393163315,0.646297518469633,0.8944519621109608,0.9933175091318756,1.0,5/15,22.12%,ACVR1B;TGFBR1;ACVR2A;SMAD2;SMAD3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3069903418552279,0.6462494328597301,0.8607784431137725,0.9929840000521748,1.0,2/10,7.32%,SMARCB1;HDAC5
prerank,telomere maintenance (GO:0000723),0.23137036366521058,0.6460008067044928,0.92880978865406,0.9928105896885487,1.0,10/50,18.57%,ZBTB48;PARP1;XRCC6;ATR;POLD3;MRE11;RAD50;TERF1;TPRKB;TERF2IP
prerank,regulation of protein localization to nucleus (GO:1900180),0.2379941968233087,0.6459550715989048,0.9283276450511946,0.9924814818950853,1.0,7/43,14.28%,EIF2AK3;FLCN;GLUL;CDK5RAP3;PARK7;LAMTOR5;TGFB1
prerank,cellular response to interleukin-1 (GO:0071347),0.21285505235935853,0.6430582956991647,0.9756592292089249,0.9945251941943813,1.0,13/143,10.46%,SFRP1;ADAMTS7;GBP3;PSMD4;NFKB1;SQSTM1;PSMB10;SIRPA;PSMD11;SOX9;USP10;PSME2;PSMC5
prerank,nucleotide metabolic process (GO:0009117),0.26144168715298854,0.6422134971039584,0.9079445145018915,0.9948704420986658,1.0,7/23,21.40%,DCK;AK4;AK5;PARK7;CMPK1;ME1;AK1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.24997357084999536,0.6413174918583683,0.8975609756097561,0.995233811010563,1.0,10/30,23.92%,CSNK2A2;SAE1;ATG13;LEPROT;ARIH2;UBE2L3;PDCD5;RHOU;SH3GLB1;FBXW7
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.2692737728636788,0.6408299958725323,0.8996138996138996,0.9952421394135802,1.0,3/20,10.90%,SNAI1;OLFM1;RBPJ
prerank,regulation of hippo signaling (GO:0035330),0.27246726422209167,0.6406342313741276,0.893387314439946,0.9950301157243864,1.0,6/17,23.31%,CIT;SOX11;WWC1;NF2;DLG5;MAP2K3
prerank,cellular protein metabolic process (GO:0044267),0.2082133684367978,0.6403780374048895,0.998,0.994860717629533,1.0,63/396,17.63%,IGF1;MRPL36;FARSB;ARAF;LCMT1;CP;UBE2S;WARS1;FSTL1;YARS2;PCSK5;LAMC1;ABL1;MIA3;CKAP4;RAB12;LTBP1;HM13;MANBA;PABPC4;FAM20C;APLP2;MRPL10;PLAT;MBTPS1;RPL35A;RPS25;AFG3L2;APP;IGFBP3;SARS1;IGFBP7;RPS15;PAPPA;RPL9;FBN1;SERP1;HARS1;MRPL3;GSPT1;LAMB1;RPL4;SFTPA1;SFTPA2;ATG3;MRPL13;RPN2;CTSH;MRRF;CHEK2;SERPIND1;MRPL24;NEDD8;UBE2L3;RPL23A;PARL;MXRA8;APOE;RPLP2;TNIP1;FBXO22;PCMT1;OMA1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2786805269819193,0.6402746812601642,0.8753501400560224,0.9945813525039275,1.0,1/14,2.36%,DDX18
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3075434527052868,0.6401740914837118,0.8932178932178932,0.9942964387809301,1.0,2/10,13.81%,JARID2;ATRX
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.31213038043132,0.6401316923666509,0.8875379939209727,0.9939649981794672,1.0,1/10,6.68%,MIA3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.2911886972226332,0.6397813845178906,0.8855507868383404,0.9938713516942355,1.0,3/13,17.57%,SNAI1;TWIST1;MDM2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.23213211672068368,0.6392034751156183,0.9340159271899886,0.9939735641991172,1.0,7/48,18.85%,SCRIB;CEBPG;TLR3;PTPN22;HSPD1;PDE4B;TRIM27
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.23019314050620734,0.6388152249326879,0.9407244785949506,0.9939252320164577,1.0,11/54,19.43%,SIRT7;OGT;TNFAIP3;SQSTM1;ARRB1;PARK7;USP4;PIAS3;SPRY2;SOX4;RPS3
prerank,glutathione metabolic process (GO:0006749),0.2429748168370225,0.6385355924466352,0.9312796208530806,0.9937961639935078,1.0,8/38,20.02%,GSTT1;CNDP2;PARK7;GCLC;ETHE1;DPEP1;HAGH;GSTT2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.23551283461148598,0.6375847807017844,0.9375,0.9941692247024342,1.0,10/44,20.46%,UCHL1;MAPK8IP1;CDK5RAP3;PIK3CB;PTPN22;SPRY2;APOE;SORL1;SMPD1;LYN
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.23929752828965156,-0.6374149396907594,0.89171974522293,0.9921174166898944,1.0,2/12,21.55%,HOMER3;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.23929752828965156,-0.6374149396907594,0.89171974522293,0.9921174166898944,1.0,2/12,21.55%,HOMER3;DYRK2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.30039391771620605,0.6363738338253888,0.8964539007092198,0.9948271939466986,1.0,2/11,10.25%,ARHGEF7;ENPP2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.2834878439175945,0.6354502263134436,0.8968926553672316,0.9952096427283021,1.0,2/13,14.45%,DCN;ARSB
prerank,response to growth factor (GO:0070848),0.2385784242100755,0.6353378968148257,0.944640753828033,0.9949247225257403,1.0,8/41,20.76%,SFRP1;TBC1D7;PLK5;RACK1;ACVR1B;TGFBR1;KLF4;ACVR2A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.22302179185038848,0.6352237233729535,0.942578548212351,0.9946564943307397,1.0,17/62,21.99%,POLR2B;CDK13;CDK9;RTF1;GTF2H3;TCEA1;POLR2K;CCNH;CDC73;CCNT1;CDK7;NELFA;MLLT3;ELP2;CCNT2;EAF1;GTF2F2
prerank,reverse cholesterol transport (GO:0043691),0.2864330784840857,0.6349591045407585,0.9106145251396648,0.9944998611912254,1.0,4/13,23.97%,APOE;ABCA5;ABCG1;ABCA1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.28395842684323447,0.6349240834083378,0.8971830985915493,0.9941628792841517,1.0,5/14,18.99%,CPSF7;CSTF2T;NUDT21;CPSF6;FIP1L1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2489754639846512,-0.6334928022027797,0.9278350515463918,0.9934821991116893,1.0,3/12,30.01%,IL17D;CD80;PAEP
prerank,regulation of transferase activity (GO:0051338),-0.21264547083485577,-0.6330924004808417,0.9429657794676806,0.992453372992469,1.0,9/17,37.63%,FEM1B;SMG6;FEM1A;NLRC5;PPP1R3F;SPTSSB;BAG5;JMJD8;HMBOX1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.21858240714308544,-0.6330278326872484,0.9330708661417323,0.9912362612593842,1.0,10/18,43.43%,ERC1;FCHSD2;SLC5A7;CHRNB1;ERC2;STAC3;KIF1B;FCHSD1;TSPOAP1;CHAT
prerank,regulation of sensory perception of pain (GO:0051930),0.29944839945125534,0.6325515772883114,0.9112781954887218,0.9956322666610331,1.0,2/11,15.49%,ZFHX2;ATPSCKMT
prerank,response to nutrient levels (GO:0031667),-0.21426909193596777,-0.6321695681105206,0.9330708661417323,0.9905511077442363,1.0,3/17,23.29%,PRKAA2;ATF4;FAM107A
prerank,sulfur compound biosynthetic process (GO:0044272),0.21445079597155545,0.6311977826041993,0.9748953974895398,0.9963295177363953,1.0,12/104,13.12%,SLC35B2;CHPF;SLC35D2;GSTT1;ST3GAL2;DCN;ST3GAL3;CHSY3;CNDP2;B4GALT5;OMD;GCLC
prerank,synaptic vesicle membrane organization (GO:0048499),0.26691638026601083,0.6310472571083636,0.9292389853137517,0.9960734269919241,1.0,3/17,14.93%,STX2;SNAP25;STX11
prerank,regulation of cell morphogenesis (GO:0022604),0.2457973602773353,0.6309706175267612,0.9231692677070829,0.9957613901855774,1.0,11/30,25.97%,PDZD8;SPARC;NTNG2;PHIP;MYO9A;CFL1;CAMSAP1;STRIP1;SH3D19;ZMYM6;BCL9L
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.22736831410995934,0.6299097027298515,0.9346846846846847,0.9962069284909317,1.0,13/51,20.88%,SMAD9;FSTL1;HTRA3;LEMD3;FBN1;SMAD6;UBE2D1;SMURF1;GREM2;SORL1;NBL1;ACVR2A;SMAD7
prerank,cell cycle G1/S phase transition (GO:0044843),0.22588238106135494,0.6299079953830633,0.9587053571428571,0.9958432659677441,1.0,10/61,17.03%,CDKN2D;CDC25A;CUL4B;E2F3;CCNH;RCC1;GSPT1;CUL5;ACVR1B;CDK7
prerank,mitotic chromosome condensation (GO:0007076),0.2518860970522572,0.6295365704188219,0.9001218026796589,0.9957748721958093,1.0,2/26,6.66%,CSNK2A2;AKAP8L
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.2495460925641435,0.6284959262592587,0.9165644171779141,0.9962070644782639,1.0,4/26,13.92%,FGFR1;GDNF;BCL2;EYA2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.26390470662100396,0.6283759723647184,0.9106438896189225,0.9959383751152138,1.0,6/18,23.04%,ABCA2;IFNGR1;ROCK2;ABCG1;EPHA4;SP1
prerank,amyloid fibril formation (GO:1990000),0.224224560815547,0.6279763521447579,0.9482758620689655,0.9958614594261924,1.0,19/51,25.86%,APP;USP9X;MAPT;GGA2;HSPG2;ITM2B;MDM2;SORL1;GSN;H3-3A;B2M;GGA3;FKBP1A;IAPP;SIAH2;GGA1;RPS27A;TSPAN14;FURIN
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.23593851996865375,-0.6278625428143022,0.9180327868852459,0.9918984278361788,1.0,3/12,16.45%,NELFB;REST;HES1
prerank,cellular response to ionizing radiation (GO:0071479),0.2281853997251078,0.6266642072704743,0.9426605504587156,0.9964857240568876,1.0,8/47,17.57%,KDM4D;NIPBL;XRCC6;ATR;NUCKS1;CLOCK;TANK;MDM2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.2906108157090277,0.6264427933313813,0.902332361516035,0.9962910215491083,1.0,3/12,17.04%,KIF3A;HOOK3;NIN
prerank,positive regulation of angiogenesis (GO:0045766),0.21155314173415515,0.626318478076879,0.9802289281997919,0.9960187736507987,1.0,16/108,18.03%,SFRP2;WNT5A;PDPK1;XBP1;PRKCA;GAB1;TWIST1;JUP;ADAM12;F3;FOXC2;CTSH;SERPINE1;MTDH;PRKD2;JAK1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.2917412734600774,0.6260043727283142,0.896600566572238,0.99588280591446,1.0,2/12,17.51%,SOAT1;MTTP
prerank,toxin transport (GO:1901998),0.29572146581563263,0.6259060022022942,0.8959537572254336,0.9955902512712174,1.0,3/10,23.17%,ANTXR1;ANTXR2;RAB40B
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.26428842170986633,0.6257155939864932,0.9131016042780749,0.9953712406837947,1.0,3/18,18.27%,MIA3;PTPN22;ASS1
prerank,regulation of mononuclear cell migration (GO:0071675),0.25522389186669564,0.6254979326792484,0.9340232858990944,0.9951605741063093,1.0,1/23,1.28%,IL34
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2177251703046759,0.6248215193357014,0.9446854663774403,0.9952961722465363,1.0,8/65,10.46%,PSMD4;USP47;PSMB10;PSMD11;CDK5RAP3;CHFR;PSME2;PSMC5
prerank,regulation of phosphatase activity (GO:0010921),0.2503575037518827,0.6238443572814508,0.9124365482233503,0.995657468842965,1.0,5/24,18.46%,PPP1R2;CDK5RAP3;PPP6R3;HTT;TIPRL
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.21825367346707458,0.6238047393647131,0.9430719656283566,0.9953218073290477,1.0,17/64,21.99%,POLR2B;CDK13;CDK9;RTF1;GTF2H3;TCEA1;POLR2K;CCNH;CDC73;CCNT1;CDK7;NELFA;MLLT3;ELP2;CCNT2;EAF1;GTF2F2
prerank,sterol biosynthetic process (GO:0016126),0.23841394113901201,0.6227278315163979,0.9395807644882861,0.9957251157051906,1.0,5/33,13.04%,LSS;INSIG1;MSMO1;SC5D;CYP51A1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.2745761529008493,0.622320296834786,0.9049586776859504,0.9956791602422798,1.0,4/16,21.29%,GDNF;PKD2;FOXD1;FGF2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.21570514519282447,0.6219702642278023,0.9621621621621622,0.9955739416524747,1.0,11/74,15.20%,SIRT2;PSMD4;PSMB10;ARNT;PSMD11;PSME2;PSMC5;RBPJ;BACH1;EGLN2;PSMD1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.24872545667386398,0.6219151050797275,0.92336217552534,0.995257965133411,1.0,4/26,12.24%,FBXO7;GPR37;PARK7;SOD2
prerank,T cell proliferation (GO:0042098),-0.23256090029300125,-0.6218808126132165,0.9473684210526315,0.9943209498954068,1.0,3/13,16.70%,CADM1;LMBR1L;MSN
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.2852666102916913,0.6194165019940937,0.9127324749642346,0.9967127257165812,1.0,3/12,15.88%,SCRIB;RAB10;AHI1
prerank,endothelial tube morphogenesis (GO:0061154),0.29136609722706586,0.6181571544671441,0.9053857350800583,0.9972485120421863,1.0,3/10,19.93%,RBPJ;PRKD2;STARD13
prerank,homocysteine metabolic process (GO:0050667),-0.24108628098747575,-0.6179947429276667,0.9446254071661238,0.9954077358395632,1.0,7/11,48.65%,MTHFR;MTRR;CBS;CTH;NOX4;MPST;BLMH
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.22395053731896367,0.6174946320035931,0.9518072289156626,0.9973513540733506,1.0,11/57,22.00%,FIS1;GRIN1;DDX3X;GRIN2A;MALT1;DAPK1;PDCD5;USP50;PDCD6;PPM1F;HMGB1
prerank,cellular response to cAMP (GO:0071320),0.2409697073624043,0.6161841741290489,0.9367396593673966,0.9978982158835622,1.0,3/30,9.43%,ZFP36L1;DMTN;RAPGEF1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2298692920299623,0.615809136839998,0.9487485101311085,0.9978111991049433,1.0,8/39,21.66%,BMP6;MIA3;TGFB1;JAG1;ASS1;KLF4;NF2;PPM1F
prerank,regulation of DNA binding (GO:0051101),0.2251677305200802,0.6157756005354125,0.9636576787807737,0.9974766820707118,1.0,5/44,14.28%,IGF1;SIRT2;EGF;CEBPG;TGFB1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.25712896402343294,0.6155981210826741,0.9267676767676768,0.9972493274643737,1.0,4/20,19.15%,DIP2B;ARRB1;PRKAA1;SOX4
prerank,positive regulation of hemostasis (GO:1900048),0.2885274315431124,0.6153576481969526,0.9084084084084084,0.9966974681953396,1.0,2/10,16.49%,DMTN;SERPINE1
prerank,positive regulation of coagulation (GO:0050820),0.2885274315431124,0.6153576481969526,0.9084084084084084,0.9966974681953396,1.0,2/10,16.49%,DMTN;SERPINE1
prerank,positive regulation of vascular permeability (GO:0043117),0.2806487089502526,0.614676814797762,0.9229671897289586,0.9968398584506175,1.0,1/12,2.58%,BMP6
prerank,androgen metabolic process (GO:0008209),-0.2064187878954499,-0.6122843505910947,0.9596774193548387,0.9973558035551614,1.0,3/18,22.19%,MED1;SPP1;SRD5A3
prerank,negative regulation of cell division (GO:0051782),0.28358053154586116,0.6114791191012681,0.9138686131386862,0.9987190236933031,1.0,2/11,16.11%,ORC6;TXNIP
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.21012296362318683,0.6108606405319026,0.9701492537313433,0.9987884861172512,1.0,14/76,19.73%,TCIM;DDX3X;PPM1B;IFI35;APP;NFAT5;RTKN2;TLR3;PTPN22;ILK;RASSF2;TERF2IP;RPS3;PPM1A
prerank,heterochromatin assembly (GO:0031507),0.25384166745775244,0.6104373755217609,0.921875,0.9987134103497087,1.0,3/20,12.36%,SIRT2;SUV39H1;HDAC1
prerank,regulation of anoikis (GO:2000209),0.2650070797546274,0.609864325143281,0.925,0.9987517479451222,1.0,6/19,22.29%,SIK1;BCL2;ANKRD13C;TLE5;ITGB1;ITGA5
prerank,positive regulation of protein binding (GO:0032092),0.2184622870592295,0.6097430149169095,0.9551912568306011,0.9984765796938442,1.0,11/56,18.68%,VTN;TCF7L2;ABL1;APP;ADD2;LRP1;DERL1;PPP2CB;APOE;USP33;FLOT1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.25268243438827126,0.6096854536947499,0.9212903225806451,0.9981462067872084,1.0,6/21,21.88%,CNOT10;CNOT9;CNOT6;SAMD4B;CNOT4;SAMD4A
prerank,regulation of acrosome reaction (GO:0060046),0.29352311226453104,0.6091990184634983,0.9126506024096386,0.9981215634787535,1.0,1/10,14.46%,GLRA1
prerank,mesoderm formation (GO:0001707),0.2613866654321686,0.6089552564001883,0.9197278911564626,0.9979230896027764,1.0,4/17,21.53%,SNAI1;KDM6B;ITGB1;SMAD2
prerank,ESCRT complex disassembly (GO:1904896),0.2870286818461321,0.6080118580201654,0.9355828220858896,0.9978408936639724,1.0,2/10,12.16%,VTA1;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.2870286818461321,0.6080118580201654,0.9355828220858896,0.9978408936639724,1.0,2/10,12.16%,VTA1;VPS4B
prerank,regulation of Notch signaling pathway (GO:0008593),0.20921094088300474,0.6080043733065452,0.9688172043010753,0.9974870403001612,1.0,14/76,19.39%,DLK1;TCIM;ARRB1;EGF;PRAG1;RBPJ;ZMIZ1;PRKCI;SNW1;JAG1;ITGB1BP1;SYNJ2BP;MMP14;YTHDF2
prerank,negative regulation of viral life cycle (GO:1903901),0.2639905126867602,0.6076847567206771,0.9221140472878998,0.9973267587417097,1.0,5/15,23.40%,TRIM11;GSN;MID2;TRIM26;IFITM3
prerank,cellular component maintenance (GO:0043954),0.2845344871574942,0.6066646579147514,0.9149560117302052,0.9976629101853363,1.0,1/12,3.83%,PICK1
prerank,modulation by host of symbiont process (GO:0051851),0.23662732672323486,0.6057323772353467,0.9519807923169268,0.9979316120046647,1.0,7/31,16.31%,SMARCB1;HDAC1;CHD1;NUCKS1;SAP30BP;SNW1;CCNT1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.2525532434784371,0.605722502329327,0.9334170854271356,0.9975771804305441,1.0,4/21,14.28%,SOX9;ENPP1;ROCK2;TGFB1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.26491963848339833,0.6056332809530608,0.907967032967033,0.9972701208505118,1.0,3/15,17.57%,TAF9B;BCL2;MDM2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.22701022375654964,-0.6049835747766824,0.9591836734693877,1.0,1.0,3/12,16.50%,IGF1R;BNIP3;IRGM
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.275780917157078,0.6046264360884849,0.9198855507868383,0.9975580059773307,1.0,2/12,11.52%,MIA3;BMP5
prerank,protein depolymerization (GO:0051261),0.24462678516381303,0.6043739630417309,0.9265255292652553,0.9973671246920632,1.0,3/27,12.16%,STMN4;KATNB1;VPS4B
prerank,negative regulation of protein secretion (GO:0050709),0.22746428380518577,0.6040741107262958,0.958628841607565,0.9971956988149976,1.0,2/38,3.84%,SFRP1;ERP29
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.26986523953928687,0.6040583344666715,0.9152298850574713,0.9968460310139137,1.0,4/13,20.27%,BMP6;TGFB1;TGFBR1;DAB2
prerank,axonemal dynein complex assembly (GO:0070286),-0.17642623774817792,-0.6039090463905189,0.9848484848484849,0.999313188263728,1.0,27/27,82.39%,SPAG1;TTC12;DNAAF5;ODAD1;CCDC39;DNAH8;DNAH5;ODAD2;DRC1;ODAD3;CCDC65;DNAAF2;ODAD4;CFAP100;DNAH17;CCDC40;DNAAF4;CCDC63;DNAH1;DNAAF1;DNAI3;ZMYND10;CFAP73;DNAL1;DNAI4;LRRC49;DNAAF3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.2535988097970269,0.6038005737829135,0.9326424870466321,0.9966594721736145,1.0,4/19,21.66%,BMP6;DENND6A;FLOT1;PPM1F
prerank,carbohydrate transport (GO:0008643),0.27734193125546686,0.6012435421362659,0.9288824383164006,0.9979238546555391,1.0,1/11,11.43%,SLC50A1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.19862557296654815,-0.6008802683865209,0.9598540145985401,0.9995039680148162,1.0,10/17,44.73%,CACNA2D1;AKAP9;SNTA1;KCNQ1;SCN4B;KCNE4;ANK2;KCNH2;SCN5A;GJA5
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.2398167230614609,0.600272134666548,0.9351145038167938,0.9981596776202142,1.0,5/24,16.69%,PID1;LEPR;MRAP2;COQ10A;ACADVL
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.263465788334298,0.5998806181447865,0.929676511954993,0.9980377107087702,1.0,2/15,12.69%,SMPD2;RACK1
prerank,regulation of response to interferon-gamma (GO:0060330),0.26385507155376564,0.5995098884376787,0.9103840682788051,0.9979081207053878,1.0,4/14,19.91%,IFNGR2;IFNGR1;JAK1;PIAS1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.2870555927262362,0.5987848222897133,0.9107142857142857,0.9979968960158135,1.0,1/10,5.93%,DHX58
prerank,positive regulation of superoxide anion generation (GO:0032930),0.2718242463288983,0.5966282487136709,0.9358437935843794,0.9989471766211141,1.0,2/13,14.28%,MAPT;TGFB1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.19801573946858236,0.5964023056516284,0.9877300613496932,0.9987249720698578,1.0,21/114,22.05%,PSMD4;MAP3K14;EDAR;TNFRSF9;EDA2R;PSMB10;PSMD11;PSME2;PSMC5;TNFRSF25;PSMD1;PSMD6;ILK;BAG4;BIRC3;PSMD5;PTK2B;PSMA4;PSMA1;PSMC6;TRAF2
prerank,regulation of vacuole organization (GO:0044088),0.24759027362939753,0.596308253398294,0.9450980392156862,0.9984276809810833,1.0,9/20,26.01%,ENO2;IFT20;ANXA2;SCARB2;NPRL2;PIKFYVE;MTM1;NPRL3;TBC1D14
prerank,cellular response to inorganic substance (GO:0071241),0.2422156890934038,0.5961745257222958,0.938961038961039,0.9981554425536927,1.0,4/21,16.81%,KCNC2;ATRX;FMR1;DPEP1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.24533788103840898,-0.5960953021803201,0.9351032448377581,1.0,1.0,7/10,39.58%,HSP90AB1;FN1;LAPTM4B;GATA6;TSKU;TYROBP;CDH3
prerank,negative regulation of hippo signaling (GO:0035331),0.2724247643052707,0.5941393067026584,0.9269005847953217,0.9990479989657661,1.0,4/12,23.31%,CIT;WWC1;DLG5;MAP2K3
prerank,regulation of superoxide anion generation (GO:0032928),0.2658378131964647,0.5937666539506927,0.9419889502762431,0.9989134775776646,1.0,2/14,14.28%,MAPT;TGFB1
prerank,nucleoside catabolic process (GO:0009164),0.2779167748043416,0.591707482310663,0.9327354260089686,0.9997946397145009,1.0,3/11,15.57%,UPP2;DPYD;NT5C3A
prerank,negative regulation of interleukin-12 production (GO:0032695),0.2672316079160615,0.5903072511455797,0.9299719887955182,1.0,1.0,1/14,8.56%,PIBF1
prerank,positive regulation of viral transcription (GO:0050434),0.2353781770941928,0.5902041785190755,0.945273631840796,0.9999535070475767,1.0,5/25,18.53%,POLR2B;CDK9;POLR2K;CCNT1;NELFA
prerank,ameboidal-type cell migration (GO:0001667),0.2112686208345799,0.5895031318917576,0.9642857142857143,1.0,1.0,13/51,22.50%,SRGAP2;SGPL1;SEMA3D;GDNF;RADIL;SEMA3E;SEMA3A;MEGF8;AMOT;PDXDC1;PDLIM1;ERBB4;PKN1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2438209721425839,0.589293735192045,0.924901185770751,0.9997704959164497,1.0,2/19,6.77%,RENBP;GNPNAT1
prerank,glutathione biosynthetic process (GO:0006750),0.27289457663603645,0.5885769976957466,0.9265785609397944,0.9998292706311904,1.0,3/11,19.70%,CNDP2;GCLC;HAGH
prerank,glucose metabolic process (GO:0006006),0.20805180455028421,0.5883346429684083,0.9755283648498332,0.9996180857184535,1.0,9/58,18.84%,G6PC3;MDH2;PGAM1;IRS2;ENO2;HECTD4;SLC25A1;OMA1;PGK1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.26517298145496276,0.588165517151238,0.9363905325443787,0.9993742825456579,1.0,3/14,15.47%,TWIST1;IRS2;ABCD2
prerank,regulation of interleukin-10 production (GO:0032653),0.21704660779936052,0.5876903694600265,0.9664739884393063,0.9992839854119118,1.0,4/44,15.53%,FCGR2B;PIBF1;CD47;HSPD1
prerank,cellular response to chemokine (GO:1990869),0.21456333029602767,0.5864883757359464,0.9740406320541761,0.9995985443552051,1.0,3/46,8.61%,CXCL12;RIPOR2;DOCK8
prerank,diol biosynthetic process (GO:0034312),0.25177917240332803,0.5859266964263515,0.9331514324693042,0.9995702172218148,1.0,2/15,15.38%,ABCA2;QDPR
prerank,regulation of gene silencing by RNA (GO:0060966),0.21290755943237624,0.5845739252926777,0.9635949943117179,0.9996058396385095,1.0,20/50,26.22%,RAE1;POLR2B;NUP188;POLR2K;NUP210;NUP88;NUP214;FMR1;NUP153;RANBP2;NUP35;TPR;H3-3A;NUP155;NUP54;NUP98;POM121;POLR2A;SEH1L;PUM2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21290755943237624,0.5845739252926777,0.9635949943117179,0.9996058396385095,1.0,20/50,26.22%,RAE1;POLR2B;NUP188;POLR2K;NUP210;NUP88;NUP214;FMR1;NUP153;RANBP2;NUP35;TPR;H3-3A;NUP155;NUP54;NUP98;POM121;POLR2A;SEH1L;PUM2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.17835727733221274,-0.5843660437519859,0.9955555555555555,1.0,1.0,4/22,17.61%,IKBKB;ROCK1;PTPA;BOD1L1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.23518381326591567,0.5842790779562181,0.9392059553349876,0.9994140452734835,1.0,7/26,22.67%,GRIN1;PRELID1;PSME2;ROCK2;USP50;LYN;EPHA4
prerank,negative regulation of TORC1 signaling (GO:1904262),0.2602036578719615,0.5835220152696883,0.9322766570605188,0.9995009253200492,1.0,2/13,11.57%,STK11;RNF152
prerank,protein palmitoylation (GO:0018345),0.22569268811353344,0.5823769024131131,0.9556650246305419,0.9997438221696218,1.0,6/30,18.18%,ZDHHC3;GLUL;CLIP3;PORCN;ZDHHC17;ZDHHC2
prerank,response to cytokine (GO:0034097),0.19209137466933637,0.58205597761945,0.9938524590163934,0.9995556583101255,1.0,15/141,11.98%,KHSRP;ANXA1;PRKCA;CDK9;ALDH1A2;TRIM56;CXCR4;PID1;HDAC4;APP;PTPN5;BCL2;SHFL;NFAT5;IL1RAPL1
prerank,cranial nerve development (GO:0021545),0.27127793120763244,0.5807735665402768,0.9299552906110283,0.999882078303323,1.0,11/11,72.89%,CHD7;SALL1;PAX2;ATOH7;ISL1;TIFAB;POU4F1;TFAP2A;CHRNB2;ERBB3;TMEM126A
prerank,protein acetylation (GO:0006473),0.2242831288212765,0.5805046822713528,0.9613947696139477,0.999681151079024,1.0,7/30,22.48%,NAT9;MAPT;HAT1;CLOCK;NAA35;FOXO1;GTF2B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.26594764119891146,0.5799289993320901,0.9362962962962963,0.9996341407206466,1.0,3/12,18.65%,LIN28B;TGFB1;NCOR2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.1934257886085612,-0.5797011465467029,0.975,1.0,1.0,4/17,27.01%,ADRA1B;ADRA1A;ADRA2A;DRD2
prerank,negative regulation of chemokine production (GO:0032682),0.2560502267579721,0.5793863162102987,0.9432918395573997,0.9995663439742897,1.0,1/14,7.34%,SIRPA
prerank,tRNA 5'-leader removal (GO:0001682),0.25942687261446984,0.5783711406593843,0.9415855354659249,0.9997566690706844,1.0,2/13,13.55%,PRORP;RPP30
prerank,TOR signaling (GO:0031929),-0.1742888952468557,-0.5779713171688711,0.9852941176470589,1.0,1.0,1/26,0.08%,RICTOR
prerank,cardiac muscle cell differentiation (GO:0055007),0.2398987478543571,0.5779496922851524,0.9520103761348897,0.9996139789394427,1.0,4/21,16.73%,SIK1;AKAP13;NRG1;KDM6B
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.2753493086792372,0.5769408745567802,0.9218989280245024,0.9997913268527525,1.0,2/10,12.08%,GPR37;PARK7
prerank,regulation of erythrocyte differentiation (GO:0045646),0.21837646882347747,0.5768747924890782,0.9623329283110571,0.9994675040192716,1.0,5/35,15.34%,ZFP36L1;BRD1;ARNT;PRMT1;ACVR1B
prerank,regulation of cell projection organization (GO:0031344),0.26527128690601487,0.576170956714066,0.9236311239193083,0.999498258838184,1.0,3/13,19.89%,NTNG2;SPRY2;MYO9A
prerank,carboxylic acid transmembrane transport (GO:1905039),0.21617934125127153,0.5759000849708955,0.9719626168224299,0.9992789932621022,1.0,3/40,10.32%,SLC7A11;SLC38A9;SLC38A10
prerank,heme biosynthetic process (GO:0006783),0.2319513105685584,0.5757870890443623,0.9601542416452442,0.9989806179996864,1.0,2/22,10.15%,UROD;SLC25A38
prerank,water transport (GO:0006833),0.25994326322404515,0.5757617024758854,0.9380281690140845,0.9986392024855977,1.0,1/12,14.55%,AQP4
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.27427393473968675,0.5751755898496407,0.9259259259259259,0.9985944570094502,1.0,1/10,7.66%,ADGRV1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.22925378159218052,0.5741070698709124,0.9541984732824428,0.9988069947214964,1.0,3/25,10.86%,CD200R1;JAM3;JUP
prerank,neural crest cell migration (GO:0001755),0.21627472684479884,0.5739772606241436,0.9739336492890995,0.9985171586613785,1.0,6/36,15.56%,NRP1;SEMA3D;GDNF;RADIL;SEMA3E;SEMA3A
prerank,regulation of interleukin-12 production (GO:0032655),0.2094368007030158,0.573883057487715,0.9617117117117117,0.9982112880433777,1.0,5/47,15.53%,TIRAP;PIBF1;CD47;TLR3;HSPD1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.20356102040801852,-0.5738591049008225,0.9539007092198581,1.0,1.0,8/14,41.51%,TSEN2;CSTF2;TSEN15;CPSF4;CPSF1;CLP1;TRPT1;TSEN54
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2695235633348959,0.5736046562718473,0.9398826979472141,0.997994056489563,1.0,3/10,20.87%,PIBF1;PARP14;NF2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.2501782548555771,0.5711855034365565,0.9512534818941504,0.9988794552119244,1.0,3/15,17.10%,LACTB2;RPP30;ZC3H12C
prerank,myofibril assembly (GO:0030239),0.2125046857134596,0.5710748369782398,0.9676674364896074,0.998583445221714,1.0,5/42,18.74%,OBSL1;TPM1;PDGFRA;TMOD2;CSRP2
prerank,chromatin assembly (GO:0031497),0.213916987460681,0.5710481679163655,0.9644970414201184,0.9982476202524909,1.0,10/38,21.66%,RBBP4;ASF1A;SOX9;SART3;NPM1;ATRX;DAXX;CTCF;NAP1L4;H3-3A
prerank,lymphocyte chemotaxis (GO:0048247),-0.15684377778725814,-0.5705701554556232,0.9937888198757764,1.0,1.0,6/34,22.72%,CCL15;CXCL16;CCL13;SLC12A2;CKLF;PIK3CD
prerank,positive regulation of phospholipase C activity (GO:0010863),0.21121992577872833,0.57012745506959,0.967816091954023,0.9983352413192169,1.0,8/40,21.29%,NTF3;FGFR1;PDGFRA;LPAR1;GNAQ;ARHGAP6;NTRK2;FGF2
prerank,positive regulation of ATPase activity (GO:0032781),0.21052204652440581,0.5690360212330603,0.9654761904761905,0.9985041713831858,1.0,11/41,21.93%,FGF10;TPM1;DNAJC24;VMP1;DNAJC10;DYNLL1;TOR1AIP2;HNRNPU;ATP1B2;MSH3;PFN2
prerank,regulation of oxidoreductase activity (GO:0051341),0.25773680539299154,0.5687650678600749,0.9295580110497238,0.9982676501992542,1.0,1/13,6.07%,ABL1
prerank,B cell differentiation (GO:0030183),0.2073086537708473,0.5682509994255615,0.9804597701149426,0.9981611906645131,1.0,6/46,15.29%,SYVN1;HDAC5;HDAC4;CEBPG;BLNK;TCF3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2275816632076091,0.5677817478826428,0.9506953223767383,0.9980358627205446,1.0,5/25,18.16%,RBPJ;CNOT9;ARAP1;CBL;CCDC88A
prerank,negative regulation of gluconeogenesis (GO:0045721),0.2659828810806052,0.5677569527921155,0.9429824561403509,0.9976947435043891,1.0,3/11,24.51%,SIK1;CLK2;CRY1
prerank,regulation of B cell apoptotic process (GO:0002902),0.26010297670097604,0.5673253695640343,0.9442934782608695,0.9975359381778787,1.0,3/12,20.46%,IRS2;BCL6;LYN
prerank,motile cilium assembly (GO:0044458),0.2602814240768357,0.5671479931011983,0.9375907111756169,0.9972692089223749,1.0,2/12,17.62%,BBOF1;DNAAF3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.23913856017718893,0.5665375124796171,0.9617918313570487,0.9971932113271145,1.0,1/19,2.38%,AASS
prerank,lipid droplet formation (GO:0140042),0.27064470845149846,0.5643404795181051,0.934876989869754,0.9978554506073205,1.0,2/10,15.93%,AUP1;CDS1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.20230135241082994,0.5639483140162799,0.985539488320356,0.9976878760489155,1.0,10/56,20.88%,BMP6;PMEPA1;SDCBP;BMP5;TGFB1;SMAD6;TGFBR1;DAB2;ACVR2A;SMAD7
prerank,mitochondrial transcription (GO:0006390),0.2677788891930934,0.5614844619036252,0.9382530120481928,0.9984772868432142,1.0,2/10,15.72%,SLC25A33;TFB1M
prerank,mitochondrial gene expression (GO:0140053),0.20325704130903116,0.5591366486649524,0.9781609195402299,0.9991734087892209,1.0,5/42,12.81%,NDUFA7;SLC25A33;GATB;MRPL47;HARS1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2352446304158337,0.5578679772285033,0.9659239842726082,0.9990207390964011,1.0,1/20,4.08%,GSTT1
prerank,glutathione derivative metabolic process (GO:1901685),0.2352446304158337,0.5578679772285033,0.9659239842726082,0.9990207390964011,1.0,1/20,4.08%,GSTT1
prerank,calcium ion transport into cytosol (GO:0060402),0.23245713707099777,0.5577908038171777,0.9730077120822622,0.9987027733730114,1.0,2/21,8.22%,GRIN1;GRIN2A
prerank,DNA packaging (GO:0006323),0.2422582090147215,0.556802318172032,0.9510869565217391,0.998794887008393,1.0,2/16,15.94%,RBBP4;HAT1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.21251780250511168,0.5561779340108196,0.9722557297949337,0.9987264796505403,1.0,3/31,15.53%,TIRAP;TLR3;HSPD1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.2116067294778974,0.555985997438775,0.9656398104265402,0.9984493946191779,1.0,8/38,18.55%,CSNK2A2;SAE1;ATG13;LEPROT;ARIH2;UBE2L3;PARL;BAG4
prerank,granulocyte chemotaxis (GO:0071621),0.19797102135227673,0.5554279045004074,0.9846491228070176,0.9983492932478714,1.0,3/55,9.33%,EDN3;ANXA1;PPIB
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.1917012783011503,0.5553153303631528,0.9881720430107527,0.9976994206542888,1.0,8/78,11.80%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.1917012783011503,0.5553153303631528,0.9881720430107527,0.9976994206542888,1.0,8/78,11.80%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,tRNA wobble base modification (GO:0002097),-0.19898893624966538,-0.5551548553735766,0.972972972972973,1.0,1.0,11/14,49.83%,ELP3;TRMT9B;DPH3;ELP4;GTPBP3;MOCS3;KTI12;ALKBH8;ADAT2;CTU2;CTU1
prerank,entry into host (GO:0044409),0.2540295842999814,0.5549386808651643,0.9508426966292135,0.9975007756632251,1.0,3/13,20.71%,CXCR4;CBL;ITGAV
prerank,embryonic digit morphogenesis (GO:0042733),0.23394005276415386,0.5535797373035801,0.9649122807017544,0.9977237799853284,1.0,4/18,21.30%,TWIST1;HDAC1;OSR1;GLI3
prerank,phosphate ion homeostasis (GO:0055062),0.2681298873715407,0.5530339730739453,0.9469153515064562,0.9976220558378321,1.0,1/10,12.01%,ENPP1
prerank,cardiac muscle cell development (GO:0055013),0.23079562892082545,0.5530097137621096,0.959792477302205,0.9972844951013231,1.0,2/20,11.29%,OBSL1;PDGFRA
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.22457300952389136,0.5521983309285765,0.9608865710560626,0.9972561358500642,1.0,4/22,20.33%,THY1;FLOT1;KLF4;GCNT2
prerank,protein insertion into membrane (GO:0051205),0.2131903027270513,0.5516595480193145,0.9678188319427891,0.9971321327041109,1.0,9/32,22.11%,GET1;APP;SERP1;SEC61G;ALDH3A2;STX5;OXA1L;RTP4;TRAM2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.2570374524935232,0.5507459979044618,0.9536231884057971,0.9971523447737307,1.0,3/12,19.22%,DSCAM;NKD1;AGTPBP1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.22929984424570662,0.5503330569855605,0.9686648501362398,0.9969752034837314,1.0,6/20,24.49%,MALT1;PRKCZ;TRAF2;B2M;IL18;TRAF6
prerank,glucan biosynthetic process (GO:0009250),-0.20682984966246667,-0.5501362017125969,0.976897689768977,1.0,1.0,4/12,27.59%,GYS1;PGM2;GYG1;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),-0.20682984966246667,-0.5501362017125969,0.976897689768977,1.0,1.0,4/12,27.59%,GYS1;PGM2;GYG1;PPP1R3C
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.24043308369498295,0.5500126513566375,0.9533898305084746,0.9967558650227433,1.0,3/15,21.43%,APOE;ABCA5;ABCG1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.20588789153223272,-0.5487201353792159,0.973421926910299,1.0,1.0,12/12,79.43%,ANXA6;RYR2;MTLN;CASQ2;ANK2;CASQ1;TRDN;FKBP1B;UBASH3B;LIME1;DIAPH1;PTK2B
prerank,thymus development (GO:0048538),0.2479000242970192,0.5486043652730911,0.9474431818181818,0.9969870358667685,1.0,1/13,4.88%,FGF10
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.18871189326978177,0.547342253115315,0.9903225806451613,0.9971252770338601,1.0,8/79,11.80%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.2474879637128491,0.5459385380197406,0.9423076923076923,0.9972958110621118,1.0,1/13,7.24%,CLPTM1
prerank,macrophage chemotaxis (GO:0048246),-0.2192932906546162,-0.5427239087404548,0.9661971830985916,1.0,1.0,10/10,78.09%,CKLF;EDNRB;TAFA4;CCL2;CCL5;CCL3;LGALS3;EDN2;SAA1;CXCL17
prerank,snRNA processing (GO:0016180),0.2336484285492941,0.5409604981096513,0.9616963064295485,0.9988397376148912,1.0,1/16,2.38%,TOE1
prerank,positive regulation of cellular senescence (GO:2000774),0.2581042686460388,0.5376192183767439,0.947289156626506,0.9997219643242331,1.0,1/10,6.71%,EEF1E1
prerank,diol metabolic process (GO:0034311),0.22428490600102824,0.5371307464877189,0.9586114819759679,0.999559685707399,1.0,1/19,2.67%,HSP90AA1
prerank,eye photoreceptor cell development (GO:0042462),0.2331528316790698,0.5370073807077328,0.9669421487603306,0.9992579294285093,1.0,2/15,17.41%,THY1;TOPORS
prerank,dendritic cell migration (GO:0036336),0.23503015343089068,0.5369387100927685,0.9553072625698324,0.9989339205501044,1.0,1/16,7.14%,CXCR4
prerank,cellular response to interleukin-15 (GO:0071350),-0.19590144753092928,-0.5349338646496461,0.9863481228668942,1.0,1.0,1/13,2.78%,STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.19590144753092928,-0.5349338646496461,0.9863481228668942,1.0,1.0,1/13,2.78%,STAT3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.2382429477086324,0.534744484999935,0.9544807965860598,0.9993817748505821,1.0,3/14,15.57%,UPP2;DPYD;NT5C3A
prerank,positive regulation of cytokinesis (GO:0032467),0.2079425238529558,0.5346570957885098,0.9842615012106537,0.9990644105676669,1.0,4/32,14.14%,CDC14B;CIT;SVIL;CSPP1
prerank,cellular response to ATP (GO:0071318),-0.19180015195386763,-0.5341613044447016,0.9795221843003413,1.0,1.0,3/14,18.46%,HSP90B1;P2RX7;P2RY12
prerank,pentose-phosphate shunt (GO:0006098),0.25044420006777823,0.5333473696708145,0.9506346967559943,0.9991555967829028,1.0,3/11,20.30%,TKT;RPIA;TALDO1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.24220287973845583,0.5326342969632334,0.9543446244477173,0.9990387172563873,1.0,1/12,5.78%,DCN
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.2572896904830705,0.5325742150718922,0.951937984496124,0.9987099120426071,1.0,2/10,16.49%,JAM3;SERPINE1
prerank,maturation of 5.8S rRNA (GO:0000460),0.22792839476559063,0.5318392655942153,0.963758389261745,0.9986027785888095,1.0,4/17,17.59%,MTREX;C1D;LAS1L;NSA2
prerank,synaptonemal complex organization (GO:0070193),-0.1898098390022843,-0.5306571009174568,0.975609756097561,1.0,1.0,9/15,52.34%,BAG6;P3H4;SYCP2;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),-0.1898098390022843,-0.5306571009174568,0.975609756097561,1.0,1.0,9/15,52.34%,BAG6;P3H4;SYCP2;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3
prerank,catecholamine metabolic process (GO:0006584),0.2398141754033523,0.5304618242613371,0.9593267882187938,0.998701467889959,1.0,14/14,76.04%,COMT;DBH;DRD4;PAH;TH;ATP7A;DRD1;SNCAIP;LRTOMT;DRD3;RNF180;DRD2;PRKN;DDC
prerank,positive regulation of neuron migration (GO:2001224),0.24995429274571754,0.5285373460247926,0.9652567975830816,0.9989758981418554,1.0,6/11,26.22%,NIPBL;SEMA3A;KIF20B;SHTN1;ARHGEF2;RAPGEF2
prerank,inorganic ion transmembrane transport (GO:0098660),-0.19589648123643652,-0.5266214144682323,0.9909365558912386,1.0,1.0,5/12,43.96%,ABCC9;CACNA1H;KCNJ8;PKD2L1;ABCC8
prerank,cGMP metabolic process (GO:0046068),-0.19979503514175778,-0.5264525160964241,0.9723076923076923,1.0,1.0,3/12,23.06%,GUCY1A1;NPR1;PDE2A
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.25149145793055827,0.5249648270379216,0.9646153846153847,0.9997549904885378,1.0,1/10,7.55%,CD24
prerank,fluid transport (GO:0042044),0.2368654771490742,0.5244831708997426,0.9730113636363636,0.9995564075859426,1.0,1/12,14.55%,AQP4
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.2581304032174705,0.5242211786434666,0.9696969696969697,0.999302697843009,1.0,4/10,26.01%,RAP2A;MYO9A;CDC42;OPHN1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.18204205943645732,0.5235144434756898,0.9888392857142857,0.9991827024194332,1.0,3/57,8.56%,IGF1;IL31RA;PIBF1
prerank,outer dynein arm assembly (GO:0036158),-0.19015631866407182,-0.5233960814217883,0.9892857142857143,1.0,1.0,14/14,81.01%,DNAAF5;ODAD1;DNAH8;DNAH5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63;DNAAF1;ZMYND10;DNAL1;LRRC49
prerank,DNA replication (GO:0006260),0.17680731158048205,0.5206133354194991,0.9948293691830403,0.9996736683078076,1.0,15/105,18.10%,WDHD1;BARD1;MCMBP;ORC6;KIN;TOP1;RBMS1;BRIP1;RMI1;ATR;HELB;MRE11;RAD50;TOP3A;RBBP8
prerank,sensory perception of pain (GO:0019233),0.21743049601116546,0.520496300215815,0.974934036939314,0.9993619263596917,1.0,1/21,4.13%,OPRK1
prerank,pigment granule transport (GO:0051904),0.22121275326095463,0.519650047547096,0.9787516600265604,0.9989062897279749,1.0,2/18,11.49%,BBS7;MYO5A
prerank,melanosome transport (GO:0032402),0.22121275326095463,0.519650047547096,0.9787516600265604,0.9989062897279749,1.0,2/18,11.49%,BBS7;MYO5A
prerank,tRNA 5'-end processing (GO:0099116),0.22684919926417718,0.518716461094172,0.979702300405954,0.9988133684969946,1.0,2/15,13.55%,PRORP;RPP30
prerank,pre-replicative complex assembly (GO:0036388),0.17998774531951048,0.5185483983436585,0.989247311827957,0.9985199439346468,1.0,6/64,10.46%,PSMD4;PSMB10;PSMD11;ORC6;PSME2;PSMC5
prerank,receptor recycling (GO:0001881),-0.20578484918132284,-0.5182709554148972,0.9878419452887538,1.0,1.0,5/10,34.24%,LMTK2;NSG1;PHETA1;PLEKHJ1;REP15
prerank,sodium ion import across plasma membrane (GO:0098719),-0.17403150298747613,-0.5169707937067451,0.9834710743801653,1.0,1.0,5/17,31.08%,SLC9A2;SLC12A2;HCN2;SLC8A1;SLC9A5
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.23437597258904536,0.5144961198799916,0.9708454810495627,0.9993110360105791,1.0,3/12,19.70%,CNDP2;GCLC;HAGH
prerank,establishment of melanosome localization (GO:0032401),0.21709485973223144,0.5138615425780394,0.9790575916230366,0.9991484449655943,1.0,2/19,11.49%,BBS7;MYO5A
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19046488569375514,0.5135619869411975,0.9873708381171068,0.9988666967190022,1.0,9/42,26.56%,CXCL12;OXSR1;CCL25;PTK2B;CX3CL1;ACKR3;CCL14;RBM15;FOXC1
prerank,negative regulation of ion transport (GO:0043271),0.209091784695741,0.5095111982457602,0.969309462915601,0.9995784884905975,1.0,6/24,22.71%,PACSIN3;WNK2;PTK2B;SYT11;PXK;WNK3
prerank,dermatan sulfate metabolic process (GO:0030205),0.2259438625386858,0.5072371976121547,0.9738372093023255,0.9998093252200854,1.0,1/13,5.78%,DCN
prerank,telomere organization (GO:0032200),0.18564703773117047,0.5044405234094157,0.9895348837209302,1.0,1.0,8/43,18.57%,PARP1;XRCC6;ATR;POLD3;MRE11;RAD50;TERF1;TERF2IP
prerank,regulation of hemopoiesis (GO:1903706),0.2381393291740504,0.5042063873625109,0.9745508982035929,0.999829865914627,1.0,3/10,24.80%,CBFB;MYSM1;RUNX1
prerank,plasma membrane repair (GO:0001778),0.22889862389795645,0.5032898096917444,0.984081041968162,0.99970891938182,1.0,5/13,23.20%,ARL8B;SMPD1;SYT11;MYH9;SYT7
prerank,regulation of cell development (GO:0060284),0.1856723366247395,0.501520827035931,0.9915458937198067,0.9997819317877956,1.0,9/36,24.95%,PRUNE1;DOCK7;ADGRA2;CLOCK;FBXO22;YTHDF2;FOXO1;YAP1;CX3CL1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.224572864561717,0.4977163153720321,0.9807162534435262,1.0,1.0,5/14,24.26%,SUFU;FAF1;PKD2;KEAP1;G3BP2
prerank,serine family amino acid metabolic process (GO:0009069),0.21731288003164895,0.49672641580107113,0.9793672627235214,1.0,1.0,2/16,13.12%,SARS1;GCLC
prerank,error-free translesion synthesis (GO:0070987),-0.15764921445782207,-0.49631075993209617,1.0,1.0,1.0,13/22,42.88%,RPA1;UBB;REV1;RFC2;SPRTN;PCNA;RPA3;RCHY1;RFC3;UBA52;RPA2;RFC4;POLD1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.22691607557592133,0.4913519800183742,0.981638418079096,1.0,1.0,12/12,77.33%,CENPC;SEH1L;CDT1;CHAMP1;KIF2C;NUF2;MAD1L1;RMDN1;NDC80;CENPE;BOD1;MIS12
prerank,regulation of neurogenesis (GO:0050767),0.17315439455548884,0.4905805684284615,0.9955357142857143,1.0,1.0,13/55,24.99%,PRUNE1;SOX11;HOOK3;DOCK7;SNW1;SORL1;YTHDF2;SERPINF1;APPL2;B2M;YAP1;CX3CL1;NAP1L1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.1956729205675675,0.4891861480321845,0.9844961240310077,1.0,1.0,5/22,22.95%,ZDHHC3;CLIP3;ZDHHC2;ZDHHC14;ZDHHC21
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.1956729205675675,0.4891861480321845,0.9844961240310077,1.0,1.0,5/22,22.95%,ZDHHC3;CLIP3;ZDHHC2;ZDHHC14;ZDHHC21
prerank,DNA-dependent DNA replication (GO:0006261),0.16351470013080738,0.4884881926980971,0.9979612640163099,1.0,1.0,9/128,10.46%,WDHD1;SIRT7;PSMD4;PSMB10;MCMBP;PSMD11;ORC6;PSME2;PSMC5
prerank,microtubule-based transport (GO:0099111),0.22653945138409393,0.4882707601519491,0.9749631811487481,0.9998494285875161,1.0,12/12,77.36%,HTT;DYNC1I2;DNAAF4;CCDC40;DNAAF2;SPA17;SPAG17;ADCY10;ROPN1L;CABYR;DYNC1I1;SPEF2
prerank,photoreceptor cell development (GO:0042461),-0.1745583113751042,-0.4878020701294355,0.9876923076923076,1.0,1.0,5/14,28.07%,ARL3;VEGFA;RP1;CEP290;MFSD2A
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.19622687754570967,-0.48731249576919317,0.9871794871794872,1.0,1.0,1/10,2.90%,SACS
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.22621139844338434,0.4848600928810371,0.9880597014925373,0.9998134064120442,1.0,11/11,77.39%,JAK1;PTK2B;IL2;IL2RB;SHC1;IL2RG;STAT5B;IL2RA;JAK3;SYK;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.22621139844338434,0.4848600928810371,0.9880597014925373,0.9998134064120442,1.0,11/11,77.39%,JAK1;PTK2B;IL2;IL2RB;SHC1;IL2RG;STAT5B;IL2RA;JAK3;SYK;STAT5A
prerank,gas transport (GO:0015669),0.23285005962467845,0.4824529648159352,0.9849397590361446,0.9998874503024406,1.0,10/10,76.73%,CA2;AQP5;AQP6;RHAG;NGB;MB;AQP1;MYC;CYGB;IPCEF1
prerank,DNA methylation or demethylation (GO:0044728),0.20115902956247034,0.48166174711656656,0.9775725593667546,0.9993415588297926,1.0,3/19,13.81%,EHMT2;EHMT1;ATRX
prerank,DNA alkylation (GO:0006305),0.20115902956247034,0.48166174711656656,0.9775725593667546,0.9993415588297926,1.0,3/19,13.81%,EHMT2;EHMT1;ATRX
prerank,thyroid hormone generation (GO:0006590),-0.1904223937739283,-0.48117064502366164,0.9823529411764705,1.0,1.0,10/10,80.98%,SLC5A5;FOXE1;DIO2;TG;TPO;DUOX1;IYD;CPQ;DUOX2;CTSK
prerank,cellular response to gamma radiation (GO:0071480),0.20964203600931533,0.48023155804617723,0.9847222222222223,0.9992398586840401,1.0,6/17,25.60%,XRCC6;ATR;MDM2;ATM;YAP1;MAP3K20
prerank,midbody abscission (GO:0061952),0.20451211622975057,0.4793660436146255,0.9852348993288591,0.9990349135264451,1.0,6/17,26.30%,CHMP3;VPS4B;CHMP4A;CHMP4B;PDCD6IP;MITD1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.16275172480572872,0.47706165484866075,0.9967948717948718,0.9990742240108834,1.0,9/76,17.53%,OPRK1;GPR4;PTH1R;HTR2C;CHRM2;LPAR1;LPAR6;AGTR1;HRH1
prerank,cilium-dependent cell motility (GO:0060285),-0.14577745342481704,-0.4733995553153269,1.0,1.0,1.0,8/22,34.45%,CFAP44;CCDC39;EFHC2;EFHC1;DNAH2;DNAH8;GAS8;RSPH9
prerank,negative regulation of axon extension (GO:0030517),0.18119611479489917,0.4715289129856882,0.9975786924939467,0.9996226879122436,1.0,4/30,15.56%,DIP2B;SEMA3D;SEMA3E;SEMA3A
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.1993045721823743,0.4707924101386646,0.9814814814814815,0.99939034474858,1.0,4/18,23.92%,FBN1;TLR3;TCTA;FBXW7
prerank,response to gamma radiation (GO:0010332),0.18953212244202217,0.4705084409231206,0.9887359198998749,0.9990827909540975,1.0,8/24,25.95%,XRCC6;ATR;MDM2;PRKAA1;ATM;YAP1;MAP3K20;DCUN1D3
prerank,regulation of actin filament-based movement (GO:1903115),-0.19242877522963897,-0.4678265074109156,0.9915966386554622,1.0,1.0,6/10,45.37%,SRI;PDE4D;PLN;ANK2;SCN5A;STC1
prerank,aorta morphogenesis (GO:0035909),0.19905178756600111,0.4647333839844598,0.9780821917808219,0.9995941877937927,1.0,3/17,16.44%,RBPJ;LRP1;JAG1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.12690131992457573,-0.4594834542457295,1.0,1.0,1.0,33/33,87.34%,TLR4;CEBPB;PRXL2A;GPR137B;TMEM178A;MAFB;GPR137;FSTL3;LILRB3;CARTPT;MTOR;LRRC17;POU4F1;BGLAP;CCR1;IL4;TNFSF11;OCSTAMP;CSF1;IL23A;TNF;IL23R;CCL3;IL12B;GPR55;UBASH3B;POU4F2;IFNG;CAMK4;TRAF6;TCTA;TLR3;FBN1
prerank,ureteric bud morphogenesis (GO:0060675),0.1967125536400634,0.4504665137600213,0.994579945799458,1.0,1.0,3/16,21.29%,GDNF;PKD2;FGF2
prerank,sulfation (GO:0051923),0.21328144614612107,0.446859626951364,0.992603550295858,1.0,1.0,11/11,78.69%,SULT1A1;UST;SULT2A1;CHST4;SULT1C2;SULT1C4;SULT6B1;SULT2B1;CHST5;SULT4A1;HS3ST5
prerank,neurotransmitter biosynthetic process (GO:0042136),0.1998281311055564,0.4445405604726795,0.9873417721518988,1.0,1.0,2/14,17.37%,SLC6A4;MOXD1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.17420030766297523,0.44171387948701996,0.9975816203143894,1.0,1.0,1/29,1.88%,NOP9
prerank,DNA strand elongation (GO:0022616),0.1857357201741969,0.4344085567172963,0.9910371318822023,1.0,1.0,3/18,16.27%,POLD3;MRE11;RAD50
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.1738530094771857,-0.4330550603544721,1.0,1.0,1.0,10/10,82.63%,PTPRC;SH2B3;MAPK7;SIGIRR;MAP2K5;PALM3;APOA1;IRAK3;KLF4;TLE5
prerank,cellular glucan metabolic process (GO:0006073),0.20542260326445386,0.43241172953536455,0.9941176470588236,1.0,1.0,2/11,18.99%,GBE1;PRKAG2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.18146549525068928,0.42288550040582545,0.9945872801082544,1.0,1.0,3/16,21.29%,FGFBP1;AGTR1;FGF2
prerank,neuron projection regeneration (GO:0031102),0.20136297272090314,0.42184282625425845,0.9969742813918305,1.0,1.0,1/10,12.38%,MAPK8IP3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.16492239967695443,-0.4125369282338993,1.0,1.0,1.0,3/10,28.82%,ANO6;NCKAP1L;CD300A
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.18871302992006522,0.4111550559842942,0.9957865168539326,1.0,1.0,6/13,28.72%,NFAT5;ZDHHC21;TRAF6;FUT9;RELA;ETS1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.13000818997684954,-0.4099715863641886,1.0,1.0,1.0,6/20,34.37%,ADRA1B;ADRA1A;ADRA2A;DRD2;PDE4D;ADRB2
prerank,tRNA wobble uridine modification (GO:0002098),-0.14360467933988041,-0.4088472180189284,1.0,0.999464352954279,1.0,1/14,3.41%,ELP3
prerank,cardiac cell development (GO:0055006),0.19106201355761984,0.4070762797893464,0.9939668174962293,1.0,1.0,11/11,80.91%,JAG1;CXADR;NOTCH1;ALPK2;MYH6;TCAP;ALPK3;TTN;SLC8A1;MYH11;VEGFA
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.17053283301896072,0.4065423729337071,0.9945945945945946,1.0,1.0,2/19,17.19%,RIC3;APOE
prerank,atrial septum development (GO:0003283),0.1773327784861074,0.3979382014075414,0.9971631205673759,1.0,1.0,1/13,9.14%,MDM4
prerank,negative regulation of T cell proliferation (GO:0042130),0.15441611037395672,0.3937395331813132,1.0,1.0,1.0,1/28,5.37%,SCRIB
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.1911608779721103,0.393305875892421,0.9969465648854962,1.0,1.0,3/10,24.20%,ATRX;INO80;SSBP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.17858263762475682,0.38925554009297747,0.9970887918486172,1.0,1.0,12/12,82.16%,CHEK2;RAD17;NAE1;TOPBP1;TICRR;CDC6;HUS1B;ORC1;SETMAR;CLSPN;HUS1;STK33
prerank,cellular copper ion homeostasis (GO:0006878),0.16905300940146523,0.38018727073676534,1.0,1.0,1.0,3/14,23.36%,APP;ATOX1;SLC31A1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.1357806588815706,0.37877298883416494,1.0,1.0,1.0,4/53,17.53%,ANXA1;HTR2C;CHRM2;HRH1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.1563023410332267,0.36083066601332786,0.9972451790633609,1.0,1.0,2/15,21.30%,HSPH1;GLI3
prerank,mitotic cytokinetic process (GO:1902410),0.1492748701391088,0.3574259093621934,1.0,0.9999772955747983,1.0,4/20,21.48%,CHMP3;VPS4B;CHMP4A;CHMP4B
prerank,sarcomere organization (GO:0045214),0.12459254378188495,0.3149375428943018,1.0,0.9999617530028881,1.0,25/27,64.17%,TPM1;CSRP2;CSRP3;WDR1;CSRP1;ANKRD1;MYOZ1;MYH3;TNNT1;LMOD2;TNNT2;MYOZ2;SYNPO2L;MYH6;OBSCN;TCAP;MYLK3;MYPN;CAPN3;CASQ1;TTN;KRT19;MYOM2;SIX4;TNNT3
